Uniprot-Accession,S2-Protein,0,3,5,7,9,11,13,15,E-value,Protein,Gene,Length,GO-BP,GO-IDs,Pathway,UniPathway,CDD,Pfam,GO-name
Q96BY7,CHOYP_ATG2A.1.1|m.57169,0,0,0,0,0,0,0,0,0,Autophagy-related protein 2 homolog B,ATG2B C14orf103,2078,autophagosome assembly [GO:0000045]; mitophagy [GO:0000422]; nucleophagy [GO:0044804],GO:0000045; GO:0000407; GO:0000422; GO:0005811; GO:0019898; GO:0034045; GO:0044804,,,,PF13329;PF09333;PF12624;,extrinsic component of membrane [GO:0019898]; lipid particle [GO:0005811]; pre-autophagosomal structure [GO:0000407]; pre-autophagosomal structure membrane [GO:0034045]; autophagosome assembly [GO:0000045]; mitophagy [GO:0000422]; nucleophagy [GO:0044804]
Q8VED2,CHOYP_BLOC1S4.1.1|m.22903,1,0,0,0,0,0,0,0,2.00E-25,Biogenesis of lysosome-related organelles complex 1 subunit 4 (BLOC-1 subunit 4) (Protein cappuccino homolog),Bloc1s4 Cno,215,anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; melanosome organization [GO:0032438]; neuromuscular process controlling balance [GO:0050885]; neuron projection development [GO:0031175]; platelet aggregation [GO:0070527],GO:0005737; GO:0008089; GO:0031083; GO:0031175; GO:0032438; GO:0048490; GO:0050885; GO:0070527; GO:1904115,,,,,axon cytoplasm [GO:1904115]; BLOC-1 complex [GO:0031083]; cytoplasm [GO:0005737]; anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; melanosome organization [GO:0032438]; neuromuscular process controlling balance [GO:0050885]; neuron projection development [GO:0031175]; platelet aggregation [GO:0070527]
Q6ZMT9,CHOYP_BRAFLDRAFT_123768.1.1|m.7223,3,0,0,0,0,0,0,0,8.00E-39,Death domain-containing protein 1,DTHD1,781,signal transduction [GO:0007165],GO:0007165,,,,PF00531;,signal transduction [GO:0007165]
Q1RMU2,CHOYP_BRAFLDRAFT_230143.1.1|m.15015,0.5,0,0,0,0,0,0,0,3.00E-174,Ubiquitin carboxyl-terminal hydrolase CYLD (EC 3.4.19.12) (Deubiquitinating enzyme CYLD) (Ubiquitin thioesterase CYLD) (Ubiquitin-specific-processing protease CYLD),CYLD CYLD1,953,"CD4-positive or CD8-positive, alpha-beta T cell lineage commitment [GO:0043369]; homeostasis of number of cells [GO:0048872]; innate immune response [GO:0045087]; necroptotic process [GO:0070266]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of NF-kappaB import into nucleus [GO:0042347]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of T cell differentiation [GO:0045581]; positive regulation of cellular protein localization [GO:1903829]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of T cell differentiation [GO:0045582]; positive regulation of T cell receptor signaling pathway [GO:0050862]; protein K63-linked deubiquitination [GO:0070536]; protein linear deubiquitination [GO:1990108]; regulation of B cell differentiation [GO:0045577]; regulation of cilium assembly [GO:1902017]; regulation of intrinsic apoptotic signaling pathway [GO:2001242]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of mitotic cell cycle [GO:0007346]; regulation of protein binding [GO:0043393]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]; ripoptosome assembly involved in necroptotic process [GO:1901026]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt signaling pathway [GO:0016055]",GO:0004843; GO:0005813; GO:0005819; GO:0005829; GO:0005881; GO:0006511; GO:0007346; GO:0008270; GO:0010803; GO:0016055; GO:0030496; GO:0031234; GO:0032088; GO:0036064; GO:0042347; GO:0043369; GO:0043393; GO:0045087; GO:0045577; GO:0045581; GO:0045582; GO:0048471; GO:0048872; GO:0050862; GO:0061578; GO:0070266; GO:0070507; GO:0070536; GO:0090090; GO:0097542; GO:1901026; GO:1902017; GO:1903829; GO:1990108; GO:1990380; GO:2001238; GO:2001242,,,,PF01302;PF00443;,"centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary tip [GO:0097542]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; midbody [GO:0030496]; perinuclear region of cytoplasm [GO:0048471]; spindle [GO:0005819]; Lys48-specific deubiquitinase activity [GO:1990380]; Lys63-specific deubiquitinase activity [GO:0061578]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; zinc ion binding [GO:0008270]; CD4-positive or CD8-positive, alpha-beta T cell lineage commitment [GO:0043369]; homeostasis of number of cells [GO:0048872]; innate immune response [GO:0045087]; necroptotic process [GO:0070266]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of NF-kappaB import into nucleus [GO:0042347]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of T cell differentiation [GO:0045581]; positive regulation of cellular protein localization [GO:1903829]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of T cell differentiation [GO:0045582]; positive regulation of T cell receptor signaling pathway [GO:0050862]; protein K63-linked deubiquitination [GO:0070536]; protein linear deubiquitination [GO:1990108]; regulation of B cell differentiation [GO:0045577]; regulation of cilium assembly [GO:1902017]; regulation of intrinsic apoptotic signaling pathway [GO:2001242]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of mitotic cell cycle [GO:0007346]; regulation of protein binding [GO:0043393]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]; ripoptosome assembly involved in necroptotic process [GO:1901026]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt signaling pathway [GO:0016055]"
P24044,CHOYP_CENTRIN.1.1|m.59526,0,0,0,0,0,0,0,0,8.00E-10,Calmodulin (CaM),,149,,GO:0005509,,,cd00051;,PF13499;,calcium ion binding [GO:0005509]
O16011,CHOYP_DYAK_GE11656.1.2|m.34706,0,0,0,0,0,0,0,0,3.00E-52,Protein muscleblind (Protein mindmelt),mbl mm CG33197,297,"apoptotic process [GO:0006915]; compound eye photoreceptor cell differentiation [GO:0001751]; embryo development [GO:0009790]; eye development [GO:0001654]; imaginal disc-derived wing morphogenesis [GO:0007476]; muscle cell cellular homeostasis [GO:0046716]; muscle organ development [GO:0007517]; peripheral nervous system development [GO:0007422]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of female receptivity [GO:0045924]; regulation of gene expression [GO:0010468]; response to stimulus [GO:0050896]; rhabdomere development [GO:0042052]; somatic muscle development [GO:0007525]; visual perception [GO:0007601]",GO:0000381; GO:0001654; GO:0001751; GO:0003676; GO:0003677; GO:0005634; GO:0005737; GO:0006915; GO:0007422; GO:0007476; GO:0007517; GO:0007525; GO:0007601; GO:0009790; GO:0010468; GO:0030018; GO:0031673; GO:0042052; GO:0045924; GO:0046716; GO:0046872; GO:0048471; GO:0050896,,,,,"cytoplasm [GO:0005737]; H zone [GO:0031673]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; Z disc [GO:0030018]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; apoptotic process [GO:0006915]; compound eye photoreceptor cell differentiation [GO:0001751]; embryo development [GO:0009790]; eye development [GO:0001654]; imaginal disc-derived wing morphogenesis [GO:0007476]; muscle cell cellular homeostasis [GO:0046716]; muscle organ development [GO:0007517]; peripheral nervous system development [GO:0007422]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of female receptivity [GO:0045924]; regulation of gene expression [GO:0010468]; response to stimulus [GO:0050896]; rhabdomere development [GO:0042052]; somatic muscle development [GO:0007525]; visual perception [GO:0007601]"
Q92630,CHOYP_EF1A.4.4|m.65743,2.5,0,0,0,0,0,0,0,0,Dual specificity tyrosine-phosphorylation-regulated kinase 2 (EC 2.7.12.1),DYRK2,601,cellular response to DNA damage stimulus [GO:0006974]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; negative regulation of NFAT protein import into nucleus [GO:0051534]; positive regulation of glycogen biosynthetic process [GO:0045725]; protein phosphorylation [GO:0006468]; regulation of signal transduction by p53 class mediator [GO:1901796]; smoothened signaling pathway [GO:0007224],GO:0000151; GO:0000287; GO:0004674; GO:0004712; GO:0004713; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006468; GO:0006974; GO:0007224; GO:0030145; GO:0030529; GO:0042771; GO:0043130; GO:0045725; GO:0051534; GO:1901796,,,,PF00069;,cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular ribonucleoprotein complex [GO:0030529]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; ubiquitin binding [GO:0043130]; cellular response to DNA damage stimulus [GO:0006974]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; negative regulation of NFAT protein import into nucleus [GO:0051534]; positive regulation of glycogen biosynthetic process [GO:0045725]; protein phosphorylation [GO:0006468]; regulation of signal transduction by p53 class mediator [GO:1901796]; smoothened signaling pathway [GO:0007224]
A2ASS6,CHOYP_HMCN1.5.44|m.7236,12,0,0,0,0,0,0,0,2.00E-135,Titin (EC 2.7.11.1) (Connectin),Ttn,35213,actin filament organization [GO:0007015]; adult heart development [GO:0007512]; cardiac muscle contraction [GO:0060048]; cardiac muscle fiber development [GO:0048739]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; regulation of catalytic activity [GO:0050790]; regulation of protein kinase activity [GO:0045859]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; striated muscle contraction [GO:0006941]; striated muscle myosin thick filament assembly [GO:0071688]; ventricular system development [GO:0021591],GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0006941; GO:0007015; GO:0007507; GO:0007512; GO:0008307; GO:0019899; GO:0019901; GO:0021591; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042805; GO:0043056; GO:0043621; GO:0045214; GO:0045859; GO:0048739; GO:0048769; GO:0050790; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0060048; GO:0060419; GO:0070062; GO:0071688; GO:0097493; GO:1901897,,,cd00063;,PF00041;PF07679;PF00069;PF02818;PF09042;,A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; extracellular exosome [GO:0070062]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein kinase binding [GO:0019901]; protein self-association [GO:0043621]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433]; actin filament organization [GO:0007015]; adult heart development [GO:0007512]; cardiac muscle contraction [GO:0060048]; cardiac muscle fiber development [GO:0048739]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; regulation of catalytic activity [GO:0050790]; regulation of protein kinase activity [GO:0045859]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; striated muscle contraction [GO:0006941]; striated muscle myosin thick filament assembly [GO:0071688]; ventricular system development [GO:0021591]
Q9W6R5,CHOYP_HMCN2.11.12|m.51619,0,0,0,0,0,0,0,0,2.00E-21,Retinoschisin (X-linked juvenile retinoschisis protein homolog),xlrs1,280,cell adhesion [GO:0007155],GO:0005576; GO:0007155; GO:0070492,,,,PF00754;,extracellular region [GO:0005576]; oligosaccharide binding [GO:0070492]; cell adhesion [GO:0007155]
Q60675,CHOYP_LAMA2.1.1|m.10439,0,0,0,0,0,0,0,0,0,Laminin subunit alpha-2 (Laminin M chain) (Laminin-12 subunit alpha) (Laminin-2 subunit alpha) (Laminin-4 subunit alpha) (Merosin heavy chain),Lama2,3118,"axon guidance [GO:0007411]; cell adhesion [GO:0007155]; extracellular matrix organization [GO:0030198]; positive regulation of synaptic transmission, cholinergic [GO:0032224]; regulation of cell adhesion [GO:0030155]; regulation of cell migration [GO:0030334]; regulation of embryonic development [GO:0045995]; Schwann cell differentiation [GO:0014037]",GO:0005576; GO:0005604; GO:0005605; GO:0005615; GO:0007155; GO:0007411; GO:0014037; GO:0030155; GO:0030198; GO:0030334; GO:0032224; GO:0042383; GO:0043197; GO:0045995; GO:0070062,,,,PF00052;PF00053;PF00054;PF02210;PF06008;PF06009;PF00055;,"basal lamina [GO:0005605]; basement membrane [GO:0005604]; dendritic spine [GO:0043197]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; sarcolemma [GO:0042383]; axon guidance [GO:0007411]; cell adhesion [GO:0007155]; extracellular matrix organization [GO:0030198]; positive regulation of synaptic transmission, cholinergic [GO:0032224]; regulation of cell adhesion [GO:0030155]; regulation of cell migration [GO:0030334]; regulation of embryonic development [GO:0045995]; Schwann cell differentiation [GO:0014037]"
Q28727,CHOYP_LOC100119310.1.1|m.22031,0,0,0,0,0,0,0,0,2.00E-44,"Ileal sodium/bile acid cotransporter (Apical sodium-dependent bile acid transporter) (ASBT) (Ileal Na(+)/bile acid cotransporter) (Ileal sodium-dependent bile acid transporter) (IBAT) (ISBT) (Na(+)-dependent ileal bile acid transporter) (Sodium/taurocholate cotransporting polypeptide, ileal) (Solute carrier family 10 member 2)",SLC10A2 NTCP2,347,,GO:0005902; GO:0008508; GO:0016021; GO:0016324,,,,PF01758;,apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]; microvillus [GO:0005902]; bile acid:sodium symporter activity [GO:0008508]
A0JPP8,CHOYP_LOC100373421.1.1|m.38932,1,0,0,0,0,0,0,0,2.00E-109,Coiled-coil domain-containing protein 61,Ccdc61,512,,GO:0005813,,,,,centrosome [GO:0005813]
P29590,CHOYP_LOC100377759.15.15|m.64824,0,0,0,0,0,0,0,0,0.000000005,Protein PML (Promyelocytic leukemia protein) (RING finger protein 71) (Tripartite motif-containing protein 19),PML MYL PP8675 RNF71 TRIM19,882,"activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; branching involved in mammary gland duct morphogenesis [GO:0060444]; cell cycle arrest [GO:0007050]; cell fate commitment [GO:0045165]; cellular response to interleukin-4 [GO:0071353]; cellular senescence [GO:0090398]; circadian regulation of gene expression [GO:0032922]; common-partner SMAD protein phosphorylation [GO:0007182]; defense response to virus [GO:0051607]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; entrainment of circadian clock by photoperiod [GO:0043153]; extrinsic apoptotic signaling pathway [GO:0097191]; fibroblast migration [GO:0010761]; innate immune response [GO:0045087]; interferon-gamma-mediated signaling pathway [GO:0060333]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; maintenance of protein location in nucleus [GO:0051457]; myeloid cell differentiation [GO:0030099]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell growth [GO:0030308]; negative regulation of cell proliferation [GO:0008285]; negative regulation of interleukin-1 beta secretion [GO:0050713]; negative regulation of mitotic cell cycle [GO:0045930]; negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process [GO:2000059]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of translation in response to oxidative stress [GO:0032938]; negative regulation of viral release from host cell [GO:1902187]; PML body organization [GO:0030578]; positive regulation of apoptotic process involved in mammary gland involution [GO:0060058]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of histone deacetylation [GO:0031065]; positive regulation of MHC class I biosynthetic process [GO:0045345]; positive regulation of protein localization to chromosome, telomeric region [GO:1904816]; positive regulation of telomere maintenance [GO:0032206]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein complex assembly [GO:0006461]; protein stabilization [GO:0050821]; protein targeting [GO:0006605]; regulation of calcium ion transport into cytosol [GO:0010522]; regulation of cell adhesion [GO:0030155]; regulation of circadian rhythm [GO:0042752]; regulation of double-strand break repair [GO:2000779]; regulation of protein phosphorylation [GO:0001932]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of transcription, DNA-templated [GO:0006355]; response to cytokine [GO:0034097]; response to gamma radiation [GO:0010332]; response to hypoxia [GO:0001666]; response to UV [GO:0009411]; retinoic acid receptor signaling pathway [GO:0048384]; SMAD protein import into nucleus [GO:0007184]; transcription, DNA-templated [GO:0006351]; transforming growth factor beta receptor signaling pathway [GO:0007179]; viral process [GO:0016032]",GO:0000784; GO:0001666; GO:0001932; GO:0002230; GO:0003677; GO:0003713; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006351; GO:0006355; GO:0006461; GO:0006605; GO:0006915; GO:0006919; GO:0006977; GO:0007050; GO:0007179; GO:0007182; GO:0007184; GO:0008270; GO:0008285; GO:0008630; GO:0008631; GO:0009411; GO:0010332; GO:0010522; GO:0010761; GO:0016032; GO:0016363; GO:0016525; GO:0016605; GO:0030099; GO:0030155; GO:0030308; GO:0030578; GO:0031065; GO:0031625; GO:0031901; GO:0031965; GO:0032183; GO:0032206; GO:0032211; GO:0032469; GO:0032922; GO:0032938; GO:0034097; GO:0042406; GO:0042752; GO:0042771; GO:0042803; GO:0043153; GO:0043161; GO:0045087; GO:0045165; GO:0045345; GO:0045892; GO:0045930; GO:0045944; GO:0046982; GO:0048146; GO:0048384; GO:0050713; GO:0050821; GO:0050897; GO:0051457; GO:0051607; GO:0051974; GO:0060058; GO:0060333; GO:0060444; GO:0070059; GO:0071353; GO:0090398; GO:0097191; GO:1901796; GO:1902187; GO:1904816; GO:2000059; GO:2000779; GO:2001238,,,,PF12126;PF00643;,"cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; extrinsic component of endoplasmic reticulum membrane [GO:0042406]; nuclear chromosome, telomeric region [GO:0000784]; nuclear matrix [GO:0016363]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; cobalt ion binding [GO:0050897]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; SUMO binding [GO:0032183]; transcription coactivator activity [GO:0003713]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; branching involved in mammary gland duct morphogenesis [GO:0060444]; cell cycle arrest [GO:0007050]; cell fate commitment [GO:0045165]; cellular response to interleukin-4 [GO:0071353]; cellular senescence [GO:0090398]; circadian regulation of gene expression [GO:0032922]; common-partner SMAD protein phosphorylation [GO:0007182]; defense response to virus [GO:0051607]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; entrainment of circadian clock by photoperiod [GO:0043153]; extrinsic apoptotic signaling pathway [GO:0097191]; fibroblast migration [GO:0010761]; innate immune response [GO:0045087]; interferon-gamma-mediated signaling pathway [GO:0060333]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; maintenance of protein location in nucleus [GO:0051457]; myeloid cell differentiation [GO:0030099]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell growth [GO:0030308]; negative regulation of cell proliferation [GO:0008285]; negative regulation of interleukin-1 beta secretion [GO:0050713]; negative regulation of mitotic cell cycle [GO:0045930]; negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process [GO:2000059]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of translation in response to oxidative stress [GO:0032938]; negative regulation of viral release from host cell [GO:1902187]; PML body organization [GO:0030578]; positive regulation of apoptotic process involved in mammary gland involution [GO:0060058]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of histone deacetylation [GO:0031065]; positive regulation of MHC class I biosynthetic process [GO:0045345]; positive regulation of protein localization to chromosome, telomeric region [GO:1904816]; positive regulation of telomere maintenance [GO:0032206]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein complex assembly [GO:0006461]; protein stabilization [GO:0050821]; protein targeting [GO:0006605]; regulation of calcium ion transport into cytosol [GO:0010522]; regulation of cell adhesion [GO:0030155]; regulation of circadian rhythm [GO:0042752]; regulation of double-strand break repair [GO:2000779]; regulation of protein phosphorylation [GO:0001932]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of transcription, DNA-templated [GO:0006355]; response to cytokine [GO:0034097]; response to gamma radiation [GO:0010332]; response to hypoxia [GO:0001666]; response to UV [GO:0009411]; retinoic acid receptor signaling pathway [GO:0048384]; SMAD protein import into nucleus [GO:0007184]; transcription, DNA-templated [GO:0006351]; transforming growth factor beta receptor signaling pathway [GO:0007179]; viral process [GO:0016032]"
Q96LI9,CHOYP_LOC100377974.1.1|m.6543,0.5,0,0,0,0,0,0,0,7.00E-75,Putative uncharacterized protein CXorf58,CXorf58,332,,,,,,,
Q99PL6,CHOYP_LOC100524481.1.1|m.14740,0,0,0,0,0,0,0,0,3.00E-102,UBX domain-containing protein 6 (UBX domain-containing protein 1),Ubxn6 Ubxd1 Ubxdc2,442,,GO:0005634; GO:0005737; GO:0005815; GO:0070062,,,,PF09409;PF00789;,cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]
O01393,CHOYP_LOC100533356.6.6|m.63561,0,0,0,0,0,0,0,0,2.00E-94,Innexin unc-9 (Uncoordinated protein 9),unc-9 R12H7.1,386,ion transmembrane transport [GO:0034220],GO:0005243; GO:0005886; GO:0005911; GO:0005921; GO:0016021; GO:0034220; GO:0055077,,,,PF00876;,cell-cell junction [GO:0005911]; gap junction [GO:0005921]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; gap junction channel activity [GO:0005243]; gap junction hemi-channel activity [GO:0055077]; ion transmembrane transport [GO:0034220]
Q5TFE4,CHOYP_LOC100556034.2.2|m.15378,0.5,0,0,0,0,0,0,0,1.00E-99,5'-nucleotidase domain-containing protein 1 (EC 3.1.3.-),NT5DC1 NT5C2L1 LP2642,455,,GO:0008253; GO:0046872,,,,PF05761;,5'-nucleotidase activity [GO:0008253]; metal ion binding [GO:0046872]
Q6PEE2,CHOYP_LOC100726220.1.1|m.8701,0.5,0,0,0,0,0,0,0,3.00E-40,CBP80/20-dependent translation initiation factor,Ctif Gm672 Kiaa0427,600,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; regulation of translational initiation [GO:0006446]",GO:0000184; GO:0003723; GO:0005829; GO:0006446; GO:0048471,,,,PF02854;,"cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]; RNA binding [GO:0003723]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; regulation of translational initiation [GO:0006446]"
Q14642,CHOYP_LOC100743250.1.1|m.12309,0.5,0,0,0,0,0,0,0,2.00E-133,"Type I inositol 1,4,5-trisphosphate 5-phosphatase (5PTase) (EC 3.1.3.56)",INPP5A,412,inositol phosphate dephosphorylation [GO:0046855]; inositol phosphate-mediated signaling [GO:0048016]; inositol phosphate metabolic process [GO:0043647]; phosphatidylinositol dephosphorylation [GO:0046856],GO:0004445; GO:0005622; GO:0005886; GO:0016020; GO:0042731; GO:0043647; GO:0046855; GO:0046856; GO:0048016; GO:0052658; GO:0052659; GO:0070062,,,,,"extracellular exosome [GO:0070062]; intracellular [GO:0005622]; membrane [GO:0016020]; plasma membrane [GO:0005886]; inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity [GO:0052659]; inositol-1,4,5-trisphosphate 5-phosphatase activity [GO:0052658]; inositol-polyphosphate 5-phosphatase activity [GO:0004445]; PH domain binding [GO:0042731]; inositol phosphate dephosphorylation [GO:0046855]; inositol phosphate metabolic process [GO:0043647]; inositol phosphate-mediated signaling [GO:0048016]; phosphatidylinositol dephosphorylation [GO:0046856]"
Q01538,CHOYP_LOC101167938.1.1|m.27316,0,0,0,0,0,0,0,0,1.00E-49,Myelin transcription factor 1 (MyT1) (Myelin transcription factor I) (MyTI) (PLPB1) (Proteolipid protein-binding protein),MYT1 KIAA0835 KIAA1050 MTF1 MYTI PLPB1,1121,"cell differentiation [GO:0030154]; nervous system development [GO:0007399]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]",GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005829; GO:0006351; GO:0006355; GO:0007399; GO:0008270; GO:0030154,,,,PF08474;PF01530;,"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; transcription factor activity, sequence-specific DNA binding [GO:0003700]; zinc ion binding [GO:0008270]; cell differentiation [GO:0030154]; nervous system development [GO:0007399]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]"
Q9D0R4,CHOYP_LOC101168798.1.1|m.6128,0,0,0,0,0,0,0,0,0,Probable ATP-dependent RNA helicase DDX56 (EC 3.6.4.13) (ATP-dependent 61 kDa nucleolar RNA helicase) (DEAD box protein 56),Ddx56 D11Ertd619e Noh61,546,positive regulation of neuron projection development [GO:0010976]; RNA secondary structure unwinding [GO:0010501]; rRNA processing [GO:0006364],GO:0003723; GO:0004004; GO:0005524; GO:0005730; GO:0006364; GO:0010501; GO:0010976; GO:0016020,,,,PF00270;PF00271;,membrane [GO:0016020]; nucleolus [GO:0005730]; ATP binding [GO:0005524]; ATP-dependent RNA helicase activity [GO:0004004]; RNA binding [GO:0003723]; positive regulation of neuron projection development [GO:0010976]; RNA secondary structure unwinding [GO:0010501]; rRNA processing [GO:0006364]
Q0P5A2,CHOYP_LOC585972.1.1|m.25356,0.5,0,0,0,0,0,0,0,5.00E-120,"2-methoxy-6-polyprenyl-1,4-benzoquinol methylase, mitochondrial (EC 2.1.1.201) (Ubiquinone biosynthesis methyltransferase COQ5)",COQ5,330,ubiquinone biosynthetic process [GO:0006744],GO:0005743; GO:0006744; GO:0102005,PATHWAY: Cofactor biosynthesis; ubiquinone biosynthesis. {ECO:0000255|HAMAP-Rule:MF_03191}.,,,PF01209;,"mitochondrial inner membrane [GO:0005743]; 2-octaprenyl-6-methoxy-1,4-benzoquinone methylase activity [GO:0102005]; ubiquinone biosynthetic process [GO:0006744]"
A2ASS6,CHOYP_PHUM_PHUM226120.6.7|m.48915,0,0,0,0,0,0,0,0,0,Titin (EC 2.7.11.1) (Connectin),Ttn,35213,actin filament organization [GO:0007015]; adult heart development [GO:0007512]; cardiac muscle contraction [GO:0060048]; cardiac muscle fiber development [GO:0048739]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; regulation of catalytic activity [GO:0050790]; regulation of protein kinase activity [GO:0045859]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; striated muscle contraction [GO:0006941]; striated muscle myosin thick filament assembly [GO:0071688]; ventricular system development [GO:0021591],GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0006941; GO:0007015; GO:0007507; GO:0007512; GO:0008307; GO:0019899; GO:0019901; GO:0021591; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042805; GO:0043056; GO:0043621; GO:0045214; GO:0045859; GO:0048739; GO:0048769; GO:0050790; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0060048; GO:0060419; GO:0070062; GO:0071688; GO:0097493; GO:1901897,,,cd00063;,PF00041;PF07679;PF00069;PF02818;PF09042;,A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; extracellular exosome [GO:0070062]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein kinase binding [GO:0019901]; protein self-association [GO:0043621]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433]; actin filament organization [GO:0007015]; adult heart development [GO:0007512]; cardiac muscle contraction [GO:0060048]; cardiac muscle fiber development [GO:0048739]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; regulation of catalytic activity [GO:0050790]; regulation of protein kinase activity [GO:0045859]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; striated muscle contraction [GO:0006941]; striated muscle myosin thick filament assembly [GO:0071688]; ventricular system development [GO:0021591]
Q6YI48,CHOYP_PTPRK.17.20|m.60780,0,0,0,0,0,0,0,0,3.00E-145,Receptor-type tyrosine-protein phosphatase U (R-PTP-U) (EC 3.1.3.48) (Receptor-type protein-tyrosine phosphatase psi) (R-PTP-psi) (cRPTPPSI),PTPRU RPTPPSI,1434,cell adhesion [GO:0007155]; cell differentiation [GO:0030154],GO:0004725; GO:0005886; GO:0007155; GO:0016021; GO:0030054; GO:0030154,,,cd00063;cd06263;,PF00041;PF00629;PF00102;,cell junction [GO:0030054]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; protein tyrosine phosphatase activity [GO:0004725]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]
Q6INX1,CHOYP_TMM98.1.1|m.51750,0,0,0,0,0,0,0,0,7.00E-68,Transmembrane protein 98,tmem98,226,,GO:0016021,,,,,integral component of membrane [GO:0016021]
P29590,CHOYP_TRIM56.2.2|m.59948,1,0,0,0,0,0,0,0,0.000008,Protein PML (Promyelocytic leukemia protein) (RING finger protein 71) (Tripartite motif-containing protein 19),PML MYL PP8675 RNF71 TRIM19,882,"activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; branching involved in mammary gland duct morphogenesis [GO:0060444]; cell cycle arrest [GO:0007050]; cell fate commitment [GO:0045165]; cellular response to interleukin-4 [GO:0071353]; cellular senescence [GO:0090398]; circadian regulation of gene expression [GO:0032922]; common-partner SMAD protein phosphorylation [GO:0007182]; defense response to virus [GO:0051607]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; entrainment of circadian clock by photoperiod [GO:0043153]; extrinsic apoptotic signaling pathway [GO:0097191]; fibroblast migration [GO:0010761]; innate immune response [GO:0045087]; interferon-gamma-mediated signaling pathway [GO:0060333]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; maintenance of protein location in nucleus [GO:0051457]; myeloid cell differentiation [GO:0030099]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell growth [GO:0030308]; negative regulation of cell proliferation [GO:0008285]; negative regulation of interleukin-1 beta secretion [GO:0050713]; negative regulation of mitotic cell cycle [GO:0045930]; negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process [GO:2000059]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of translation in response to oxidative stress [GO:0032938]; negative regulation of viral release from host cell [GO:1902187]; PML body organization [GO:0030578]; positive regulation of apoptotic process involved in mammary gland involution [GO:0060058]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of histone deacetylation [GO:0031065]; positive regulation of MHC class I biosynthetic process [GO:0045345]; positive regulation of protein localization to chromosome, telomeric region [GO:1904816]; positive regulation of telomere maintenance [GO:0032206]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein complex assembly [GO:0006461]; protein stabilization [GO:0050821]; protein targeting [GO:0006605]; regulation of calcium ion transport into cytosol [GO:0010522]; regulation of cell adhesion [GO:0030155]; regulation of circadian rhythm [GO:0042752]; regulation of double-strand break repair [GO:2000779]; regulation of protein phosphorylation [GO:0001932]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of transcription, DNA-templated [GO:0006355]; response to cytokine [GO:0034097]; response to gamma radiation [GO:0010332]; response to hypoxia [GO:0001666]; response to UV [GO:0009411]; retinoic acid receptor signaling pathway [GO:0048384]; SMAD protein import into nucleus [GO:0007184]; transcription, DNA-templated [GO:0006351]; transforming growth factor beta receptor signaling pathway [GO:0007179]; viral process [GO:0016032]",GO:0000784; GO:0001666; GO:0001932; GO:0002230; GO:0003677; GO:0003713; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006351; GO:0006355; GO:0006461; GO:0006605; GO:0006915; GO:0006919; GO:0006977; GO:0007050; GO:0007179; GO:0007182; GO:0007184; GO:0008270; GO:0008285; GO:0008630; GO:0008631; GO:0009411; GO:0010332; GO:0010522; GO:0010761; GO:0016032; GO:0016363; GO:0016525; GO:0016605; GO:0030099; GO:0030155; GO:0030308; GO:0030578; GO:0031065; GO:0031625; GO:0031901; GO:0031965; GO:0032183; GO:0032206; GO:0032211; GO:0032469; GO:0032922; GO:0032938; GO:0034097; GO:0042406; GO:0042752; GO:0042771; GO:0042803; GO:0043153; GO:0043161; GO:0045087; GO:0045165; GO:0045345; GO:0045892; GO:0045930; GO:0045944; GO:0046982; GO:0048146; GO:0048384; GO:0050713; GO:0050821; GO:0050897; GO:0051457; GO:0051607; GO:0051974; GO:0060058; GO:0060333; GO:0060444; GO:0070059; GO:0071353; GO:0090398; GO:0097191; GO:1901796; GO:1902187; GO:1904816; GO:2000059; GO:2000779; GO:2001238,,,,PF12126;PF00643;,"cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; extrinsic component of endoplasmic reticulum membrane [GO:0042406]; nuclear chromosome, telomeric region [GO:0000784]; nuclear matrix [GO:0016363]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; cobalt ion binding [GO:0050897]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; SUMO binding [GO:0032183]; transcription coactivator activity [GO:0003713]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; branching involved in mammary gland duct morphogenesis [GO:0060444]; cell cycle arrest [GO:0007050]; cell fate commitment [GO:0045165]; cellular response to interleukin-4 [GO:0071353]; cellular senescence [GO:0090398]; circadian regulation of gene expression [GO:0032922]; common-partner SMAD protein phosphorylation [GO:0007182]; defense response to virus [GO:0051607]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; entrainment of circadian clock by photoperiod [GO:0043153]; extrinsic apoptotic signaling pathway [GO:0097191]; fibroblast migration [GO:0010761]; innate immune response [GO:0045087]; interferon-gamma-mediated signaling pathway [GO:0060333]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; maintenance of protein location in nucleus [GO:0051457]; myeloid cell differentiation [GO:0030099]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell growth [GO:0030308]; negative regulation of cell proliferation [GO:0008285]; negative regulation of interleukin-1 beta secretion [GO:0050713]; negative regulation of mitotic cell cycle [GO:0045930]; negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process [GO:2000059]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of translation in response to oxidative stress [GO:0032938]; negative regulation of viral release from host cell [GO:1902187]; PML body organization [GO:0030578]; positive regulation of apoptotic process involved in mammary gland involution [GO:0060058]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of histone deacetylation [GO:0031065]; positive regulation of MHC class I biosynthetic process [GO:0045345]; positive regulation of protein localization to chromosome, telomeric region [GO:1904816]; positive regulation of telomere maintenance [GO:0032206]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein complex assembly [GO:0006461]; protein stabilization [GO:0050821]; protein targeting [GO:0006605]; regulation of calcium ion transport into cytosol [GO:0010522]; regulation of cell adhesion [GO:0030155]; regulation of circadian rhythm [GO:0042752]; regulation of double-strand break repair [GO:2000779]; regulation of protein phosphorylation [GO:0001932]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of transcription, DNA-templated [GO:0006355]; response to cytokine [GO:0034097]; response to gamma radiation [GO:0010332]; response to hypoxia [GO:0001666]; response to UV [GO:0009411]; retinoic acid receptor signaling pathway [GO:0048384]; SMAD protein import into nucleus [GO:0007184]; transcription, DNA-templated [GO:0006351]; transforming growth factor beta receptor signaling pathway [GO:0007179]; viral process [GO:0016032]"
Q6DUZ9,CHOYP_TSSC1.1.1|m.66470,0,0,0,0,0,0,0,0,0,Protein TSSC1,TSSC1 GekBS030P,387,,,,,,PF00400;,
Q3KRG3,CHOYP_BRAFLDRAFT_215413.1.1|m.2004,0,0,0,0,0,0,0,0,2.00E-33,Pre-rRNA-processing protein TSR2 homolog,tsr2 dt1p1a10l zgc:109784,181,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]",GO:0000462; GO:0005634,,,,PF10273;,"nucleus [GO:0005634]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]"
Q6NZJ6,CHOYP_BRAFLDRAFT_277494.1.3|m.54113,0,0,0,0,0,0,0,0,6.00E-105,Eukaryotic translation initiation factor 4 gamma 1 (eIF-4-gamma 1) (eIF-4G 1) (eIF-4G1),Eif4g1,1600,behavioral fear response [GO:0001662]; cellular macromolecule biosynthetic process [GO:0034645]; lung development [GO:0030324]; mitochondrion organization [GO:0007005]; negative regulation of autophagy [GO:0010507]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; positive regulation of cell growth [GO:0030307]; positive regulation of cell proliferation [GO:0008284]; positive regulation of cellular protein metabolic process [GO:0032270]; positive regulation of energy homeostasis [GO:2000507]; positive regulation of eukaryotic translation initiation factor 4F complex assembly [GO:1905537]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of miRNA mediated inhibition of translation [GO:1905618]; positive regulation of mRNA cap binding [GO:1905612]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; regulation of polysome binding [GO:1905696]; regulation of presynapse assembly [GO:1905606]; regulation of translational initiation [GO:0006446]; response to ethanol [GO:0045471]; translation [GO:0006412],GO:0001662; GO:0003723; GO:0003729; GO:0003743; GO:0005524; GO:0005634; GO:0005737; GO:0005844; GO:0005913; GO:0006412; GO:0006446; GO:0007005; GO:0008135; GO:0008190; GO:0008284; GO:0010507; GO:0010801; GO:0016020; GO:0016281; GO:0030307; GO:0030324; GO:0032270; GO:0033138; GO:0034645; GO:0045471; GO:0045666; GO:0098641; GO:1900087; GO:1905537; GO:1905606; GO:1905612; GO:1905618; GO:1905696; GO:2000507,,,,PF02847;PF02854;PF02020;,"cell-cell adherens junction [GO:0005913]; cytoplasm [GO:0005737]; eukaryotic translation initiation factor 4F complex [GO:0016281]; membrane [GO:0016020]; nucleus [GO:0005634]; polysome [GO:0005844]; ATP binding [GO:0005524]; cadherin binding involved in cell-cell adhesion [GO:0098641]; eukaryotic initiation factor 4E binding [GO:0008190]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; translation factor activity, RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]; behavioral fear response [GO:0001662]; cellular macromolecule biosynthetic process [GO:0034645]; lung development [GO:0030324]; mitochondrion organization [GO:0007005]; negative regulation of autophagy [GO:0010507]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; positive regulation of cell growth [GO:0030307]; positive regulation of cell proliferation [GO:0008284]; positive regulation of cellular protein metabolic process [GO:0032270]; positive regulation of energy homeostasis [GO:2000507]; positive regulation of eukaryotic translation initiation factor 4F complex assembly [GO:1905537]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of miRNA mediated inhibition of translation [GO:1905618]; positive regulation of mRNA cap binding [GO:1905612]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; regulation of polysome binding [GO:1905696]; regulation of presynapse assembly [GO:1905606]; regulation of translational initiation [GO:0006446]; response to ethanol [GO:0045471]; translation [GO:0006412]"
Q6ZV70,CHOYP_BRAFLDRAFT_76662.3.3|m.61577,1,0,0,0,0,0,0,0,4.00E-120,LanC-like protein 3,LANCL3,420,signal transduction [GO:0007165],GO:0003824; GO:0005886; GO:0007165,,,cd04794;,PF05147;,plasma membrane [GO:0005886]; catalytic activity [GO:0003824]; signal transduction [GO:0007165]
Q5HZB6,CHOYP_CLASR.1.2|m.27688,0.5,0,0,0,0,0,0,0,4.00E-102,"CLK4-associating serine/arginine rich protein (Splicing factor, arginine/serine-rich 16)",Clasrp Sfrs16,668,mRNA processing [GO:0006397]; RNA splicing [GO:0008380],GO:0005634; GO:0006397; GO:0008380,,,,PF09750;,nucleus [GO:0005634]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]
Q07008,CHOYP_DNER.1.1|m.28378,0,0,0,0,0,0,0,0,2.00E-20,Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)],Notch1,2531,"animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; auditory receptor cell fate commitment [GO:0009912]; axonogenesis [GO:0007409]; brain development [GO:0007420]; branching morphogenesis of an epithelial tube [GO:0048754]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell proliferation [GO:0060038]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac vascular smooth muscle cell development [GO:0060948]; cell differentiation in spinal cord [GO:0021515]; cell fate specification [GO:0001708]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary vein morphogenesis [GO:0003169]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; endocardial cell differentiation [GO:0060956]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart looping [GO:0001947]; humoral immune response [GO:0006959]; inflammatory response to antigenic stimulus [GO:0002437]; interleukin-4 secretion [GO:0072602]; in utero embryonic development [GO:0001701]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of auditory receptor cell differentiation [GO:0045608]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell proliferation [GO:0008285]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; neural tube development [GO:0021915]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation [GO:0003270]; oligodendrocyte differentiation [GO:0048709]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process [GO:0043065]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of glial cell differentiation [GO:0045687]; positive regulation of JAK-STAT cascade [GO:0046427]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061419]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of viral genome replication [GO:0045070]; prostate gland epithelium morphogenesis [GO:0060740]; pulmonary valve morphogenesis [GO:0003184]; regulation of cardioblast proliferation [GO:0003264]; regulation of cell proliferation [GO:0042127]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of somitogenesis [GO:0014807]; regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation [GO:0003256]; response to corticosteroid [GO:0031960]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; tissue regeneration [GO:0042246]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222]",GO:0000122; GO:0001047; GO:0001190; GO:0001669; GO:0001701; GO:0001708; GO:0001726; GO:0001889; GO:0001947; GO:0002040; GO:0002052; GO:0002193; GO:0002437; GO:0003160; GO:0003162; GO:0003169; GO:0003180; GO:0003184; GO:0003192; GO:0003198; GO:0003213; GO:0003214; GO:0003219; GO:0003222; GO:0003241; GO:0003256; GO:0003264; GO:0003270; GO:0003273; GO:0003344; GO:0003700; GO:0004857; GO:0004872; GO:0005509; GO:0005634; GO:0005783; GO:0005794; GO:0005856; GO:0005886; GO:0005912; GO:0006959; GO:0007219; GO:0007221; GO:0007283; GO:0007386; GO:0007409; GO:0007420; GO:0007440; GO:0007492; GO:0008285; GO:0009912; GO:0009986; GO:0010718; GO:0010812; GO:0010832; GO:0014031; GO:0014807; GO:0016021; GO:0016324; GO:0019899; GO:0021515; GO:0021915; GO:0030027; GO:0030216; GO:0030324; GO:0030335; GO:0030513; GO:0030514; GO:0030900; GO:0031069; GO:0031100; GO:0031490; GO:0031960; GO:0032495; GO:0032496; GO:0035116; GO:0035148; GO:0035914; GO:0035924; GO:0042127; GO:0042246; GO:0043065; GO:0043086; GO:0043235; GO:0043565; GO:0045070; GO:0045603; GO:0045608; GO:0045618; GO:0045662; GO:0045665; GO:0045668; GO:0045687; GO:0045747; GO:0045893; GO:0045944; GO:0045955; GO:0046427; GO:0046533; GO:0048103; GO:0048708; GO:0048709; GO:0048711; GO:0048715; GO:0048754; GO:0050679; GO:0050768; GO:0060038; GO:0060045; GO:0060253; GO:0060271; GO:0060412; GO:0060528; GO:0060740; GO:0060768; GO:0060842; GO:0060843; GO:0060948; GO:0060956; GO:0060979; GO:0060982; GO:0061314; GO:0061419; GO:0070986; GO:0071372; GO:0072017; GO:0072044; GO:0072144; GO:0072602; GO:0090051; GO:0090090; GO:0097150; GO:1901201; GO:1902263; GO:1903849; GO:2000737; GO:2000811; GO:2000974; GO:2001027,,,,PF12796;PF11936;PF00008;PF07645;PF12661;PF06816;PF07684;PF00066;,"acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; cytoskeleton [GO:0005856]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; lamellipodium [GO:0030027]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ruffle [GO:0001726]; calcium ion binding [GO:0005509]; chromatin DNA binding [GO:0031490]; core promoter binding [GO:0001047]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; receptor activity [GO:0004872]; sequence-specific DNA binding [GO:0043565]; transcription factor activity, sequence-specific DNA binding [GO:0003700]; transcriptional activator activity, RNA polymerase II transcription factor binding [GO:0001190]; animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; auditory receptor cell fate commitment [GO:0009912]; axonogenesis [GO:0007409]; brain development [GO:0007420]; branching morphogenesis of an epithelial tube [GO:0048754]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell proliferation [GO:0060038]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac vascular smooth muscle cell development [GO:0060948]; cell differentiation in spinal cord [GO:0021515]; cell fate specification [GO:0001708]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary vein morphogenesis [GO:0003169]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; endocardial cell differentiation [GO:0060956]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart looping [GO:0001947]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; interleukin-4 secretion [GO:0072602]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of auditory receptor cell differentiation [GO:0045608]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell proliferation [GO:0008285]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; neural tube development [GO:0021915]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation [GO:0003270]; oligodendrocyte differentiation [GO:0048709]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process [GO:0043065]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of glial cell differentiation [GO:0045687]; positive regulation of JAK-STAT cascade [GO:0046427]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061419]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of viral genome replication [GO:0045070]; prostate gland epithelium morphogenesis [GO:0060740]; pulmonary valve morphogenesis [GO:0003184]; regulation of cardioblast proliferation [GO:0003264]; regulation of cell proliferation [GO:0042127]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of somitogenesis [GO:0014807]; regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation [GO:0003256]; response to corticosteroid [GO:0031960]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; tissue regeneration [GO:0042246]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222]"
Q61493,CHOYP_DPOLZ.1.1|m.49299,0,0,0,0,0,0,0,0,0,DNA polymerase zeta catalytic subunit (EC 2.7.7.7) (Protein reversionless 3-like) (REV3-like) (Seizure-related protein 4),Rev3l Polz Sez4,3122,DNA repair [GO:0006281]; DNA replication [GO:0006260]; error-prone translesion synthesis [GO:0042276],GO:0000166; GO:0003677; GO:0003887; GO:0005730; GO:0006260; GO:0006281; GO:0008408; GO:0016035; GO:0042276; GO:0046872; GO:0051539,,,,PF00136;PF03104;PF15735;PF14260;,"nucleolus [GO:0005730]; zeta DNA polymerase complex [GO:0016035]; 3'-5' exonuclease activity [GO:0008408]; 4 iron, 4 sulfur cluster binding [GO:0051539]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; error-prone translesion synthesis [GO:0042276]"
Q8CIY2,CHOYP_DUOX1.1.4|m.14285,0.5,0,0,0,0,0,0,0,0,Dual oxidase 1 (EC 1.11.1.-) (EC 1.6.3.1),Duox1,1551,cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590],GO:0004601; GO:0005509; GO:0006590; GO:0006979; GO:0016021; GO:0016174; GO:0016324; GO:0019221; GO:0020037; GO:0042335; GO:0042446; GO:0042744; GO:0050665; GO:0051591,PATHWAY: Hormone biosynthesis; thyroid hormone biosynthesis.,,cd00051;,PF03098;PF00036;PF08022;PF01794;PF08030;,apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; heme binding [GO:0020037]; NAD(P)H oxidase activity [GO:0016174]; peroxidase activity [GO:0004601]; cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]
A0JNG4,CHOYP_LOC100374974.12.16|m.47308,0,0,0,0,0,0,0,0,0.000000007,RING finger protein 207,RNF207,556,,GO:0005737; GO:0008270,,,,PF00643;PF00097;,cytoplasm [GO:0005737]; zinc ion binding [GO:0008270]
Q2NL11,CHOYP_LOC100378269.1.2|m.12226,2,0,0,0,0,0,0,0,2.00E-24,Uncharacterized protein C8orf74 homolog,,293,,,,,,PF14769;,
Q7T006,CHOYP_LOC588739.1.1|m.19304,0,0,0,0,0,0,0,0,0,Telomere length regulation protein TEL2 homolog,telo2 si:ch211-153c20.2 zgc:153824,822,,GO:0005634; GO:0005737; GO:0016020,,,,PF10193;,cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634]
C3YWU0,CHOYP_LOC660225.1.1|m.35196,0,0,0,0,0,0,0,0,2.00E-159,Alpha-L-fucosidase (EC 3.2.1.51) (Alpha-L-fucoside fucohydrolase),BRAFLDRAFT_56888,449,fucose metabolic process [GO:0006004],GO:0004560; GO:0005576; GO:0006004,,,,PF01120;PF16757;,extracellular region [GO:0005576]; alpha-L-fucosidase activity [GO:0004560]; fucose metabolic process [GO:0006004]
O07552,CHOYP_NEMVEDRAFT_V1G236573.1.2|m.46431,0,0,0,0,0,0,0,0,1.00E-11,Stress response protein NhaX,nhaX yheK BSU09690,166,response to stress [GO:0006950],GO:0006950,,,,PF00582;,response to stress [GO:0006950]
Q9QUM7,CHOYP_NEMVEDRAFT_V1G238590.1.1|m.49168,1,0,0,0,0,0,0,0,0,MutS protein homolog 5,Msh5,833,female gamete generation [GO:0007292]; meiosis I [GO:0007127]; mismatch repair [GO:0006298]; synapsis [GO:0007129],GO:0000795; GO:0005524; GO:0005654; GO:0006298; GO:0007127; GO:0007129; GO:0007292; GO:0030983,,,,PF05192;PF05190;PF00488;,nucleoplasm [GO:0005654]; synaptonemal complex [GO:0000795]; ATP binding [GO:0005524]; mismatched DNA binding [GO:0030983]; female gamete generation [GO:0007292]; meiosis I [GO:0007127]; mismatch repair [GO:0006298]; synapsis [GO:0007129]
P35992,CHOYP_PTPRB.4.4|m.66782,0,0,0,0,0,0,0,0,2.00E-88,Tyrosine-protein phosphatase 10D (EC 3.1.3.48) (Receptor-linked protein-tyrosine phosphatase 10D) (DPTP10D),Ptp10D CG1817,1990,axon guidance [GO:0007411]; central nervous system development [GO:0007417]; long-term memory [GO:0007616]; motor neuron axon guidance [GO:0008045]; open tracheal system development [GO:0007424]; protein dephosphorylation [GO:0006470],GO:0004721; GO:0004725; GO:0005001; GO:0005886; GO:0006470; GO:0007411; GO:0007417; GO:0007424; GO:0007616; GO:0008045; GO:0016021; GO:0030424; GO:0045177,,,cd00063;,PF00041;PF00102;,apical part of cell [GO:0045177]; axon [GO:0030424]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; phosphoprotein phosphatase activity [GO:0004721]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; axon guidance [GO:0007411]; central nervous system development [GO:0007417]; long-term memory [GO:0007616]; motor neuron axon guidance [GO:0008045]; open tracheal system development [GO:0007424]; protein dephosphorylation [GO:0006470]
P82596,CHOYP_AJL2.1.1|m.26431,0,0,0,0,0,0,0,0,3.00E-21,Perlucin,,155,,GO:0030246,,,,PF00059;,carbohydrate binding [GO:0030246]
Q9CQ46,CHOYP_BRAFLDRAFT_122339.1.1|m.58748,1.5,0,0,0,0,0,0,0,7.00E-73,EF-hand calcium-binding domain-containing protein 2,Efcab2,164,,GO:0005509,,,,,calcium ion binding [GO:0005509]
Q4R8M9,CHOYP_BRAFLDRAFT_124130.2.3|m.30247,0,0,0,0,0,0,0,0,2.00E-21,Gametocyte-specific factor 1 (Protein FAM112B),GTSF1 FAM112B QtsA-12026,167,cell differentiation [GO:0030154]; spermatogenesis [GO:0007283],GO:0005737; GO:0007283; GO:0030154; GO:0046872,,,,PF05253;,cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; cell differentiation [GO:0030154]; spermatogenesis [GO:0007283]
Q7ZTY7,CHOYP_BRAFLDRAFT_125999.1.1|m.24819,0,0,0,0,0,0,0,0,4.00E-49,Vesicle transport protein USE1 (USE1-like protein),use1 use1l zgc:56402,258,protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192],GO:0005789; GO:0015031; GO:0016021; GO:0016192,,,,PF09753;,endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]
Q503Y4,CHOYP_BRAFLDRAFT_126058.1.1|m.1201,0.5,0,0,0,0,0,0,0,2.00E-72,Esterase OVCA2 (EC 3.1.2.-) (Ovarian cancer-associated gene 2 protein homolog),ovca2 zgc:110011,227,,GO:0016787,,,,PF03959;,hydrolase activity [GO:0016787]
Q61549,CHOYP_BRAFLDRAFT_98740.5.7|m.58200,0,0,0,0,0,0,0,0,7.00E-43,Adhesion G protein-coupled receptor E1 (Cell surface glycoprotein F4/80) (EGF-like module receptor 1) (EGF-like module-containing mucin-like hormone receptor-like 1) (EMR1 hormone receptor),Adgre1 Emr1 Gpf480,931,adaptive immune response [GO:0002250]; cell surface receptor signaling pathway [GO:0007166],GO:0002250; GO:0004930; GO:0005509; GO:0005886; GO:0007166; GO:0009897; GO:0016021; GO:0071944,,,,PF00002;PF12662;PF07645;PF01825;,cell periphery [GO:0071944]; external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; G-protein coupled receptor activity [GO:0004930]; adaptive immune response [GO:0002250]; cell surface receptor signaling pathway [GO:0007166]
Q9QZQ1,CHOYP_CBR-LET-2.2.2|m.44682,0,0,0,0,0,0,0,0,0.0000004,Afadin (Afadin adherens junction formation factor) (Protein Af-6),Afdn Af6 Mllt4,1820,adherens junction maintenance [GO:0034334]; brain morphogenesis [GO:0048854]; cell adhesion [GO:0007155]; cerebral cortex development [GO:0021987]; establishment of endothelial intestinal barrier [GO:0090557]; homeostasis of number of cells [GO:0048872]; neuroepithelial cell differentiation [GO:0060563]; positive regulation of GTPase activity [GO:0043547]; protein localization to cell junction [GO:1902414]; radial glial cell differentiation [GO:0060019]; regulation of oligodendrocyte progenitor proliferation [GO:0070445]; regulation of protein localization [GO:0032880]; signal transduction [GO:0007165]; telencephalon development [GO:0021537],GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0005911; GO:0005912; GO:0005913; GO:0007155; GO:0007165; GO:0016607; GO:0017016; GO:0021537; GO:0021987; GO:0030054; GO:0032880; GO:0034334; GO:0043296; GO:0043547; GO:0045177; GO:0048854; GO:0048872; GO:0050839; GO:0060019; GO:0060563; GO:0070445; GO:0090557; GO:0098641; GO:1902414,,,,PF01843;PF00498;PF00595;PF00788;,adherens junction [GO:0005912]; apical junction complex [GO:0043296]; apical part of cell [GO:0045177]; cell junction [GO:0030054]; cell-cell adherens junction [GO:0005913]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; cadherin binding involved in cell-cell adhesion [GO:0098641]; cell adhesion molecule binding [GO:0050839]; Ras GTPase binding [GO:0017016]; adherens junction maintenance [GO:0034334]; brain morphogenesis [GO:0048854]; cell adhesion [GO:0007155]; cerebral cortex development [GO:0021987]; establishment of endothelial intestinal barrier [GO:0090557]; homeostasis of number of cells [GO:0048872]; neuroepithelial cell differentiation [GO:0060563]; positive regulation of GTPase activity [GO:0043547]; protein localization to cell junction [GO:1902414]; radial glial cell differentiation [GO:0060019]; regulation of oligodendrocyte progenitor proliferation [GO:0070445]; regulation of protein localization [GO:0032880]; signal transduction [GO:0007165]; telencephalon development [GO:0021537]
Q569L8,CHOYP_CENPJ.1.1|m.49318,0,0,0,0,0,0,0,0,3.00E-84,Centromere protein J (CENP-J),Cenpj,1344,astral microtubule nucleation [GO:0030954]; cell division [GO:0051301]; centriole assembly [GO:0098534]; centriole elongation [GO:0061511]; centriole replication [GO:0007099]; centrosome duplication [GO:0051298]; microtubule polymerization [GO:0046785]; mitotic spindle pole body duplication [GO:1903087]; motile cilium assembly [GO:0044458]; non-motile cilium assembly [GO:1905515]; positive regulation of JAK-STAT cascade [GO:0046427]; positive regulation of non-motile cilium assembly [GO:1902857]; regulation of centriole replication [GO:0046599]; smoothened signaling pathway [GO:0007224],GO:0003713; GO:0005654; GO:0005737; GO:0005813; GO:0005814; GO:0005874; GO:0005886; GO:0007099; GO:0007224; GO:0015631; GO:0019901; GO:0019904; GO:0030954; GO:0036064; GO:0043015; GO:0044458; GO:0046427; GO:0046599; GO:0046785; GO:0051298; GO:0051301; GO:0061511; GO:0098534; GO:1902857; GO:1903087; GO:1905515,,,,PF07202;,centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; gamma-tubulin binding [GO:0043015]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; transcription coactivator activity [GO:0003713]; tubulin binding [GO:0015631]; astral microtubule nucleation [GO:0030954]; cell division [GO:0051301]; centriole assembly [GO:0098534]; centriole elongation [GO:0061511]; centriole replication [GO:0007099]; centrosome duplication [GO:0051298]; microtubule polymerization [GO:0046785]; mitotic spindle pole body duplication [GO:1903087]; motile cilium assembly [GO:0044458]; non-motile cilium assembly [GO:1905515]; positive regulation of JAK-STAT cascade [GO:0046427]; positive regulation of non-motile cilium assembly [GO:1902857]; regulation of centriole replication [GO:0046599]; smoothened signaling pathway [GO:0007224]
Q710D6,CHOYP_COX5B.1.3|m.20245,0,0,0,0,0,0,0,0,4.00E-13,"Cytochrome c oxidase subunit 5B, mitochondrial (Cytochrome c oxidase polypeptide Vb) (Sperm protein 8) (fSP8)",COX5B SP8,128,,GO:0004129; GO:0005743; GO:0046872,,,cd00924;,PF01215;,mitochondrial inner membrane [GO:0005743]; cytochrome-c oxidase activity [GO:0004129]; metal ion binding [GO:0046872]
Q7ZUH5,CHOYP_CPIPJ_CPIJ008190.1.1|m.21761,0,0,0,0,0,0,0,0,1.00E-32,"39S ribosomal protein L14, mitochondrial (L14mt) (MRP-L14)",mrpl14 zgc:56531,141,translation [GO:0006412],GO:0003735; GO:0005739; GO:0005762; GO:0006412,,,,PF00238;,mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]
Q96MK2,CHOYP_FA65A.1.1|m.24019,0,0,0,0,0,0,0,0,9.00E-73,Protein FAM65C,FAM65C C20orf175,946,,,,,,PF15903;,
Q99MK9,CHOYP_ISCW_ISCW007158.2.2|m.53689,0.5,0,0,0,0,0,0,0,5.00E-54,Ras association domain-containing protein 1 (Protein 123F2),Rassf1,340,cell cycle arrest [GO:0007050]; cellular response to DNA damage stimulus [GO:0006974]; negative regulation of cell cycle arrest [GO:0071157]; positive regulation of protein ubiquitination [GO:0031398]; protein stabilization [GO:0050821]; Ras protein signal transduction [GO:0007265]; regulation of microtubule cytoskeleton organization [GO:0070507],GO:0000922; GO:0005634; GO:0005737; GO:0005815; GO:0005874; GO:0006974; GO:0007050; GO:0007265; GO:0015630; GO:0031398; GO:0042802; GO:0046872; GO:0047485; GO:0050821; GO:0070507; GO:0071157,,,cd00029;,PF00130;PF16517;PF00788;,cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; spindle pole [GO:0000922]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein N-terminus binding [GO:0047485]; cell cycle arrest [GO:0007050]; cellular response to DNA damage stimulus [GO:0006974]; negative regulation of cell cycle arrest [GO:0071157]; positive regulation of protein ubiquitination [GO:0031398]; protein stabilization [GO:0050821]; Ras protein signal transduction [GO:0007265]; regulation of microtubule cytoskeleton organization [GO:0070507]
Q642C0,CHOYP_LOC100368924.1.1|m.5031,0.5,0,0,0,0,0,0,0,9.00E-91,DnaJ homolog subfamily C member 8,Dnajc8,253,,,,,cd06257;,PF00226;,
Q503V0,CHOYP_LOC100533291.4.7|m.29195,4.5,0,0,0,0,0,0,0,2.00E-69,Charged multivesicular body protein 6 (Chromatin-modifying protein 6),chmp6 chmp6l,206,protein transport [GO:0015031]; vacuolar transport [GO:0007034],GO:0007034; GO:0015031; GO:0031902,,,,PF03357;,late endosome membrane [GO:0031902]; protein transport [GO:0015031]; vacuolar transport [GO:0007034]
Q9FKK7,CHOYP_LOC100632370.1.1|m.25156,0,0,0,0,0,0,0,0,1.00E-171,Xylose isomerase (EC 5.3.1.5),XYLA At5g57655 MUA2.25,477,D-xylose metabolic process [GO:0042732]; pentose-phosphate shunt [GO:0006098],GO:0005737; GO:0005773; GO:0005774; GO:0005783; GO:0005794; GO:0006098; GO:0009045; GO:0016020; GO:0042732; GO:0046872,,,,,cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; vacuolar membrane [GO:0005774]; vacuole [GO:0005773]; metal ion binding [GO:0046872]; xylose isomerase activity [GO:0009045]; D-xylose metabolic process [GO:0042732]; pentose-phosphate shunt [GO:0006098]
P50219,CHOYP_LOC100707249.1.1|m.15336,0,0,0,0,0,0,0,0,3.00E-43,Motor neuron and pancreas homeobox protein 1 (Homeobox protein HB9),MNX1 HLXB9,401,"anatomical structure morphogenesis [GO:0009653]; endocrine pancreas development [GO:0031018]; humoral immune response [GO:0006959]; neuron projection morphogenesis [GO:0048812]; regulation of transcription from RNA polymerase II promoter [GO:0006357]; spinal cord motor neuron cell fate specification [GO:0021520]; transcription, DNA-templated [GO:0006351]",GO:0003700; GO:0005634; GO:0005730; GO:0005829; GO:0006351; GO:0006357; GO:0006959; GO:0009653; GO:0021520; GO:0031018; GO:0043565; GO:0048812,,,,PF00046;,"cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634]; sequence-specific DNA binding [GO:0043565]; transcription factor activity, sequence-specific DNA binding [GO:0003700]; anatomical structure morphogenesis [GO:0009653]; endocrine pancreas development [GO:0031018]; humoral immune response [GO:0006959]; neuron projection morphogenesis [GO:0048812]; regulation of transcription from RNA polymerase II promoter [GO:0006357]; spinal cord motor neuron cell fate specification [GO:0021520]; transcription, DNA-templated [GO:0006351]"
O57460,CHOYP_LOC100898124.1.1|m.49610,0,0,0,0,0,0,0,0,0.00000003,Dorsal-ventral patterning tolloid-like protein 1 (EC 3.4.24.-) (Mini fin protein),tll1 mfn tld tolloid,1022,blood vessel development [GO:0001568]; determination of ventral identity [GO:0048264]; dorsal/ventral pattern formation [GO:0009953]; embryonic caudal fin morphogenesis [GO:0035124]; embryonic hemopoiesis [GO:0035162]; endothelial cell development [GO:0001885]; mesoderm formation [GO:0001707]; positive regulation of BMP signaling pathway [GO:0030513]; post-anal tail morphogenesis [GO:0036342]; proteolysis [GO:0006508],GO:0001568; GO:0001707; GO:0001885; GO:0004222; GO:0005509; GO:0005576; GO:0006508; GO:0008233; GO:0008237; GO:0008270; GO:0009953; GO:0030513; GO:0035124; GO:0035162; GO:0036342; GO:0048264,,,cd00041;cd04281;,PF01400;PF00431;,extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; peptidase activity [GO:0008233]; zinc ion binding [GO:0008270]; blood vessel development [GO:0001568]; determination of ventral identity [GO:0048264]; dorsal/ventral pattern formation [GO:0009953]; embryonic caudal fin morphogenesis [GO:0035124]; embryonic hemopoiesis [GO:0035162]; endothelial cell development [GO:0001885]; mesoderm formation [GO:0001707]; positive regulation of BMP signaling pathway [GO:0030513]; post-anal tail morphogenesis [GO:0036342]; proteolysis [GO:0006508]
Q99466,CHOYP_LOC579946.17.24|m.53406,0,0,0,0,0,0,0,0,1.00E-11,Neurogenic locus notch homolog protein 4 (Notch 4) (hNotch4) [Cleaved into: Notch 4 extracellular truncation; Notch 4 intracellular domain],NOTCH4 INT3,2003,"branching involved in blood vessel morphogenesis [GO:0001569]; cell differentiation [GO:0030154]; cell fate determination [GO:0001709]; embryo development [GO:0009790]; endothelial cell morphogenesis [GO:0001886]; hemopoiesis [GO:0030097]; mammary gland development [GO:0030879]; morphogenesis of a branching structure [GO:0001763]; negative regulation of cell differentiation [GO:0045596]; negative regulation of endothelial cell differentiation [GO:0045602]; Notch receptor processing [GO:0007220]; Notch signaling pathway [GO:0007219]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription of Notch receptor target [GO:0007221]; transcription initiation from RNA polymerase II promoter [GO:0006367]",GO:0000139; GO:0001569; GO:0001709; GO:0001763; GO:0001886; GO:0004872; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005789; GO:0005829; GO:0005886; GO:0005887; GO:0006367; GO:0007219; GO:0007220; GO:0007221; GO:0009790; GO:0009986; GO:0030097; GO:0030154; GO:0030879; GO:0045596; GO:0045602; GO:0045893; GO:0046982,,,,PF00023;PF12796;PF00008;PF07645;PF12661;PF06816;PF07684;PF00066;,"cell surface [GO:0009986]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; protein heterodimerization activity [GO:0046982]; receptor activity [GO:0004872]; branching involved in blood vessel morphogenesis [GO:0001569]; cell differentiation [GO:0030154]; cell fate determination [GO:0001709]; embryo development [GO:0009790]; endothelial cell morphogenesis [GO:0001886]; hemopoiesis [GO:0030097]; mammary gland development [GO:0030879]; morphogenesis of a branching structure [GO:0001763]; negative regulation of cell differentiation [GO:0045596]; negative regulation of endothelial cell differentiation [GO:0045602]; Notch receptor processing [GO:0007220]; Notch signaling pathway [GO:0007219]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of transcription, DNA-templated [GO:0045893]; transcription initiation from RNA polymerase II promoter [GO:0006367]"
Q6P9N1,CHOYP_PHUM_PHUM176650.1.1|m.13332,1.5,0,0,0,0,0,0,0,8.00E-70,Hyccin (Down-regulated by CTNNB1 protein A) (Protein FAM126A),Fam126a Drctnnb1a,521,establishment of protein localization to plasma membrane [GO:0090002]; myelination [GO:0042552]; phosphatidylinositol phosphorylation [GO:0046854],GO:0005737; GO:0005829; GO:0005886; GO:0042552; GO:0043005; GO:0046854; GO:0090002,,,,PF09790;,cytoplasm [GO:0005737]; cytosol [GO:0005829]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; establishment of protein localization to plasma membrane [GO:0090002]; myelination [GO:0042552]; phosphatidylinositol phosphorylation [GO:0046854]
P16620,CHOYP_PTPRK.10.20|m.31769,0,0,0,0,0,0,0,0,3.00E-56,Tyrosine-protein phosphatase 69D (EC 3.1.3.48) (Protein-tyrosine-phosphate phosphohydrolase) (DPTP),Ptp69D DPTP CG10975,1462,axonal defasciculation [GO:0007414]; axon guidance [GO:0007411]; cell adhesion [GO:0007155]; defasciculation of motor neuron axon [GO:0007415]; dendrite morphogenesis [GO:0048813]; fasciculation of sensory neuron axon [GO:0097155]; lateral inhibition [GO:0046331]; motor neuron axon guidance [GO:0008045]; protein dephosphorylation [GO:0006470],GO:0004725; GO:0005001; GO:0005886; GO:0006470; GO:0007155; GO:0007411; GO:0007414; GO:0007415; GO:0008045; GO:0016021; GO:0030424; GO:0046331; GO:0048813; GO:0097155,,,cd00063;,PF00041;PF00102;,axon [GO:0030424]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; axon guidance [GO:0007411]; axonal defasciculation [GO:0007414]; cell adhesion [GO:0007155]; defasciculation of motor neuron axon [GO:0007415]; dendrite morphogenesis [GO:0048813]; fasciculation of sensory neuron axon [GO:0097155]; lateral inhibition [GO:0046331]; motor neuron axon guidance [GO:0008045]; protein dephosphorylation [GO:0006470]
Q16827,CHOYP_PTPRZ.4.9|m.21524,0,0,0,0,0,0,0,0,7.00E-50,Receptor-type tyrosine-protein phosphatase O (R-PTP-O) (EC 3.1.3.48) (Glomerular epithelial protein 1) (Protein tyrosine phosphatase U2) (PTP-U2) (PTPase U2),PTPRO GLEPP1 PTPU2,1216,axon guidance [GO:0007411]; cell morphogenesis [GO:0000902]; glomerular visceral epithelial cell differentiation [GO:0072112]; glomerulus development [GO:0032835]; lamellipodium assembly [GO:0030032]; monocyte chemotaxis [GO:0002548]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of glomerular filtration [GO:0003105]; negative regulation of neuron projection development [GO:0010977]; negative regulation of retinal ganglion cell axon guidance [GO:0090260]; peptidyl-tyrosine dephosphorylation [GO:0035335]; protein dephosphorylation [GO:0006470]; regulation of glomerular filtration [GO:0003093]; slit diaphragm assembly [GO:0036060],GO:0000902; GO:0002548; GO:0003093; GO:0003105; GO:0004725; GO:0005001; GO:0005886; GO:0005887; GO:0006470; GO:0007411; GO:0010812; GO:0010977; GO:0016021; GO:0016324; GO:0016328; GO:0016791; GO:0017147; GO:0030027; GO:0030032; GO:0030424; GO:0030426; GO:0032835; GO:0035335; GO:0036060; GO:0042803; GO:0043005; GO:0043197; GO:0070062; GO:0072112; GO:0090090; GO:0090260,,,cd00063;,PF00041;PF00102;,apical plasma membrane [GO:0016324]; axon [GO:0030424]; dendritic spine [GO:0043197]; extracellular exosome [GO:0070062]; growth cone [GO:0030426]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; lamellipodium [GO:0030027]; lateral plasma membrane [GO:0016328]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; phosphatase activity [GO:0016791]; protein homodimerization activity [GO:0042803]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; Wnt-protein binding [GO:0017147]; axon guidance [GO:0007411]; cell morphogenesis [GO:0000902]; glomerular visceral epithelial cell differentiation [GO:0072112]; glomerulus development [GO:0032835]; lamellipodium assembly [GO:0030032]; monocyte chemotaxis [GO:0002548]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of glomerular filtration [GO:0003105]; negative regulation of neuron projection development [GO:0010977]; negative regulation of retinal ganglion cell axon guidance [GO:0090260]; peptidyl-tyrosine dephosphorylation [GO:0035335]; protein dephosphorylation [GO:0006470]; regulation of glomerular filtration [GO:0003093]; slit diaphragm assembly [GO:0036060]
Q5TUE9,CHOYP_RM23.1.1|m.173,0.5,0,0,0,0,0,0,0,6.00E-24,"Probable 39S ribosomal protein L23, mitochondrial (L23mt) (MRP-L23)",mRpL23 AGAP010338,151,DNA restriction-modification system [GO:0009307]; mitochondrial translation [GO:0032543],GO:0000166; GO:0003677; GO:0003723; GO:0003735; GO:0005762; GO:0009036; GO:0009307; GO:0032543,,,,PF00276;,mitochondrial large ribosomal subunit [GO:0005762]; DNA binding [GO:0003677]; nucleotide binding [GO:0000166]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; Type II site-specific deoxyribonuclease activity [GO:0009036]; DNA restriction-modification system [GO:0009307]; mitochondrial translation [GO:0032543]
Q58DN7,CHOYP_ACSF3.1.1|m.14825,1,0,0,0,0,0,0,0,2.00E-152,"Acyl-CoA synthetase family member 3, mitochondrial (EC 6.2.1.-)",ACSF3,586,fatty acid biosynthetic process [GO:0006633]; malonate catabolic process [GO:0090410],GO:0005524; GO:0005739; GO:0006633; GO:0090409; GO:0090410,,,,PF00501;PF13193;,mitochondrion [GO:0005739]; ATP binding [GO:0005524]; malonyl-CoA synthetase activity [GO:0090409]; fatty acid biosynthetic process [GO:0006633]; malonate catabolic process [GO:0090410]
Q9Z2H2,CHOYP_AGAP_AGAP000232.1.1|m.1999,1,0,0,0,0,0,0,0,1.00E-90,Regulator of G-protein signaling 6 (RGS6),Rgs6,472,G-protein coupled receptor signaling pathway [GO:0007186]; intracellular signal transduction [GO:0035556]; negative regulation of signal transduction [GO:0009968]; positive regulation of GTPase activity [GO:0043547],GO:0004871; GO:0005096; GO:0005634; GO:0005737; GO:0005829; GO:0005834; GO:0005886; GO:0007186; GO:0009968; GO:0019898; GO:0035556; GO:0043547,,,cd00068;,PF00610;PF00631;PF00615;,cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; heterotrimeric G-protein complex [GO:0005834]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; GTPase activator activity [GO:0005096]; signal transducer activity [GO:0004871]; G-protein coupled receptor signaling pathway [GO:0007186]; intracellular signal transduction [GO:0035556]; negative regulation of signal transduction [GO:0009968]; positive regulation of GTPase activity [GO:0043547]
Q0VB26,CHOYP_BRAFLDRAFT_117083.3.3|m.59001,3.5,0,0,0,0,0,0,0,3.00E-12,Testis-expressed protein 26,Tex26,296,,,,,,,
Q20616,CHOYP_BRAFLDRAFT_125550.1.5|m.9080,1.5,0,0,0,0,0,0,0,4.00E-71,Peroxidase skpo-1 (EC 1.11.1.7) (ShKT and peroxidase domain-containing protein 1),skpo-1 F49E12.1,655,defense response to Gram-positive bacterium [GO:0050830]; determination of adult lifespan [GO:0008340]; innate immune response [GO:0045087]; negative regulation of gene expression [GO:0010629]; response to oxidative stress [GO:0006979],GO:0004601; GO:0005615; GO:0006979; GO:0008340; GO:0010629; GO:0020037; GO:0045087; GO:0046872; GO:0050830,,,,PF03098;PF01549;,extracellular space [GO:0005615]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]; defense response to Gram-positive bacterium [GO:0050830]; determination of adult lifespan [GO:0008340]; innate immune response [GO:0045087]; negative regulation of gene expression [GO:0010629]; response to oxidative stress [GO:0006979]
Q9NQG7,CHOYP_BRAFLDRAFT_84245.2.2|m.53621,0,0,0,0,0,0,0,0,5.00E-21,Hermansky-Pudlak syndrome 4 protein (Light-ear protein homolog),HPS4 KIAA1667,708,blood coagulation [GO:0007596]; hemostasis [GO:0007599]; lysosome organization [GO:0007040]; melanocyte differentiation [GO:0030318]; melanosome assembly [GO:1903232]; membrane organization [GO:0061024]; positive regulation of eye pigmentation [GO:0048075]; positive regulation of protein targeting to mitochondrion [GO:1903955]; protein stabilization [GO:0050821]; protein targeting [GO:0006605],GO:0005085; GO:0005737; GO:0005764; GO:0005829; GO:0006605; GO:0007040; GO:0007596; GO:0007599; GO:0016020; GO:0017137; GO:0030318; GO:0031085; GO:0042470; GO:0042803; GO:0042827; GO:0046983; GO:0048075; GO:0050821; GO:0061024; GO:1903232; GO:1903955,,,,,BLOC-3 complex [GO:0031085]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lysosome [GO:0005764]; melanosome [GO:0042470]; membrane [GO:0016020]; platelet dense granule [GO:0042827]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein dimerization activity [GO:0046983]; protein homodimerization activity [GO:0042803]; Rab GTPase binding [GO:0017137]; blood coagulation [GO:0007596]; hemostasis [GO:0007599]; lysosome organization [GO:0007040]; melanocyte differentiation [GO:0030318]; melanosome assembly [GO:1903232]; membrane organization [GO:0061024]; positive regulation of eye pigmentation [GO:0048075]; positive regulation of protein targeting to mitochondrion [GO:1903955]; protein stabilization [GO:0050821]; protein targeting [GO:0006605]
P27393,CHOYP_CO9A1.1.1|m.62338,0,0,0,0,0,0,0,0,6.00E-64,Collagen alpha-2(IV) chain,,1763,,GO:0005201; GO:0005581; GO:0005604,,,,PF01413;PF01391;,basement membrane [GO:0005604]; collagen trimer [GO:0005581]; extracellular matrix structural constituent [GO:0005201]
P14963,CHOYP_EF1A2.1.3|m.30022,0,0,0,0,0,0,0,0,0,Elongation factor 1-alpha (EF-1-alpha),TEF,445,,GO:0003746; GO:0003924; GO:0005525; GO:0005737,,,,PF03144;PF03143;,cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]
Q8BZM1,CHOYP_GLMN.1.1|m.17085,0.5,0,0,0,0,0,0,0,4.00E-54,Glomulin (FK506-binding protein-associated protein) (FAP) (FKBP-associated protein),Glmn Fap48,596,"cell surface receptor signaling pathway [GO:0007166]; circulatory system development [GO:0072359]; muscle cell differentiation [GO:0042692]; negative regulation of cell proliferation [GO:0008285]; negative regulation of T cell proliferation [GO:0042130]; neural tube closure [GO:0001843]; positive regulation of cytokine secretion [GO:0050715]; positive regulation of interleukin-2 biosynthetic process [GO:0045086]; positive regulation of phosphorylation [GO:0042327]; regulation of gene expression, epigenetic [GO:0040029]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434]; vasculogenesis [GO:0001570]",GO:0001570; GO:0001843; GO:0005102; GO:0005171; GO:0005737; GO:0007166; GO:0008285; GO:0031461; GO:0031462; GO:0031463; GO:0031464; GO:0031625; GO:0032434; GO:0040029; GO:0042130; GO:0042327; GO:0042692; GO:0045086; GO:0050715; GO:0055105; GO:0072359,,,,PF08568;,"Cul2-RING ubiquitin ligase complex [GO:0031462]; Cul3-RING ubiquitin ligase complex [GO:0031463]; Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; cullin-RING ubiquitin ligase complex [GO:0031461]; cytoplasm [GO:0005737]; hepatocyte growth factor receptor binding [GO:0005171]; receptor binding [GO:0005102]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase inhibitor activity [GO:0055105]; cell surface receptor signaling pathway [GO:0007166]; circulatory system development [GO:0072359]; muscle cell differentiation [GO:0042692]; negative regulation of cell proliferation [GO:0008285]; negative regulation of T cell proliferation [GO:0042130]; neural tube closure [GO:0001843]; positive regulation of cytokine secretion [GO:0050715]; positive regulation of interleukin-2 biosynthetic process [GO:0045086]; positive regulation of phosphorylation [GO:0042327]; regulation of gene expression, epigenetic [GO:0040029]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434]; vasculogenesis [GO:0001570]"
P07291,CHOYP_HNRPR.1.2|m.44126,0,0,0,0,0,0,0,0,8.00E-62,"Myosin essential light chain, striated adductor muscle (E-LC) (Sulfhydryl light chain) (SHLC)",,157,,GO:0005509; GO:0016459,,,cd00051;,PF13499;,myosin complex [GO:0016459]; calcium ion binding [GO:0005509]
P28213,CHOYP_LOC100208023.8.8|m.49917,0,0,0,0,0,0,0,0,5.00E-14,Tyrosine-protein phosphatase 21 (EC 3.1.3.48) (Fragment),STY-21,115,,GO:0004725,,,,PF00102;,protein tyrosine phosphatase activity [GO:0004725]
P86221,CHOYP_LOC100366486.1.1|m.15010,1.5,0,0,0,0,0,0,0,4.00E-104,Tubulin beta-4B chain (Tubulin beta-2C chain) (Fragments),TUBB4B TUBB2C,290,microtubule-based process [GO:0007017],GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017,,,,PF00091;,cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]
Q92113,CHOYP_LOC100367956.2.2|m.62044,0,0,0,0,0,0,0,0,1.00E-62,"Steroid 17-alpha-hydroxylase/17,20 lyase (EC 1.14.14.19) (EC 1.14.14.32) (17-alpha-hydroxyprogesterone aldolase) (CYPXVII) (Cytochrome P450 17A1) (Cytochrome P450-C17) (Cytochrome P450c17)",CYP17A1 CYP17,509,sex differentiation [GO:0007548]; steroid biosynthetic process [GO:0006694],GO:0004508; GO:0005506; GO:0006694; GO:0007548; GO:0016020; GO:0020037; GO:0047442,PATHWAY: Lipid metabolism; steroid biosynthesis.,,,PF00067;,membrane [GO:0016020]; 17-alpha-hydroxyprogesterone aldolase activity [GO:0047442]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; steroid 17-alpha-monooxygenase activity [GO:0004508]; sex differentiation [GO:0007548]; steroid biosynthetic process [GO:0006694]
Q09654,CHOYP_LOC100369754.6.10|m.53352,0,0,0,0,0,0,0,0,0.00000004,E3 ubiquitin-protein ligase arc-1 (EC 2.3.2.27) (Putative GTP-binding protein trim-23 homolog) (RING-type E3 ubiquitin transferase arc-1),arc-1 arl-4 ZK1320.6,539,protein ubiquitination [GO:0016567]; small GTPase mediated signal transduction [GO:0007264],GO:0005525; GO:0005622; GO:0007264; GO:0008270; GO:0016567; GO:0016740,PATHWAY: Protein modification; protein ubiquitination.,,,PF00025;PF00643;PF13445;,intracellular [GO:0005622]; GTP binding [GO:0005525]; transferase activity [GO:0016740]; zinc ion binding [GO:0008270]; protein ubiquitination [GO:0016567]; small GTPase mediated signal transduction [GO:0007264]
Q5XJ13,CHOYP_LOC100371435.1.1|m.6503,1,0,0,0,0,0,0,0,3.00E-11,Ankyrin repeat and SAM domain-containing protein 6 (Ankyrin repeat domain-containing protein 14) (SamCystin) (Sterile alpha motif domain-containing protein 6) (SAM domain-containing protein 6),anks6 samd6 zgc:85964,739,pronephros development [GO:0048793],GO:0005929; GO:0048793,,,,PF12796;PF00536;,cilium [GO:0005929]; pronephros development [GO:0048793]
Q9MBF8,CHOYP_LOC100376274.7.7|m.64553,0,0,0,0,0,0,0,0,5.00E-63,"Dynein-1-beta heavy chain, flagellar inner arm I1 complex (1-beta DHC) (Dynein-1, subspecies f)",DHC10 IDA2,4513,cilium movement involved in cell motility [GO:0060294]; inner dynein arm assembly [GO:0036159],GO:0003777; GO:0005524; GO:0005737; GO:0005874; GO:0005930; GO:0008017; GO:0016887; GO:0031514; GO:0036156; GO:0036159; GO:0060294,,,,PF07728;PF12780;PF08385;PF08393;PF03028;PF12777;,axoneme [GO:0005930]; cytoplasm [GO:0005737]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]; motile cilium [GO:0031514]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; cilium movement involved in cell motility [GO:0060294]; inner dynein arm assembly [GO:0036159]
P29114,CHOYP_LOC584481.10.10|m.66365,0,0,0,0,0,0,0,0,1.00E-45,Linoleate 9S-lipoxygenase 1 (EC 1.13.11.58) (Lipoxygenase 1),LOX1.1 LOXA,862,oxylipin biosynthetic process [GO:0031408],GO:0016702; GO:0031408; GO:0046872,PATHWAY: Lipid metabolism; oxylipin biosynthesis. {ECO:0000255|PROSITE-ProRule:PRU00726}.,,,PF00305;PF01477;,"metal ion binding [GO:0046872]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; oxylipin biosynthetic process [GO:0031408]"
Q8IYS1,CHOYP_P20D2.2.2|m.47191,0.5,0,0,0,0,0,0,0,1.00E-137,Peptidase M20 domain-containing protein 2 (Aminoacylase-1-like protein 2),PM20D2 ACY1L2,436,proteolysis [GO:0006508]; regulation of cellular protein metabolic process [GO:0032268],GO:0005654; GO:0006508; GO:0016805; GO:0032268; GO:0070062,,,,PF07687;PF01546;,extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; dipeptidase activity [GO:0016805]; proteolysis [GO:0006508]; regulation of cellular protein metabolic process [GO:0032268]
Q80U87,CHOYP_SELMODRAFT_2432.1.1|m.60719,0,0,0,0,0,0,0,0,1.00E-16,Ubiquitin carboxyl-terminal hydrolase 8 (EC 3.4.19.12) (Deubiquitinating enzyme 8) (Ubiquitin isopeptidase Y) (mUBPy) (Ubiquitin thioesterase 8) (Ubiquitin-specific-processing protease 8),Usp8 Kiaa0055 Ubpy,1080,endosome organization [GO:0007032]; mitotic cytokinesis [GO:0000281]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; Ras protein signal transduction [GO:0007265]; ubiquitin-dependent protein catabolic process [GO:0006511],GO:0000281; GO:0004843; GO:0005622; GO:0005634; GO:0005737; GO:0005769; GO:0005829; GO:0005913; GO:0006511; GO:0007032; GO:0007265; GO:0016579; GO:0019897; GO:0030496; GO:0031313; GO:0070536; GO:0071108; GO:0098641,,,,PF00581;PF00443;PF08969;,cell-cell adherens junction [GO:0005913]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; extrinsic component of endosome membrane [GO:0031313]; extrinsic component of plasma membrane [GO:0019897]; intracellular [GO:0005622]; midbody [GO:0030496]; nucleus [GO:0005634]; cadherin binding involved in cell-cell adhesion [GO:0098641]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; endosome organization [GO:0007032]; mitotic cytokinesis [GO:0000281]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; Ras protein signal transduction [GO:0007265]; ubiquitin-dependent protein catabolic process [GO:0006511]
Q09654,CHOYP_TIF1A.5.8|m.32570,1,0,0,0,0,0,0,0,0.000002,E3 ubiquitin-protein ligase arc-1 (EC 2.3.2.27) (Putative GTP-binding protein trim-23 homolog) (RING-type E3 ubiquitin transferase arc-1),arc-1 arl-4 ZK1320.6,539,protein ubiquitination [GO:0016567]; small GTPase mediated signal transduction [GO:0007264],GO:0005525; GO:0005622; GO:0007264; GO:0008270; GO:0016567; GO:0016740,PATHWAY: Protein modification; protein ubiquitination.,,,PF00025;PF00643;PF13445;,intracellular [GO:0005622]; GTP binding [GO:0005525]; transferase activity [GO:0016740]; zinc ion binding [GO:0008270]; protein ubiquitination [GO:0016567]; small GTPase mediated signal transduction [GO:0007264]
Q6IP57,CHOYP_UBD2A.1.1|m.63050,0.5,0,0,0,0,0,0,0,2.00E-28,UBA-like domain-containing protein 2-A,ubald2-a fam100b-a,166,,,,,,,
Q9VR59,CHOYP_VIP2.1.1|m.54883,1.5,0,0,0,0,0,0,0,0,Inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase (EC 2.7.4.21) (EC 2.7.4.24) (InsP6 and PP-IP5 kinase),l(1)G0196 CG14616,1696,inositol metabolic process [GO:0006020]; inositol phosphate biosynthetic process [GO:0032958],GO:0000827; GO:0000828; GO:0000829; GO:0000832; GO:0005524; GO:0005829; GO:0006020; GO:0032958; GO:0033857; GO:0052723; GO:0052724,,,cd07061;,PF00328;,"cytosol [GO:0005829]; ATP binding [GO:0005524]; diphosphoinositol-pentakisphosphate kinase activity [GO:0033857]; inositol heptakisphosphate kinase activity [GO:0000829]; inositol hexakisphosphate 1-kinase activity [GO:0052723]; inositol hexakisphosphate 3-kinase activity [GO:0052724]; inositol hexakisphosphate 5-kinase activity [GO:0000832]; inositol hexakisphosphate kinase activity [GO:0000828]; inositol-1,3,4,5,6-pentakisphosphate kinase activity [GO:0000827]; inositol metabolic process [GO:0006020]; inositol phosphate biosynthetic process [GO:0032958]"
Q9BRS2,CHOYP_BRAFLDRAFT_124526.1.1|m.25228,0.5,0,0,0,0,0,0,0,0,Serine/threonine-protein kinase RIO1 (EC 2.7.11.1) (EC 3.6.3.-) (RIO kinase 1),RIOK1,568,maturation of SSU-rRNA [GO:0030490]; positive regulation of rRNA processing [GO:2000234]; ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364],GO:0004674; GO:0005524; GO:0005654; GO:0005829; GO:0006364; GO:0016787; GO:0030490; GO:0030688; GO:0042274; GO:0046872; GO:2000234,,,,,"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; preribosome, small subunit precursor [GO:0030688]; ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; maturation of SSU-rRNA [GO:0030490]; positive regulation of rRNA processing [GO:2000234]; ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364]"
P0DH96,CHOYP_CML1.1.1|m.30763,1,0,0,0,0,0,0,0,2.00E-22,Calmodulin-4 (CaM-4),CAM4 At1g66410 F28G11.13 T27F4.1,149,,GO:0005509,,,cd00051;,PF13499;,calcium ion binding [GO:0005509]
Q6DC53,CHOYP_CTU2.1.1|m.43200,0,0,0,0,0,0,0,0,4.00E-117,Cytoplasmic tRNA 2-thiolation protein 2,ctu2 ncs2 zgc:101113,501,tRNA thio-modification [GO:0034227]; tRNA wobble position uridine thiolation [GO:0002143]; tRNA wobble uridine modification [GO:0002098],GO:0000049; GO:0002098; GO:0002143; GO:0005829; GO:0016783; GO:0034227,PATHWAY: tRNA modification; 5-methoxycarbonylmethyl-2-thiouridine-tRNA biosynthesis. {ECO:0000255|HAMAP-Rule:MF_03054}.,,,PF10288;,cytosol [GO:0005829]; sulfurtransferase activity [GO:0016783]; tRNA binding [GO:0000049]; tRNA thio-modification [GO:0034227]; tRNA wobble position uridine thiolation [GO:0002143]; tRNA wobble uridine modification [GO:0002098]
O95786,CHOYP_DDX58.9.9|m.62757,1,0,0,0,0,0,0,0,1.00E-94,Probable ATP-dependent RNA helicase DDX58 (EC 3.6.4.13) (DEAD box protein 58) (RIG-I-like receptor 1) (RLR-1) (Retinoic acid-inducible gene 1 protein) (RIG-1) (Retinoic acid-inducible gene I protein) (RIG-I),DDX58,925,cytoplasmic pattern recognition receptor signaling pathway in response to virus [GO:0039528]; detection of virus [GO:0009597]; innate immune response [GO:0045087]; negative regulation of type I interferon production [GO:0032480]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of gene expression [GO:0010628]; positive regulation of granulocyte macrophage colony-stimulating factor production [GO:0032725]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of sequence-specific DNA binding transcription factor activity [GO:0051091]; positive regulation of transcription factor import into nucleus [GO:0042993]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein deubiquitination [GO:0016579]; regulation of cell migration [GO:0030334]; regulation of type III interferon production [GO:0034344]; response to exogenous dsRNA [GO:0043330]; response to virus [GO:0009615]; RIG-I signaling pathway [GO:0039529]; viral process [GO:0016032],GO:0002230; GO:0003690; GO:0003725; GO:0003727; GO:0004386; GO:0005524; GO:0005737; GO:0005829; GO:0005923; GO:0008270; GO:0009597; GO:0009615; GO:0010628; GO:0015629; GO:0016032; GO:0016579; GO:0030334; GO:0031625; GO:0032480; GO:0032587; GO:0032725; GO:0032727; GO:0032728; GO:0032755; GO:0032757; GO:0034344; GO:0039528; GO:0039529; GO:0042802; GO:0042993; GO:0043330; GO:0045087; GO:0045944; GO:0051091,,,,PF16739;PF00270;PF00271;PF11648;,actin cytoskeleton [GO:0015629]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; ruffle membrane [GO:0032587]; ATP binding [GO:0005524]; double-stranded DNA binding [GO:0003690]; double-stranded RNA binding [GO:0003725]; helicase activity [GO:0004386]; identical protein binding [GO:0042802]; single-stranded RNA binding [GO:0003727]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; cytoplasmic pattern recognition receptor signaling pathway in response to virus [GO:0039528]; detection of virus [GO:0009597]; innate immune response [GO:0045087]; negative regulation of type I interferon production [GO:0032480]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of gene expression [GO:0010628]; positive regulation of granulocyte macrophage colony-stimulating factor production [GO:0032725]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of sequence-specific DNA binding transcription factor activity [GO:0051091]; positive regulation of transcription factor import into nucleus [GO:0042993]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein deubiquitination [GO:0016579]; regulation of cell migration [GO:0030334]; regulation of type III interferon production [GO:0034344]; response to exogenous dsRNA [GO:0043330]; response to virus [GO:0009615]; RIG-I signaling pathway [GO:0039529]; viral process [GO:0016032]
Q9Y2D4,CHOYP_EXC6B.1.1|m.38489,0,0,0,0,0,0,0,0,0,Exocyst complex component 6B (Exocyst complex component Sec15B) (SEC15-like protein 2),EXOC6B KIAA0919 SEC15B SEC15L2,811,protein transport [GO:0015031]; vesicle docking involved in exocytosis [GO:0006904],GO:0000145; GO:0006904; GO:0015031,,,,PF04091;,exocyst [GO:0000145]; protein transport [GO:0015031]; vesicle docking involved in exocytosis [GO:0006904]
Q640P2,CHOYP_FGL1.1.6|m.30450,0,0,0,0,0,0,0,0,3.00E-50,Angiopoietin-related protein 1 (Angiopoietin-like protein 1),Angptl1,490,transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],GO:0005102; GO:0005615; GO:0007169; GO:0070062,,,cd00087;,PF00147;,extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; receptor binding [GO:0005102]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]
Q9JI19,CHOYP_FIBP.1.1|m.36402,0,0,0,0,0,0,0,0,3.00E-131,Acidic fibroblast growth factor intracellular-binding protein (aFGF intracellular-binding protein) (FGF-1 intracellular-binding protein),Fibp,357,platelet aggregation [GO:0070527],GO:0005634; GO:0012505; GO:0016020; GO:0016607; GO:0017134; GO:0070062; GO:0070527,,,,PF05427;,endomembrane system [GO:0012505]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; fibroblast growth factor binding [GO:0017134]; platelet aggregation [GO:0070527]
G5ED84,CHOYP_LOC100123307.1.1|m.13647,0,0,0,0,0,0,0,0,0.000002,Kelch-like protein 8,kel-8 W02G9.2,690,protein ubiquitination [GO:0016567]; protein ubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0042787],GO:0014069; GO:0016567; GO:0030054; GO:0031463; GO:0042787; GO:0043005; GO:0043025,PATHWAY: Protein modification; protein ubiquitination.,,,PF07707;PF00651;PF01344;,cell junction [GO:0030054]; Cul3-RING ubiquitin ligase complex [GO:0031463]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; postsynaptic density [GO:0014069]; protein ubiquitination [GO:0016567]; protein ubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0042787]
Q9BXW4,CHOYP_LOC100367880.1.1|m.12770,0,0,0,0,0,0,0,0,5.00E-57,Microtubule-associated proteins 1A/1B light chain 3C (Autophagy-related protein LC3 C) (Autophagy-related ubiquitin-like modifier LC3 C) (MAP1 light chain 3-like protein 3) (MAP1A/MAP1B light chain 3 C) (MAP1A/MAP1B LC3 C) (Microtubule-associated protein 1 light chain 3 gamma),MAP1LC3C,147,autophagosome maturation [GO:0097352]; macroautophagy [GO:0016236],GO:0000421; GO:0000932; GO:0005776; GO:0005829; GO:0005874; GO:0012505; GO:0016236; GO:0031090; GO:0031410; GO:0031625; GO:0097352,,,cd01611;,PF02991;,autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; microtubule [GO:0005874]; organelle membrane [GO:0031090]; P-body [GO:0000932]; ubiquitin protein ligase binding [GO:0031625]; autophagosome maturation [GO:0097352]; macroautophagy [GO:0016236]
Q8IX29,CHOYP_LOC100486001.1.1|m.6209,1,0,0,0,0,0,0,0,2.00E-68,F-box only protein 16,FBXO16 FBX16,292,,,,,,PF12937;,
G5ED84,CHOYP_LOC100698240.2.4|m.14964,0,0,0,0,0,0,0,0,4.00E-11,Kelch-like protein 8,kel-8 W02G9.2,690,protein ubiquitination [GO:0016567]; protein ubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0042787],GO:0014069; GO:0016567; GO:0030054; GO:0031463; GO:0042787; GO:0043005; GO:0043025,PATHWAY: Protein modification; protein ubiquitination.,,,PF07707;PF00651;PF01344;,cell junction [GO:0030054]; Cul3-RING ubiquitin ligase complex [GO:0031463]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; postsynaptic density [GO:0014069]; protein ubiquitination [GO:0016567]; protein ubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0042787]
Q99M80,CHOYP_LOC101071230.1.1|m.22193,0,0,0,0,0,0,0,0,4.00E-82,Receptor-type tyrosine-protein phosphatase T (R-PTP-T) (EC 3.1.3.48) (RPTPmam4) (Receptor-type tyrosine-protein phosphatase rho) (RPTP-rho) (mRPTPrho),Ptprt,1454,homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; protein dephosphorylation [GO:0006470]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],GO:0004725; GO:0005886; GO:0006470; GO:0007156; GO:0007169; GO:0008013; GO:0009986; GO:0016021; GO:0016790; GO:0045294; GO:0045295; GO:0045296; GO:0051393; GO:0070097,,,cd00063;cd06263;,PF00041;PF00629;PF00102;,cell surface [GO:0009986]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; alpha-actinin binding [GO:0051393]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; delta-catenin binding [GO:0070097]; gamma-catenin binding [GO:0045295]; protein tyrosine phosphatase activity [GO:0004725]; thiolester hydrolase activity [GO:0016790]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; protein dephosphorylation [GO:0006470]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]
O95428,CHOYP_LOC101162499.1.1|m.47400,0,0,0,0,0,0,0,0,2.00E-81,Papilin,PAPLN UNQ2420/PRO4977,1278,,GO:0004222; GO:0004867; GO:0005578; GO:0008270,,,,PF05986;PF07679;PF00014;PF08686;PF00090;,proteinaceous extracellular matrix [GO:0005578]; metalloendopeptidase activity [GO:0004222]; serine-type endopeptidase inhibitor activity [GO:0004867]; zinc ion binding [GO:0008270]
Q99M80,CHOYP_LOC101384981.1.1|m.53468,0,0,0,0,0,0,0,0,8.00E-65,Receptor-type tyrosine-protein phosphatase T (R-PTP-T) (EC 3.1.3.48) (RPTPmam4) (Receptor-type tyrosine-protein phosphatase rho) (RPTP-rho) (mRPTPrho),Ptprt,1454,homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; protein dephosphorylation [GO:0006470]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],GO:0004725; GO:0005886; GO:0006470; GO:0007156; GO:0007169; GO:0008013; GO:0009986; GO:0016021; GO:0016790; GO:0045294; GO:0045295; GO:0045296; GO:0051393; GO:0070097,,,cd00063;cd06263;,PF00041;PF00629;PF00102;,cell surface [GO:0009986]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; alpha-actinin binding [GO:0051393]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; delta-catenin binding [GO:0070097]; gamma-catenin binding [GO:0045295]; protein tyrosine phosphatase activity [GO:0004725]; thiolester hydrolase activity [GO:0016790]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; protein dephosphorylation [GO:0006470]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]
Q4R6I5,CHOYP_LOC578979.1.1|m.10409,0,0,0,0,0,0,0,0,2.00E-90,Clathrin heavy chain linker domain-containing protein 1,CLHC1 QtsA-17948,586,,,,,,PF15739;,
Q9U1M8,CHOYP_MYO22.2.2|m.24750,0,0,0,0,0,0,0,0,1.00E-179,Myosin-I heavy chain (Class VII unconventional myosin) (DdMVII) (DdM7),myoI DDB_G0274455,2357,actin filament-based movement [GO:0030048]; cell morphogenesis [GO:0000902]; cell-substrate adhesion [GO:0031589]; filopodium assembly [GO:0046847]; phagocytosis [GO:0006909]; spore germination [GO:0009847],GO:0000902; GO:0001891; GO:0003774; GO:0003779; GO:0005524; GO:0005829; GO:0006909; GO:0008017; GO:0009847; GO:0016020; GO:0016459; GO:0030048; GO:0030175; GO:0030898; GO:0031252; GO:0031589; GO:0043621; GO:0046847; GO:0051015,,,,PF00373;PF00063;PF00784;PF07653;,cell leading edge [GO:0031252]; cytosol [GO:0005829]; filopodium [GO:0030175]; membrane [GO:0016020]; myosin complex [GO:0016459]; phagocytic cup [GO:0001891]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; microtubule binding [GO:0008017]; motor activity [GO:0003774]; protein self-association [GO:0043621]; actin filament-based movement [GO:0030048]; cell morphogenesis [GO:0000902]; cell-substrate adhesion [GO:0031589]; filopodium assembly [GO:0046847]; phagocytosis [GO:0006909]; spore germination [GO:0009847]
B7U179,CHOYP_NEMVEDRAFT_V1G221088.1.1|m.66380,0.5,0,0,0,0,0,0,0,1.00E-10,ARMADILLO BTB ARABIDOPSIS PROTEIN 1 (ABAP1),ABAP1 At5g13060 T19L5.20,737,DNA-dependent DNA replication [GO:0006261]; negative regulation of cell proliferation [GO:0008285]; negative regulation of DNA-dependent DNA replication [GO:2000104]; protein ubiquitination [GO:0016567]; regulation of cell proliferation [GO:0042127],GO:0005634; GO:0005737; GO:0006261; GO:0008285; GO:0016567; GO:0031261; GO:0042127; GO:2000104,PATHWAY: Protein modification; protein ubiquitination.,,,PF00514;PF00651;,cytoplasm [GO:0005737]; DNA replication preinitiation complex [GO:0031261]; nucleus [GO:0005634]; DNA-dependent DNA replication [GO:0006261]; negative regulation of cell proliferation [GO:0008285]; negative regulation of DNA-dependent DNA replication [GO:2000104]; protein ubiquitination [GO:0016567]; regulation of cell proliferation [GO:0042127]
Q8N5N7,CHOYP_PHUM_PHUM174810.1.1|m.31029,0.5,0,0,0,0,0,0,0,9.00E-16,"39S ribosomal protein L50, mitochondrial (L50mt) (MRP-L50) (Mitochondrial large ribosomal subunit protein mL50)",MRPL50,158,mitochondrial translational elongation [GO:0070125]; mitochondrial translational termination [GO:0070126],GO:0005743; GO:0005762; GO:0070125; GO:0070126,,,,PF10501;,mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial translational elongation [GO:0070125]; mitochondrial translational termination [GO:0070126]
Q99M80,CHOYP_PTPRA.2.22|m.3118,0,0,0,0,0,0,0,0,1.00E-82,Receptor-type tyrosine-protein phosphatase T (R-PTP-T) (EC 3.1.3.48) (RPTPmam4) (Receptor-type tyrosine-protein phosphatase rho) (RPTP-rho) (mRPTPrho),Ptprt,1454,homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; protein dephosphorylation [GO:0006470]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],GO:0004725; GO:0005886; GO:0006470; GO:0007156; GO:0007169; GO:0008013; GO:0009986; GO:0016021; GO:0016790; GO:0045294; GO:0045295; GO:0045296; GO:0051393; GO:0070097,,,cd00063;cd06263;,PF00041;PF00629;PF00102;,cell surface [GO:0009986]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; alpha-actinin binding [GO:0051393]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; delta-catenin binding [GO:0070097]; gamma-catenin binding [GO:0045295]; protein tyrosine phosphatase activity [GO:0004725]; thiolester hydrolase activity [GO:0016790]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; protein dephosphorylation [GO:0006470]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]
A0A0R4IBK5,CHOYP_RN213.12.13|m.60577,0.5,0,0,0,0,0,0,0,0,E3 ubiquitin-protein ligase rnf213-alpha (EC 2.3.2.27) (EC 3.6.4.-) (Mysterin-A) (Mysterin-alpha) (RING finger protein 213-A) (RING finger protein 213-alpha) (RING-type E3 ubiquitin transferase rnf213-alpha),rnf213a,5209,sprouting angiogenesis [GO:0002040],GO:0002040; GO:0004842; GO:0005829; GO:0008270; GO:0016887,PATHWAY: Protein modification; protein ubiquitination. {ECO:0000250|UniProtKB:Q63HN8}.,,,,cytosol [GO:0005829]; ATPase activity [GO:0016887]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; sprouting angiogenesis [GO:0002040]
Q9D7N6,CHOYP_SMP_102490.1.2|m.22219,0,0,0,0,0,0,0,0,1.00E-13,"39S ribosomal protein L30, mitochondrial (L30mt) (MRP-L30)",Mrpl30,160,translation [GO:0006412],GO:0003735; GO:0005739; GO:0005761; GO:0005762; GO:0006412,,,cd01658;,PF00327;,mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial ribosome [GO:0005761]; mitochondrion [GO:0005739]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]
Q8CHC4,CHOYP_SYNJ1.1.1|m.42275,0,0,0,0,0,0,0,0,0,"Synaptojanin-1 (EC 3.1.3.36) (Synaptic inositol 1,4,5-trisphosphate 5-phosphatase 1)",Synj1 Kiaa0910,1574,inositol phosphate dephosphorylation [GO:0046855]; learning [GO:0007612]; neurotransmitter transport [GO:0006836]; phosphatidylinositol dephosphorylation [GO:0046856]; phosphatidylinositol-mediated signaling [GO:0048015]; phosphatidylinositol metabolic process [GO:0046488]; positive regulation of endosome organization [GO:1904980]; postsynaptic neurotransmitter receptor internalization [GO:0098884]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle priming [GO:0016082]; synaptic vesicle transport [GO:0048489]; synaptic vesicle uncoating [GO:0016191],GO:0000166; GO:0003723; GO:0004438; GO:0004439; GO:0006836; GO:0007612; GO:0016082; GO:0016191; GO:0030117; GO:0030118; GO:0030132; GO:0034595; GO:0043812; GO:0046488; GO:0046855; GO:0046856; GO:0048015; GO:0048488; GO:0048489; GO:0097060; GO:0098793; GO:0098884; GO:1904980,,,,PF08952;PF03372;PF02383;,"clathrin coat [GO:0030118]; clathrin coat of coated pit [GO:0030132]; membrane coat [GO:0030117]; presynapse [GO:0098793]; synaptic membrane [GO:0097060]; nucleotide binding [GO:0000166]; phosphatidylinositol phosphate 5-phosphatase activity [GO:0034595]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity [GO:0004439]; phosphatidylinositol-4-phosphate phosphatase activity [GO:0043812]; RNA binding [GO:0003723]; inositol phosphate dephosphorylation [GO:0046855]; learning [GO:0007612]; neurotransmitter transport [GO:0006836]; phosphatidylinositol dephosphorylation [GO:0046856]; phosphatidylinositol metabolic process [GO:0046488]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of endosome organization [GO:1904980]; postsynaptic neurotransmitter receptor internalization [GO:0098884]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle priming [GO:0016082]; synaptic vesicle transport [GO:0048489]; synaptic vesicle uncoating [GO:0016191]"
P18699,CHOYP_TBB2.2.2|m.53001,0,0,0,0,0,0,0,0,1.00E-70,Tubulin beta chain (Beta-tubulin) (Fragment),,111,microtubule-based process [GO:0007017],GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017,,,,PF03953;,cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]
Q9BXT4,CHOYP_TDRD1.1.1|m.34821,0,0,0,0,0,0,0,0,1.00E-10,Tudor domain-containing protein 1 (Cancer/testis antigen 41.1) (CT41.1),TDRD1,1180,DNA methylation involved in gamete generation [GO:0043046]; gene silencing by RNA [GO:0031047]; germ cell development [GO:0007281]; meiotic cell cycle [GO:0051321]; multicellular organism development [GO:0007275]; piRNA metabolic process [GO:0034587]; spermatogenesis [GO:0007283],GO:0005737; GO:0007275; GO:0007281; GO:0007283; GO:0031047; GO:0033391; GO:0034587; GO:0043046; GO:0043186; GO:0046872; GO:0051321; GO:0071546,,,,PF00567;PF01753;,chromatoid body [GO:0033391]; cytoplasm [GO:0005737]; P granule [GO:0043186]; pi-body [GO:0071546]; metal ion binding [GO:0046872]; DNA methylation involved in gamete generation [GO:0043046]; gene silencing by RNA [GO:0031047]; germ cell development [GO:0007281]; meiotic cell cycle [GO:0051321]; multicellular organism development [GO:0007275]; piRNA metabolic process [GO:0034587]; spermatogenesis [GO:0007283]
Q8NFA0,CHOYP_UBP32.1.1|m.56373,0,0,0,0,0,0,0,0,0,Ubiquitin carboxyl-terminal hydrolase 32 (EC 3.4.19.12) (Deubiquitinating enzyme 32) (Renal carcinoma antigen NY-REN-60) (Ubiquitin thioesterase 32) (Ubiquitin-specific-processing protease 32),USP32 USP10,1604,protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511],GO:0004843; GO:0005509; GO:0005794; GO:0005829; GO:0006511; GO:0016020; GO:0016579,,,cd00051;,PF06337;PF13202;PF14836;PF00443;,cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511]
A8XZB0,CHOYP_contig_054901|m.65508,0.5,0,0,0,0,0,0,0,3.00E-16,"ATPase inhibitor mai-2, mitochondrial",mai-2 CBG21048,109,heme biosynthetic process [GO:0006783]; negative regulation of ATPase activity [GO:0032780],GO:0005739; GO:0006783; GO:0032780; GO:0042030; GO:0051117,,,,PF04568;,mitochondrion [GO:0005739]; ATPase binding [GO:0051117]; ATPase inhibitor activity [GO:0042030]; heme biosynthetic process [GO:0006783]; negative regulation of ATPase activity [GO:0032780]
P06605,CHOYP_AAEL_AAEL013229.1.2|m.30359,4.5,0,0,0,0,0,0,0,1.00E-80,Tubulin alpha-3 chain,alphaTub84D TubA84D CG2512,450,microtubule-based process [GO:0007017]; mitotic cytokinesis [GO:0000281],GO:0000281; GO:0003924; GO:0005200; GO:0005525; GO:0005811; GO:0005874; GO:0007017; GO:0017022; GO:0048471,,,,PF00091;PF03953;,lipid particle [GO:0005811]; microtubule [GO:0005874]; perinuclear region of cytoplasm [GO:0048471]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; myosin binding [GO:0017022]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]; mitotic cytokinesis [GO:0000281]
Q3UNX5,CHOYP_ACSM3.1.1|m.23686,0,0,0,0,0,0,0,0,0,"Acyl-coenzyme A synthetase ACSM3, mitochondrial (EC 6.2.1.2) (Acyl-CoA synthetase medium-chain family member 3) (Butyrate--CoA ligase 3) (Butyryl-coenzyme A synthetase 3) (Middle-chain acyl-CoA synthetase 3) (Protein SA homolog)",Acsm3 Sa Sah,580,acyl-CoA metabolic process [GO:0006637]; fatty acid biosynthetic process [GO:0006633],GO:0003996; GO:0004321; GO:0005524; GO:0005739; GO:0005759; GO:0006633; GO:0006637; GO:0015645; GO:0046872; GO:0047760,,,,PF00501;PF13193;,mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; acyl-CoA ligase activity [GO:0003996]; ATP binding [GO:0005524]; butyrate-CoA ligase activity [GO:0047760]; fatty acid ligase activity [GO:0015645]; fatty-acyl-CoA synthase activity [GO:0004321]; metal ion binding [GO:0046872]; acyl-CoA metabolic process [GO:0006637]; fatty acid biosynthetic process [GO:0006633]
Q9CQY2,CHOYP_BRAFLDRAFT_221294.2.2|m.52722,2,0,0,0,0,0,0,0,0.000000006,RNMT-activating mini protein (RAM) (Protein FAM103A1),Fam103a1,119,7-methylguanosine mRNA capping [GO:0006370]; methylation [GO:0032259]; recruitment of mRNA capping enzyme to RNA polymerase II holoenzyme complex [GO:0036031],GO:0003723; GO:0005634; GO:0005654; GO:0005845; GO:0006370; GO:0032259; GO:0036031,,,,PF15320;,mRNA cap binding complex [GO:0005845]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA binding [GO:0003723]; 7-methylguanosine mRNA capping [GO:0006370]; methylation [GO:0032259]; recruitment of mRNA capping enzyme to RNA polymerase II holoenzyme complex [GO:0036031]
Q16829,CHOYP_BRAFLDRAFT_60200.2.3|m.33251,0,0,0,0,0,0,0,0,5.00E-104,Dual specificity protein phosphatase 7 (EC 3.1.3.16) (EC 3.1.3.48) (Dual specificity protein phosphatase PYST2),DUSP7 PYST2,419,activation of MAPK activity [GO:0000187]; MAPK cascade [GO:0000165]; negative regulation of MAP kinase activity [GO:0043407]; peptidyl-tyrosine dephosphorylation [GO:0035335],GO:0000165; GO:0000187; GO:0004725; GO:0005654; GO:0005829; GO:0008138; GO:0017017; GO:0035335; GO:0043407,,,cd00127;,PF00782;PF00581;,cytosol [GO:0005829]; nucleoplasm [GO:0005654]; MAP kinase tyrosine/serine/threonine phosphatase activity [GO:0017017]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; activation of MAPK activity [GO:0000187]; MAPK cascade [GO:0000165]; negative regulation of MAP kinase activity [GO:0043407]; peptidyl-tyrosine dephosphorylation [GO:0035335]
Q9J5H8,CHOYP_CLPB.1.3|m.14233,0,0,0,0,0,0,0,0,0.000000001,Putative ankyrin repeat protein FPV023,FPV023,434,,,,,,PF12796;,
Q28FE8,CHOYP_DSRAD.2.4|m.5410,2.5,0,0,0,0,0,0,0,1.00E-14,tRNA-specific adenosine deaminase 1 (EC 3.5.4.34) (tRNA-specific adenosine-37 deaminase),adat1 TEgg036c08.1,472,tRNA processing [GO:0008033],GO:0003723; GO:0008033; GO:0008251; GO:0046872,,,,PF02137;,metal ion binding [GO:0046872]; RNA binding [GO:0003723]; tRNA-specific adenosine deaminase activity [GO:0008251]; tRNA processing [GO:0008033]
Q6ZRF8,CHOYP_EME1.1.1|m.33089,0,0,0,0,0,0,0,0,0.0000002,RING finger protein 207,RNF207 C1orf188,634,cell-cell signaling involved in cardiac conduction [GO:0086019]; positive regulation of delayed rectifier potassium channel activity [GO:1902261]; positive regulation of gene expression [GO:0010628]; positive regulation of voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization [GO:1903954]; positive regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization [GO:1903762]; regulation of cardiac muscle contraction [GO:0055117]; regulation of heart looping [GO:1901207],GO:0008270; GO:0010628; GO:0030544; GO:0044325; GO:0048471; GO:0051087; GO:0055117; GO:0086019; GO:1901207; GO:1902261; GO:1903762; GO:1903954,,,,PF00643;PF00097;,perinuclear region of cytoplasm [GO:0048471]; chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; ion channel binding [GO:0044325]; zinc ion binding [GO:0008270]; cell-cell signaling involved in cardiac conduction [GO:0086019]; positive regulation of delayed rectifier potassium channel activity [GO:1902261]; positive regulation of gene expression [GO:0010628]; positive regulation of voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization [GO:1903954]; positive regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization [GO:1903762]; regulation of cardiac muscle contraction [GO:0055117]; regulation of heart looping [GO:1901207]
P86788,CHOYP_GIGA5.3.4|m.17227,0,0,0,0,0,0,0,0,4.00E-41,Gigasin-5 (Fragment),,113,,,,,,,
Q66KE3,CHOYP_ISCW_ISCW021476.1.1|m.29578,0,0,0,0,0,0,0,0,7.00E-113,Cleavage and polyadenylation specificity factor subunit 4,cpsf4,269,mRNA polyadenylation [GO:0006378]; pre-mRNA cleavage required for polyadenylation [GO:0098789],GO:0003723; GO:0004521; GO:0005847; GO:0006378; GO:0008270; GO:0098789,,,,PF00098;,mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; endoribonuclease activity [GO:0004521]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; mRNA polyadenylation [GO:0006378]; pre-mRNA cleavage required for polyadenylation [GO:0098789]
Q8K4Q8,CHOYP_LECG.3.4|m.29627,0,0,0,0,0,0,0,0,2.00E-16,Collectin-12 (Collectin placenta protein 1) (CL-P1) (Scavenger receptor with C-type lectin),Colec12 Clp1 Srcl,742,"cellular response to exogenous dsRNA [GO:0071360]; immune response [GO:0006955]; phagocytosis, recognition [GO:0006910]; positive regulation of cell adhesion molecule production [GO:0060355]; toll-like receptor 3 signaling pathway [GO:0034138]",GO:0005581; GO:0006910; GO:0006955; GO:0008329; GO:0016021; GO:0030169; GO:0030246; GO:0034138; GO:0046872; GO:0060355; GO:0070062; GO:0071360,,,cd03590;,PF01391;PF00059;,"collagen trimer [GO:0005581]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; low-density lipoprotein particle binding [GO:0030169]; metal ion binding [GO:0046872]; signaling pattern recognition receptor activity [GO:0008329]; cellular response to exogenous dsRNA [GO:0071360]; immune response [GO:0006955]; phagocytosis, recognition [GO:0006910]; positive regulation of cell adhesion molecule production [GO:0060355]; toll-like receptor 3 signaling pathway [GO:0034138]"
Q6ZRF8,CHOYP_LOC100369929.1.5|m.32680,0,0,0,0,0,0,0,0,0.000000007,RING finger protein 207,RNF207 C1orf188,634,cell-cell signaling involved in cardiac conduction [GO:0086019]; positive regulation of delayed rectifier potassium channel activity [GO:1902261]; positive regulation of gene expression [GO:0010628]; positive regulation of voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization [GO:1903954]; positive regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization [GO:1903762]; regulation of cardiac muscle contraction [GO:0055117]; regulation of heart looping [GO:1901207],GO:0008270; GO:0010628; GO:0030544; GO:0044325; GO:0048471; GO:0051087; GO:0055117; GO:0086019; GO:1901207; GO:1902261; GO:1903762; GO:1903954,,,,PF00643;PF00097;,perinuclear region of cytoplasm [GO:0048471]; chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; ion channel binding [GO:0044325]; zinc ion binding [GO:0008270]; cell-cell signaling involved in cardiac conduction [GO:0086019]; positive regulation of delayed rectifier potassium channel activity [GO:1902261]; positive regulation of gene expression [GO:0010628]; positive regulation of voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization [GO:1903954]; positive regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization [GO:1903762]; regulation of cardiac muscle contraction [GO:0055117]; regulation of heart looping [GO:1901207]
B0SJT4,CHOYP_LOC100371374.1.1|m.46502,0,0,0,0,0,0,0,0,5.00E-12,Nucleoside diphosphate kinase (NDK) (NDP kinase) (EC 2.7.4.6) (Nucleoside-2-P kinase),ndk LEPBI_I0084,137,CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; UTP biosynthetic process [GO:0006228],GO:0004550; GO:0005524; GO:0005737; GO:0006183; GO:0006228; GO:0006241; GO:0046872,,,,PF00334;,cytoplasm [GO:0005737]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; nucleoside diphosphate kinase activity [GO:0004550]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; UTP biosynthetic process [GO:0006228]
Q6ZRF8,CHOYP_LOC100373906.1.2|m.21267,0,0,0,0,0,0,0,0,0.000000005,RING finger protein 207,RNF207 C1orf188,634,cell-cell signaling involved in cardiac conduction [GO:0086019]; positive regulation of delayed rectifier potassium channel activity [GO:1902261]; positive regulation of gene expression [GO:0010628]; positive regulation of voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization [GO:1903954]; positive regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization [GO:1903762]; regulation of cardiac muscle contraction [GO:0055117]; regulation of heart looping [GO:1901207],GO:0008270; GO:0010628; GO:0030544; GO:0044325; GO:0048471; GO:0051087; GO:0055117; GO:0086019; GO:1901207; GO:1902261; GO:1903762; GO:1903954,,,,PF00643;PF00097;,perinuclear region of cytoplasm [GO:0048471]; chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; ion channel binding [GO:0044325]; zinc ion binding [GO:0008270]; cell-cell signaling involved in cardiac conduction [GO:0086019]; positive regulation of delayed rectifier potassium channel activity [GO:1902261]; positive regulation of gene expression [GO:0010628]; positive regulation of voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization [GO:1903954]; positive regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization [GO:1903762]; regulation of cardiac muscle contraction [GO:0055117]; regulation of heart looping [GO:1901207]
Q9NQZ5,CHOYP_LOC100374471.1.1|m.55948,0,0,0,0,0,0,0,0,4.00E-65,"StAR-related lipid transfer protein 7, mitochondrial (Gestational trophoblastic tumor protein 1) (START domain-containing protein 7) (StARD7)",STARD7 GTT1,370,phosphatidylcholine biosynthetic process [GO:0006656]; positive regulation of protein targeting to mitochondrion [GO:1903955],GO:0005741; GO:0006656; GO:0008289; GO:1903955,,,,PF01852;,mitochondrial outer membrane [GO:0005741]; lipid binding [GO:0008289]; phosphatidylcholine biosynthetic process [GO:0006656]; positive regulation of protein targeting to mitochondrion [GO:1903955]
Q96MY1,CHOYP_LOC100376296.1.1|m.36837,0,0,0,0,0,0,0,0,7.00E-65,Nucleolar protein 4-like,NOL4L C20orf112 C20orf113,436,,GO:0005654; GO:0005829,,,,,cytosol [GO:0005829]; nucleoplasm [GO:0005654]
Q6ZRF8,CHOYP_LOC100376608.3.4|m.51379,0,0,0,0,0,0,0,0,2.00E-10,RING finger protein 207,RNF207 C1orf188,634,cell-cell signaling involved in cardiac conduction [GO:0086019]; positive regulation of delayed rectifier potassium channel activity [GO:1902261]; positive regulation of gene expression [GO:0010628]; positive regulation of voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization [GO:1903954]; positive regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization [GO:1903762]; regulation of cardiac muscle contraction [GO:0055117]; regulation of heart looping [GO:1901207],GO:0008270; GO:0010628; GO:0030544; GO:0044325; GO:0048471; GO:0051087; GO:0055117; GO:0086019; GO:1901207; GO:1902261; GO:1903762; GO:1903954,,,,PF00643;PF00097;,perinuclear region of cytoplasm [GO:0048471]; chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; ion channel binding [GO:0044325]; zinc ion binding [GO:0008270]; cell-cell signaling involved in cardiac conduction [GO:0086019]; positive regulation of delayed rectifier potassium channel activity [GO:1902261]; positive regulation of gene expression [GO:0010628]; positive regulation of voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization [GO:1903954]; positive regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization [GO:1903762]; regulation of cardiac muscle contraction [GO:0055117]; regulation of heart looping [GO:1901207]
P42205,CHOYP_LOC100378615.1.2|m.25321,0,0,0,0,0,0,0,0,0.000000005,Probable glucarate transporter (D-glucarate permease),gudP,456,transmembrane transport [GO:0055085],GO:0005215; GO:0005886; GO:0016021; GO:0055085,,,cd06174;,PF07690;,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; transporter activity [GO:0005215]; transmembrane transport [GO:0055085]
Q55CD9,CHOYP_LOC100634472.2.3|m.17596,0,0,0,0,0,0,0,0,9.00E-105,Probable NADH dehydrogenase (EC 1.6.-.-),DDB_G0270104,451,,GO:0016491,,,,PF07992;,oxidoreductase activity [GO:0016491]
Q9UBI9,CHOYP_LOC100644701.2.2|m.54959,1,0,0,0,0,0,0,0,1.00E-88,Headcase protein homolog (hHDC),HECA HDC,543,negative regulation of mitotic cell cycle [GO:0045930]; respiratory tube development [GO:0030323],GO:0005634; GO:0005737; GO:0016020; GO:0030323; GO:0045930,,,,PF16002;PF15353;,cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634]; negative regulation of mitotic cell cycle [GO:0045930]; respiratory tube development [GO:0030323]
Q47944,CHOYP_LOC100903758.1.1|m.43697,0,0,0,0,0,0,0,0,3.00E-97,L-sorbose 1-dehydrogenase (SDH) (EC 1.1.99.32),,531,,GO:0016614; GO:0050660,,,,PF05199;PF00732;,"flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on CH-OH group of donors [GO:0016614]"
P83425,CHOYP_LOC101159074.1.1|m.29872,0,0,0,0,0,0,0,0,0.00000002,Heavy metal-binding protein HIP,,213,,GO:0005576; GO:0046872,,,,PF00386;,extracellular region [GO:0005576]; metal ion binding [GO:0046872]
Q9Y7Y3,CHOYP_LOC580669.1.1|m.7758,0,0,0,0,0,0,0,0,2.00E-21,Uncharacterized RNA-binding protein C365.04c,SPBC365.04c,233,ribosomal small subunit biogenesis [GO:0042274]; ribosome biogenesis [GO:0042254],GO:0000166; GO:0003723; GO:0005634; GO:0005730; GO:0019843; GO:0030686; GO:0042254; GO:0042274,,,cd12400;,PF00076;,90S preribosome [GO:0030686]; nucleolus [GO:0005730]; nucleus [GO:0005634]; nucleotide binding [GO:0000166]; RNA binding [GO:0003723]; rRNA binding [GO:0019843]; ribosomal small subunit biogenesis [GO:0042274]; ribosome biogenesis [GO:0042254]
D3ZSI8,CHOYP_LOC663424.1.2|m.49957,1,0,0,0,0,0,0,0,0,Phosphatidylinositol 4-phosphate 5-kinase type-1 alpha (PIP5K1-alpha) (PtdIns(4)P-5-kinase 1 alpha) (EC 2.7.1.68) (68 kDa type I phosphatidylinositol 4-phosphate 5-kinase) (Phosphatidylinositol 4-phosphate 5-kinase type I alpha) (PIP5KIalpha),Pip5k1a,546,actin cytoskeleton reorganization [GO:0031532]; activation of GTPase activity [GO:0090630]; cell chemotaxis [GO:0060326]; fibroblast migration [GO:0010761]; focal adhesion assembly [GO:0048041]; phosphatidylinositol biosynthetic process [GO:0006661]; protein targeting to plasma membrane [GO:0072661]; ruffle assembly [GO:0097178],GO:0005524; GO:0005829; GO:0005847; GO:0005925; GO:0006661; GO:0010761; GO:0016308; GO:0016607; GO:0030027; GO:0031532; GO:0032587; GO:0048041; GO:0060326; GO:0072661; GO:0090630; GO:0097178,,,,PF01504;,cytosol [GO:0005829]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nuclear speck [GO:0016607]; ruffle membrane [GO:0032587]; 1-phosphatidylinositol-4-phosphate 5-kinase activity [GO:0016308]; ATP binding [GO:0005524]; actin cytoskeleton reorganization [GO:0031532]; activation of GTPase activity [GO:0090630]; cell chemotaxis [GO:0060326]; fibroblast migration [GO:0010761]; focal adhesion assembly [GO:0048041]; phosphatidylinositol biosynthetic process [GO:0006661]; protein targeting to plasma membrane [GO:0072661]; ruffle assembly [GO:0097178]
Q8N9B4,CHOYP_LOC755594.5.6|m.54446,0,0,0,0,0,0,0,0,5.00E-11,Ankyrin repeat domain-containing protein 42,ANKRD42,389,,,,,,PF12796;,
Q9ESN4,CHOYP_LOC794295.1.1|m.42748,0,0,0,0,0,0,0,0,0.000000007,Complement C1q-like protein 3 (C1q and tumor necrosis factor-related protein 13) (C1q/TNF-related protein 13) (CTRP13) (Gliacolin),C1ql3 C1ql Ctrp13,255,regulation of synapse organization [GO:0050807],GO:0005576; GO:0005581; GO:0050807,,,,PF00386;PF01391;,collagen trimer [GO:0005581]; extracellular region [GO:0005576]; regulation of synapse organization [GO:0050807]
P86856,CHOYP_MANL.2.9|m.16934,0,0,0,0,0,0,0,0,5.00E-40,Nacrein-like protein (Fragment),,321,,GO:0005576,,,,PF00194;,extracellular region [GO:0005576]
Q6ZQ89,CHOYP_MARH6.1.1|m.11430,0,0,0,0,0,0,0,0,0,E3 ubiquitin-protein ligase MARCH6 (EC 2.3.2.27) (Membrane-associated RING finger protein 6) (Membrane-associated RING-CH protein VI) (MARCH-VI) (RING-type E3 ubiquitin transferase MARCH6),March6 Kiaa0597,909,ER-associated ubiquitin-dependent protein catabolic process [GO:0030433]; proteasomal protein catabolic process [GO:0010498]; protein K48-linked ubiquitination [GO:0070936],GO:0004842; GO:0005783; GO:0008270; GO:0010498; GO:0016020; GO:0016021; GO:0019899; GO:0030176; GO:0030433; GO:0031624; GO:0070936; GO:1904264; GO:1990381,PATHWAY: Protein modification; protein ubiquitination.,,,PF12906;,endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; enzyme binding [GO:0019899]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity involved in ERAD pathway [GO:1904264]; ubiquitin-protein transferase activity [GO:0004842]; ubiquitin-specific protease binding [GO:1990381]; zinc ion binding [GO:0008270]; ER-associated ubiquitin-dependent protein catabolic process [GO:0030433]; proteasomal protein catabolic process [GO:0010498]; protein K48-linked ubiquitination [GO:0070936]
P42674,CHOYP_NAS13.1.1|m.30415,0,0,0,0,0,0,0,0,2.00E-52,Blastula protease 10 (EC 3.4.24.-),BP10,597,,GO:0004222; GO:0005615; GO:0005938; GO:0008270; GO:0048471,,,cd00041;cd04280;,PF01400;PF00431;,cell cortex [GO:0005938]; extracellular space [GO:0005615]; perinuclear region of cytoplasm [GO:0048471]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]
Q9HC56,CHOYP_PCDH9.4.5|m.58558,0,0,0,0,0,0,0,0,2.00E-108,Protocadherin-9,PCDH9,1237,forebrain development [GO:0030900]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156],GO:0005509; GO:0005886; GO:0007156; GO:0016021; GO:0030426; GO:0030900; GO:0044291,,,,PF00028;PF08266;PF08374;,cell-cell contact zone [GO:0044291]; growth cone [GO:0030426]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; forebrain development [GO:0030900]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]
Q8QFV0,CHOYP_PHUM_PHUM562900.1.1|m.43674,0,0,0,0,0,0,0,0,0,Potassium channel subfamily T member 1 (Sequence like a calcium-activated potassium channel subunit),KCNT1 SLACK,1201,,GO:0005249; GO:0008076; GO:0015269,,,,PF03493;PF07885;,voltage-gated potassium channel complex [GO:0008076]; calcium-activated potassium channel activity [GO:0015269]; voltage-gated potassium channel activity [GO:0005249]
Q96M20,CHOYP_SMP_147320.1.1|m.27463,0,0,0,0,0,0,0,0,1.00E-11,Cyclic nucleotide-binding domain-containing protein 2,CNBD2 C20orf152,576,spermatogenesis [GO:0007283],GO:0005829; GO:0007283; GO:0030552,,,,PF00027;,cytosol [GO:0005829]; cAMP binding [GO:0030552]; spermatogenesis [GO:0007283]
Q6ZRF8,CHOYP_TR12A.1.2|m.32633,0,0,0,0,0,0,0,0,0.00000007,RING finger protein 207,RNF207 C1orf188,634,cell-cell signaling involved in cardiac conduction [GO:0086019]; positive regulation of delayed rectifier potassium channel activity [GO:1902261]; positive regulation of gene expression [GO:0010628]; positive regulation of voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization [GO:1903954]; positive regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization [GO:1903762]; regulation of cardiac muscle contraction [GO:0055117]; regulation of heart looping [GO:1901207],GO:0008270; GO:0010628; GO:0030544; GO:0044325; GO:0048471; GO:0051087; GO:0055117; GO:0086019; GO:1901207; GO:1902261; GO:1903762; GO:1903954,,,,PF00643;PF00097;,perinuclear region of cytoplasm [GO:0048471]; chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; ion channel binding [GO:0044325]; zinc ion binding [GO:0008270]; cell-cell signaling involved in cardiac conduction [GO:0086019]; positive regulation of delayed rectifier potassium channel activity [GO:1902261]; positive regulation of gene expression [GO:0010628]; positive regulation of voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization [GO:1903954]; positive regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization [GO:1903762]; regulation of cardiac muscle contraction [GO:0055117]; regulation of heart looping [GO:1901207]
P83088,CHOYP_TRIADDRAFT_26518.1.1|m.16475,0,0,0,0,0,0,0,0,7.00E-28,"Alpha-(1,3)-fucosyltransferase C (EC 2.4.1.-) (Galactoside 3-L-fucosyltransferase)",FucTC CG40305,425,protein glycosylation [GO:0006486],GO:0000139; GO:0006486; GO:0008417; GO:0016021; GO:0032580; GO:0046920,PATHWAY: Protein modification; protein glycosylation.,,,PF17039;PF00852;,Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosyltransferase activity [GO:0008417]; protein glycosylation [GO:0006486]
Q6ZRF8,CHOYP_TVAG_127540.1.10|m.21803,0,0,0,0,0,0,0,0,0.00000003,RING finger protein 207,RNF207 C1orf188,634,cell-cell signaling involved in cardiac conduction [GO:0086019]; positive regulation of delayed rectifier potassium channel activity [GO:1902261]; positive regulation of gene expression [GO:0010628]; positive regulation of voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization [GO:1903954]; positive regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization [GO:1903762]; regulation of cardiac muscle contraction [GO:0055117]; regulation of heart looping [GO:1901207],GO:0008270; GO:0010628; GO:0030544; GO:0044325; GO:0048471; GO:0051087; GO:0055117; GO:0086019; GO:1901207; GO:1902261; GO:1903762; GO:1903954,,,,PF00643;PF00097;,perinuclear region of cytoplasm [GO:0048471]; chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; ion channel binding [GO:0044325]; zinc ion binding [GO:0008270]; cell-cell signaling involved in cardiac conduction [GO:0086019]; positive regulation of delayed rectifier potassium channel activity [GO:1902261]; positive regulation of gene expression [GO:0010628]; positive regulation of voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization [GO:1903954]; positive regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization [GO:1903762]; regulation of cardiac muscle contraction [GO:0055117]; regulation of heart looping [GO:1901207]
Q6R7F6,CHOYP_Y071.1.1|m.29248,0,0,0,0,0,0,0,0,9.00E-134,Uncharacterized protein ORF72,ORF72,188,,GO:0016021; GO:0033644,,,,,host cell membrane [GO:0033644]; integral component of membrane [GO:0016021]
Q6PFX9,CHOYP_BRAFLDRAFT_126480.1.1|m.31307,0,0,0,0,0,0,0,0,0.000002,Tankyrase-1 (TANK1) (EC 2.4.2.30) (ADP-ribosyltransferase diphtheria toxin-like 5) (ARTD5) (TRF1-interacting ankyrin-related ADP-ribose polymerase 1) (Tankyrase I),Tnks Tnks1,1320,"cell division [GO:0051301]; mitotic nuclear division [GO:0007067]; mRNA transport [GO:0051028]; negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric [GO:1904908]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; negative regulation of telomeric DNA binding [GO:1904743]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein ADP-ribosylation [GO:0006471]; protein auto-ADP-ribosylation [GO:0070213]; protein localization to chromosome, telomeric region [GO:0070198]; protein poly-ADP-ribosylation [GO:0070212]; protein polyubiquitination [GO:0000209]; protein transport [GO:0015031]; spindle assembly [GO:0051225]; Wnt signaling pathway [GO:0016055]",GO:0000139; GO:0000209; GO:0000775; GO:0000781; GO:0000784; GO:0000922; GO:0003950; GO:0005643; GO:0005654; GO:0005794; GO:0005829; GO:0006471; GO:0007067; GO:0008270; GO:0015031; GO:0016055; GO:0016604; GO:0018105; GO:0018107; GO:0031965; GO:0032212; GO:0042393; GO:0045944; GO:0051028; GO:0051225; GO:0051301; GO:0051973; GO:0070198; GO:0070212; GO:0070213; GO:0090263; GO:1904355; GO:1904357; GO:1904743; GO:1904908,,,,PF00023;PF12796;PF13606;PF00644;PF07647;,"chromosome, centromeric region [GO:0000775]; chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nuclear body [GO:0016604]; nuclear chromosome, telomeric region [GO:0000784]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; spindle pole [GO:0000922]; histone binding [GO:0042393]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; zinc ion binding [GO:0008270]; cell division [GO:0051301]; mitotic nuclear division [GO:0007067]; mRNA transport [GO:0051028]; negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric [GO:1904908]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; negative regulation of telomeric DNA binding [GO:1904743]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein ADP-ribosylation [GO:0006471]; protein auto-ADP-ribosylation [GO:0070213]; protein localization to chromosome, telomeric region [GO:0070198]; protein poly-ADP-ribosylation [GO:0070212]; protein polyubiquitination [GO:0000209]; protein transport [GO:0015031]; spindle assembly [GO:0051225]; Wnt signaling pathway [GO:0016055]"
D6REC4,CHOYP_BRAFLDRAFT_128345.1.1|m.9897,1,0,0,0,0,0,0,0,3.00E-67,Cilia- and flagella-associated protein 99,CFAP99,459,,GO:0042995,,,,,cell projection [GO:0042995]
Q5BIM1,CHOYP_BRAFLDRAFT_80577.2.6|m.24330,0,0,0,0,0,0,0,0,9.00E-15,Tripartite motif-containing protein 45,TRIM45,580,bone development [GO:0060348],GO:0005654; GO:0005829; GO:0008270; GO:0045171; GO:0060348,,,,PF00630;PF00643;PF13445;,cytosol [GO:0005829]; intercellular bridge [GO:0045171]; nucleoplasm [GO:0005654]; zinc ion binding [GO:0008270]; bone development [GO:0060348]
P21180,CHOYP_CTRA.1.2|m.26705,4.5,0,0,0,0,0,0,0,9.00E-11,Complement C2 (EC 3.4.21.43) (C3/C5 convertase) [Cleaved into: Complement C2b fragment; Complement C2a fragment],C2,760,"complement activation [GO:0006956]; complement activation, classical pathway [GO:0006958]; innate immune response [GO:0045087]; positive regulation of apoptotic cell clearance [GO:2000427]; response to nutrient [GO:0007584]",GO:0004252; GO:0005615; GO:0006956; GO:0006958; GO:0007584; GO:0045087; GO:0046872; GO:0070062; GO:2000427,,,cd00033;cd00190;,PF00084;PF00089;PF00092;,"extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; complement activation [GO:0006956]; complement activation, classical pathway [GO:0006958]; innate immune response [GO:0045087]; positive regulation of apoptotic cell clearance [GO:2000427]; response to nutrient [GO:0007584]"
Q7KVW5,CHOYP_DGRI_GH24618.1.2|m.1995,0,0,0,0,0,0,0,0,0,Small conductance calcium-activated potassium channel protein (Protein SK) (dSK),SK CG10706,927,potassium ion transport [GO:0006813]; regulation of membrane potential in photoreceptor cell [GO:0016057],GO:0005516; GO:0005886; GO:0006813; GO:0009881; GO:0016021; GO:0016057; GO:0016286; GO:0043025,,,,PF02888;PF07885;PF03530;,integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; calmodulin binding [GO:0005516]; photoreceptor activity [GO:0009881]; small conductance calcium-activated potassium channel activity [GO:0016286]; potassium ion transport [GO:0006813]; regulation of membrane potential in photoreceptor cell [GO:0016057]
Q5REG4,CHOYP_DTX3.3.3|m.64703,0.5,0,0,0,0,0,0,0,7.00E-62,Probable E3 ubiquitin-protein ligase DTX3 (EC 2.3.2.27) (Protein deltex-3) (Deltex3) (RING-type E3 ubiquitin transferase DTX3),DTX3,347,Notch signaling pathway [GO:0007219]; protein ubiquitination [GO:0016567],GO:0005737; GO:0007219; GO:0008270; GO:0016567; GO:0016740,PATHWAY: Protein modification; protein ubiquitination.,,,,cytoplasm [GO:0005737]; transferase activity [GO:0016740]; zinc ion binding [GO:0008270]; Notch signaling pathway [GO:0007219]; protein ubiquitination [GO:0016567]
Q6TH47,CHOYP_FA13A.1.2|m.297,0,0,0,0,0,0,0,0,1.00E-73,STAM-binding protein-like A (EC 3.4.19.-),stambpa amsh stambp,418,,GO:0008237; GO:0046872,,,,PF01398;PF08969;,metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]
Q90W98,CHOYP_IVBI.2.2|m.67049,0.5,0,0,0,0,0,0,0,2.00E-13,Kunitz-type serine protease inhibitor textilinin-4 (Txln-4),,83,,GO:0004867; GO:0005576,,,,PF00014;,extracellular region [GO:0005576]; serine-type endopeptidase inhibitor activity [GO:0004867]
A2RT67,CHOYP_LOC100083076.1.1|m.35327,0,0,0,0,0,0,0,0,1.00E-169,DENN domain-containing protein 3,Dennd3 Kiaa0870,1274,cellular protein catabolic process [GO:0044257]; endosome to lysosome transport [GO:0008333],GO:0005622; GO:0008333; GO:0017112; GO:0044257,,,,PF02141;,intracellular [GO:0005622]; Rab guanyl-nucleotide exchange factor activity [GO:0017112]; cellular protein catabolic process [GO:0044257]; endosome to lysosome transport [GO:0008333]
Q5BIM1,CHOYP_LOC100157373.1.1|m.51867,0,0,0,0,0,0,0,0,0.000000005,Tripartite motif-containing protein 45,TRIM45,580,bone development [GO:0060348],GO:0005654; GO:0005829; GO:0008270; GO:0045171; GO:0060348,,,,PF00630;PF00643;PF13445;,cytosol [GO:0005829]; intercellular bridge [GO:0045171]; nucleoplasm [GO:0005654]; zinc ion binding [GO:0008270]; bone development [GO:0060348]
P20072,CHOYP_LOC100367736.2.2|m.66862,2,0,0,0,0,0,0,0,1.00E-127,Annexin A7 (Annexin VII) (Annexin-7) (Synexin),ANXA7 ANX7,463,autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to salt stress [GO:0009651]; social behavior [GO:0035176],GO:0003723; GO:0005509; GO:0005544; GO:0005635; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007599; GO:0008283; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0030855; GO:0035176; GO:0042584; GO:0042802; GO:0048306; GO:0070062,,,,PF00191;,chromaffin granule membrane [GO:0042584]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; nuclear envelope [GO:0005635]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; calcium-dependent protein binding [GO:0048306]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to salt stress [GO:0009651]; social behavior [GO:0035176]
Q5REG4,CHOYP_LOC100368715.1.3|m.31823,0,0,0,0,0,0,0,0,2.00E-58,Probable E3 ubiquitin-protein ligase DTX3 (EC 2.3.2.27) (Protein deltex-3) (Deltex3) (RING-type E3 ubiquitin transferase DTX3),DTX3,347,Notch signaling pathway [GO:0007219]; protein ubiquitination [GO:0016567],GO:0005737; GO:0007219; GO:0008270; GO:0016567; GO:0016740,PATHWAY: Protein modification; protein ubiquitination.,,,,cytoplasm [GO:0005737]; transferase activity [GO:0016740]; zinc ion binding [GO:0008270]; Notch signaling pathway [GO:0007219]; protein ubiquitination [GO:0016567]
Q9DBB5,CHOYP_LOC100370061.1.1|m.41505,2,0,0,0,0,0,0,0,5.00E-72,Eukaryotic translation initiation factor 4E type 3 (eIF-4E type 3) (eIF-4E3) (eIF4E type 3) (eIF4E-3),Eif4e3,207,regulation of translation [GO:0006417],GO:0003743; GO:0005737; GO:0005845; GO:0006417,,,,PF01652;,cytoplasm [GO:0005737]; mRNA cap binding complex [GO:0005845]; translation initiation factor activity [GO:0003743]; regulation of translation [GO:0006417]
Q6NXP6,CHOYP_LOC100375012.1.1|m.11931,1,0,0,0,0,0,0,0,2.00E-56,NADP-dependent oxidoreductase domain-containing protein 1 (EC 1.-.-.-) (Pyrroline-5-carboxylate reductase-like protein C14orf148),NOXRED1 C14orf148,359,proline biosynthetic process [GO:0006561],GO:0004735; GO:0006561,,,,PF03807;,pyrroline-5-carboxylate reductase activity [GO:0004735]; proline biosynthetic process [GO:0006561]
P35556,CHOYP_LOC100637925.1.4|m.34491,0,0,0,0,0,0,0,0,5.00E-117,Fibrillin-2 [Cleaved into: Fibrillin-2 C-terminal peptide],FBN2,2912,bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; extracellular matrix disassembly [GO:0022617]; extracellular matrix organization [GO:0030198]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of cellular response to growth factor stimulus [GO:0090287]; sequestering of TGFbeta in extracellular matrix [GO:0035583],GO:0001527; GO:0005201; GO:0005509; GO:0005576; GO:0005578; GO:0022617; GO:0030023; GO:0030198; GO:0030326; GO:0030501; GO:0031012; GO:0035583; GO:0043010; GO:0045669; GO:0048048; GO:0060346; GO:0090287,,,,PF12662;PF07645;PF12661;PF00683;,extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; microfibril [GO:0001527]; proteinaceous extracellular matrix [GO:0005578]; calcium ion binding [GO:0005509]; extracellular matrix constituent conferring elasticity [GO:0030023]; extracellular matrix structural constituent [GO:0005201]; bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; extracellular matrix disassembly [GO:0022617]; extracellular matrix organization [GO:0030198]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of cellular response to growth factor stimulus [GO:0090287]; sequestering of TGFbeta in extracellular matrix [GO:0035583]
P11147,CHOYP_LOC100899882.1.3|m.27725,1,0,0,0,0,0,0,0,8.00E-13,Heat shock 70 kDa protein cognate 4 (Heat shock 70 kDa protein 88E),Hsc70-4 Hsc4 CG4264,651,"axonal fasciculation [GO:0007413]; axon guidance [GO:0007411]; cellular response to topologically incorrect protein [GO:0035967]; chaperone-mediated protein folding [GO:0061077]; embryonic development via the syncytial blastoderm [GO:0001700]; heterochromatin organization involved in chromatin silencing [GO:0070868]; late endosomal microautophagy [GO:0061738]; membrane organization [GO:0061024]; mRNA splicing, via spliceosome [GO:0000398]; nervous system development [GO:0007399]; neurotransmitter secretion [GO:0007269]; ovarian follicle cell development [GO:0030707]; protein folding [GO:0006457]; RNA interference [GO:0016246]; vesicle-mediated transport [GO:0016192]",GO:0000398; GO:0001700; GO:0005524; GO:0005634; GO:0005726; GO:0005737; GO:0005739; GO:0005811; GO:0005875; GO:0006457; GO:0007269; GO:0007399; GO:0007411; GO:0007413; GO:0016192; GO:0016246; GO:0030707; GO:0035967; GO:0048471; GO:0051082; GO:0051087; GO:0061024; GO:0061077; GO:0061738; GO:0070868; GO:0071011; GO:0071013; GO:0098793,,,,PF00012;,"catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; lipid particle [GO:0005811]; microtubule associated complex [GO:0005875]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perichromatin fibrils [GO:0005726]; perinuclear region of cytoplasm [GO:0048471]; precatalytic spliceosome [GO:0071011]; presynapse [GO:0098793]; ATP binding [GO:0005524]; chaperone binding [GO:0051087]; unfolded protein binding [GO:0051082]; axon guidance [GO:0007411]; axonal fasciculation [GO:0007413]; cellular response to topologically incorrect protein [GO:0035967]; chaperone-mediated protein folding [GO:0061077]; embryonic development via the syncytial blastoderm [GO:0001700]; heterochromatin organization involved in chromatin silencing [GO:0070868]; late endosomal microautophagy [GO:0061738]; membrane organization [GO:0061024]; mRNA splicing, via spliceosome [GO:0000398]; nervous system development [GO:0007399]; neurotransmitter secretion [GO:0007269]; ovarian follicle cell development [GO:0030707]; protein folding [GO:0006457]; RNA interference [GO:0016246]; vesicle-mediated transport [GO:0016192]"
Q6DRD9,CHOYP_LOC101163682.1.1|m.10220,0,0,0,0,0,0,0,0,8.00E-77,Protein ABHD11 (EC 3.-.-.-) (Alpha/beta hydrolase domain-containing protein 11) (Abhydrolase domain-containing protein 11) (Williams-Beuren syndrome chromosomal region 21 protein homolog),abhd11 wbscr21,317,,GO:0016787,,,,PF00561;,hydrolase activity [GO:0016787]
Q9NRF2,CHOYP_LOC552012.1.1|m.65224,0.5,0,0,0,0,0,0,0,1.00E-74,"SH2B adapter protein 1 (Pro-rich, PH and SH2 domain-containing signaling mediator) (PSM) (SH2 domain-containing protein 1B)",SH2B1 KIAA1299 SH2B,756,blood coagulation [GO:0007596]; intracellular signal transduction [GO:0035556]; lamellipodium assembly [GO:0030032]; positive regulation of mitotic nuclear division [GO:0045840]; regulation of DNA biosynthetic process [GO:2000278],GO:0004871; GO:0005634; GO:0005829; GO:0007596; GO:0016020; GO:0030032; GO:0035556; GO:0035591; GO:0045840; GO:2000278,,,,PF00169;PF08916;PF00017;,cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; signal transducer activity [GO:0004871]; signaling adaptor activity [GO:0035591]; blood coagulation [GO:0007596]; intracellular signal transduction [GO:0035556]; lamellipodium assembly [GO:0030032]; positive regulation of mitotic nuclear division [GO:0045840]; regulation of DNA biosynthetic process [GO:2000278]
Q6PIP5,CHOYP_LOC590657.1.1|m.634,0.5,0,0,0,0,0,0,0,2.00E-137,NudC domain-containing protein 1,Nudcd1,582,,GO:0005654; GO:0005829,,,,PF04969;,cytosol [GO:0005829]; nucleoplasm [GO:0005654]
P46198,CHOYP_MTIF2.1.1|m.17935,0,0,0,0,0,0,0,0,2.00E-158,"Translation initiation factor IF-2, mitochondrial (IF-2(Mt)) (IF-2Mt) (IF2(mt))",MTIF2,727,mitochondrial translational initiation [GO:0070124]; ribosome disassembly [GO:0032790],GO:0003743; GO:0003924; GO:0005525; GO:0005654; GO:0005739; GO:0005759; GO:0008135; GO:0032790; GO:0043024; GO:0070124,,,,PF11987;,"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; ribosomal small subunit binding [GO:0043024]; translation factor activity, RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]; mitochondrial translational initiation [GO:0070124]; ribosome disassembly [GO:0032790]"
Q9UI36,CHOYP_PHUM_PHUM350510.1.1|m.44180,0,0,0,0,0,0,0,0,7.00E-60,Dachshund homolog 1 (Dach1),DACH1 DACH,760,"cell proliferation [GO:0008283]; development of primary female sexual characteristics [GO:0046545]; multicellular organism development [GO:0007275]; negative regulation of cell migration [GO:0030336]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; negative regulation of DNA biosynthetic process [GO:2000279]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by competitive promoter binding [GO:0010944]; regulation of nuclear cell cycle DNA replication [GO:0033262]; respiratory gaseous exchange [GO:0007585]; suckling behavior [GO:0001967]",GO:0001075; GO:0001078; GO:0001967; GO:0003677; GO:0005634; GO:0005667; GO:0005737; GO:0007275; GO:0007585; GO:0008283; GO:0010944; GO:0030336; GO:0033262; GO:0045892; GO:0046545; GO:0048147; GO:0060244; GO:2000279,,,,PF02437;,"cytoplasm [GO:0005737]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; DNA binding [GO:0003677]; transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly [GO:0001075]; transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding [GO:0001078]; cell proliferation [GO:0008283]; development of primary female sexual characteristics [GO:0046545]; multicellular organism development [GO:0007275]; negative regulation of cell migration [GO:0030336]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; negative regulation of DNA biosynthetic process [GO:2000279]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of transcription by competitive promoter binding [GO:0010944]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of nuclear cell cycle DNA replication [GO:0033262]; respiratory gaseous exchange [GO:0007585]; suckling behavior [GO:0001967]"
Q5UPH4,CHOYP_TVAG_020440.14.21|m.33137,0,0,0,0,0,0,0,0,0.000000009,Putative ankyrin repeat protein R96,MIMI_R96,1015,,,,,,PF12796;,
Q66KB0,CHOYP_UBE2Z.1.1|m.61760,0,0,0,0,0,0,0,0,9.00E-137,Ubiquitin-conjugating enzyme E2 Z (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme Z) (Ubiquitin carrier protein Z) (Ubiquitin-protein ligase Z),ube2z,313,apoptotic process [GO:0006915],GO:0005524; GO:0005634; GO:0005737; GO:0006915; GO:0031625; GO:0061630,PATHWAY: Protein modification; protein ubiquitination. {ECO:0000255|PROSITE-ProRule:PRU00388}.,,,PF00179;,cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; apoptotic process [GO:0006915]
Q01650,CHOYP_BAT1.4.4|m.32273,0,0,0,0,0,0,0,0,2.00E-107,Large neutral amino acids transporter small subunit 1 (4F2 light chain) (4F2 LC) (4F2LC) (CD98 light chain) (Integral membrane protein E16) (L-type amino acid transporter 1) (hLAT1) (Solute carrier family 7 member 5) (y+ system cationic amino acid transporter),SLC7A5 CD98LC LAT1 MPE16,507,amino acid transport [GO:0006865]; cell differentiation [GO:0030154]; cellular amino acid metabolic process [GO:0006520]; leukocyte migration [GO:0050900]; nervous system development [GO:0007399]; neutral amino acid transport [GO:0015804]; transport [GO:0006810]; tryptophan catabolic process [GO:0006569],GO:0005829; GO:0005886; GO:0005887; GO:0006520; GO:0006569; GO:0006810; GO:0006865; GO:0007399; GO:0015171; GO:0015175; GO:0015179; GO:0015297; GO:0015804; GO:0016020; GO:0016324; GO:0030154; GO:0042605; GO:0043231; GO:0050900; GO:0070062,,,,PF13520;,apical plasma membrane [GO:0016324]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; plasma membrane [GO:0005886]; amino acid transmembrane transporter activity [GO:0015171]; antiporter activity [GO:0015297]; L-amino acid transmembrane transporter activity [GO:0015179]; neutral amino acid transmembrane transporter activity [GO:0015175]; peptide antigen binding [GO:0042605]; amino acid transport [GO:0006865]; cell differentiation [GO:0030154]; cellular amino acid metabolic process [GO:0006520]; leukocyte migration [GO:0050900]; nervous system development [GO:0007399]; neutral amino acid transport [GO:0015804]; transport [GO:0006810]; tryptophan catabolic process [GO:0006569]
Q00808,CHOYP_BRAFLDRAFT_117940.1.1|m.59223,0.5,0,0,0,0,0,0,0,1.00E-12,Vegetative incompatibility protein HET-E-1,HET-E1,1356,,GO:0005525,,,,PF06985;PF00400;,GTP binding [GO:0005525]
P60027,CHOYP_BRAFLDRAFT_57175.1.1|m.7616,0,0,0,0,0,0,0,0,0,General transcription factor IIH subunit 4 (Basic transcription factor 2 52 kDa subunit) (BTF2 p52) (General transcription factor IIH polypeptide 4) (TFIIH basal transcription factor complex p52 subunit),GTF2H4,462,nucleotide-excision repair [GO:0006289]; phosphorylation of RNA polymerase II C-terminal domain [GO:0070816]; transcription from RNA polymerase II promoter [GO:0006366],GO:0000438; GO:0000439; GO:0003690; GO:0003700; GO:0004003; GO:0005634; GO:0005669; GO:0005675; GO:0006289; GO:0006366; GO:0008353; GO:0016607; GO:0070816,,,,PF03849;,"core TFIIH complex [GO:0000439]; core TFIIH complex portion of holo TFIIH complex [GO:0000438]; holo TFIIH complex [GO:0005675]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669]; ATP-dependent DNA helicase activity [GO:0004003]; double-stranded DNA binding [GO:0003690]; RNA polymerase II carboxy-terminal domain kinase activity [GO:0008353]; transcription factor activity, sequence-specific DNA binding [GO:0003700]; nucleotide-excision repair [GO:0006289]; phosphorylation of RNA polymerase II C-terminal domain [GO:0070816]; transcription from RNA polymerase II promoter [GO:0006366]"
Q5HV33,CHOYP_BRAFLDRAFT_57788.8.10|m.49717,0,0,0,0,0,0,0,0,0.000000001,Chaperone protein DnaK (HSP70) (Heat shock 70 kDa protein) (Heat shock protein 70),dnaK CJE0850,623,protein folding [GO:0006457]; response to heat [GO:0009408],GO:0005524; GO:0006457; GO:0009408,,,,PF00012;,ATP binding [GO:0005524]; protein folding [GO:0006457]; response to heat [GO:0009408]
Q92485,CHOYP_BRAFLDRAFT_67999.1.1|m.44535,0,0,0,0,0,0,0,0,3.00E-100,Acid sphingomyelinase-like phosphodiesterase 3b (ASM-like phosphodiesterase 3b) (EC 3.1.4.-),SMPDL3B ASML3B,455,inflammatory response [GO:0006954]; innate immune response [GO:0045087]; membrane lipid catabolic process [GO:0046466]; negative regulation of inflammatory response [GO:0050728]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; sphingomyelin catabolic process [GO:0006685],GO:0004767; GO:0005615; GO:0005886; GO:0006685; GO:0006954; GO:0008081; GO:0016798; GO:0031225; GO:0034122; GO:0045087; GO:0046466; GO:0046872; GO:0050728; GO:0070062,,,,PF00149;,"anchored component of membrane [GO:0031225]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; hydrolase activity, acting on glycosyl bonds [GO:0016798]; metal ion binding [GO:0046872]; phosphoric diester hydrolase activity [GO:0008081]; sphingomyelin phosphodiesterase activity [GO:0004767]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; membrane lipid catabolic process [GO:0046466]; negative regulation of inflammatory response [GO:0050728]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; sphingomyelin catabolic process [GO:0006685]"
P20397,CHOYP_CALM.31.50|m.48469,0,0,0,0,0,0,0,0,2.00E-15,Nucleolin (Protein C23),ncl,651,,GO:0000166; GO:0003677; GO:0003723; GO:0005730,,,cd12403;cd12404;cd12405;cd12406;,PF00076;,nucleolus [GO:0005730]; DNA binding [GO:0003677]; nucleotide binding [GO:0000166]; RNA binding [GO:0003723]
Q6IQX7,CHOYP_CHSS2.1.1|m.19314,0,0,0,0,0,0,0,0,6.00E-122,Chondroitin sulfate synthase 2 (EC 2.4.1.175) (EC 2.4.1.226) (Chondroitin glucuronyltransferase 2) (Chondroitin-polymerizing factor) (ChPF) (Glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase II) (N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase II) (N-acetylgalactosaminyltransferase 2),Chpf Css2 D1Bwg1363e,774,chondroitin sulfate biosynthetic process [GO:0030206],GO:0005759; GO:0005829; GO:0016021; GO:0016757; GO:0030206; GO:0032580; GO:0046872; GO:0047238; GO:0050510,,,,PF05679;,"cytosol [GO:0005829]; Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; mitochondrial matrix [GO:0005759]; glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity [GO:0047238]; metal ion binding [GO:0046872]; N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity [GO:0050510]; transferase activity, transferring glycosyl groups [GO:0016757]; chondroitin sulfate biosynthetic process [GO:0030206]"
A3DC27,CHOYP_COL6A6.1.2|m.39071,0,0,0,0,0,0,0,0,7.00E-11,Anti-sigma-I factor RsgI2,rsgI2 Cthe_0267,671,carbohydrate metabolic process [GO:0005975],GO:0005886; GO:0005975; GO:0016021; GO:0030248; GO:0046872,,,,PF00942;PF12791;,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cellulose binding [GO:0030248]; metal ion binding [GO:0046872]; carbohydrate metabolic process [GO:0005975]
Q9V3D2,CHOYP_HEM6.1.1|m.17205,0,0,0,0,0,0,0,0,7.00E-165,Oxygen-dependent coproporphyrinogen-III oxidase (COX) (Coprogen oxidase) (Coproporphyrinogenase) (EC 1.3.3.3),Coprox CG3433,390,heme biosynthetic process [GO:0006783]; protoporphyrinogen IX biosynthetic process [GO:0006782],GO:0004109; GO:0005739; GO:0006782; GO:0006783; GO:0042803,PATHWAY: Porphyrin-containing compound metabolism; protoporphyrin-IX biosynthesis; protoporphyrinogen-IX from coproporphyrinogen-III (O2 route): step 1/1.,,,PF01218;,mitochondrion [GO:0005739]; coproporphyrinogen oxidase activity [GO:0004109]; protein homodimerization activity [GO:0042803]; heme biosynthetic process [GO:0006783]; protoporphyrinogen IX biosynthetic process [GO:0006782]
P41095,CHOYP_ISCW_ISCW007303.1.1|m.42263,0,0,0,0,0,0,0,0,4.00E-21,60S acidic ribosomal protein P0,Os08g0130500 LOC_Os08g03640 P0582D05.130-1,319,ribosome biogenesis [GO:0042254],GO:0005840; GO:0042254,,,,PF00466;,ribosome [GO:0005840]; ribosome biogenesis [GO:0042254]
Q9NZM5,CHOYP_ISCW_ISCW008669.1.1|m.20227,0,0,0,0,0,0,0,0,2.00E-37,Glioma tumor suppressor candidate region gene 2 protein (p60),GLTSCR2,478,,GO:0003723; GO:0005622; GO:0005730; GO:0043231,,,,PF07767;,intracellular [GO:0005622]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; RNA binding [GO:0003723]
Q5RBG4,CHOYP_KAT5.1.1|m.9015,0,0,0,0,0,0,0,0,0,Histone acetyltransferase KAT5 (EC 2.3.1.48) (60 kDa Tat-interactive protein) (Tip60) (Histone acetyltransferase HTATIP) (Lysine acetyltransferase 5),KAT5 HTATIP TIP60,461,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:0006978]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of growth [GO:0040008]; transcription, DNA-templated [GO:0006351]",GO:0000812; GO:0003713; GO:0004402; GO:0005730; GO:0006351; GO:0006978; GO:0032777; GO:0035267; GO:0040008; GO:0045893; GO:0046872; GO:0048471,,,,PF01853;PF11717;,"NuA4 histone acetyltransferase complex [GO:0035267]; nucleolus [GO:0005730]; perinuclear region of cytoplasm [GO:0048471]; Piccolo NuA4 histone acetyltransferase complex [GO:0032777]; Swr1 complex [GO:0000812]; histone acetyltransferase activity [GO:0004402]; metal ion binding [GO:0046872]; transcription coactivator activity [GO:0003713]; DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:0006978]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of growth [GO:0040008]; transcription, DNA-templated [GO:0006351]"
Q28178,CHOYP_LOC100332237.1.1|m.18128,0,0,0,0,0,0,0,0,8.00E-18,Thrombospondin-1,THBS1 TSP-1 TSP1,1170,behavioral response to pain [GO:0048266]; cell adhesion [GO:0007155]; inflammatory response [GO:0006954]; negative regulation of angiogenesis [GO:0016525]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986],GO:0005509; GO:0005615; GO:0005783; GO:0006954; GO:0006986; GO:0007155; GO:0008201; GO:0016525; GO:0016529; GO:0034976; GO:0048266; GO:0050840,,,,PF12662;PF00090;PF02412;PF05735;PF00093;,endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; sarcoplasmic reticulum [GO:0016529]; calcium ion binding [GO:0005509]; extracellular matrix binding [GO:0050840]; heparin binding [GO:0008201]; behavioral response to pain [GO:0048266]; cell adhesion [GO:0007155]; inflammatory response [GO:0006954]; negative regulation of angiogenesis [GO:0016525]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986]
A7E3W5,CHOYP_LOC100373178.1.1|m.61012,0,0,0,0,0,0,0,0,3.00E-55,Synaptogyrin-2 (Cellugyrin),SYNGR2,224,,GO:0016021; GO:0030672; GO:0031594; GO:0070062,,,,PF01284;,extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; neuromuscular junction [GO:0031594]; synaptic vesicle membrane [GO:0030672]
Q8AXY6,CHOYP_LOC100566968.1.1|m.15268,0,0,0,0,0,0,0,0,0,"Muscle, skeletal receptor tyrosine protein kinase (EC 2.7.10.1) (Muscle-specific tyrosine protein kinase receptor) (MuSK) (Muscle-specific kinase receptor)",MUSK,947,cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of synaptic growth at neuromuscular junction [GO:0008582],GO:0004714; GO:0005524; GO:0005886; GO:0007275; GO:0008582; GO:0016021; GO:0030054; GO:0030154; GO:0045211,,,,PF01392;PF07679;PF00051;PF07714;,cell junction [GO:0030054]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of synaptic growth at neuromuscular junction [GO:0008582]
Q8NFH5,CHOYP_LOC101064384.1.1|m.19175,0,0,0,0,0,0,0,0,4.00E-68,Nucleoporin NUP53 (35 kDa nucleoporin) (Mitotic phosphoprotein 44) (MP-44) (Nuclear pore complex protein Nup53) (Nucleoporin Nup35),NUP35 MP44 NUP53,326,"gene silencing by RNA [GO:0031047]; intracellular transport of virus [GO:0075733]; mitotic nuclear envelope disassembly [GO:0007077]; mRNA export from nucleus [GO:0006406]; NLS-bearing protein import into nucleus [GO:0006607]; nuclear pore organization [GO:0006999]; protein sumoylation [GO:0016925]; regulation of cellular response to heat [GO:1900034]; regulation of glucose transport [GO:0010827]; regulation of transcription, DNA-templated [GO:0006355]; transmembrane transport [GO:0055085]; tRNA export from nucleus [GO:0006409]; viral process [GO:0016032]; viral transcription [GO:0019083]",GO:0003697; GO:0005487; GO:0005543; GO:0005635; GO:0005652; GO:0005654; GO:0005886; GO:0006355; GO:0006406; GO:0006409; GO:0006607; GO:0006999; GO:0007077; GO:0010827; GO:0016032; GO:0016925; GO:0019083; GO:0031047; GO:0031965; GO:0044613; GO:0044615; GO:0055085; GO:0075733; GO:1900034,,,,PF05172;,"nuclear envelope [GO:0005635]; nuclear lamina [GO:0005652]; nuclear membrane [GO:0031965]; nuclear pore central transport channel [GO:0044613]; nuclear pore nuclear basket [GO:0044615]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; nucleocytoplasmic transporter activity [GO:0005487]; phospholipid binding [GO:0005543]; single-stranded DNA binding [GO:0003697]; gene silencing by RNA [GO:0031047]; intracellular transport of virus [GO:0075733]; mitotic nuclear envelope disassembly [GO:0007077]; mRNA export from nucleus [GO:0006406]; NLS-bearing protein import into nucleus [GO:0006607]; nuclear pore organization [GO:0006999]; protein sumoylation [GO:0016925]; regulation of cellular response to heat [GO:1900034]; regulation of glucose transport [GO:0010827]; regulation of transcription, DNA-templated [GO:0006355]; transmembrane transport [GO:0055085]; tRNA export from nucleus [GO:0006409]; viral process [GO:0016032]; viral transcription [GO:0019083]"
Q68ED3,CHOYP_LOC552662.1.1|m.15078,0,0,0,0,0,0,0,0,1.00E-163,Non-canonical poly(A) RNA polymerase PAPD5 (EC 2.7.7.19) (PAP-associated domain-containing protein 5) (Terminal uridylyltransferase 3) (TUTase 3) (Topoisomerase-related function protein 4-2) (TRF4-2),Papd5,633,cell division [GO:0051301]; histone mRNA catabolic process [GO:0071044]; mitotic nuclear division [GO:0007067]; mRNA processing [GO:0006397]; rRNA processing [GO:0006364],GO:0003677; GO:0003723; GO:0003887; GO:0004652; GO:0005730; GO:0005737; GO:0006364; GO:0006397; GO:0007067; GO:0046872; GO:0051301; GO:0071044,,,,PF01909;PF03828;,cytoplasm [GO:0005737]; nucleolus [GO:0005730]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; polynucleotide adenylyltransferase activity [GO:0004652]; RNA binding [GO:0003723]; cell division [GO:0051301]; histone mRNA catabolic process [GO:0071044]; mitotic nuclear division [GO:0007067]; mRNA processing [GO:0006397]; rRNA processing [GO:0006364]
Q4UMH6,CHOYP_LOC755594.4.6|m.53187,0,0,0,0,0,0,0,0,2.00E-24,Putative ankyrin repeat protein RF_0381,RF_0381,1179,guanosine tetraphosphate metabolic process [GO:0015969],GO:0015969,,,cd05399;,PF00023;PF12796;PF04607;,guanosine tetraphosphate metabolic process [GO:0015969]
Q7PR68,CHOYP_MED7.1.1|m.48813,0,0,0,0,0,0,0,0,6.00E-87,Mediator of RNA polymerase II transcription subunit 7 (Mediator complex subunit 7),MED7 AGAP002823,219,"transcription, DNA-templated [GO:0006351]",GO:0001104; GO:0006351; GO:0016592; GO:0070847,,,,PF05983;,"core mediator complex [GO:0070847]; mediator complex [GO:0016592]; RNA polymerase II transcription cofactor activity [GO:0001104]; transcription, DNA-templated [GO:0006351]"
Q5FVR2,CHOYP_NEMVEDRAFT_V1G241446.2.2|m.47394,0,0,0,0,0,0,0,0,1.00E-116,Thymidine phosphorylase (TP) (EC 2.4.2.4) (TdRPase),Tymp Ecgf1,476,pyrimidine nucleobase metabolic process [GO:0006206]; pyrimidine nucleoside metabolic process [GO:0006213],GO:0004645; GO:0005829; GO:0006206; GO:0006213; GO:0009032; GO:0016154,PATHWAY: Pyrimidine metabolism; dTMP biosynthesis via salvage pathway; dTMP from thymine: step 1/2.,,,PF02885;PF00591;PF07831;,cytosol [GO:0005829]; phosphorylase activity [GO:0004645]; pyrimidine-nucleoside phosphorylase activity [GO:0016154]; thymidine phosphorylase activity [GO:0009032]; pyrimidine nucleobase metabolic process [GO:0006206]; pyrimidine nucleoside metabolic process [GO:0006213]
Q3T0L3,CHOYP_PHUM_PHUM229210.1.1|m.50089,0,0,0,0,0,0,0,0,2.00E-13,"39S ribosomal protein L17, mitochondrial (L17mt) (MRP-L17)",MRPL17,172,mitochondrial genome maintenance [GO:0000002]; mitochondrial translational elongation [GO:0070125]; mitochondrial translational initiation [GO:0070124],GO:0000002; GO:0003735; GO:0005743; GO:0005762; GO:0070124; GO:0070125,,,,PF01196;,mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; structural constituent of ribosome [GO:0003735]; mitochondrial genome maintenance [GO:0000002]; mitochondrial translational elongation [GO:0070125]; mitochondrial translational initiation [GO:0070124]
P08043,CHOYP_ZN568.1.1|m.61611,0,0,0,0,0,0,0,0,2.00E-85,Zinc finger protein 2 (Zfp-2) (Protein mKR2),Zfp2 Fnp-2 Mkr2 Zfp-2,459,"regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]",GO:0003677; GO:0003700; GO:0005634; GO:0006351; GO:0006355; GO:0046872,,,,PF00096;,"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; transcription factor activity, sequence-specific DNA binding [GO:0003700]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]"
P08953,CHOYP_AAEL_AAEL000057.1.1|m.36013,0,0,0,0,0,0,0,0,0.0000002,Protein toll,Tl CG5490,1097,antifungal humoral response [GO:0019732]; antimicrobial humoral response [GO:0019730]; cell adhesion [GO:0007155]; defense response [GO:0006952]; defense response to fungus [GO:0050832]; defense response to Gram-positive bacterium [GO:0050830]; defense response to oomycetes [GO:0002229]; dorsal/ventral axis specification [GO:0009950]; embryonic pattern specification [GO:0009880]; heart development [GO:0007507]; hemocyte proliferation [GO:0035172]; hemopoiesis [GO:0030097]; immune response [GO:0006955]; innate immune response [GO:0045087]; larval somatic muscle development [GO:0007526]; mitotic cytokinesis [GO:0000281]; positive regulation of antibacterial peptide biosynthetic process [GO:0006963]; positive regulation of antifungal peptide biosynthetic process [GO:0006967]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of embryonic pattern specification [GO:1902875]; regulation of hemocyte differentiation [GO:0045610]; regulation of melanization defense response [GO:0035007]; response to bacterium [GO:0009617]; response to fungus [GO:0009620]; synapse assembly [GO:0007416]; synaptic target inhibition [GO:0016201]; Toll signaling pathway [GO:0008063]; zygotic specification of dorsal/ventral axis [GO:0007352],GO:0000281; GO:0002229; GO:0004888; GO:0005737; GO:0005769; GO:0005886; GO:0006952; GO:0006955; GO:0006963; GO:0006967; GO:0007155; GO:0007352; GO:0007416; GO:0007507; GO:0007526; GO:0008063; GO:0009617; GO:0009620; GO:0009880; GO:0009897; GO:0009950; GO:0009986; GO:0016021; GO:0016201; GO:0019730; GO:0019732; GO:0019955; GO:0030097; GO:0032154; GO:0035007; GO:0035172; GO:0042802; GO:0043234; GO:0045087; GO:0045610; GO:0045944; GO:0050830; GO:0050832; GO:0070976; GO:1902875,,,,PF00560;PF13306;PF13855;PF01462;PF01582;,cell surface [GO:0009986]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; protein complex [GO:0043234]; cytokine binding [GO:0019955]; identical protein binding [GO:0042802]; TIR domain binding [GO:0070976]; transmembrane signaling receptor activity [GO:0004888]; antifungal humoral response [GO:0019732]; antimicrobial humoral response [GO:0019730]; cell adhesion [GO:0007155]; defense response [GO:0006952]; defense response to fungus [GO:0050832]; defense response to Gram-positive bacterium [GO:0050830]; defense response to oomycetes [GO:0002229]; dorsal/ventral axis specification [GO:0009950]; embryonic pattern specification [GO:0009880]; heart development [GO:0007507]; hemocyte proliferation [GO:0035172]; hemopoiesis [GO:0030097]; immune response [GO:0006955]; innate immune response [GO:0045087]; larval somatic muscle development [GO:0007526]; mitotic cytokinesis [GO:0000281]; positive regulation of antibacterial peptide biosynthetic process [GO:0006963]; positive regulation of antifungal peptide biosynthetic process [GO:0006967]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of embryonic pattern specification [GO:1902875]; regulation of hemocyte differentiation [GO:0045610]; regulation of melanization defense response [GO:0035007]; response to bacterium [GO:0009617]; response to fungus [GO:0009620]; synapse assembly [GO:0007416]; synaptic target inhibition [GO:0016201]; Toll signaling pathway [GO:0008063]; zygotic specification of dorsal/ventral axis [GO:0007352]
Q7TSU7,CHOYP_AAEL_AAEL003853.1.2|m.39529,0,0,0,0,0,0,0,0,0.0000002,Kin of IRRE-like protein 2 (Kin of irregular chiasm-like protein 2),Kirrel2 Neph3,700,negative regulation of protein phosphorylation [GO:0001933]; single organismal cell-cell adhesion [GO:0016337],GO:0001933; GO:0005886; GO:0005911; GO:0016021; GO:0016337; GO:0036057,,,,PF08205;PF07679;,cell-cell junction [GO:0005911]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; slit diaphragm [GO:0036057]; negative regulation of protein phosphorylation [GO:0001933]; single organismal cell-cell adhesion [GO:0016337]
Q96JP0,CHOYP_AGAP_AGAP004499.1.1|m.13546,0,0,0,0,0,0,0,0,1.00E-118,Protein fem-1 homolog C (FEM1c) (FEM1-gamma),FEM1C KIAA1785,617,protein ubiquitination [GO:0016567],GO:0005654; GO:0005829; GO:0016567,PATHWAY: Protein modification; protein ubiquitination.,,,PF12796;,cytosol [GO:0005829]; nucleoplasm [GO:0005654]; protein ubiquitination [GO:0016567]
Q7ZWB7,CHOYP_BBS5.1.1|m.56560,0.5,0,0,0,0,0,0,0,0,Bardet-Biedl syndrome 5 protein homolog,bbs5 zgc:56578,342,cilium assembly [GO:0060271]; compound eye development [GO:0048749]; compound eye photoreceptor development [GO:0042051]; gastrulation [GO:0007369]; heart looping [GO:0001947]; intracellular transport [GO:0046907]; Kupffer's vesicle development [GO:0070121]; melanosome transport [GO:0032402]; pigment granule aggregation in cell center [GO:0051877]; pronephros formation [GO:0072116],GO:0001947; GO:0005737; GO:0007369; GO:0032266; GO:0032402; GO:0034464; GO:0036064; GO:0042051; GO:0046907; GO:0048749; GO:0051877; GO:0060170; GO:0060271; GO:0070121; GO:0072116,,,,PF07289;,BBSome [GO:0034464]; ciliary basal body [GO:0036064]; ciliary membrane [GO:0060170]; cytoplasm [GO:0005737]; phosphatidylinositol-3-phosphate binding [GO:0032266]; cilium assembly [GO:0060271]; compound eye development [GO:0048749]; compound eye photoreceptor development [GO:0042051]; gastrulation [GO:0007369]; heart looping [GO:0001947]; intracellular transport [GO:0046907]; Kupffer's vesicle development [GO:0070121]; melanosome transport [GO:0032402]; pigment granule aggregation in cell center [GO:0051877]; pronephros formation [GO:0072116]
Q5PQ44,CHOYP_BRAFLDRAFT_122572.1.1|m.29320,2.5,0,0,0,0,0,0,0,8.00E-119,Uncharacterized protein C4orf22 homolog,,233,,,,,,PF14713;,
P00378,CHOYP_BRAFLDRAFT_268308.1.1|m.17043,0,0,0,0,0,0,0,0,4.00E-51,Dihydrofolate reductase (EC 1.5.1.3),DHFR,189,glycine biosynthetic process [GO:0006545]; nucleotide biosynthetic process [GO:0009165]; one-carbon metabolic process [GO:0006730]; response to methotrexate [GO:0031427]; tetrahydrofolate biosynthetic process [GO:0046654]; tetrahydrofolate metabolic process [GO:0046653],GO:0003729; GO:0004146; GO:0006545; GO:0006730; GO:0008144; GO:0009165; GO:0031427; GO:0046653; GO:0046654; GO:0050661,"PATHWAY: Cofactor biosynthesis; tetrahydrofolate biosynthesis; 5,6,7,8-tetrahydrofolate from 7,8-dihydrofolate: step 1/1.",,cd00209;,PF00186;,dihydrofolate reductase activity [GO:0004146]; drug binding [GO:0008144]; mRNA binding [GO:0003729]; NADP binding [GO:0050661]; glycine biosynthetic process [GO:0006545]; nucleotide biosynthetic process [GO:0009165]; one-carbon metabolic process [GO:0006730]; response to methotrexate [GO:0031427]; tetrahydrofolate biosynthetic process [GO:0046654]; tetrahydrofolate metabolic process [GO:0046653]
Q5PQR5,CHOYP_BRAFLDRAFT_279143.1.1|m.50630,0,0,0,0,0,0,0,0,2.00E-141,U3 small nucleolar ribonucleoprotein protein IMP4 (U3 snoRNP protein IMP4),Imp4,291,rRNA processing [GO:0006364],GO:0001650; GO:0006364; GO:0030515; GO:0032040; GO:0034457; GO:0042134,,,,PF04427;,fibrillar center [GO:0001650]; Mpp10 complex [GO:0034457]; small-subunit processome [GO:0032040]; rRNA primary transcript binding [GO:0042134]; snoRNA binding [GO:0030515]; rRNA processing [GO:0006364]
A0JNH6,CHOYP_C102A.1.1|m.23591,0.5,0,0,0,0,0,0,0,2.00E-115,Coiled-coil domain-containing protein 102A,CCDC102A,555,,GO:0003774; GO:0016459,,,,PF01576;,myosin complex [GO:0016459]; motor activity [GO:0003774]
Q9V9L1,CHOYP_CP3AO.1.1|m.63459,0,0,0,0,0,0,0,0,4.00E-70,Probable cytochrome P450 6w1 (EC 1.14.-.-) (CYPVIW1),Cyp6w1 CG8345,514,sensory perception of smell [GO:0007608],GO:0004497; GO:0005506; GO:0005789; GO:0007608; GO:0016491; GO:0016705; GO:0020037; GO:0031090,,,,PF00067;,"endoplasmic reticulum membrane [GO:0005789]; organelle membrane [GO:0031090]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]; sensory perception of smell [GO:0007608]"
Q3V6T2,CHOYP_GRDN.1.5|m.12675,0,0,0,0,0,0,0,0,0,Girdin (Akt phosphorylation enhancer) (APE) (Coiled-coil domain-containing protein 88A) (G alpha-interacting vesicle-associated protein) (GIV) (Girders of actin filament) (Hook-related protein 1) (HkRP1),CCDC88A APE GRDN KIAA1212,1871,activation of protein kinase B activity [GO:0032148]; cell migration [GO:0016477]; cytoplasmic microtubule organization [GO:0031122]; cytoskeleton-dependent intracellular transport [GO:0030705]; DNA replication [GO:0006260]; lamellipodium assembly [GO:0030032]; membrane organization [GO:0061024]; positive regulation of cilium assembly [GO:0045724]; positive regulation of protein localization to cilium [GO:1903566]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell proliferation [GO:0042127]; regulation of DNA replication [GO:0006275]; regulation of neuron projection development [GO:0010975]; regulation of protein phosphorylation [GO:0001932]; TOR signaling [GO:0031929],GO:0001932; GO:0003779; GO:0005783; GO:0005794; GO:0005813; GO:0005814; GO:0005829; GO:0005886; GO:0006260; GO:0006275; GO:0008017; GO:0010975; GO:0016020; GO:0016477; GO:0030027; GO:0030032; GO:0030705; GO:0031122; GO:0031410; GO:0031929; GO:0032148; GO:0032956; GO:0035091; GO:0036064; GO:0042127; GO:0042803; GO:0043422; GO:0045724; GO:0051959; GO:0061024; GO:1903566,,,,PF05622;,centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; lamellipodium [GO:0030027]; membrane [GO:0016020]; plasma membrane [GO:0005886]; actin binding [GO:0003779]; dynein light intermediate chain binding [GO:0051959]; microtubule binding [GO:0008017]; phosphatidylinositol binding [GO:0035091]; protein homodimerization activity [GO:0042803]; protein kinase B binding [GO:0043422]; activation of protein kinase B activity [GO:0032148]; cell migration [GO:0016477]; cytoplasmic microtubule organization [GO:0031122]; cytoskeleton-dependent intracellular transport [GO:0030705]; DNA replication [GO:0006260]; lamellipodium assembly [GO:0030032]; membrane organization [GO:0061024]; positive regulation of cilium assembly [GO:0045724]; positive regulation of protein localization to cilium [GO:1903566]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell proliferation [GO:0042127]; regulation of DNA replication [GO:0006275]; regulation of neuron projection development [GO:0010975]; regulation of protein phosphorylation [GO:0001932]; TOR signaling [GO:0031929]
Q80YR4,CHOYP_LOC100119750.1.1|m.7019,1,0,0,0,0,0,0,0,2.00E-106,Zinc finger protein 598,Znf598 Zfp598,908,,GO:0003723; GO:0008270,,,,,RNA binding [GO:0003723]; zinc ion binding [GO:0008270]
Q60HE9,CHOYP_LOC100176799.1.1|m.3132,0,0,0,0,0,0,0,0,0,Lysosomal alpha-mannosidase (Laman) (EC 3.2.1.24) (Lysosomal acid alpha-mannosidase) (Mannosidase alpha class 2B member 1) (Mannosidase alpha-B),MAN2B1 QmoA-10471,1012,mannose metabolic process [GO:0006013],GO:0004559; GO:0005764; GO:0006013; GO:0008270; GO:0030246,,,,PF09261;PF01074;PF07748;,lysosome [GO:0005764]; alpha-mannosidase activity [GO:0004559]; carbohydrate binding [GO:0030246]; zinc ion binding [GO:0008270]; mannose metabolic process [GO:0006013]
Q8JZM4,CHOYP_LOC100366797.1.3|m.20765,0,0,0,0,0,0,0,0,0.0000001,Delta and Notch-like epidermal growth factor-related receptor (Brain EGF repeat-containing transmembrane protein),Dner Bet Bret,737,central nervous system development [GO:0007417]; glial cell differentiation [GO:0010001]; Notch receptor processing [GO:0007220]; Notch signaling pathway [GO:0007219]; skeletal muscle fiber development [GO:0048741],GO:0005112; GO:0005509; GO:0005769; GO:0005886; GO:0007219; GO:0007220; GO:0007417; GO:0010001; GO:0016021; GO:0030425; GO:0043025; GO:0048741,,,,PF00008;PF12661;,dendrite [GO:0030425]; early endosome [GO:0005769]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; central nervous system development [GO:0007417]; glial cell differentiation [GO:0010001]; Notch receptor processing [GO:0007220]; Notch signaling pathway [GO:0007219]; skeletal muscle fiber development [GO:0048741]
Q9BGT1,CHOYP_LOC100366957.1.1|m.10938,0.5,0,0,0,0,0,0,0,2.00E-30,Tetratricopeptide repeat protein 9C (TPR repeat protein 9C),TTC9C QflA-13179,171,,,,,,PF07719;,
Q5R8X6,CHOYP_LOC100465916.1.1|m.44328,0,0,0,0,0,0,0,0,2.00E-25,"Plasminogen (EC 3.4.21.7) [Cleaved into: Plasmin heavy chain A; Activation peptide; Plasmin heavy chain A, short form; Plasmin light chain B]",PLG,810,blood coagulation [GO:0007596]; fibrinolysis [GO:0042730]; tissue remodeling [GO:0048771],GO:0004252; GO:0005576; GO:0007596; GO:0042730; GO:0048771,,,cd00190;,PF00051;PF00024;PF00089;,extracellular region [GO:0005576]; serine-type endopeptidase activity [GO:0004252]; blood coagulation [GO:0007596]; fibrinolysis [GO:0042730]; tissue remodeling [GO:0048771]
Q6P360,CHOYP_LOC100471656.2.2|m.34266,0,0,0,0,0,0,0,0,8.00E-151,RING finger protein 121,rnf121,327,endoplasmic reticulum unfolded protein response [GO:0030968]; ER-associated ubiquitin-dependent protein catabolic process [GO:0030433]; neuronal action potential [GO:0019228]; protein localization to plasma membrane [GO:0072659]; regulation of ER-associated ubiquitin-dependent protein catabolic process [GO:1903069]; thigmotaxis [GO:0001966],GO:0000139; GO:0001966; GO:0005789; GO:0008270; GO:0016021; GO:0019228; GO:0030433; GO:0030968; GO:0061630; GO:0072659; GO:1903069,,,,,endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; endoplasmic reticulum unfolded protein response [GO:0030968]; ER-associated ubiquitin-dependent protein catabolic process [GO:0030433]; neuronal action potential [GO:0019228]; protein localization to plasma membrane [GO:0072659]; regulation of ER-associated ubiquitin-dependent protein catabolic process [GO:1903069]; thigmotaxis [GO:0001966]
B8ARK7,CHOYP_LOC100632618.2.3|m.30752,0,0,0,0,0,0,0,0,3.00E-45,NAD-dependent protein deacetylase SRT1 (EC 3.5.1.-) (Regulatory protein SIR2 homolog 1) (SIR2-like protein 1),SRT1 OsI_15145,484,,GO:0005634; GO:0016787; GO:0046872; GO:0070403,,,,PF02146;,nucleus [GO:0005634]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; NAD+ binding [GO:0070403]
P35448,CHOYP_LOC100888702.1.1|m.56287,0,0,0,0,0,0,0,0,6.00E-13,Thrombospondin-1,thbs1 tsp1,1173,cell adhesion [GO:0007155]; inflammatory response [GO:0006954]; negative regulation of angiogenesis [GO:0016525]; response to unfolded protein [GO:0006986],GO:0005509; GO:0005615; GO:0005783; GO:0006954; GO:0006986; GO:0007155; GO:0008201; GO:0016525; GO:0016529; GO:0050840,,,,PF12947;PF00090;PF02412;PF05735;PF00093;,endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; sarcoplasmic reticulum [GO:0016529]; calcium ion binding [GO:0005509]; extracellular matrix binding [GO:0050840]; heparin binding [GO:0008201]; cell adhesion [GO:0007155]; inflammatory response [GO:0006954]; negative regulation of angiogenesis [GO:0016525]; response to unfolded protein [GO:0006986]
Q13449,CHOYP_LSAMP.1.1|m.36104,0,0,0,0,0,0,0,0,3.00E-14,Limbic system-associated membrane protein (LSAMP) (IgLON family member 3),LSAMP IGLON3 LAMP,338,cell adhesion [GO:0007155]; C-terminal protein lipidation [GO:0006501]; locomotory exploration behavior [GO:0035641]; nervous system development [GO:0007399],GO:0005576; GO:0005886; GO:0006501; GO:0007155; GO:0007399; GO:0031225; GO:0035641,,,,PF07679;,anchored component of membrane [GO:0031225]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; C-terminal protein lipidation [GO:0006501]; cell adhesion [GO:0007155]; locomotory exploration behavior [GO:0035641]; nervous system development [GO:0007399]
P97798,CHOYP_NEO1.3.3|m.61836,0,0,0,0,0,0,0,0,0,Neogenin,Neo1 Ngn,1493,"axon guidance [GO:0007411]; cell adhesion [GO:0007155]; iron ion homeostasis [GO:0055072]; myoblast fusion [GO:0007520]; negative regulation of axon regeneration [GO:0048681]; negative regulation of protein secretion [GO:0050709]; neuron migration [GO:0001764]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of muscle cell differentiation [GO:0051149]; regulation of axon regeneration [GO:0048679]; regulation of neuron migration [GO:2001222]; regulation of transcription, DNA-templated [GO:0006355]",GO:0001764; GO:0004872; GO:0005654; GO:0005794; GO:0005886; GO:0005887; GO:0006355; GO:0007155; GO:0007411; GO:0007520; GO:0009986; GO:0016020; GO:0030513; GO:0038023; GO:0039706; GO:0045296; GO:0048679; GO:0048681; GO:0050709; GO:0051149; GO:0055072; GO:0070700; GO:0097708; GO:0098797; GO:2001222,,,cd00063;,PF00041;PF07679;PF13895;PF06583;,"cell surface [GO:0009986]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; intracellular vesicle [GO:0097708]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; BMP receptor binding [GO:0070700]; cadherin binding [GO:0045296]; co-receptor binding [GO:0039706]; receptor activity [GO:0004872]; signaling receptor activity [GO:0038023]; axon guidance [GO:0007411]; cell adhesion [GO:0007155]; iron ion homeostasis [GO:0055072]; myoblast fusion [GO:0007520]; negative regulation of axon regeneration [GO:0048681]; negative regulation of protein secretion [GO:0050709]; neuron migration [GO:0001764]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of muscle cell differentiation [GO:0051149]; regulation of axon regeneration [GO:0048679]; regulation of neuron migration [GO:2001222]; regulation of transcription, DNA-templated [GO:0006355]"
Q8MIQ9,CHOYP_OCA2.1.1|m.46084,0,0,0,0,0,0,0,0,0,P protein (Melanocyte-specific transporter protein) (Pink-eyed dilution protein homolog),Oca2 P,845,transmembrane transport [GO:0055085],GO:0016021; GO:0033162; GO:0055085,,,,PF03600;,integral component of membrane [GO:0016021]; melanosome membrane [GO:0033162]; transmembrane transport [GO:0055085]
Q9NWU1,CHOYP_OXSM.1.1|m.30217,0,0,0,0,0,0,0,0,1.00E-154,"3-oxoacyl-[acyl-carrier-protein] synthase, mitochondrial (EC 2.3.1.41) (Beta-ketoacyl-ACP synthase)",OXSM,459,acyl-CoA metabolic process [GO:0006637]; medium-chain fatty acid biosynthetic process [GO:0051792]; short-chain fatty acid biosynthetic process [GO:0051790],GO:0004315; GO:0005739; GO:0005829; GO:0006637; GO:0051790; GO:0051792,PATHWAY: Lipid metabolism; fatty acid biosynthesis.,,,PF00109;PF02801;,cytosol [GO:0005829]; mitochondrion [GO:0005739]; 3-oxoacyl-[acyl-carrier-protein] synthase activity [GO:0004315]; acyl-CoA metabolic process [GO:0006637]; medium-chain fatty acid biosynthetic process [GO:0051792]; short-chain fatty acid biosynthetic process [GO:0051790]
Q6P4W8,CHOYP_PCH2.1.1|m.7113,0,0,0,0,0,0,0,0,0,Pachytene checkpoint protein 2 homolog (Thyroid hormone receptor interactor 13 homolog) (Thyroid receptor-interacting protein 13 homolog) (TR-interacting protein 13 homolog) (TRIP-13 homolog),trip13 pch2,432,double-strand break repair [GO:0006302]; oogenesis [GO:0048477]; reciprocal meiotic recombination [GO:0007131]; spermatogenesis [GO:0007283]; synaptonemal complex assembly [GO:0007130],GO:0005524; GO:0006302; GO:0007130; GO:0007131; GO:0007283; GO:0048477,,,,PF00004;,ATP binding [GO:0005524]; double-strand break repair [GO:0006302]; oogenesis [GO:0048477]; reciprocal meiotic recombination [GO:0007131]; spermatogenesis [GO:0007283]; synaptonemal complex assembly [GO:0007130]
Q5ZHN9,CHOYP_PGPS1.1.1|m.10148,0,0,0,0,0,0,0,0,4.00E-140,"CDP-diacylglycerol--glycerol-3-phosphate 3-phosphatidyltransferase, mitochondrial (EC 2.7.8.5) (Phosphatidylglycerophosphate synthase 1) (PGP synthase 1)",PGS1 RCJMB04_35a14,557,phosphatidylglycerol biosynthetic process [GO:0006655],GO:0005524; GO:0005739; GO:0005783; GO:0006655; GO:0008444,PATHWAY: Phospholipid metabolism; phosphatidylglycerol biosynthesis; phosphatidylglycerol from CDP-diacylglycerol: step 1/2.,,,,endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; CDP-diacylglycerol-glycerol-3-phosphate 3-phosphatidyltransferase activity [GO:0008444]; phosphatidylglycerol biosynthetic process [GO:0006655]
P49747,CHOYP_PHUM_PHUM370970.1.2|m.40102,0.5,0,0,0,0,0,0,0,0,Cartilage oligomeric matrix protein (COMP) (Thrombospondin-5) (TSP5),COMP,757,animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; cell adhesion [GO:0007155]; extracellular matrix organization [GO:0030198]; growth plate cartilage development [GO:0003417]; limb development [GO:0060173]; negative regulation of apoptotic process [GO:0043066]; skeletal system development [GO:0001501],GO:0001501; GO:0002020; GO:0003417; GO:0005201; GO:0005509; GO:0005518; GO:0005576; GO:0005578; GO:0005615; GO:0006915; GO:0007155; GO:0008201; GO:0009887; GO:0030198; GO:0043066; GO:0043395; GO:0060173; GO:0070062,,,,PF11598;PF07645;PF02412;PF05735;,extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; proteinaceous extracellular matrix [GO:0005578]; calcium ion binding [GO:0005509]; collagen binding [GO:0005518]; extracellular matrix structural constituent [GO:0005201]; heparan sulfate proteoglycan binding [GO:0043395]; heparin binding [GO:0008201]; protease binding [GO:0002020]; animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; cell adhesion [GO:0007155]; extracellular matrix organization [GO:0030198]; growth plate cartilage development [GO:0003417]; limb development [GO:0060173]; negative regulation of apoptotic process [GO:0043066]; skeletal system development [GO:0001501]
P16621,CHOYP_PTPRF.3.6|m.28841,0.5,0,0,0,0,0,0,0,0,Tyrosine-protein phosphatase Lar (EC 3.1.3.48) (Protein-tyrosine-phosphate phosphohydrolase) (dLAR),Lar CG10443,2029,axon extension [GO:0048675]; axon guidance [GO:0007411]; axon target recognition [GO:0007412]; cell adhesion [GO:0007155]; embryonic development via the syncytial blastoderm [GO:0001700]; motor neuron axon guidance [GO:0008045]; negative regulation of homophilic cell adhesion [GO:1903386]; nervous system development [GO:0007399]; oogenesis [GO:0048477]; photoreceptor cell morphogenesis [GO:0008594]; protein dephosphorylation [GO:0006470]; R7 cell development [GO:0045467]; regulation of axon extension involved in axon guidance [GO:0048841]; regulation of cell shape [GO:0008360]; retinal ganglion cell axon guidance [GO:0031290]; spermatogenesis [GO:0007283]; synaptic growth at neuromuscular junction [GO:0051124],GO:0001700; GO:0004725; GO:0005001; GO:0005875; GO:0005886; GO:0005925; GO:0006470; GO:0007155; GO:0007283; GO:0007399; GO:0007411; GO:0007412; GO:0008045; GO:0008201; GO:0008360; GO:0008594; GO:0016021; GO:0030424; GO:0031290; GO:0032093; GO:0045467; GO:0048477; GO:0048675; GO:0048841; GO:0051124; GO:1903386,,,cd00063;,PF00041;PF07679;PF00102;,axon [GO:0030424]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; microtubule associated complex [GO:0005875]; plasma membrane [GO:0005886]; heparin binding [GO:0008201]; protein tyrosine phosphatase activity [GO:0004725]; SAM domain binding [GO:0032093]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; axon extension [GO:0048675]; axon guidance [GO:0007411]; axon target recognition [GO:0007412]; cell adhesion [GO:0007155]; embryonic development via the syncytial blastoderm [GO:0001700]; motor neuron axon guidance [GO:0008045]; negative regulation of homophilic cell adhesion [GO:1903386]; nervous system development [GO:0007399]; oogenesis [GO:0048477]; photoreceptor cell morphogenesis [GO:0008594]; protein dephosphorylation [GO:0006470]; R7 cell development [GO:0045467]; regulation of axon extension involved in axon guidance [GO:0048841]; regulation of cell shape [GO:0008360]; retinal ganglion cell axon guidance [GO:0031290]; spermatogenesis [GO:0007283]; synaptic growth at neuromuscular junction [GO:0051124]
Q9DBU3,CHOYP_RIOK3.1.1|m.54195,0,0,0,0,0,0,0,0,2.00E-175,Serine/threonine-protein kinase RIO3 (EC 2.7.11.1) (RIO kinase 3),Riok3,519,cellular response to dsDNA [GO:1990786]; cellular response to dsRNA [GO:0071359]; cellular response to virus [GO:0098586]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of MDA-5 signaling pathway [GO:0039534]; negative regulation of protein homooligomerization [GO:0032463]; positive regulation of innate immune response [GO:0045089]; positive regulation of interferon-beta production [GO:0032728],GO:0004674; GO:0005524; GO:0032463; GO:0032728; GO:0039534; GO:0043124; GO:0045089; GO:0046872; GO:0071359; GO:0089720; GO:0098586; GO:1990786,,,,,ATP binding [GO:0005524]; caspase binding [GO:0089720]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; cellular response to dsDNA [GO:1990786]; cellular response to dsRNA [GO:0071359]; cellular response to virus [GO:0098586]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of MDA-5 signaling pathway [GO:0039534]; negative regulation of protein homooligomerization [GO:0032463]; positive regulation of innate immune response [GO:0045089]; positive regulation of interferon-beta production [GO:0032728]
Q9JJ80,CHOYP_RPF2.2.2|m.27891,0,0,0,0,0,0,0,0,3.00E-140,Ribosome production factor 2 homolog (Brix domain-containing protein 1) (Ribosome biogenesis protein RPF2 homolog),Rpf2 Bxdc1 MNCb-4285,306,"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]; ribosomal large subunit assembly [GO:0000027]",GO:0000027; GO:0000463; GO:0003723; GO:0005634; GO:0005730; GO:0019843,,,,PF04427;,"nucleolus [GO:0005730]; nucleus [GO:0005634]; RNA binding [GO:0003723]; rRNA binding [GO:0019843]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]; ribosomal large subunit assembly [GO:0000027]"
Q6P4S6,CHOYP_SIK3.1.1|m.8214,0,0,0,0,0,0,0,0,0,Serine/threonine-protein kinase SIK3 (EC 2.7.11.1) (Salt-inducible kinase 3) (SIK-3) (Serine/threonine-protein kinase QSK),Sik3 Kiaa0999 Qsk,1311,cartilage development involved in endochondral bone morphogenesis [GO:0060351]; endochondral ossification [GO:0001958]; limb morphogenesis [GO:0035108]; multicellular organism growth [GO:0035264]; protein phosphorylation [GO:0006468]; regulation of protein localization [GO:0032880]; skeletal system morphogenesis [GO:0048705],GO:0000287; GO:0001958; GO:0004674; GO:0005524; GO:0005737; GO:0006468; GO:0032880; GO:0035108; GO:0035264; GO:0048705; GO:0060351,,,,PF00069;,cytoplasm [GO:0005737]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]; cartilage development involved in endochondral bone morphogenesis [GO:0060351]; endochondral ossification [GO:0001958]; limb morphogenesis [GO:0035108]; multicellular organism growth [GO:0035264]; protein phosphorylation [GO:0006468]; regulation of protein localization [GO:0032880]; skeletal system morphogenesis [GO:0048705]
Q7TQ69,CHOYP_TMC3.1.1|m.4078,0,0,0,0,0,0,0,0,7.00E-85,Transmembrane channel-like protein 3,Tmc3,1130,ion transport [GO:0006811],GO:0006811; GO:0016021,,,,PF07810;,integral component of membrane [GO:0016021]; ion transport [GO:0006811]
Q9NTG1,CHOYP_TRIADDRAFT_53596.1.1|m.47642,0,0,0,0,0,0,0,0,3.00E-90,Polycystic kidney disease and receptor for egg jelly-related protein (PKD and REJ homolog),PKDREJ,2253,acrosome reaction [GO:0007340]; detection of mechanical stimulus [GO:0050982],GO:0005262; GO:0005509; GO:0007340; GO:0016020; GO:0016021; GO:0050982,,,,PF08016;PF01477;PF02010;,integral component of membrane [GO:0016021]; membrane [GO:0016020]; calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; acrosome reaction [GO:0007340]; detection of mechanical stimulus [GO:0050982]
Q9JMB1,CHOYP_BRAFLDRAFT_120588.1.1|m.22993,1.5,0,0,0,0,0,0,0,2.00E-12,Testicular haploid expressed gene protein,Theg,375,cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; spermatogenesis [GO:0007283],GO:0005634; GO:0005737; GO:0007275; GO:0007283; GO:0030154,,,,PF14912;,cytoplasm [GO:0005737]; nucleus [GO:0005634]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; spermatogenesis [GO:0007283]
Q14790,CHOYP_BRAFLDRAFT_120993.1.2|m.41307,0,0,0,0,0,0,0,0,0.00000004,Caspase-8 (CASP-8) (EC 3.4.22.61) (Apoptotic cysteine protease) (Apoptotic protease Mch-5) (CAP4) (FADD-homologous ICE/ced-3-like protease) (FADD-like ICE) (FLICE) (ICE-like apoptotic protease 5) (MORT1-associated ced-3 homolog) (MACH) [Cleaved into: Caspase-8 subunit p18; Caspase-8 subunit p10],CASP8 MCH5,479,activation of cysteine-type endopeptidase activity [GO:0097202]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:0097296]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; B cell activation [GO:0042113]; cell surface receptor signaling pathway [GO:0007166]; cellular response to mechanical stimulus [GO:0071260]; cellular response to organic cyclic compound [GO:0071407]; death-inducing signaling complex assembly [GO:0071550]; execution phase of apoptosis [GO:0097194]; extrinsic apoptotic signaling pathway [GO:0097191]; macrophage differentiation [GO:0030225]; natural killer cell activation [GO:0030101]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; nucleotide-binding oligomerization domain containing signaling pathway [GO:0070423]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of macrophage differentiation [GO:0045651]; positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway [GO:1900740]; positive regulation of proteolysis [GO:0045862]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902041]; regulation of necroptotic process [GO:0060544]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]; response to antibiotic [GO:0046677]; response to cobalt ion [GO:0032025]; response to cold [GO:0009409]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to lipopolysaccharide [GO:0032496]; response to tumor necrosis factor [GO:0034612]; suppression by virus of host cysteine-type endopeptidase activity involved in apoptotic process [GO:0039650]; syncytiotrophoblast cell differentiation involved in labyrinthine layer development [GO:0060715]; T cell activation [GO:0042110]; TRAIL-activated apoptotic signaling pathway [GO:0036462]; TRIF-dependent toll-like receptor signaling pathway [GO:0035666],GO:0004197; GO:0005654; GO:0005739; GO:0005741; GO:0005829; GO:0005856; GO:0006508; GO:0006915; GO:0006919; GO:0007166; GO:0008233; GO:0008234; GO:0009409; GO:0010803; GO:0030101; GO:0030225; GO:0031264; GO:0031265; GO:0031625; GO:0032025; GO:0032355; GO:0032496; GO:0034612; GO:0035666; GO:0035877; GO:0036462; GO:0039650; GO:0042110; GO:0042113; GO:0042802; GO:0043005; GO:0043123; GO:0043124; GO:0044297; GO:0045121; GO:0045471; GO:0045651; GO:0045862; GO:0046677; GO:0051603; GO:0060544; GO:0060715; GO:0070423; GO:0071260; GO:0071407; GO:0071550; GO:0097110; GO:0097153; GO:0097190; GO:0097191; GO:0097194; GO:0097199; GO:0097200; GO:0097202; GO:0097296; GO:0097342; GO:1900740; GO:1902041; GO:1902042,,,cd00032;,PF01335;,CD95 death-inducing signaling complex [GO:0031265]; cell body [GO:0044297]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; death-inducing signaling complex [GO:0031264]; membrane raft [GO:0045121]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; ripoptosome [GO:0097342]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:0097199]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; cysteine-type peptidase activity [GO:0008234]; death effector domain binding [GO:0035877]; identical protein binding [GO:0042802]; peptidase activity [GO:0008233]; scaffold protein binding [GO:0097110]; ubiquitin protein ligase binding [GO:0031625]; activation of cysteine-type endopeptidase activity [GO:0097202]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:0097296]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; B cell activation [GO:0042113]; cell surface receptor signaling pathway [GO:0007166]; cellular response to mechanical stimulus [GO:0071260]; cellular response to organic cyclic compound [GO:0071407]; death-inducing signaling complex assembly [GO:0071550]; execution phase of apoptosis [GO:0097194]; extrinsic apoptotic signaling pathway [GO:0097191]; macrophage differentiation [GO:0030225]; natural killer cell activation [GO:0030101]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; nucleotide-binding oligomerization domain containing signaling pathway [GO:0070423]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of macrophage differentiation [GO:0045651]; positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway [GO:1900740]; positive regulation of proteolysis [GO:0045862]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902041]; regulation of necroptotic process [GO:0060544]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]; response to antibiotic [GO:0046677]; response to cobalt ion [GO:0032025]; response to cold [GO:0009409]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to lipopolysaccharide [GO:0032496]; response to tumor necrosis factor [GO:0034612]; suppression by virus of host cysteine-type endopeptidase activity involved in apoptotic process [GO:0039650]; syncytiotrophoblast cell differentiation involved in labyrinthine layer development [GO:0060715]; T cell activation [GO:0042110]; TRAIL-activated apoptotic signaling pathway [GO:0036462]; TRIF-dependent toll-like receptor signaling pathway [GO:0035666]
Q08295,CHOYP_BRAFLDRAFT_265208.7.7|m.62510,1.5,0,0,0,0,0,0,0,8.00E-34,"Oligo-1,6-glucosidase IMA2 (EC 3.2.1.10) (Alpha-glucosidase) (Isomaltase 2)",IMA2 YOL157C,589,disaccharide catabolic process [GO:0046352]; maltose metabolic process [GO:0000023],GO:0000023; GO:0004574; GO:0004575; GO:0046352,,,,PF00128;,"oligo-1,6-glucosidase activity [GO:0004574]; sucrose alpha-glucosidase activity [GO:0004575]; disaccharide catabolic process [GO:0046352]; maltose metabolic process [GO:0000023]"
Q9BPW9,CHOYP_BRAFLDRAFT_290492.1.1|m.21887,0,0,0,0,0,0,0,0,4.00E-74,Dehydrogenase/reductase SDR family member 9 (EC 1.1.-.-) (3-alpha hydroxysteroid dehydrogenase) (3-alpha-HSD) (NADP-dependent retinol dehydrogenase/reductase) (RDH-E2) (RDHL) (Retinol dehydrogenase 15) (Short chain dehydrogenase/reductase family 9C member 4) (Short-chain dehydrogenase/reductase retSDR8) (Tracheobronchial epithelial cell-specific retinol dehydrogenase) (RDH-TBE),DHRS9 RDH15 SDR9C4 UNQ835/PRO1773,319,9-cis-retinoic acid biosynthetic process [GO:0042904]; androgen metabolic process [GO:0008209]; epithelial cell differentiation [GO:0030855]; progesterone metabolic process [GO:0042448]; retinol metabolic process [GO:0042572],GO:0004022; GO:0004745; GO:0005789; GO:0008209; GO:0016854; GO:0030176; GO:0030855; GO:0031090; GO:0042448; GO:0042572; GO:0042904; GO:0047035,,,,PF00106;,endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; organelle membrane [GO:0031090]; alcohol dehydrogenase (NAD) activity [GO:0004022]; racemase and epimerase activity [GO:0016854]; retinol dehydrogenase activity [GO:0004745]; testosterone dehydrogenase (NAD+) activity [GO:0047035]; 9-cis-retinoic acid biosynthetic process [GO:0042904]; androgen metabolic process [GO:0008209]; epithelial cell differentiation [GO:0030855]; progesterone metabolic process [GO:0042448]; retinol metabolic process [GO:0042572]
Q6XZF7,CHOYP_BRAFLDRAFT_91062.1.1|m.77,0,0,0,0,0,0,0,0,1.00E-112,Dynamin-binding protein (Scaffold protein Tuba),DNMBP KIAA1010,1577,positive regulation of GTPase activity [GO:0043547]; regulation of Rho protein signal transduction [GO:0035023]; small GTPase mediated signal transduction [GO:0007264],GO:0005089; GO:0005795; GO:0005856; GO:0007264; GO:0030054; GO:0035023; GO:0043547; GO:0045202,,,,PF03114;PF00621;PF00018;PF07653;PF14604;,cell junction [GO:0030054]; cytoskeleton [GO:0005856]; Golgi stack [GO:0005795]; synapse [GO:0045202]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; positive regulation of GTPase activity [GO:0043547]; regulation of Rho protein signal transduction [GO:0035023]; small GTPase mediated signal transduction [GO:0007264]
Q8IWY4,CHOYP_BRAFLDRAFT_98740.3.7|m.46571,0.5,0,0,0,0,0,0,0,2.00E-40,"Signal peptide, CUB and EGF-like domain-containing protein 1",SCUBE1,988,adult heart development [GO:0007512]; blood coagulation [GO:0007596]; cell differentiation [GO:0030154]; endothelial cell differentiation [GO:0045446]; inflammatory response [GO:0006954]; positive regulation of smoothened signaling pathway [GO:0045880]; post-embryonic development [GO:0009791]; protein homooligomerization [GO:0051260]; signal transduction [GO:0007165],GO:0005509; GO:0005615; GO:0006954; GO:0007165; GO:0007512; GO:0007596; GO:0009791; GO:0009897; GO:0009986; GO:0019897; GO:0030154; GO:0042802; GO:0045446; GO:0045880; GO:0046982; GO:0051260,,,cd00041;,PF12662;PF00431;PF12947;PF07645;PF07699;,cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; extrinsic component of plasma membrane [GO:0019897]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; adult heart development [GO:0007512]; blood coagulation [GO:0007596]; cell differentiation [GO:0030154]; endothelial cell differentiation [GO:0045446]; inflammatory response [GO:0006954]; positive regulation of smoothened signaling pathway [GO:0045880]; post-embryonic development [GO:0009791]; protein homooligomerization [GO:0051260]; signal transduction [GO:0007165]
O75841,CHOYP_DMOJ_GI12939.1.3|m.5732,0,0,0,0,0,0,0,0,0.000001,Uroplakin-1b (UP1b) (Tetraspanin-20) (Tspan-20) (Uroplakin Ib) (UPIb),UPK1B TSPAN20,260,cell surface receptor signaling pathway [GO:0007166]; epithelial cell differentiation [GO:0030855],GO:0005198; GO:0005887; GO:0007166; GO:0016021; GO:0016324; GO:0030855; GO:0070062,,,,PF00335;,apical plasma membrane [GO:0016324]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; structural molecule activity [GO:0005198]; cell surface receptor signaling pathway [GO:0007166]; epithelial cell differentiation [GO:0030855]
P16354,CHOYP_LOC100149324.1.1|m.5536,0,0,0,0,0,0,0,0,5.00E-28,Phospholipase A2 isozymes PA3A/PA3B/PA5 (PLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),,143,arachidonic acid secretion [GO:0050482]; lipid catabolic process [GO:0016042]; phospholipid metabolic process [GO:0006644],GO:0004623; GO:0005576; GO:0006644; GO:0016042; GO:0046872; GO:0050482,,,,PF05826;,extracellular region [GO:0005576]; metal ion binding [GO:0046872]; phospholipase A2 activity [GO:0004623]; arachidonic acid secretion [GO:0050482]; lipid catabolic process [GO:0016042]; phospholipid metabolic process [GO:0006644]
Q69Z37,CHOYP_LOC100367242.1.2|m.48297,0,0,0,0,0,0,0,0,3.00E-70,Sterile alpha motif domain-containing protein 9-like (SAM domain-containing protein 9-like),Samd9l Kiaa2005,1561,common myeloid progenitor cell proliferation [GO:0035726]; endosomal vesicle fusion [GO:0034058]; hematopoietic progenitor cell differentiation [GO:0002244]; regulation of protein catabolic process [GO:0042176]; spleen development [GO:0048536]; stem cell division [GO:0017145],GO:0002244; GO:0005769; GO:0017145; GO:0034058; GO:0035726; GO:0042176; GO:0048536,,,,,early endosome [GO:0005769]; common myeloid progenitor cell proliferation [GO:0035726]; endosomal vesicle fusion [GO:0034058]; hematopoietic progenitor cell differentiation [GO:0002244]; regulation of protein catabolic process [GO:0042176]; spleen development [GO:0048536]; stem cell division [GO:0017145]
Q53GL7,CHOYP_LOC100368410.2.2|m.44510,0,0,0,0,0,0,0,0,0.0000003,Poly [ADP-ribose] polymerase 10 (PARP-10) (EC 2.4.2.30) (ADP-ribosyltransferase diphtheria toxin-like 10) (ARTD10),PARP10,1025,"NAD biosynthesis via nicotinamide riboside salvage pathway [GO:0034356]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of gene expression [GO:0010629]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of protein import into nucleus, translocation [GO:0033159]; negative regulation of protein K63-linked ubiquitination [GO:1900045]; negative regulation of viral genome replication [GO:0045071]; protein ADP-ribosylation [GO:0006471]; protein auto-ADP-ribosylation [GO:0070213]; protein poly-ADP-ribosylation [GO:0070212]; regulation of chromatin assembly [GO:0010847]",GO:0003950; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0006471; GO:0010629; GO:0010847; GO:0032088; GO:0033159; GO:0034356; GO:0043231; GO:0045071; GO:0048147; GO:0070212; GO:0070213; GO:0070530; GO:1900045,,,,PF00644;,"cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; nucleus [GO:0005634]; K63-linked polyubiquitin binding [GO:0070530]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD biosynthesis via nicotinamide riboside salvage pathway [GO:0034356]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of gene expression [GO:0010629]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of protein import into nucleus, translocation [GO:0033159]; negative regulation of protein K63-linked ubiquitination [GO:1900045]; negative regulation of viral genome replication [GO:0045071]; protein ADP-ribosylation [GO:0006471]; protein auto-ADP-ribosylation [GO:0070213]; protein poly-ADP-ribosylation [GO:0070212]; regulation of chromatin assembly [GO:0010847]"
Q7JQD3,CHOYP_LOC100371249.1.1|m.63118,0,0,0,0,0,0,0,0,4.00E-108,Gelsolin-like protein 1 (Actin-modulator) (EWAM) (EWAM-P1),AM,367,actin filament capping [GO:0051693]; actin filament fragmentation [GO:0030043]; actin filament polymerization [GO:0030041]; actin filament severing [GO:0051014]; actin nucleation [GO:0045010]; multicellular organism development [GO:0007275],GO:0003779; GO:0005509; GO:0005737; GO:0005856; GO:0007275; GO:0030041; GO:0030043; GO:0045010; GO:0051014; GO:0051693,,,,PF00626;,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; actin binding [GO:0003779]; calcium ion binding [GO:0005509]; actin filament capping [GO:0051693]; actin filament fragmentation [GO:0030043]; actin filament polymerization [GO:0030041]; actin filament severing [GO:0051014]; actin nucleation [GO:0045010]; multicellular organism development [GO:0007275]
Q7LHG5,CHOYP_LOC100708199.6.6|m.57028,0,0,0,0,0,0,0,0,2.00E-104,Transposon Ty3-I Gag-Pol polyprotein (Gag3-Pol3) (Transposon Ty3-2 TYA-TYB polyprotein) [Cleaved into: Capsid protein (CA) (p24); Spacer peptide p3; Nucleocapsid protein p11 (NC); Ty3 protease (PR) (EC 3.4.23.-) (p16); Spacer peptide J; Reverse transcriptase/ribonuclease H (RT) (RT-RH) (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.1.26.4) (p55); Integrase p52 (IN); Integrase p49 (IN)],TY3B-I YILWTy3-1 POL YIL082W-A,1498,"DNA integration [GO:0015074]; DNA recombination [GO:0006310]; transposition, RNA-mediated [GO:0032197]",GO:0000943; GO:0003677; GO:0003723; GO:0003887; GO:0003964; GO:0004190; GO:0004523; GO:0004540; GO:0005524; GO:0005634; GO:0005737; GO:0006310; GO:0008233; GO:0008270; GO:0015074; GO:0032197,,,,PF12384;PF00665;PF00078;,"cytoplasm [GO:0005737]; nucleus [GO:0005634]; retrotransposon nucleocapsid [GO:0000943]; aspartic-type endopeptidase activity [GO:0004190]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; peptidase activity [GO:0008233]; ribonuclease activity [GO:0004540]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; zinc ion binding [GO:0008270]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]; transposition, RNA-mediated [GO:0032197]"
Q28521,CHOYP_LOC100748395.6.7|m.57994,0,0,0,0,0,0,0,0,7.00E-63,"Heterogeneous nuclear ribonucleoprotein A1 (hnRNP A1) (Helix-destabilizing protein) (Single-strand-binding protein) (hnRNP core protein A1) [Cleaved into: Heterogeneous nuclear ribonucleoprotein A1, N-terminally processed]",HNRNPA1 HNRPA1,320,cellular response to sodium arsenite [GO:1903936]; mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; RNA splicing [GO:0008380],GO:0000166; GO:0003723; GO:0005634; GO:0005681; GO:0005737; GO:0006397; GO:0008380; GO:0030529; GO:0051028; GO:1903936,,,,PF11627;PF00076;,cytoplasm [GO:0005737]; intracellular ribonucleoprotein complex [GO:0030529]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; nucleotide binding [GO:0000166]; RNA binding [GO:0003723]; cellular response to sodium arsenite [GO:1903936]; mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; RNA splicing [GO:0008380]
A2RRH5,CHOYP_LOC100888253.1.1|m.18761,0.5,0,0,0,0,0,0,0,2.00E-133,WD repeat-containing protein 27,WDR27,827,,GO:0005654,,,,PF00400;,nucleoplasm [GO:0005654]
P23800,CHOYP_LOC574943.1.1|m.56446,0,0,0,0,0,0,0,0,6.00E-39,Regulator of chromosome condensation (Chromosome condensation protein 1),RCC1 CHC1,421,cell division [GO:0051301]; chromosome segregation [GO:0007059]; mitotic nuclear division [GO:0007067]; spindle assembly [GO:0051225],GO:0005085; GO:0005634; GO:0005737; GO:0007059; GO:0007067; GO:0031492; GO:0051225; GO:0051301,,,,PF00415;,cytoplasm [GO:0005737]; nucleus [GO:0005634]; guanyl-nucleotide exchange factor activity [GO:0005085]; nucleosomal DNA binding [GO:0031492]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; mitotic nuclear division [GO:0007067]; spindle assembly [GO:0051225]
Q60596,CHOYP_LOC591797.1.3|m.11526,1,0,0,0,0,0,0,0,1.00E-146,DNA repair protein XRCC1 (X-ray repair cross-complementing protein 1),Xrcc1 Xrcc-1,631,base-excision repair [GO:0006284]; DNA repair [GO:0006281]; double-strand break repair via nonhomologous end joining [GO:0006303]; hippocampus development [GO:0021766]; negative regulation of protection from non-homologous end joining at telomere [GO:1905765]; response to drug [GO:0042493]; response to hypoxia [GO:0001666]; response to organic substance [GO:0010033]; single strand break repair [GO:0000012]; telomeric DNA-containing double minutes formation [GO:0061819],GO:0000012; GO:0000784; GO:0001666; GO:0003684; GO:0005634; GO:0006281; GO:0006284; GO:0006303; GO:0010033; GO:0019899; GO:0021766; GO:0042493; GO:0061819; GO:0070522; GO:1905765,,,cd00027;,PF00533;PF16589;PF01834;,"ERCC4-ERCC1 complex [GO:0070522]; nuclear chromosome, telomeric region [GO:0000784]; nucleus [GO:0005634]; damaged DNA binding [GO:0003684]; enzyme binding [GO:0019899]; base-excision repair [GO:0006284]; DNA repair [GO:0006281]; double-strand break repair via nonhomologous end joining [GO:0006303]; hippocampus development [GO:0021766]; negative regulation of protection from non-homologous end joining at telomere [GO:1905765]; response to drug [GO:0042493]; response to hypoxia [GO:0001666]; response to organic substance [GO:0010033]; single strand break repair [GO:0000012]; telomeric DNA-containing double minutes formation [GO:0061819]"
Q8VCM3,CHOYP_LOC763340.1.1|m.60271,0,0,0,0,0,0,0,0,5.00E-57,Zinc finger FYVE domain-containing protein 21,Zfyve21,234,,GO:0005768; GO:0005925; GO:0046872,,,,PF01363;PF16696;,endosome [GO:0005768]; focal adhesion [GO:0005925]; metal ion binding [GO:0046872]
Q9FKW9,CHOYP_MA2A1.1.1|m.19620,0.5,0,0,0,0,0,0,0,3.00E-47,Probable alpha-mannosidase At5g66150 (EC 3.2.1.24),At5g66150 K2A18.23,1047,mannose metabolic process [GO:0006013]; protein deglycosylation [GO:0006517],GO:0004559; GO:0005773; GO:0006013; GO:0006517; GO:0008270; GO:0030246,,,,PF09261;PF01074;PF07748;,vacuole [GO:0005773]; alpha-mannosidase activity [GO:0004559]; carbohydrate binding [GO:0030246]; zinc ion binding [GO:0008270]; mannose metabolic process [GO:0006013]; protein deglycosylation [GO:0006517]
Q29H55,CHOYP_MB21L.1.1|m.35723,0,0,0,0,0,0,0,0,0.000000004,Protein mab-21-like,GA18415,368,,,,,,PF03281;,
Q8BU85,CHOYP_MSRB3.2.4|m.17278,1,0,0,0,0,0,0,0,3.00E-61,"Methionine-R-sulfoxide reductase B3, mitochondrial (MsrB3) (EC 1.8.4.-)",Msrb3,253,protein repair [GO:0030091]; response to oxidative stress [GO:0006979],GO:0005739; GO:0005783; GO:0006979; GO:0008270; GO:0030091; GO:0033743,,,,PF01641;,endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739]; peptide-methionine (R)-S-oxide reductase activity [GO:0033743]; zinc ion binding [GO:0008270]; protein repair [GO:0030091]; response to oxidative stress [GO:0006979]
A0JPI9,CHOYP_NEMVEDRAFT_V1G245744.1.1|m.36806,0.5,0,0,0,0,0,0,0,1.00E-44,Leucine-rich repeat-containing protein 74A (Leucine-rich repeat-containing protein 74),Lrrc74a Lrrc74,479,,,,,,PF13516;,
Q9Y4C8,CHOYP_RBM19.1.2|m.28228,0,0,0,0,0,0,0,0,0,Probable RNA-binding protein 19 (RNA-binding motif protein 19),RBM19 KIAA0682,960,multicellular organism development [GO:0007275]; positive regulation of embryonic development [GO:0040019],GO:0000166; GO:0003723; GO:0005654; GO:0005694; GO:0005730; GO:0005737; GO:0007275; GO:0016020; GO:0040019,,,,PF00076;,chromosome [GO:0005694]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleotide binding [GO:0000166]; RNA binding [GO:0003723]; multicellular organism development [GO:0007275]; positive regulation of embryonic development [GO:0040019]
O57415,CHOYP_RREB1.1.1|m.11945,0.5,0,0,0,0,0,0,0,8.00E-62,Ras-responsive element-binding protein 1 (RREB-1),RREB1,1615,"multicellular organism development [GO:0007275]; regulation of transcription, DNA-templated [GO:0006355]; signal transduction [GO:0007165]; transcription from RNA polymerase II promoter [GO:0006366]",GO:0003700; GO:0005634; GO:0006355; GO:0006366; GO:0007165; GO:0007275; GO:0043565; GO:0044212; GO:0046872,,,,PF13912;,"nucleus [GO:0005634]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; transcription factor activity, sequence-specific DNA binding [GO:0003700]; transcription regulatory region DNA binding [GO:0044212]; multicellular organism development [GO:0007275]; regulation of transcription, DNA-templated [GO:0006355]; signal transduction [GO:0007165]; transcription from RNA polymerase II promoter [GO:0006366]"
P70122,CHOYP_SBDS.1.1|m.27786,0.5,0,0,0,0,0,0,0,7.00E-122,Ribosome maturation protein SBDS (Protein 22A3) (Shwachman-Bodian-Diamond syndrome protein homolog),Sbds,250,bone marrow development [GO:0048539]; bone mineralization [GO:0030282]; cell proliferation [GO:0008283]; inner cell mass cell proliferation [GO:0001833]; leukocyte chemotaxis [GO:0030595]; mature ribosome assembly [GO:0042256]; mitotic spindle organization [GO:0007052]; rRNA processing [GO:0006364],GO:0000922; GO:0001833; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006364; GO:0007052; GO:0008017; GO:0008283; GO:0019843; GO:0030282; GO:0030595; GO:0042256; GO:0043022; GO:0048539,,,,PF01172;PF09377;,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle pole [GO:0000922]; microtubule binding [GO:0008017]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; rRNA binding [GO:0019843]; bone marrow development [GO:0048539]; bone mineralization [GO:0030282]; cell proliferation [GO:0008283]; inner cell mass cell proliferation [GO:0001833]; leukocyte chemotaxis [GO:0030595]; mature ribosome assembly [GO:0042256]; mitotic spindle organization [GO:0007052]; rRNA processing [GO:0006364]
Q9D9G2,CHOYP_AAEL_AAEL007549.1.1|m.13827,0,0,0,0,0,0,0,0,2.00E-22,Phosphatidylethanolamine-binding protein 4 (PEBP-4),Pebp4,242,,GO:0005764; GO:0070062,,,,PF01161;,extracellular exosome [GO:0070062]; lysosome [GO:0005764]
B9E6X1,CHOYP_BRAFLDRAFT_208436.29.32|m.61624,0,0,0,0,0,0,0,0,0.000000007,Chaperone protein DnaK (HSP70) (Heat shock 70 kDa protein) (Heat shock protein 70),dnaK MCCL_1232,607,protein folding [GO:0006457],GO:0005524; GO:0006457,,,,PF00012;,ATP binding [GO:0005524]; protein folding [GO:0006457]
P15129,CHOYP_BRAFLDRAFT_61250.8.14|m.44214,0,0,0,0,0,0,0,0,2.00E-115,Cytochrome P450 4B1 (EC 1.14.14.1) (CYPIVB1) (Cytochrome P450 L-2) (Cytochrome P450 isozyme 5),Cyp4b1 Cyp4b-1,511,biphenyl metabolic process [GO:0018879]; cellular aromatic compound metabolic process [GO:0006725]; exogenous drug catabolic process [GO:0042738]; fluorene metabolic process [GO:0018917],GO:0004497; GO:0005506; GO:0005789; GO:0006725; GO:0008144; GO:0015643; GO:0018585; GO:0018879; GO:0018917; GO:0020037; GO:0031090; GO:0042738; GO:0043231; GO:0070330,,,,PF00067;,endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; organelle membrane [GO:0031090]; aromatase activity [GO:0070330]; drug binding [GO:0008144]; fluorene oxygenase activity [GO:0018585]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; toxic substance binding [GO:0015643]; biphenyl metabolic process [GO:0018879]; cellular aromatic compound metabolic process [GO:0006725]; exogenous drug catabolic process [GO:0042738]; fluorene metabolic process [GO:0018917]
A2AIW0,CHOYP_BRAFLDRAFT_65137.1.1|m.64534,0,0,0,0,0,0,0,0,7.00E-18,Serologically defined colon cancer antigen 3 homolog,Sdccag3,432,"cell cycle [GO:0007049]; cell division [GO:0051301]; protein transport [GO:0015031]; regulation of cytokinesis [GO:0032465]; retrograde transport, endosome to plasma membrane [GO:1990126]",GO:0005768; GO:0005769; GO:0007049; GO:0015031; GO:0030496; GO:0030904; GO:0032465; GO:0051301; GO:0055037; GO:1990126,,,,,"early endosome [GO:0005769]; endosome [GO:0005768]; midbody [GO:0030496]; recycling endosome [GO:0055037]; retromer complex [GO:0030904]; cell cycle [GO:0007049]; cell division [GO:0051301]; protein transport [GO:0015031]; regulation of cytokinesis [GO:0032465]; retrograde transport, endosome to plasma membrane [GO:1990126]"
P20481,CHOYP_BUCC.1.2|m.10972,0,0,0,0,0,0,0,0,4.00E-40,Buccalin [Cleaved into: Buccalin-D; Buccalin-E; Buccalin-F; Buccalin-G; Buccalin-H; Buccalin-A; Buccalin-I; Buccalin-J; Buccalin-K; Buccalin-L; Buccalin-B (BUCb); Buccalin-M; Buccalin gene-predicted acidic peptide A (BGPAP A); Buccalin-N; Buccalin-O; Buccalin-P; Buccalin-Q; Buccalin-R; Buccalin-C; Buccalin-S; Buccalin gene-predicted acidic peptide B (BGPAP B)],,505,neuropeptide signaling pathway [GO:0007218],GO:0005576; GO:0007218,,,,,extracellular region [GO:0005576]; neuropeptide signaling pathway [GO:0007218]
A0FKG7,CHOYP_CAN8.1.2|m.21091,0,0,0,0,0,0,0,0,3.00E-24,Calpain-7 (EC 3.4.22.-),CAPN7,813,proteolysis [GO:0006508],GO:0004198; GO:0005634; GO:0005737; GO:0006508,,,cd00044;,PF01067;PF04212;PF00648;,cytoplasm [GO:0005737]; nucleus [GO:0005634]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; proteolysis [GO:0006508]
Q460N5,CHOYP_DSPP.5.8|m.37255,0,0,0,0,0,0,0,0,3.00E-18,Poly [ADP-ribose] polymerase 14 (PARP-14) (EC 2.4.2.30) (ADP-ribosyltransferase diphtheria toxin-like 8) (ARTD8) (B aggressive lymphoma protein 2),PARP14 BAL2 KIAA1268,1801,"regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]",GO:0003950; GO:0005634; GO:0005829; GO:0006351; GO:0006355; GO:0016020,,,,PF01661;PF00644;,"cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]"
Q9HCC6,CHOYP_HES1.2.3|m.27001,0,0,0,0,0,0,0,0,6.00E-46,Transcription factor HES-4 (hHES4) (Class B basic helix-loop-helix protein 42) (bHLHb42) (Hairy and enhancer of split 4) (bHLH factor Hes4),HES4 BHLHB42,221,"cell differentiation [GO:0030154]; nervous system development [GO:0007399]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]",GO:0003677; GO:0005634; GO:0006351; GO:0006355; GO:0007399; GO:0008134; GO:0030154,,,,PF07527;PF00010;,"nucleus [GO:0005634]; DNA binding [GO:0003677]; transcription factor binding [GO:0008134]; cell differentiation [GO:0030154]; nervous system development [GO:0007399]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]"
Q2M2Z5,CHOYP_KIZ.1.1|m.57618,0.5,0,0,0,0,0,0,0,2.00E-14,Centrosomal protein kizuna (Polo-like kinase 1 substrate 1),KIZ C20orf19 NCRNA00153 PLK1S1 HT013,673,spindle organization [GO:0007051],GO:0005737; GO:0005813; GO:0007051; GO:0019901; GO:0042995,,,,,cell projection [GO:0042995]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; protein kinase binding [GO:0019901]; spindle organization [GO:0007051]
Q3KQ80,CHOYP_LOC100178916.1.1|m.26391,0,0,0,0,0,0,0,0,7.00E-80,O(6)-methylguanine-induced apoptosis 2 (MAPO2) (Sperm-tail PG-rich repeat-containing protein 1),stpg1,352,apoptotic process [GO:0006915],GO:0005634; GO:0005737; GO:0006915,,,,PF07004;,cytoplasm [GO:0005737]; nucleus [GO:0005634]; apoptotic process [GO:0006915]
O35963,CHOYP_LOC100367291.1.1|m.51818,0,0,0,0,0,0,0,0,3.00E-100,Ras-related protein Rab-33B,Rab33b,229,"autophagy [GO:0006914]; intra-Golgi vesicle-mediated transport [GO:0006891]; negative regulation of constitutive secretory pathway [GO:1903434]; protein targeting to Golgi [GO:0000042]; regulation of autophagosome assembly [GO:2000785]; regulation of Golgi organization [GO:1903358]; regulation of retrograde vesicle-mediated transport, Golgi to ER [GO:2000156]; skeletal system morphogenesis [GO:0048705]; small GTPase mediated signal transduction [GO:0007264]",GO:0000042; GO:0000139; GO:0003924; GO:0005525; GO:0005794; GO:0005796; GO:0006891; GO:0006914; GO:0007264; GO:0048705; GO:0070062; GO:1903358; GO:1903434; GO:2000156; GO:2000785,,,,PF00071;,"extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi lumen [GO:0005796]; Golgi membrane [GO:0000139]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; autophagy [GO:0006914]; intra-Golgi vesicle-mediated transport [GO:0006891]; negative regulation of constitutive secretory pathway [GO:1903434]; protein targeting to Golgi [GO:0000042]; regulation of autophagosome assembly [GO:2000785]; regulation of Golgi organization [GO:1903358]; regulation of retrograde vesicle-mediated transport, Golgi to ER [GO:2000156]; skeletal system morphogenesis [GO:0048705]; small GTPase mediated signal transduction [GO:0007264]"
Q4QQY7,CHOYP_LOC100367470.1.1|m.51904,0,0,0,0,0,0,0,0,0,Queuine tRNA-ribosyltransferase catalytic subunit 1 (EC 2.4.2.29) (Guanine insertion enzyme) (tRNA-guanine transglycosylase),qtrt1,396,queuosine biosynthetic process [GO:0008616]; tRNA-guanine transglycosylation [GO:0101030],GO:0005741; GO:0008479; GO:0008616; GO:0042803; GO:0046872; GO:0046982; GO:0101030,,,,PF01702;,mitochondrial outer membrane [GO:0005741]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; queuine tRNA-ribosyltransferase activity [GO:0008479]; queuosine biosynthetic process [GO:0008616]; tRNA-guanine transglycosylation [GO:0101030]
B5X7E4,CHOYP_LOC100368907.1.1|m.22004,0.5,0,0,0,0,0,0,0,9.00E-45,Intraflagellar transport protein 43 homolog B,ift43b,215,cilium assembly [GO:0060271]; intraciliary retrograde transport [GO:0035721],GO:0005929; GO:0030991; GO:0035721; GO:0060271,,,,PF15305;,cilium [GO:0005929]; intraciliary transport particle A [GO:0030991]; cilium assembly [GO:0060271]; intraciliary retrograde transport [GO:0035721]
Q0V9W6,CHOYP_LOC100375232.1.2|m.2686,0,0,0,0,0,0,0,0,1.00E-51,BTB/POZ domain-containing protein 6,btbd6,529,neurogenesis [GO:0022008]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0042787]; regulation of proteolysis [GO:0030162],GO:0000932; GO:0005829; GO:0019005; GO:0022008; GO:0030162; GO:0031625; GO:0042787; GO:0043161,,,,PF07707;PF00651;PF08005;,cytosol [GO:0005829]; P-body [GO:0000932]; SCF ubiquitin ligase complex [GO:0019005]; ubiquitin protein ligase binding [GO:0031625]; neurogenesis [GO:0022008]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0042787]; regulation of proteolysis [GO:0030162]
O35375,CHOYP_LOC100552730.1.1|m.18699,0,0,0,0,0,0,0,0,2.00E-20,Neuropilin-2 (Vascular endothelial cell growth factor 165 receptor 2),Nrp2,931,angiogenesis [GO:0001525]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; dorsal root ganglion morphogenesis [GO:1904835]; facial nerve structural organization [GO:0021612]; facioacoustic ganglion development [GO:1903375]; gonadotrophin-releasing hormone neuronal migration to the hypothalamus [GO:0021828]; heart development [GO:0007507]; negative chemotaxis [GO:0050919]; nerve development [GO:0021675]; neural crest cell migration [GO:0001755]; neural crest cell migration involved in autonomic nervous system development [GO:1901166]; neuron migration [GO:0001764]; semaphorin-plexin signaling pathway involved in neuron projection guidance [GO:1902285]; sensory neuron axon guidance [GO:0097374]; sympathetic ganglion development [GO:0061549]; sympathetic neuron projection extension [GO:0097490]; sympathetic neuron projection guidance [GO:0097491]; trigeminal ganglion development [GO:0061551]; ventral trunk neural crest cell migration [GO:0036486]; vestibulocochlear nerve structural organization [GO:0021649],GO:0001525; GO:0001755; GO:0001764; GO:0005021; GO:0005886; GO:0007411; GO:0007507; GO:0008201; GO:0016021; GO:0017154; GO:0021612; GO:0021649; GO:0021675; GO:0021828; GO:0030424; GO:0036486; GO:0046872; GO:0048846; GO:0050919; GO:0061549; GO:0061551; GO:0097374; GO:0097490; GO:0097491; GO:1901166; GO:1902285; GO:1903375; GO:1904835,,,cd00041;cd06263;,PF00431;PF11980;PF00754;PF00629;,axon [GO:0030424]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; heparin binding [GO:0008201]; metal ion binding [GO:0046872]; semaphorin receptor activity [GO:0017154]; vascular endothelial growth factor-activated receptor activity [GO:0005021]; angiogenesis [GO:0001525]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; dorsal root ganglion morphogenesis [GO:1904835]; facial nerve structural organization [GO:0021612]; facioacoustic ganglion development [GO:1903375]; gonadotrophin-releasing hormone neuronal migration to the hypothalamus [GO:0021828]; heart development [GO:0007507]; negative chemotaxis [GO:0050919]; nerve development [GO:0021675]; neural crest cell migration [GO:0001755]; neural crest cell migration involved in autonomic nervous system development [GO:1901166]; neuron migration [GO:0001764]; semaphorin-plexin signaling pathway involved in neuron projection guidance [GO:1902285]; sensory neuron axon guidance [GO:0097374]; sympathetic ganglion development [GO:0061549]; sympathetic neuron projection extension [GO:0097490]; sympathetic neuron projection guidance [GO:0097491]; trigeminal ganglion development [GO:0061551]; ventral trunk neural crest cell migration [GO:0036486]; vestibulocochlear nerve structural organization [GO:0021649]
Q8WWT9,CHOYP_LOC100692894.1.1|m.10137,0,0,0,0,0,0,0,0,4.00E-144,Solute carrier family 13 member 3 (Na(+)/dicarboxylate cotransporter 3) (NaDC-3) (hNaDC3) (Sodium-dependent high-affinity dicarboxylate transporter 2),SLC13A3 NADC3 SDCT2,602,citrate transport [GO:0015746],GO:0005886; GO:0005887; GO:0015137; GO:0015141; GO:0015362; GO:0015746; GO:0017153; GO:0070062,,,,PF00939;,extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; citrate transmembrane transporter activity [GO:0015137]; high-affinity sodium:dicarboxylate symporter activity [GO:0015362]; sodium:dicarboxylate symporter activity [GO:0017153]; succinate transmembrane transporter activity [GO:0015141]; citrate transport [GO:0015746]
A7X4K1,CHOYP_LOC100700188.1.1|m.30931,0,0,0,0,0,0,0,0,0.000000001,Waprin-Phi1,,134,defense response to bacterium [GO:0042742],GO:0005576; GO:0030414; GO:0042742,,,,PF00095;,extracellular region [GO:0005576]; peptidase inhibitor activity [GO:0030414]; defense response to bacterium [GO:0042742]
Q9NL89,CHOYP_LOC100889837.2.2|m.31074,0,0,0,0,0,0,0,0,2.00E-30,"Beta-1,3-glucan-binding protein (BGBP) (Beta-1,3-glucan recognition protein) (BetaGRP)",,495,carbohydrate metabolic process [GO:0005975]; innate immune response [GO:0045087]; regulation of innate immune response [GO:0045088],GO:0004553; GO:0005576; GO:0005975; GO:0030246; GO:0045087; GO:0045088,,,,PF15886;PF00722;,"extracellular region [GO:0005576]; carbohydrate binding [GO:0030246]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; carbohydrate metabolic process [GO:0005975]; innate immune response [GO:0045087]; regulation of innate immune response [GO:0045088]"
Q6AYR9,CHOYP_LOC101157895.2.2|m.28009,0,0,0,0,0,0,0,0,0.00000004,Tetraspanin-1 (Tspan-1),Tspan1,241,cell migration [GO:0016477]; cell proliferation [GO:0008283]; cell surface receptor signaling pathway [GO:0007166]; positive regulation of endocytosis [GO:0045807]; protein stabilization [GO:0050821],GO:0005654; GO:0005765; GO:0005887; GO:0007166; GO:0008283; GO:0016477; GO:0030054; GO:0045807; GO:0048471; GO:0050821; GO:0070062,,,,PF00335;,cell junction [GO:0030054]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; cell migration [GO:0016477]; cell proliferation [GO:0008283]; cell surface receptor signaling pathway [GO:0007166]; positive regulation of endocytosis [GO:0045807]; protein stabilization [GO:0050821]
Q9N2V2,CHOYP_LOC581452.3.4|m.41000,0,0,0,0,0,0,0,0,2.00E-38,Zinc metalloproteinase nas-30 (EC 3.4.24.21) (Nematode astacin 30),nas-30 Y95B8A.1,685,,GO:0004222; GO:0008270,,,cd04280;,PF01400;,metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]
E9PGG2,CHOYP_SIX1.1.2|m.49270,0,0,0,0,0,0,0,0,1.00E-11,Anomalous homeobox protein,ANHX,379,"regulation of transcription, DNA-templated [GO:0006355]",GO:0005634; GO:0006355; GO:0043565,,,,PF00046;PF16878;,"nucleus [GO:0005634]; sequence-specific DNA binding [GO:0043565]; regulation of transcription, DNA-templated [GO:0006355]"
A2VDD2,CHOYP_TC1DB.1.1|m.22354,1.5,0,0,0,0,0,0,0,4.00E-68,Tctex1 domain-containing protein 1-B (Fragment),tctex1d1-b,176,,,,,,PF03645;,
B6CHA3,CHOYP_UHRF1.1.1|m.10935,0,0,0,0,0,0,0,0,0,E3 ubiquitin-protein ligase UHRF1 (EC 2.3.2.27) (Nuclear zinc finger protein Np95) (XNp95) (RING-type E3 ubiquitin transferase UHRF1) (Ubiquitin-like PHD and RING finger domain-containing protein 1) (Ubiquitin-like-containing PHD and RING finger domains protein 1),uhrf1 np95,772,"cell cycle [GO:0007049]; histone ubiquitination [GO:0016574]; maintenance of DNA methylation [GO:0010216]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; protein autoubiquitination [GO:0051865]; protein ubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0042787]; transcription, DNA-templated [GO:0006351]",GO:0000122; GO:0000790; GO:0000791; GO:0000792; GO:0004842; GO:0005657; GO:0006351; GO:0007049; GO:0008270; GO:0010216; GO:0016574; GO:0035064; GO:0042393; GO:0042787; GO:0044729; GO:0051865,PATHWAY: Protein modification; protein ubiquitination.,,,PF00628;PF02182;PF12148;PF00240;,"euchromatin [GO:0000791]; heterochromatin [GO:0000792]; nuclear chromatin [GO:0000790]; replication fork [GO:0005657]; hemi-methylated DNA-binding [GO:0044729]; histone binding [GO:0042393]; methylated histone binding [GO:0035064]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; cell cycle [GO:0007049]; histone ubiquitination [GO:0016574]; maintenance of DNA methylation [GO:0010216]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; protein autoubiquitination [GO:0051865]; protein ubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0042787]; transcription, DNA-templated [GO:0006351]"
Q8NHV1,CHOYP_ZGC_113625.1.2|m.2855,0,0,0,0,0,0,0,0,5.00E-51,GTPase IMAP family member 7 (Immunity-associated nucleotide 7 protein) (IAN-7),GIMAP7 IAN7,300,,GO:0003924; GO:0005525; GO:0005783; GO:0005794; GO:0005811; GO:0005829; GO:0042803; GO:0043231,,,,PF04548;,cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; lipid particle [GO:0005811]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein homodimerization activity [GO:0042803]
P86948,CHOYP_AAEL_AAEL007437.1.1|m.29443,0,0,0,0,0,0,0,0,2.00E-16,Mantle protein (MP),,260,,GO:0005576,,,,,extracellular region [GO:0005576]
Q801G1,CHOYP_ARH.2.2|m.25884,0.5,0,0,0,0,0,0,0,6.00E-48,Low density lipoprotein receptor adapter protein 1-A (Autosomal recessive hypercholesterolemia protein homolog alpha) (ARH alpha) (xARH alpha) (Phosphotyrosine-binding protein) (Xcat4),ldlrap1-a,309,cholesterol metabolic process [GO:0008203]; endocytosis [GO:0006897],GO:0005737; GO:0006897; GO:0008203,,,,PF00640;,cytoplasm [GO:0005737]; cholesterol metabolic process [GO:0008203]; endocytosis [GO:0006897]
P20693,CHOYP_ASGR2.1.4|m.4187,0,0,0,0,0,0,0,0,1.00E-19,Low affinity immunoglobulin epsilon Fc receptor (Fc-epsilon-RII) (Lymphocyte IgE receptor) (CD antigen CD23),Fcer2 Fcer2a,331,positive regulation of humoral immune response mediated by circulating immunoglobulin [GO:0002925]; positive regulation of killing of cells of other organism [GO:0051712]; positive regulation of nitric-oxide synthase activity [GO:0051000]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770],GO:0002925; GO:0009897; GO:0016021; GO:0030246; GO:0046872; GO:0051000; GO:0051712; GO:0051770; GO:0070062,,,cd03590;,PF00059;,external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; positive regulation of humoral immune response mediated by circulating immunoglobulin [GO:0002925]; positive regulation of killing of cells of other organism [GO:0051712]; positive regulation of nitric-oxide synthase activity [GO:0051000]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]
Q9EQ32,CHOYP_BRAFLDRAFT_118043.1.1|m.26278,0,0,0,0,0,0,0,0,0.000003,Phosphoinositide 3-kinase adapter protein 1 (B-cell adapter for phosphoinositide 3-kinase) (B-cell phosphoinositide 3-kinase adapter protein 1),Pik3ap1 Bcap,811,negative regulation of toll-like receptor signaling pathway [GO:0034122]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of toll-like receptor signaling pathway [GO:0034123]; regulation of inflammatory response [GO:0050727]; toll-like receptor 2 signaling pathway [GO:0034134]; toll-like receptor 4 signaling pathway [GO:0034142]; toll-like receptor 7 signaling pathway [GO:0034154]; toll-like receptor 9 signaling pathway [GO:0034162],GO:0005737; GO:0005829; GO:0005886; GO:0014068; GO:0016020; GO:0034122; GO:0034123; GO:0034134; GO:0034142; GO:0034154; GO:0034162; GO:0036312; GO:0042802; GO:0050727,,,,PF14545;,cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; phosphatidylinositol 3-kinase regulatory subunit binding [GO:0036312]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of toll-like receptor signaling pathway [GO:0034123]; regulation of inflammatory response [GO:0050727]; toll-like receptor 2 signaling pathway [GO:0034134]; toll-like receptor 4 signaling pathway [GO:0034142]; toll-like receptor 7 signaling pathway [GO:0034154]; toll-like receptor 9 signaling pathway [GO:0034162]
Q6DJK9,CHOYP_BRAFLDRAFT_119424.1.1|m.15350,0,0,0,0,0,0,0,0,7.00E-103,Coiled-coil domain-containing protein 130,ccdc130,384,,,,,,PF04502;,
Q99973,CHOYP_BRAFLDRAFT_128562.2.4|m.33663,0.5,0,0,0,0,0,0,0,6.00E-152,Telomerase protein component 1 (Telomerase-associated protein 1) (Telomerase protein 1) (p240) (p80 telomerase homolog),TEP1 TLP1 TP1,2627,RNA splicing [GO:0008380]; telomere maintenance via recombination [GO:0000722],GO:0000722; GO:0000781; GO:0002039; GO:0003720; GO:0003723; GO:0005524; GO:0005682; GO:0005697; GO:0005737; GO:0008380; GO:0016363; GO:0019899; GO:0030529; GO:0070034; GO:0071011; GO:0071013,,,,PF13271;PF05386;PF05731;PF00400;,"catalytic step 2 spliceosome [GO:0071013]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; intracellular ribonucleoprotein complex [GO:0030529]; nuclear matrix [GO:0016363]; precatalytic spliceosome [GO:0071011]; telomerase holoenzyme complex [GO:0005697]; U5 snRNP [GO:0005682]; ATP binding [GO:0005524]; enzyme binding [GO:0019899]; p53 binding [GO:0002039]; RNA binding [GO:0003723]; telomerase activity [GO:0003720]; telomerase RNA binding [GO:0070034]; RNA splicing [GO:0008380]; telomere maintenance via recombination [GO:0000722]"
Q8WYH8,CHOYP_BRAFLDRAFT_133135.1.1|m.18788,1,0,0,0,0,0,0,0,1.00E-106,Inhibitor of growth protein 5 (p28ING5),ING5,240,"DNA replication [GO:0006260]; histone H3 acetylation [GO:0043966]; negative regulation of cell proliferation [GO:0008285]; negative regulation of growth [GO:0045926]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of transcription, DNA-templated [GO:0045893]; protein acetylation [GO:0006473]; regulation of signal transduction by p53 class mediator [GO:1901796]; transcription, DNA-templated [GO:0006351]",GO:0003682; GO:0005634; GO:0005654; GO:0006260; GO:0006351; GO:0006473; GO:0008270; GO:0008285; GO:0035064; GO:0043065; GO:0043966; GO:0045893; GO:0045926; GO:0070776; GO:1901796; GO:2001235,,,,PF12998;,"MOZ/MORF histone acetyltransferase complex [GO:0070776]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; methylated histone binding [GO:0035064]; zinc ion binding [GO:0008270]; DNA replication [GO:0006260]; histone H3 acetylation [GO:0043966]; negative regulation of cell proliferation [GO:0008285]; negative regulation of growth [GO:0045926]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of transcription, DNA-templated [GO:0045893]; protein acetylation [GO:0006473]; regulation of signal transduction by p53 class mediator [GO:1901796]; transcription, DNA-templated [GO:0006351]"
P21613,CHOYP_BRAFLDRAFT_208436.27.32|m.61232,0,0,0,0,0,0,0,0,3.00E-31,Kinesin heavy chain,,967,microtubule-based movement [GO:0007018],GO:0003777; GO:0005524; GO:0005737; GO:0005874; GO:0007018,,,,PF00225;,cytoplasm [GO:0005737]; microtubule [GO:0005874]; ATP binding [GO:0005524]; microtubule motor activity [GO:0003777]; microtubule-based movement [GO:0007018]
Q6P2Y2,CHOYP_BRAFLDRAFT_287844.1.1|m.63253,3,0,0,0,0,0,0,0,0,Dynein assembly factor with WDR repeat domains 1 (Outer row dynein assembly protein 16 homolog) (WD repeat-containing protein 69),daw1 wdr69,415,,GO:0005737; GO:0005929,,,,PF00400;,cilium [GO:0005929]; cytoplasm [GO:0005737]
Q62261,CHOYP_BRAFLDRAFT_93030.1.1|m.29276,0,0,0,0,0,0,0,0,1.00E-137,"Spectrin beta chain, non-erythrocytic 1 (Beta-II spectrin) (Embryonic liver fodrin) (Fodrin beta chain)",Sptbn1 Elf Spnb-2 Spnb2 Sptb2,2363,actin filament capping [GO:0051693]; common-partner SMAD protein phosphorylation [GO:0007182]; Golgi to plasma membrane protein transport [GO:0043001]; membrane assembly [GO:0071709]; mitotic cytokinesis [GO:0000281]; plasma membrane organization [GO:0007009]; positive regulation of interleukin-2 secretion [GO:1900042]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein targeting to plasma membrane [GO:0072661]; regulation of protein localization to plasma membrane [GO:1903076]; SMAD protein import into nucleus [GO:0007184],GO:0000281; GO:0003723; GO:0005200; GO:0005543; GO:0005634; GO:0005730; GO:0005737; GO:0005886; GO:0005913; GO:0007009; GO:0007182; GO:0007184; GO:0008091; GO:0012505; GO:0014069; GO:0016020; GO:0030506; GO:0030673; GO:0030863; GO:0031430; GO:0032437; GO:0043001; GO:0043234; GO:0051020; GO:0051693; GO:0070062; GO:0071709; GO:0072661; GO:0098641; GO:1900042; GO:1903076; GO:1903078,,,cd00014;,PF00307;PF00435;,axolemma [GO:0030673]; cell-cell adherens junction [GO:0005913]; cortical cytoskeleton [GO:0030863]; cuticular plate [GO:0032437]; cytoplasm [GO:0005737]; endomembrane system [GO:0012505]; extracellular exosome [GO:0070062]; M band [GO:0031430]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; protein complex [GO:0043234]; spectrin [GO:0008091]; ankyrin binding [GO:0030506]; cadherin binding involved in cell-cell adhesion [GO:0098641]; GTPase binding [GO:0051020]; phospholipid binding [GO:0005543]; RNA binding [GO:0003723]; structural constituent of cytoskeleton [GO:0005200]; actin filament capping [GO:0051693]; common-partner SMAD protein phosphorylation [GO:0007182]; Golgi to plasma membrane protein transport [GO:0043001]; membrane assembly [GO:0071709]; mitotic cytokinesis [GO:0000281]; plasma membrane organization [GO:0007009]; positive regulation of interleukin-2 secretion [GO:1900042]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein targeting to plasma membrane [GO:0072661]; regulation of protein localization to plasma membrane [GO:1903076]; SMAD protein import into nucleus [GO:0007184]
Q8BGN2,CHOYP_CD033.1.1|m.25350,0,0,0,0,0,0,0,0,5.00E-65,UPF0462 protein C4orf33 homolog,D3Ertd751e,192,,,,,,,
Q96MW5,CHOYP_COG8.1.1|m.10907,0,0,0,0,0,0,0,0,0,Conserved oligomeric Golgi complex subunit 8 (COG complex subunit 8) (Component of oligomeric Golgi complex 8),COG8,612,ER to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; protein transport [GO:0015031],GO:0000139; GO:0005794; GO:0006888; GO:0006891; GO:0015031; GO:0016020; GO:0017119; GO:0032588,,,,PF04124;,Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi transport complex [GO:0017119]; membrane [GO:0016020]; trans-Golgi network membrane [GO:0032588]; ER to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; protein transport [GO:0015031]
P53013,CHOYP_LOC100118048.1.1|m.62638,0,0,0,0,0,0,0,0,1.00E-115,Elongation factor 1-alpha (EF-1-alpha),eft-3 F31E3.5; eft-4 R03G5.1,463,embryo development ending in birth or egg hatching [GO:0009792]; growth [GO:0040007],GO:0003746; GO:0003924; GO:0005525; GO:0005622; GO:0005737; GO:0008135; GO:0009792; GO:0040007,,,,PF03144;PF03143;,"cytoplasm [GO:0005737]; intracellular [GO:0005622]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]; translation factor activity, RNA binding [GO:0008135]; embryo development ending in birth or egg hatching [GO:0009792]; growth [GO:0040007]"
Q0P4P2,CHOYP_LOC100635487.1.1|m.21915,0,0,0,0,0,0,0,0,3.00E-57,Fibrinogen C domain-containing protein 1,fibcd1,457,,GO:0008061; GO:0016021; GO:0046872,,,cd00087;,PF00147;,integral component of membrane [GO:0016021]; chitin binding [GO:0008061]; metal ion binding [GO:0046872]
A1XBS5,CHOYP_LOC100879052.1.1|m.53743,0,0,0,0,0,0,0,0,9.00E-49,Protein FAM92A1,FAM92A1,289,cilium assembly [GO:0060271],GO:0005634; GO:0005737; GO:0005814; GO:0036064; GO:0060271,,,,PF06730;,centriole [GO:0005814]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; cilium assembly [GO:0060271]
Q4V348,CHOYP_LOC100918713.1.1|m.17833,0.5,0,0,0,0,0,0,0,4.00E-19,Zinc finger protein 658B,ZNF658B,819,"regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]",GO:0003677; GO:0005634; GO:0006351; GO:0006355; GO:0046872,,,,PF00096;PF13912;,"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]"
Q5T5Y3,CHOYP_LOC100932567.1.1|m.26590,0,0,0,0,0,0,0,0,5.00E-61,Calmodulin-regulated spectrin-associated protein 1,CAMSAP1,1602,cytoskeleton organization [GO:0007010]; neuron projection development [GO:0031175]; regulation of cell morphogenesis [GO:0022604],GO:0005516; GO:0005737; GO:0005874; GO:0007010; GO:0008017; GO:0022604; GO:0030507; GO:0031175,,,,PF17095;PF11971;PF08683;,cytoplasm [GO:0005737]; microtubule [GO:0005874]; calmodulin binding [GO:0005516]; microtubule binding [GO:0008017]; spectrin binding [GO:0030507]; cytoskeleton organization [GO:0007010]; neuron projection development [GO:0031175]; regulation of cell morphogenesis [GO:0022604]
Q9JII1,CHOYP_LOC101070553.1.1|m.9549,0.5,0,0,0,0,0,0,0,2.00E-119,"72 kDa inositol polyphosphate 5-phosphatase (EC 3.1.3.36) (Phosphatidylinositol 4,5-bisphosphate 5-phosphatase) (Phosphatidylinositol polyphosphate 5-phosphatase type IV)",Inpp5e,647,inositol phosphate dephosphorylation [GO:0046855]; phosphatidylinositol dephosphorylation [GO:0046856]; phosphatidylinositol metabolic process [GO:0046488],GO:0000139; GO:0001726; GO:0004439; GO:0005886; GO:0005930; GO:0032580; GO:0046488; GO:0046855; GO:0046856,,,,PF03372;,"axoneme [GO:0005930]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity [GO:0004439]; inositol phosphate dephosphorylation [GO:0046855]; phosphatidylinositol dephosphorylation [GO:0046856]; phosphatidylinositol metabolic process [GO:0046488]"
A0JM12,CHOYP_LOC101160063.1.4|m.2465,0,0,0,0,0,0,0,0,9.00E-41,Multiple epidermal growth factor-like domains protein 10 (Multiple EGF-like domains protein 10),megf10,1114,cell adhesion [GO:0007155]; myofibril assembly [GO:0030239]; phagocytosis [GO:0006909]; skeletal muscle satellite cell activation [GO:0014719]; skeletal muscle satellite cell differentiation [GO:0014816]; skeletal muscle satellite cell proliferation [GO:0014841],GO:0005886; GO:0006909; GO:0007155; GO:0014719; GO:0014816; GO:0014841; GO:0016021; GO:0030239,,,,PF12661;PF00053;,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cell adhesion [GO:0007155]; myofibril assembly [GO:0030239]; phagocytosis [GO:0006909]; skeletal muscle satellite cell activation [GO:0014719]; skeletal muscle satellite cell differentiation [GO:0014816]; skeletal muscle satellite cell proliferation [GO:0014841]
Q9VY77,CHOYP_LOC408431.1.1|m.18046,0,0,0,0,0,0,0,0,3.00E-128,LIM domain-containing protein jub,jub CG11063,728,"cytoskeleton organization [GO:0007010]; hippo signaling [GO:0035329]; mitotic nuclear division [GO:0007067]; negative regulation of hippo signaling [GO:0035331]; ovarian follicle cell development [GO:0030707]; positive regulation of gene silencing by miRNA [GO:2000637]; positive regulation of imaginal disc growth [GO:0045572]; positive regulation of organ growth [GO:0046622]; protein localization to centrosome [GO:0071539]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]",GO:0000932; GO:0001666; GO:0003714; GO:0003779; GO:0005634; GO:0005667; GO:0005911; GO:0005912; GO:0006355; GO:0007010; GO:0007067; GO:0008270; GO:0030707; GO:0035329; GO:0035331; GO:0045177; GO:0045179; GO:0045572; GO:0046622; GO:0071539; GO:2000637,,,,PF00412;,"adherens junction [GO:0005912]; apical cortex [GO:0045179]; apical part of cell [GO:0045177]; cell-cell junction [GO:0005911]; nucleus [GO:0005634]; P-body [GO:0000932]; transcription factor complex [GO:0005667]; actin binding [GO:0003779]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270]; cytoskeleton organization [GO:0007010]; hippo signaling [GO:0035329]; mitotic nuclear division [GO:0007067]; negative regulation of hippo signaling [GO:0035331]; ovarian follicle cell development [GO:0030707]; positive regulation of gene silencing by miRNA [GO:2000637]; positive regulation of imaginal disc growth [GO:0045572]; positive regulation of organ growth [GO:0046622]; protein localization to centrosome [GO:0071539]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]"
Q5BKR2,CHOYP_LOC584015.1.1|m.10227,0,0,0,0,0,0,0,0,2.00E-112,Mitochondrial sodium/hydrogen exchanger 9B2 (Mitochondrial Na(+)/H(+) exchanger NHA2) (NHA-oc) (Na(+)/H(+) exchanger-like domain-containing protein 2) (NHE domain-containing protein 2) (Sodium/hydrogen exchanger-like domain-containing protein 2) (Solute carrier family 9 subfamily B member 2),Slc9b2 Nha2 Nhedc2,547,positive regulation of osteoclast development [GO:2001206]; sodium ion transport [GO:0006814],GO:0006814; GO:0015299; GO:0016021; GO:0031966; GO:2001206,,,,PF00999;,integral component of membrane [GO:0016021]; mitochondrial membrane [GO:0031966]; solute:proton antiporter activity [GO:0015299]; positive regulation of osteoclast development [GO:2001206]; sodium ion transport [GO:0006814]
P27987,CHOYP_LOC590949.1.2|m.13540,1.5,0,0,0,0,0,0,0,2.00E-127,"Inositol-trisphosphate 3-kinase B (EC 2.7.1.127) (Inositol 1,4,5-trisphosphate 3-kinase B) (IP3 3-kinase B) (IP3K B) (InsP 3-kinase B)",ITPKB,946,cell surface receptor signaling pathway [GO:0007166]; cellular response to calcium ion [GO:0071277]; common myeloid progenitor cell proliferation [GO:0035726]; inositol phosphate metabolic process [GO:0043647]; inositol trisphosphate metabolic process [GO:0032957]; MAPK cascade [GO:0000165]; myeloid cell homeostasis [GO:0002262]; negative regulation of myeloid cell differentiation [GO:0045638]; negative regulation of neutrophil apoptotic process [GO:0033030]; positive regulation of alpha-beta T cell differentiation [GO:0046638]; positive regulation of Ras protein signal transduction [GO:0046579]; positive thymic T cell selection [GO:0045059]; regulation of protein phosphorylation [GO:0001932]; signal transduction [GO:0007165],GO:0000165; GO:0001932; GO:0002262; GO:0005524; GO:0005634; GO:0005829; GO:0007165; GO:0007166; GO:0008440; GO:0016020; GO:0032957; GO:0033030; GO:0035726; GO:0043647; GO:0045059; GO:0045638; GO:0046579; GO:0046638; GO:0071277,,,,PF03770;,"cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; ATP binding [GO:0005524]; inositol-1,4,5-trisphosphate 3-kinase activity [GO:0008440]; cell surface receptor signaling pathway [GO:0007166]; cellular response to calcium ion [GO:0071277]; common myeloid progenitor cell proliferation [GO:0035726]; inositol phosphate metabolic process [GO:0043647]; inositol trisphosphate metabolic process [GO:0032957]; MAPK cascade [GO:0000165]; myeloid cell homeostasis [GO:0002262]; negative regulation of myeloid cell differentiation [GO:0045638]; negative regulation of neutrophil apoptotic process [GO:0033030]; positive regulation of alpha-beta T cell differentiation [GO:0046638]; positive regulation of Ras protein signal transduction [GO:0046579]; positive thymic T cell selection [GO:0045059]; regulation of protein phosphorylation [GO:0001932]; signal transduction [GO:0007165]"
Q5BKR2,CHOYP_LOC594676.1.1|m.8936,0,0,0,0,0,0,0,0,4.00E-131,Mitochondrial sodium/hydrogen exchanger 9B2 (Mitochondrial Na(+)/H(+) exchanger NHA2) (NHA-oc) (Na(+)/H(+) exchanger-like domain-containing protein 2) (NHE domain-containing protein 2) (Sodium/hydrogen exchanger-like domain-containing protein 2) (Solute carrier family 9 subfamily B member 2),Slc9b2 Nha2 Nhedc2,547,positive regulation of osteoclast development [GO:2001206]; sodium ion transport [GO:0006814],GO:0006814; GO:0015299; GO:0016021; GO:0031966; GO:2001206,,,,PF00999;,integral component of membrane [GO:0016021]; mitochondrial membrane [GO:0031966]; solute:proton antiporter activity [GO:0015299]; positive regulation of osteoclast development [GO:2001206]; sodium ion transport [GO:0006814]
O75954,CHOYP_LOC751836.5.6|m.43257,0,0,0,0,0,0,0,0,2.00E-13,Tetraspanin-9 (Tspan-9) (Tetraspan NET-5),TSPAN9 NET5,239,cell surface receptor signaling pathway [GO:0007166],GO:0005886; GO:0005887; GO:0005925; GO:0007166; GO:0097197,,,,PF00335;,focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; tetraspanin-enriched microdomain [GO:0097197]; cell surface receptor signaling pathway [GO:0007166]
P0C6B8,CHOYP_LRP1B.2.2|m.54317,0,0,0,0,0,0,0,0,4.00E-20,"Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1",Svep1,3564,cell adhesion [GO:0007155],GO:0005509; GO:0005576; GO:0005737; GO:0007155; GO:0016020,,,cd00033;cd00152;,PF00008;PF07645;PF07699;PF02494;PF00354;PF00084;PF00092;,cytoplasm [GO:0005737]; extracellular region [GO:0005576]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155]
P21440,CHOYP_MDR1B.1.2|m.12480,0,0,0,0,0,0,0,0,0,Phosphatidylcholine translocator ABCB4 (ATP-binding cassette sub-family B member 4) (Multidrug resistance protein 2) (Multidrug resistance protein 3) (EC 3.6.3.44) (P-glycoprotein 2) (P-glycoprotein 3),Abcb4 Mdr2 Pgy-2 Pgy2,1276,bile acid secretion [GO:0032782]; brain development [GO:0007420]; carbohydrate export [GO:0033231]; cellular hyperosmotic salinity response [GO:0071475]; cellular response to alkaloid [GO:0071312]; cellular response to antibiotic [GO:0071236]; cellular response to bile acid [GO:1903413]; cellular response to borneol [GO:1905231]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to estradiol stimulus [GO:0071392]; cellular response to external biotic stimulus [GO:0071217]; cellular response to L-glutamate [GO:1905232]; cellular response to mycotoxin [GO:0036146]; circadian rhythm [GO:0007623]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transport across blood-brain barrier [GO:1990962]; establishment of blood-brain barrier [GO:0060856]; establishment of blood-retinal barrier [GO:1990963]; hormone transport [GO:0009914]; intestinal absorption [GO:0050892]; lactation [GO:0007595]; lipid homeostasis [GO:0055088]; maintenance of permeability of blood-brain barrier [GO:0035633]; negative regulation of cell death [GO:0060548]; phospholipid translocation [GO:0045332]; placenta development [GO:0001890]; positive regulation of cholesterol transport [GO:0032376]; positive regulation of phospholipid translocation [GO:0061092]; positive regulation of phospholipid transport [GO:2001140]; positive regulation of response to drug [GO:2001025]; response to antineoplastic agent [GO:0097327]; response to cadmium ion [GO:0046686]; response to codeine [GO:1905233]; response to cyclosporin A [GO:1905237]; response to fenofibrate [GO:1901557]; response to glycoside [GO:1903416]; response to hypoxia [GO:0001666]; response to morphine [GO:0043278]; response to quercetin [GO:1905235]; response to thyroxine [GO:0097068]; response to vitamin A [GO:0033189]; response to vitamin D [GO:0033280],GO:0001666; GO:0001890; GO:0005524; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0005925; GO:0007420; GO:0007595; GO:0007623; GO:0008525; GO:0009914; GO:0015629; GO:0016020; GO:0016021; GO:0016324; GO:0030136; GO:0031526; GO:0032376; GO:0032782; GO:0033189; GO:0033231; GO:0033280; GO:0035633; GO:0036146; GO:0042626; GO:0043215; GO:0043278; GO:0045121; GO:0045332; GO:0046581; GO:0046618; GO:0046686; GO:0050892; GO:0055088; GO:0060548; GO:0060856; GO:0061092; GO:0070062; GO:0071217; GO:0071236; GO:0071312; GO:0071392; GO:0071475; GO:0071549; GO:0090554; GO:0097068; GO:0097327; GO:1901557; GO:1903413; GO:1903416; GO:1905231; GO:1905232; GO:1905233; GO:1905235; GO:1905237; GO:1990962; GO:1990963; GO:2001025; GO:2001140,,,,PF00664;PF00005;,"actin cytoskeleton [GO:0015629]; apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; intercellular canaliculus [GO:0046581]; membrane [GO:0016020]; membrane raft [GO:0045121]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity, coupled to transmembrane movement of substances [GO:0042626]; phosphatidylcholine transporter activity [GO:0008525]; phosphatidylcholine-translocating ATPase activity [GO:0090554]; bile acid secretion [GO:0032782]; brain development [GO:0007420]; carbohydrate export [GO:0033231]; cellular hyperosmotic salinity response [GO:0071475]; cellular response to alkaloid [GO:0071312]; cellular response to antibiotic [GO:0071236]; cellular response to bile acid [GO:1903413]; cellular response to borneol [GO:1905231]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to estradiol stimulus [GO:0071392]; cellular response to external biotic stimulus [GO:0071217]; cellular response to L-glutamate [GO:1905232]; cellular response to mycotoxin [GO:0036146]; circadian rhythm [GO:0007623]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transport across blood-brain barrier [GO:1990962]; establishment of blood-brain barrier [GO:0060856]; establishment of blood-retinal barrier [GO:1990963]; hormone transport [GO:0009914]; intestinal absorption [GO:0050892]; lactation [GO:0007595]; lipid homeostasis [GO:0055088]; maintenance of permeability of blood-brain barrier [GO:0035633]; negative regulation of cell death [GO:0060548]; phospholipid translocation [GO:0045332]; placenta development [GO:0001890]; positive regulation of cholesterol transport [GO:0032376]; positive regulation of phospholipid translocation [GO:0061092]; positive regulation of phospholipid transport [GO:2001140]; positive regulation of response to drug [GO:2001025]; response to antineoplastic agent [GO:0097327]; response to cadmium ion [GO:0046686]; response to codeine [GO:1905233]; response to cyclosporin A [GO:1905237]; response to fenofibrate [GO:1901557]; response to glycoside [GO:1903416]; response to hypoxia [GO:0001666]; response to morphine [GO:0043278]; response to quercetin [GO:1905235]; response to thyroxine [GO:0097068]; response to vitamin A [GO:0033189]; response to vitamin D [GO:0033280]"
Q9H9L4,CHOYP_MGC154513.1.1|m.20908,0,0,0,0,0,0,0,0,2.00E-93,KAT8 regulatory NSL complex subunit 2 (NSL complex protein NSL2) (Non-specific lethal 2 homolog),KANSL2 C12orf41 NSL2,492,histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982],GO:0000123; GO:0005654; GO:0005829; GO:0005886; GO:0015629; GO:0043981; GO:0043982; GO:0043984,,,,PF13891;,actin cytoskeleton [GO:0015629]; cytosol [GO:0005829]; histone acetyltransferase complex [GO:0000123]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]
P97532,CHOYP_MPST.1.1|m.11853,0,0,0,0,0,0,0,0,1.00E-95,3-mercaptopyruvate sulfurtransferase (MST) (EC 2.8.1.2),Mpst,297,hydrogen sulfide biosynthetic process [GO:0070814]; kidney development [GO:0001822]; liver development [GO:0001889]; spinal cord development [GO:0021510]; transsulfuration [GO:0019346],GO:0001822; GO:0001889; GO:0004792; GO:0005737; GO:0005739; GO:0005829; GO:0016784; GO:0019346; GO:0021510; GO:0030054; GO:0042802; GO:0043005; GO:0045202; GO:0070062; GO:0070814,,,,PF00581;,cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; synapse [GO:0045202]; 3-mercaptopyruvate sulfurtransferase activity [GO:0016784]; identical protein binding [GO:0042802]; thiosulfate sulfurtransferase activity [GO:0004792]; hydrogen sulfide biosynthetic process [GO:0070814]; kidney development [GO:0001822]; liver development [GO:0001889]; spinal cord development [GO:0021510]; transsulfuration [GO:0019346]
Q9NPB1,CHOYP_NT5M.1.1|m.6188,0,0,0,0,0,0,0,0,3.00E-62,"5'(3')-deoxyribonucleotidase, mitochondrial (5',3'-nucleotidase, mitochondrial) (EC 3.1.3.-) (Deoxy-5'-nucleotidase 2) (dNT-2)",NT5M DNT2,228,DNA replication [GO:0006260]; dUMP catabolic process [GO:0046079]; pyrimidine deoxyribonucleotide catabolic process [GO:0009223]; pyrimidine nucleoside catabolic process [GO:0046135],GO:0000166; GO:0005739; GO:0005759; GO:0006260; GO:0008252; GO:0008253; GO:0009223; GO:0046079; GO:0046135; GO:0046872,,,,PF06941;,mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; 5'-nucleotidase activity [GO:0008253]; metal ion binding [GO:0046872]; nucleotidase activity [GO:0008252]; nucleotide binding [GO:0000166]; DNA replication [GO:0006260]; dUMP catabolic process [GO:0046079]; pyrimidine deoxyribonucleotide catabolic process [GO:0009223]; pyrimidine nucleoside catabolic process [GO:0046135]
Q9UKG9,CHOYP_OCTC.1.1|m.31819,0,0,0,0,0,0,0,0,0,Peroxisomal carnitine O-octanoyltransferase (COT) (EC 2.3.1.137),CROT COT,612,carnitine metabolic process [GO:0009437]; coenzyme A metabolic process [GO:0015936]; fatty acid beta-oxidation [GO:0006635]; fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; fatty acid metabolic process [GO:0006631]; fatty acid transport [GO:0015908]; generation of precursor metabolites and energy [GO:0006091]; medium-chain fatty acid metabolic process [GO:0051791],GO:0005102; GO:0005739; GO:0005777; GO:0005782; GO:0006091; GO:0006631; GO:0006635; GO:0008458; GO:0009437; GO:0015908; GO:0015936; GO:0033540; GO:0043231; GO:0051791,PATHWAY: Lipid metabolism; fatty acid beta-oxidation.,,,PF00755;,intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; carnitine O-octanoyltransferase activity [GO:0008458]; receptor binding [GO:0005102]; carnitine metabolic process [GO:0009437]; coenzyme A metabolic process [GO:0015936]; fatty acid beta-oxidation [GO:0006635]; fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; fatty acid metabolic process [GO:0006631]; fatty acid transport [GO:0015908]; generation of precursor metabolites and energy [GO:0006091]; medium-chain fatty acid metabolic process [GO:0051791]
Q4VBI7,CHOYP_STX18.2.2|m.51179,0,0,0,0,0,0,0,0,1.00E-106,Syntaxin-18,stx18 zgc:112326,314,"ER to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; membrane fusion [GO:0061025]; retrograde vesicle-mediated transport, Golgi to ER [GO:0006890]",GO:0005783; GO:0005789; GO:0006886; GO:0006888; GO:0006890; GO:0016021; GO:0031201; GO:0061025,,,,PF10496;,"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; SNARE complex [GO:0031201]; ER to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; membrane fusion [GO:0061025]; retrograde vesicle-mediated transport, Golgi to ER [GO:0006890]"
P24043,CHOYP_TVAG_012450.7.8|m.63509,0.5,0,0,0,0,0,0,0,0.000000002,Laminin subunit alpha-2 (Laminin M chain) (Laminin-12 subunit alpha) (Laminin-2 subunit alpha) (Laminin-4 subunit alpha) (Merosin heavy chain),LAMA2 LAMM,3122,"axon guidance [GO:0007411]; cell adhesion [GO:0007155]; extracellular matrix organization [GO:0030198]; muscle organ development [GO:0007517]; positive regulation of synaptic transmission, cholinergic [GO:0032224]; regulation of cell adhesion [GO:0030155]; regulation of cell migration [GO:0030334]; regulation of embryonic development [GO:0045995]; Schwann cell differentiation [GO:0014037]",GO:0005198; GO:0005576; GO:0005604; GO:0005605; GO:0005615; GO:0007155; GO:0007411; GO:0007517; GO:0014037; GO:0030155; GO:0030198; GO:0030334; GO:0032224; GO:0042383; GO:0043197; GO:0045995; GO:0070062,,,,PF00052;PF00053;PF00054;PF02210;PF06008;PF06009;PF00055;,"basal lamina [GO:0005605]; basement membrane [GO:0005604]; dendritic spine [GO:0043197]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; sarcolemma [GO:0042383]; structural molecule activity [GO:0005198]; axon guidance [GO:0007411]; cell adhesion [GO:0007155]; extracellular matrix organization [GO:0030198]; muscle organ development [GO:0007517]; positive regulation of synaptic transmission, cholinergic [GO:0032224]; regulation of cell adhesion [GO:0030155]; regulation of cell migration [GO:0030334]; regulation of embryonic development [GO:0045995]; Schwann cell differentiation [GO:0014037]"
Q6CEJ6,CHOYP_BRAFLDRAFT_109077.1.1|m.7494,0.5,0,0,0,0,0,0,0,2.00E-36,Glucose-repressible alcohol dehydrogenase transcriptional effector (EC 3.1.13.4) (Carbon catabolite repressor protein 4) (Cytoplasmic deadenylase),CCR4 YALI0B15147g,705,"regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]",GO:0003723; GO:0004535; GO:0005634; GO:0005737; GO:0006351; GO:0006355; GO:0046872,,,,PF03372;,"cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; poly(A)-specific ribonuclease activity [GO:0004535]; RNA binding [GO:0003723]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]"
Q6DF57,CHOYP_BRAFLDRAFT_264304.1.1|m.35625,0,0,0,0,0,0,0,0,5.00E-66,G patch domain-containing protein 11 (Coiled-coil domain-containing protein 75),gpatch11 ccdc75,261,,GO:0000776; GO:0000777; GO:0003676,,,,PF13821;PF01585;,condensed chromosome kinetochore [GO:0000777]; kinetochore [GO:0000776]; nucleic acid binding [GO:0003676]
Q2FVD5,CHOYP_DHR11.2.2|m.36445,1.5,0,0,0,0,0,0,0,7.00E-42,Uncharacterized oxidoreductase SAOUHSC_02778 (EC 1.-.-.-),SAOUHSC_02778,231,,GO:0016491,,,,PF00106;,oxidoreductase activity [GO:0016491]
P20273,CHOYP_DPER_GL17448.1.1|m.54836,0,0,0,0,0,0,0,0,9.00E-25,B-cell receptor CD22 (B-lymphocyte cell adhesion molecule) (BL-CAM) (Sialic acid-binding Ig-like lectin 2) (Siglec-2) (T-cell surface antigen Leu-14) (CD antigen CD22),CD22 SIGLEC2,847,cell adhesion [GO:0007155],GO:0005886; GO:0007155; GO:0016021; GO:0030246; GO:0070062,,,,PF08205;PF13895;,extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; carbohydrate binding [GO:0030246]; cell adhesion [GO:0007155]
Q03112,CHOYP_EVI1.1.1|m.62064,0,0,0,0,0,0,0,0,7.00E-67,MDS1 and EVI1 complex locus protein EVI1 (Ecotropic virus integration site 1 protein homolog) (EVI-1),MECOM EVI1,1051,"apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; hematopoietic stem cell proliferation [GO:0071425]; negative regulation of JNK cascade [GO:0046329]; negative regulation of programmed cell death [GO:0043069]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell cycle [GO:0051726]; transcription, DNA-templated [GO:0006351]",GO:0003677; GO:0003700; GO:0005634; GO:0005829; GO:0006351; GO:0006915; GO:0016607; GO:0018024; GO:0030154; GO:0042803; GO:0043069; GO:0045892; GO:0045893; GO:0046329; GO:0046872; GO:0051726; GO:0071425,,,,PF00096;PF13912;,"cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; DNA binding [GO:0003677]; histone-lysine N-methyltransferase activity [GO:0018024]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; transcription factor activity, sequence-specific DNA binding [GO:0003700]; apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; hematopoietic stem cell proliferation [GO:0071425]; negative regulation of JNK cascade [GO:0046329]; negative regulation of programmed cell death [GO:0043069]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell cycle [GO:0051726]; transcription, DNA-templated [GO:0006351]"
Q8MQI6,CHOYP_ISCW_ISCW008316.1.3|m.11997,0,0,0,0,0,0,0,0,2.00E-44,Transcription elongation factor 1 homolog,CG40228,82,chromatin-mediated maintenance of transcription [GO:0048096]; transcription elongation from RNA polymerase II promoter [GO:0006368],GO:0000993; GO:0006368; GO:0008023; GO:0046872; GO:0048096,,,,PF05129;,transcription elongation factor complex [GO:0008023]; metal ion binding [GO:0046872]; RNA polymerase II core binding [GO:0000993]; chromatin-mediated maintenance of transcription [GO:0048096]; transcription elongation from RNA polymerase II promoter [GO:0006368]
Q6IQ55,CHOYP_KC1A.1.2|m.14719,0.5,0,0,0,0,0,0,0,4.00E-45,Tau-tubulin kinase 2 (EC 2.7.11.1),TTBK2 KIAA0847,1244,ciliary basal body docking [GO:0097711]; cilium assembly [GO:0060271]; peptidyl-serine phosphorylation [GO:0018105]; regulation of cell shape [GO:0008360]; smoothened signaling pathway [GO:0007224],GO:0004674; GO:0005524; GO:0005615; GO:0005634; GO:0005814; GO:0005829; GO:0007224; GO:0008360; GO:0018105; GO:0035869; GO:0036064; GO:0060271; GO:0097711,,,,PF00069;,centriole [GO:0005814]; ciliary basal body [GO:0036064]; ciliary transition zone [GO:0035869]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; ciliary basal body docking [GO:0097711]; cilium assembly [GO:0060271]; peptidyl-serine phosphorylation [GO:0018105]; regulation of cell shape [GO:0008360]; smoothened signaling pathway [GO:0007224]
Q9NG98,CHOYP_LOC100121991.1.1|m.13778,0,0,0,0,0,0,0,0,1.00E-17,DNA topoisomerase 3-alpha (EC 5.99.1.2) (DNA topoisomerase III alpha),Top3alpha CG10123,1250,developmental growth [GO:0048589]; DNA topological change [GO:0006265]; double-strand break repair via homologous recombination [GO:0000724]; mitochondrial genome maintenance [GO:0000002]; tissue regeneration [GO:0042246],GO:0000002; GO:0000724; GO:0003677; GO:0003916; GO:0003917; GO:0005634; GO:0005694; GO:0005739; GO:0006265; GO:0008270; GO:0042246; GO:0048589,,,cd00186;cd03362;,PF01131;PF01751;PF01396;PF06839;,chromosome [GO:0005694]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA topoisomerase activity [GO:0003916]; DNA topoisomerase type I activity [GO:0003917]; zinc ion binding [GO:0008270]; developmental growth [GO:0048589]; DNA topological change [GO:0006265]; double-strand break repair via homologous recombination [GO:0000724]; mitochondrial genome maintenance [GO:0000002]; tissue regeneration [GO:0042246]
Q6P0I8,CHOYP_LOC100369488.1.1|m.10559,0.5,0,0,0,0,0,0,0,5.00E-81,Exosome complex component MTR3 (Exosome component 6) (mRNA transport regulator 3 homolog),exosc6 mtr3,271,"nuclear mRNA surveillance [GO:0071028]; nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' [GO:0034427]; polyadenylation-dependent snoRNA 3'-end processing [GO:0071051]; rRNA 3'-end processing [GO:0031125]; rRNA catabolic process [GO:0016075]; U4 snRNA 3'-end processing [GO:0034475]",GO:0000176; GO:0000177; GO:0000178; GO:0003723; GO:0005730; GO:0016075; GO:0031125; GO:0034427; GO:0034475; GO:0071028; GO:0071051,,,,PF01138;,"cytoplasmic exosome (RNase complex) [GO:0000177]; exosome (RNase complex) [GO:0000178]; nuclear exosome (RNase complex) [GO:0000176]; nucleolus [GO:0005730]; RNA binding [GO:0003723]; nuclear mRNA surveillance [GO:0071028]; nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' [GO:0034427]; polyadenylation-dependent snoRNA 3'-end processing [GO:0071051]; rRNA 3'-end processing [GO:0031125]; rRNA catabolic process [GO:0016075]; U4 snRNA 3'-end processing [GO:0034475]"
A7RX26,CHOYP_LOC100371597.1.1|m.3330,0,0,0,0,0,0,0,0,8.00E-142,Probable imidazolonepropionase (EC 3.5.2.7) (Amidohydrolase domain-containing protein 1 homolog),amdhd1 v1g163675,429,histidine catabolic process to glutamate and formamide [GO:0019556]; histidine catabolic process to glutamate and formate [GO:0019557],GO:0005737; GO:0019556; GO:0019557; GO:0046872; GO:0050480,PATHWAY: Amino-acid degradation; L-histidine degradation into L-glutamate; N-formimidoyl-L-glutamate from L-histidine: step 3/3.,,cd01296;,PF01979;,cytoplasm [GO:0005737]; imidazolonepropionase activity [GO:0050480]; metal ion binding [GO:0046872]; histidine catabolic process to glutamate and formamide [GO:0019556]; histidine catabolic process to glutamate and formate [GO:0019557]
Q63HQ0,CHOYP_LOC100372482.1.1|m.61581,0,0,0,0,0,0,0,0,7.00E-23,AP-1 complex-associated regulatory protein (2c18) (Adaptor-related protein complex 1-associated regulatory protein) (Gamma-1-adaptin brefeldin A resistance protein) (GBAR) (Gamma-BAR) (Gamma-A1-adaptin and kinesin interactor) (Gadkin),AP1AR C4orf16 PRO0971,302,"cellular protein localization [GO:0034613]; negative regulation of cell motility [GO:2000146]; negative regulation of receptor recycling [GO:0001920]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; protein transport [GO:0015031]; regulation of Arp2/3 complex-mediated actin nucleation [GO:0034315]; vesicle targeting, trans-Golgi to endosome [GO:0048203]",GO:0001920; GO:0005768; GO:0005769; GO:0005770; GO:0005794; GO:0005829; GO:0015031; GO:0019894; GO:0030133; GO:0034315; GO:0034613; GO:0035650; GO:0048203; GO:1900025; GO:2000146,,,,PF15745;,"cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; transport vesicle [GO:0030133]; AP-1 adaptor complex binding [GO:0035650]; kinesin binding [GO:0019894]; cellular protein localization [GO:0034613]; negative regulation of cell motility [GO:2000146]; negative regulation of receptor recycling [GO:0001920]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; protein transport [GO:0015031]; regulation of Arp2/3 complex-mediated actin nucleation [GO:0034315]; vesicle targeting, trans-Golgi to endosome [GO:0048203]"
B3EWZ6,CHOYP_LOC100372487.1.1|m.39712,0,0,0,0,0,0,0,0,4.00E-21,MAM and LDL-receptor class A domain-containing protein 2 (Skeletal organic matrix MAM and LDL-receptor 2) (SOM MAM and LDL-receptor 2) (Fragment),,7311,,GO:0005576; GO:0016020,,,cd06263;cd00111;,PF00057;PF00629;PF00088;,extracellular region [GO:0005576]; membrane [GO:0016020]
D2H8V8,CHOYP_LOC100372601.1.1|m.13567,0,0,0,0,0,0,0,0,2.00E-95,5' exonuclease Apollo (EC 3.1.-.-) (DNA cross-link repair 1B protein) (SNM1 homolog B),DCLRE1B SNM1B PANDA_006715,529,cell cycle checkpoint [GO:0000075]; DNA repair [GO:0006281]; protection from non-homologous end joining at telomere [GO:0031848]; telomere maintenance [GO:0000723]; telomeric 3' overhang formation [GO:0031860]; telomeric loop formation [GO:0031627],GO:0000075; GO:0000723; GO:0000781; GO:0005634; GO:0005737; GO:0005813; GO:0006281; GO:0008409; GO:0031627; GO:0031848; GO:0031860,,,,PF07522;,"centrosome [GO:0005813]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; 5'-3' exonuclease activity [GO:0008409]; cell cycle checkpoint [GO:0000075]; DNA repair [GO:0006281]; protection from non-homologous end joining at telomere [GO:0031848]; telomere maintenance [GO:0000723]; telomeric 3' overhang formation [GO:0031860]; telomeric loop formation [GO:0031627]"
Q96JC1,CHOYP_LOC100378848.1.1|m.29949,0.5,0,0,0,0,0,0,0,0,Vam6/Vps39-like protein (TRAP1-like protein) (hVam6p),VPS39 KIAA0770 TLP VAM6,886,"autophagy [GO:0006914]; endosomal vesicle fusion [GO:0034058]; endosome to lysosome transport [GO:0008333]; intracellular protein transport [GO:0006886]; late endosome to lysosome transport [GO:1902774]; retrograde transport, endosome to plasma membrane [GO:1990126]; vacuole fusion [GO:0097576]",GO:0005765; GO:0006886; GO:0006914; GO:0008333; GO:0030123; GO:0030897; GO:0031902; GO:0034058; GO:0097576; GO:1902774; GO:1990126,,,,PF00780;PF10366;PF10367;,"AP-3 adaptor complex [GO:0030123]; HOPS complex [GO:0030897]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; autophagy [GO:0006914]; endosomal vesicle fusion [GO:0034058]; endosome to lysosome transport [GO:0008333]; intracellular protein transport [GO:0006886]; late endosome to lysosome transport [GO:1902774]; retrograde transport, endosome to plasma membrane [GO:1990126]; vacuole fusion [GO:0097576]"
Q9CQ90,CHOYP_LOC100650709.1.1|m.12958,0,0,0,0,0,0,0,0,6.00E-35,Uncharacterized protein C9orf85 homolog,,155,,,,,,PF10217;,
Q6MHJ5,CHOYP_LOC100888299.1.3|m.3738,0,0,0,0,0,0,0,0,7.00E-29,ATP-dependent DNA helicase pif1 (EC 3.6.4.12),pif1 Bd3546,439,DNA recombination [GO:0006310]; DNA repair [GO:0006281]; telomere maintenance [GO:0000723],GO:0000723; GO:0003677; GO:0003678; GO:0005524; GO:0006281; GO:0006310,,,,PF05970;,ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; telomere maintenance [GO:0000723]
Q6P2D8,CHOYP_LOC584905.1.1|m.51595,1.5,0,0,0,0,0,0,0,2.00E-56,X-ray radiation resistance-associated protein 1,XRRA1,792,response to X-ray [GO:0010165],GO:0005634; GO:0005654; GO:0005737; GO:0010165; GO:0016604,,,,,cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; response to X-ray [GO:0010165]
Q6NUB2,CHOYP_LOC592411.1.1|m.19664,0,0,0,0,0,0,0,0,2.00E-88,Protein CWC15 homolog A,cwc15-a,228,"mRNA splicing, via spliceosome [GO:0000398]",GO:0000398; GO:0003723; GO:0005634; GO:0005681,,,,PF04889;,"nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]"
Q8IYE1,CHOYP_LOC594533.1.1|m.58830,0,0,0,0,0,0,0,0,1.00E-106,Coiled-coil domain-containing protein 13,CCDC13,715,cellular response to DNA damage stimulus [GO:0006974]; cytoplasmic microtubule organization [GO:0031122]; non-motile cilium assembly [GO:1905515],GO:0005634; GO:0005813; GO:0005829; GO:0006974; GO:0031122; GO:0034451; GO:0042995; GO:1905515,,,,,cell projection [GO:0042995]; centriolar satellite [GO:0034451]; centrosome [GO:0005813]; cytosol [GO:0005829]; nucleus [GO:0005634]; cellular response to DNA damage stimulus [GO:0006974]; cytoplasmic microtubule organization [GO:0031122]; non-motile cilium assembly [GO:1905515]
Q6V0I7,CHOYP_MEGF6.44.59|m.47511,0.5,0,0,0,0,0,0,0,0.00000002,Protocadherin Fat 4 (hFat4) (Cadherin family member 14) (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J),FAT4 CDHF14 FATJ Nbla00548,4981,branching involved in ureteric bud morphogenesis [GO:0001658]; cerebral cortex development [GO:0021987]; condensed mesenchymal cell proliferation [GO:0072137]; digestive tract development [GO:0048565]; fibroblast growth factor receptor signaling pathway [GO:0008543]; heart morphogenesis [GO:0003007]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear receptor stereocilium organization [GO:0060122]; neurogenesis [GO:0022008]; Notch signaling pathway [GO:0007219]; ossification involved in bone maturation [GO:0043931]; plasma membrane organization [GO:0007009]; regulation of metanephric nephron tubule epithelial cell differentiation [GO:0072307],GO:0001658; GO:0003007; GO:0005509; GO:0005622; GO:0005886; GO:0007009; GO:0007156; GO:0007157; GO:0007219; GO:0008543; GO:0016021; GO:0021987; GO:0022008; GO:0035329; GO:0043931; GO:0045177; GO:0048565; GO:0060122; GO:0070062; GO:0072137; GO:0072307,,,,PF00028;PF07645;PF12661;PF02210;,apical part of cell [GO:0045177]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; intracellular [GO:0005622]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; branching involved in ureteric bud morphogenesis [GO:0001658]; cerebral cortex development [GO:0021987]; condensed mesenchymal cell proliferation [GO:0072137]; digestive tract development [GO:0048565]; fibroblast growth factor receptor signaling pathway [GO:0008543]; heart morphogenesis [GO:0003007]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear receptor stereocilium organization [GO:0060122]; neurogenesis [GO:0022008]; Notch signaling pathway [GO:0007219]; ossification involved in bone maturation [GO:0043931]; plasma membrane organization [GO:0007009]; regulation of metanephric nephron tubule epithelial cell differentiation [GO:0072307]
Q96RV3,CHOYP_PCX1.1.1|m.55309,0,0,0,0,0,0,0,0,0,Pecanex-like protein 1 (Pecanex homolog protein 1),PCNX1 KIAA0805 KIAA0995 PCNX PCNXL1,2341,,GO:0016021,,,,PF05041;,integral component of membrane [GO:0016021]
Q8QHL5,CHOYP_PHC2.1.1|m.48379,0.5,0,0,0,0,0,0,0,2.00E-56,Polyhomeotic-like protein 2,phc2 edr2 ph2,827,multicellular organism development [GO:0007275],GO:0003677; GO:0007275; GO:0008270; GO:0031519; GO:0035102,,,,PF00536;,PcG protein complex [GO:0031519]; PRC1 complex [GO:0035102]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275]
P20273,CHOYP_PHUM_PHUM427190.1.1|m.57126,0,0,0,0,0,0,0,0,2.00E-21,B-cell receptor CD22 (B-lymphocyte cell adhesion molecule) (BL-CAM) (Sialic acid-binding Ig-like lectin 2) (Siglec-2) (T-cell surface antigen Leu-14) (CD antigen CD22),CD22 SIGLEC2,847,cell adhesion [GO:0007155],GO:0005886; GO:0007155; GO:0016021; GO:0030246; GO:0070062,,,,PF08205;PF13895;,extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; carbohydrate binding [GO:0030246]; cell adhesion [GO:0007155]
Q9Y2Y1,CHOYP_POLR3K.1.1|m.8423,0,0,0,0,0,0,0,0,1.00E-62,DNA-directed RNA polymerase III subunit RPC10 (RNA polymerase III subunit C10) (DNA-directed RNA polymerase III subunit K) (RNA polymerase III 12.5 kDa subunit) (RPC12.5) (RNA polymerase III subunit C11) (HsC11p) (RPC11) (hRPC11),POLR3K RPC11 My010,108,defense response to virus [GO:0051607]; innate immune response [GO:0045087]; mRNA cleavage [GO:0006379]; positive regulation of type I interferon production [GO:0032481]; transcription from RNA polymerase III promoter [GO:0006383],GO:0003676; GO:0003899; GO:0005654; GO:0005666; GO:0005730; GO:0005829; GO:0006379; GO:0006383; GO:0008270; GO:0032481; GO:0045087; GO:0051607,,,cd10509;,PF02150;PF01096;,cytosol [GO:0005829]; DNA-directed RNA polymerase III complex [GO:0005666]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; mRNA cleavage [GO:0006379]; positive regulation of type I interferon production [GO:0032481]; transcription from RNA polymerase III promoter [GO:0006383]
Q5XIN7,CHOYP_POMGNT1.1.1|m.33377,0,0,0,0,0,0,0,0,0,"Protein O-linked-mannose beta-1,2-N-acetylglucosaminyltransferase 1 (POMGnT1) (EC 2.4.1.-)",Pomgnt1,660,protein O-linked glycosylation [GO:0006493],GO:0000139; GO:0006493; GO:0008375; GO:0016021; GO:0047223,PATHWAY: Protein modification; protein glycosylation. {ECO:0000250|UniProtKB:Q8WZA1}.,,,PF03071;,"Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; acetylglucosaminyltransferase activity [GO:0008375]; beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity [GO:0047223]; protein O-linked glycosylation [GO:0006493]"
Q9D787,CHOYP_PPIL2.1.1|m.55184,0,0,0,0,0,0,0,0,0,Peptidyl-prolyl cis-trans isomerase-like 2 (PPIase) (EC 2.3.2.27) (EC 5.2.1.8) (CYC4) (Cyclophilin-60) (Cyclophilin-like protein Cyp-60) (RING-type E3 ubiquitin transferase isomerase-like 2) (Rotamase PPIL2),Ppil2,521,protein folding [GO:0006457]; protein localization to plasma membrane [GO:0072659]; protein polyubiquitination [GO:0000209],GO:0000209; GO:0003755; GO:0004842; GO:0005634; GO:0005654; GO:0005737; GO:0005886; GO:0006457; GO:0034450; GO:0061630; GO:0072659,PATHWAY: Protein modification; protein ubiquitination. {ECO:0000250|UniProtKB:Q13356}.,,,PF00160;,cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; ubiquitin-ubiquitin ligase activity [GO:0034450]; protein folding [GO:0006457]; protein localization to plasma membrane [GO:0072659]; protein polyubiquitination [GO:0000209]
Q7SYJ9,CHOYP_SPAG7.1.1|m.66661,0,0,0,0,0,0,0,0,4.00E-68,Sperm-associated antigen 7 homolog,spag7,230,,GO:0003676,,,cd02636;,PF01424;,nucleic acid binding [GO:0003676]
Q8R508,CHOYP_SREC2.7.9|m.44662,0,0,0,0,0,0,0,0,0.000003,Protocadherin Fat 3 (FAT tumor suppressor homolog 3),Fat3,4555,homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; multicellular organism development [GO:0007275],GO:0005509; GO:0005886; GO:0007156; GO:0007275; GO:0016021,,,,PF00028;PF00008;PF02210;,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; multicellular organism development [GO:0007275]
P20273,CHOYP_TITIN.4.19|m.19569,0,0,0,0,0,0,0,0,9.00E-18,B-cell receptor CD22 (B-lymphocyte cell adhesion molecule) (BL-CAM) (Sialic acid-binding Ig-like lectin 2) (Siglec-2) (T-cell surface antigen Leu-14) (CD antigen CD22),CD22 SIGLEC2,847,cell adhesion [GO:0007155],GO:0005886; GO:0007155; GO:0016021; GO:0030246; GO:0070062,,,,PF08205;PF13895;,extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; carbohydrate binding [GO:0030246]; cell adhesion [GO:0007155]
P58727,CHOYP_TLR6.1.2|m.24581,0,0,0,0,0,0,0,0,5.00E-30,Toll-like receptor 4 (CD antigen CD284),TLR4,833,defense response to Gram-negative bacterium [GO:0050829]; detection of lipopolysaccharide [GO:0032497]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; interleukin-1 beta secretion [GO:0050702]; macrophage activation [GO:0042116]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; regulation of cytokine secretion [GO:0050707]; toll-like receptor 4 signaling pathway [GO:0034142]; toll-like receptor signaling pathway [GO:0002224],GO:0001530; GO:0001875; GO:0002224; GO:0002755; GO:0004888; GO:0005887; GO:0006954; GO:0032497; GO:0034142; GO:0042116; GO:0045087; GO:0046696; GO:0050702; GO:0050707; GO:0050829; GO:1900227,,,,PF00560;PF13855;PF01582;,integral component of plasma membrane [GO:0005887]; lipopolysaccharide receptor complex [GO:0046696]; lipopolysaccharide binding [GO:0001530]; lipopolysaccharide receptor activity [GO:0001875]; transmembrane signaling receptor activity [GO:0004888]; defense response to Gram-negative bacterium [GO:0050829]; detection of lipopolysaccharide [GO:0032497]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; interleukin-1 beta secretion [GO:0050702]; macrophage activation [GO:0042116]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; regulation of cytokine secretion [GO:0050707]; toll-like receptor 4 signaling pathway [GO:0034142]; toll-like receptor signaling pathway [GO:0002224]
Q9QUQ5,CHOYP_TRPM3.7.7|m.59826,0,0,0,0,0,0,0,0,4.00E-14,Short transient receptor potential channel 4 (TrpC4) (Capacitative calcium entry channel Trp4) (Receptor-activated cation channel TRP4),Trpc4 Trrp4,974,calcium ion import [GO:0070509]; gamma-aminobutyric acid secretion [GO:0014051]; manganese ion transport [GO:0006828]; oligodendrocyte differentiation [GO:0048709]; regulation of cytosolic calcium ion concentration [GO:0051480],GO:0005886; GO:0005887; GO:0005901; GO:0005911; GO:0006828; GO:0008013; GO:0009986; GO:0014051; GO:0015279; GO:0016323; GO:0030863; GO:0034704; GO:0043234; GO:0045121; GO:0045296; GO:0048709; GO:0051480; GO:0070509; GO:0070679,,,,PF00520;PF08344;,"basolateral plasma membrane [GO:0016323]; calcium channel complex [GO:0034704]; caveola [GO:0005901]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; cortical cytoskeleton [GO:0030863]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; protein complex [GO:0043234]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; inositol 1,4,5 trisphosphate binding [GO:0070679]; store-operated calcium channel activity [GO:0015279]; calcium ion import [GO:0070509]; gamma-aminobutyric acid secretion [GO:0014051]; manganese ion transport [GO:0006828]; oligodendrocyte differentiation [GO:0048709]; regulation of cytosolic calcium ion concentration [GO:0051480]"
O43150,CHOYP_BRAFLDRAFT_199108.1.2|m.24078,0,0,0,0,0,0,0,0,0,"Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 2 (Development and differentiation-enhancing factor 2) (Paxillin-associated protein with ARF GAP activity 3) (PAG3) (Pyk2 C-terminus-associated protein) (PAP)",ASAP2 DDEF2 KIAA0400,1006,,GO:0005096; GO:0005886; GO:0008047; GO:0032580; GO:0046872,,,,PF12796;PF01412;PF00169;PF14604;,Golgi cisterna membrane [GO:0032580]; plasma membrane [GO:0005886]; enzyme activator activity [GO:0008047]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]
Q02858,CHOYP_BRAFLDRAFT_224574.18.18|m.65591,0,0,0,0,0,0,0,0,0.00000005,Angiopoietin-1 receptor (EC 2.7.10.1) (Endothelial tyrosine kinase) (HYK) (STK1) (Tunica interna endothelial cell kinase) (Tyrosine kinase with Ig and EGF homology domains-2) (Tyrosine-protein kinase receptor TEK) (Tyrosine-protein kinase receptor TIE-2) (mTIE2) (p140 TEK) (CD antigen CD202b),Tek Hyk Tie-2 Tie2,1122,angiogenesis [GO:0001525]; branching involved in blood vessel morphogenesis [GO:0001569]; cell-matrix adhesion [GO:0007160]; endothelial cell proliferation [GO:0001935]; heart development [GO:0007507]; heart trabecula formation [GO:0060347]; hemopoiesis [GO:0030097]; leukocyte migration [GO:0050900]; negative regulation of angiogenesis [GO:0016525]; negative regulation of apoptotic process [GO:0043066]; negative regulation of endothelial cell apoptotic process [GO:2000352]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of actin cytoskeleton reorganization [GO:2000251]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cytokine secretion involved in immune response [GO:0002741]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; protein autophosphorylation [GO:0046777]; protein oligomerization [GO:0051259]; regulation of angiogenesis [GO:0045765]; regulation of cell migration [GO:0030334]; regulation of endothelial cell proliferation [GO:0001936]; regulation of establishment or maintenance of cell polarity [GO:0032878]; regulation of NIK/NF-kappaB signaling [GO:1901222]; response to retinoic acid [GO:0032526]; single organismal cell-cell adhesion [GO:0016337]; sprouting angiogenesis [GO:0002040]; substrate adhesion-dependent cell spreading [GO:0034446]; Tie signaling pathway [GO:0048014]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vasculogenesis [GO:0001570],GO:0001525; GO:0001569; GO:0001570; GO:0001934; GO:0001935; GO:0001936; GO:0002040; GO:0002741; GO:0004713; GO:0004714; GO:0004872; GO:0005524; GO:0005576; GO:0005815; GO:0005886; GO:0005887; GO:0005902; GO:0005911; GO:0005925; GO:0007160; GO:0007169; GO:0007507; GO:0009925; GO:0009986; GO:0010595; GO:0014068; GO:0016021; GO:0016323; GO:0016324; GO:0016337; GO:0016525; GO:0018108; GO:0030097; GO:0030334; GO:0030949; GO:0032526; GO:0032878; GO:0033138; GO:0034446; GO:0042307; GO:0043066; GO:0043552; GO:0045121; GO:0045765; GO:0045766; GO:0045785; GO:0046777; GO:0048014; GO:0048471; GO:0050900; GO:0051259; GO:0051894; GO:0051897; GO:0060347; GO:0070374; GO:1901222; GO:1902533; GO:2000251; GO:2000352,,,cd00063;,PF00041;PF10430;PF07714;,apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; microtubule organizing center [GO:0005815]; microvillus [GO:0005902]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; protein tyrosine kinase activity [GO:0004713]; receptor activity [GO:0004872]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; angiogenesis [GO:0001525]; branching involved in blood vessel morphogenesis [GO:0001569]; cell-matrix adhesion [GO:0007160]; endothelial cell proliferation [GO:0001935]; heart development [GO:0007507]; heart trabecula formation [GO:0060347]; hemopoiesis [GO:0030097]; leukocyte migration [GO:0050900]; negative regulation of angiogenesis [GO:0016525]; negative regulation of apoptotic process [GO:0043066]; negative regulation of endothelial cell apoptotic process [GO:2000352]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of actin cytoskeleton reorganization [GO:2000251]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cytokine secretion involved in immune response [GO:0002741]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; protein autophosphorylation [GO:0046777]; protein oligomerization [GO:0051259]; regulation of angiogenesis [GO:0045765]; regulation of cell migration [GO:0030334]; regulation of endothelial cell proliferation [GO:0001936]; regulation of establishment or maintenance of cell polarity [GO:0032878]; regulation of NIK/NF-kappaB signaling [GO:1901222]; response to retinoic acid [GO:0032526]; single organismal cell-cell adhesion [GO:0016337]; sprouting angiogenesis [GO:0002040]; substrate adhesion-dependent cell spreading [GO:0034446]; Tie signaling pathway [GO:0048014]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vasculogenesis [GO:0001570]
Q6P3R8,CHOYP_BRAFLDRAFT_63676.1.1|m.37146,0.5,0,0,0,0,0,0,0,1.00E-79,Serine/threonine-protein kinase Nek5 (EC 2.7.11.1) (Never in mitosis A-related kinase 5) (NimA-related protein kinase 5),NEK5,708,positive regulation of cysteine-type endopeptidase activity [GO:2001056]; positive regulation of striated muscle cell differentiation [GO:0051155],GO:0004674; GO:0005524; GO:0046872; GO:0051155; GO:2001056,,,,PF00069;,ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; positive regulation of cysteine-type endopeptidase activity [GO:2001056]; positive regulation of striated muscle cell differentiation [GO:0051155]
Q5ZK62,CHOYP_ENO.1.2|m.7680,0.5,0,0,0,0,0,0,0,0,"Arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 2 (Centaurin-beta-2) (Cnt-b2)",ACAP2 CENTB2 RCJMB04_12p24,781,cellular response to nerve growth factor stimulus [GO:1990090]; protein localization to endosome [GO:0036010],GO:0005096; GO:0010008; GO:0036010; GO:0046872; GO:1990090,,,,PF12796;PF01412;PF00169;,endosome membrane [GO:0010008]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; cellular response to nerve growth factor stimulus [GO:1990090]; protein localization to endosome [GO:0036010]
Q5R6J7,CHOYP_GPAT4.1.1|m.56178,0.5,0,0,0,0,0,0,0,2.00E-156,Glycerol-3-phosphate acyltransferase 4 (GPAT4) (EC 2.3.1.15) (1-acylglycerol-3-phosphate O-acyltransferase 6) (1-AGP acyltransferase 6) (1-AGPAT 6) (Acyl-CoA:glycerol-3-phosphate acyltransferase 4) (Lysophosphatidic acid acyltransferase zeta) (LPAAT-zeta),GPAT4 AGPAT6,456,acyl-CoA metabolic process [GO:0006637]; CDP-diacylglycerol biosynthetic process [GO:0016024]; diacylglycerol metabolic process [GO:0046339]; fatty acid metabolic process [GO:0006631]; glandular epithelial cell maturation [GO:0002071]; lactation [GO:0007595]; lipid biosynthetic process [GO:0008610]; phosphatidylcholine biosynthetic process [GO:0006656]; regulation of multicellular organism growth [GO:0040014]; triglyceride biosynthetic process [GO:0019432],GO:0002071; GO:0004366; GO:0005783; GO:0005789; GO:0006631; GO:0006637; GO:0006656; GO:0007595; GO:0008610; GO:0016021; GO:0016024; GO:0019432; GO:0040014; GO:0046339,PATHWAY: Phospholipid metabolism; CDP-diacylglycerol biosynthesis; CDP-diacylglycerol from sn-glycerol 3-phosphate: step 1/3.,,,PF01553;,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; glycerol-3-phosphate O-acyltransferase activity [GO:0004366]; acyl-CoA metabolic process [GO:0006637]; CDP-diacylglycerol biosynthetic process [GO:0016024]; diacylglycerol metabolic process [GO:0046339]; fatty acid metabolic process [GO:0006631]; glandular epithelial cell maturation [GO:0002071]; lactation [GO:0007595]; lipid biosynthetic process [GO:0008610]; phosphatidylcholine biosynthetic process [GO:0006656]; regulation of multicellular organism growth [GO:0040014]; triglyceride biosynthetic process [GO:0019432]
P22063,CHOYP_HMCN1.39.44|m.61047,0,0,0,0,0,0,0,0,3.00E-31,Contactin-2 (Axonal glycoprotein TAG-1) (Axonin-1) (Transient axonal glycoprotein 1) (TAX-1),Cntn2 Tax1,1040,axonogenesis [GO:0007409]; cell-matrix adhesion [GO:0007160]; presynaptic membrane organization [GO:0097090],GO:0005886; GO:0007160; GO:0007409; GO:0009986; GO:0031225; GO:0045202; GO:0097090,,,cd00063;,PF00041;PF07679;,anchored component of membrane [GO:0031225]; cell surface [GO:0009986]; plasma membrane [GO:0005886]; synapse [GO:0045202]; axonogenesis [GO:0007409]; cell-matrix adhesion [GO:0007160]; presynaptic membrane organization [GO:0097090]
Q9NUV9,CHOYP_LOC100005182.1.1|m.53007,0,0,0,0,0,0,0,0,1.00E-64,GTPase IMAP family member 4 (Immunity-associated nucleotide 1 protein) (IAN-1) (hIAN1) (Immunity-associated protein 4),GIMAP4 IAN1 IMAP4 MSTP062,329,,GO:0005525; GO:0005829,,,,PF04548;,cytosol [GO:0005829]; GTP binding [GO:0005525]
Q91ZW6,CHOYP_LOC100024134.1.1|m.61877,0,0,0,0,0,0,0,0,5.00E-49,"Trimethyllysine dioxygenase, mitochondrial (EC 1.14.11.8) (Epsilon-trimethyllysine 2-oxoglutarate dioxygenase) (TML hydroxylase) (TML-alpha-ketoglutarate dioxygenase) (TML dioxygenase) (TMLD)",Tmlhe Tmlh,421,carnitine biosynthetic process [GO:0045329],GO:0005506; GO:0005739; GO:0005759; GO:0016702; GO:0031418; GO:0045329; GO:0050353,PATHWAY: Amine and polyamine biosynthesis; carnitine biosynthesis.,,,PF06155;PF02668;,"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; trimethyllysine dioxygenase activity [GO:0050353]; carnitine biosynthetic process [GO:0045329]"
Q62940,CHOYP_LOC100367954.2.2|m.66596,0,0,0,0,0,0,0,0,0.000000002,E3 ubiquitin-protein ligase NEDD4 (EC 2.3.2.26) (HECT-type E3 ubiquitin transferase NEDD4),Nedd4 Nedd4a,887,immune response [GO:0006955]; negative regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030948]; protein K63-linked ubiquitination [GO:0070534]; protein ubiquitination [GO:0016567]; regulation of dendrite morphogenesis [GO:0048814]; response to denervation involved in regulation of muscle adaptation [GO:0014894],GO:0004842; GO:0005737; GO:0005886; GO:0005902; GO:0006955; GO:0008022; GO:0014894; GO:0016567; GO:0030948; GO:0045121; GO:0048814; GO:0070534,PATHWAY: Protein modification; protein ubiquitination.,,cd00078;,PF00168;PF00632;PF00397;,cytoplasm [GO:0005737]; membrane raft [GO:0045121]; microvillus [GO:0005902]; plasma membrane [GO:0005886]; protein C-terminus binding [GO:0008022]; ubiquitin-protein transferase activity [GO:0004842]; immune response [GO:0006955]; negative regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030948]; protein K63-linked ubiquitination [GO:0070534]; protein ubiquitination [GO:0016567]; regulation of dendrite morphogenesis [GO:0048814]; response to denervation involved in regulation of muscle adaptation [GO:0014894]
P09848,CHOYP_LOC100371429.1.1|m.13499,0,0,0,0,0,0,0,0,0,Lactase-phlorizin hydrolase (Lactase-glycosylceramidase) [Includes: Lactase (EC 3.2.1.108); Phlorizin hydrolase (EC 3.2.1.62)],LCT LPH,1927,carbohydrate metabolic process [GO:0005975]; glycosyl compound metabolic process [GO:1901657]; polysaccharide digestion [GO:0044245],GO:0000016; GO:0005886; GO:0005887; GO:0005975; GO:0008422; GO:0016020; GO:0016324; GO:0017042; GO:0044245; GO:1901657,,,,PF00232;,apical plasma membrane [GO:0016324]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; beta-glucosidase activity [GO:0008422]; glycosylceramidase activity [GO:0017042]; lactase activity [GO:0000016]; carbohydrate metabolic process [GO:0005975]; glycosyl compound metabolic process [GO:1901657]; polysaccharide digestion [GO:0044245]
Q08DB5,CHOYP_LOC100372966.1.1|m.18755,0,0,0,0,0,0,0,0,4.00E-120,Syntaxin-5,STX5,355,early endosome to Golgi transport [GO:0034498]; ER to Golgi vesicle-mediated transport [GO:0006888]; Golgi disassembly [GO:0090166]; intracellular protein transport [GO:0006886]; positive regulation of protein catabolic process [GO:0045732]; regulation of Golgi organization [GO:1903358]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906],GO:0000139; GO:0000149; GO:0005484; GO:0005829; GO:0006886; GO:0006888; GO:0006906; GO:0016021; GO:0031201; GO:0031982; GO:0033116; GO:0034498; GO:0045732; GO:0048278; GO:0090166; GO:1903358,,,,PF05739;PF11416;,cytosol [GO:0005829]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; SNARE complex [GO:0031201]; vesicle [GO:0031982]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; early endosome to Golgi transport [GO:0034498]; ER to Golgi vesicle-mediated transport [GO:0006888]; Golgi disassembly [GO:0090166]; intracellular protein transport [GO:0006886]; positive regulation of protein catabolic process [GO:0045732]; regulation of Golgi organization [GO:1903358]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906]
O75592,CHOYP_LOC100560904.1.1|m.37479,0,0,0,0,0,0,0,0,3.00E-70,E3 ubiquitin-protein ligase MYCBP2 (EC 2.3.2.27) (Myc-binding protein 2) (Pam/highwire/rpm-1 protein) (Protein associated with Myc) (RING-type E3 ubiquitin transferase MYCBP2),MYCBP2 KIAA0916 PAM,4640,"protein ubiquitination [GO:0016567]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]",GO:0005634; GO:0006351; GO:0006355; GO:0008270; GO:0016020; GO:0016567; GO:0016740,PATHWAY: Protein modification; protein ubiquitination.,,,PF03256;PF00630;PF08005;PF00415;PF08239;PF13639;,"membrane [GO:0016020]; nucleus [GO:0005634]; transferase activity [GO:0016740]; zinc ion binding [GO:0008270]; protein ubiquitination [GO:0016567]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]"
Q9WTN5,CHOYP_LOC100714922.1.1|m.39817,0,0,0,0,0,0,0,0,8.00E-60,Two pore calcium channel protein 1 (Voltage-dependent calcium channel protein TPC1),Tpcn1 Tpc1,817,membrane depolarization during action potential [GO:0086010],GO:0005245; GO:0005765; GO:0005886; GO:0010008; GO:0016021; GO:0072345; GO:0086010,,,,PF00520;,endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; NAADP-sensitive calcium-release channel activity [GO:0072345]; voltage-gated calcium channel activity [GO:0005245]; membrane depolarization during action potential [GO:0086010]
O35598,CHOYP_LOC100745330.1.1|m.65802,0,0,0,0,0,0,0,0,7.00E-172,Disintegrin and metalloproteinase domain-containing protein 10 (ADAM 10) (EC 3.4.24.81) (Kuzbanian protein homolog) (Mammalian disintegrin-metalloprotease) (CD antigen CD156c),Adam10 Kuz Madm,749,constitutive protein ectodomain proteolysis [GO:0051089]; epidermal growth factor receptor signaling pathway [GO:0007173]; in utero embryonic development [GO:0001701]; membrane protein ectodomain proteolysis [GO:0006509]; monocyte activation [GO:0042117]; negative regulation of cell adhesion [GO:0007162]; Notch receptor processing [GO:0007220]; Notch signaling pathway [GO:0007219]; nucleocytoplasmic transport [GO:0006913]; PMA-inducible membrane protein ectodomain proteolysis [GO:0051088]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of cell proliferation [GO:0008284]; positive regulation of T cell chemotaxis [GO:0010820]; protein phosphorylation [GO:0006468]; protein processing [GO:0016485]; response to tumor necrosis factor [GO:0034612],GO:0000139; GO:0001701; GO:0004175; GO:0004222; GO:0005615; GO:0005634; GO:0005737; GO:0005794; GO:0005798; GO:0005886; GO:0005925; GO:0006468; GO:0006509; GO:0006913; GO:0007162; GO:0007173; GO:0007219; GO:0007220; GO:0008237; GO:0008284; GO:0009986; GO:0010820; GO:0014069; GO:0016020; GO:0016021; GO:0016485; GO:0019901; GO:0030307; GO:0030335; GO:0034612; GO:0042117; GO:0042169; GO:0042803; GO:0046872; GO:0051088; GO:0051089; GO:0070062; GO:0097038; GO:0097197,,,cd04270;,PF00200;PF01562;,cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi-associated vesicle [GO:0005798]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; tetraspanin-enriched microdomain [GO:0097197]; endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; SH2 domain binding [GO:0042169]; constitutive protein ectodomain proteolysis [GO:0051089]; epidermal growth factor receptor signaling pathway [GO:0007173]; in utero embryonic development [GO:0001701]; membrane protein ectodomain proteolysis [GO:0006509]; monocyte activation [GO:0042117]; negative regulation of cell adhesion [GO:0007162]; Notch receptor processing [GO:0007220]; Notch signaling pathway [GO:0007219]; nucleocytoplasmic transport [GO:0006913]; PMA-inducible membrane protein ectodomain proteolysis [GO:0051088]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of cell proliferation [GO:0008284]; positive regulation of T cell chemotaxis [GO:0010820]; protein phosphorylation [GO:0006468]; protein processing [GO:0016485]; response to tumor necrosis factor [GO:0034612]
O75095,CHOYP_LOC101242430.1.2|m.23519,0,0,0,0,0,0,0,0,0.000002,Multiple epidermal growth factor-like domains protein 6 (Multiple EGF-like domains protein 6) (Epidermal growth factor-like protein 3) (EGF-like protein 3),MEGF6 EGFL3 KIAA0815,1541,,GO:0005509; GO:0005576,,,,PF07645;PF12661;PF00053;,extracellular region [GO:0005576]; calcium ion binding [GO:0005509]
Q5ZT34,CHOYP_LOC574855.4.9|m.22339,0,0,0,0,0,0,0,0,0.000001,Malonyl-[acyl-carrier protein] O-methyltransferase (Malonyl-ACP O-methyltransferase) (EC 2.1.1.197) (Biotin synthesis protein BioC),bioC lpg2331,284,biotin biosynthetic process [GO:0009102],GO:0009102; GO:0010340,PATHWAY: Cofactor biosynthesis; biotin biosynthesis. {ECO:0000255|HAMAP-Rule:MF_00835}.,,,PF08241;,carboxyl-O-methyltransferase activity [GO:0010340]; biotin biosynthetic process [GO:0009102]
Q5ZQU0,CHOYP_LOC580675.1.1|m.44042,0,0,0,0,0,0,0,0,3.00E-17,"Sushi, nidogen and EGF-like domain-containing protein 1 (Insulin-responsive sequence DNA-binding protein 1) (IRE-BP1)",Sned1,1403,cell-matrix adhesion [GO:0007160],GO:0005509; GO:0005576; GO:0007160,,,cd00033;cd00063;,PF00008;PF00041;PF12661;PF06119;,extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; cell-matrix adhesion [GO:0007160]
Q00725,CHOYP_LOC689840.1.1|m.6512,2.5,0,0,0,0,0,0,0,0.00000002,Salivary glue protein Sgs-4,Sgs4 Sgs-4 CG12181,297,,GO:0005576,,,,,extracellular region [GO:0005576]
Q2KIR0,CHOYP_NEMVEDRAFT_V1G208725.1.1|m.36498,1,0,0,0,0,0,0,0,8.00E-12,Uncharacterized protein C4orf45 homolog,,197,,,,,,PF15123;,
Q0VFH6,CHOYP_RM22.1.1|m.63127,0,0,0,0,0,0,0,0,2.00E-36,"39S ribosomal protein L22, mitochondrial (L22mt) (MRP-L22)",mrpl22,204,translation [GO:0006412],GO:0003735; GO:0005739; GO:0005762; GO:0006412,,,cd00336;,PF00237;,mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]
Q96KE9,CHOYP_TSP_07884.1.1|m.41175,0,0,0,0,0,0,0,0,1.00E-26,BTB/POZ domain-containing protein 6 (Lens BTB domain protein),BTBD6 BDPL,485,neurogenesis [GO:0022008]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0042787]; regulation of proteolysis [GO:0030162],GO:0000932; GO:0005829; GO:0019005; GO:0022008; GO:0030162; GO:0031625; GO:0042787; GO:0043161,,,,PF07707;PF00651;PF08005;,cytosol [GO:0005829]; P-body [GO:0000932]; SCF ubiquitin ligase complex [GO:0019005]; ubiquitin protein ligase binding [GO:0031625]; neurogenesis [GO:0022008]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0042787]; regulation of proteolysis [GO:0030162]
P57080,CHOYP_UBP25.1.1|m.61531,0.5,0,0,0,0,0,0,0,0,Ubiquitin carboxyl-terminal hydrolase 25 (EC 3.4.19.12) (Deubiquitinating enzyme 25) (Ubiquitin thioesterase 25) (Ubiquitin-specific-processing protease 25) (mUSP25),Usp25,1055,negative regulation of ERAD pathway [GO:1904293]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; ubiquitin-dependent protein catabolic process [GO:0006511],GO:0000502; GO:0004843; GO:0005634; GO:0005783; GO:0005829; GO:0006511; GO:0016579; GO:0031625; GO:0032183; GO:0051117; GO:0070536; GO:0071108; GO:1904293,,,,PF00443;PF02809;,cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; ATPase binding [GO:0051117]; SUMO binding [GO:0032183]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; ubiquitin protein ligase binding [GO:0031625]; negative regulation of ERAD pathway [GO:1904293]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; ubiquitin-dependent protein catabolic process [GO:0006511]
Q9N0A8,CHOYP_ARHGEF3.1.1|m.13898,0.5,0,0,0,0,0,0,0,3.00E-132,Rho guanine nucleotide exchange factor 3,ARHGEF3 QccE-16434,526,intracellular signal transduction [GO:0035556]; regulation of Rho protein signal transduction [GO:0035023],GO:0005089; GO:0005737; GO:0035023; GO:0035556,,,,PF00621;,cytoplasm [GO:0005737]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; intracellular signal transduction [GO:0035556]; regulation of Rho protein signal transduction [GO:0035023]
P45962,CHOYP_BRAFLDRAFT_118210.1.1|m.51280,0,0,0,0,0,0,0,0,6.00E-90,Kinesin-like protein klp-3,klp-3 T09A5.2,598,microtubule-based movement [GO:0007018],GO:0003777; GO:0005524; GO:0005737; GO:0005871; GO:0005874; GO:0007018; GO:0016887,,,,PF00225;,cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; microtubule motor activity [GO:0003777]; microtubule-based movement [GO:0007018]
Q8CDY7,CHOYP_BRAFLDRAFT_126378.2.2|m.11826,3,0,0,0,0,0,0,0,1.00E-21,Tctex1 domain-containing protein 4,Tctex1d4,219,,GO:0001669; GO:0005634; GO:0005737; GO:0005815; GO:0005930; GO:0008157; GO:0036126,,,,PF03645;,acrosomal vesicle [GO:0001669]; axoneme [GO:0005930]; cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; sperm flagellum [GO:0036126]; protein phosphatase 1 binding [GO:0008157]
Q8R3V6,CHOYP_BRAFLDRAFT_131608.1.1|m.44249,0,0,0,0,0,0,0,0,9.00E-14,CUE domain-containing protein 1,Cuedc1,388,,,,,,PF02845;,
O43301,CHOYP_BRAFLDRAFT_208436.1.32|m.14239,1.5,0,0,0,0,0,0,0,4.00E-112,Heat shock 70 kDa protein 12A,HSPA12A KIAA0417,675,,GO:0005524; GO:0070062,,,,,extracellular exosome [GO:0070062]; ATP binding [GO:0005524]
P22105,CHOYP_BRAFLDRAFT_235412.2.2|m.58139,0,0,0,0,0,0,0,0,2.00E-23,Tenascin-X (TN-X) (Hexabrachion-like protein),TNXB HXBL TNX TNXB1 TNXB2 XB,4242,actin cytoskeleton organization [GO:0030036]; cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; elastic fiber assembly [GO:0048251],GO:0005178; GO:0005578; GO:0005615; GO:0005622; GO:0007155; GO:0008201; GO:0030036; GO:0030199; GO:0032963; GO:0048251; GO:0070062,,,cd00063;cd00087;,PF07974;PF00147;PF00041;,extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; intracellular [GO:0005622]; proteinaceous extracellular matrix [GO:0005578]; heparin binding [GO:0008201]; integrin binding [GO:0005178]; actin cytoskeleton organization [GO:0030036]; cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; elastic fiber assembly [GO:0048251]
Q54728,CHOYP_BRAFLDRAFT_268591.1.1|m.59744,0,0,0,0,0,0,0,0,6.00E-19,Uncharacterized oxidoreductase SP_1686 (EC 1.-.-.-),SP_1686,367,,GO:0016491,,,,PF01408;PF02894;,oxidoreductase activity [GO:0016491]
Q6P632,CHOYP_BRAFLDRAFT_284784.1.1|m.12397,0,0,0,0,0,0,0,0,2.00E-94,N-alpha-acetyltransferase 20 (EC 2.3.1.254) (Methionine N-acetyltransferase) (N-acetyltransferase 5) (N-terminal acetyltransferase B complex catalytic subunit NAA20) (N-terminal acetyltransferase B complex catalytic subunit NAT5) (NatB complex subunit NAT5) (NatB catalytic subunit),naa20 nat5,178,N-terminal peptidyl-methionine acetylation [GO:0017196],GO:0004596; GO:0005634; GO:0005737; GO:0017196; GO:0031416,,,,PF00583;,cytoplasm [GO:0005737]; NatB complex [GO:0031416]; nucleus [GO:0005634]; peptide alpha-N-acetyltransferase activity [GO:0004596]; N-terminal peptidyl-methionine acetylation [GO:0017196]
Q8WWZ8,CHOYP_BRAFLDRAFT_68915.2.7|m.3908,0,0,0,0,0,0,0,0,1.00E-17,Oncoprotein-induced transcript 3 protein (Liver-specific zona pellucida domain-containing protein),OIT3 LZP UNQ826/PRO1753,545,urate homeostasis [GO:1903118],GO:0005509; GO:0005635; GO:1903118,,,,PF00100;,nuclear envelope [GO:0005635]; calcium ion binding [GO:0005509]; urate homeostasis [GO:1903118]
Q9P2K2,CHOYP_BRAFLDRAFT_78229.1.1|m.52210,0,0,0,0,0,0,0,0,5.00E-55,Thioredoxin domain-containing protein 16,TXNDC16 ERP90 KIAA1344,825,cell redox homeostasis [GO:0045454],GO:0005788; GO:0045454; GO:0070062,,,,PF00085;,endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; cell redox homeostasis [GO:0045454]
Q6AZ60,CHOYP_BRAFLDRAFT_99630.6.9|m.39673,0,0,0,0,0,0,0,0,0.000008,Epidermal growth factor-like protein 7 (EGF-like protein 7) (Multiple epidermal growth factor-like domains protein 7) (Multiple EGF-like domains protein 7),Egfl7 Cbl20 Megf7,279,angiogenesis [GO:0001525]; blood vessel development [GO:0001568]; cell adhesion [GO:0007155]; negative regulation of Notch signaling pathway [GO:0045746]; positive regulation of endothelial cell proliferation [GO:0001938]; vasculogenesis [GO:0001570],GO:0001525; GO:0001568; GO:0001570; GO:0001938; GO:0005509; GO:0005576; GO:0005615; GO:0007155; GO:0031012; GO:0045746,,,,PF07974;PF07645;PF07546;,extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; angiogenesis [GO:0001525]; blood vessel development [GO:0001568]; cell adhesion [GO:0007155]; negative regulation of Notch signaling pathway [GO:0045746]; positive regulation of endothelial cell proliferation [GO:0001938]; vasculogenesis [GO:0001570]
Q6AZ60,CHOYP_BRAFLDRAFT_99630.9.9|m.62562,0,0,0,0,0,0,0,0,0.000008,Epidermal growth factor-like protein 7 (EGF-like protein 7) (Multiple epidermal growth factor-like domains protein 7) (Multiple EGF-like domains protein 7),Egfl7 Cbl20 Megf7,279,angiogenesis [GO:0001525]; blood vessel development [GO:0001568]; cell adhesion [GO:0007155]; negative regulation of Notch signaling pathway [GO:0045746]; positive regulation of endothelial cell proliferation [GO:0001938]; vasculogenesis [GO:0001570],GO:0001525; GO:0001568; GO:0001570; GO:0001938; GO:0005509; GO:0005576; GO:0005615; GO:0007155; GO:0031012; GO:0045746,,,,PF07974;PF07645;PF07546;,extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; angiogenesis [GO:0001525]; blood vessel development [GO:0001568]; cell adhesion [GO:0007155]; negative regulation of Notch signaling pathway [GO:0045746]; positive regulation of endothelial cell proliferation [GO:0001938]; vasculogenesis [GO:0001570]
Q717B4,CHOYP_CAOG_01182.1.1|m.8019,1,0,0,0,0,0,0,0,7.00E-18,TD and POZ domain-containing protein 3,Tdpoz3,365,proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0042787]; regulation of proteolysis [GO:0030162],GO:0005634; GO:0005737; GO:0019005; GO:0030162; GO:0031625; GO:0042787; GO:0043161,,,cd14734;,PF00651;,cytoplasm [GO:0005737]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]; ubiquitin protein ligase binding [GO:0031625]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0042787]; regulation of proteolysis [GO:0030162]
P54099,CHOYP_DPOG1.1.1|m.35597,0,0,0,0,0,0,0,0,0,DNA polymerase subunit gamma-1 (EC 2.7.7.7) (Mitochondrial DNA polymerase catalytic subunit) (PolG-alpha),Polg Polg1,1218,aging [GO:0007568]; mitochondrial DNA replication [GO:0006264],GO:0002020; GO:0003677; GO:0003682; GO:0003887; GO:0004527; GO:0005739; GO:0005743; GO:0005760; GO:0006264; GO:0007568; GO:0008408; GO:0042645; GO:0043234; GO:0070062,,,,PF00476;,extracellular exosome [GO:0070062]; gamma DNA polymerase complex [GO:0005760]; mitochondrial inner membrane [GO:0005743]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; protein complex [GO:0043234]; 3'-5' exonuclease activity [GO:0008408]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; exonuclease activity [GO:0004527]; protease binding [GO:0002020]; aging [GO:0007568]; mitochondrial DNA replication [GO:0006264]
Q3ZBT2,CHOYP_FBX9.1.1|m.49865,0.5,0,0,0,0,0,0,0,2.00E-102,F-box only protein 9,FBXO9,437,fat cell differentiation [GO:0045444]; innate immune response [GO:0045087]; protein ubiquitination [GO:0016567]; regulation of TOR signaling [GO:0032006]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146],GO:0005737; GO:0016567; GO:0019005; GO:0031146; GO:0032006; GO:0045087; GO:0045444,PATHWAY: Protein modification; protein ubiquitination.,,,PF12937;,cytoplasm [GO:0005737]; SCF ubiquitin ligase complex [GO:0019005]; fat cell differentiation [GO:0045444]; innate immune response [GO:0045087]; protein ubiquitination [GO:0016567]; regulation of TOR signaling [GO:0032006]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]
Q9Z1T6,CHOYP_FYV1.1.1|m.41923,0,0,0,0,0,0,0,0,0,1-phosphatidylinositol 3-phosphate 5-kinase (Phosphatidylinositol 3-phosphate 5-kinase) (EC 2.7.1.150) (FYVE finger-containing phosphoinositide kinase) (PIKfyve) (Phosphatidylinositol 3-phosphate 5-kinase type III) (PIPkin-III) (Type III PIP kinase) (p235),Pikfyve Kiaa0981 Pip5k3,2097,"intracellular signal transduction [GO:0035556]; myelin assembly [GO:0032288]; protein localization to nucleus [GO:0034504]; regulation of autophagosome assembly [GO:2000785]; retrograde transport, endosome to Golgi [GO:0042147]",GO:0000139; GO:0000285; GO:0005524; GO:0005829; GO:0005911; GO:0008270; GO:0010008; GO:0012506; GO:0016308; GO:0030659; GO:0031410; GO:0031901; GO:0031902; GO:0032288; GO:0034504; GO:0035556; GO:0042147; GO:0045121; GO:0048471; GO:0052810; GO:2000785,,,,PF00118;PF00610;PF01363;PF01504;,"cell-cell junction [GO:0005911]; cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; Golgi membrane [GO:0000139]; late endosome membrane [GO:0031902]; membrane raft [GO:0045121]; perinuclear region of cytoplasm [GO:0048471]; vesicle membrane [GO:0012506]; 1-phosphatidylinositol-3-phosphate 5-kinase activity [GO:0000285]; 1-phosphatidylinositol-4-phosphate 5-kinase activity [GO:0016308]; 1-phosphatidylinositol-5-kinase activity [GO:0052810]; ATP binding [GO:0005524]; zinc ion binding [GO:0008270]; intracellular signal transduction [GO:0035556]; myelin assembly [GO:0032288]; protein localization to nucleus [GO:0034504]; regulation of autophagosome assembly [GO:2000785]; retrograde transport, endosome to Golgi [GO:0042147]"
Q7VC04,CHOYP_HSPA12A.5.27|m.21251,0,0,0,0,0,0,0,0,5.00E-11,Chaperone protein dnaK1 (HSP70-1) (Heat shock 70 kDa protein 1) (Heat shock protein 70-1),dnaK1 Pro_0938,666,protein folding [GO:0006457],GO:0005524; GO:0006457,,,,PF00012;,ATP binding [GO:0005524]; protein folding [GO:0006457]
Q05695,CHOYP_ISCW_ISCW020054.1.1|m.58472,0,0,0,0,0,0,0,0,2.00E-25,Neural cell adhesion molecule L1 (N-CAM-L1) (NCAM-L1) (Nerve-growth factor-inducible large external glycoprotein) (NILE) (CD antigen CD171),L1cam Caml1,1259,axonal fasciculation [GO:0007413]; cell adhesion [GO:0007155]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to ethanol [GO:0071361]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to thyroxine stimulus [GO:0097069]; cellular response to transforming growth factor beta stimulus [GO:0071560]; dopaminergic neuron differentiation [GO:0071542]; neuron differentiation [GO:0030182]; positive regulation of axon extension [GO:0045773]; positive regulation of cell-substrate adhesion [GO:0010811]; regulation of ERK1 and ERK2 cascade [GO:0070372]; response to activity [GO:0014823]; response to thyroid hormone [GO:0097066],GO:0005768; GO:0005886; GO:0007155; GO:0007413; GO:0009986; GO:0010811; GO:0014823; GO:0016021; GO:0030165; GO:0030182; GO:0030424; GO:0030425; GO:0043025; GO:0044294; GO:0044295; GO:0045121; GO:0045773; GO:0070372; GO:0071361; GO:0071542; GO:0071549; GO:0071560; GO:0097066; GO:0097069; GO:1990090,,,cd00063;,PF13882;PF00041;PF07679;,axon [GO:0030424]; axonal growth cone [GO:0044295]; cell surface [GO:0009986]; dendrite [GO:0030425]; dendritic growth cone [GO:0044294]; endosome [GO:0005768]; integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; PDZ domain binding [GO:0030165]; axonal fasciculation [GO:0007413]; cell adhesion [GO:0007155]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to ethanol [GO:0071361]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to thyroxine stimulus [GO:0097069]; cellular response to transforming growth factor beta stimulus [GO:0071560]; dopaminergic neuron differentiation [GO:0071542]; neuron differentiation [GO:0030182]; positive regulation of axon extension [GO:0045773]; positive regulation of cell-substrate adhesion [GO:0010811]; regulation of ERK1 and ERK2 cascade [GO:0070372]; response to activity [GO:0014823]; response to thyroid hormone [GO:0097066]
P22105,CHOYP_LOC100160385.1.2|m.40193,0,0,0,0,0,0,0,0,0.000008,Tenascin-X (TN-X) (Hexabrachion-like protein),TNXB HXBL TNX TNXB1 TNXB2 XB,4242,actin cytoskeleton organization [GO:0030036]; cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; elastic fiber assembly [GO:0048251],GO:0005178; GO:0005578; GO:0005615; GO:0005622; GO:0007155; GO:0008201; GO:0030036; GO:0030199; GO:0032963; GO:0048251; GO:0070062,,,cd00063;cd00087;,PF07974;PF00147;PF00041;,extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; intracellular [GO:0005622]; proteinaceous extracellular matrix [GO:0005578]; heparin binding [GO:0008201]; integrin binding [GO:0005178]; actin cytoskeleton organization [GO:0030036]; cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; elastic fiber assembly [GO:0048251]
Q9D2K4,CHOYP_LOC100368865.1.1|m.48100,0.5,0,0,0,0,0,0,0,0,IQ domain-containing protein H,Iqch,1071,,,,,,,
P22105,CHOYP_LOC100369350.2.6|m.42373,0,0,0,0,0,0,0,0,4.00E-47,Tenascin-X (TN-X) (Hexabrachion-like protein),TNXB HXBL TNX TNXB1 TNXB2 XB,4242,actin cytoskeleton organization [GO:0030036]; cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; elastic fiber assembly [GO:0048251],GO:0005178; GO:0005578; GO:0005615; GO:0005622; GO:0007155; GO:0008201; GO:0030036; GO:0030199; GO:0032963; GO:0048251; GO:0070062,,,cd00063;cd00087;,PF07974;PF00147;PF00041;,extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; intracellular [GO:0005622]; proteinaceous extracellular matrix [GO:0005578]; heparin binding [GO:0008201]; integrin binding [GO:0005178]; actin cytoskeleton organization [GO:0030036]; cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; elastic fiber assembly [GO:0048251]
Q2Q1W2,CHOYP_LOC100376608.2.4|m.47059,0,0,0,0,0,0,0,0,0.000000005,E3 ubiquitin-protein ligase TRIM71 (EC 2.3.2.27) (Protein lin-41 homolog) (RING-type E3 ubiquitin transferase TRIM71) (Tripartite motif-containing protein 71),TRIM71 LIN41,868,3'-UTR-mediated mRNA destabilization [GO:0061158]; fibroblast growth factor receptor signaling pathway [GO:0008543]; G1/S transition of mitotic cell cycle [GO:0000082]; miRNA mediated inhibition of translation [GO:0035278]; miRNA metabolic process [GO:0010586]; negative regulation of translation [GO:0017148]; neural tube closure [GO:0001843]; neural tube development [GO:0021915]; positive regulation of gene silencing by miRNA [GO:2000637]; protein autoubiquitination [GO:0051865]; regulation of gene silencing by miRNA [GO:0060964]; regulation of neural precursor cell proliferation [GO:2000177]; stem cell proliferation [GO:0072089],GO:0000082; GO:0000932; GO:0001843; GO:0004842; GO:0008270; GO:0008543; GO:0010586; GO:0017148; GO:0021915; GO:0030371; GO:0035198; GO:0035278; GO:0051865; GO:0060964; GO:0061158; GO:0061630; GO:0072089; GO:2000177; GO:2000637,PATHWAY: Protein modification; protein ubiquitination.,,,PF00630;PF01436;PF00643;,P-body [GO:0000932]; miRNA binding [GO:0035198]; translation repressor activity [GO:0030371]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; 3'-UTR-mediated mRNA destabilization [GO:0061158]; fibroblast growth factor receptor signaling pathway [GO:0008543]; G1/S transition of mitotic cell cycle [GO:0000082]; miRNA mediated inhibition of translation [GO:0035278]; miRNA metabolic process [GO:0010586]; negative regulation of translation [GO:0017148]; neural tube closure [GO:0001843]; neural tube development [GO:0021915]; positive regulation of gene silencing by miRNA [GO:2000637]; protein autoubiquitination [GO:0051865]; regulation of gene silencing by miRNA [GO:0060964]; regulation of neural precursor cell proliferation [GO:2000177]; stem cell proliferation [GO:0072089]
Q9Z139,CHOYP_LOC100533220.2.2|m.13989,0,0,0,0,0,0,0,0,0,"Inactive tyrosine-protein kinase transmembrane receptor ROR1 (mROR1) (Neurotrophic tyrosine kinase, receptor-related 1)",Ror1 Ntrkr1,937,astrocyte development [GO:0014002]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; Wnt signaling pathway [GO:0016055],GO:0001725; GO:0004714; GO:0005524; GO:0005737; GO:0005887; GO:0007169; GO:0009986; GO:0014002; GO:0016055; GO:0017147; GO:0043235,,,,PF01392;PF07679;PF00051;PF07714;,cell surface [GO:0009986]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; receptor complex [GO:0043235]; stress fiber [GO:0001725]; ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; Wnt-protein binding [GO:0017147]; astrocyte development [GO:0014002]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; Wnt signaling pathway [GO:0016055]
Q01815,CHOYP_LOC100647135.1.2|m.21531,1,0,0,0,0,0,0,0,0,"Voltage-dependent L-type calcium channel subunit alpha-1C (Calcium channel, L type, alpha-1 polypeptide, isoform 1, cardiac muscle) (MELC-CC) (Mouse brain class C) (MBC) (Voltage-gated calcium channel subunit alpha Cav1.2)",Cacna1c Cach2 Cacn2 Cacnl1a1 Cchl1a1,2139,adult walking behavior [GO:0007628]; calcium ion regulated exocytosis [GO:0017156]; calcium ion transmembrane transport [GO:0070588]; calcium ion transmembrane transport via high voltage-gated calcium channel [GO:0061577]; calcium ion transport [GO:0006816]; camera-type eye development [GO:0043010]; cardiac conduction [GO:0061337]; cardiac muscle cell action potential involved in contraction [GO:0086002]; cellular calcium ion homeostasis [GO:0006874]; chemical synaptic transmission [GO:0007268]; embryonic forelimb morphogenesis [GO:0035115]; glucose homeostasis [GO:0042593]; growth hormone secretion [GO:0030252]; heart development [GO:0007507]; immune system development [GO:0002520]; insulin secretion [GO:0030073]; membrane depolarization during action potential [GO:0086010]; membrane depolarization during atrial cardiac muscle cell action potential [GO:0098912]; membrane depolarization during AV node cell action potential [GO:0086045]; membrane depolarization during cardiac muscle cell action potential [GO:0086012]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; regulation of blood pressure [GO:0008217]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of organ growth [GO:0046620]; regulation of vasoconstriction [GO:0019229]; regulation of ventricular cardiac muscle cell action potential [GO:0098911]; smooth muscle contraction [GO:0006939]; smooth muscle contraction involved in micturition [GO:0060083]; visual learning [GO:0008542],GO:0002095; GO:0002520; GO:0005245; GO:0005516; GO:0005737; GO:0005886; GO:0005891; GO:0006816; GO:0006874; GO:0006939; GO:0007204; GO:0007268; GO:0007507; GO:0007628; GO:0008217; GO:0008331; GO:0008542; GO:0014069; GO:0016020; GO:0016021; GO:0017156; GO:0019229; GO:0019899; GO:0030018; GO:0030073; GO:0030252; GO:0030315; GO:0035115; GO:0042593; GO:0043010; GO:0043025; GO:0043198; GO:0045211; GO:0046620; GO:0046872; GO:0051393; GO:0060083; GO:0061337; GO:0061577; GO:0070588; GO:0086002; GO:0086007; GO:0086010; GO:0086012; GO:0086045; GO:0086056; GO:0086091; GO:0098911; GO:0098912; GO:1905030; GO:1990454,,,,PF08763;PF16885;PF16905;PF00520;,caveolar macromolecular signaling complex [GO:0002095]; cytoplasm [GO:0005737]; dendritic shaft [GO:0043198]; integral component of membrane [GO:0016021]; L-type voltage-gated calcium channel complex [GO:1990454]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; T-tubule [GO:0030315]; voltage-gated calcium channel complex [GO:0005891]; Z disc [GO:0030018]; alpha-actinin binding [GO:0051393]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; high voltage-gated calcium channel activity [GO:0008331]; metal ion binding [GO:0046872]; voltage-gated calcium channel activity [GO:0005245]; voltage-gated calcium channel activity involved in AV node cell action potential [GO:0086056]; voltage-gated calcium channel activity involved in cardiac muscle cell action potential [GO:0086007]; voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1905030]; adult walking behavior [GO:0007628]; calcium ion regulated exocytosis [GO:0017156]; calcium ion transmembrane transport [GO:0070588]; calcium ion transmembrane transport via high voltage-gated calcium channel [GO:0061577]; calcium ion transport [GO:0006816]; camera-type eye development [GO:0043010]; cardiac conduction [GO:0061337]; cardiac muscle cell action potential involved in contraction [GO:0086002]; cellular calcium ion homeostasis [GO:0006874]; chemical synaptic transmission [GO:0007268]; embryonic forelimb morphogenesis [GO:0035115]; glucose homeostasis [GO:0042593]; growth hormone secretion [GO:0030252]; heart development [GO:0007507]; immune system development [GO:0002520]; insulin secretion [GO:0030073]; membrane depolarization during action potential [GO:0086010]; membrane depolarization during atrial cardiac muscle cell action potential [GO:0098912]; membrane depolarization during AV node cell action potential [GO:0086045]; membrane depolarization during cardiac muscle cell action potential [GO:0086012]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; regulation of blood pressure [GO:0008217]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of organ growth [GO:0046620]; regulation of vasoconstriction [GO:0019229]; regulation of ventricular cardiac muscle cell action potential [GO:0098911]; smooth muscle contraction [GO:0006939]; smooth muscle contraction involved in micturition [GO:0060083]; visual learning [GO:0008542]
Q7ZWI4,CHOYP_LOC100888910.1.1|m.64827,0,0,0,0,0,0,0,0,2.00E-29,GSK3-beta interaction protein (GSKIP),gskip zgc:55683,133,,GO:0005737,,,,PF05303;,cytoplasm [GO:0005737]
O14522,CHOYP_LOC578968.2.2|m.54316,0,0,0,0,0,0,0,0,2.00E-61,Receptor-type tyrosine-protein phosphatase T (R-PTP-T) (EC 3.1.3.48) (Receptor-type tyrosine-protein phosphatase rho) (RPTP-rho),PTPRT KIAA0283,1441,cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; protein dephosphorylation [GO:0006470]; signal transduction [GO:0007165]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],GO:0004725; GO:0005886; GO:0006470; GO:0007155; GO:0007156; GO:0007165; GO:0007169; GO:0008013; GO:0009986; GO:0016021; GO:0045294; GO:0045295; GO:0045296; GO:0070097,,,cd00063;cd06263;,PF00041;PF00629;PF00102;,cell surface [GO:0009986]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; delta-catenin binding [GO:0070097]; gamma-catenin binding [GO:0045295]; protein tyrosine phosphatase activity [GO:0004725]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; protein dephosphorylation [GO:0006470]; signal transduction [GO:0007165]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]
P53369,CHOYP_LOC587752.1.1|m.66173,0,0,0,0,0,0,0,0,2.00E-62,"7,8-dihydro-8-oxoguanine triphosphatase (EC 3.6.1.55) (2-hydroxy-dATP diphosphatase) (EC 3.6.1.56) (8-oxo-dGTPase) (Nucleoside diphosphate-linked moiety X motif 1) (Nudix motif 1)",Nudt1 Mth1,156,aging [GO:0007568]; dATP catabolic process [GO:0046061]; dGTP catabolic process [GO:0006203]; DNA protection [GO:0042262]; DNA repair [GO:0006281]; male gonad development [GO:0008584]; purine nucleotide catabolic process [GO:0006195]; response to cadmium ion [GO:0046686],GO:0001669; GO:0005615; GO:0005634; GO:0005737; GO:0005739; GO:0005759; GO:0005829; GO:0005886; GO:0006195; GO:0006203; GO:0006281; GO:0007568; GO:0008413; GO:0008584; GO:0030515; GO:0031965; GO:0035539; GO:0036219; GO:0042262; GO:0046061; GO:0046686; GO:0046872; GO:0047693; GO:0070062,,,,PF00293;,"acrosomal vesicle [GO:0001669]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; 8-oxo-7,8-dihydrodeoxyguanosine triphosphate pyrophosphatase activity [GO:0035539]; 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity [GO:0008413]; ATP diphosphatase activity [GO:0047693]; GTP diphosphatase activity [GO:0036219]; metal ion binding [GO:0046872]; snoRNA binding [GO:0030515]; aging [GO:0007568]; dATP catabolic process [GO:0046061]; dGTP catabolic process [GO:0006203]; DNA protection [GO:0042262]; DNA repair [GO:0006281]; male gonad development [GO:0008584]; purine nucleotide catabolic process [GO:0006195]; response to cadmium ion [GO:0046686]"
Q8WZ42,CHOYP_LOC658092.2.2|m.60940,0,0,0,0,0,0,0,0,3.00E-17,Titin (EC 2.7.11.1) (Connectin) (Rhabdomyosarcoma antigen MU-RMS-40.14),TTN,34350,cardiac muscle contraction [GO:0060048]; cardiac muscle fiber development [GO:0048739]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; mitotic chromosome condensation [GO:0007076]; muscle contraction [GO:0006936]; muscle filament sliding [GO:0030049]; platelet degranulation [GO:0002576]; regulation of catalytic activity [GO:0050790]; regulation of protein kinase activity [GO:0045859]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; striated muscle contraction [GO:0006941],GO:0000794; GO:0002020; GO:0002576; GO:0003300; GO:0004674; GO:0004713; GO:0005509; GO:0005516; GO:0005524; GO:0005576; GO:0005829; GO:0005859; GO:0005865; GO:0006936; GO:0006941; GO:0007076; GO:0008307; GO:0019899; GO:0019901; GO:0030018; GO:0030049; GO:0030240; GO:0030241; GO:0031430; GO:0031433; GO:0031674; GO:0035995; GO:0042802; GO:0042805; GO:0043621; GO:0045214; GO:0045859; GO:0048739; GO:0048769; GO:0050790; GO:0051015; GO:0051371; GO:0051592; GO:0055003; GO:0055008; GO:0060048; GO:0070062; GO:0097493,,,cd00063;,PF00041;PF07679;PF00069;PF02818;PF09042;,condensed nuclear chromosome [GO:0000794]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein kinase binding [GO:0019901]; protein self-association [GO:0043621]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433]; cardiac muscle contraction [GO:0060048]; cardiac muscle fiber development [GO:0048739]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; mitotic chromosome condensation [GO:0007076]; muscle contraction [GO:0006936]; muscle filament sliding [GO:0030049]; platelet degranulation [GO:0002576]; regulation of catalytic activity [GO:0050790]; regulation of protein kinase activity [GO:0045859]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; striated muscle contraction [GO:0006941]
Q54P70,CHOYP_MYBV.1.1|m.62683,0,0,0,0,0,0,0,0,4.00E-11,OTU domain-containing protein DDB_G0284757 (EC 3.1.2.-),DDB_G0284757,766,,GO:0008234,,,,PF02338;,cysteine-type peptidase activity [GO:0008234]
P10079,CHOYP_NEMVEDRAFT_V1G141380.2.4|m.8974,0,0,0,0,0,0,0,0,2.00E-82,Fibropellin-1 (Epidermal growth factor-related protein 1) (Fibropellin-I) (SpEGF I) (UEGF-1),EGF1,1064,,GO:0005509; GO:0005615; GO:0031410; GO:0032579,,,cd00041;,PF01382;PF00431;PF00008;PF12661;,apical lamina of hyaline layer [GO:0032579]; cytoplasmic vesicle [GO:0031410]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]
Q8CI17,CHOYP_NEMVEDRAFT_V1G218914.4.4|m.62116,0,0,0,0,0,0,0,0,0.000004,Protein mab-21-like 3,Mab21L3,429,,,,,,PF03281;,
Q8CIW5,CHOYP_PEO1.1.1|m.14775,0,0,0,0,0,0,0,0,3.00E-10,"Twinkle protein, mitochondrial (EC 3.6.4.12) (Progressive external ophthalmoplegia 1 protein homolog) (T7 gp4-like protein with intramitochondrial nucleoid localization) (T7-like mitochondrial DNA helicase)",Peo1,685,cellular response to glucose stimulus [GO:0071333]; DNA unwinding involved in DNA replication [GO:0006268]; mitochondrial DNA replication [GO:0006264]; protein hexamerization [GO:0034214]; protein homooligomerization [GO:0051260]; transcription from mitochondrial promoter [GO:0006390],GO:0002020; GO:0003678; GO:0003697; GO:0005524; GO:0005739; GO:0006264; GO:0006268; GO:0006390; GO:0034214; GO:0042645; GO:0043139; GO:0051260; GO:0071333,,,cd01029;,,mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; 5'-3' DNA helicase activity [GO:0043139]; ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; protease binding [GO:0002020]; single-stranded DNA binding [GO:0003697]; cellular response to glucose stimulus [GO:0071333]; DNA unwinding involved in DNA replication [GO:0006268]; mitochondrial DNA replication [GO:0006264]; protein hexamerization [GO:0034214]; protein homooligomerization [GO:0051260]; transcription from mitochondrial promoter [GO:0006390]
Q6XBJ3,CHOYP_PHUM_PHUM228480.1.1|m.498,0,0,0,0,0,0,0,0,0.00000005,One cut domain family member 2 (One cut homeobox 2) (Transcription factor ONECUT-2) (OC-2),Onecut2 Oc2,505,anatomical structure morphogenesis [GO:0009653]; cell fate commitment [GO:0045165]; cilium assembly [GO:0060271]; endocrine pancreas development [GO:0031018]; epithelial cell development [GO:0002064]; liver development [GO:0001889]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; pancreas development [GO:0031016]; peripheral nervous system neuron development [GO:0048935]; positive regulation of cell migration [GO:0030335]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of cell-matrix adhesion [GO:0001952],GO:0000978; GO:0001077; GO:0001889; GO:0001952; GO:0002064; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0009653; GO:0015629; GO:0030335; GO:0030512; GO:0031016; GO:0031018; GO:0045165; GO:0045944; GO:0048935; GO:0060271,,,,PF02376;PF00046;,"actin cytoskeleton [GO:0015629]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; RNA polymerase II core promoter proximal region sequence-specific DNA binding [GO:0000978]; transcription factor activity, sequence-specific DNA binding [GO:0003700]; transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding [GO:0001077]; anatomical structure morphogenesis [GO:0009653]; cell fate commitment [GO:0045165]; cilium assembly [GO:0060271]; endocrine pancreas development [GO:0031018]; epithelial cell development [GO:0002064]; liver development [GO:0001889]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; pancreas development [GO:0031016]; peripheral nervous system neuron development [GO:0048935]; positive regulation of cell migration [GO:0030335]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of cell-matrix adhesion [GO:0001952]"
Q5ZIJ9,CHOYP_PHUM_PHUM516040.1.1|m.55603,0,0,0,0,0,0,0,0,0,E3 ubiquitin-protein ligase MIB2 (EC 2.3.2.27) (Mind bomb homolog 2) (RING-type E3 ubiquitin transferase MIB2),MIB2 RCJMB04_25j24,954,Notch signaling pathway [GO:0007219],GO:0004842; GO:0005737; GO:0007219; GO:0008270,PATHWAY: Protein modification; protein ubiquitination.,,,PF12796;PF06701;PF00569;,cytoplasm [GO:0005737]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; Notch signaling pathway [GO:0007219]
Q08628,CHOYP_TBA1A.2.4|m.19573,0,0,0,0,0,0,0,0,6.00E-16,Tubulin alpha chain (Fragment),,50,microtubule-based process [GO:0007017],GO:0005525; GO:0005737; GO:0005874; GO:0007017,,,,,cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; microtubule-based process [GO:0007017]
Q5QJ74,CHOYP_TBCEL.2.2|m.26805,0,0,0,0,0,0,0,0,1.00E-75,Tubulin-specific chaperone cofactor E-like protein (EL) (Leucine-rich repeat-containing protein 35),TBCEL LRRC35,424,,GO:0005737; GO:0005856,,,,PF14560;,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]
Q96M86,CHOYP_TRIADDRAFT_56463.2.2|m.36123,0,0,0,0,0,0,0,0,0.00000002,Dynein heavy chain domain-containing protein 1 (Dynein heavy chain domain 1-like protein) (Protein CCDC35),DNHD1 C11orf47 CCDC35 DHCD1 DNHD1L UNQ5781/PRO12970,4753,microtubule-based movement [GO:0007018],GO:0003777; GO:0007018; GO:0030286; GO:0070062,,,,PF08393;PF03028;PF12777;,dynein complex [GO:0030286]; extracellular exosome [GO:0070062]; microtubule motor activity [GO:0003777]; microtubule-based movement [GO:0007018]
Q96AY4,CHOYP_TTC28.1.1|m.51607,0,0,0,0,0,0,0,0,0,Tetratricopeptide repeat protein 28 (TPR repeat protein 28) (TPR repeat-containing big gene cloned at Keio),TTC28 KIAA1043 TPRBK,2481,cell division [GO:0051301]; mitotic nuclear division [GO:0007067]; regulation of mitotic cell cycle [GO:0007346],GO:0000922; GO:0005737; GO:0005813; GO:0007067; GO:0007346; GO:0030496; GO:0051301,,,,PF12770;PF13176;PF13181;,centrosome [GO:0005813]; cytoplasm [GO:0005737]; midbody [GO:0030496]; spindle pole [GO:0000922]; cell division [GO:0051301]; mitotic nuclear division [GO:0007067]; regulation of mitotic cell cycle [GO:0007346]
Q96GQ7,CHOYP_VP13D.2.3|m.58593,0,0,0,0,0,0,0,0,0,Probable ATP-dependent RNA helicase DDX27 (EC 3.6.4.13) (DEAD box protein 27),DDX27 cPERP-F RHLP HSPC259 PP3241,796,RNA secondary structure unwinding [GO:0010501]; rRNA processing [GO:0006364],GO:0003723; GO:0004004; GO:0005524; GO:0005694; GO:0005730; GO:0006364; GO:0010501,,,,PF00270;PF00271;,chromosome [GO:0005694]; nucleolus [GO:0005730]; ATP binding [GO:0005524]; ATP-dependent RNA helicase activity [GO:0004004]; RNA binding [GO:0003723]; RNA secondary structure unwinding [GO:0010501]; rRNA processing [GO:0006364]
Q5ZIM6,CHOYP_AATF.1.1|m.34004,0,0,0,0,0,0,0,0,2.00E-113,Protein AATF (Apoptosis-antagonizing transcription factor),AATF RCJMB04_24o4,574,cell adhesion [GO:0007155]; cellular response to DNA damage stimulus [GO:0006974]; embryonic cleavage [GO:0040016]; negative regulation of amyloid precursor protein biosynthetic process [GO:0042985]; negative regulation of apoptotic process [GO:0043066]; negative regulation of superoxide anion generation [GO:0032929]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of mitotic cell cycle [GO:0007346]; regulation of transcription from RNA polymerase II promoter [GO:0006357]; ribosome biogenesis [GO:0042254],GO:0003723; GO:0005730; GO:0005737; GO:0006357; GO:0006974; GO:0007155; GO:0007346; GO:0032929; GO:0040016; GO:0042254; GO:0042985; GO:0043066; GO:0045944,,,,PF13339;PF08164;,cytoplasm [GO:0005737]; nucleolus [GO:0005730]; RNA binding [GO:0003723]; cell adhesion [GO:0007155]; cellular response to DNA damage stimulus [GO:0006974]; embryonic cleavage [GO:0040016]; negative regulation of amyloid precursor protein biosynthetic process [GO:0042985]; negative regulation of apoptotic process [GO:0043066]; negative regulation of superoxide anion generation [GO:0032929]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of mitotic cell cycle [GO:0007346]; regulation of transcription from RNA polymerase II promoter [GO:0006357]; ribosome biogenesis [GO:0042254]
A9CPT4,CHOYP_BRAFLDRAFT_125037.2.3|m.13981,0,0,0,0,0,0,0,0,2.00E-48,Tudor domain-containing protein 1,tdrd1,1133,DNA methylation involved in gamete generation [GO:0043046]; gene silencing by RNA [GO:0031047]; germ cell development [GO:0007281]; meiotic cell cycle [GO:0051321]; multicellular organism development [GO:0007275]; piRNA metabolic process [GO:0034587]; spermatogenesis [GO:0007283],GO:0007275; GO:0007281; GO:0007283; GO:0031047; GO:0034587; GO:0043046; GO:0043186; GO:0046872; GO:0051321; GO:0071546,,,,PF00567;PF01753;,P granule [GO:0043186]; pi-body [GO:0071546]; metal ion binding [GO:0046872]; DNA methylation involved in gamete generation [GO:0043046]; gene silencing by RNA [GO:0031047]; germ cell development [GO:0007281]; meiotic cell cycle [GO:0051321]; multicellular organism development [GO:0007275]; piRNA metabolic process [GO:0034587]; spermatogenesis [GO:0007283]
Q8NA69,CHOYP_BRAFLDRAFT_125998.1.1|m.63211,7,0,0,0,0,0,0,0,4.00E-11,Uncharacterized protein C19orf45,C19orf45,505,,,,,,PF15373;,
Q497B8,CHOYP_BRAFLDRAFT_129074.1.1|m.25032,1,0,0,0,0,0,0,0,2.00E-25,Lysine-specific demethylase 8 (EC 1.14.11.27) (JmjC domain-containing protein 5) (Jumonji domain-containing protein 5),Kdm8 Jmjd5,414,"G2/M transition of mitotic cell cycle [GO:0000086]; histone H3-K36 demethylation [GO:0070544]; positive regulation of transcription, DNA-templated [GO:0045893]; transcription, DNA-templated [GO:0006351]",GO:0000086; GO:0003682; GO:0005634; GO:0006351; GO:0045893; GO:0046872; GO:0051864; GO:0070544,,,,,"nucleus [GO:0005634]; chromatin binding [GO:0003682]; histone demethylase activity (H3-K36 specific) [GO:0051864]; metal ion binding [GO:0046872]; G2/M transition of mitotic cell cycle [GO:0000086]; histone H3-K36 demethylation [GO:0070544]; positive regulation of transcription, DNA-templated [GO:0045893]; transcription, DNA-templated [GO:0006351]"
Q4QR86,CHOYP_BRAFLDRAFT_214790.1.1|m.15955,0,0,0,0,0,0,0,0,6.00E-57,DEP domain-containing protein 7,Depdc7,511,intracellular signal transduction [GO:0035556]; signal transduction [GO:0007165],GO:0005622; GO:0007165; GO:0035556,,,,PF00610;,intracellular [GO:0005622]; intracellular signal transduction [GO:0035556]; signal transduction [GO:0007165]
Q23023,CHOYP_DPSE_GA10675.1.1|m.23860,0,0,0,0,0,0,0,0,1.00E-124,Serine/threonine-protein kinase unc-51 (EC 2.7.11.1) (Uncoordinated protein 51),unc-51 Y60A3A.1,856,apoptotic cell clearance [GO:0043277]; autophagy [GO:0006914]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; cell migration [GO:0016477]; dauer larval development [GO:0040024]; determination of adult lifespan [GO:0008340]; embryo development ending in birth or egg hatching [GO:0009792]; nematode male tail tip morphogenesis [GO:0045138]; programmed cell death [GO:0012501]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of axon extension [GO:0030516]; regulation of cell size [GO:0008361]; regulation of multicellular organism growth [GO:0040014]; regulation of protein localization [GO:0032880],GO:0004672; GO:0004674; GO:0005524; GO:0006468; GO:0006914; GO:0007409; GO:0007411; GO:0008340; GO:0008361; GO:0009792; GO:0012501; GO:0016477; GO:0030424; GO:0030516; GO:0032880; GO:0040014; GO:0040024; GO:0043005; GO:0043025; GO:0043277; GO:0045138; GO:0046777; GO:0046872,,,,PF12063;PF00069;,axon [GO:0030424]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; apoptotic cell clearance [GO:0043277]; autophagy [GO:0006914]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; cell migration [GO:0016477]; dauer larval development [GO:0040024]; determination of adult lifespan [GO:0008340]; embryo development ending in birth or egg hatching [GO:0009792]; nematode male tail tip morphogenesis [GO:0045138]; programmed cell death [GO:0012501]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of axon extension [GO:0030516]; regulation of cell size [GO:0008361]; regulation of multicellular organism growth [GO:0040014]; regulation of protein localization [GO:0032880]
Q6DIB5,CHOYP_EGF1.1.2|m.46366,0,0,0,0,0,0,0,0,2.00E-18,Multiple epidermal growth factor-like domains protein 10 (Multiple EGF-like domains protein 10),Megf10,1147,apoptotic process involved in development [GO:1902742]; engulfment of apoptotic cell [GO:0043652]; homotypic cell-cell adhesion [GO:0034109]; muscle cell development [GO:0055001]; recognition of apoptotic cell [GO:0043654]; regulation of muscle cell differentiation [GO:0051147]; regulation of skeletal muscle tissue development [GO:0048641]; skeletal muscle satellite cell activation [GO:0014719]; skeletal muscle satellite cell differentiation [GO:0014816]; skeletal muscle satellite cell proliferation [GO:0014841],GO:0001849; GO:0001891; GO:0005044; GO:0014719; GO:0014816; GO:0014841; GO:0016021; GO:0016323; GO:0034109; GO:0042995; GO:0043652; GO:0043654; GO:0048641; GO:0051147; GO:0055001; GO:1902742,,,,PF12661;PF00053;,basolateral plasma membrane [GO:0016323]; cell projection [GO:0042995]; integral component of membrane [GO:0016021]; phagocytic cup [GO:0001891]; complement component C1q binding [GO:0001849]; scavenger receptor activity [GO:0005044]; apoptotic process involved in development [GO:1902742]; engulfment of apoptotic cell [GO:0043652]; homotypic cell-cell adhesion [GO:0034109]; muscle cell development [GO:0055001]; recognition of apoptotic cell [GO:0043654]; regulation of muscle cell differentiation [GO:0051147]; regulation of skeletal muscle tissue development [GO:0048641]; skeletal muscle satellite cell activation [GO:0014719]; skeletal muscle satellite cell differentiation [GO:0014816]; skeletal muscle satellite cell proliferation [GO:0014841]
P50901,CHOYP_HXD3.1.1|m.40287,0,0,0,0,0,0,0,0,2.00E-39,Homeobox protein HOX3,,411,"multicellular organism development [GO:0007275]; transcription, DNA-templated [GO:0006351]",GO:0003700; GO:0005634; GO:0006351; GO:0007275; GO:0043565,,,,PF00046;,"nucleus [GO:0005634]; sequence-specific DNA binding [GO:0043565]; transcription factor activity, sequence-specific DNA binding [GO:0003700]; multicellular organism development [GO:0007275]; transcription, DNA-templated [GO:0006351]"
Q8N801,CHOYP_ITIH3.1.3|m.21736,1.5,0,0,0,0,0,0,0,3.00E-38,Uncharacterized protein C2orf61,C2orf61,248,C-5 methylation of cytosine [GO:0090116],GO:0001939; GO:0001940; GO:0005737; GO:0042585; GO:0090116,,,,PF07004;,cytoplasm [GO:0005737]; female pronucleus [GO:0001939]; germinal vesicle [GO:0042585]; male pronucleus [GO:0001940]; C-5 methylation of cytosine [GO:0090116]
P79402,CHOYP_LOC100371043.3.5|m.24649,0,0,0,0,0,0,0,0,1.00E-49,Cytochrome P450 2C42 (EC 1.14.14.1) (CYPIIC42) (Fragment),CYP2C42,327,epoxygenase P450 pathway [GO:0019373],GO:0005506; GO:0005789; GO:0008392; GO:0019373; GO:0020037; GO:0031090; GO:0070330,,,,PF00067;,endoplasmic reticulum membrane [GO:0005789]; organelle membrane [GO:0031090]; arachidonic acid epoxygenase activity [GO:0008392]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; epoxygenase P450 pathway [GO:0019373]
Q9QYE0,CHOYP_LOC100695438.1.1|m.8594,0,0,0,0,0,0,0,0,1.00E-65,Zinc finger protein PLAG1 (Pleiomorphic adenoma gene 1 protein),Plag1,499,gland morphogenesis [GO:0022612]; multicellular organism growth [GO:0035264]; negative regulation of gene expression [GO:0010629]; organ growth [GO:0035265]; positive regulation of gene expression [GO:0010628]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; prostate gland growth [GO:0060736],GO:0000978; GO:0000981; GO:0001077; GO:0005634; GO:0010628; GO:0010629; GO:0016607; GO:0022612; GO:0035264; GO:0035265; GO:0045944; GO:0046872; GO:0060252; GO:0060736,,,,,"nuclear speck [GO:0016607]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; RNA polymerase II core promoter proximal region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription factor activity, sequence-specific DNA binding [GO:0000981]; transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding [GO:0001077]; gland morphogenesis [GO:0022612]; multicellular organism growth [GO:0035264]; negative regulation of gene expression [GO:0010629]; organ growth [GO:0035265]; positive regulation of gene expression [GO:0010628]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; prostate gland growth [GO:0060736]"
Q66IH2,CHOYP_LOC100708602.1.1|m.65805,0.5,0,0,0,0,0,0,0,1.00E-67,Transforming growth factor beta regulator 1,tbrg1 TEgg020g14.1,409,cell cycle [GO:0007049],GO:0005634; GO:0007049,,,,PF05965;PF05964;,nucleus [GO:0005634]; cell cycle [GO:0007049]
Q16831,CHOYP_LOC100876012.1.1|m.8280,3.5,0,0,0,0,0,0,0,4.00E-94,Uridine phosphorylase 1 (UPase 1) (UrdPase 1) (EC 2.4.2.3),UPP1 UP,310,cellular response to glucose starvation [GO:0042149]; nucleobase-containing compound metabolic process [GO:0006139]; nucleotide catabolic process [GO:0009166]; pyrimidine nucleoside catabolic process [GO:0046135]; pyrimidine nucleoside salvage [GO:0043097]; UMP salvage [GO:0044206]; uridine catabolic process [GO:0006218],GO:0004850; GO:0005829; GO:0006139; GO:0006218; GO:0009166; GO:0042149; GO:0043097; GO:0044206; GO:0046135,PATHWAY: Pyrimidine metabolism; UMP biosynthesis via salvage pathway; uracil from uridine (phosphorylase route): step 1/1. {ECO:0000305}.,,,PF01048;,cytosol [GO:0005829]; uridine phosphorylase activity [GO:0004850]; cellular response to glucose starvation [GO:0042149]; nucleobase-containing compound metabolic process [GO:0006139]; nucleotide catabolic process [GO:0009166]; pyrimidine nucleoside catabolic process [GO:0046135]; pyrimidine nucleoside salvage [GO:0043097]; UMP salvage [GO:0044206]; uridine catabolic process [GO:0006218]
O54926,CHOYP_LOC100892743.1.1|m.55850,0.5,0,0,0,0,0,0,0,3.00E-21,Apoptosis regulatory protein Siva (CD27-binding protein) (CD27BP),Siva1 Siva,175,activation-induced cell death of T cells [GO:0006924]; extrinsic apoptotic signaling pathway [GO:0097191]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901030],GO:0001618; GO:0005164; GO:0005175; GO:0005654; GO:0005737; GO:0005739; GO:0006924; GO:0008270; GO:0032088; GO:0097191; GO:1901030,,,,PF05458;,cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; CD27 receptor binding [GO:0005175]; tumor necrosis factor receptor binding [GO:0005164]; virus receptor activity [GO:0001618]; zinc ion binding [GO:0008270]; activation-induced cell death of T cells [GO:0006924]; extrinsic apoptotic signaling pathway [GO:0097191]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901030]
B0JZV4,CHOYP_LOC100893981.1.1|m.56774,0,0,0,0,0,0,0,0,6.00E-152,Cytosolic carboxypeptidase-like protein 5 (EC 3.4.17.-) (ATP/GTP-binding protein-like 5),agbl5 ccp5,944,defense response to virus [GO:0051607]; protein branching point deglutamylation [GO:0035611]; protein deglutamylation [GO:0035608],GO:0004181; GO:0005634; GO:0005829; GO:0008270; GO:0015631; GO:0030496; GO:0035608; GO:0035611; GO:0051607; GO:0072686,,,cd06236;,PF00246;,cytosol [GO:0005829]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; metallocarboxypeptidase activity [GO:0004181]; tubulin binding [GO:0015631]; zinc ion binding [GO:0008270]; defense response to virus [GO:0051607]; protein branching point deglutamylation [GO:0035611]; protein deglutamylation [GO:0035608]
P59222,CHOYP_LOC101077597.2.3|m.25843,0,0,0,0,0,0,0,0,0.00000005,Scavenger receptor class F member 2 (Scavenger receptor expressed by endothelial cells 2 protein) (SREC-II),Scarf2 Srec2,833,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157],GO:0005044; GO:0005925; GO:0007157; GO:0016021,,,,PF00053;,focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; scavenger receptor activity [GO:0005044]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]
Q00690,CHOYP_LOC578599.8.8|m.57682,0,0,0,0,0,0,0,0,8.00E-18,E-selectin (CD62 antigen-like family member E) (Endothelial leukocyte adhesion molecule 1) (ELAM-1) (Leukocyte-endothelial cell adhesion molecule 2) (LECAM2) (CD antigen CD62E),Sele Elam-1,612,actin filament-based process [GO:0030029]; activation of phospholipase C activity [GO:0007202]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; leukocyte cell-cell adhesion [GO:0007159]; leukocyte tethering or rolling [GO:0050901]; positive regulation of leukocyte migration [GO:0002687]; positive regulation of receptor internalization [GO:0002092]; response to interleukin-1 [GO:0070555],GO:0002092; GO:0002687; GO:0004888; GO:0005509; GO:0005615; GO:0005901; GO:0005905; GO:0007157; GO:0007159; GO:0007202; GO:0016021; GO:0030029; GO:0030863; GO:0033691; GO:0043274; GO:0045121; GO:0048471; GO:0050901; GO:0070492; GO:0070555,,,cd00033;cd03592;,PF00008;PF00059;PF00084;,caveola [GO:0005901]; clathrin-coated pit [GO:0005905]; cortical cytoskeleton [GO:0030863]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; perinuclear region of cytoplasm [GO:0048471]; calcium ion binding [GO:0005509]; oligosaccharide binding [GO:0070492]; phospholipase binding [GO:0043274]; sialic acid binding [GO:0033691]; transmembrane signaling receptor activity [GO:0004888]; actin filament-based process [GO:0030029]; activation of phospholipase C activity [GO:0007202]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; leukocyte cell-cell adhesion [GO:0007159]; leukocyte tethering or rolling [GO:0050901]; positive regulation of leukocyte migration [GO:0002687]; positive regulation of receptor internalization [GO:0002092]; response to interleukin-1 [GO:0070555]
Q14919,CHOYP_NC2A.1.1|m.22786,0.5,0,0,0,0,0,0,0,4.00E-47,Dr1-associated corepressor (Dr1-associated protein 1) (Negative cofactor 2-alpha) (NC2-alpha),DRAP1,205,"negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; transcription, DNA-templated [GO:0006351]",GO:0000122; GO:0003677; GO:0003700; GO:0003714; GO:0005634; GO:0006351; GO:0042802,,,,PF00808;,"nucleus [GO:0005634]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; transcription corepressor activity [GO:0003714]; transcription factor activity, sequence-specific DNA binding [GO:0003700]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; transcription, DNA-templated [GO:0006351]"
Q497B8,CHOYP_NEMVEDRAFT_V1G245101.1.1|m.56451,0,0,0,0,0,0,0,0,5.00E-21,Lysine-specific demethylase 8 (EC 1.14.11.27) (JmjC domain-containing protein 5) (Jumonji domain-containing protein 5),Kdm8 Jmjd5,414,"G2/M transition of mitotic cell cycle [GO:0000086]; histone H3-K36 demethylation [GO:0070544]; positive regulation of transcription, DNA-templated [GO:0045893]; transcription, DNA-templated [GO:0006351]",GO:0000086; GO:0003682; GO:0005634; GO:0006351; GO:0045893; GO:0046872; GO:0051864; GO:0070544,,,,,"nucleus [GO:0005634]; chromatin binding [GO:0003682]; histone demethylase activity (H3-K36 specific) [GO:0051864]; metal ion binding [GO:0046872]; G2/M transition of mitotic cell cycle [GO:0000086]; histone H3-K36 demethylation [GO:0070544]; positive regulation of transcription, DNA-templated [GO:0045893]; transcription, DNA-templated [GO:0006351]"
O34371,CHOYP_PHT4.1.1|m.18841,0,0,0,0,0,0,0,0,1.00E-17,Putative oxidoreductase YteT (EC 1.-.-.-),yteT BSU30100,428,,GO:0016491,,,,PF01408;PF02894;,oxidoreductase activity [GO:0016491]
O76463,CHOYP_PHUM_PHUM328150.1.1|m.8592,0,0,0,0,0,0,0,0,1.00E-147,"Nitrilase and fragile histidine triad fusion protein NitFhit [Includes: Bis(5'-adenosyl)-triphosphatase (EC 3.6.1.29) (AP3A hydrolase) (AP3Aase) (Diadenosine 5',5'''-P1,P3-triphosphate hydrolase) (Dinucleosidetriphosphatase); Nitrilase homolog (EC 3.5.-.-)]",nft-1 Y56A3A.13,440,nucleobase-containing compound metabolic process [GO:0006139],GO:0000166; GO:0006139; GO:0016810; GO:0047710,,,,PF00795;PF01230;,"bis(5'-adenosyl)-triphosphatase activity [GO:0047710]; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds [GO:0016810]; nucleotide binding [GO:0000166]; nucleobase-containing compound metabolic process [GO:0006139]"
A4YCY6,CHOYP_RS2.4.10|m.21705,0,0,0,0,0,0,0,0,8.00E-54,30S ribosomal protein S5,rps5 Msed_0111,214,translation [GO:0006412],GO:0003735; GO:0006412; GO:0015935; GO:0019843,,,,PF00333;PF03719;,small ribosomal subunit [GO:0015935]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]
O13046,CHOYP_WDHD1.1.1|m.23505,0,0,0,0,0,0,0,0,0,WD repeat and HMG-box DNA-binding protein 1 (Acidic nucleoplasmic DNA-binding protein 1) (And-1),wdhd1,1127,,GO:0003677; GO:0005654; GO:0005737,,,,PF08662;PF00505;PF12341;PF00400;,cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]
Q6R7F2,CHOYP_Y077.1.1|m.27629,0,0,0,0,0,0,0,0,0,Uncharacterized protein ORF77,ORF77,1264,,GO:0016021; GO:0033644,,,,,host cell membrane [GO:0033644]; integral component of membrane [GO:0016021]
Q08D64,CHOYP_ABCB6.3.3|m.53101,0,0,0,0,0,0,0,0,0,"ATP-binding cassette sub-family B member 6, mitochondrial",abcb6,849,,GO:0005524; GO:0005741; GO:0005783; GO:0005794; GO:0005886; GO:0016021; GO:0042626,,,,PF00664;PF00005;PF16185;,"endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity, coupled to transmembrane movement of substances [GO:0042626]"
Q29RU1,CHOYP_AGAP_AGAP013102.1.1|m.50186,0,0,0,0,0,0,0,0,9.00E-40,"28S ribosomal protein S12, mitochondrial (MRP-S12) (S12mt)",MRPS12,139,mitochondrial translation [GO:0032543]; mitochondrial translational elongation [GO:0070125]; mitochondrial translational initiation [GO:0070124],GO:0003723; GO:0003735; GO:0005743; GO:0005763; GO:0032543; GO:0070124; GO:0070125,,,cd03368;,PF00164;,mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]; mitochondrial translational elongation [GO:0070125]; mitochondrial translational initiation [GO:0070124]
Q0UI56,CHOYP_BRAFLDRAFT_215208.1.1|m.40012,0,0,0,0,0,0,0,0,7.00E-88,Cytosolic Fe-S cluster assembly factor NBP35 (Nucleotide-binding protein 35),NBP35 SNOG_08558,340,iron-sulfur cluster assembly [GO:0016226],GO:0005524; GO:0005737; GO:0016226; GO:0046872; GO:0051539,,,cd02037;,PF10609;,"cytoplasm [GO:0005737]; 4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; iron-sulfur cluster assembly [GO:0016226]"
Q8BP56,CHOYP_BRAFLDRAFT_261940.2.2|m.53422,0,0,0,0,0,0,0,0,1.00E-142,Acid trehalase-like protein 1 (EC 3.2.1.-),Athl1,690,carbohydrate metabolic process [GO:0005975],GO:0005829; GO:0005975; GO:0016798,,,,PF03632;,"cytosol [GO:0005829]; hydrolase activity, acting on glycosyl bonds [GO:0016798]; carbohydrate metabolic process [GO:0005975]"
Q69Z89,CHOYP_BRAFLDRAFT_85170.1.1|m.8699,0,0,0,0,0,0,0,0,5.00E-86,Ras-associating and dilute domain-containing protein,Radil Kiaa1849,1099,multicellular organism development [GO:0007275]; signal transduction [GO:0007165]; substrate adhesion-dependent cell spreading [GO:0034446],GO:0005874; GO:0007165; GO:0007275; GO:0034446,,,,PF01843;PF00595;PF00788;,microtubule [GO:0005874]; multicellular organism development [GO:0007275]; signal transduction [GO:0007165]; substrate adhesion-dependent cell spreading [GO:0034446]
C9J6K1,CHOYP_CS081.1.1|m.48577,0,0,0,0,0,0,0,0,0.0000006,Putative uncharacterized protein C19orf81,C19orf81,198,,,,,,PF15876;,
Q9VCU9,CHOYP_DICER.1.3|m.9936,0,0,0,0,0,0,0,0,2.00E-160,Endoribonuclease Dcr-1 (Protein dicer-1) (EC 3.1.26.-),Dcr-1 CG4792,2249,"dendrite morphogenesis [GO:0048813]; dsRNA transport [GO:0033227]; germarium-derived female germ-line cyst formation [GO:0030727]; germarium-derived oocyte fate determination [GO:0007294]; germ-line stem cell division [GO:0042078]; mitotic cell cycle, embryonic [GO:0045448]; pole cell formation [GO:0007279]; pre-miRNA processing [GO:0031054]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]; production of siRNA involved in RNA interference [GO:0030422]; response to starvation [GO:0042594]; RNA interference [GO:0016246]; segment polarity determination [GO:0007367]; siRNA loading onto RISC involved in RNA interference [GO:0035087]",GO:0003725; GO:0003727; GO:0004386; GO:0004525; GO:0005524; GO:0005737; GO:0007279; GO:0007294; GO:0007367; GO:0016246; GO:0016442; GO:0016443; GO:0030422; GO:0030727; GO:0031054; GO:0033227; GO:0035087; GO:0035196; GO:0042078; GO:0042594; GO:0045448; GO:0046872; GO:0048813; GO:0070883,,,cd00593;,PF03368;PF00271;PF02170;PF00636;,"cytoplasm [GO:0005737]; RISC complex [GO:0016442]; ATP binding [GO:0005524]; bidentate ribonuclease III activity [GO:0016443]; double-stranded RNA binding [GO:0003725]; helicase activity [GO:0004386]; metal ion binding [GO:0046872]; pre-miRNA binding [GO:0070883]; ribonuclease III activity [GO:0004525]; single-stranded RNA binding [GO:0003727]; dendrite morphogenesis [GO:0048813]; dsRNA transport [GO:0033227]; germ-line stem cell division [GO:0042078]; germarium-derived female germ-line cyst formation [GO:0030727]; germarium-derived oocyte fate determination [GO:0007294]; mitotic cell cycle, embryonic [GO:0045448]; pole cell formation [GO:0007279]; pre-miRNA processing [GO:0031054]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]; production of siRNA involved in RNA interference [GO:0030422]; response to starvation [GO:0042594]; RNA interference [GO:0016246]; segment polarity determination [GO:0007367]; siRNA loading onto RISC involved in RNA interference [GO:0035087]"
Q9H9B1,CHOYP_EHMT2.1.1|m.263,0,0,0,0,0,0,0,0,0,Histone-lysine N-methyltransferase EHMT1 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 1) (Eu-HMTase1) (G9a-like protein 1) (GLP) (GLP1) (Histone H3-K9 methyltransferase 5) (H3-K9-HMTase 5) (Lysine N-methyltransferase 1D),EHMT1 EUHMTASE1 GLP KIAA1876 KMT1D,1298,"chromatin organization [GO:0006325]; DNA methylation [GO:0006306]; embryo development [GO:0009790]; histone methylation [GO:0016571]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; regulation of signal transduction by p53 class mediator [GO:1901796]; response to fungicide [GO:0060992]",GO:0000122; GO:0002039; GO:0005634; GO:0005654; GO:0005694; GO:0006306; GO:0006325; GO:0008168; GO:0008270; GO:0009790; GO:0016279; GO:0016571; GO:0016604; GO:0018024; GO:0018026; GO:0018027; GO:0045892; GO:0046974; GO:0046976; GO:0060992; GO:1901796,,,,PF12796;PF05033;PF00856;,"chromosome [GO:0005694]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; histone methyltransferase activity (H3-K27 specific) [GO:0046976]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; histone-lysine N-methyltransferase activity [GO:0018024]; methyltransferase activity [GO:0008168]; p53 binding [GO:0002039]; protein-lysine N-methyltransferase activity [GO:0016279]; zinc ion binding [GO:0008270]; chromatin organization [GO:0006325]; DNA methylation [GO:0006306]; embryo development [GO:0009790]; histone methylation [GO:0016571]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; regulation of signal transduction by p53 class mediator [GO:1901796]; response to fungicide [GO:0060992]"
Q9I931,CHOYP_FUCL1.1.1|m.28893,11.5,0,0,0,0,0,0,0,1.00E-14,Fucolectin-1,,178,"regulation of cellular defense response [GO:0010185]; regulation of complement activation, lectin pathway [GO:0001868]; regulation of innate immune response [GO:0045088]",GO:0001868; GO:0005509; GO:0005615; GO:0010185; GO:0030246; GO:0042806; GO:0045088,,,,PF00754;,"extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; fucose binding [GO:0042806]; regulation of cellular defense response [GO:0010185]; regulation of complement activation, lectin pathway [GO:0001868]; regulation of innate immune response [GO:0045088]"
P19468,CHOYP_GSH1.1.1|m.8927,0,0,0,0,0,0,0,0,0,Glutamate--cysteine ligase catalytic subunit (EC 6.3.2.2) (GCS heavy chain) (Gamma-ECS) (Gamma-glutamylcysteine synthetase),Gclc Glclc,637,"aging [GO:0007568]; apoptotic mitochondrial changes [GO:0008637]; cell redox homeostasis [GO:0045454]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to glucose stimulus [GO:0071333]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to insulin stimulus [GO:0032869]; cellular response to mechanical stimulus [GO:0071260]; cellular response to thyroxine stimulus [GO:0097069]; cysteine metabolic process [GO:0006534]; glutamate metabolic process [GO:0006536]; glutathione biosynthetic process [GO:0006750]; L-ascorbic acid metabolic process [GO:0019852]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of hepatic stellate cell activation [GO:2000490]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; regulation of blood vessel size [GO:0050880]; regulation of mitochondrial depolarization [GO:0051900]; response to activity [GO:0014823]; response to arsenic-containing substance [GO:0046685]; response to cadmium ion [GO:0046686]; response to heat [GO:0009408]; response to hormone [GO:0009725]; response to human chorionic gonadotropin [GO:0044752]; response to interleukin-1 [GO:0070555]; response to nitrosative stress [GO:0051409]; response to nutrient [GO:0007584]; response to oxidative stress [GO:0006979]; response to xenobiotic stimulus [GO:0009410]",GO:0000287; GO:0004357; GO:0005524; GO:0005829; GO:0006534; GO:0006536; GO:0006750; GO:0006979; GO:0007568; GO:0007584; GO:0008637; GO:0009408; GO:0009410; GO:0009725; GO:0014823; GO:0016595; GO:0017109; GO:0019852; GO:0031397; GO:0032436; GO:0032869; GO:0035729; GO:0043066; GO:0043524; GO:0043531; GO:0044344; GO:0044752; GO:0045454; GO:0045892; GO:0046685; GO:0046686; GO:0046982; GO:0050662; GO:0050880; GO:0051409; GO:0051900; GO:0070555; GO:0071260; GO:0071333; GO:0071372; GO:0097069; GO:2000490; GO:2001237,PATHWAY: Sulfur metabolism; glutathione biosynthesis; glutathione from L-cysteine and L-glutamate: step 1/2.,,,PF03074;,"cytosol [GO:0005829]; glutamate-cysteine ligase complex [GO:0017109]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; coenzyme binding [GO:0050662]; glutamate binding [GO:0016595]; glutamate-cysteine ligase activity [GO:0004357]; magnesium ion binding [GO:0000287]; protein heterodimerization activity [GO:0046982]; aging [GO:0007568]; apoptotic mitochondrial changes [GO:0008637]; cell redox homeostasis [GO:0045454]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to glucose stimulus [GO:0071333]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to insulin stimulus [GO:0032869]; cellular response to mechanical stimulus [GO:0071260]; cellular response to thyroxine stimulus [GO:0097069]; cysteine metabolic process [GO:0006534]; glutamate metabolic process [GO:0006536]; glutathione biosynthetic process [GO:0006750]; L-ascorbic acid metabolic process [GO:0019852]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of hepatic stellate cell activation [GO:2000490]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; regulation of blood vessel size [GO:0050880]; regulation of mitochondrial depolarization [GO:0051900]; response to activity [GO:0014823]; response to arsenic-containing substance [GO:0046685]; response to cadmium ion [GO:0046686]; response to heat [GO:0009408]; response to hormone [GO:0009725]; response to human chorionic gonadotropin [GO:0044752]; response to interleukin-1 [GO:0070555]; response to nitrosative stress [GO:0051409]; response to nutrient [GO:0007584]; response to oxidative stress [GO:0006979]; response to xenobiotic stimulus [GO:0009410]"
O88271,CHOYP_HHEX.2.2|m.19527,0,0,0,0,0,0,0,0,4.00E-57,Craniofacial development protein 1 (27 kDa craniofacial protein) (Bucentaur) (Protein Cp27),Cfdp1 Bcnt Cfdp Cp27,295,cell adhesion [GO:0007155]; multicellular organism development [GO:0007275]; negative regulation of fibroblast apoptotic process [GO:2000270]; regulation of cell proliferation [GO:0042127]; regulation of cell shape [GO:0008360],GO:0000777; GO:0005604; GO:0005654; GO:0007155; GO:0007275; GO:0008360; GO:0042127; GO:2000270,,,,PF07572;,basement membrane [GO:0005604]; condensed chromosome kinetochore [GO:0000777]; nucleoplasm [GO:0005654]; cell adhesion [GO:0007155]; multicellular organism development [GO:0007275]; negative regulation of fibroblast apoptotic process [GO:2000270]; regulation of cell proliferation [GO:0042127]; regulation of cell shape [GO:0008360]
Q6AXX4,CHOYP_ISCW_ISCW011328.1.1|m.8861,0,0,0,0,0,0,0,0,1.00E-80,Something about silencing protein 10 (Charged amino acid-rich leucine zipper 1) (Disrupter of silencing SAS10) (UTP3 homolog),Utp3 Crlz1 Sas10,470,"brain development [GO:0007420]; covalent chromatin modification [GO:0016569]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]",GO:0000462; GO:0003723; GO:0005634; GO:0005730; GO:0007420; GO:0016569; GO:0032040,,,,PF09368;PF04000;,"nucleolus [GO:0005730]; nucleus [GO:0005634]; small-subunit processome [GO:0032040]; RNA binding [GO:0003723]; brain development [GO:0007420]; covalent chromatin modification [GO:0016569]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]"
P61315,CHOYP_LOC100206557.1.1|m.11857,0.5,0,0,0,0,0,0,0,7.00E-37,"Galactose-3-O-sulfotransferase 3 (Gal3ST-3) (EC 2.8.2.-) (Beta-galactose-3-O-sulfotransferase 3) (Gal-beta-1, 3-GalNAc 3'-sulfotransferase 3)",Gal3st3,431,glycolipid biosynthetic process [GO:0009247],GO:0001733; GO:0009247; GO:0016021; GO:0032580; GO:0050694,PATHWAY: Protein modification; carbohydrate sulfation.,,,PF06990;,Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; galactose 3-O-sulfotransferase activity [GO:0050694]; galactosylceramide sulfotransferase activity [GO:0001733]; glycolipid biosynthetic process [GO:0009247]
P49746,CHOYP_LOC100367144.1.1|m.34153,0,0,0,0,0,0,0,0,8.00E-150,Thrombospondin-3,THBS3 TSP3,956,bone trabecula formation [GO:0060346]; cell-matrix adhesion [GO:0007160]; growth plate cartilage development [GO:0003417]; ossification involved in bone maturation [GO:0043931],GO:0003417; GO:0005509; GO:0005576; GO:0007160; GO:0008201; GO:0043931; GO:0048471; GO:0060346,,,,PF11598;PF07645;PF02412;PF05735;,extracellular region [GO:0005576]; perinuclear region of cytoplasm [GO:0048471]; calcium ion binding [GO:0005509]; heparin binding [GO:0008201]; bone trabecula formation [GO:0060346]; cell-matrix adhesion [GO:0007160]; growth plate cartilage development [GO:0003417]; ossification involved in bone maturation [GO:0043931]
Q1XHU0,CHOYP_LOC100374741.38.83|m.33463,0,0,0,0,0,0,0,0,0.000003,E3 ubiquitin-protein ligase TRIM39 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase TRIM39) (Tripartite motif-containing protein 39),TRIM39,518,apoptotic process [GO:0006915]; negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process [GO:2000059]; positive regulation of apoptotic signaling pathway [GO:2001235]; protein ubiquitination [GO:0016567],GO:0005739; GO:0005829; GO:0006915; GO:0008270; GO:0016567; GO:0016740; GO:2000059; GO:2001235,PATHWAY: Protein modification; protein ubiquitination.,,,PF13765;PF00622;PF00643;,cytosol [GO:0005829]; mitochondrion [GO:0005739]; transferase activity [GO:0016740]; zinc ion binding [GO:0008270]; apoptotic process [GO:0006915]; negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process [GO:2000059]; positive regulation of apoptotic signaling pathway [GO:2001235]; protein ubiquitination [GO:0016567]
Q9R001,CHOYP_LOC100770235.1.1|m.2514,0,0,0,0,0,0,0,0,6.00E-34,A disintegrin and metalloproteinase with thrombospondin motifs 5 (ADAM-TS 5) (ADAM-TS5) (ADAMTS-5) (EC 3.4.24.-) (ADMP-2) (Aggrecanase-2) (Implantin),Adamts5,930,defense response to bacterium [GO:0042742]; tooth eruption [GO:0044691],GO:0004222; GO:0005578; GO:0005615; GO:0008201; GO:0008237; GO:0008270; GO:0042742; GO:0044691; GO:0050840,,,,PF05986;PF01562;PF01421;PF00090;,extracellular space [GO:0005615]; proteinaceous extracellular matrix [GO:0005578]; extracellular matrix binding [GO:0050840]; heparin binding [GO:0008201]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270]; defense response to bacterium [GO:0042742]; tooth eruption [GO:0044691]
Q9V0D5,CHOYP_LOC101069440.2.3|m.16645,0,0,0,0,0,0,0,0,7.00E-73,Malate dehydrogenase (EC 1.1.1.37),mdh PYRAB08550 PAB1791,362,tricarboxylic acid cycle [GO:0006099],GO:0005737; GO:0006099; GO:0030060,,,,PF02615;,cytoplasm [GO:0005737]; L-malate dehydrogenase activity [GO:0030060]; tricarboxylic acid cycle [GO:0006099]
P07314,CHOYP_LOC580355.1.1|m.29389,0,0,0,0,0,0,0,0,8.00E-108,Gamma-glutamyltranspeptidase 1 (GGT 1) (EC 2.3.2.2) (Gamma-glutamyltransferase 1) (Glutathione hydrolase 1) (EC 3.4.19.13) (Leukotriene-C4 hydrolase) (EC 3.4.19.14) (CD antigen CD224) [Cleaved into: Gamma-glutamyltranspeptidase 1 heavy chain; Gamma-glutamyltranspeptidase 1 light chain],Ggt1 Ggt,568,aging [GO:0007568]; cellular response to oxidative stress [GO:0034599]; glutamate metabolic process [GO:0006536]; glutathione biosynthetic process [GO:0006750]; glutathione catabolic process [GO:0006751]; peptide modification [GO:0031179]; response to estradiol [GO:0032355]; response to lipopolysaccharide [GO:0032496]; response to tumor necrosis factor [GO:0034612]; zymogen activation [GO:0031638],GO:0003840; GO:0005615; GO:0005886; GO:0005887; GO:0006536; GO:0006750; GO:0006751; GO:0007568; GO:0016755; GO:0031179; GO:0031638; GO:0032355; GO:0032496; GO:0034599; GO:0034612; GO:0036374,PATHWAY: Sulfur metabolism; glutathione metabolism.,,,PF01019;,"extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; gamma-glutamyltransferase activity [GO:0003840]; glutathione hydrolase activity [GO:0036374]; transferase activity, transferring amino-acyl groups [GO:0016755]; aging [GO:0007568]; cellular response to oxidative stress [GO:0034599]; glutamate metabolic process [GO:0006536]; glutathione biosynthetic process [GO:0006750]; glutathione catabolic process [GO:0006751]; peptide modification [GO:0031179]; response to estradiol [GO:0032355]; response to lipopolysaccharide [GO:0032496]; response to tumor necrosis factor [GO:0034612]; zymogen activation [GO:0031638]"
Q6DCY9,CHOYP_LOC583843.1.1|m.11191,0,0,0,0,0,0,0,0,2.00E-73,HAUS augmin-like complex subunit 3,haus3,597,cell division [GO:0051301]; centrosome organization [GO:0051297]; mitotic nuclear division [GO:0007067]; spindle assembly [GO:0051225],GO:0005737; GO:0005815; GO:0005819; GO:0005874; GO:0007067; GO:0051225; GO:0051297; GO:0051301; GO:0070652,,,,PF14932;,cytoplasm [GO:0005737]; HAUS complex [GO:0070652]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; spindle [GO:0005819]; cell division [GO:0051301]; centrosome organization [GO:0051297]; mitotic nuclear division [GO:0007067]; spindle assembly [GO:0051225]
P53563,CHOYP_LOC585734.1.1|m.36212,0,0,0,0,0,0,0,0,0.000004,Bcl-2-like protein 1 (Bcl2-L-1) (Apoptosis regulator Bcl-X),Bcl2l1 Bclx Blc2l,233,aging [GO:0007568]; apoptotic process [GO:0006915]; cellular response to astaxanthin [GO:1905218]; cellular response to cAMP [GO:0071320]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to drug [GO:0035690]; cellular response to erythropoietin [GO:0036018]; cellular response to hypoxia [GO:0071456]; cellular response to interleukin-1 [GO:0071347]; cellular response to prolactin [GO:1990646]; cellular response to thapsigargin [GO:1904579]; cellular response to tumor necrosis factor [GO:0071356]; cerebral cortex development [GO:0021987]; cytokinesis [GO:0000910]; endocytosis [GO:0006897]; mitotic cell cycle checkpoint [GO:0007093]; negative regulation of apoptotic process [GO:0043066]; negative regulation of execution phase of apoptosis [GO:1900118]; ovarian follicle development [GO:0001541]; positive regulation of apoptotic process [GO:0043065]; regulation of apoptotic process [GO:0042981]; response to drug [GO:0042493]; response to electrical stimulus [GO:0051602]; response to erythropoietin [GO:0036017]; response to hydrogen peroxide [GO:0042542]; response to hypoxia [GO:0001666]; response to inorganic substance [GO:0010035]; response to ischemia [GO:0002931]; response to lead ion [GO:0010288]; response to lipopolysaccharide [GO:0032496]; response to organic cyclic compound [GO:0014070]; response to organonitrogen compound [GO:0010243]; response to oxidative stress [GO:0006979]; response to peptide hormone [GO:0043434],GO:0000910; GO:0001541; GO:0001666; GO:0002931; GO:0005739; GO:0005740; GO:0005741; GO:0005743; GO:0005759; GO:0005813; GO:0005829; GO:0006897; GO:0006915; GO:0006979; GO:0007093; GO:0007568; GO:0008134; GO:0010035; GO:0010243; GO:0010288; GO:0014070; GO:0016021; GO:0021987; GO:0030054; GO:0030672; GO:0031965; GO:0032496; GO:0035690; GO:0036017; GO:0036018; GO:0042493; GO:0042542; GO:0042981; GO:0043027; GO:0043065; GO:0043066; GO:0043434; GO:0046982; GO:0051400; GO:0051602; GO:0071320; GO:0071347; GO:0071356; GO:0071456; GO:0071549; GO:0097371; GO:1900118; GO:1904579; GO:1905218; GO:1990646,,,,PF00452;PF02180;,cell junction [GO:0030054]; centrosome [GO:0005813]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; mitochondrial envelope [GO:0005740]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nuclear membrane [GO:0031965]; synaptic vesicle membrane [GO:0030672]; BH domain binding [GO:0051400]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; MDM2/MDM4 family protein binding [GO:0097371]; protein heterodimerization activity [GO:0046982]; transcription factor binding [GO:0008134]; aging [GO:0007568]; apoptotic process [GO:0006915]; cellular response to astaxanthin [GO:1905218]; cellular response to cAMP [GO:0071320]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to drug [GO:0035690]; cellular response to erythropoietin [GO:0036018]; cellular response to hypoxia [GO:0071456]; cellular response to interleukin-1 [GO:0071347]; cellular response to prolactin [GO:1990646]; cellular response to thapsigargin [GO:1904579]; cellular response to tumor necrosis factor [GO:0071356]; cerebral cortex development [GO:0021987]; cytokinesis [GO:0000910]; endocytosis [GO:0006897]; mitotic cell cycle checkpoint [GO:0007093]; negative regulation of apoptotic process [GO:0043066]; negative regulation of execution phase of apoptosis [GO:1900118]; ovarian follicle development [GO:0001541]; positive regulation of apoptotic process [GO:0043065]; regulation of apoptotic process [GO:0042981]; response to drug [GO:0042493]; response to electrical stimulus [GO:0051602]; response to erythropoietin [GO:0036017]; response to hydrogen peroxide [GO:0042542]; response to hypoxia [GO:0001666]; response to inorganic substance [GO:0010035]; response to ischemia [GO:0002931]; response to lead ion [GO:0010288]; response to lipopolysaccharide [GO:0032496]; response to organic cyclic compound [GO:0014070]; response to organonitrogen compound [GO:0010243]; response to oxidative stress [GO:0006979]; response to peptide hormone [GO:0043434]
Q5XIJ8,CHOYP_LOC585839.1.1|m.51865,2,0,0,0,0,0,0,0,9.00E-147,Coiled-coil domain-containing protein 65,Ccdc65,502,,,,,,,
Q9NR21,CHOYP_MIB2.5.6|m.43978,2.5,0,0,0,0,0,0,0,7.00E-38,Poly [ADP-ribose] polymerase 11 (PARP-11) (EC 2.4.2.30) (ADP-ribosyltransferase diphtheria toxin-like 11) (ARTD11),PARP11 C12orf6,331,cell differentiation [GO:0030154]; mRNA transport [GO:0051028]; nuclear envelope organization [GO:0006998]; protein transport [GO:0015031]; spermatogenesis [GO:0007283],GO:0003950; GO:0005635; GO:0005643; GO:0006998; GO:0007283; GO:0015031; GO:0030154; GO:0051028,,,,PF00644;PF02825;,nuclear envelope [GO:0005635]; nuclear pore [GO:0005643]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; cell differentiation [GO:0030154]; mRNA transport [GO:0051028]; nuclear envelope organization [GO:0006998]; protein transport [GO:0015031]; spermatogenesis [GO:0007283]
Q8N3A8,CHOYP_PARP8.1.1|m.55346,0,0,0,0,0,0,0,0,8.00E-165,Poly [ADP-ribose] polymerase 8 (PARP-8) (EC 2.4.2.30) (ADP-ribosyltransferase diphtheria toxin-like 16) (ARTD16),PARP8,854,,GO:0003950; GO:0005622,,,,PF00644;,intracellular [GO:0005622]; NAD+ ADP-ribosyltransferase activity [GO:0003950]
Q5ZHY5,CHOYP_PHUM_PHUM234540.1.1|m.9211,0,0,0,0,0,0,0,0,1.00E-116,STIP1 homology and U box-containing protein 1 (EC 2.3.2.27) (E3 ubiquitin-protein ligase CHIP) (RING-type E3 ubiquitin transferase CHIP),STUB1 RCJMB04_32b21,314,cellular response to misfolded protein [GO:0071218]; DNA repair [GO:0006281]; endoplasmic reticulum unfolded protein response [GO:0030968]; misfolded or incompletely synthesized protein catabolic process [GO:0006515]; negative regulation of protein binding [GO:0032091]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of chaperone-mediated protein complex assembly [GO:0090035]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; protein ubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0042787]; regulation of glucocorticoid metabolic process [GO:0031943]; regulation of protein stability [GO:0031647]; ubiquitin-dependent protein catabolic process [GO:0006511]; ubiquitin-dependent SMAD protein catabolic process [GO:0030579],GO:0000151; GO:0000209; GO:0004842; GO:0005654; GO:0005783; GO:0005829; GO:0006281; GO:0006511; GO:0006515; GO:0030018; GO:0030512; GO:0030579; GO:0030968; GO:0031647; GO:0031943; GO:0032091; GO:0032436; GO:0034450; GO:0042405; GO:0042787; GO:0042803; GO:0043161; GO:0051443; GO:0051865; GO:0070062; GO:0070534; GO:0071218; GO:0090035; GO:1904264,,,,PF04564;,cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; nuclear inclusion body [GO:0042405]; nucleoplasm [GO:0005654]; ubiquitin ligase complex [GO:0000151]; Z disc [GO:0030018]; protein homodimerization activity [GO:0042803]; ubiquitin protein ligase activity involved in ERAD pathway [GO:1904264]; ubiquitin-protein transferase activity [GO:0004842]; ubiquitin-ubiquitin ligase activity [GO:0034450]; cellular response to misfolded protein [GO:0071218]; DNA repair [GO:0006281]; endoplasmic reticulum unfolded protein response [GO:0030968]; misfolded or incompletely synthesized protein catabolic process [GO:0006515]; negative regulation of protein binding [GO:0032091]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of chaperone-mediated protein complex assembly [GO:0090035]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; protein ubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0042787]; regulation of glucocorticoid metabolic process [GO:0031943]; regulation of protein stability [GO:0031647]; ubiquitin-dependent protein catabolic process [GO:0006511]; ubiquitin-dependent SMAD protein catabolic process [GO:0030579]
H2A0M7,CHOYP_PLSP.4.5|m.44386,0,0,0,0,0,0,0,0,1.00E-136,Peroxidase-like protein,,793,response to oxidative stress [GO:0006979],GO:0004601; GO:0005576; GO:0006979; GO:0020037,,,,PF03098;,extracellular region [GO:0005576]; heme binding [GO:0020037]; peroxidase activity [GO:0004601]; response to oxidative stress [GO:0006979]
P22935,CHOYP_RABP2.1.1|m.29597,0,0,0,0,0,0,0,0,3.00E-25,Cellular retinoic acid-binding protein 2 (Cellular retinoic acid-binding protein II) (CRABP-II),Crabp2,138,embryonic forelimb morphogenesis [GO:0035115]; positive regulation of collateral sprouting [GO:0048672]; regulation of retinoic acid receptor signaling pathway [GO:0048385]; retinoic acid metabolic process [GO:0042573],GO:0001972; GO:0005215; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005829; GO:0016918; GO:0019841; GO:0030332; GO:0035115; GO:0042573; GO:0048385; GO:0048672; GO:0070062,,,,PF00061;,cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cyclin binding [GO:0030332]; retinal binding [GO:0016918]; retinoic acid binding [GO:0001972]; retinol binding [GO:0019841]; transporter activity [GO:0005215]; embryonic forelimb morphogenesis [GO:0035115]; positive regulation of collateral sprouting [GO:0048672]; regulation of retinoic acid receptor signaling pathway [GO:0048385]; retinoic acid metabolic process [GO:0042573]
Q923L3,CHOYP_SELE.2.2|m.50343,0,0,0,0,0,0,0,0,1.00E-28,CUB and sushi domain-containing protein 1 (CUB and sushi multiple domains protein 1),Csmd1,3564,glucose homeostasis [GO:0042593]; startle response [GO:0001964],GO:0001964; GO:0016021; GO:0042593,,,cd00033;cd00041;,PF00431;PF00084;,integral component of membrane [GO:0016021]; glucose homeostasis [GO:0042593]; startle response [GO:0001964]
Q7ZWG6,CHOYP_SLC46A1.1.1|m.9990,0,0,0,0,0,0,0,0,8.00E-34,Proton-coupled folate transporter (Heme carrier protein 1) (PCFT/HCP1) (Solute carrier family 46 member 1),slc46a1 hcp1 pcft zgc:56400,481,transmembrane transport [GO:0055085],GO:0005542; GO:0016021; GO:0055085,,,cd06174;,PF07690;,integral component of membrane [GO:0016021]; folic acid binding [GO:0005542]; transmembrane transport [GO:0055085]
O15072,CHOYP_ATS20.2.2|m.52571,0,0,0,0,0,0,0,0,3.00E-156,A disintegrin and metalloproteinase with thrombospondin motifs 3 (ADAM-TS 3) (ADAM-TS3) (ADAMTS-3) (EC 3.4.24.-) (Procollagen II N-proteinase) (PC II-NP) (Procollagen II amino propeptide-processing enzyme),ADAMTS3 KIAA0366,1205,collagen biosynthetic process [GO:0032964]; collagen catabolic process [GO:0030574]; collagen fibril organization [GO:0030199]; positive regulation of vascular endothelial growth factor signaling pathway [GO:1900748]; protein processing [GO:0016485]; supramolecular fiber organization [GO:0097435]; vascular endothelial growth factor production [GO:0010573],GO:0004175; GO:0004222; GO:0005576; GO:0005578; GO:0005615; GO:0008201; GO:0008270; GO:0010573; GO:0016485; GO:0030199; GO:0030574; GO:0032964; GO:0070062; GO:0097435; GO:1900748,,,,PF05986;PF01562;PF01421;PF00090;,extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; proteinaceous extracellular matrix [GO:0005578]; endopeptidase activity [GO:0004175]; heparin binding [GO:0008201]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; collagen biosynthetic process [GO:0032964]; collagen catabolic process [GO:0030574]; collagen fibril organization [GO:0030199]; positive regulation of vascular endothelial growth factor signaling pathway [GO:1900748]; protein processing [GO:0016485]; supramolecular fiber organization [GO:0097435]; vascular endothelial growth factor production [GO:0010573]
P20749,CHOYP_BCL3.1.2|m.56007,0,0,0,0,0,0,0,0,1.00E-40,B-cell lymphoma 3 protein (BCL-3) (Proto-oncogene BCL3),BCL3 BCL4 D19S37,454,"antimicrobial humoral response [GO:0019730]; cellular response to DNA damage stimulus [GO:0006974]; defense response to bacterium [GO:0042742]; defense response to protozoan [GO:0042832]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; extracellular matrix organization [GO:0030198]; follicular dendritic cell differentiation [GO:0002268]; germinal center formation [GO:0002467]; humoral immune response mediated by circulating immunoglobulin [GO:0002455]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; maintenance of protein location in nucleus [GO:0051457]; marginal zone B cell differentiation [GO:0002315]; negative regulation of apoptotic process [GO:0043066]; negative regulation of interleukin-8 biosynthetic process [GO:0045415]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of tumor necrosis factor biosynthetic process [GO:0042536]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-10 biosynthetic process [GO:0045082]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; positive regulation of translation [GO:0045727]; protein import into nucleus, translocation [GO:0000060]; regulation of apoptotic process [GO:0042981]; regulation of DNA binding [GO:0051101]; regulation of NF-kappaB import into nucleus [GO:0042345]; response to UV-C [GO:0010225]; response to virus [GO:0009615]; spleen development [GO:0048536]; T-helper 1 type immune response [GO:0042088]; T-helper 2 cell differentiation [GO:0045064]; transcription, DNA-templated [GO:0006351]",GO:0000060; GO:0002268; GO:0002315; GO:0002455; GO:0002467; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0006351; GO:0006974; GO:0007249; GO:0008134; GO:0009615; GO:0010225; GO:0019730; GO:0030198; GO:0030330; GO:0030496; GO:0030674; GO:0032729; GO:0032996; GO:0033257; GO:0042088; GO:0042345; GO:0042536; GO:0042742; GO:0042771; GO:0042832; GO:0042981; GO:0043066; GO:0043231; GO:0043234; GO:0045064; GO:0045082; GO:0045415; GO:0045727; GO:0045892; GO:0045893; GO:0045944; GO:0048471; GO:0048536; GO:0051101; GO:0051457,,,,PF12796;,"Bcl3-Bcl10 complex [GO:0032996]; Bcl3/NF-kappaB2 complex [GO:0033257]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein complex [GO:0043234]; DNA binding [GO:0003677]; protein binding, bridging [GO:0030674]; transcription factor activity, sequence-specific DNA binding [GO:0003700]; transcription factor binding [GO:0008134]; antimicrobial humoral response [GO:0019730]; cellular response to DNA damage stimulus [GO:0006974]; defense response to bacterium [GO:0042742]; defense response to protozoan [GO:0042832]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; extracellular matrix organization [GO:0030198]; follicular dendritic cell differentiation [GO:0002268]; germinal center formation [GO:0002467]; humoral immune response mediated by circulating immunoglobulin [GO:0002455]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; maintenance of protein location in nucleus [GO:0051457]; marginal zone B cell differentiation [GO:0002315]; negative regulation of apoptotic process [GO:0043066]; negative regulation of interleukin-8 biosynthetic process [GO:0045415]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of tumor necrosis factor biosynthetic process [GO:0042536]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-10 biosynthetic process [GO:0045082]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of translation [GO:0045727]; protein import into nucleus, translocation [GO:0000060]; regulation of apoptotic process [GO:0042981]; regulation of DNA binding [GO:0051101]; regulation of NF-kappaB import into nucleus [GO:0042345]; response to UV-C [GO:0010225]; response to virus [GO:0009615]; spleen development [GO:0048536]; T-helper 1 type immune response [GO:0042088]; T-helper 2 cell differentiation [GO:0045064]; transcription, DNA-templated [GO:0006351]"
Q6DF94,CHOYP_BRAFLDRAFT_129034.1.1|m.17626,0,0,0,0,0,0,0,0,3.00E-46,Spindle and centriole-associated protein 1 (Coiled-coil domain-containing protein 52),spice1 ccdc52,793,cell division [GO:0051301]; mitotic spindle assembly [GO:0090307]; regulation of centriole replication [GO:0046599],GO:0005814; GO:0005819; GO:0046599; GO:0051301; GO:0090307,,,,PF15678;,centriole [GO:0005814]; spindle [GO:0005819]; cell division [GO:0051301]; mitotic spindle assembly [GO:0090307]; regulation of centriole replication [GO:0046599]
Q14DK5,CHOYP_BRAFLDRAFT_68917.2.3|m.28554,0.5,0,0,0,0,0,0,0,9.00E-19,HHIP-like protein 1,Hhipl1 Hhip2 Kiaa1822,791,carbohydrate metabolic process [GO:0005975],GO:0005044; GO:0005576; GO:0005975; GO:0016020; GO:0016901; GO:0048038,,,,PF03024;PF07995;PF00530;,"extracellular region [GO:0005576]; membrane [GO:0016020]; oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor [GO:0016901]; quinone binding [GO:0048038]; scavenger receptor activity [GO:0005044]; carbohydrate metabolic process [GO:0005975]"
Q96ST8,CHOYP_CEP89.1.2|m.14339,0,0,0,0,0,0,0,0,3.00E-77,Centrosomal protein of 89 kDa (Cep89) (Centrosomal protein 123) (Cep123) (Coiled-coil domain-containing protein 123),CEP89 CCDC123,783,chemical synaptic transmission [GO:0007268]; ciliary basal body docking [GO:0097711]; cilium assembly [GO:0060271]; mitochondrion organization [GO:0007005]; non-motile cilium assembly [GO:1905515],GO:0000922; GO:0005758; GO:0005813; GO:0005814; GO:0005829; GO:0005886; GO:0007005; GO:0007268; GO:0031514; GO:0060271; GO:0097539; GO:0097711; GO:0097730; GO:1905515,,,,,centriole [GO:0005814]; centrosome [GO:0005813]; ciliary transition fiber [GO:0097539]; cytosol [GO:0005829]; mitochondrial intermembrane space [GO:0005758]; motile cilium [GO:0031514]; non-motile cilium [GO:0097730]; plasma membrane [GO:0005886]; spindle pole [GO:0000922]; chemical synaptic transmission [GO:0007268]; ciliary basal body docking [GO:0097711]; cilium assembly [GO:0060271]; mitochondrion organization [GO:0007005]; non-motile cilium assembly [GO:1905515]
Q20681,CHOYP_CRE_06881.1.1|m.62783,0,0,0,0,0,0,0,0,6.00E-10,BTB and MATH domain-containing protein 38,bath-38 F52H3.3,387,,,,,,PF00651;PF00917;,
P20480,CHOYP_CTK2.3.3|m.51999,0,0,0,0,0,0,0,0,3.00E-74,Protein claret segregational,ncd CA(ND) CG7831,700,cell division [GO:0051301]; centrosome duplication [GO:0051298]; centrosome organization [GO:0051297]; chromosome segregation [GO:0007059]; distributive segregation [GO:0032837]; meiotic spindle organization [GO:0000212]; microtubule-based movement [GO:0007018]; microtubule bundle formation [GO:0001578]; minus-end directed microtubule sliding [GO:0031534]; mitotic centrosome separation [GO:0007100]; mitotic spindle assembly [GO:0090307]; mitotic spindle elongation [GO:0000022]; mitotic spindle organization [GO:0007052]; mRNA transport [GO:0051028]; regulation of mitotic spindle assembly [GO:1901673]; regulation of mitotic spindle elongation [GO:0032888]; spindle assembly involved in female meiosis [GO:0007056]; spindle assembly involved in meiosis [GO:0090306]; spindle organization [GO:0007051],GO:0000022; GO:0000212; GO:0001578; GO:0003777; GO:0005524; GO:0005634; GO:0005813; GO:0005819; GO:0005829; GO:0005871; GO:0007018; GO:0007051; GO:0007052; GO:0007056; GO:0007059; GO:0007100; GO:0008569; GO:0016887; GO:0031534; GO:0032837; GO:0032888; GO:0042803; GO:0051028; GO:0051297; GO:0051298; GO:0051301; GO:0072687; GO:0090306; GO:0090307; GO:1901673; GO:1990498,,,,PF00225;,"centrosome [GO:0005813]; cytosol [GO:0005829]; kinesin complex [GO:0005871]; meiotic spindle [GO:0072687]; mitotic spindle microtubule [GO:1990498]; nucleus [GO:0005634]; spindle [GO:0005819]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; ATPase activity [GO:0016887]; microtubule motor activity [GO:0003777]; protein homodimerization activity [GO:0042803]; cell division [GO:0051301]; centrosome duplication [GO:0051298]; centrosome organization [GO:0051297]; chromosome segregation [GO:0007059]; distributive segregation [GO:0032837]; meiotic spindle organization [GO:0000212]; microtubule bundle formation [GO:0001578]; microtubule-based movement [GO:0007018]; minus-end directed microtubule sliding [GO:0031534]; mitotic centrosome separation [GO:0007100]; mitotic spindle assembly [GO:0090307]; mitotic spindle elongation [GO:0000022]; mitotic spindle organization [GO:0007052]; mRNA transport [GO:0051028]; regulation of mitotic spindle assembly [GO:1901673]; regulation of mitotic spindle elongation [GO:0032888]; spindle assembly involved in female meiosis [GO:0007056]; spindle assembly involved in meiosis [GO:0090306]; spindle organization [GO:0007051]"
Q9R0X0,CHOYP_DHX57.2.2|m.45703,0,0,0,0,0,0,0,0,2.00E-60,Mediator of RNA polymerase II transcription subunit 20 (Mediator complex subunit 20) (TRF-proximal protein homolog),Med20 Trfp,212,"regulation of transcription from RNA polymerase II promoter [GO:0006357]; skeletal muscle cell differentiation [GO:0035914]; transcription, DNA-templated [GO:0006351]",GO:0001104; GO:0003713; GO:0005654; GO:0006351; GO:0006357; GO:0016592; GO:0035914,,,,PF08612;,"mediator complex [GO:0016592]; nucleoplasm [GO:0005654]; RNA polymerase II transcription cofactor activity [GO:0001104]; transcription coactivator activity [GO:0003713]; regulation of transcription from RNA polymerase II promoter [GO:0006357]; skeletal muscle cell differentiation [GO:0035914]; transcription, DNA-templated [GO:0006351]"
Q92193,CHOYP_FAF1.1.1|m.35623,0,0,0,0,0,0,0,0,2.00E-88,Actin (Fragment),,266,,GO:0005524; GO:0005737; GO:0005856,,,,PF00022;,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]
O08662,CHOYP_ISCW_ISCW015061.1.1|m.51,1,0,0,0,0,0,0,0,0,Phosphatidylinositol 4-kinase alpha (PI4-kinase alpha) (PI4K-alpha) (PtdIns-4-kinase alpha) (EC 2.7.1.67),Pi4ka Pik4ca,2096,phosphatidylinositol-mediated signaling [GO:0048015],GO:0004430; GO:0005524; GO:0005886; GO:0030660; GO:0048015,,,,PF00454;PF00613;,Golgi-associated vesicle membrane [GO:0030660]; plasma membrane [GO:0005886]; 1-phosphatidylinositol 4-kinase activity [GO:0004430]; ATP binding [GO:0005524]; phosphatidylinositol-mediated signaling [GO:0048015]
Q9CAG8,CHOYP_KLHL7.1.1|m.9444,0,0,0,0,0,0,0,0,9.00E-14,F-box/kelch-repeat protein At1g67480,At1g67480 F12B7.3 T1F15.5,376,protein ubiquitination [GO:0016567],GO:0016567; GO:0031463,,,,PF01344;,Cul3-RING ubiquitin ligase complex [GO:0031463]; protein ubiquitination [GO:0016567]
Q3TLI0,CHOYP_LOC100122904.1.1|m.45984,0,0,0,0,0,0,0,0,6.00E-172,Trafficking protein particle complex subunit 10 (Trafficking protein particle complex subunit TMEM1) (Transport protein particle subunit TMEM1) (TRAPP subunit TMEM1),Trappc10 Tmem1,1259,early endosome to Golgi transport [GO:0034498]; intra-Golgi vesicle-mediated transport [GO:0006891],GO:0005829; GO:0006891; GO:0034498; GO:1990071,,,,PF12584;,cytosol [GO:0005829]; TRAPPII protein complex [GO:1990071]; early endosome to Golgi transport [GO:0034498]; intra-Golgi vesicle-mediated transport [GO:0006891]
Q5UQ35,CHOYP_LOC100372473.4.5|m.48798,0.5,0,0,0,0,0,0,0,1.00E-11,Putative ariadne-like RING finger protein R811,MIMI_R811,990,,GO:0008270,,,,PF01485;,zinc ion binding [GO:0008270]
Q9BZ19,CHOYP_LOC100374676.1.1|m.61638,1,0,0,0,0,0,0,0,4.00E-43,Ankyrin repeat domain-containing protein 60,ANKRD60 C20orf86,345,,,,,,PF12796;,
Q52MA5,CHOYP_LOC100377702.1.1|m.57555,0,0,0,0,0,0,0,0,0.0000002,Mitochondrial dynamics protein MID51 (Mitochondrial dynamics protein of 51 kDa homolog) (Mitochondrial elongation factor 1) (Smith-Magenis syndrome chromosomal region candidate gene 7 protein-like),mief1 mid51 smcr7l,463,positive regulation of mitochondrial fission [GO:0090141]; positive regulation of protein targeting to membrane [GO:0090314],GO:0000166; GO:0005739; GO:0005741; GO:0016021; GO:0090141; GO:0090314,,,,PF03281;,integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleotide binding [GO:0000166]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of protein targeting to membrane [GO:0090314]
Q9QXE5,CHOYP_LOC100377982.1.1|m.43510,0.5,0,0,0,0,0,0,0,6.00E-110,Thymus-specific serine protease (EC 3.4.-.-) (Serine protease 16),Prss16 Tssp,509,,GO:0005764; GO:0005768; GO:0008236,,,,PF05577;,endosome [GO:0005768]; lysosome [GO:0005764]; serine-type peptidase activity [GO:0008236]
Q5EAD5,CHOYP_LOC100378658.1.1|m.38454,0,0,0,0,0,0,0,0,1.00E-155,Geranylgeranyl transferase type-1 subunit beta (EC 2.5.1.59) (Geranylgeranyl transferase type I subunit beta) (GGTase-I-beta) (Type I protein geranyl-geranyltransferase subunit beta),PGGT1B,377,protein geranylgeranylation [GO:0018344],GO:0004661; GO:0004662; GO:0005953; GO:0008270; GO:0018344,,,,PF00432;,CAAX-protein geranylgeranyltransferase complex [GO:0005953]; CAAX-protein geranylgeranyltransferase activity [GO:0004662]; protein geranylgeranyltransferase activity [GO:0004661]; zinc ion binding [GO:0008270]; protein geranylgeranylation [GO:0018344]
Q6R5N8,CHOYP_LOC100559714.1.1|m.45488,0,0,0,0,0,0,0,0,2.00E-36,Toll-like receptor 13,Tlr13,991,inflammatory response [GO:0006954]; innate immune response [GO:0045087]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; regulation of MAPK cascade [GO:0043408]; response to virus [GO:0009615]; toll-like receptor 13 signaling pathway [GO:0034178],GO:0002755; GO:0004872; GO:0005737; GO:0005768; GO:0005887; GO:0006954; GO:0009615; GO:0010008; GO:0019843; GO:0034178; GO:0042803; GO:0043408; GO:0045087,,,,PF00560;PF12799;PF13855;PF01582;,cytoplasm [GO:0005737]; endosome [GO:0005768]; endosome membrane [GO:0010008]; integral component of plasma membrane [GO:0005887]; protein homodimerization activity [GO:0042803]; receptor activity [GO:0004872]; rRNA binding [GO:0019843]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; regulation of MAPK cascade [GO:0043408]; response to virus [GO:0009615]; toll-like receptor 13 signaling pathway [GO:0034178]
Q9Y305,CHOYP_LOC100691486.1.1|m.24964,0,0,0,0,0,0,0,0,2.00E-111,"Acyl-coenzyme A thioesterase 9, mitochondrial (Acyl-CoA thioesterase 9) (EC 3.1.2.-) (Acyl-CoA thioester hydrolase 9)",ACOT9 CGI-16,439,acyl-CoA metabolic process [GO:0006637]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338],GO:0003986; GO:0005739; GO:0005759; GO:0006637; GO:0035338; GO:0047617; GO:0052689,,,,,mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; acetyl-CoA hydrolase activity [GO:0003986]; acyl-CoA hydrolase activity [GO:0047617]; carboxylic ester hydrolase activity [GO:0052689]; acyl-CoA metabolic process [GO:0006637]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]
A5PMU4,CHOYP_LOC101076145.1.1|m.26253,0,0,0,0,0,0,0,0,0.00000002,Ankyrin repeat and sterile alpha motif domain-containing protein 1B,anks1b si:ch211-211o1.2 si:dkey-11k24.3,1280,regulation of synaptic plasticity by receptor localization to synapse [GO:1900383],GO:0005737; GO:0016020; GO:1900383,,,,PF12796;PF00640;PF00536;PF07647;,cytoplasm [GO:0005737]; membrane [GO:0016020]; regulation of synaptic plasticity by receptor localization to synapse [GO:1900383]
P0C6F1,CHOYP_LOC101242248.1.2|m.24785,0,0,0,0,0,0,0,0,0,"Dynein heavy chain 2, axonemal (Axonemal beta dynein heavy chain 2) (Ciliary dynein heavy chain 2)",Dnah2 Dnahc2,4456,microtubule-based movement [GO:0007018],GO:0003777; GO:0005524; GO:0005737; GO:0005874; GO:0007018; GO:0016887; GO:0031514; GO:0036156,,,,PF07728;PF12780;PF08385;PF08393;PF03028;PF12777;,cytoplasm [GO:0005737]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]; motile cilium [GO:0031514]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; microtubule motor activity [GO:0003777]; microtubule-based movement [GO:0007018]
Q28FY0,CHOYP_LOC586953.1.1|m.19600,0,0,0,0,0,0,0,0,2.00E-158,Protein tilB homolog (Leucine-rich repeat-containing protein 6),lrrc6 TGas012h22.1,470,cilium movement [GO:0003341],GO:0003341; GO:0005737; GO:0005929,,,,,cilium [GO:0005929]; cytoplasm [GO:0005737]; cilium movement [GO:0003341]
Q5T0B9,CHOYP_LOC660560.4.4|m.54542,0.5,0,0,0,0,0,0,0,3.00E-32,Zinc finger protein 362,ZNF362 PP6997,420,"regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]",GO:0003677; GO:0005634; GO:0006351; GO:0006355; GO:0046872,,,,PF00096;,"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]"
P0C2B8,CHOYP_MRPL55.1.1|m.1120,0,0,0,0,0,0,0,0,2.00E-19,"39S ribosomal protein L55, mitochondrial (L55mt) (MRP-L55)",MRPL55,126,mitochondrial translational elongation [GO:0070125]; mitochondrial translational initiation [GO:0070124]; translation [GO:0006412],GO:0003735; GO:0005743; GO:0005762; GO:0006412; GO:0070124; GO:0070125,,,,PF09776;,mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; structural constituent of ribosome [GO:0003735]; mitochondrial translational elongation [GO:0070125]; mitochondrial translational initiation [GO:0070124]; translation [GO:0006412]
Q9PT61,CHOYP_OTX5B.1.1|m.10054,0.5,0,0,0,0,0,0,0,3.00E-68,Homeobox protein otx5-B (Orthodenticle homolog 5-B) (XOtx5b),otx5-b otx5b,290,"anterior/posterior pattern specification [GO:0009952]; eye photoreceptor cell fate commitment [GO:0042706]; positive regulation of rhodopsin gene expression [GO:0045872]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; transcription, DNA-templated [GO:0006351]",GO:0003700; GO:0005634; GO:0006351; GO:0009952; GO:0042706; GO:0043565; GO:0045872; GO:0045893; GO:0045944,,,,PF00046;PF03529;,"nucleus [GO:0005634]; sequence-specific DNA binding [GO:0043565]; transcription factor activity, sequence-specific DNA binding [GO:0003700]; anterior/posterior pattern specification [GO:0009952]; eye photoreceptor cell fate commitment [GO:0042706]; positive regulation of rhodopsin gene expression [GO:0045872]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; transcription, DNA-templated [GO:0006351]"
Q8C033,CHOYP_PHUM_PHUM169900.2.2|m.61606,0,0,0,0,0,0,0,0,7.00E-120,Rho guanine nucleotide exchange factor 10,Arhgef10 Kiaa0294,1345,activation of GTPase activity [GO:0090630]; centrosome duplication [GO:0051298]; mitotic spindle assembly [GO:0090307]; myelination in peripheral nervous system [GO:0022011]; positive regulation of stress fiber assembly [GO:0051496]; regulation of Rho protein signal transduction [GO:0035023],GO:0005089; GO:0005813; GO:0005829; GO:0019894; GO:0022011; GO:0035023; GO:0051298; GO:0051496; GO:0090307; GO:0090630,,,,PF00621;,centrosome [GO:0005813]; cytosol [GO:0005829]; kinesin binding [GO:0019894]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; activation of GTPase activity [GO:0090630]; centrosome duplication [GO:0051298]; mitotic spindle assembly [GO:0090307]; myelination in peripheral nervous system [GO:0022011]; positive regulation of stress fiber assembly [GO:0051496]; regulation of Rho protein signal transduction [GO:0035023]
Q05909,CHOYP_PTPRE.8.19|m.40114,0,0,0,0,0,0,0,0,9.00E-75,Receptor-type tyrosine-protein phosphatase gamma (Protein-tyrosine phosphatase gamma) (R-PTP-gamma) (EC 3.1.3.48),Ptprg,1442,negative regulation of epithelial cell migration [GO:0010633]; toxin transport [GO:1901998],GO:0004725; GO:0010633; GO:0016021; GO:0042802; GO:0070062; GO:1901998,,,cd00063;,PF00194;PF00041;PF00102;,extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; identical protein binding [GO:0042802]; protein tyrosine phosphatase activity [GO:0004725]; negative regulation of epithelial cell migration [GO:0010633]; toxin transport [GO:1901998]
P06800,CHOYP_PTPRT.12.45|m.39573,0.5,0,0,0,0,0,0,0,7.00E-54,Receptor-type tyrosine-protein phosphatase C (EC 3.1.3.48) (Leukocyte common antigen) (L-CA) (Lymphocyte antigen 5) (Ly-5) (T200) (CD antigen CD45),Ptprc Ly-5,1291,activation of MAPK activity [GO:0000187]; B cell differentiation [GO:0030183]; B cell proliferation [GO:0042100]; B cell receptor signaling pathway [GO:0050853]; bone marrow development [GO:0048539]; cell cycle phase transition [GO:0044770]; defense response to virus [GO:0051607]; dephosphorylation [GO:0016311]; hematopoietic progenitor cell differentiation [GO:0002244]; heterotypic cell-cell adhesion [GO:0034113]; immunoglobulin biosynthetic process [GO:0002378]; leukocyte cell-cell adhesion [GO:0007159]; negative regulation of cell adhesion involved in substrate-bound cell migration [GO:0006933]; negative regulation of cytokine-mediated signaling pathway [GO:0001960]; negative regulation of peptidyl-tyrosine phosphorylation [GO:0050732]; negative regulation of protein autophosphorylation [GO:0031953]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of T cell mediated cytotoxicity [GO:0001915]; negative thymic T cell selection [GO:0045060]; positive regulation of alpha-beta T cell proliferation [GO:0046641]; positive regulation of antigen receptor-mediated signaling pathway [GO:0050857]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of gamma-delta T cell differentiation [GO:0045588]; positive regulation of hematopoietic stem cell migration [GO:2000473]; positive regulation of humoral immune response mediated by circulating immunoglobulin [GO:0002925]; positive regulation of isotype switching to IgG isotypes [GO:0048304]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of T cell differentiation [GO:0045582]; positive regulation of T cell mediated cytotoxicity [GO:0001916]; positive regulation of T cell mediated immunity [GO:0002711]; positive regulation of T cell proliferation [GO:0042102]; positive thymic T cell selection [GO:0045059]; protein dephosphorylation [GO:0006470]; regulation of B cell differentiation [GO:0045577]; regulation of B cell receptor signaling pathway [GO:0050855]; regulation of cell cycle [GO:0051726]; regulation of extrinsic apoptotic signaling pathway [GO:2001236]; regulation of humoral immune response mediated by circulating immunoglobulin [GO:0002923]; release of sequestered calcium ion into cytosol [GO:0051209]; stem cell development [GO:0048864]; T cell differentiation [GO:0030217]; T cell proliferation [GO:0042098]; T cell receptor signaling pathway [GO:0050852],GO:0000187; GO:0001915; GO:0001916; GO:0001960; GO:0002244; GO:0002378; GO:0002711; GO:0002923; GO:0002925; GO:0004725; GO:0005886; GO:0005887; GO:0005925; GO:0006469; GO:0006470; GO:0006933; GO:0007159; GO:0008201; GO:0009897; GO:0009986; GO:0016020; GO:0016311; GO:0019901; GO:0030183; GO:0030217; GO:0030890; GO:0031953; GO:0034113; GO:0042098; GO:0042100; GO:0042102; GO:0043395; GO:0043410; GO:0044770; GO:0045059; GO:0045060; GO:0045121; GO:0045577; GO:0045582; GO:0045588; GO:0046641; GO:0048304; GO:0048539; GO:0048864; GO:0050732; GO:0050852; GO:0050853; GO:0050855; GO:0050857; GO:0051209; GO:0051607; GO:0051726; GO:0070062; GO:0071944; GO:2000473; GO:2000648; GO:2001236; GO:2001238,,,cd00063;,PF12567;PF12453;PF00102;,cell periphery [GO:0071944]; cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; heparan sulfate proteoglycan binding [GO:0043395]; heparin binding [GO:0008201]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]; activation of MAPK activity [GO:0000187]; B cell differentiation [GO:0030183]; B cell proliferation [GO:0042100]; B cell receptor signaling pathway [GO:0050853]; bone marrow development [GO:0048539]; cell cycle phase transition [GO:0044770]; defense response to virus [GO:0051607]; dephosphorylation [GO:0016311]; hematopoietic progenitor cell differentiation [GO:0002244]; heterotypic cell-cell adhesion [GO:0034113]; immunoglobulin biosynthetic process [GO:0002378]; leukocyte cell-cell adhesion [GO:0007159]; negative regulation of cell adhesion involved in substrate-bound cell migration [GO:0006933]; negative regulation of cytokine-mediated signaling pathway [GO:0001960]; negative regulation of peptidyl-tyrosine phosphorylation [GO:0050732]; negative regulation of protein autophosphorylation [GO:0031953]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of T cell mediated cytotoxicity [GO:0001915]; negative thymic T cell selection [GO:0045060]; positive regulation of alpha-beta T cell proliferation [GO:0046641]; positive regulation of antigen receptor-mediated signaling pathway [GO:0050857]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of gamma-delta T cell differentiation [GO:0045588]; positive regulation of hematopoietic stem cell migration [GO:2000473]; positive regulation of humoral immune response mediated by circulating immunoglobulin [GO:0002925]; positive regulation of isotype switching to IgG isotypes [GO:0048304]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of T cell differentiation [GO:0045582]; positive regulation of T cell mediated cytotoxicity [GO:0001916]; positive regulation of T cell mediated immunity [GO:0002711]; positive regulation of T cell proliferation [GO:0042102]; positive thymic T cell selection [GO:0045059]; protein dephosphorylation [GO:0006470]; regulation of B cell differentiation [GO:0045577]; regulation of B cell receptor signaling pathway [GO:0050855]; regulation of cell cycle [GO:0051726]; regulation of extrinsic apoptotic signaling pathway [GO:2001236]; regulation of humoral immune response mediated by circulating immunoglobulin [GO:0002923]; release of sequestered calcium ion into cytosol [GO:0051209]; stem cell development [GO:0048864]; T cell differentiation [GO:0030217]; T cell proliferation [GO:0042098]; T cell receptor signaling pathway [GO:0050852]
Q8BX57,CHOYP_PXK.1.1|m.27815,0,0,0,0,0,0,0,0,0,"PX domain-containing protein kinase-like protein (Modulator of Na,K-ATPase) (MONaKA)",Pxk,582,inflammatory response [GO:0006954]; modulation of synaptic transmission [GO:0050804]; negative regulation of ATPase activity [GO:0032780]; negative regulation of ion transport [GO:0043271],GO:0004672; GO:0005524; GO:0005634; GO:0005737; GO:0005815; GO:0005829; GO:0005886; GO:0006954; GO:0008022; GO:0032780; GO:0035091; GO:0043234; GO:0043271; GO:0050804,,,,PF00069;PF00787;PF02205;,cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein complex [GO:0043234]; ATP binding [GO:0005524]; phosphatidylinositol binding [GO:0035091]; protein C-terminus binding [GO:0008022]; protein kinase activity [GO:0004672]; inflammatory response [GO:0006954]; modulation of synaptic transmission [GO:0050804]; negative regulation of ATPase activity [GO:0032780]; negative regulation of ion transport [GO:0043271]
Q8N7Z5,CHOYP_WRI_006090.1.1|m.34650,9,0,0,0,0,0,0,0,1.00E-14,Putative ankyrin repeat domain-containing protein 31,ANKRD31,1873,,,,,,PF00023;PF12796;,
Q96QU8,CHOYP_XPO6.1.1|m.15288,0,0,0,0,0,0,0,0,0,Exportin-6 (Exp6) (Ran-binding protein 20),XPO6 KIAA0370 RANBP20,1125,protein export from nucleus [GO:0006611],GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0005886; GO:0006611; GO:0008565,,,,PF03810;PF08389;,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein transporter activity [GO:0008565]; protein export from nucleus [GO:0006611]
Q9NFS4,CHOYP_ANXA4.1.2|m.19913,1,0,0,0,0,0,0,0,2.00E-11,Annexin E1 (Annexin 21) (Annexin XXI),ANXE1 ANX21,337,cell projection organization [GO:0030030],GO:0005509; GO:0005544; GO:0030030; GO:0031514,,,,PF00191;,motile cilium [GO:0031514]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; cell projection organization [GO:0030030]
Q9D8Z1,CHOYP_ASCC1.1.1|m.39863,0,0,0,0,0,0,0,0,4.00E-125,Activating signal cointegrator 1 complex subunit 1 (ASC-1 complex subunit p50) (Trip4 complex subunit p50),Ascc1,356,"regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]",GO:0003723; GO:0005634; GO:0005667; GO:0006351; GO:0006355; GO:0031594,,,,PF10469;PF00013;,"neuromuscular junction [GO:0031594]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; RNA binding [GO:0003723]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]"
Q6ZUJ8,CHOYP_BCAP.2.2|m.41601,0,0,0,0,0,0,0,0,2.00E-23,Phosphoinositide 3-kinase adapter protein 1 (B-cell adapter for phosphoinositide 3-kinase) (B-cell phosphoinositide 3-kinase adapter protein 1),PIK3AP1 BCAP,805,phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; regulation of inflammatory response [GO:0050727]; regulation of phosphatidylinositol 3-kinase signaling [GO:0014066]; toll-like receptor 2 signaling pathway [GO:0034134]; toll-like receptor 4 signaling pathway [GO:0034142]; toll-like receptor 7 signaling pathway [GO:0034154]; toll-like receptor 9 signaling pathway [GO:0034162],GO:0005829; GO:0005886; GO:0014066; GO:0014068; GO:0016020; GO:0034134; GO:0034142; GO:0034154; GO:0034162; GO:0036312; GO:0046934; GO:0048015; GO:0050727,,,,PF14545;,"cytosol [GO:0005829]; membrane [GO:0016020]; plasma membrane [GO:0005886]; phosphatidylinositol 3-kinase regulatory subunit binding [GO:0036312]; phosphatidylinositol-4,5-bisphosphate 3-kinase activity [GO:0046934]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; regulation of inflammatory response [GO:0050727]; regulation of phosphatidylinositol 3-kinase signaling [GO:0014066]; toll-like receptor 2 signaling pathway [GO:0034134]; toll-like receptor 4 signaling pathway [GO:0034142]; toll-like receptor 7 signaling pathway [GO:0034154]; toll-like receptor 9 signaling pathway [GO:0034162]"
Q96P65,CHOYP_BRAFLDRAFT_202783.1.2|m.21505,0,0,0,0,0,0,0,0,9.00E-42,Pyroglutamylated RFamide peptide receptor (AQ27) (G-protein coupled receptor 103) (Orexigenic neuropeptide QRFP receptor) (SP9155),QRFPR GPR103,431,cellular response to hormone stimulus [GO:0032870]; G-protein coupled receptor signaling pathway [GO:0007186]; response to peptide [GO:1901652],GO:0004930; GO:0004983; GO:0005886; GO:0005887; GO:0007186; GO:0016021; GO:0032870; GO:0042277; GO:1901652,,,,PF00001;,integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; G-protein coupled receptor activity [GO:0004930]; neuropeptide Y receptor activity [GO:0004983]; peptide binding [GO:0042277]; cellular response to hormone stimulus [GO:0032870]; G-protein coupled receptor signaling pathway [GO:0007186]; response to peptide [GO:1901652]
P86854,CHOYP_BRAFLDRAFT_223573.1.1|m.4526,0,0,0,0,0,0,0,0,2.00E-16,Perlucin-like protein,,156,,GO:0005576; GO:0030246,,,cd03590;,PF00059;,extracellular region [GO:0005576]; carbohydrate binding [GO:0030246]
Q9UHJ3,CHOYP_BRAFLDRAFT_226942.1.1|m.49751,0,0,0,0,0,0,0,0,0,Scm-like with four MBT domains protein 1 (hSFMBT) (Renal ubiquitous protein 1),SFMBT1 RU1,866,"cell differentiation [GO:0030154]; covalent chromatin modification [GO:0016569]; negative regulation of muscle organ development [GO:0048635]; negative regulation of transcription, DNA-templated [GO:0045892]; spermatogenesis [GO:0007283]; transcription, DNA-templated [GO:0006351]",GO:0003714; GO:0005634; GO:0005654; GO:0006351; GO:0007283; GO:0016569; GO:0030154; GO:0042393; GO:0045892; GO:0048635,,,,PF02820;PF00536;PF12140;,"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; histone binding [GO:0042393]; transcription corepressor activity [GO:0003714]; cell differentiation [GO:0030154]; covalent chromatin modification [GO:0016569]; negative regulation of muscle organ development [GO:0048635]; negative regulation of transcription, DNA-templated [GO:0045892]; spermatogenesis [GO:0007283]; transcription, DNA-templated [GO:0006351]"
Q28J59,CHOYP_BRAFLDRAFT_239751.2.3|m.36889,2.5,0,0,0,0,0,0,0,1.00E-116,Protein FAM221A,fam221a TNeu087m24.1,295,,,,,,PF14753;,
Q6P3Z3,CHOYP_BRAFLDRAFT_65518.1.1|m.29803,0,0,0,0,0,0,0,0,7.00E-43,THAP domain-containing protein 4,Thap4,569,,GO:0003677; GO:0046872,,,cd07828;,PF08768;PF05485;,DNA binding [GO:0003677]; metal ion binding [GO:0046872]
Q8CIZ8,CHOYP_CO6A6.3.3|m.51505,0,0,0,0,0,0,0,0,2.00E-25,von Willebrand factor (vWF) [Cleaved into: von Willebrand antigen 2 (von Willebrand antigen II)],Vwf,2813,blood coagulation [GO:0007596]; cell adhesion [GO:0007155]; cell-substrate adhesion [GO:0031589]; hemostasis [GO:0007599]; liver development [GO:0001889]; placenta development [GO:0001890]; platelet activation [GO:0030168]; protein homooligomerization [GO:0051260],GO:0001889; GO:0001890; GO:0001948; GO:0002020; GO:0005178; GO:0005518; GO:0005576; GO:0005578; GO:0005615; GO:0005783; GO:0007155; GO:0007596; GO:0007599; GO:0009897; GO:0019865; GO:0030168; GO:0031012; GO:0031589; GO:0033093; GO:0042802; GO:0042803; GO:0047485; GO:0051087; GO:0051260; GO:0070062,,,,PF08742;PF01826;PF00092;PF16164;PF00093;PF00094;,endoplasmic reticulum [GO:0005783]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; proteinaceous extracellular matrix [GO:0005578]; Weibel-Palade body [GO:0033093]; chaperone binding [GO:0051087]; collagen binding [GO:0005518]; glycoprotein binding [GO:0001948]; identical protein binding [GO:0042802]; immunoglobulin binding [GO:0019865]; integrin binding [GO:0005178]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein N-terminus binding [GO:0047485]; blood coagulation [GO:0007596]; cell adhesion [GO:0007155]; cell-substrate adhesion [GO:0031589]; hemostasis [GO:0007599]; liver development [GO:0001889]; placenta development [GO:0001890]; platelet activation [GO:0030168]; protein homooligomerization [GO:0051260]
Q10Q46,CHOYP_CYT5.1.1|m.29960,0,0,0,0,0,0,0,0,0.00000001,Cysteine proteinase inhibitor 6 (Oryzacystatin VI) (OC-VI) (Oryzacystatin-6),Os03g0210200 LOC_Os03g11180,113,defense response [GO:0006952],GO:0004869; GO:0005576; GO:0006952,,,cd00042;,PF16845;,extracellular region [GO:0005576]; cysteine-type endopeptidase inhibitor activity [GO:0004869]; defense response [GO:0006952]
Q96IK5,CHOYP_GMCLL.1.1|m.15031,0,0,0,0,0,0,0,0,1.00E-145,Germ cell-less protein-like 1,GMCL1 GCL,515,"cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of transcription, DNA-templated [GO:0006355]; spermatogenesis [GO:0007283]",GO:0000151; GO:0005634; GO:0005635; GO:0006355; GO:0007275; GO:0007283; GO:0016363; GO:0030154; GO:0042802,,,,PF07707;PF00651;,"nuclear envelope [GO:0005635]; nuclear matrix [GO:0016363]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; identical protein binding [GO:0042802]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of transcription, DNA-templated [GO:0006355]; spermatogenesis [GO:0007283]"
A4IFJ6,CHOYP_IKZF.1.1|m.55498,0,0,0,0,0,0,0,0,9.00E-12,Zinc finger protein Pegasus (Ikaros family zinc finger protein 5),IKZF5,419,"regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]",GO:0003677; GO:0005634; GO:0006351; GO:0006355; GO:0046872,,,,,"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]"
Q8VI63,CHOYP_ISCW_ISCW022842.1.1|m.5648,0,0,0,0,0,0,0,0,1.00E-70,MOB kinase activator 2 (Mob2 homolog) (Mps one binder kinase activator-like 2) (Ovary-specific MOB-like protein),Mob2 Mmh,235,actin cytoskeleton organization [GO:0030036]; positive regulation of neuron projection development [GO:0010976]; positive regulation of protein phosphorylation [GO:0001934],GO:0001934; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0010976; GO:0030036; GO:0044306; GO:0046872; GO:0048471,,,,PF03637;,cytoplasm [GO:0005737]; cytosol [GO:0005829]; neuron projection terminus [GO:0044306]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; metal ion binding [GO:0046872]; actin cytoskeleton organization [GO:0030036]; positive regulation of neuron projection development [GO:0010976]; positive regulation of protein phosphorylation [GO:0001934]
Q9TV36,CHOYP_KC1D.3.3|m.61498,0,0,0,0,0,0,0,0,1.00E-61,Fibrillin-1 [Cleaved into: Asprosin],FBN1,2871,activation of protein kinase A activity [GO:0034199]; anatomical structure morphogenesis [GO:0009653]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; protein kinase A signaling [GO:0010737]; regulation of cellular response to growth factor stimulus [GO:0090287],GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005578; GO:0005615; GO:0005622; GO:0006006; GO:0008201; GO:0009653; GO:0010737; GO:0034199; GO:0042593; GO:0090287,,,,PF12662;PF07645;PF00683;,extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular [GO:0005622]; proteinaceous extracellular matrix [GO:0005578]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; hormone activity [GO:0005179]; activation of protein kinase A activity [GO:0034199]; anatomical structure morphogenesis [GO:0009653]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; protein kinase A signaling [GO:0010737]; regulation of cellular response to growth factor stimulus [GO:0090287]
Q0VAA2,CHOYP_LOC100187037.1.1|m.55673,0,0,0,0,0,0,0,0,3.00E-66,Leucine-rich repeat-containing protein 74A (Leucine-rich repeat-containing protein 74),LRRC74A C14orf166B LRRC74,488,,,,,,PF13516;,
P54267,CHOYP_LOC100212386.1.2|m.33906,0,0,0,0,0,0,0,0,1.00E-19,Chitin synthase G (EC 2.4.1.16) (Chitin-UDP acetyl-glucosaminyl transferase G) (Class-III chitin synthase G),chsG AFUA_3G14420,911,cell wall organization [GO:0071555]; chitin biosynthetic process [GO:0006031]; conidium formation [GO:0048315]; hyphal growth [GO:0030448],GO:0004100; GO:0005886; GO:0006031; GO:0016021; GO:0030448; GO:0048315; GO:0071555,,,,PF01644;PF08407;,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; chitin synthase activity [GO:0004100]; cell wall organization [GO:0071555]; chitin biosynthetic process [GO:0006031]; conidium formation [GO:0048315]; hyphal growth [GO:0030448]
O70277,CHOYP_LOC100373444.44.79|m.39021,2.5,0,0,0,0,0,0,0,4.00E-14,Tripartite motif-containing protein 3 (Brain-expressed RING finger protein) (RING finger protein 22),Trim3 Berp Rnf22,744,protein transport [GO:0015031],GO:0005737; GO:0005769; GO:0005794; GO:0008270; GO:0015031; GO:0030425,,,,PF00630;PF01436;PF00643;PF13445;,cytoplasm [GO:0005737]; dendrite [GO:0030425]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; zinc ion binding [GO:0008270]; protein transport [GO:0015031]
Q32LJ3,CHOYP_LOC100373454.1.1|m.59681,2.5,0,0,0,0,0,0,0,9.00E-12,Uncharacterized protein CXorf65 homolog,,174,,,,,,,
O70277,CHOYP_LOC100374981.4.16|m.24874,0,0,0,0,0,0,0,0,2.00E-12,Tripartite motif-containing protein 3 (Brain-expressed RING finger protein) (RING finger protein 22),Trim3 Berp Rnf22,744,protein transport [GO:0015031],GO:0005737; GO:0005769; GO:0005794; GO:0008270; GO:0015031; GO:0030425,,,,PF00630;PF01436;PF00643;PF13445;,cytoplasm [GO:0005737]; dendrite [GO:0030425]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; zinc ion binding [GO:0008270]; protein transport [GO:0015031]
B9EQ30,CHOYP_LOC100376200.1.1|m.19157,0,0,0,0,0,0,0,0,3.00E-22,SOSS complex subunit C (INTS3- and NABP-interacting protein) (Sensor of single-strand DNA complex subunit C) (Sensor of ssDNA subunit C) (SOSS-C) (Single-stranded DNA-binding protein-interacting protein 1) (SSB-interacting protein 1),inip ssbip1,107,cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; response to ionizing radiation [GO:0010212],GO:0005634; GO:0006281; GO:0006974; GO:0010212; GO:0070876,,,,PF15925;,nucleus [GO:0005634]; SOSS complex [GO:0070876]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; response to ionizing radiation [GO:0010212]
Q5VZQ5,CHOYP_LOC100377647.1.2|m.10110,3,0,0,0,0,0,0,0,2.00E-13,Testis-expressed protein 36,TEX36 C10orf122,186,,,,,,PF15115;,
Q5BK09,CHOYP_LOC100576447.2.2|m.55515,0.5,0,0,0,0,0,0,0,1.00E-38,DNA damage-regulated autophagy modulator protein 2 (Transmembrane protein 77),Dram2 Tmem77,267,apoptotic process [GO:0006915]; autophagy [GO:0006914]; photoreceptor cell maintenance [GO:0045494]; regulation of autophagy [GO:0010506]; visual perception [GO:0007601],GO:0001917; GO:0005764; GO:0005765; GO:0006914; GO:0006915; GO:0007601; GO:0010506; GO:0016021; GO:0016324; GO:0045494,,,,PF10277;,apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; photoreceptor inner segment [GO:0001917]; apoptotic process [GO:0006915]; autophagy [GO:0006914]; photoreceptor cell maintenance [GO:0045494]; regulation of autophagy [GO:0010506]; visual perception [GO:0007601]
Q9QYP0,CHOYP_LOC101156767.1.1|m.65605,0,0,0,0,0,0,0,0,0,Multiple epidermal growth factor-like domains protein 8 (Multiple EGF-like domains protein 8) (Epidermal growth factor-like protein 4) (EGF-like protein 4),Megf8 Egfl4,2788,BMP signaling pathway [GO:0030509]; determination of digestive tract left/right asymmetry [GO:0071907]; determination of heart left/right asymmetry [GO:0061371]; embryonic heart tube left/right pattern formation [GO:0060971]; embryonic heart tube morphogenesis [GO:0003143]; embryonic limb morphogenesis [GO:0030326]; embryonic skeletal system morphogenesis [GO:0048704]; fasciculation of sensory neuron axon [GO:0097155]; left/right pattern formation [GO:0060972]; positive regulation of axon extension involved in axon guidance [GO:0048842]; regulation of gene expression [GO:0010468],GO:0003143; GO:0005509; GO:0005634; GO:0010468; GO:0016021; GO:0030326; GO:0030509; GO:0048704; GO:0048842; GO:0060971; GO:0060972; GO:0061371; GO:0071907; GO:0097155,,,cd00041;,PF00431;PF12947;PF07645;PF00053;PF01437;PF17205;,integral component of membrane [GO:0016021]; nucleus [GO:0005634]; calcium ion binding [GO:0005509]; BMP signaling pathway [GO:0030509]; determination of digestive tract left/right asymmetry [GO:0071907]; determination of heart left/right asymmetry [GO:0061371]; embryonic heart tube left/right pattern formation [GO:0060971]; embryonic heart tube morphogenesis [GO:0003143]; embryonic limb morphogenesis [GO:0030326]; embryonic skeletal system morphogenesis [GO:0048704]; fasciculation of sensory neuron axon [GO:0097155]; left/right pattern formation [GO:0060972]; positive regulation of axon extension involved in axon guidance [GO:0048842]; regulation of gene expression [GO:0010468]
B2RU80,CHOYP_LOC586044.1.1|m.60359,0,0,0,0,0,0,0,0,1.00E-86,Receptor-type tyrosine-protein phosphatase beta (Protein-tyrosine phosphatase beta) (R-PTP-beta) (EC 3.1.3.48) (Vascular endothelial protein tyrosine phosphatase) (VE-PTP),Ptprb,1998,angiogenesis [GO:0001525]; dephosphorylation [GO:0016311],GO:0001525; GO:0004725; GO:0016021; GO:0016311; GO:0043235,,,cd00063;,PF00041;PF00102;,integral component of membrane [GO:0016021]; receptor complex [GO:0043235]; protein tyrosine phosphatase activity [GO:0004725]; angiogenesis [GO:0001525]; dephosphorylation [GO:0016311]
Q8NE09,CHOYP_LOC752884.1.1|m.4412,0,0,0,0,0,0,0,0,1.00E-12,Regulator of G-protein signaling 22 (RGS22),RGS22,1264,negative regulation of signal transduction [GO:0009968],GO:0005096; GO:0005634; GO:0005737; GO:0005886; GO:0009968,,,,PF00615;,cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; GTPase activator activity [GO:0005096]; negative regulation of signal transduction [GO:0009968]
P23606,CHOYP_NEMVEDRAFT_V1G194582.2.2|m.40726,0,0,0,0,0,0,0,0,3.00E-99,Protein-glutamine gamma-glutamyltransferase K (EC 2.3.2.13) (Epidermal TGase) (Transglutaminase K) (TG(K)) (TGK) (TGase K) (Transglutaminase-1) (TGase-1),Tgm1,824,keratinization [GO:0031424]; peptide cross-linking [GO:0018149]; positive regulation of cell cycle [GO:0045787]; positive regulation of keratinocyte proliferation [GO:0010838],GO:0003810; GO:0010838; GO:0018149; GO:0031224; GO:0031424; GO:0045787; GO:0046872; GO:0070062,,,,PF00927;PF01841;PF00868;,extracellular exosome [GO:0070062]; intrinsic component of membrane [GO:0031224]; metal ion binding [GO:0046872]; protein-glutamine gamma-glutamyltransferase activity [GO:0003810]; keratinization [GO:0031424]; peptide cross-linking [GO:0018149]; positive regulation of cell cycle [GO:0045787]; positive regulation of keratinocyte proliferation [GO:0010838]
Q9VB11,CHOYP_PHUM_PHUM244880.1.2|m.691,0,0,0,0,0,0,0,0,0,Protein unc-80 homolog,unc80 CG18437,3303,cation homeostasis [GO:0055080]; locomotor rhythm [GO:0045475],GO:0005261; GO:0034703; GO:0045475; GO:0055080,,,,PF15778;,cation channel complex [GO:0034703]; cation channel activity [GO:0005261]; cation homeostasis [GO:0055080]; locomotor rhythm [GO:0045475]
O95822,CHOYP_PHUM_PHUM479110.1.1|m.54103,0.5,0,0,0,0,0,0,0,1.00E-133,"Malonyl-CoA decarboxylase, mitochondrial (MCD) (EC 4.1.1.9)",MLYCD,493,acetyl-CoA biosynthetic process [GO:0006085]; acyl-CoA metabolic process [GO:0006637]; fatty acid biosynthetic process [GO:0006633]; malonyl-CoA catabolic process [GO:2001294]; positive regulation of fatty acid oxidation [GO:0046321]; regulation of glucose metabolic process [GO:0010906]; response to ischemia [GO:0002931],GO:0002931; GO:0005102; GO:0005737; GO:0005739; GO:0005759; GO:0005777; GO:0005782; GO:0006085; GO:0006633; GO:0006637; GO:0010906; GO:0046321; GO:0050080; GO:2001294,PATHWAY: Metabolic intermediate biosynthesis; acetyl-CoA biosynthesis; acetyl-CoA from malonyl-CoA: step 1/1.,,,PF05292;,cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; malonyl-CoA decarboxylase activity [GO:0050080]; receptor binding [GO:0005102]; acetyl-CoA biosynthetic process [GO:0006085]; acyl-CoA metabolic process [GO:0006637]; fatty acid biosynthetic process [GO:0006633]; malonyl-CoA catabolic process [GO:2001294]; positive regulation of fatty acid oxidation [GO:0046321]; regulation of glucose metabolic process [GO:0010906]; response to ischemia [GO:0002931]
Q8BWF0,CHOYP_POPTRDRAFT_1091519.1.1|m.56854,0,0,0,0,0,0,0,0,0,"Succinate-semialdehyde dehydrogenase, mitochondrial (EC 1.2.1.24) (Aldehyde dehydrogenase family 5 member A1) (NAD(+)-dependent succinic semialdehyde dehydrogenase)",Aldh5a1,523,acetate metabolic process [GO:0006083]; central nervous system development [GO:0007417]; galactosylceramide metabolic process [GO:0006681]; gamma-aminobutyric acid catabolic process [GO:0009450]; gamma-aminobutyric acid metabolic process [GO:0009448]; glucose metabolic process [GO:0006006]; glucosylceramide metabolic process [GO:0006678]; glutamate metabolic process [GO:0006536]; glutamine metabolic process [GO:0006541]; glutathione metabolic process [GO:0006749]; glycerophospholipid metabolic process [GO:0006650]; neurotransmitter catabolic process [GO:0042135]; oxidation-reduction process [GO:0055114]; post-embryonic development [GO:0009791]; protein homotetramerization [GO:0051289]; respiratory electron transport chain [GO:0022904]; short-chain fatty acid metabolic process [GO:0046459]; succinate metabolic process [GO:0006105],GO:0004777; GO:0005739; GO:0006006; GO:0006083; GO:0006105; GO:0006536; GO:0006541; GO:0006650; GO:0006678; GO:0006681; GO:0006749; GO:0007417; GO:0009013; GO:0009448; GO:0009450; GO:0009791; GO:0022904; GO:0042135; GO:0046459; GO:0051289; GO:0055114,PATHWAY: Amino-acid degradation; 4-aminobutanoate degradation.,,,PF00171;,mitochondrion [GO:0005739]; succinate-semialdehyde dehydrogenase (NAD+) activity [GO:0004777]; succinate-semialdehyde dehydrogenase [NAD(P)+] activity [GO:0009013]; acetate metabolic process [GO:0006083]; central nervous system development [GO:0007417]; galactosylceramide metabolic process [GO:0006681]; gamma-aminobutyric acid catabolic process [GO:0009450]; gamma-aminobutyric acid metabolic process [GO:0009448]; glucose metabolic process [GO:0006006]; glucosylceramide metabolic process [GO:0006678]; glutamate metabolic process [GO:0006536]; glutamine metabolic process [GO:0006541]; glutathione metabolic process [GO:0006749]; glycerophospholipid metabolic process [GO:0006650]; neurotransmitter catabolic process [GO:0042135]; oxidation-reduction process [GO:0055114]; post-embryonic development [GO:0009791]; protein homotetramerization [GO:0051289]; respiratory electron transport chain [GO:0022904]; short-chain fatty acid metabolic process [GO:0046459]; succinate metabolic process [GO:0006105]
P29352,CHOYP_PTPRF.2.6|m.17540,1,0,0,0,0,0,0,0,4.00E-45,Tyrosine-protein phosphatase non-receptor type 22 (EC 3.1.3.48) (Hematopoietic cell protein-tyrosine phosphatase 70Z-PEP) (PEST-domain phosphatase) (PEP),Ptpn22 Ptpn8,802,"autophagy [GO:0006914]; cellular response to muramyl dipeptide [GO:0071225]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; negative regulation of autophagy [GO:0010507]; negative regulation of gene expression [GO:0010629]; negative regulation of interleukin-6 secretion [GO:1900165]; negative regulation of interleukin-8 secretion [GO:2000483]; negative regulation of JUN kinase activity [GO:0043508]; negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway [GO:0070433]; negative regulation of p38MAPK cascade [GO:1903753]; negative regulation of T cell activation [GO:0050868]; negative regulation of T cell receptor signaling pathway [GO:0050860]; negative regulation of tumor necrosis factor production [GO:0032720]; phosphoanandamide dephosphorylation [GO:0035644]; positive regulation of CD8-positive, alpha-beta T cell proliferation [GO:2000566]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of granzyme B production [GO:0071663]; positive regulation of interferon-alpha secretion [GO:1902741]; positive regulation of interferon-beta secretion [GO:0035549]; positive regulation of interferon-gamma secretion [GO:1902715]; positive regulation of protein K63-linked ubiquitination [GO:1902523]; positive regulation of toll-like receptor 3 signaling pathway [GO:0034141]; positive regulation of toll-like receptor 4 signaling pathway [GO:0034145]; positive regulation of toll-like receptor 7 signaling pathway [GO:0034157]; positive regulation of toll-like receptor 9 signaling pathway [GO:0034165]; positive regulation of transcription factor import into nucleus [GO:0042993]; positive regulation of type I interferon production [GO:0032481]; protein dephosphorylation [GO:0006470]; regulation of calcium ion transmembrane transport [GO:1903169]; regulation of leukocyte migration [GO:0002685]; regulation of natural killer cell proliferation [GO:0032817]; regulation of NIK/NF-kappaB signaling [GO:1901222]; regulation of peptidyl-tyrosine phosphorylation [GO:0050730]; response to lipopolysaccharide [GO:0032496]; T cell differentiation [GO:0030217]; T cell receptor signaling pathway [GO:0050852]",GO:0002230; GO:0002685; GO:0004725; GO:0005634; GO:0005737; GO:0006470; GO:0006914; GO:0009898; GO:0010507; GO:0010628; GO:0010629; GO:0016791; GO:0017124; GO:0019900; GO:0030217; GO:0031625; GO:0031663; GO:0032481; GO:0032496; GO:0032720; GO:0032817; GO:0034141; GO:0034145; GO:0034157; GO:0034165; GO:0035549; GO:0035644; GO:0042993; GO:0043508; GO:0048471; GO:0050730; GO:0050852; GO:0050860; GO:0050868; GO:0070374; GO:0070433; GO:0071225; GO:0071663; GO:1900165; GO:1901222; GO:1902523; GO:1902715; GO:1902741; GO:1903169; GO:1903753; GO:2000483; GO:2000566,,,,PF00102;,"cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; kinase binding [GO:0019900]; phosphatase activity [GO:0016791]; protein tyrosine phosphatase activity [GO:0004725]; SH3 domain binding [GO:0017124]; ubiquitin protein ligase binding [GO:0031625]; autophagy [GO:0006914]; cellular response to muramyl dipeptide [GO:0071225]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; negative regulation of autophagy [GO:0010507]; negative regulation of gene expression [GO:0010629]; negative regulation of interleukin-6 secretion [GO:1900165]; negative regulation of interleukin-8 secretion [GO:2000483]; negative regulation of JUN kinase activity [GO:0043508]; negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway [GO:0070433]; negative regulation of p38MAPK cascade [GO:1903753]; negative regulation of T cell activation [GO:0050868]; negative regulation of T cell receptor signaling pathway [GO:0050860]; negative regulation of tumor necrosis factor production [GO:0032720]; phosphoanandamide dephosphorylation [GO:0035644]; positive regulation of CD8-positive, alpha-beta T cell proliferation [GO:2000566]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of granzyme B production [GO:0071663]; positive regulation of interferon-alpha secretion [GO:1902741]; positive regulation of interferon-beta secretion [GO:0035549]; positive regulation of interferon-gamma secretion [GO:1902715]; positive regulation of protein K63-linked ubiquitination [GO:1902523]; positive regulation of toll-like receptor 3 signaling pathway [GO:0034141]; positive regulation of toll-like receptor 4 signaling pathway [GO:0034145]; positive regulation of toll-like receptor 7 signaling pathway [GO:0034157]; positive regulation of toll-like receptor 9 signaling pathway [GO:0034165]; positive regulation of transcription factor import into nucleus [GO:0042993]; positive regulation of type I interferon production [GO:0032481]; protein dephosphorylation [GO:0006470]; regulation of calcium ion transmembrane transport [GO:1903169]; regulation of leukocyte migration [GO:0002685]; regulation of natural killer cell proliferation [GO:0032817]; regulation of NIK/NF-kappaB signaling [GO:1901222]; regulation of peptidyl-tyrosine phosphorylation [GO:0050730]; response to lipopolysaccharide [GO:0032496]; T cell differentiation [GO:0030217]; T cell receptor signaling pathway [GO:0050852]"
F4JLS1,CHOYP_SORBIDRAFT_06G032450.1.1|m.16356,0,0,0,0,0,0,0,0,2.00E-33,Lysine-specific histone demethylase 1 homolog 3 (EC 1.-.-.-) (Flavin-containing amine oxidase domain-containing protein 3) (Protein LSD1-like 3),LDL3 At4g16310/At4g16320 dl4185w/dl4190w FCAALL.342/ FCAALL.344,1628,"covalent chromatin modification [GO:0016569]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]",GO:0003677; GO:0005634; GO:0006351; GO:0006355; GO:0016491; GO:0016569,,,,PF01593;PF04433;,"nucleus [GO:0005634]; DNA binding [GO:0003677]; oxidoreductase activity [GO:0016491]; covalent chromatin modification [GO:0016569]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]"
Q5RBZ3,CHOYP_WDR89.1.1|m.30861,0,0,0,0,0,0,0,0,1.00E-68,WD repeat-containing protein 89,WDR89,387,,,,,,PF00400;,
Q60542,CHOYP_ZEB2.1.1|m.29733,0.5,0,0,0,0,0,0,0,0.000000002,Zinc finger E-box-binding homeobox 1 (Transcription factor 8) (TCF-8) (Zinc finger protein BZP),ZEB1 BZP TCF8,1043,"negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of neuron differentiation [GO:0045666]; transcription, DNA-templated [GO:0006351]",GO:0005634; GO:0006351; GO:0045666; GO:0045892; GO:0046872; GO:0070888,,,,PF00046;PF05605;,"nucleus [GO:0005634]; E-box binding [GO:0070888]; metal ion binding [GO:0046872]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of neuron differentiation [GO:0045666]; transcription, DNA-templated [GO:0006351]"
Q5UNS9,CHOYP_contig_025639|m.29255,0,0,0,0,0,0,0,0,7.00E-54,Collagen-like protein 7,MIMI_L669,1937,,GO:0019012,,,,PF01391;,virion [GO:0019012]
P15287,CHOYP_AGSA.1.1|m.5200,0,0,0,0,0,0,0,0,3.00E-55,Adenosine deaminase AGSA (EC 3.5.4.4) (Atrial gland-specific antigen) (AGSA) (Mollusk-derived growth factor) (MDGF),,525,,GO:0004000; GO:0005615; GO:0046872,,,,PF00962;PF08451;,extracellular space [GO:0005615]; adenosine deaminase activity [GO:0004000]; metal ion binding [GO:0046872]
P36956,CHOYP_BRAFLDRAFT_117231.1.1|m.4966,0,0,0,0,0,0,0,0,0,Sterol regulatory element-binding protein 1 (SREBP-1) (Class D basic helix-loop-helix protein 1) (bHLHd1) (Sterol regulatory element-binding transcription factor 1) [Cleaved into: Processed sterol regulatory element-binding protein 1],SREBF1 BHLHD1 SREBP1,1147,aging [GO:0007568]; cellular response to fatty acid [GO:0071398]; cellular response to starvation [GO:0009267]; cholesterol metabolic process [GO:0008203]; circadian rhythm [GO:0007623]; fat cell differentiation [GO:0045444]; insulin receptor signaling pathway [GO:0008286]; lipid biosynthetic process [GO:0008610]; lipid metabolic process [GO:0006629]; lung development [GO:0030324]; mRNA transcription from RNA polymerase II promoter [GO:0042789]; negative regulation of insulin secretion [GO:0046676]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of cholesterol biosynthetic process [GO:0045542]; positive regulation of histone deacetylation [GO:0031065]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; positive regulation of triglyceride biosynthetic process [GO:0010867]; regulation of fatty acid metabolic process [GO:0019217]; regulation of heart rate by chemical signal [GO:0003062]; regulation of mitophagy [GO:1903146]; regulation of protein stability [GO:0031647]; regulation of protein targeting to mitochondrion [GO:1903214]; regulation of transcription from RNA polymerase II promoter [GO:0006357]; response to cAMP [GO:0051591]; response to drug [GO:0042493]; response to food [GO:0032094]; response to glucagon [GO:0033762]; response to glucose [GO:0009749]; response to progesterone [GO:0032570]; response to retinoic acid [GO:0032526],GO:0000122; GO:0000139; GO:0000977; GO:0000978; GO:0001077; GO:0003062; GO:0003677; GO:0003682; GO:0003700; GO:0004879; GO:0005634; GO:0005635; GO:0005654; GO:0005737; GO:0005783; GO:0005789; GO:0005829; GO:0006357; GO:0006629; GO:0007568; GO:0007623; GO:0008203; GO:0008286; GO:0008610; GO:0009267; GO:0009749; GO:0010867; GO:0012507; GO:0016021; GO:0019217; GO:0030324; GO:0031065; GO:0031647; GO:0032094; GO:0032526; GO:0032570; GO:0032810; GO:0033762; GO:0042493; GO:0042789; GO:0043234; GO:0045444; GO:0045542; GO:0045944; GO:0046676; GO:0051591; GO:0071398; GO:1903146; GO:1903214,,,,PF00010;,"cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein complex [GO:0043234]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; RNA polymerase II core promoter proximal region sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding [GO:0004879]; sterol response element binding [GO:0032810]; transcription factor activity, sequence-specific DNA binding [GO:0003700]; transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding [GO:0001077]; aging [GO:0007568]; cellular response to fatty acid [GO:0071398]; cellular response to starvation [GO:0009267]; cholesterol metabolic process [GO:0008203]; circadian rhythm [GO:0007623]; fat cell differentiation [GO:0045444]; insulin receptor signaling pathway [GO:0008286]; lipid biosynthetic process [GO:0008610]; lipid metabolic process [GO:0006629]; lung development [GO:0030324]; mRNA transcription from RNA polymerase II promoter [GO:0042789]; negative regulation of insulin secretion [GO:0046676]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of cholesterol biosynthetic process [GO:0045542]; positive regulation of histone deacetylation [GO:0031065]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; positive regulation of triglyceride biosynthetic process [GO:0010867]; regulation of fatty acid metabolic process [GO:0019217]; regulation of heart rate by chemical signal [GO:0003062]; regulation of mitophagy [GO:1903146]; regulation of protein stability [GO:0031647]; regulation of protein targeting to mitochondrion [GO:1903214]; regulation of transcription from RNA polymerase II promoter [GO:0006357]; response to cAMP [GO:0051591]; response to drug [GO:0042493]; response to food [GO:0032094]; response to glucagon [GO:0033762]; response to glucose [GO:0009749]; response to progesterone [GO:0032570]; response to retinoic acid [GO:0032526]"
Q9NZJ4,CHOYP_BRAFLDRAFT_118535.8.8|m.61819,1,0,0,0,0,0,0,0,0,Sacsin (DnaJ homolog subfamily C member 29) (DNAJC29),SACS KIAA0730,4579,negative regulation of inclusion body assembly [GO:0090084]; protein folding [GO:0006457],GO:0005634; GO:0005737; GO:0005739; GO:0006457; GO:0030424; GO:0030425; GO:0030544; GO:0051087; GO:0070628; GO:0070852; GO:0090084,,,,PF05168;PF00240;,axon [GO:0030424]; cell body fiber [GO:0070852]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; proteasome binding [GO:0070628]; negative regulation of inclusion body assembly [GO:0090084]; protein folding [GO:0006457]
A0JNH9,CHOYP_BRAFLDRAFT_122376.1.1|m.49446,0,0,0,0,0,0,0,0,0.000000008,Aprataxin and PNK-like factor (EC 4.2.99.18) (Apurinic-apyrimidinic endonuclease APLF),APLF,485,cellular response to DNA damage stimulus [GO:0006974]; double-strand break repair [GO:0006302]; single strand break repair [GO:0000012],GO:0000012; GO:0000166; GO:0003906; GO:0004520; GO:0005634; GO:0005829; GO:0006302; GO:0006974; GO:0008408; GO:0046872,,,,PF10283;,cytosol [GO:0005829]; nucleus [GO:0005634]; 3'-5' exonuclease activity [GO:0008408]; DNA-(apurinic or apyrimidinic site) lyase activity [GO:0003906]; endodeoxyribonuclease activity [GO:0004520]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; cellular response to DNA damage stimulus [GO:0006974]; double-strand break repair [GO:0006302]; single strand break repair [GO:0000012]
B3EWY9,CHOYP_BRAFLDRAFT_129967.1.4|m.4020,0,0,0,0,0,0,0,0,2.00E-104,Mucin-like protein (Fragment),,1594,cell-matrix adhesion [GO:0007160],GO:0005509; GO:0007160; GO:0016021,,,,PF12662;PF06119;PF00090;PF00094;,integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; cell-matrix adhesion [GO:0007160]
Q96IG2,CHOYP_BRAFLDRAFT_74861.1.1|m.16599,0,0,0,0,0,0,0,0,4.00E-11,F-box/LRR-repeat protein 20 (F-box and leucine-rich repeat protein 20) (F-box/LRR-repeat protein 2-like),FBXL20 FBL2,436,behavioral fear response [GO:0001662]; protein polyubiquitination [GO:0000209],GO:0000209; GO:0001662; GO:0004842; GO:0005829,,,,PF12937;PF13516;,cytosol [GO:0005829]; ubiquitin-protein transferase activity [GO:0004842]; behavioral fear response [GO:0001662]; protein polyubiquitination [GO:0000209]
B3EWY9,CHOYP_BRAFLDRAFT_92365.3.3|m.51160,0,0,0,0,0,0,0,0,6.00E-47,Mucin-like protein (Fragment),,1594,cell-matrix adhesion [GO:0007160],GO:0005509; GO:0007160; GO:0016021,,,,PF12662;PF06119;PF00090;PF00094;,integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; cell-matrix adhesion [GO:0007160]
A1A4R8,CHOYP_CDC23.1.1|m.6463,0,0,0,0,0,0,0,0,0,Cell division cycle protein 23 homolog (Anaphase-promoting complex subunit 8) (APC8) (Cyclosome subunit 8),CDC23 ANAPC8,597,cell division [GO:0051301]; mitotic metaphase plate congression [GO:0007080]; protein K11-linked ubiquitination [GO:0070979]; regulation of mitotic metaphase/anaphase transition [GO:0030071],GO:0005680; GO:0007080; GO:0030071; GO:0051301; GO:0070979,PATHWAY: Protein modification; protein ubiquitination.,,,PF04049;PF13414;PF13181;,anaphase-promoting complex [GO:0005680]; cell division [GO:0051301]; mitotic metaphase plate congression [GO:0007080]; protein K11-linked ubiquitination [GO:0070979]; regulation of mitotic metaphase/anaphase transition [GO:0030071]
A2AJ76,CHOYP_CRE-UNC-89.3.3|m.61234,0,0,0,0,0,0,0,0,0.0000002,Hemicentin-2,Hmcn2,5100,positive regulation of cell migration [GO:0030335]; response to stimulus [GO:0050896]; smooth muscle contraction [GO:0006939],GO:0005509; GO:0005576; GO:0005604; GO:0005938; GO:0006939; GO:0030054; GO:0030335; GO:0032154; GO:0050896,,,,PF12662;PF07645;PF07474;PF07679;,basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; positive regulation of cell migration [GO:0030335]; response to stimulus [GO:0050896]; smooth muscle contraction [GO:0006939]
Q0UI93,CHOYP_IFIH1.4.14|m.40815,0,0,0,0,0,0,0,0,2.00E-14,Dicer-like protein 1 [Includes: Endoribonuclease DCL1 (EC 3.1.26.-); ATP-dependent helicase DCL1 (EC 3.6.4.-)],DCL1 SNOG_08521,1522,defense response to virus [GO:0051607]; production of siRNA involved in RNA interference [GO:0030422]; regulation of defense response to virus [GO:0050688],GO:0003677; GO:0003723; GO:0004386; GO:0004525; GO:0005524; GO:0005634; GO:0005737; GO:0016442; GO:0030422; GO:0046872; GO:0050688; GO:0051607,,,cd00593;,PF03368;PF00271;PF04851;PF00636;,cytoplasm [GO:0005737]; nucleus [GO:0005634]; RISC complex [GO:0016442]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; metal ion binding [GO:0046872]; ribonuclease III activity [GO:0004525]; RNA binding [GO:0003723]; defense response to virus [GO:0051607]; production of siRNA involved in RNA interference [GO:0030422]; regulation of defense response to virus [GO:0050688]
Q5RH71,CHOYP_LOC100162380.1.1|m.23942,0,0,0,0,0,0,0,0,6.00E-48,Tetraspanin-33 (Tspan-33),tspan33 zgc:92266,281,cell surface receptor signaling pathway [GO:0007166],GO:0005887; GO:0007166,,,,PF00335;,integral component of plasma membrane [GO:0005887]; cell surface receptor signaling pathway [GO:0007166]
P18293,CHOYP_LOC100197876.1.1|m.45271,0.5,0,0,0,0,0,0,0,3.00E-153,Atrial natriuretic peptide receptor 1 (EC 4.6.1.2) (Atrial natriuretic peptide receptor type A) (ANP-A) (ANPR-A) (NPR-A) (Guanylate cyclase A) (GC-A),Npr1 Npra,1057,cGMP biosynthetic process [GO:0006182]; dopamine metabolic process [GO:0042417]; intracellular signal transduction [GO:0035556]; negative regulation of smooth muscle cell proliferation [GO:0048662]; positive regulation of cGMP biosynthetic process [GO:0030828]; receptor guanylyl cyclase signaling pathway [GO:0007168]; regulation of blood vessel size [GO:0050880],GO:0004383; GO:0004672; GO:0005524; GO:0005525; GO:0005886; GO:0006182; GO:0007168; GO:0008074; GO:0016021; GO:0016941; GO:0017046; GO:0030828; GO:0035556; GO:0042417; GO:0042562; GO:0043235; GO:0048662; GO:0050880,,,,PF01094;PF00211;PF07714;,"guanylate cyclase complex, soluble [GO:0008074]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; hormone binding [GO:0042562]; natriuretic peptide receptor activity [GO:0016941]; peptide hormone binding [GO:0017046]; protein kinase activity [GO:0004672]; cGMP biosynthetic process [GO:0006182]; dopamine metabolic process [GO:0042417]; intracellular signal transduction [GO:0035556]; negative regulation of smooth muscle cell proliferation [GO:0048662]; positive regulation of cGMP biosynthetic process [GO:0030828]; receptor guanylyl cyclase signaling pathway [GO:0007168]; regulation of blood vessel size [GO:0050880]"
P18433,CHOYP_LOC100208023.1.8|m.8628,0,0,0,0,0,0,0,0,1.00E-72,Receptor-type tyrosine-protein phosphatase alpha (Protein-tyrosine phosphatase alpha) (R-PTP-alpha) (EC 3.1.3.48),PTPRA PTPA PTPRL2,802,axon guidance [GO:0007411]; insulin receptor signaling pathway [GO:0008286]; MAPK cascade [GO:0000165],GO:0000165; GO:0004725; GO:0005001; GO:0005088; GO:0005622; GO:0005886; GO:0005887; GO:0007411; GO:0008286; GO:0043235; GO:0070062,,,,PF00102;,extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; intracellular [GO:0005622]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; protein tyrosine phosphatase activity [GO:0004725]; Ras guanyl-nucleotide exchange factor activity [GO:0005088]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; axon guidance [GO:0007411]; insulin receptor signaling pathway [GO:0008286]; MAPK cascade [GO:0000165]
Q9JM83,CHOYP_LOC100261610.1.1|m.6374,1.5,0,0,0,0,0,0,0,1.00E-15,Calmodulin-4 (Calcium-binding protein Dd112),Calm4 Dd112,148,,GO:0005509; GO:0070062,,,cd00051;,PF13499;,extracellular exosome [GO:0070062]; calcium ion binding [GO:0005509]
Q8BTK5,CHOYP_LOC100372698.1.1|m.18674,0,0,0,0,0,0,0,0,2.00E-51,SET and MYND domain-containing protein 4 (EC 2.1.1.-),Smyd4 Kiaa1936,799,,GO:0008168; GO:0046872,,,,PF00856;PF01753;,metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]
Q7K4Y6,CHOYP_LOC100375514.4.6|m.41109,0,0,0,0,0,0,0,0,3.00E-172,Sodium-dependent dopamine transporter (Protein fumin),DAT fmn CG8380,631,adult locomotory behavior [GO:0008344]; circadian sleep/wake cycle [GO:0042745]; dopamine transport [GO:0015872]; regulation of presynaptic cytosolic calcium ion concentration [GO:0099509]; response to odorant [GO:1990834]; sleep [GO:0030431],GO:0005328; GO:0005329; GO:0005887; GO:0008344; GO:0015872; GO:0019811; GO:0030431; GO:0042745; GO:0046872; GO:0098793; GO:0099509; GO:1990834,,,,PF00209;,integral component of plasma membrane [GO:0005887]; presynapse [GO:0098793]; cocaine binding [GO:0019811]; dopamine transmembrane transporter activity [GO:0005329]; metal ion binding [GO:0046872]; neurotransmitter:sodium symporter activity [GO:0005328]; adult locomotory behavior [GO:0008344]; circadian sleep/wake cycle [GO:0042745]; dopamine transport [GO:0015872]; regulation of presynaptic cytosolic calcium ion concentration [GO:0099509]; response to odorant [GO:1990834]; sleep [GO:0030431]
P23469,CHOYP_LOC100890753.2.3|m.53551,0,0,0,0,0,0,0,0,7.00E-74,Receptor-type tyrosine-protein phosphatase epsilon (Protein-tyrosine phosphatase epsilon) (R-PTP-epsilon) (EC 3.1.3.48),PTPRE,700,negative regulation of insulin receptor signaling pathway [GO:0046627]; protein dephosphorylation [GO:0006470]; regulation of mast cell activation [GO:0033003]; transmembrane receptor protein tyrosine phosphatase signaling pathway [GO:0007185],GO:0005001; GO:0005634; GO:0005737; GO:0005886; GO:0006470; GO:0007185; GO:0016021; GO:0033003; GO:0046627,,,,PF00102;,cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; negative regulation of insulin receptor signaling pathway [GO:0046627]; protein dephosphorylation [GO:0006470]; regulation of mast cell activation [GO:0033003]; transmembrane receptor protein tyrosine phosphatase signaling pathway [GO:0007185]
Q8N841,CHOYP_LOC660482.1.1|m.8222,0,0,0,0,0,0,0,0,1.00E-21,Tubulin polyglutamylase TTLL6 (EC 6.-.-.-) (Tubulin--tyrosine ligase-like protein 6),TTLL6 TTL.6,843,microtubule bundle formation [GO:0001578]; microtubule severing [GO:0051013]; positive regulation of cilium movement [GO:0003353]; protein polyglutamylation [GO:0018095],GO:0001578; GO:0003353; GO:0005524; GO:0005737; GO:0005874; GO:0015631; GO:0018095; GO:0036064; GO:0051013; GO:0070739,,,,PF03133;,ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; ATP binding [GO:0005524]; protein-glutamic acid ligase activity [GO:0070739]; tubulin binding [GO:0015631]; microtubule bundle formation [GO:0001578]; microtubule severing [GO:0051013]; positive regulation of cilium movement [GO:0003353]; protein polyglutamylation [GO:0018095]
O43614,CHOYP_LOC762961.3.5|m.46330,0.5,0,0,0,0,0,0,0,8.00E-25,Orexin receptor type 2 (Ox-2-R) (Ox2-R) (Ox2R) (Hypocretin receptor type 2),HCRTR2,444,"cellular response to hormone stimulus [GO:0032870]; chemical synaptic transmission [GO:0007268]; circadian sleep/wake cycle process [GO:0022410]; feeding behavior [GO:0007631]; neuropeptide signaling pathway [GO:0007218]; phospholipase C-activating G-protein coupled receptor signaling pathway [GO:0007200]; regulation of circadian sleep/wake cycle, sleep [GO:0045187]; regulation of circadian sleep/wake cycle, wakefulness [GO:0010840]; regulation of cytosolic calcium ion concentration [GO:0051480]; response to peptide [GO:1901652]",GO:0005886; GO:0005887; GO:0007200; GO:0007218; GO:0007268; GO:0007631; GO:0008188; GO:0010840; GO:0016499; GO:0017046; GO:0022410; GO:0032870; GO:0042277; GO:0045187; GO:0051480; GO:1901652,,,,PF00001;PF03827;,"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; neuropeptide receptor activity [GO:0008188]; orexin receptor activity [GO:0016499]; peptide binding [GO:0042277]; peptide hormone binding [GO:0017046]; cellular response to hormone stimulus [GO:0032870]; chemical synaptic transmission [GO:0007268]; circadian sleep/wake cycle process [GO:0022410]; feeding behavior [GO:0007631]; neuropeptide signaling pathway [GO:0007218]; phospholipase C-activating G-protein coupled receptor signaling pathway [GO:0007200]; regulation of circadian sleep/wake cycle, sleep [GO:0045187]; regulation of circadian sleep/wake cycle, wakefulness [GO:0010840]; regulation of cytosolic calcium ion concentration [GO:0051480]; response to peptide [GO:1901652]"
Q62925,CHOYP_M3K1.1.1|m.7202,0,0,0,0,0,0,0,0,8.00E-119,Mitogen-activated protein kinase kinase kinase 1 (EC 2.7.11.25) (MAPK/ERK kinase kinase 1) (MEK kinase 1) (MEKK 1),Map3k1 Mekk Mekk1,1493,activation of JNKK activity [GO:0007256]; activation of MAPKK activity [GO:0000186]; MAPK cascade [GO:0000165]; negative regulation of actin filament bundle assembly [GO:0032232]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of apoptotic process [GO:0043065]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; positive regulation of viral transcription [GO:0050434]; protein autophosphorylation [GO:0046777]; protein oligomerization [GO:0051259]; protein phosphorylation [GO:0006468]; protein polyubiquitination [GO:0000209]; protein ubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0042787]; response to osmotic stress [GO:0006970],GO:0000165; GO:0000186; GO:0000209; GO:0004706; GO:0004709; GO:0004842; GO:0005524; GO:0005737; GO:0006468; GO:0006970; GO:0007256; GO:0008270; GO:0008432; GO:0016020; GO:0018105; GO:0031434; GO:0032232; GO:0042787; GO:0043065; GO:0043406; GO:0043507; GO:0045944; GO:0046625; GO:0046777; GO:0050434; GO:0051019; GO:0051259,,,,PF00069;,cytoplasm [GO:0005737]; membrane [GO:0016020]; ATP binding [GO:0005524]; JUN kinase binding [GO:0008432]; JUN kinase kinase kinase activity [GO:0004706]; MAP kinase kinase kinase activity [GO:0004709]; mitogen-activated protein kinase binding [GO:0051019]; mitogen-activated protein kinase kinase binding [GO:0031434]; sphingolipid binding [GO:0046625]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; activation of JNKK activity [GO:0007256]; activation of MAPKK activity [GO:0000186]; MAPK cascade [GO:0000165]; negative regulation of actin filament bundle assembly [GO:0032232]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of apoptotic process [GO:0043065]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; positive regulation of viral transcription [GO:0050434]; protein autophosphorylation [GO:0046777]; protein oligomerization [GO:0051259]; protein phosphorylation [GO:0006468]; protein polyubiquitination [GO:0000209]; protein ubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0042787]; response to osmotic stress [GO:0006970]
Q5M865,CHOYP_PAGR1.1.1|m.18447,0,0,0,0,0,0,0,0,0.00000001,PAXIP1-associated glutamate-rich protein 1 (PAXIP1-associated protein 1) (PTIP-associated protein 1),PAGR1,253,"DNA recombination [GO:0006310]; DNA repair [GO:0006281]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]",GO:0005634; GO:0006281; GO:0006310; GO:0006351; GO:0006355,,,,PF15364;,"nucleus [GO:0005634]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]"
Q96CD2,CHOYP_PPCDC.1.1|m.41651,0,0,0,0,0,0,0,0,4.00E-78,Phosphopantothenoylcysteine decarboxylase (PPC-DC) (EC 4.1.1.36) (CoaC),PPCDC COAC MDS018 UNQ9365/PRO34154,204,coenzyme A biosynthetic process [GO:0015937]; coenzyme biosynthetic process [GO:0009108],GO:0004633; GO:0005829; GO:0009108; GO:0015937; GO:0042802,PATHWAY: Cofactor biosynthesis; coenzyme A biosynthesis; CoA from (R)-pantothenate: step 3/5.,,,PF02441;,cytosol [GO:0005829]; identical protein binding [GO:0042802]; phosphopantothenoylcysteine decarboxylase activity [GO:0004633]; coenzyme A biosynthetic process [GO:0015937]; coenzyme biosynthetic process [GO:0009108]
P23470,CHOYP_PTPRG.3.3|m.65311,0,0,0,0,0,0,0,0,4.00E-83,Receptor-type tyrosine-protein phosphatase gamma (Protein-tyrosine phosphatase gamma) (R-PTP-gamma) (EC 3.1.3.48),PTPRG PTPG,1445,brain development [GO:0007420]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of neuron projection development [GO:0010977]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],GO:0004725; GO:0005001; GO:0005615; GO:0005887; GO:0007169; GO:0007420; GO:0010633; GO:0010977; GO:0042802; GO:0070062,,,cd00063;,PF00194;PF00041;PF00102;,extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; identical protein binding [GO:0042802]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; brain development [GO:0007420]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of neuron projection development [GO:0010977]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]
Q5RFQ3,CHOYP_PWP2.1.1|m.7530,0,0,0,0,0,0,0,0,0,Periodic tryptophan protein 2 homolog,PWP2,918,,GO:0005730,,,,PF04003;PF00400;,nucleolus [GO:0005730]
Q80VJ2,CHOYP_SRA1.1.1|m.56432,0,0,0,0,0,0,0,0,4.00E-14,Steroid receptor RNA activator 1 (Steroid receptor RNA activator protein) (SRAP),Sra1,232,"apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; cell proliferation [GO:0008283]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of apoptotic process [GO:0042981]; regulation of transcription from RNA polymerase II promoter [GO:0006357]; transcription, DNA-templated [GO:0006351]",GO:0003677; GO:0003712; GO:0003713; GO:0005634; GO:0005654; GO:0005667; GO:0005829; GO:0005831; GO:0005886; GO:0006351; GO:0006357; GO:0006915; GO:0008283; GO:0010861; GO:0015630; GO:0030154; GO:0030374; GO:0030529; GO:0031252; GO:0042981; GO:0045171; GO:0045944,,,,PF07304;,"cell leading edge [GO:0031252]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; intracellular ribonucleoprotein complex [GO:0030529]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; steroid hormone aporeceptor complex [GO:0005831]; transcription factor complex [GO:0005667]; DNA binding [GO:0003677]; ligand-dependent nuclear receptor transcription coactivator activity [GO:0030374]; thyroid hormone receptor activator activity [GO:0010861]; transcription coactivator activity [GO:0003713]; transcription cofactor activity [GO:0003712]; apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; cell proliferation [GO:0008283]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of apoptotic process [GO:0042981]; regulation of transcription from RNA polymerase II promoter [GO:0006357]; transcription, DNA-templated [GO:0006351]"
Q6ZMP0,CHOYP_THSD4.1.2|m.36522,0,0,0,0,0,0,0,0,3.00E-142,Thrombospondin type-1 domain-containing protein 4 (A disintegrin and metalloproteinase with thrombospondin motifs-like protein 6) (ADAMTS-like protein 6) (ADAMTSL-6),THSD4 UNQ9334/PRO34005,1018,elastic fiber assembly [GO:0048251],GO:0001527; GO:0004222; GO:0005578; GO:0031012; GO:0048251; GO:0070062,,,,PF05986;PF08686;PF00090;,extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; microfibril [GO:0001527]; proteinaceous extracellular matrix [GO:0005578]; metalloendopeptidase activity [GO:0004222]; elastic fiber assembly [GO:0048251]
Q7YRQ8,CHOYP_WFIKKN1.1.1|m.28942,3,0,0,0,0,0,0,0,6.00E-16,Tissue factor pathway inhibitor 2 (TFPI-2),TFPI2,234,blood coagulation [GO:0007596],GO:0004867; GO:0007596; GO:0031012,,,,PF00014;,extracellular matrix [GO:0031012]; serine-type endopeptidase inhibitor activity [GO:0004867]; blood coagulation [GO:0007596]
Q9QW30,CHOYP_BCL3.2.2|m.57485,0,0,0,0,0,0,0,0,0.000001,Neurogenic locus notch homolog protein 2 (Notch 2) [Cleaved into: Notch 2 extracellular truncation; Notch 2 intracellular domain],Notch2,2471,"animal organ morphogenesis [GO:0009887]; cell cycle arrest [GO:0007050]; cell fate determination [GO:0001709]; cell growth [GO:0016049]; marginal zone B cell differentiation [GO:0002315]; negative regulation of cell proliferation [GO:0008285]; Notch signaling pathway [GO:0007219]; positive regulation of Ras protein signal transduction [GO:0046579]; regulation of developmental process [GO:0050793]; regulation of transcription, DNA-templated [GO:0006355]; tissue regeneration [GO:0042246]; transcription, DNA-templated [GO:0006351]",GO:0001709; GO:0002315; GO:0004872; GO:0005509; GO:0005576; GO:0005634; GO:0005829; GO:0005886; GO:0005887; GO:0006351; GO:0006355; GO:0007050; GO:0007219; GO:0008285; GO:0009887; GO:0009986; GO:0016049; GO:0042246; GO:0046579; GO:0050793,,,,PF12796;PF11936;PF00008;PF07645;PF12661;PF06816;PF07684;PF00066;,"cell surface [GO:0009986]; cytosol [GO:0005829]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; receptor activity [GO:0004872]; animal organ morphogenesis [GO:0009887]; cell cycle arrest [GO:0007050]; cell fate determination [GO:0001709]; cell growth [GO:0016049]; marginal zone B cell differentiation [GO:0002315]; negative regulation of cell proliferation [GO:0008285]; Notch signaling pathway [GO:0007219]; positive regulation of Ras protein signal transduction [GO:0046579]; regulation of developmental process [GO:0050793]; regulation of transcription, DNA-templated [GO:0006355]; tissue regeneration [GO:0042246]; transcription, DNA-templated [GO:0006351]"
Q54SW1,CHOYP_BRAFLDRAFT_120431.1.1|m.49038,0.5,0,0,0,0,0,0,0,0.00000005,Putative phosphatidylglycerol/phosphatidylinositol transfer protein DDB_G0282179,DDB_G0282179,145,lipid transport [GO:0006869],GO:0006869,,,,PF02221;,lipid transport [GO:0006869]
A5IXT5,CHOYP_BRAFLDRAFT_208197.18.21|m.59194,0,0,0,0,0,0,0,0,3.00E-11,Chaperone protein DnaK (HSP70) (Heat shock 70 kDa protein) (Heat shock protein 70),dnaK MAG1460,598,protein folding [GO:0006457],GO:0005524; GO:0006457,,,,PF00012;,ATP binding [GO:0005524]; protein folding [GO:0006457]
Q1ZXD6,CHOYP_BRAFLDRAFT_208436.11.32|m.42955,0,0,0,0,0,0,0,0,0.000000009,Probable serine/threonine-protein kinase roco5 (EC 2.7.11.1) (Ras of complex proteins and C-terminal of roc 5),roco5 DDB_G0294533,2800,intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468]; regulation of Rho protein signal transduction [GO:0035023]; small GTPase mediated signal transduction [GO:0007264]; sorocarp development [GO:0030587],GO:0004672; GO:0004674; GO:0004871; GO:0005089; GO:0005524; GO:0005525; GO:0005737; GO:0006468; GO:0007264; GO:0030587; GO:0035023; GO:0035556,,,,PF16095;PF13516;PF13855;PF07714;PF00621;PF08477;,cytoplasm [GO:0005737]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; signal transducer activity [GO:0004871]; intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468]; regulation of Rho protein signal transduction [GO:0035023]; small GTPase mediated signal transduction [GO:0007264]; sorocarp development [GO:0030587]
O75382,CHOYP_BRAFLDRAFT_86890.2.4|m.23914,0,0,0,0,0,0,0,0,5.00E-13,Tripartite motif-containing protein 3 (Brain-expressed RING finger protein) (RING finger protein 22) (RING finger protein 97),TRIM3 BERP RNF22 RNF97,744,nervous system development [GO:0007399]; protein transport [GO:0015031],GO:0005737; GO:0005769; GO:0005794; GO:0007399; GO:0008022; GO:0008270; GO:0015031; GO:0030425; GO:0061630,,,,PF00630;PF01436;PF00643;PF13445;,cytoplasm [GO:0005737]; dendrite [GO:0030425]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; protein C-terminus binding [GO:0008022]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; nervous system development [GO:0007399]; protein transport [GO:0015031]
Q28IU1,CHOYP_DHB12.1.1|m.62534,0,0,0,0,0,0,0,0,2.00E-103,Very-long-chain 3-oxoacyl-CoA reductase (EC 1.1.1.330) (17-beta-hydroxysteroid dehydrogenase 12) (17-beta-HSD 12) (3-ketoacyl-CoA reductase) (KAR) (Estradiol 17-beta-dehydrogenase 12) (EC 1.1.1.62),hsd17b12 TNeu053h21.1,320,estrogen biosynthetic process [GO:0006703]; fatty acid biosynthetic process [GO:0006633]; steroid biosynthetic process [GO:0006694],GO:0004303; GO:0005789; GO:0006633; GO:0006694; GO:0006703; GO:0016021; GO:0102339; GO:0102340; GO:0102341; GO:0102342,PATHWAY: Lipid metabolism; fatty acid biosynthesis. {ECO:0000250|UniProtKB:Q53GQ0}.; PATHWAY: Steroid biosynthesis; estrogen biosynthesis. {ECO:0000250|UniProtKB:Q53GQ0}.,,,PF00106;,endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; 3-oxo-arachidoyl-CoA reductase activity [GO:0102339]; 3-oxo-behenoyl-CoA reductase activity [GO:0102340]; 3-oxo-cerotoyl-CoA reductase activity [GO:0102342]; 3-oxo-lignoceroyl-CoA reductase activity [GO:0102341]; estradiol 17-beta-dehydrogenase activity [GO:0004303]; estrogen biosynthetic process [GO:0006703]; fatty acid biosynthetic process [GO:0006633]; steroid biosynthetic process [GO:0006694]
Q9Y600,CHOYP_GADL1.1.1|m.14433,0,0,0,0,0,0,0,0,0,Cysteine sulfinic acid decarboxylase (EC 4.1.1.29) (Cysteine-sulfinate decarboxylase) (Sulfinoalanine decarboxylase),CSAD CSD,493,carboxylic acid metabolic process [GO:0019752]; taurine biosynthetic process [GO:0042412],GO:0004782; GO:0019752; GO:0030170; GO:0042412,PATHWAY: Organosulfur biosynthesis; taurine biosynthesis; hypotaurine from L-cysteine: step 2/2.,,,PF00282;,pyridoxal phosphate binding [GO:0030170]; sulfinoalanine decarboxylase activity [GO:0004782]; carboxylic acid metabolic process [GO:0019752]; taurine biosynthetic process [GO:0042412]
O75496,CHOYP_LOC100313617.1.1|m.18024,0,0,0,0,0,0,0,0,3.00E-15,Geminin,GMNN,209,"animal organ morphogenesis [GO:0009887]; cell cycle [GO:0007049]; negative regulation of cell cycle [GO:0045786]; negative regulation of DNA replication [GO:0008156]; negative regulation of transcription, DNA-templated [GO:0045892]; protein complex assembly [GO:0006461]",GO:0003714; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006461; GO:0007049; GO:0008156; GO:0009887; GO:0042826; GO:0045786; GO:0045892,,,,PF07412;,"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; histone deacetylase binding [GO:0042826]; transcription corepressor activity [GO:0003714]; animal organ morphogenesis [GO:0009887]; cell cycle [GO:0007049]; negative regulation of cell cycle [GO:0045786]; negative regulation of DNA replication [GO:0008156]; negative regulation of transcription, DNA-templated [GO:0045892]; protein complex assembly [GO:0006461]"
Q96S38,CHOYP_LOC100371127.1.1|m.23427,0,0,0,0,0,0,0,0,7.00E-59,Ribosomal protein S6 kinase delta-1 (S6K-delta-1) (EC 2.7.11.1) (52 kDa ribosomal protein S6 kinase) (Ribosomal S6 kinase-like protein with two PSK domains 118 kDa protein) (SPHK1-binding protein),RPS6KC1 RPK118,1066,signal transduction [GO:0007165],GO:0004674; GO:0005524; GO:0005769; GO:0007165; GO:0016020; GO:0035091,,,,PF04212;PF00069;PF00787;,early endosome [GO:0005769]; membrane [GO:0016020]; ATP binding [GO:0005524]; phosphatidylinositol binding [GO:0035091]; protein serine/threonine kinase activity [GO:0004674]; signal transduction [GO:0007165]
O88327,CHOYP_LOC100371831.1.1|m.11775,0,0,0,0,0,0,0,0,0,Alpha-catulin (Alpha-catenin-related protein) (ACRP) (Catenin alpha-like protein 1),Ctnnal1 Catnal1,731,cell adhesion [GO:0007155]; Rho protein signal transduction [GO:0007266],GO:0005829; GO:0005856; GO:0005886; GO:0007155; GO:0007266,,,,PF01044;,cytoskeleton [GO:0005856]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; cell adhesion [GO:0007155]; Rho protein signal transduction [GO:0007266]
Q6ZUK4,CHOYP_LOC100372311.1.1|m.6654,0,0,0,0,0,0,0,0,4.00E-39,Transmembrane protein 26,TMEM26,368,,GO:0016021,,,,PF09772;,integral component of membrane [GO:0016021]
P48181,CHOYP_LOC100533245.3.6|m.31982,0,0,0,0,0,0,0,0,1.00E-143,Acetylcholine receptor subunit beta-type unc-29 (Uncoordinated protein 29),unc-29 T08G11.5,493,locomotion [GO:0040011]; neuromuscular synaptic transmission [GO:0007274]; regulation of oviposition [GO:0046662]; regulation of pharyngeal pumping [GO:0043051],GO:0007274; GO:0016021; GO:0022848; GO:0030054; GO:0040011; GO:0043005; GO:0043025; GO:0043051; GO:0045202; GO:0045211; GO:0046662,,,,PF02931;PF02932;,cell junction [GO:0030054]; integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; acetylcholine-gated cation-selective channel activity [GO:0022848]; locomotion [GO:0040011]; neuromuscular synaptic transmission [GO:0007274]; regulation of oviposition [GO:0046662]; regulation of pharyngeal pumping [GO:0043051]
Q99LG0,CHOYP_LOC585494.1.1|m.64158,0.5,0,0,0,0,0,0,0,4.00E-86,Ubiquitin carboxyl-terminal hydrolase 16 (EC 3.4.19.12) (Deubiquitinating enzyme 16) (Ubiquitin thioesterase 16) (Ubiquitin-specific-processing protease 16),Usp16,825,"cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; histone deubiquitination [GO:0016578]; histone H2A K63-linked deubiquitination [GO:0070537]; mitotic nuclear division [GO:0007067]; monoubiquitinated histone H2A deubiquitination [GO:0035522]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; positive regulation of translational elongation [GO:0045901]; protein homotetramerization [GO:0051289]; regulation of cell cycle [GO:0051726]; regulation of transcription from RNA polymerase II promoter [GO:0006357]; transcription, DNA-templated [GO:0006351]; ubiquitin-dependent protein catabolic process [GO:0006511]",GO:0003713; GO:0004197; GO:0004843; GO:0005634; GO:0006351; GO:0006357; GO:0006511; GO:0006974; GO:0007067; GO:0008270; GO:0016578; GO:0035522; GO:0042393; GO:0043130; GO:0045893; GO:0045901; GO:0045944; GO:0051289; GO:0051301; GO:0051726; GO:0070537,,,,PF00443;PF02148;,"nucleus [GO:0005634]; cysteine-type endopeptidase activity [GO:0004197]; histone binding [GO:0042393]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; transcription coactivator activity [GO:0003713]; ubiquitin binding [GO:0043130]; zinc ion binding [GO:0008270]; cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; histone deubiquitination [GO:0016578]; histone H2A K63-linked deubiquitination [GO:0070537]; mitotic nuclear division [GO:0007067]; monoubiquitinated histone H2A deubiquitination [GO:0035522]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of translational elongation [GO:0045901]; protein homotetramerization [GO:0051289]; regulation of cell cycle [GO:0051726]; regulation of transcription from RNA polymerase II promoter [GO:0006357]; transcription, DNA-templated [GO:0006351]; ubiquitin-dependent protein catabolic process [GO:0006511]"
Q1ZXD6,CHOYP_LOC755594.2.6|m.51265,0,0,0,0,0,0,0,0,4.00E-13,Probable serine/threonine-protein kinase roco5 (EC 2.7.11.1) (Ras of complex proteins and C-terminal of roc 5),roco5 DDB_G0294533,2800,intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468]; regulation of Rho protein signal transduction [GO:0035023]; small GTPase mediated signal transduction [GO:0007264]; sorocarp development [GO:0030587],GO:0004672; GO:0004674; GO:0004871; GO:0005089; GO:0005524; GO:0005525; GO:0005737; GO:0006468; GO:0007264; GO:0030587; GO:0035023; GO:0035556,,,,PF16095;PF13516;PF13855;PF07714;PF00621;PF08477;,cytoplasm [GO:0005737]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; signal transducer activity [GO:0004871]; intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468]; regulation of Rho protein signal transduction [GO:0035023]; small GTPase mediated signal transduction [GO:0007264]; sorocarp development [GO:0030587]
Q6R7L4,CHOYP_OSHV1_GP010.1.2|m.28852,0,0,0,0,0,0,0,0,0,Putative RING finger protein ORF9,ORF9,592,,GO:0008270,,,,,zinc ion binding [GO:0008270]
O75382,CHOYP_PE2R3.2.2|m.61863,0,0,0,0,0,0,0,0,2.00E-13,Tripartite motif-containing protein 3 (Brain-expressed RING finger protein) (RING finger protein 22) (RING finger protein 97),TRIM3 BERP RNF22 RNF97,744,nervous system development [GO:0007399]; protein transport [GO:0015031],GO:0005737; GO:0005769; GO:0005794; GO:0007399; GO:0008022; GO:0008270; GO:0015031; GO:0030425; GO:0061630,,,,PF00630;PF01436;PF00643;PF13445;,cytoplasm [GO:0005737]; dendrite [GO:0030425]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; protein C-terminus binding [GO:0008022]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; nervous system development [GO:0007399]; protein transport [GO:0015031]
Q59641,CHOYP_PPIB.2.4|m.40019,2,0,0,0,0,0,0,0,0.000000004,Peptidyl-prolyl cis-trans isomerase A (PPIase A) (EC 5.2.1.8) (Cyclophilin A) (Rotamase A),ppiA cypH PA3227,187,protein folding [GO:0006457],GO:0003755; GO:0006457; GO:0042597,,,,PF00160;,periplasmic space [GO:0042597]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; protein folding [GO:0006457]
Q5ZJ85,CHOYP_PRPF3.1.1|m.736,0,0,0,0,0,0,0,0,0,U4/U6 small nuclear ribonucleoprotein Prp3 (Pre-mRNA-splicing factor 3),PRPF3 RCJMB04_20b24,684,"mRNA splicing, via spliceosome [GO:0000398]; spliceosomal tri-snRNP complex assembly [GO:0000244]",GO:0000244; GO:0000398; GO:0005634; GO:0005681; GO:0016607; GO:0046540,,,,PF06544;PF08572;PF01480;,"nuclear speck [GO:0016607]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; mRNA splicing, via spliceosome [GO:0000398]; spliceosomal tri-snRNP complex assembly [GO:0000244]"
P94459,CHOYP_SLIP_0475.1.1|m.57121,0,0,0,0,0,0,0,0,7.00E-24,Plipastatin synthase subunit D (EC 2.3.1.-) (Peptide synthase 4) [Includes: ATP-dependent proline adenylase (ProA 1) (Proline activase 1); ATP-dependent glutamine adenylase (GlnA) (Glutamine activase); ATP-dependent tyrosine adenylase 2 (TyrA 2) (Tyrosine activase 2)],ppsD pps4 BSU18310,3603,antibiotic biosynthetic process [GO:0017000],GO:0016740; GO:0017000; GO:0031177,,,,PF00501;PF13193;PF00668;PF00550;,phosphopantetheine binding [GO:0031177]; transferase activity [GO:0016740]; antibiotic biosynthetic process [GO:0017000]
Q6ZV89,CHOYP_SMP_105540.1.1|m.40275,0.5,0,0,0,0,0,0,0,1.00E-22,SH2 domain-containing protein 5,SH2D5,423,,GO:0014069; GO:0030054; GO:0045211,,,,,cell junction [GO:0030054]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]
Q66J74,CHOYP_TFP11.1.1|m.65838,0.5,0,0,0,0,0,0,0,0,Tuftelin-interacting protein 11 (Septin and tuftelin-interacting protein 1) (STIP-1),tfip11 stip,824,"mRNA processing [GO:0006397]; regulation of transcription, DNA-templated [GO:0006355]; RNA splicing [GO:0008380]",GO:0003677; GO:0005681; GO:0006355; GO:0006397; GO:0008380,,,,PF01585;PF07842;PF12457;,"spliceosomal complex [GO:0005681]; DNA binding [GO:0003677]; mRNA processing [GO:0006397]; regulation of transcription, DNA-templated [GO:0006355]; RNA splicing [GO:0008380]"
A4IGL7,CHOYP_UNC89.16.19|m.57422,0,0,0,0,0,0,0,0,0.000001,Peroxidasin (EC 1.11.1.7),pxdn pxn,1457,hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979],GO:0004601; GO:0005615; GO:0006979; GO:0020037; GO:0042744; GO:0046872,,,,PF03098;PF07679;PF13855;PF00093;,extracellular space [GO:0005615]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]; hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]
Q5ZLG9,CHOYP_WDR59.4.5|m.55404,0.5,0,0,0,0,0,0,0,0,WD repeat-containing protein 59,WDR59 RCJMB04_6d21,973,cellular response to amino acid starvation [GO:0034198]; positive regulation of TOR signaling [GO:0032008],GO:0032008; GO:0034198; GO:0061700,,,,PF00400;,GATOR2 complex [GO:0061700]; cellular response to amino acid starvation [GO:0034198]; positive regulation of TOR signaling [GO:0032008]
Q9H222,CHOYP_ABCG8.1.1|m.3707,0,0,0,0,0,0,0,0,1.00E-163,ATP-binding cassette sub-family G member 5 (Sterolin-1),ABCG5,651,cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; drug transmembrane transport [GO:0006855]; excretion [GO:0007588]; intestinal cholesterol absorption [GO:0030299]; negative regulation of intestinal cholesterol absorption [GO:0045796]; negative regulation of intestinal phytosterol absorption [GO:0010949]; response to ionizing radiation [GO:0010212]; response to nutrient [GO:0007584]; sterol transport [GO:0015918]; transmembrane transport [GO:0055085],GO:0005524; GO:0005886; GO:0006855; GO:0007584; GO:0007588; GO:0010212; GO:0010949; GO:0015918; GO:0016324; GO:0017127; GO:0030299; GO:0033344; GO:0042626; GO:0042632; GO:0043190; GO:0043235; GO:0045796; GO:0046982; GO:0055085,,,,PF01061;PF00005;,"apical plasma membrane [GO:0016324]; ATP-binding cassette (ABC) transporter complex [GO:0043190]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; ATPase activity, coupled to transmembrane movement of substances [GO:0042626]; cholesterol transporter activity [GO:0017127]; protein heterodimerization activity [GO:0046982]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; drug transmembrane transport [GO:0006855]; excretion [GO:0007588]; intestinal cholesterol absorption [GO:0030299]; negative regulation of intestinal cholesterol absorption [GO:0045796]; negative regulation of intestinal phytosterol absorption [GO:0010949]; response to ionizing radiation [GO:0010212]; response to nutrient [GO:0007584]; sterol transport [GO:0015918]; transmembrane transport [GO:0055085]"
Q96QF0,CHOYP_BRAFLDRAFT_199346.1.3|m.11369,0,0,0,0,0,0,0,0,3.00E-89,Rab-3A-interacting protein (Rab3A-interacting protein) (Rabin-3) (SSX2-interacting protein),RAB3IP RABIN8,476,ciliary basal body docking [GO:0097711]; cilium assembly [GO:0060271]; Golgi to plasma membrane transport [GO:0006893]; membrane organization [GO:0061024]; protein localization to organelle [GO:0033365]; protein targeting to membrane [GO:0006612],GO:0005634; GO:0005813; GO:0005829; GO:0005856; GO:0006612; GO:0006893; GO:0017112; GO:0030027; GO:0033365; GO:0036064; GO:0060271; GO:0061024; GO:0097711,,,,PF06428;,centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; Rab guanyl-nucleotide exchange factor activity [GO:0017112]; ciliary basal body docking [GO:0097711]; cilium assembly [GO:0060271]; Golgi to plasma membrane transport [GO:0006893]; membrane organization [GO:0061024]; protein localization to organelle [GO:0033365]; protein targeting to membrane [GO:0006612]
Q6DGP2,CHOYP_BRAFLDRAFT_238139.1.1|m.12224,0.5,0,0,0,0,0,0,0,1.00E-92,Pre-mRNA-splicing factor syf2,syf2 zgc:92835,238,mRNA processing [GO:0006397]; RNA splicing [GO:0008380],GO:0000974; GO:0006397; GO:0008380; GO:0071013; GO:0071014,,,,PF08231;,catalytic step 2 spliceosome [GO:0071013]; post-mRNA release spliceosomal complex [GO:0071014]; Prp19 complex [GO:0000974]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]
Q9JJH7,CHOYP_BRAFLDRAFT_70987.2.2|m.58284,1,0,0,0,0,0,0,0,1.00E-52,Transient receptor potential cation channel subfamily M member 5 (Long transient receptor potential channel 5) (LTrpC-5) (LTrpC5) (MLSN1- and TRP-related gene 1 protein),Trpm5 Ltrpc5 Mtr1,1158,ion transmembrane transport [GO:0034220]; sensory perception of taste [GO:0050909],GO:0005227; GO:0005244; GO:0005267; GO:0005272; GO:0005886; GO:0016021; GO:0030425; GO:0034220; GO:0043025; GO:0050909,,,,PF00520;,dendrite [GO:0030425]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; calcium activated cation channel activity [GO:0005227]; potassium channel activity [GO:0005267]; sodium channel activity [GO:0005272]; voltage-gated ion channel activity [GO:0005244]; ion transmembrane transport [GO:0034220]; sensory perception of taste [GO:0050909]
Q8EYT0,CHOYP_BRAFLDRAFT_84838.6.6|m.66693,0,0,0,0,0,0,0,0,3.00E-27,Macro domain-containing protein LA_4133,LA_4133,175,,,,,,PF01661;,
Q8IYE0,CHOYP_CCDC146.1.1|m.11347,1.5,0,0,0,0,0,0,0,0,Coiled-coil domain-containing protein 146,CCDC146 KIAA1505,955,,GO:0005814,,,,,centriole [GO:0005814]
P07207,CHOYP_DLL1.1.1|m.4589,0,0,0,0,0,0,0,0,6.00E-26,Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein],N CG3936,2703,"actin filament organization [GO:0007015]; anterior/posterior pattern specification [GO:0009952]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell adhesion [GO:0007155]; cell fate specification [GO:0001708]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compound eye cone cell fate commitment [GO:0042676]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal/ventral lineage restriction, imaginal disc [GO:0007451]; dorsal/ventral pattern formation, imaginal disc [GO:0007450]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; ectoderm development [GO:0007398]; embryonic crystal cell differentiation [GO:0035165]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; epithelium development [GO:0060429]; establishment of ommatidial planar polarity [GO:0042067]; eye-antennal disc development [GO:0035214]; female germ-line stem cell population maintenance [GO:0036099]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germarium-derived egg chamber formation [GO:0007293]; germarium-derived female germ-line cyst encapsulation [GO:0030708]; germ-line stem-cell niche homeostasis [GO:0060250]; germ-line stem cell population maintenance [GO:0030718]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; I-kappaB phosphorylation [GO:0007252]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; imaginal disc growth [GO:0007446]; imaginal disc pattern formation [GO:0007447]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland crystal cell differentiation [GO:0035170]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of follicular epithelium [GO:0016333]; motor neuron axon guidance [GO:0008045]; muscle cell fate determination [GO:0007521]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of fusion cell fate specification [GO:0035157]; negative regulation of gene expression [GO:0010629]; negative regulation of JNK cascade [GO:0046329]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; negative regulation of terminal cell fate specification, open tracheal system [GO:0035155]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; neuroblast fate determination [GO:0007400]; neurological system process [GO:0050877]; neuron development [GO:0048666]; Notch signaling pathway [GO:0007219]; oocyte anterior/posterior axis specification [GO:0007314]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; open tracheal system development [GO:0007424]; ovarian follicle cell development [GO:0030707]; ovarian follicle cell migration [GO:0007297]; ovarian follicle cell stalk formation [GO:0030713]; peripheral nervous system development [GO:0007422]; positive regulation of cell proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell fate commitment [GO:0007464]; R7 cell differentiation [GO:0045466]; R8 cell development [GO:0045463]; R8 cell differentiation [GO:0045465]; R8 cell fate commitment [GO:0007460]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of crystal cell differentiation [GO:0042689]; regulation of filopodium assembly [GO:0051489]; regulation of glucose metabolic process [GO:0010906]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neurogenesis [GO:0050767]; regulation of R8 cell spacing in compound eye [GO:0045468]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; skeletal muscle tissue development [GO:0007519]; stem cell differentiation [GO:0048863]; transcription, DNA-templated [GO:0006351]; ventral cord development [GO:0007419]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222]; wing disc proximal/distal pattern formation [GO:0007473]",GO:0000122; GO:0001708; GO:0001745; GO:0002213; GO:0003682; GO:0004872; GO:0004888; GO:0005509; GO:0005622; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005770; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0006351; GO:0007015; GO:0007155; GO:0007157; GO:0007219; GO:0007252; GO:0007293; GO:0007297; GO:0007298; GO:0007314; GO:0007346; GO:0007391; GO:0007398; GO:0007400; GO:0007403; GO:0007411; GO:0007419; GO:0007422; GO:0007423; GO:0007424; GO:0007440; GO:0007446; GO:0007447; GO:0007450; GO:0007451; GO:0007460; GO:0007464; GO:0007473; GO:0007474; GO:0007476; GO:0007478; GO:0007498; GO:0007519; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009952; GO:0009986; GO:0010001; GO:0010629; GO:0010906; GO:0016021; GO:0016330; GO:0016333; GO:0016348; GO:0022416; GO:0030139; GO:0030707; GO:0030708; GO:0030713; GO:0030718; GO:0030720; GO:0035003; GO:0035153; GO:0035155; GO:0035157; GO:0035162; GO:0035165; GO:0035167; GO:0035170; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042067; GO:0042676; GO:0042686; GO:0042688; GO:0042689; GO:0042691; GO:0043234; GO:0045316; GO:0045463; GO:0045465; GO:0045466; GO:0045468; GO:0045595; GO:0045747; GO:0045893; GO:0045944; GO:0046329; GO:0046331; GO:0046666; GO:0046667; GO:0046843; GO:0048052; GO:0048190; GO:0048477; GO:0048542; GO:0048666; GO:0048749; GO:0048803; GO:0048863; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060429; GO:0061331; GO:0061382; GO:1900087; GO:2000048,,,,PF12796;PF11936;PF00008;PF07645;PF12661;PF06816;PF07684;PF00066;,"adherens junction [GO:0005912]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; integral component of membrane [GO:0016021]; intracellular [GO:0005622]; late endosome [GO:0005770]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein complex [GO:0043234]; subapical complex [GO:0035003]; calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; receptor activity [GO:0004872]; transmembrane signaling receptor activity [GO:0004888]; actin filament organization [GO:0007015]; anterior/posterior pattern specification [GO:0009952]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell adhesion [GO:0007155]; cell fate specification [GO:0001708]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compound eye cone cell fate commitment [GO:0042676]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral lineage restriction, imaginal disc [GO:0007451]; dorsal/ventral pattern formation, imaginal disc [GO:0007450]; ectoderm development [GO:0007398]; embryonic crystal cell differentiation [GO:0035165]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; epithelium development [GO:0060429]; establishment of ommatidial planar polarity [GO:0042067]; eye-antennal disc development [GO:0035214]; female germ-line stem cell population maintenance [GO:0036099]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; germarium-derived female germ-line cyst encapsulation [GO:0030708]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; I-kappaB phosphorylation [GO:0007252]; imaginal disc growth [GO:0007446]; imaginal disc pattern formation [GO:0007447]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland crystal cell differentiation [GO:0035170]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of follicular epithelium [GO:0016333]; motor neuron axon guidance [GO:0008045]; muscle cell fate determination [GO:0007521]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of fusion cell fate specification [GO:0035157]; negative regulation of gene expression [GO:0010629]; negative regulation of JNK cascade [GO:0046329]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; negative regulation of terminal cell fate specification, open tracheal system [GO:0035155]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; neuroblast fate determination [GO:0007400]; neurological system process [GO:0050877]; neuron development [GO:0048666]; Notch signaling pathway [GO:0007219]; oocyte anterior/posterior axis specification [GO:0007314]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; open tracheal system development [GO:0007424]; ovarian follicle cell development [GO:0030707]; ovarian follicle cell migration [GO:0007297]; ovarian follicle cell stalk formation [GO:0030713]; peripheral nervous system development [GO:0007422]; positive regulation of cell proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell fate commitment [GO:0007464]; R7 cell differentiation [GO:0045466]; R8 cell development [GO:0045463]; R8 cell differentiation [GO:0045465]; R8 cell fate commitment [GO:0007460]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of crystal cell differentiation [GO:0042689]; regulation of filopodium assembly [GO:0051489]; regulation of glucose metabolic process [GO:0010906]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neurogenesis [GO:0050767]; regulation of R8 cell spacing in compound eye [GO:0045468]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; skeletal muscle tissue development [GO:0007519]; stem cell differentiation [GO:0048863]; transcription, DNA-templated [GO:0006351]; ventral cord development [GO:0007419]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222]; wing disc proximal/distal pattern formation [GO:0007473]"
Q8MRC9,CHOYP_DPSE_GA25136.1.1|m.66680,0.5,0,0,0,0,0,0,0,2.00E-35,Putative polypeptide N-acetylgalactosaminyltransferase 9 (pp-GaNTase 9) (EC 2.4.1.41) (Protein-UDP acetylgalactosaminyltransferase 9) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 9),pgant9 CG30463,650,multicellular organism reproduction [GO:0032504]; protein O-linked glycosylation [GO:0006493],GO:0000139; GO:0004653; GO:0005794; GO:0005829; GO:0006493; GO:0016021; GO:0030246; GO:0031985; GO:0032504; GO:0046872,PATHWAY: Protein modification; protein glycosylation.,,,PF00535;PF00652;,cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi cisterna [GO:0031985]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; multicellular organism reproduction [GO:0032504]; protein O-linked glycosylation [GO:0006493]
Q5XIS2,CHOYP_DSIM_GD25210.1.1|m.29275,0.5,0,0,0,0,0,0,0,4.00E-42,Ceramide-1-phosphate transfer protein (Glycolipid transfer protein domain-containing protein 1) (CPTP),Cptp Gltpd1,216,ceramide 1-phosphate transport [GO:1902389],GO:0005543; GO:0005548; GO:0005640; GO:0005794; GO:0005829; GO:0005886; GO:0010008; GO:0017089; GO:0051861; GO:1902387; GO:1902388; GO:1902389,,,,PF08718;,cytosol [GO:0005829]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; nuclear outer membrane [GO:0005640]; plasma membrane [GO:0005886]; ceramide 1-phosphate binding [GO:1902387]; ceramide 1-phosphate transporter activity [GO:1902388]; glycolipid binding [GO:0051861]; glycolipid transporter activity [GO:0017089]; phospholipid binding [GO:0005543]; phospholipid transporter activity [GO:0005548]; ceramide 1-phosphate transport [GO:1902389]
P86787,CHOYP_GIGA4.1.3|m.10521,0,0,0,0,0,0,0,0,7.00E-37,Gigasin-4 (Fragment),,58,,,,,,,
Q8N7X2,CHOYP_LOC100175702.1.1|m.56240,1.5,0,0,0,0,0,0,0,0.0000006,Protein STPG3 (Sperm-tail PG-rich repeat-containing protein 3),STPG3 C9orf173,389,,,,,,,
Q6P2C0,CHOYP_LOC100370122.2.2|m.59310,2.5,0,0,0,0,0,0,0,4.00E-68,WD repeat-containing protein 93,WDR93,686,electron transport chain [GO:0022900],GO:0016651; GO:0022900,,,,,"oxidoreductase activity, acting on NAD(P)H [GO:0016651]; electron transport chain [GO:0022900]"
Q14159,CHOYP_LOC100374845.1.1|m.49323,0.5,0,0,0,0,0,0,0,0.00000001,DNA repair-scaffolding protein (Scaffolding protein involved in DNA repair),SPIDR KIAA0146,915,cellular response to camptothecin [GO:0072757]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to hydroxyurea [GO:0072711]; cellular response to ionizing radiation [GO:0071479]; double-strand break repair via homologous recombination [GO:0000724]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of protein complex assembly [GO:0031334]; regulation of double-strand break repair via homologous recombination [GO:0010569]; regulation of establishment of protein localization to chromosome [GO:0070202],GO:0000228; GO:0000724; GO:0005654; GO:0006974; GO:0010569; GO:0031334; GO:0070202; GO:0071479; GO:0072711; GO:0072757; GO:2000781,,,,PF14950;PF14951;,nuclear chromosome [GO:0000228]; nucleoplasm [GO:0005654]; cellular response to camptothecin [GO:0072757]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to hydroxyurea [GO:0072711]; cellular response to ionizing radiation [GO:0071479]; double-strand break repair via homologous recombination [GO:0000724]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of protein complex assembly [GO:0031334]; regulation of double-strand break repair via homologous recombination [GO:0010569]; regulation of establishment of protein localization to chromosome [GO:0070202]
Q9DDT2,CHOYP_LOC101078145.1.1|m.54616,0,0,0,0,0,0,0,0,3.00E-13,Phosphoinositide 3-kinase adapter protein 1 (B-cell adapter for phosphoinositide 3-kinase) (B-cell phosphoinositide 3-kinase adapter protein 1),PIK3AP1 BCAP,800,cellular response to insulin stimulus [GO:0032869]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; regulation of inflammatory response [GO:0050727]; regulation of kinase activity [GO:0043549]; regulation of phosphorylation [GO:0042325]; toll-like receptor 2 signaling pathway [GO:0034134]; toll-like receptor 4 signaling pathway [GO:0034142]; toll-like receptor 7 signaling pathway [GO:0034154]; toll-like receptor 9 signaling pathway [GO:0034162]; TOR signaling [GO:0031929],GO:0005829; GO:0005886; GO:0014068; GO:0016020; GO:0031929; GO:0032869; GO:0034134; GO:0034142; GO:0034154; GO:0034162; GO:0036312; GO:0042325; GO:0043549; GO:0050727,,,,PF14545;,cytosol [GO:0005829]; membrane [GO:0016020]; plasma membrane [GO:0005886]; phosphatidylinositol 3-kinase regulatory subunit binding [GO:0036312]; cellular response to insulin stimulus [GO:0032869]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; regulation of inflammatory response [GO:0050727]; regulation of kinase activity [GO:0043549]; regulation of phosphorylation [GO:0042325]; toll-like receptor 2 signaling pathway [GO:0034134]; toll-like receptor 4 signaling pathway [GO:0034142]; toll-like receptor 7 signaling pathway [GO:0034154]; toll-like receptor 9 signaling pathway [GO:0034162]; TOR signaling [GO:0031929]
Q9JLC8,CHOYP_LOC558150.4.4|m.53050,1,0,0,0,0,0,0,0,0,Sacsin (DnaJ homolog subfamily C member 29) (DNAJC29),Sacs Kiaa0730,4582,,GO:0005737; GO:0050750,,,,PF05168;,cytoplasm [GO:0005737]; low-density lipoprotein particle receptor binding [GO:0050750]
Q9NX08,CHOYP_LOC584270.1.1|m.49225,0.5,0,0,0,0,0,0,0,2.00E-41,COMM domain-containing protein 8,COMMD8 MDS022,183,"regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]",GO:0005654; GO:0005829; GO:0006351; GO:0006355,,,,PF07258;,"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]"
Q3UFM5,CHOYP_LOC659901.1.1|m.348,0,0,0,0,0,0,0,0,8.00E-156,Nucleolar MIF4G domain-containing protein 1 (SGD1 homolog),Nom1 Gm1040,854,hair follicle maturation [GO:0048820]; neurogenesis [GO:0022008]; ribosomal small subunit biogenesis [GO:0042274],GO:0003723; GO:0005634; GO:0005730; GO:0022008; GO:0042274; GO:0048820,,,,PF02847;PF02854;,nucleolus [GO:0005730]; nucleus [GO:0005634]; RNA binding [GO:0003723]; hair follicle maturation [GO:0048820]; neurogenesis [GO:0022008]; ribosomal small subunit biogenesis [GO:0042274]
Q5UQX8,CHOYP_LOC753709.10.44|m.22246,0,0,0,0,0,0,0,0,2.00E-15,Putative ankyrin repeat protein R880,MIMI_R880,255,,,,,,PF12796;,
Q2KJC3,CHOYP_MPEG1.4.5|m.49975,0,0,0,0,0,0,0,0,6.00E-157,Macrophage-expressed gene 1 protein (Macrophage gene 1 protein) (Mpg-1),MPEG1,717,,GO:0016021,,,,PF01823;,integral component of membrane [GO:0016021]
Q49A92,CHOYP_NEMVEDRAFT_V1G215851.2.2|m.18129,0.5,0,0,0,0,0,0,0,5.00E-22,Uncharacterized protein C8orf34 (Protein VEST-1),C8orf34,452,,,,,,,
Q80YV2,CHOYP_NIPA.1.1|m.13987,0,0,0,0,0,0,0,0,3.00E-36,Nuclear-interacting partner of ALK (Nuclear-interacting partner of anaplastic lymphoma kinase) (mNIPA) (Zinc finger C3HC-type protein 1),Zc3hc1 Nipa,501,cell division [GO:0051301]; mitotic nuclear division [GO:0007067]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; protein ubiquitination [GO:0016567],GO:0005634; GO:0007067; GO:0008270; GO:0016567; GO:0019901; GO:0031965; GO:0051301; GO:2001240,PATHWAY: Protein modification; protein ubiquitination.,,,PF08600;PF07967;,nuclear membrane [GO:0031965]; nucleus [GO:0005634]; protein kinase binding [GO:0019901]; zinc ion binding [GO:0008270]; cell division [GO:0051301]; mitotic nuclear division [GO:0007067]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; protein ubiquitination [GO:0016567]
Q4V8V2,CHOYP_NUD17.1.1|m.13156,1.5,0,0,0,0,0,0,0,4.00E-67,Nucleoside diphosphate-linked moiety X motif 17 (Nudix motif 17) (EC 3.6.1.-),nudt17 zgc:114128,300,,GO:0016787; GO:0046872,,,cd04694;,PF00293;,hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]
Q5R995,CHOYP_PABP4.5.6|m.38922,0,0,0,0,0,0,0,0,0.000000001,CUGBP Elav-like family member 1 (CELF-1) (Bruno-like protein 2) (CUG triplet repeat RNA-binding protein 1) (CUG-BP1) (CUG-BP- and ETR-3-like factor 1) (RNA-binding protein BRUNOL-2),CELF1 CUGBP1,513,mRNA processing [GO:0006397]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380],GO:0000166; GO:0003723; GO:0005634; GO:0005737; GO:0006397; GO:0008380; GO:0043484,,,cd12631;cd12634;cd12638;,PF00076;,cytoplasm [GO:0005737]; nucleus [GO:0005634]; nucleotide binding [GO:0000166]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380]
Q46AN4,CHOYP_RS3A.10.15|m.40676,0,0,0,0,0,0,0,0,6.00E-21,30S ribosomal protein S3Ae (Ribosomal protein S1e),rps3ae Mbar_A2127,207,translation [GO:0006412],GO:0003735; GO:0005840; GO:0006412,,,,PF01015;,ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]
Q6PG29,CHOYP_SKAP2.1.1|m.63022,1,0,0,0,0,0,0,0,6.00E-47,Src kinase-associated phosphoprotein 2 (Src family-associated phosphoprotein 2),skap2 scap2 zgc:65975,341,B cell activation [GO:0042113]; immune response-activating signal transduction [GO:0002757],GO:0002757; GO:0005070; GO:0005737; GO:0005886; GO:0042113,,,,PF00169;PF00018;,cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; SH3/SH2 adaptor activity [GO:0005070]; B cell activation [GO:0042113]; immune response-activating signal transduction [GO:0002757]
Q9JHI9,CHOYP_SLC40A1.1.1|m.55100,0,0,0,0,0,0,0,0,2.00E-50,Solute carrier family 40 member 1 (Ferroportin-1) (Iron-regulated transporter 1) (Metal transporter protein 1) (MTP1),Slc40a1 Fpn1 Ireg1 Slc11a3 Slc39a1,570,cellular iron ion homeostasis [GO:0006879]; endothelium development [GO:0003158]; ferrous iron export [GO:1903988]; iron ion homeostasis [GO:0055072]; iron ion transmembrane transport [GO:0034755]; iron ion transport [GO:0006826]; lymphocyte homeostasis [GO:0002260]; multicellular organismal iron ion homeostasis [GO:0060586]; negative regulation of apoptotic process [GO:0043066]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of transcription from RNA polymerase II promoter in response to iron [GO:0034395]; spleen development [GO:0048536]; spleen trabecula formation [GO:0060345],GO:0002260; GO:0003158; GO:0004872; GO:0005381; GO:0005622; GO:0005654; GO:0005829; GO:0005886; GO:0006826; GO:0006879; GO:0008021; GO:0015093; GO:0016021; GO:0016323; GO:0017046; GO:0034395; GO:0034755; GO:0043066; GO:0045944; GO:0048536; GO:0055072; GO:0060345; GO:0060586; GO:0097689; GO:1903988,,,,PF06963;,basolateral plasma membrane [GO:0016323]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; intracellular [GO:0005622]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]; ferrous iron transmembrane transporter activity [GO:0015093]; iron channel activity [GO:0097689]; iron ion transmembrane transporter activity [GO:0005381]; peptide hormone binding [GO:0017046]; receptor activity [GO:0004872]; cellular iron ion homeostasis [GO:0006879]; endothelium development [GO:0003158]; ferrous iron export [GO:1903988]; iron ion homeostasis [GO:0055072]; iron ion transmembrane transport [GO:0034755]; iron ion transport [GO:0006826]; lymphocyte homeostasis [GO:0002260]; multicellular organismal iron ion homeostasis [GO:0060586]; negative regulation of apoptotic process [GO:0043066]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of transcription from RNA polymerase II promoter in response to iron [GO:0034395]; spleen development [GO:0048536]; spleen trabecula formation [GO:0060345]
P05156,CHOYP_SORL.1.3|m.4531,0,0,0,0,0,0,0,0,3.00E-10,Complement factor I (EC 3.4.21.45) (C3B/C4B inactivator) [Cleaved into: Complement factor I heavy chain; Complement factor I light chain],CFI IF,583,"complement activation, classical pathway [GO:0006958]; innate immune response [GO:0045087]; regulation of complement activation [GO:0030449]",GO:0004252; GO:0005044; GO:0005576; GO:0005615; GO:0006958; GO:0016020; GO:0030449; GO:0045087; GO:0046872; GO:0070062,,,cd00190;,PF00057;PF00530;PF00089;,"extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; metal ion binding [GO:0046872]; scavenger receptor activity [GO:0005044]; serine-type endopeptidase activity [GO:0004252]; complement activation, classical pathway [GO:0006958]; innate immune response [GO:0045087]; regulation of complement activation [GO:0030449]"
G5EFX6,CHOYP_TOLL-1.1.1|m.37581,0,0,0,0,0,0,0,0,5.00E-10,Slit homolog 1 protein (Slt-1),slt-1 F40E10.4,1410,dorsal/ventral axon guidance [GO:0033563]; negative regulation of axon extension involved in axon guidance [GO:0048843]; neuron migration [GO:0001764]; regulation of sensory neuron axon guidance [GO:1905489]; sensory neuron axon guidance [GO:0097374],GO:0001764; GO:0005102; GO:0005509; GO:0005576; GO:0033563; GO:0048843; GO:0097374; GO:1905489,,,,PF00008;PF12661;PF00054;PF13855;PF01462;,extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; receptor binding [GO:0005102]; dorsal/ventral axon guidance [GO:0033563]; negative regulation of axon extension involved in axon guidance [GO:0048843]; neuron migration [GO:0001764]; regulation of sensory neuron axon guidance [GO:1905489]; sensory neuron axon guidance [GO:0097374]
Q9JJH7,CHOYP_TRPM3.3.7|m.16169,0,0,0,0,0,0,0,0,6.00E-119,Transient receptor potential cation channel subfamily M member 5 (Long transient receptor potential channel 5) (LTrpC-5) (LTrpC5) (MLSN1- and TRP-related gene 1 protein),Trpm5 Ltrpc5 Mtr1,1158,ion transmembrane transport [GO:0034220]; sensory perception of taste [GO:0050909],GO:0005227; GO:0005244; GO:0005267; GO:0005272; GO:0005886; GO:0016021; GO:0030425; GO:0034220; GO:0043025; GO:0050909,,,,PF00520;,dendrite [GO:0030425]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; calcium activated cation channel activity [GO:0005227]; potassium channel activity [GO:0005267]; sodium channel activity [GO:0005272]; voltage-gated ion channel activity [GO:0005244]; ion transmembrane transport [GO:0034220]; sensory perception of taste [GO:0050909]
P10394,CHOYP_YG31B.1.3|m.6174,0.5,0,0,0,0,0,0,0,1.00E-93,Retrovirus-related Pol polyprotein from transposon 412 [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease],POL ORF3,1237,DNA integration [GO:0015074],GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0015074,,,cd06095;,PF00665;PF00077;PF00078;PF09337;,aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]
Q8R205,CHOYP_ZC3HA.1.1|m.27569,1,0,0,0,0,0,0,0,3.00E-76,Zinc finger CCCH domain-containing protein 10,Zc3h10,435,,GO:0003723; GO:0046872,,,,PF00642;,metal ion binding [GO:0046872]; RNA binding [GO:0003723]
P15153,CHOYP_AAEL_AAEL015271.1.1|m.56223,0.5,0,0,0,0,0,0,0,3.00E-102,Ras-related C3 botulinum toxin substrate 2 (GX) (Small G protein) (p21-Rac2),RAC2,192,actin filament organization [GO:0007015]; bone resorption [GO:0045453]; cell projection assembly [GO:0030031]; chemotaxis [GO:0006935]; G-protein coupled receptor signaling pathway [GO:0007186]; lymphocyte aggregation [GO:0071593]; platelet activation [GO:0030168]; positive regulation of cell proliferation [GO:0008284]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of protein targeting to mitochondrion [GO:1903955]; regulation of cell-substrate adhesion [GO:0010810]; regulation of hydrogen peroxide metabolic process [GO:0010310]; regulation of mast cell chemotaxis [GO:0060753]; regulation of mast cell degranulation [GO:0043304]; regulation of neutrophil migration [GO:1902622]; regulation of respiratory burst [GO:0060263]; regulation of small GTPase mediated signal transduction [GO:0051056]; regulation of T cell proliferation [GO:0042129]; signal transduction [GO:0007165]; small GTPase mediated signal transduction [GO:0007264],GO:0003924; GO:0005525; GO:0005635; GO:0005829; GO:0005886; GO:0005925; GO:0006935; GO:0007015; GO:0007165; GO:0007186; GO:0007264; GO:0008284; GO:0010310; GO:0010592; GO:0010810; GO:0019887; GO:0030027; GO:0030031; GO:0030168; GO:0030670; GO:0042129; GO:0043304; GO:0045453; GO:0051056; GO:0060263; GO:0060753; GO:0070062; GO:0071593; GO:0090023; GO:1902622; GO:1903955,,,,PF00071;,cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; nuclear envelope [GO:0005635]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein kinase regulator activity [GO:0019887]; actin filament organization [GO:0007015]; bone resorption [GO:0045453]; cell projection assembly [GO:0030031]; chemotaxis [GO:0006935]; G-protein coupled receptor signaling pathway [GO:0007186]; lymphocyte aggregation [GO:0071593]; platelet activation [GO:0030168]; positive regulation of cell proliferation [GO:0008284]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of protein targeting to mitochondrion [GO:1903955]; regulation of cell-substrate adhesion [GO:0010810]; regulation of hydrogen peroxide metabolic process [GO:0010310]; regulation of mast cell chemotaxis [GO:0060753]; regulation of mast cell degranulation [GO:0043304]; regulation of neutrophil migration [GO:1902622]; regulation of respiratory burst [GO:0060263]; regulation of small GTPase mediated signal transduction [GO:0051056]; regulation of T cell proliferation [GO:0042129]; signal transduction [GO:0007165]; small GTPase mediated signal transduction [GO:0007264]
P48445,CHOYP_BPL1.1.1|m.15002,0,0,0,0,0,0,0,0,1.00E-21,Biotin--protein ligase (EC 6.3.4.-) (Biotin apo-protein ligase) [Includes: Biotin--[methylmalonyl-CoA-carboxytransferase] ligase (EC 6.3.4.9); Biotin--[propionyl-CoA-carboxylase [ATP-hydrolyzing]] ligase (EC 6.3.4.10) (Holocarboxylase synthetase) (HCS); Biotin--[methylcrotonoyl-CoA-carboxylase] ligase (EC 6.3.4.11); Biotin--[acetyl-CoA-carboxylase] ligase (EC 6.3.4.15)],BPL1 ACC2 YDL141W D2140,690,protein biotinylation [GO:0009305],GO:0004077; GO:0004078; GO:0004079; GO:0004080; GO:0005524; GO:0005737; GO:0009305; GO:0071734,,,,PF02237;PF03099;PF09825;,cytoplasm [GO:0005737]; ATP binding [GO:0005524]; biotin-[acetyl-CoA-carboxylase] ligase activity [GO:0004077]; biotin-[methylcrotonoyl-CoA-carboxylase] ligase activity [GO:0004078]; biotin-[methylmalonyl-CoA-carboxytransferase] ligase activity [GO:0004079]; biotin-[propionyl-CoA-carboxylase (ATP-hydrolyzing)] ligase activity [GO:0004080]; biotin-[pyruvate-carboxylase] ligase activity [GO:0071734]; protein biotinylation [GO:0009305]
P53352,CHOYP_BRAFLDRAFT_117292.1.1|m.19637,0,0,0,0,0,0,0,0,2.00E-43,Inner centromere protein,INCENP,877,chromosome segregation [GO:0007059]; cytokinesis [GO:0000910]; mitotic nuclear division [GO:0007067],GO:0000775; GO:0000777; GO:0000910; GO:0005634; GO:0005721; GO:0005737; GO:0005819; GO:0005874; GO:0007059; GO:0007067; GO:0030496; GO:0043234,,,,PF03941;PF12178;,"chromosome, centromeric region [GO:0000775]; condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; midbody [GO:0030496]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; protein complex [GO:0043234]; spindle [GO:0005819]; chromosome segregation [GO:0007059]; cytokinesis [GO:0000910]; mitotic nuclear division [GO:0007067]"
O95295,CHOYP_BRAFLDRAFT_118250.1.1|m.11178,0.5,0,0,0,0,0,0,0,3.00E-33,SNARE-associated protein Snapin (Biogenesis of lysosome-related organelles complex 1 subunit 7) (BLOC-1 subunit 7) (Synaptosomal-associated protein 25-binding protein) (SNAP-associated protein),SNAPIN BLOC1S7 SNAP25BP SNAPAP,136,anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; autophagosome maturation [GO:0097352]; cellular protein complex localization [GO:0034629]; endosome to lysosome transport [GO:0008333]; intracellular protein transport [GO:0006886]; late endosome to lysosome transport [GO:1902774]; lysosomal lumen acidification [GO:0007042]; lysosome localization [GO:0032418]; melanosome organization [GO:0032438]; negative regulation of neuron projection development [GO:0010977]; neuron projection development [GO:0031175]; neurotransmitter secretion [GO:0007269]; positive regulation of late endosome to lysosome transport [GO:1902824]; protein maturation [GO:0051604]; regulation of protein binding [GO:0043393]; retrograde axonal transport [GO:0008090]; synaptic vesicle exocytosis [GO:0016079]; synaptic vesicle fusion to presynaptic active zone membrane [GO:0031629]; synaptic vesicle maturation [GO:0016188]; synaptic vesicle transport [GO:0048489]; terminal button organization [GO:0072553]; viral process [GO:0016032],GO:0000139; GO:0000149; GO:0005765; GO:0006886; GO:0007042; GO:0007269; GO:0008021; GO:0008089; GO:0008090; GO:0008333; GO:0010977; GO:0016032; GO:0016079; GO:0016188; GO:0030054; GO:0030141; GO:0030672; GO:0031083; GO:0031175; GO:0031629; GO:0032418; GO:0032438; GO:0034629; GO:0043393; GO:0045202; GO:0048471; GO:0048489; GO:0048490; GO:0051604; GO:0072553; GO:0097352; GO:0099078; GO:1902774; GO:1902824; GO:1904115,,,,PF14712;,axon cytoplasm [GO:1904115]; BLOC-1 complex [GO:0031083]; BORC complex [GO:0099078]; cell junction [GO:0030054]; Golgi membrane [GO:0000139]; lysosomal membrane [GO:0005765]; perinuclear region of cytoplasm [GO:0048471]; secretory granule [GO:0030141]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; SNARE binding [GO:0000149]; anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; autophagosome maturation [GO:0097352]; cellular protein complex localization [GO:0034629]; endosome to lysosome transport [GO:0008333]; intracellular protein transport [GO:0006886]; late endosome to lysosome transport [GO:1902774]; lysosomal lumen acidification [GO:0007042]; lysosome localization [GO:0032418]; melanosome organization [GO:0032438]; negative regulation of neuron projection development [GO:0010977]; neuron projection development [GO:0031175]; neurotransmitter secretion [GO:0007269]; positive regulation of late endosome to lysosome transport [GO:1902824]; protein maturation [GO:0051604]; regulation of protein binding [GO:0043393]; retrograde axonal transport [GO:0008090]; synaptic vesicle exocytosis [GO:0016079]; synaptic vesicle fusion to presynaptic active zone membrane [GO:0031629]; synaptic vesicle maturation [GO:0016188]; synaptic vesicle transport [GO:0048489]; terminal button organization [GO:0072553]; viral process [GO:0016032]
Q80ZA4,CHOYP_BRAFLDRAFT_118430.2.2|m.44188,0,0,0,0,0,0,0,0,0.00000003,Fibrocystin-L (Polycystic kidney and hepatic disease 1-like protein 1) (PKHD1-like protein 1) (Protein D86),Pkhd1l1,4249,,GO:0005929; GO:0016021,,,,PF10162;PF07691;PF01833;,cilium [GO:0005929]; integral component of membrane [GO:0016021]
A0JPH4,CHOYP_BRAFLDRAFT_118545.2.2|m.54585,0,0,0,0,0,0,0,0,0,Sterol regulatory element-binding protein cleavage-activating protein (SCAP) (SREBP cleavage-activating protein),scap,1311,cholesterol metabolic process [GO:0008203]; SREBP signaling pathway [GO:0032933],GO:0000139; GO:0005789; GO:0008203; GO:0012507; GO:0015485; GO:0016021; GO:0032933,,,,PF12349;PF00400;,endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; cholesterol binding [GO:0015485]; cholesterol metabolic process [GO:0008203]; SREBP signaling pathway [GO:0032933]
Q80ZA4,CHOYP_BRAFLDRAFT_119774.4.4|m.33349,0,0,0,0,0,0,0,0,0,Fibrocystin-L (Polycystic kidney and hepatic disease 1-like protein 1) (PKHD1-like protein 1) (Protein D86),Pkhd1l1,4249,,GO:0005929; GO:0016021,,,,PF10162;PF07691;PF01833;,cilium [GO:0005929]; integral component of membrane [GO:0016021]
Q8N6F8,CHOYP_BRAFLDRAFT_121459.1.1|m.21810,0,0,0,0,0,0,0,0,5.00E-27,Williams-Beuren syndrome chromosomal region 27 protein,WBSCR27,245,,,,,,,
P58340,CHOYP_BRAFLDRAFT_127486.1.1|m.57687,0.5,0,0,0,0,0,0,0,4.00E-39,Myeloid leukemia factor 1 (Myelodysplasia-myeloid leukemia factor 1),MLF1,268,"cell cycle arrest [GO:0007050]; myeloid progenitor cell differentiation [GO:0002318]; transcription, DNA-templated [GO:0006351]",GO:0002318; GO:0003677; GO:0005634; GO:0005737; GO:0006351; GO:0007050; GO:0019904,,,,PF10248;,"cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein domain specific binding [GO:0019904]; cell cycle arrest [GO:0007050]; myeloid progenitor cell differentiation [GO:0002318]; transcription, DNA-templated [GO:0006351]"
P35447,CHOYP_BRAFLDRAFT_236936.2.6|m.17168,0,0,0,0,0,0,0,0,4.00E-20,Spondin-1 (F-spondin),spon1,803,cell adhesion [GO:0007155],GO:0005578; GO:0007155; GO:0046872,,,cd08544;,PF02014;PF06468;PF00090;,proteinaceous extracellular matrix [GO:0005578]; metal ion binding [GO:0046872]; cell adhesion [GO:0007155]
Q46UT0,CHOYP_BRAFLDRAFT_244533.1.2|m.40480,0,0,0,0,0,0,0,0,4.00E-31,"Bifunctional ribose 1,5-bisphosphokinase-thymidine phosphorylase [Includes: Ribose 1,5-bisphosphate phosphokinase PhnN (EC 2.7.4.23) (Ribose 1,5-bisphosphokinase); Putative thymidine phosphorylase (EC 2.4.2.4) (TdRPase)]",phnN Reut_B3746,602,5-phosphoribose 1-diphosphate biosynthetic process [GO:0006015]; organic phosphonate transport [GO:0015716]; pyrimidine nucleobase metabolic process [GO:0006206]; pyrimidine nucleoside metabolic process [GO:0006213],GO:0004645; GO:0005524; GO:0006015; GO:0006206; GO:0006213; GO:0009032; GO:0015716; GO:0033863,PATHWAY: Metabolic intermediate biosynthesis; 5-phospho-alpha-D-ribose 1-diphosphate biosynthesis; 5-phospho-alpha-D-ribose 1-diphosphate from D-ribose 5-phosphate (route II): step 3/3.,,,PF00591;PF07831;,"ATP binding [GO:0005524]; phosphorylase activity [GO:0004645]; ribose 1,5-bisphosphate phosphokinase activity [GO:0033863]; thymidine phosphorylase activity [GO:0009032]; 5-phosphoribose 1-diphosphate biosynthetic process [GO:0006015]; organic phosphonate transport [GO:0015716]; pyrimidine nucleobase metabolic process [GO:0006206]; pyrimidine nucleoside metabolic process [GO:0006213]"
Q91WV0,CHOYP_BRAFLDRAFT_68934.1.2|m.57609,0.5,0,0,0,0,0,0,0,2.00E-66,Protein Dr1 (Down-regulator of transcription 1) (Negative cofactor 2-beta) (NC2-beta) (TATA-binding protein-associated phosphoprotein),Dr1,176,"histone H3 acetylation [GO:0043966]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]",GO:0003677; GO:0005634; GO:0005671; GO:0006351; GO:0006355; GO:0017025; GO:0043966,,,,PF00808;,"Ada2/Gcn5/Ada3 transcription activator complex [GO:0005671]; nucleus [GO:0005634]; DNA binding [GO:0003677]; TBP-class protein binding [GO:0017025]; histone H3 acetylation [GO:0043966]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]"
Q8AY75,CHOYP_CALM.37.50|m.52385,0,0,0,0,0,0,0,0,1.00E-37,Calglandulin,,156,,GO:0005509; GO:0005737,,,cd00051;,PF13499;PF13833;,cytoplasm [GO:0005737]; calcium ion binding [GO:0005509]
P49366,CHOYP_DHPS.1.1|m.55870,0,0,0,0,0,0,0,0,0,Deoxyhypusine synthase (DHS) (EC 2.5.1.46),DHPS DS,369,glucose homeostasis [GO:0042593]; peptidyl-lysine modification to peptidyl-hypusine [GO:0008612]; positive regulation of cell proliferation [GO:0008284]; positive regulation of T cell proliferation [GO:0042102]; protein homotetramerization [GO:0051289]; spermidine catabolic process [GO:0046203]; spermidine metabolic process [GO:0008216]; translation [GO:0006412],GO:0005737; GO:0005829; GO:0006412; GO:0008216; GO:0008284; GO:0008612; GO:0034038; GO:0042102; GO:0042593; GO:0042802; GO:0046203; GO:0051289,PATHWAY: Protein modification; eIF5A hypusination.,,,PF01916;,cytoplasm [GO:0005737]; cytosol [GO:0005829]; deoxyhypusine synthase activity [GO:0034038]; identical protein binding [GO:0042802]; glucose homeostasis [GO:0042593]; peptidyl-lysine modification to peptidyl-hypusine [GO:0008612]; positive regulation of cell proliferation [GO:0008284]; positive regulation of T cell proliferation [GO:0042102]; protein homotetramerization [GO:0051289]; spermidine catabolic process [GO:0046203]; spermidine metabolic process [GO:0008216]; translation [GO:0006412]
Q0IIF6,CHOYP_FAIM1.1.1|m.36651,0.5,0,0,0,0,0,0,0,3.00E-79,Fas apoptotic inhibitory molecule 1,FAIM,201,apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066],GO:0005737; GO:0006915; GO:0043066,,,,PF06905;,cytoplasm [GO:0005737]; apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]
P57102,CHOYP_HAND1.1.1|m.10874,0,0,0,0,0,0,0,0,6.00E-53,"Heart- and neural crest derivatives-expressed protein 2 (Deciduum, heart, autonomic nervous system and neural crest derivatives-expressed protein 2) (dHAND)",hand2 dhand,208,"cardiac muscle cell differentiation [GO:0055007]; cardioblast differentiation [GO:0010002]; cardiocyte differentiation [GO:0035051]; cardiogenic plate morphogenesis [GO:0003142]; determination of intestine left/right asymmetry [GO:0071908]; embryonic heart tube formation [GO:0003144]; embryonic pectoral fin morphogenesis [GO:0035118]; embryonic viscerocranium morphogenesis [GO:0048703]; heart contraction [GO:0060047]; heart looping [GO:0001947]; heart morphogenesis [GO:0003007]; noradrenergic neuron differentiation [GO:0003357]; polarized epithelial cell differentiation [GO:0030859]; proepicardium development [GO:0003342]; regulation of transcription, DNA-templated [GO:0006355]; sympathetic nervous system development [GO:0048485]; thyroid gland development [GO:0030878]; transcription, DNA-templated [GO:0006351]",GO:0001947; GO:0003007; GO:0003142; GO:0003144; GO:0003342; GO:0003357; GO:0003677; GO:0005634; GO:0006351; GO:0006355; GO:0010002; GO:0030859; GO:0030878; GO:0035051; GO:0035118; GO:0048485; GO:0048703; GO:0055007; GO:0060047; GO:0071908,,,,PF00010;,"nucleus [GO:0005634]; DNA binding [GO:0003677]; cardiac muscle cell differentiation [GO:0055007]; cardioblast differentiation [GO:0010002]; cardiocyte differentiation [GO:0035051]; cardiogenic plate morphogenesis [GO:0003142]; determination of intestine left/right asymmetry [GO:0071908]; embryonic heart tube formation [GO:0003144]; embryonic pectoral fin morphogenesis [GO:0035118]; embryonic viscerocranium morphogenesis [GO:0048703]; heart contraction [GO:0060047]; heart looping [GO:0001947]; heart morphogenesis [GO:0003007]; noradrenergic neuron differentiation [GO:0003357]; polarized epithelial cell differentiation [GO:0030859]; proepicardium development [GO:0003342]; regulation of transcription, DNA-templated [GO:0006355]; sympathetic nervous system development [GO:0048485]; thyroid gland development [GO:0030878]; transcription, DNA-templated [GO:0006351]"
P16591,CHOYP_LOC100119086.1.1|m.55425,1,0,0,0,0,0,0,0,0,Tyrosine-protein kinase Fer (EC 2.7.10.2) (Feline encephalitis virus-related kinase FER) (Fujinami poultry sarcoma/Feline sarcoma-related protein Fer) (Proto-oncogene c-Fer) (Tyrosine kinase 3) (p94-Fer),FER TYK3,822,actin cytoskeleton reorganization [GO:0031532]; cell adhesion [GO:0007155]; cell-cell adhesion mediated by cadherin [GO:0044331]; cell differentiation [GO:0030154]; cell proliferation [GO:0008283]; cellular response to insulin stimulus [GO:0032869]; cellular response to macrophage colony-stimulating factor stimulus [GO:0036006]; cellular response to reactive oxygen species [GO:0034614]; chemotaxis [GO:0006935]; cytokine-mediated signaling pathway [GO:0019221]; diapedesis [GO:0050904]; extracellular matrix-cell signaling [GO:0035426]; Fc-epsilon receptor signaling pathway [GO:0038095]; innate immune response [GO:0045087]; insulin receptor signaling pathway via phosphatidylinositol 3-kinase [GO:0038028]; interleukin-6-mediated signaling pathway [GO:0070102]; intracellular signal transduction [GO:0035556]; Kit signaling pathway [GO:0038109]; microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278]; negative regulation of mast cell activation involved in immune response [GO:0033007]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of cell proliferation [GO:0008284]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of epidermal growth factor receptor signaling pathway [GO:0042058]; regulation of fibroblast migration [GO:0010762]; regulation of lamellipodium assembly [GO:0010591]; regulation of mast cell degranulation [GO:0043304]; regulation of protein phosphorylation [GO:0001932]; response to lipopolysaccharide [GO:0032496]; response to platelet-derived growth factor [GO:0036119]; substrate adhesion-dependent cell spreading [GO:0034446]; tyrosine phosphorylation of Stat3 protein [GO:0042503],GO:0000226; GO:0000278; GO:0001932; GO:0004713; GO:0004715; GO:0005154; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005856; GO:0005938; GO:0006468; GO:0006935; GO:0007155; GO:0008283; GO:0008284; GO:0008289; GO:0010591; GO:0010762; GO:0018108; GO:0019221; GO:0030054; GO:0030154; GO:0030335; GO:0030838; GO:0031234; GO:0031532; GO:0032496; GO:0032869; GO:0033007; GO:0034446; GO:0034614; GO:0035426; GO:0035556; GO:0036006; GO:0036119; GO:0038028; GO:0038083; GO:0038095; GO:0038109; GO:0042058; GO:0042503; GO:0042995; GO:0043304; GO:0044331; GO:0045087; GO:0046777; GO:0048008; GO:0050904; GO:0051092; GO:0070102,,,,PF00611;PF07714;PF00017;,cell cortex [GO:0005938]; cell junction [GO:0030054]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; nucleus [GO:0005634]; ATP binding [GO:0005524]; epidermal growth factor receptor binding [GO:0005154]; lipid binding [GO:0008289]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein tyrosine kinase activity [GO:0004713]; actin cytoskeleton reorganization [GO:0031532]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; cell proliferation [GO:0008283]; cell-cell adhesion mediated by cadherin [GO:0044331]; cellular response to insulin stimulus [GO:0032869]; cellular response to macrophage colony-stimulating factor stimulus [GO:0036006]; cellular response to reactive oxygen species [GO:0034614]; chemotaxis [GO:0006935]; cytokine-mediated signaling pathway [GO:0019221]; diapedesis [GO:0050904]; extracellular matrix-cell signaling [GO:0035426]; Fc-epsilon receptor signaling pathway [GO:0038095]; innate immune response [GO:0045087]; insulin receptor signaling pathway via phosphatidylinositol 3-kinase [GO:0038028]; interleukin-6-mediated signaling pathway [GO:0070102]; intracellular signal transduction [GO:0035556]; Kit signaling pathway [GO:0038109]; microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278]; negative regulation of mast cell activation involved in immune response [GO:0033007]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of cell proliferation [GO:0008284]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of epidermal growth factor receptor signaling pathway [GO:0042058]; regulation of fibroblast migration [GO:0010762]; regulation of lamellipodium assembly [GO:0010591]; regulation of mast cell degranulation [GO:0043304]; regulation of protein phosphorylation [GO:0001932]; response to lipopolysaccharide [GO:0032496]; response to platelet-derived growth factor [GO:0036119]; substrate adhesion-dependent cell spreading [GO:0034446]; tyrosine phosphorylation of Stat3 protein [GO:0042503]
Q9TUP7,CHOYP_LOC100120994.1.1|m.54109,0,0,0,0,0,0,0,0,4.00E-91,Orexin receptor type 2 (Ox-2-R) (Ox2-R) (Ox2R) (Hypocretin receptor type 2),HCRTR2,444,"cellular response to hormone stimulus [GO:0032870]; circadian sleep/wake cycle process [GO:0022410]; feeding behavior [GO:0007631]; neuropeptide signaling pathway [GO:0007218]; phospholipase C-activating G-protein coupled receptor signaling pathway [GO:0007200]; regulation of circadian sleep/wake cycle, sleep [GO:0045187]; regulation of circadian sleep/wake cycle, wakefulness [GO:0010840]; regulation of cytosolic calcium ion concentration [GO:0051480]; response to peptide [GO:1901652]",GO:0005887; GO:0007200; GO:0007218; GO:0007631; GO:0010840; GO:0016499; GO:0022410; GO:0032870; GO:0042277; GO:0045187; GO:0051480; GO:1901652,,,,PF00001;PF03827;,"integral component of plasma membrane [GO:0005887]; orexin receptor activity [GO:0016499]; peptide binding [GO:0042277]; cellular response to hormone stimulus [GO:0032870]; circadian sleep/wake cycle process [GO:0022410]; feeding behavior [GO:0007631]; neuropeptide signaling pathway [GO:0007218]; phospholipase C-activating G-protein coupled receptor signaling pathway [GO:0007200]; regulation of circadian sleep/wake cycle, sleep [GO:0045187]; regulation of circadian sleep/wake cycle, wakefulness [GO:0010840]; regulation of cytosolic calcium ion concentration [GO:0051480]; response to peptide [GO:1901652]"
P19208,CHOYP_LOC100200137.1.1|m.23041,0,0,0,0,0,0,0,0,0,Heat shock 70 kDa protein C,hsp-3 CBG14829,661,endoplasmic reticulum unfolded protein response [GO:0030968],GO:0005524; GO:0005788; GO:0030968,,,,PF00012;,endoplasmic reticulum lumen [GO:0005788]; ATP binding [GO:0005524]; endoplasmic reticulum unfolded protein response [GO:0030968]
Q5EB30,CHOYP_LOC100207216.2.2|m.28185,2,0,0,0,0,0,0,0,6.00E-45,Outer dense fiber protein 3 (Outer dense fiber of sperm tails protein 3),odf3 TTpA001k06.1,256,,GO:0005737,,,,PF07004;,cytoplasm [GO:0005737]
Q5R7X9,CHOYP_LOC100370910.1.1|m.13897,0,0,0,0,0,0,0,0,1.00E-145,Cell cycle checkpoint protein RAD1 (EC 3.1.11.2) (DNA repair exonuclease rad1 homolog),RAD1,282,cellular response to ionizing radiation [GO:0071479]; DNA damage checkpoint [GO:0000077]; DNA repair [GO:0006281]; meiotic recombination checkpoint [GO:0051598]; substantia nigra development [GO:0021762],GO:0000077; GO:0005654; GO:0005694; GO:0006281; GO:0008408; GO:0008853; GO:0021762; GO:0051598; GO:0071479,,,,PF02144;,chromosome [GO:0005694]; nucleoplasm [GO:0005654]; 3'-5' exonuclease activity [GO:0008408]; exodeoxyribonuclease III activity [GO:0008853]; cellular response to ionizing radiation [GO:0071479]; DNA damage checkpoint [GO:0000077]; DNA repair [GO:0006281]; meiotic recombination checkpoint [GO:0051598]; substantia nigra development [GO:0021762]
Q66IC8,CHOYP_LOC100371143.1.1|m.27046,1.5,0,0,0,0,0,0,0,2.00E-26,Tctex1 domain-containing protein 1,tctex1d1 zgc:101774,173,,,,,,PF03645;,
P38942,CHOYP_LOC100372560.1.1|m.25500,0,0,0,0,0,0,0,0,2.00E-25,4-hydroxybutyrate coenzyme A transferase (EC 2.8.3.-),cat2 CKL_3018,429,acetyl-CoA metabolic process [GO:0006084],GO:0006084; GO:0016740,,,,PF13336;PF02550;,transferase activity [GO:0016740]; acetyl-CoA metabolic process [GO:0006084]
Q62158,CHOYP_LOC100373444.8.79|m.3255,0,0,0,0,0,0,0,0,0.000009,Zinc finger protein RFP (EC 2.3.2.27) (RING-type E3 ubiquitin transferase TRIM27) (Ret finger protein) (Tripartite motif-containing protein 27),Trim27 Rfp,513,"Arp2/3 complex-mediated actin nucleation [GO:0034314]; innate immune response [GO:0045087]; interferon-gamma secretion [GO:0072643]; negative regulation of adaptive immune response [GO:0002820]; negative regulation of calcium ion import [GO:0090281]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of interleukin-2 secretion [GO:1900041]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; negative regulation of tumor necrosis factor production [GO:0032720]; negative regulation of viral release from host cell [GO:1902187]; negative regulation of viral transcription [GO:0032897]; positive regulation of actin nucleation [GO:0051127]; positive regulation of sequence-specific DNA binding transcription factor activity [GO:0051091]; protein K63-linked ubiquitination [GO:0070534]; protein trimerization [GO:0070206]; retrograde transport, endosome to Golgi [GO:0042147]; transcription, DNA-templated [GO:0006351]",GO:0000122; GO:0001650; GO:0002820; GO:0003677; GO:0004842; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005768; GO:0005829; GO:0006351; GO:0006469; GO:0008270; GO:0016605; GO:0030904; GO:0031965; GO:0032720; GO:0032897; GO:0034314; GO:0042147; GO:0042802; GO:0045087; GO:0045814; GO:0051091; GO:0051127; GO:0070206; GO:0070534; GO:0072643; GO:0090281; GO:1900041; GO:1902187,,,,PF13765;PF00622;PF00643;,"cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; fibrillar center [GO:0001650]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; retromer complex [GO:0030904]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; Arp2/3 complex-mediated actin nucleation [GO:0034314]; innate immune response [GO:0045087]; interferon-gamma secretion [GO:0072643]; negative regulation of adaptive immune response [GO:0002820]; negative regulation of calcium ion import [GO:0090281]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of interleukin-2 secretion [GO:1900041]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; negative regulation of tumor necrosis factor production [GO:0032720]; negative regulation of viral release from host cell [GO:1902187]; negative regulation of viral transcription [GO:0032897]; positive regulation of actin nucleation [GO:0051127]; positive regulation of sequence-specific DNA binding transcription factor activity [GO:0051091]; protein K63-linked ubiquitination [GO:0070534]; protein trimerization [GO:0070206]; retrograde transport, endosome to Golgi [GO:0042147]; transcription, DNA-templated [GO:0006351]"
P21369,CHOYP_LOC100374320.1.1|m.54274,1.5,0,0,0,0,0,0,0,1.00E-33,Nicotinamidase (EC 3.5.1.19) (Nicotinamide deamidase) (NAMase) (Pyrazinamidase) (PZAase) (EC 3.5.1.-),pncA nam ydjB b1768 JW1757,213,pyridine nucleotide biosynthetic process [GO:0019363],GO:0008936; GO:0019363; GO:0046872,PATHWAY: Cofactor biosynthesis; nicotinate biosynthesis; nicotinate from nicotinamide: step 1/1. {ECO:0000305|PubMed:4399474}.,,,PF00857;,metal ion binding [GO:0046872]; nicotinamidase activity [GO:0008936]; pyridine nucleotide biosynthetic process [GO:0019363]
P39429,CHOYP_LOC100697308.1.1|m.5118,0,0,0,0,0,0,0,0,3.00E-120,TNF receptor-associated factor 2 (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRAF2) (RING-type E3 ubiquitin transferase TRAF2),Traf2,501,activation of NF-kappaB-inducing kinase activity [GO:0007250]; apoptotic process [GO:0006915]; cellular protein complex assembly [GO:0043623]; cellular response to nitric oxide [GO:0071732]; negative regulation of apoptotic process [GO:0043066]; negative regulation of glial cell apoptotic process [GO:0034351]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of I-kappaB phosphorylation [GO:1903721]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein homodimerization activity [GO:0090073]; positive regulation of sequence-specific DNA binding transcription factor activity [GO:0051091]; positive regulation of T cell cytokine production [GO:0002726]; positive regulation of tumor necrosis factor-mediated signaling pathway [GO:1903265]; programmed necrotic cell death [GO:0097300]; protein autoubiquitination [GO:0051865]; protein catabolic process [GO:0030163]; protein heterooligomerization [GO:0051291]; protein homotrimerization [GO:0070207]; protein K63-linked ubiquitination [GO:0070534]; regulation of apoptotic process [GO:0042981]; regulation of immunoglobulin secretion [GO:0051023]; regulation of JNK cascade [GO:0046328]; signal transduction [GO:0007165]; tumor necrosis factor-mediated signaling pathway [GO:0033209],GO:0000151; GO:0002726; GO:0004842; GO:0005164; GO:0005174; GO:0005737; GO:0005829; GO:0005938; GO:0006915; GO:0007165; GO:0007250; GO:0008270; GO:0009898; GO:0012506; GO:0019899; GO:0019901; GO:0019903; GO:0030163; GO:0031625; GO:0031996; GO:0032743; GO:0033209; GO:0034351; GO:0035631; GO:0042802; GO:0042981; GO:0043066; GO:0043123; GO:0043507; GO:0043623; GO:0045121; GO:0046328; GO:0046625; GO:0051023; GO:0051091; GO:0051092; GO:0051291; GO:0051865; GO:0070207; GO:0070534; GO:0071732; GO:0090073; GO:0097057; GO:0097300; GO:1903265; GO:1903721; GO:1990604; GO:2001238,PATHWAY: Protein modification; protein ubiquitination.,,,PF16673;PF00097;PF02176;,CD40 receptor complex [GO:0035631]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; IRE1-TRAF2-ASK1 complex [GO:1990604]; membrane raft [GO:0045121]; TRAF2-GSTP1 complex [GO:0097057]; ubiquitin ligase complex [GO:0000151]; vesicle membrane [GO:0012506]; CD40 receptor binding [GO:0005174]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; sphingolipid binding [GO:0046625]; thioesterase binding [GO:0031996]; tumor necrosis factor receptor binding [GO:0005164]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; activation of NF-kappaB-inducing kinase activity [GO:0007250]; apoptotic process [GO:0006915]; cellular protein complex assembly [GO:0043623]; cellular response to nitric oxide [GO:0071732]; negative regulation of apoptotic process [GO:0043066]; negative regulation of glial cell apoptotic process [GO:0034351]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of I-kappaB phosphorylation [GO:1903721]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein homodimerization activity [GO:0090073]; positive regulation of sequence-specific DNA binding transcription factor activity [GO:0051091]; positive regulation of T cell cytokine production [GO:0002726]; positive regulation of tumor necrosis factor-mediated signaling pathway [GO:1903265]; programmed necrotic cell death [GO:0097300]; protein autoubiquitination [GO:0051865]; protein catabolic process [GO:0030163]; protein heterooligomerization [GO:0051291]; protein homotrimerization [GO:0070207]; protein K63-linked ubiquitination [GO:0070534]; regulation of apoptotic process [GO:0042981]; regulation of immunoglobulin secretion [GO:0051023]; regulation of JNK cascade [GO:0046328]; signal transduction [GO:0007165]; tumor necrosis factor-mediated signaling pathway [GO:0033209]
Q5ZJL9,CHOYP_LOC101162528.1.1|m.17841,0,0,0,0,0,0,0,0,2.00E-101,Deoxynucleoside triphosphate triphosphohydrolase SAMHD1 (dNTPase) (EC 3.1.5.-),SAMHD1 RCJMB04_17d8,614,dATP catabolic process [GO:0046061]; defense response to virus [GO:0051607]; dGTP catabolic process [GO:0006203]; innate immune response [GO:0045087]; regulation of innate immune response [GO:0045088],GO:0003676; GO:0003723; GO:0005634; GO:0006203; GO:0008270; GO:0008832; GO:0032567; GO:0045087; GO:0045088; GO:0046061; GO:0051607,,,,PF01966;,nucleus [GO:0005634]; dGTP binding [GO:0032567]; dGTPase activity [GO:0008832]; nucleic acid binding [GO:0003676]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; dATP catabolic process [GO:0046061]; defense response to virus [GO:0051607]; dGTP catabolic process [GO:0006203]; innate immune response [GO:0045087]; regulation of innate immune response [GO:0045088]
Q8BZ25,CHOYP_LOC590657.1.1|m.633,0,0,0,0,0,0,0,0,8.00E-34,Ankyrin repeat and protein kinase domain-containing protein 1 (EC 2.7.11.1),Ankk1,745,,GO:0004674; GO:0005524,,,,PF00023;PF12796;PF07714;,ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]
Q9Y2H2,CHOYP_LOC663138.1.1|m.7661,0,0,0,0,0,0,0,0,1.00E-109,Phosphatidylinositide phosphatase SAC2 (EC 3.1.3.25) (Inositol polyphosphate 5-phosphatase F) (Sac domain-containing inositol phosphatase 2) (Sac domain-containing phosphoinositide 4-phosphatase 2) (hSAC2),INPP5F KIAA0966 SAC2 MSTP007 MSTP047,1132,adult locomotory behavior [GO:0008344]; cardiac muscle hypertrophy in response to stress [GO:0014898]; clathrin-dependent endocytosis [GO:0072583]; negative regulation of axon regeneration [GO:0048681]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of tyrosine phosphorylation of Stat3 protein [GO:0042518]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol catabolic process [GO:0031161]; phosphatidylinositol dephosphorylation [GO:0046856]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of receptor recycling [GO:0001921]; regulation of cell motility [GO:2000145]; regulation of endocytic recycling [GO:2001135]; regulation of protein kinase B signaling [GO:0051896],GO:0001921; GO:0005769; GO:0005905; GO:0006661; GO:0008344; GO:0008934; GO:0014898; GO:0030424; GO:0030425; GO:0031161; GO:0031901; GO:0033137; GO:0034595; GO:0034596; GO:0042518; GO:0042803; GO:0043025; GO:0045334; GO:0046856; GO:0048015; GO:0048681; GO:0051896; GO:0052832; GO:0052833; GO:0055037; GO:0072583; GO:2000145; GO:2001135,,,,PF12456;PF02383;,axon [GO:0030424]; clathrin-coated endocytic vesicle [GO:0045334]; clathrin-coated pit [GO:0005905]; dendrite [GO:0030425]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; neuronal cell body [GO:0043025]; recycling endosome [GO:0055037]; inositol monophosphate 1-phosphatase activity [GO:0008934]; inositol monophosphate 3-phosphatase activity [GO:0052832]; inositol monophosphate 4-phosphatase activity [GO:0052833]; phosphatidylinositol phosphate 4-phosphatase activity [GO:0034596]; phosphatidylinositol phosphate 5-phosphatase activity [GO:0034595]; protein homodimerization activity [GO:0042803]; adult locomotory behavior [GO:0008344]; cardiac muscle hypertrophy in response to stress [GO:0014898]; clathrin-dependent endocytosis [GO:0072583]; negative regulation of axon regeneration [GO:0048681]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of tyrosine phosphorylation of Stat3 protein [GO:0042518]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol catabolic process [GO:0031161]; phosphatidylinositol dephosphorylation [GO:0046856]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of receptor recycling [GO:0001921]; regulation of cell motility [GO:2000145]; regulation of endocytic recycling [GO:2001135]; regulation of protein kinase B signaling [GO:0051896]
Q9D9R9,CHOYP_NEMVEDRAFT_V1G214844.22.34|m.54623,1.5,0,0,0,0,0,0,0,3.00E-25,Protein FAM186A,FAM186A Gm920,1790,,,,,,,
P23665,CHOYP_NEMVEDRAFT_V1G83869.3.3|m.30283,2,0,0,0,0,0,0,0,1.00E-11,"Endoglucanase A (EC 3.2.1.4) (Cellulase) (Endo-1,4-beta-glucanase)",endA,453,cellulose catabolic process [GO:0030245],GO:0008810; GO:0030245; GO:0042597,,,,PF00759;,periplasmic space [GO:0042597]; cellulase activity [GO:0008810]; cellulose catabolic process [GO:0030245]
Q9Y2C9,CHOYP_TLR1.1.3|m.1564,0,0,0,0,0,0,0,0,4.00E-28,Toll-like receptor 6 (CD antigen CD286),TLR6,796,activation of NF-kappaB-inducing kinase activity [GO:0007250]; cellular response to diacyl bacterial lipopeptide [GO:0071726]; defense response to bacterium [GO:0042742]; detection of diacyl bacterial lipopeptide [GO:0042496]; immune response [GO:0006955]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; interleukin-1 beta secretion [GO:0050702]; microglial cell activation [GO:0001774]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; nitric oxide metabolic process [GO:0046209]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interleukin-6 biosynthetic process [GO:0045410]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; regulation of cytokine secretion [GO:0050707]; signal transduction [GO:0007165]; T-helper 1 type immune response [GO:0042088]; toll-like receptor 6 signaling pathway [GO:0034150]; toll-like receptor signaling pathway [GO:0002224]; toll-like receptor TLR6:TLR2 signaling pathway [GO:0038124],GO:0001774; GO:0002224; GO:0002755; GO:0004872; GO:0004888; GO:0005794; GO:0005886; GO:0005887; GO:0006954; GO:0006955; GO:0007165; GO:0007250; GO:0030670; GO:0034150; GO:0035355; GO:0035663; GO:0038124; GO:0042088; GO:0042496; GO:0042742; GO:0043123; GO:0043507; GO:0045087; GO:0045121; GO:0045410; GO:0046209; GO:0050702; GO:0050707; GO:0071723; GO:0071726; GO:1900227,,,,PF13855;PF01463;PF01582;,Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; Toll-like receptor 2-Toll-like receptor 6 protein complex [GO:0035355]; lipopeptide binding [GO:0071723]; receptor activity [GO:0004872]; Toll-like receptor 2 binding [GO:0035663]; transmembrane signaling receptor activity [GO:0004888]; activation of NF-kappaB-inducing kinase activity [GO:0007250]; cellular response to diacyl bacterial lipopeptide [GO:0071726]; defense response to bacterium [GO:0042742]; detection of diacyl bacterial lipopeptide [GO:0042496]; immune response [GO:0006955]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; interleukin-1 beta secretion [GO:0050702]; microglial cell activation [GO:0001774]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; nitric oxide metabolic process [GO:0046209]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interleukin-6 biosynthetic process [GO:0045410]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; regulation of cytokine secretion [GO:0050707]; signal transduction [GO:0007165]; T-helper 1 type immune response [GO:0042088]; toll-like receptor 6 signaling pathway [GO:0034150]; toll-like receptor signaling pathway [GO:0002224]; toll-like receptor TLR6:TLR2 signaling pathway [GO:0038124]
Q8N584,CHOYP_TT39C.1.1|m.6317,0,0,0,0,0,0,0,0,3.00E-178,Tetratricopeptide repeat protein 39C (TPR repeat protein 39C),TTC39C C18orf17,583,,,,,,PF10300;,
Q3L254,CHOYP_WNT7B.1.2|m.36042,0,0,0,0,0,0,0,0,5.00E-160,Protein Wnt-7b,WNT7B,349,cell fate commitment [GO:0045165]; lens fiber cell development [GO:0070307]; neuron differentiation [GO:0030182]; Wnt signaling pathway [GO:0016055],GO:0005109; GO:0005578; GO:0005615; GO:0016055; GO:0030182; GO:0045165; GO:0070307,,,,PF00110;,extracellular space [GO:0005615]; proteinaceous extracellular matrix [GO:0005578]; frizzled binding [GO:0005109]; cell fate commitment [GO:0045165]; lens fiber cell development [GO:0070307]; neuron differentiation [GO:0030182]; Wnt signaling pathway [GO:0016055]
Q9FMR5,CHOYP_BRAFLDRAFT_140951.1.1|m.40225,0.5,0,0,0,0,0,0,0,7.00E-42,Vesicle-associated membrane protein 714 (AtVAMP714),VAMP714 At5g22360 MWD9.16,221,exocytosis [GO:0006887]; protein transport [GO:0015031]; response to salt stress [GO:0009651]; vesicle fusion [GO:0006906],GO:0000139; GO:0000149; GO:0005484; GO:0005773; GO:0005794; GO:0006887; GO:0006906; GO:0009651; GO:0015031; GO:0016021; GO:0031201,,,,PF13774;PF00957;,Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; SNARE complex [GO:0031201]; vacuole [GO:0005773]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; exocytosis [GO:0006887]; protein transport [GO:0015031]; response to salt stress [GO:0009651]; vesicle fusion [GO:0006906]
Q9QYI4,CHOYP_BRAFLDRAFT_209304.2.2|m.63768,0,0,0,0,0,0,0,0,1.00E-106,DnaJ homolog subfamily B member 12 (mDj10),Dnajb12,376,,GO:0016020; GO:0016021,,,cd06257;,PF00226;PF09320;,integral component of membrane [GO:0016021]; membrane [GO:0016020]
Q498J9,CHOYP_BRAFLDRAFT_227287.1.1|m.14669,0.5,0,0,0,0,0,0,0,1.00E-49,Metallo-beta-lactamase domain-containing protein 1 (EC 3.-.-.-),mblac1,233,,GO:0016787; GO:0046872,,,,PF00753;,hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]
O14815,CHOYP_CAPN9.1.1|m.9975,0,0,0,0,0,0,0,0,6.00E-143,Calpain-9 (EC 3.4.22.-) (Digestive tract-specific calpain) (New calpain 4) (nCL-4) (Protein CG36),CAPN9 NCL4,690,digestion [GO:0007586]; proteolysis [GO:0006508],GO:0004198; GO:0005509; GO:0005737; GO:0006508; GO:0007586,,,cd00214;cd00044;cd00051;,PF01067;PF13833;PF00648;,cytoplasm [GO:0005737]; calcium ion binding [GO:0005509]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; digestion [GO:0007586]; proteolysis [GO:0006508]
Q6GQ29,CHOYP_CBPQ.1.1|m.58629,0.5,0,0,0,0,0,0,0,0,Carboxypeptidase Q (EC 3.4.17.-) (Plasma glutamate carboxypeptidase),cpq pgcp,469,peptide catabolic process [GO:0043171]; proteolysis [GO:0006508],GO:0004180; GO:0005615; GO:0005737; GO:0005764; GO:0005783; GO:0005794; GO:0006508; GO:0042803; GO:0043171; GO:0046872; GO:0070573,,,,PF04389;,cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; carboxypeptidase activity [GO:0004180]; metal ion binding [GO:0046872]; metallodipeptidase activity [GO:0070573]; protein homodimerization activity [GO:0042803]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]
Q761V0,CHOYP_DGRI_GH22876.2.3|m.54068,0.5,0,0,0,0,0,0,0,1.00E-180,Sodium- and chloride-dependent glycine transporter 2 (GlyT-2) (GlyT2) (Solute carrier family 6 member 5),Slc6a5 Glyt2,799,"glycine import [GO:0036233]; synaptic transmission, glycinergic [GO:0060012]",GO:0005328; GO:0005886; GO:0005887; GO:0015375; GO:0036233; GO:0046872; GO:0060012,,,,PF00209;,"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; glycine:sodium symporter activity [GO:0015375]; metal ion binding [GO:0046872]; neurotransmitter:sodium symporter activity [GO:0005328]; glycine import [GO:0036233]; synaptic transmission, glycinergic [GO:0060012]"
P55265,CHOYP_DSRAD.1.4|m.4228,1,0,0,0,0,0,0,0,6.00E-117,Double-stranded RNA-specific adenosine deaminase (DRADA) (EC 3.5.4.37) (136 kDa double-stranded RNA-binding protein) (p136) (Interferon-inducible protein 4) (IFI-4) (K88DSRBP),ADAR ADAR1 DSRAD G1P1 IFI4,1226,adenosine to inosine editing [GO:0006382]; base conversion or substitution editing [GO:0016553]; cellular response to virus [GO:0098586]; defense response to virus [GO:0051607]; definitive hemopoiesis [GO:0060216]; erythrocyte differentiation [GO:0030218]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell homeostasis [GO:0061484]; innate immune response [GO:0045087]; in utero embryonic development [GO:0001701]; miRNA loading onto RISC involved in gene silencing by miRNA [GO:0035280]; mRNA processing [GO:0006397]; negative regulation of apoptotic process [GO:0043066]; negative regulation of protein kinase activity by regulation of protein phosphorylation [GO:0044387]; negative regulation of RNA interference [GO:1900369]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; negative regulation of viral genome replication [GO:0045071]; osteoblast differentiation [GO:0001649]; positive regulation of viral genome replication [GO:0045070]; pre-miRNA processing [GO:0031054]; protein export from nucleus [GO:0006611]; protein import into nucleus [GO:0006606]; response to interferon-alpha [GO:0035455]; response to virus [GO:0009615]; somatic diversification of immune receptors via somatic mutation [GO:0002566]; type I interferon signaling pathway [GO:0060337],GO:0001649; GO:0001701; GO:0002244; GO:0002566; GO:0003677; GO:0003723; GO:0003726; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006382; GO:0006397; GO:0006606; GO:0006611; GO:0009615; GO:0016020; GO:0016553; GO:0030218; GO:0031054; GO:0035280; GO:0035455; GO:0043066; GO:0044387; GO:0044530; GO:0045070; GO:0045071; GO:0045087; GO:0046872; GO:0051607; GO:0060216; GO:0060337; GO:0060339; GO:0061484; GO:0098586; GO:1900369,,,,PF02137;PF00035;PF02295;,cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; supraspliceosomal complex [GO:0044530]; DNA binding [GO:0003677]; double-stranded RNA adenosine deaminase activity [GO:0003726]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; adenosine to inosine editing [GO:0006382]; base conversion or substitution editing [GO:0016553]; cellular response to virus [GO:0098586]; defense response to virus [GO:0051607]; definitive hemopoiesis [GO:0060216]; erythrocyte differentiation [GO:0030218]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell homeostasis [GO:0061484]; in utero embryonic development [GO:0001701]; innate immune response [GO:0045087]; miRNA loading onto RISC involved in gene silencing by miRNA [GO:0035280]; mRNA processing [GO:0006397]; negative regulation of apoptotic process [GO:0043066]; negative regulation of protein kinase activity by regulation of protein phosphorylation [GO:0044387]; negative regulation of RNA interference [GO:1900369]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; negative regulation of viral genome replication [GO:0045071]; osteoblast differentiation [GO:0001649]; positive regulation of viral genome replication [GO:0045070]; pre-miRNA processing [GO:0031054]; protein export from nucleus [GO:0006611]; protein import into nucleus [GO:0006606]; response to interferon-alpha [GO:0035455]; response to virus [GO:0009615]; somatic diversification of immune receptors via somatic mutation [GO:0002566]; type I interferon signaling pathway [GO:0060337]
Q8S3U9,CHOYP_EXOC2.1.3|m.360,0,0,0,0,0,0,0,0,4.00E-33,Exocyst complex component SEC5A (AtSec5a) (Exocyst complex component 2),SEC5A At1g76850 F7O12.2,1090,acceptance of pollen [GO:0060321]; exocyst assembly [GO:0001927]; Golgi to plasma membrane transport [GO:0006893],GO:0000145; GO:0001927; GO:0005829; GO:0005886; GO:0006893; GO:0009506; GO:0060321,,,,,cytosol [GO:0005829]; exocyst [GO:0000145]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]; acceptance of pollen [GO:0060321]; exocyst assembly [GO:0001927]; Golgi to plasma membrane transport [GO:0006893]
Q9JLY7,CHOYP_LOAG_05814.1.1|m.56611,0,0,0,0,0,0,0,0,2.00E-58,Dual specificity protein phosphatase 14 (EC 3.1.3.16) (EC 3.1.3.48) (Mitogen-activated protein kinase phosphatase 6) (MAP kinase phosphatase 6) (MKP-6),Dusp14 Mkp6,198,peptidyl-tyrosine dephosphorylation [GO:0035335],GO:0003723; GO:0004725; GO:0005634; GO:0005737; GO:0017017; GO:0035335,,,cd00127;,PF00782;,cytoplasm [GO:0005737]; nucleus [GO:0005634]; MAP kinase tyrosine/serine/threonine phosphatase activity [GO:0017017]; protein tyrosine phosphatase activity [GO:0004725]; RNA binding [GO:0003723]; peptidyl-tyrosine dephosphorylation [GO:0035335]
Q6Q2B2,CHOYP_LOC100142119.1.2|m.2339,0,0,0,0,0,0,0,0,5.00E-79,Muscleblind-like protein 2a (Tmbnl2a),mbnl2a,351,mRNA processing [GO:0006397]; RNA splicing [GO:0008380],GO:0003723; GO:0005634; GO:0005737; GO:0006397; GO:0008380; GO:0046872,,,,PF00642;,cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]
B7Z6K7,CHOYP_LOC100148223.1.1|m.10633,0,0,0,0,0,0,0,0,2.00E-40,Putative uncharacterized zinc finger protein 814 (Putative zinc finger protein LOC730051),ZNF814,855,"negative regulation of transcription, DNA-templated [GO:0045892]",GO:0003676; GO:0005622; GO:0045892; GO:0046872,,,cd07765;,PF01352;PF00096;PF13912;,"intracellular [GO:0005622]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; negative regulation of transcription, DNA-templated [GO:0045892]"
Q9CXS4,CHOYP_LOC100366455.2.3|m.25037,0,0,0,0,0,0,0,0,3.00E-55,Centromere protein V (CENP-V) (Proline-rich protein 6),Cenpv Prr6,252,ameboidal-type cell migration [GO:0001667]; cell division [GO:0051301]; centromere complex assembly [GO:0034508]; metabolic process [GO:0008152]; mitotic nuclear division [GO:0007067]; pericentric heterochromatin assembly [GO:0031508]; positive regulation of cytokinesis [GO:0032467]; regulation of chromosome organization [GO:0033044],GO:0000776; GO:0000777; GO:0001667; GO:0005634; GO:0005654; GO:0005829; GO:0007067; GO:0008152; GO:0015630; GO:0016846; GO:0031508; GO:0032467; GO:0033044; GO:0034508; GO:0051233; GO:0051301,,,,PF04828;,condensed chromosome kinetochore [GO:0000777]; cytosol [GO:0005829]; kinetochore [GO:0000776]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle midzone [GO:0051233]; carbon-sulfur lyase activity [GO:0016846]; ameboidal-type cell migration [GO:0001667]; cell division [GO:0051301]; centromere complex assembly [GO:0034508]; metabolic process [GO:0008152]; mitotic nuclear division [GO:0007067]; pericentric heterochromatin assembly [GO:0031508]; positive regulation of cytokinesis [GO:0032467]; regulation of chromosome organization [GO:0033044]
Q15650,CHOYP_LOC100367001.1.1|m.55663,1,0,0,0,0,0,0,0,5.00E-158,Activating signal cointegrator 1 (ASC-1) (Thyroid receptor-interacting protein 4) (TR-interacting protein 4) (TRIP-4),TRIP4,581,"intracellular estrogen receptor signaling pathway [GO:0030520]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of myoblast differentiation [GO:0045661]; regulation of transcription, DNA-templated [GO:0006355]; toxin transport [GO:1901998]; transcription, DNA-templated [GO:0006351]",GO:0002020; GO:0003713; GO:0005634; GO:0005654; GO:0005737; GO:0005815; GO:0005829; GO:0006351; GO:0006355; GO:0008270; GO:0016604; GO:0016922; GO:0030331; GO:0030520; GO:0031594; GO:0035035; GO:0044389; GO:0045661; GO:0045893; GO:0099053; GO:1901998,,,,PF04266;PF06221;,"activating signal cointegrator 1 complex [GO:0099053]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; neuromuscular junction [GO:0031594]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; estrogen receptor binding [GO:0030331]; histone acetyltransferase binding [GO:0035035]; ligand-dependent nuclear receptor binding [GO:0016922]; protease binding [GO:0002020]; transcription coactivator activity [GO:0003713]; ubiquitin-like protein ligase binding [GO:0044389]; zinc ion binding [GO:0008270]; intracellular estrogen receptor signaling pathway [GO:0030520]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of myoblast differentiation [GO:0045661]; regulation of transcription, DNA-templated [GO:0006355]; toxin transport [GO:1901998]; transcription, DNA-templated [GO:0006351]"
Q96CN5,CHOYP_LOC100376045.1.1|m.30010,0,0,0,0,0,0,0,0,0,Leucine-rich repeat-containing protein 45,LRRC45,670,,GO:0005654; GO:0005813; GO:0005829; GO:0005886,,,,PF13516;,centrosome [GO:0005813]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]
P24045,CHOYP_LOC100533289.6.6|m.59221,0,0,0,0,0,0,0,0,4.00E-82,Gamma-aminobutyric acid receptor subunit beta-4 (GABA(A) receptor subunit beta-4),GABRB4,488,,GO:0004890; GO:0005230; GO:0005254; GO:0030054; GO:0034707; GO:0045211; GO:1902711,,,,PF02931;PF02932;,cell junction [GO:0030054]; chloride channel complex [GO:0034707]; GABA-A receptor complex [GO:1902711]; postsynaptic membrane [GO:0045211]; chloride channel activity [GO:0005254]; extracellular ligand-gated ion channel activity [GO:0005230]; GABA-A receptor activity [GO:0004890]
Q8K1S3,CHOYP_LOC101236385.3.6|m.4348,0,0,0,0,0,0,0,0,2.00E-25,Netrin receptor UNC5B (Protein unc-5 homolog 2) (Protein unc-5 homolog B),Unc5b Unc5h2,945,angiogenesis [GO:0001525]; anterior/posterior axon guidance [GO:0033564]; axon guidance [GO:0007411]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068],GO:0001525; GO:0005829; GO:0005886; GO:0007411; GO:0014068; GO:0016021; GO:0033564; GO:0043524; GO:0045121; GO:0097192; GO:2001240,,,,PF00531;PF07679;PF00090;PF17217;PF00791;,cytosol [GO:0005829]; integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; angiogenesis [GO:0001525]; anterior/posterior axon guidance [GO:0033564]; axon guidance [GO:0007411]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]
O95490,CHOYP_LOC578280.1.1|m.42277,0,0,0,0,0,0,0,0,1.00E-63,Adhesion G protein-coupled receptor L2 (Calcium-independent alpha-latrotoxin receptor 2) (CIRL-2) (Latrophilin homolog 1) (Latrophilin-2) (Lectomedin-1),ADGRL2 KIAA0786 LEC1 LPHH1 LPHN2,1459,cell surface receptor signaling pathway [GO:0007166]; G-protein coupled receptor signaling pathway [GO:0007186],GO:0004930; GO:0007166; GO:0007186; GO:0016021; GO:0016524; GO:0030246,,,,PF00002;PF16489;PF02140;PF01825;PF02793;PF02354;PF02191;,integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; G-protein coupled receptor activity [GO:0004930]; latrotoxin receptor activity [GO:0016524]; cell surface receptor signaling pathway [GO:0007166]; G-protein coupled receptor signaling pathway [GO:0007186]
Q8BUG5,CHOYP_LOC579381.1.1|m.10900,0,0,0,0,0,0,0,0,8.00E-95,Calcyphosin-2 (Calcyphosine-2),Caps2,550,calcium ion homeostasis [GO:0055074],GO:0005432; GO:0005509; GO:0055074,,,,,calcium ion binding [GO:0005509]; calcium:sodium antiporter activity [GO:0005432]; calcium ion homeostasis [GO:0055074]
Q9CY21,CHOYP_LOC581711.1.1|m.14276,0,0,0,0,0,0,0,0,7.00E-124,Probable 18S rRNA (guanine-N(7))-methyltransferase (EC 2.1.1.-) (Bud site selection protein 23 homolog) (Williams-Beuren syndrome chromosomal region 22 protein homolog),Wbscr22,281,"covalent chromatin modification [GO:0016569]; regulation of transcription, DNA-templated [GO:0006355]; rRNA (guanine-N7)-methylation [GO:0070476]; transcription, DNA-templated [GO:0006351]",GO:0003723; GO:0005634; GO:0005730; GO:0005737; GO:0006351; GO:0006355; GO:0016435; GO:0016569; GO:0070476,,,,PF08241;PF12589;,"cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleus [GO:0005634]; RNA binding [GO:0003723]; rRNA (guanine) methyltransferase activity [GO:0016435]; covalent chromatin modification [GO:0016569]; regulation of transcription, DNA-templated [GO:0006355]; rRNA (guanine-N7)-methylation [GO:0070476]; transcription, DNA-templated [GO:0006351]"
Q93129,CHOYP_LOC752782.1.1|m.53938,0,0,0,0,0,0,0,0,6.00E-150,"Actin, cytoplasmic (BbCA1) [Cleaved into: Actin, cytoplasmic, N-terminally processed]",,375,,GO:0005524; GO:0005737; GO:0005856,,,,PF00022;,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]
Q9ERH3,CHOYP_PHUM_PHUM035190.1.1|m.16675,0,0,0,0,0,0,0,0,0,WD repeat-containing protein 7 (TGF-beta resistance-associated protein TRAG),Wdr7 Trag,1488,hematopoietic progenitor cell differentiation [GO:0002244],GO:0002244; GO:0008021,,,,PF00400;,synaptic vesicle [GO:0008021]; hematopoietic progenitor cell differentiation [GO:0002244]
P51539,CHOYP_RALA.1.4|m.8443,0.5,0,0,0,0,0,0,0,7.00E-55,Ras-like protein RAS1,RAS1,194,small GTPase mediated signal transduction [GO:0007264],GO:0005525; GO:0005622; GO:0005886; GO:0007264,,,,PF00071;,intracellular [GO:0005622]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; small GTPase mediated signal transduction [GO:0007264]
Q2PZL6,CHOYP_RB886.1.1|m.36185,0,0,0,0,0,0,0,0,1.00E-23,Protocadherin Fat 4 (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J),Fat4 Fatj,4981,branching involved in ureteric bud morphogenesis [GO:0001658]; cerebral cortex development [GO:0021987]; condensed mesenchymal cell proliferation [GO:0072137]; digestive tract development [GO:0048565]; establishment of planar polarity [GO:0001736]; fibroblast growth factor receptor signaling pathway [GO:0008543]; heart morphogenesis [GO:0003007]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear receptor stereocilium organization [GO:0060122]; kidney development [GO:0001822]; nephron development [GO:0072006]; neurogenesis [GO:0022008]; Notch signaling pathway [GO:0007219]; ossification involved in bone maturation [GO:0043931]; plasma membrane organization [GO:0007009]; regulation of metanephric nephron tubule epithelial cell differentiation [GO:0072307],GO:0001658; GO:0001736; GO:0001822; GO:0003007; GO:0005509; GO:0005622; GO:0005886; GO:0007009; GO:0007156; GO:0007157; GO:0007219; GO:0008543; GO:0016021; GO:0021987; GO:0022008; GO:0035329; GO:0043931; GO:0045177; GO:0048565; GO:0060122; GO:0070062; GO:0072006; GO:0072137; GO:0072307,,,,PF00028;PF00008;PF07645;PF12661;PF02210;,apical part of cell [GO:0045177]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; intracellular [GO:0005622]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; branching involved in ureteric bud morphogenesis [GO:0001658]; cerebral cortex development [GO:0021987]; condensed mesenchymal cell proliferation [GO:0072137]; digestive tract development [GO:0048565]; establishment of planar polarity [GO:0001736]; fibroblast growth factor receptor signaling pathway [GO:0008543]; heart morphogenesis [GO:0003007]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear receptor stereocilium organization [GO:0060122]; kidney development [GO:0001822]; nephron development [GO:0072006]; neurogenesis [GO:0022008]; Notch signaling pathway [GO:0007219]; ossification involved in bone maturation [GO:0043931]; plasma membrane organization [GO:0007009]; regulation of metanephric nephron tubule epithelial cell differentiation [GO:0072307]
Q761V0,CHOYP_SC6A9.5.6|m.26569,0,0,0,0,0,0,0,0,0,Sodium- and chloride-dependent glycine transporter 2 (GlyT-2) (GlyT2) (Solute carrier family 6 member 5),Slc6a5 Glyt2,799,"glycine import [GO:0036233]; synaptic transmission, glycinergic [GO:0060012]",GO:0005328; GO:0005886; GO:0005887; GO:0015375; GO:0036233; GO:0046872; GO:0060012,,,,PF00209;,"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; glycine:sodium symporter activity [GO:0015375]; metal ion binding [GO:0046872]; neurotransmitter:sodium symporter activity [GO:0005328]; glycine import [GO:0036233]; synaptic transmission, glycinergic [GO:0060012]"
Q24K03,CHOYP_THUM1.1.1|m.47876,0.5,0,0,0,0,0,0,0,8.00E-67,THUMP domain-containing protein 1,THUMPD1,357,tRNA modification [GO:0006400],GO:0003723; GO:0006400,,,,PF02926;,RNA binding [GO:0003723]; tRNA modification [GO:0006400]
Q5RBP1,CHOYP_TRIADDRAFT_26633.4.6|m.50465,0,0,0,0,0,0,0,0,0.000003,Nephronectin,NPNT,565,cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275],GO:0005509; GO:0005578; GO:0007155; GO:0007275; GO:0016020; GO:0030154,,,cd06263;,PF07645;PF00629;,membrane [GO:0016020]; proteinaceous extracellular matrix [GO:0005578]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]
O94966,CHOYP_UBP19.1.1|m.55642,0,0,0,0,0,0,0,0,0,Ubiquitin carboxyl-terminal hydrolase 19 (EC 3.4.19.12) (Deubiquitinating enzyme 19) (Ubiquitin thioesterase 19) (Ubiquitin-specific-processing protease 19) (Zinc finger MYND domain-containing protein 9),USP19 KIAA0891 ZMYND9,1318,ER-associated ubiquitin-dependent protein catabolic process [GO:0030433]; negative regulation of proteasomal protein catabolic process [GO:1901799]; negative regulation of skeletal muscle tissue development [GO:0048642]; positive regulation of cell cycle process [GO:0090068]; protein deubiquitination [GO:0016579]; protein stabilization [GO:0050821]; regulation of cellular response to hypoxia [GO:1900037]; regulation of ERAD pathway [GO:1904292]; regulation of protein stability [GO:0031647]; response to endoplasmic reticulum stress [GO:0034976],GO:0004843; GO:0005789; GO:0005829; GO:0016021; GO:0016579; GO:0030433; GO:0031647; GO:0034976; GO:0036459; GO:0046872; GO:0048642; GO:0050821; GO:0051879; GO:0090068; GO:1900037; GO:1901799; GO:1904292; GO:1990380,,,,PF04969;PF00443;PF01753;,cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; Hsp90 protein binding [GO:0051879]; Lys48-specific deubiquitinase activity [GO:1990380]; metal ion binding [GO:0046872]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; ER-associated ubiquitin-dependent protein catabolic process [GO:0030433]; negative regulation of proteasomal protein catabolic process [GO:1901799]; negative regulation of skeletal muscle tissue development [GO:0048642]; positive regulation of cell cycle process [GO:0090068]; protein deubiquitination [GO:0016579]; protein stabilization [GO:0050821]; regulation of cellular response to hypoxia [GO:1900037]; regulation of ERAD pathway [GO:1904292]; regulation of protein stability [GO:0031647]; response to endoplasmic reticulum stress [GO:0034976]
Q6WKZ8,CHOYP_UBR2.2.2|m.54412,1.5,0,0,0,0,0,0,0,0,E3 ubiquitin-protein ligase UBR2 (EC 2.3.2.27) (N-recognin-2) (RING-type E3 ubiquitin transferase UBR2) (Ubiquitin-protein ligase E3-alpha-2) (Ubiquitin-protein ligase E3-alpha-II),Ubr2 Kiaa0349,1755,cellular response to leucine [GO:0071233]; chromatin silencing [GO:0006342]; histone H2A ubiquitination [GO:0033522]; male meiosis I [GO:0007141]; negative regulation of TOR signaling [GO:0032007]; spermatogenesis [GO:0007283]; ubiquitin-dependent protein catabolic process [GO:0006511]; ubiquitin-dependent protein catabolic process via the N-end rule pathway [GO:0071596],GO:0000151; GO:0004842; GO:0005634; GO:0005737; GO:0006342; GO:0006511; GO:0007141; GO:0007283; GO:0008270; GO:0032007; GO:0033522; GO:0061630; GO:0070728; GO:0071233; GO:0071596,PATHWAY: Protein modification; protein ubiquitination.,,,PF02617;PF02207;,cytoplasm [GO:0005737]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; leucine binding [GO:0070728]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; cellular response to leucine [GO:0071233]; chromatin silencing [GO:0006342]; histone H2A ubiquitination [GO:0033522]; male meiosis I [GO:0007141]; negative regulation of TOR signaling [GO:0032007]; spermatogenesis [GO:0007283]; ubiquitin-dependent protein catabolic process [GO:0006511]; ubiquitin-dependent protein catabolic process via the N-end rule pathway [GO:0071596]
P70701,CHOYP_WN10A.1.1|m.28564,0,0,0,0,0,0,0,0,1.00E-123,Protein Wnt-10a,Wnt10a,417,animal organ morphogenesis [GO:0009887]; cell-cell signaling [GO:0007267]; cell fate commitment [GO:0045165]; cellular response to transforming growth factor beta stimulus [GO:0071560]; epidermis morphogenesis [GO:0048730]; hair follicle development [GO:0001942]; hair follicle morphogenesis [GO:0031069]; neural crest cell differentiation [GO:0014033]; neuron differentiation [GO:0030182]; odontogenesis [GO:0042476]; positive regulation of gene expression [GO:0010628]; regulation of odontogenesis of dentin-containing tooth [GO:0042487]; sebaceous gland development [GO:0048733]; signal transduction [GO:0007165]; skin development [GO:0043588]; tongue development [GO:0043586]; Wnt signaling pathway [GO:0016055],GO:0001942; GO:0005102; GO:0005109; GO:0005578; GO:0005615; GO:0007165; GO:0007267; GO:0009887; GO:0010628; GO:0014033; GO:0016055; GO:0030182; GO:0031069; GO:0042476; GO:0042487; GO:0043586; GO:0043588; GO:0045165; GO:0048730; GO:0048733; GO:0071560,,,,PF00110;,extracellular space [GO:0005615]; proteinaceous extracellular matrix [GO:0005578]; frizzled binding [GO:0005109]; receptor binding [GO:0005102]; animal organ morphogenesis [GO:0009887]; cell fate commitment [GO:0045165]; cell-cell signaling [GO:0007267]; cellular response to transforming growth factor beta stimulus [GO:0071560]; epidermis morphogenesis [GO:0048730]; hair follicle development [GO:0001942]; hair follicle morphogenesis [GO:0031069]; neural crest cell differentiation [GO:0014033]; neuron differentiation [GO:0030182]; odontogenesis [GO:0042476]; positive regulation of gene expression [GO:0010628]; regulation of odontogenesis of dentin-containing tooth [GO:0042487]; sebaceous gland development [GO:0048733]; signal transduction [GO:0007165]; skin development [GO:0043588]; tongue development [GO:0043586]; Wnt signaling pathway [GO:0016055]
Q8IUH5,CHOYP_ZDHHC17.1.1|m.29726,0.5,0,0,0,0,0,0,0,0,Palmitoyltransferase ZDHHC17 (EC 2.3.1.225) (Huntingtin yeast partner H) (Huntingtin-interacting protein 14) (HIP-14) (Huntingtin-interacting protein 3) (HIP-3) (Huntingtin-interacting protein H) (Putative MAPK-activating protein PM11) (Putative NF-kappa-B-activating protein 205) (Zinc finger DHHC domain-containing protein 17) (DHHC-17),ZDHHC17 HIP14 HIP3 HYPH KIAA0946 HSPC294,632,lipoprotein transport [GO:0042953]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; protein palmitoylation [GO:0018345],GO:0000139; GO:0004871; GO:0005794; GO:0005829; GO:0015095; GO:0016021; GO:0016409; GO:0018345; GO:0019706; GO:0030054; GO:0030659; GO:0030660; GO:0042734; GO:0042802; GO:0042953; GO:0043123; GO:0043231,,,,PF12796;PF01529;,cell junction [GO:0030054]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi-associated vesicle membrane [GO:0030660]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; presynaptic membrane [GO:0042734]; identical protein binding [GO:0042802]; magnesium ion transmembrane transporter activity [GO:0015095]; palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; signal transducer activity [GO:0004871]; lipoprotein transport [GO:0042953]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; protein palmitoylation [GO:0018345]
Q5BK43,CHOYP_BRAFLDRAFT_119549.1.1|m.56597,1,0,0,0,0,0,0,0,5.00E-12,Epithelial-stromal interaction protein 1,Epsti1,314,,,,,,,
Q6IR74,CHOYP_BRAFLDRAFT_130395.1.1|m.38394,0,0,0,0,0,0,0,0,0,Choline transporter-like protein 1 (Solute carrier family 44 member 1),slc44a1 ctl1,651,,GO:0016021,,,,PF04515;,integral component of membrane [GO:0016021]
O18404,CHOYP_BRAFLDRAFT_291364.1.1|m.47990,0.5,0,0,0,0,0,0,0,2.00E-54,3-hydroxyacyl-CoA dehydrogenase type-2 (EC 1.1.1.35) (17-beta-hydroxysteroid dehydrogenase 10) (17-beta-HSD 10) (EC 1.1.1.51) (3-hydroxy-2-methylbutyryl-CoA dehydrogenase) (EC 1.1.1.178) (3-hydroxyacyl-CoA dehydrogenase type II) (Mitochondrial ribonuclease P protein 2) (Mitochondrial RNase P protein 2) (Scully protein) (Type II HADH),scu CG7113,255,acyl-CoA metabolic process [GO:0006637]; androgen metabolic process [GO:0008209]; ATP metabolic process [GO:0046034]; ecdysone metabolic process [GO:0008205]; estrogen metabolic process [GO:0008210]; fatty acid metabolic process [GO:0006631]; mitochondrial tRNA processing [GO:0090646]; mitochondrion morphogenesis [GO:0070584]; steroid metabolic process [GO:0008202],GO:0003857; GO:0004303; GO:0005739; GO:0005811; GO:0005829; GO:0005875; GO:0006631; GO:0006637; GO:0008202; GO:0008205; GO:0008209; GO:0008210; GO:0016229; GO:0018454; GO:0030283; GO:0046034; GO:0047015; GO:0047022; GO:0047035; GO:0070584; GO:0090646,,,,PF00106;,cytosol [GO:0005829]; lipid particle [GO:0005811]; microtubule associated complex [GO:0005875]; mitochondrion [GO:0005739]; 3-hydroxy-2-methylbutyryl-CoA dehydrogenase activity [GO:0047015]; 3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; 7-beta-hydroxysteroid dehydrogenase (NADP+) activity [GO:0047022]; acetoacetyl-CoA reductase activity [GO:0018454]; estradiol 17-beta-dehydrogenase activity [GO:0004303]; steroid dehydrogenase activity [GO:0016229]; testosterone dehydrogenase (NAD+) activity [GO:0047035]; testosterone dehydrogenase [NAD(P)] activity [GO:0030283]; acyl-CoA metabolic process [GO:0006637]; androgen metabolic process [GO:0008209]; ATP metabolic process [GO:0046034]; ecdysone metabolic process [GO:0008205]; estrogen metabolic process [GO:0008210]; fatty acid metabolic process [GO:0006631]; mitochondrial tRNA processing [GO:0090646]; mitochondrion morphogenesis [GO:0070584]; steroid metabolic process [GO:0008202]
Q9JHA8,CHOYP_BRAFLDRAFT_63397.6.8|m.48804,0,0,0,0,0,0,0,0,2.00E-53,von Willebrand factor A domain-containing protein 7 (Protein G7c),Vwa7 D17h6s56e-3 G7c,891,,GO:0005576,,,,,extracellular region [GO:0005576]
Q5ZJL4,CHOYP_CLP1.1.1|m.11641,0,0,0,0,0,0,0,0,0,Polyribonucleotide 5'-hydroxyl-kinase Clp1 (EC 2.7.1.78) (Polyadenylation factor Clp1) (Polynucleotide kinase Clp1) (Pre-mRNA cleavage complex II protein Clp1),CLP1 RCJMB04_17f4,425,"cerebellar cortex development [GO:0021695]; mRNA cleavage [GO:0006379]; mRNA polyadenylation [GO:0006378]; siRNA loading onto RISC involved in RNA interference [GO:0035087]; targeting of mRNA for destruction involved in RNA interference [GO:0030423]; tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388]",GO:0000214; GO:0005524; GO:0005634; GO:0005829; GO:0005849; GO:0006378; GO:0006379; GO:0006388; GO:0021695; GO:0030423; GO:0035087; GO:0046404; GO:0051731; GO:0051733; GO:0051736,,,,PF06807;PF16573;PF16575;,"cytosol [GO:0005829]; mRNA cleavage factor complex [GO:0005849]; nucleus [GO:0005634]; tRNA-intron endonuclease complex [GO:0000214]; ATP binding [GO:0005524]; ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity [GO:0046404]; ATP-dependent polyribonucleotide 5'-hydroxyl-kinase activity [GO:0051736]; polydeoxyribonucleotide kinase activity [GO:0051733]; polynucleotide 5'-hydroxyl-kinase activity [GO:0051731]; cerebellar cortex development [GO:0021695]; mRNA cleavage [GO:0006379]; mRNA polyadenylation [GO:0006378]; siRNA loading onto RISC involved in RNA interference [GO:0035087]; targeting of mRNA for destruction involved in RNA interference [GO:0030423]; tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388]"
Q8CB62,CHOYP_CNTROB.1.1|m.11584,0,0,0,0,0,0,0,0,9.00E-62,Centrobin (Centrosomal BRCA2-interacting protein) (LYST-interacting protein 8),Cntrob Lip8,887,centriole replication [GO:0007099]; centrosome separation [GO:0051299]; mitotic cytokinetic process [GO:1902410],GO:0005813; GO:0005814; GO:0005829; GO:0007099; GO:0019904; GO:0051299; GO:1902410,,,,,centriole [GO:0005814]; centrosome [GO:0005813]; cytosol [GO:0005829]; protein domain specific binding [GO:0019904]; centriole replication [GO:0007099]; centrosome separation [GO:0051299]; mitotic cytokinetic process [GO:1902410]
Q9VZW5,CHOYP_CRE_21950.1.1|m.55,0,0,0,0,0,0,0,0,7.00E-24,FMRFamide receptor (DFR) (DrmFMRFa-R) (Larval opioid receptor),FR FMRFaR CG2114,549,adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G-protein coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204],GO:0001653; GO:0002209; GO:0004930; GO:0005887; GO:0007186; GO:0007204; GO:0007218; GO:0008188; GO:0008344; GO:0008345; GO:0016021,,,,PF10324;,integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; G-protein coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]; adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G-protein coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]
P80416,CHOYP_CSTA.1.3|m.6422,1,0,0,0,0,0,0,0,2.00E-16,"Cystatin-A (Cystatin-AS) (Stefin-A) [Cleaved into: Cystatin-A, N-terminally processed]",CSTA STF1,98,,GO:0004869; GO:0005737,,,cd00042;,PF00031;,cytoplasm [GO:0005737]; cysteine-type endopeptidase inhibitor activity [GO:0004869]
P61374,CHOYP_ISL1.1.1|m.10993,0.5,0,0,0,0,0,0,0,1.00E-156,Insulin gene enhancer protein ISL-1 (Islet-1),Isl1,349,"atrial septum morphogenesis [GO:0060413]; axon regeneration [GO:0031103]; cardiac cell fate determination [GO:0060913]; cardiac muscle cell myoblast differentiation [GO:0060379]; cardiac right ventricle morphogenesis [GO:0003215]; cellular response to glucocorticoid stimulus [GO:0071385]; endocardial cushion morphogenesis [GO:0003203]; innervation [GO:0060384]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of inflammatory response [GO:0050728]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of protein homodimerization activity [GO:0090074]; neural crest cell migration [GO:0001755]; outflow tract septum morphogenesis [GO:0003148]; pancreas development [GO:0031016]; peripheral nervous system neuron axonogenesis [GO:0048936]; pharyngeal system development [GO:0060037]; pituitary gland development [GO:0021983]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell proliferation [GO:0008284]; positive regulation of DNA binding [GO:0043388]; positive regulation of granulocyte colony-stimulating factor production [GO:0071657]; positive regulation of granulocyte macrophage colony-stimulating factor production [GO:0032725]; positive regulation of histone acetylation [GO:0035066]; positive regulation of insulin secretion [GO:0032024]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-1 alpha production [GO:0032730]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of tyrosine phosphorylation of Stat3 protein [GO:0042517]; positive regulation of vascular endothelial growth factor production [GO:0010575]; regulation of secondary heart field cardioblast proliferation [GO:0003266]; regulation of transcription, DNA-templated [GO:0006355]; retinal ganglion cell axon guidance [GO:0031290]; secondary heart field specification [GO:0003139]; sensory system development [GO:0048880]; spinal cord motor neuron cell fate specification [GO:0021520]; trigeminal nerve development [GO:0021559]; ventricular cardiac muscle tissue morphogenesis [GO:0055010]; visceral motor neuron differentiation [GO:0021524]",GO:0000978; GO:0001077; GO:0001105; GO:0001158; GO:0001755; GO:0003139; GO:0003148; GO:0003203; GO:0003215; GO:0003266; GO:0005634; GO:0005654; GO:0006355; GO:0008270; GO:0008284; GO:0010575; GO:0016922; GO:0021520; GO:0021524; GO:0021559; GO:0021983; GO:0030331; GO:0031016; GO:0031103; GO:0031290; GO:0032024; GO:0032725; GO:0032729; GO:0032730; GO:0032731; GO:0032735; GO:0032755; GO:0032760; GO:0033147; GO:0035066; GO:0042517; GO:0043388; GO:0043524; GO:0043565; GO:0045597; GO:0045665; GO:0045766; GO:0045944; GO:0048880; GO:0048936; GO:0050728; GO:0055010; GO:0060037; GO:0060379; GO:0060384; GO:0060413; GO:0060913; GO:0071385; GO:0071657; GO:0090074; GO:0090090; GO:1990841,,,,PF00046;PF00412;,"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; enhancer sequence-specific DNA binding [GO:0001158]; estrogen receptor binding [GO:0030331]; ligand-dependent nuclear receptor binding [GO:0016922]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II core promoter proximal region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription coactivator activity [GO:0001105]; sequence-specific DNA binding [GO:0043565]; transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding [GO:0001077]; zinc ion binding [GO:0008270]; atrial septum morphogenesis [GO:0060413]; axon regeneration [GO:0031103]; cardiac cell fate determination [GO:0060913]; cardiac muscle cell myoblast differentiation [GO:0060379]; cardiac right ventricle morphogenesis [GO:0003215]; cellular response to glucocorticoid stimulus [GO:0071385]; endocardial cushion morphogenesis [GO:0003203]; innervation [GO:0060384]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of inflammatory response [GO:0050728]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of protein homodimerization activity [GO:0090074]; neural crest cell migration [GO:0001755]; outflow tract septum morphogenesis [GO:0003148]; pancreas development [GO:0031016]; peripheral nervous system neuron axonogenesis [GO:0048936]; pharyngeal system development [GO:0060037]; pituitary gland development [GO:0021983]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell proliferation [GO:0008284]; positive regulation of DNA binding [GO:0043388]; positive regulation of granulocyte colony-stimulating factor production [GO:0071657]; positive regulation of granulocyte macrophage colony-stimulating factor production [GO:0032725]; positive regulation of histone acetylation [GO:0035066]; positive regulation of insulin secretion [GO:0032024]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-1 alpha production [GO:0032730]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of tyrosine phosphorylation of Stat3 protein [GO:0042517]; positive regulation of vascular endothelial growth factor production [GO:0010575]; regulation of secondary heart field cardioblast proliferation [GO:0003266]; regulation of transcription, DNA-templated [GO:0006355]; retinal ganglion cell axon guidance [GO:0031290]; secondary heart field specification [GO:0003139]; sensory system development [GO:0048880]; spinal cord motor neuron cell fate specification [GO:0021520]; trigeminal nerve development [GO:0021559]; ventricular cardiac muscle tissue morphogenesis [GO:0055010]; visceral motor neuron differentiation [GO:0021524]"
Q17GZ9,CHOYP_LOC100370071.1.1|m.46123,1,0,0,0,0,0,0,0,0,Actin-related protein 5,Arp5 AAEL002822,655,"chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]",GO:0005634; GO:0006281; GO:0006310; GO:0006338; GO:0006351; GO:0006355,,,,PF00022;,"nucleus [GO:0005634]; chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]"
Q64127,CHOYP_LOC100373444.22.79|m.26109,0,0,0,0,0,0,0,0,0.00000003,Transcription intermediary factor 1-alpha (TIF1-alpha) (EC 2.3.2.27) (E3 ubiquitin-protein ligase Trim24) (RING-type E3 ubiquitin transferase TIF1-alpha) (Tripartite motif-containing protein 24),Trim24 Tif1 Tif1a,1051,"calcium ion homeostasis [GO:0055074]; cellular response to estrogen stimulus [GO:0071391]; negative regulation of cell proliferation [GO:0008285]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; protein catabolic process [GO:0030163]; protein phosphorylation [GO:0006468]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; regulation of protein stability [GO:0031647]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of vitamin D receptor signaling pathway [GO:0070562]; transcription, DNA-templated [GO:0006351]",GO:0002039; GO:0003682; GO:0003713; GO:0004672; GO:0004842; GO:0005634; GO:0005654; GO:0005719; GO:0005726; GO:0005737; GO:0006351; GO:0006468; GO:0008270; GO:0008285; GO:0010628; GO:0016567; GO:0016922; GO:0030163; GO:0031647; GO:0034056; GO:0042981; GO:0043565; GO:0045892; GO:0045893; GO:0046777; GO:0055074; GO:0061630; GO:0070562; GO:0070577; GO:0071391; GO:1901796,PATHWAY: Protein modification; protein ubiquitination.,,,PF00439;PF00628;PF00643;,"cytoplasm [GO:0005737]; nuclear euchromatin [GO:0005719]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perichromatin fibrils [GO:0005726]; chromatin binding [GO:0003682]; estrogen response element binding [GO:0034056]; ligand-dependent nuclear receptor binding [GO:0016922]; lysine-acetylated histone binding [GO:0070577]; p53 binding [GO:0002039]; protein kinase activity [GO:0004672]; sequence-specific DNA binding [GO:0043565]; transcription coactivator activity [GO:0003713]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; calcium ion homeostasis [GO:0055074]; cellular response to estrogen stimulus [GO:0071391]; negative regulation of cell proliferation [GO:0008285]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; protein catabolic process [GO:0030163]; protein phosphorylation [GO:0006468]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; regulation of protein stability [GO:0031647]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of vitamin D receptor signaling pathway [GO:0070562]; transcription, DNA-templated [GO:0006351]"
P34611,CHOYP_LOC100374741.72.83|m.60196,0,0,0,0,0,0,0,0,0.000001,B-box type zinc finger protein ncl-1,ncl-1 ZK112.2,851,negative regulation of ribosome biogenesis [GO:0090071],GO:0005737; GO:0008270; GO:0090071,,,,PF01436;PF00643;,cytoplasm [GO:0005737]; zinc ion binding [GO:0008270]; negative regulation of ribosome biogenesis [GO:0090071]
Q65YR7,CHOYP_LOC100899149.1.2|m.6146,0.5,0,0,0,0,0,0,0,1.00E-12,Cystatin-A2,cpiB DDB_G0280439,95,proteolysis [GO:0006508],GO:0004869; GO:0005829; GO:0006508,,,,PF00031;,cytosol [GO:0005829]; cysteine-type endopeptidase inhibitor activity [GO:0004869]; proteolysis [GO:0006508]
Q9WV07,CHOYP_LOC584481.8.10|m.61433,0,0,0,0,0,0,0,0,7.00E-84,Hydroperoxide isomerase ALOXE3 (EC 5.4.4.7) (Epidermis-type lipoxygenase 3) (Epidermal LOX-3) (e-LOX-3) (eLOX-3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152),Aloxe3,711,arachidonic acid metabolic process [GO:0019369]; ceramide biosynthetic process [GO:0046513]; establishment of skin barrier [GO:0061436]; fat cell differentiation [GO:0045444]; hepoxilin biosynthetic process [GO:0051122]; linoleic acid metabolic process [GO:0043651]; lipoxygenase pathway [GO:0019372]; peroxisome proliferator activated receptor signaling pathway [GO:0035357]; sensory perception of pain [GO:0019233]; sphingolipid metabolic process [GO:0006665],GO:0003824; GO:0005506; GO:0005737; GO:0006665; GO:0016702; GO:0016829; GO:0019233; GO:0019369; GO:0019372; GO:0035357; GO:0043651; GO:0045444; GO:0046513; GO:0051120; GO:0051122; GO:0061436,PATHWAY: Lipid metabolism; hydroperoxy eicosatetraenoic acid biosynthesis.; PATHWAY: Lipid metabolism; sphingolipid metabolism.,,,PF00305;PF01477;,"cytoplasm [GO:0005737]; catalytic activity [GO:0003824]; hepoxilin A3 synthase activity [GO:0051120]; iron ion binding [GO:0005506]; lyase activity [GO:0016829]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; arachidonic acid metabolic process [GO:0019369]; ceramide biosynthetic process [GO:0046513]; establishment of skin barrier [GO:0061436]; fat cell differentiation [GO:0045444]; hepoxilin biosynthetic process [GO:0051122]; linoleic acid metabolic process [GO:0043651]; lipoxygenase pathway [GO:0019372]; peroxisome proliferator activated receptor signaling pathway [GO:0035357]; sensory perception of pain [GO:0019233]; sphingolipid metabolic process [GO:0006665]"
Q9UGU0,CHOYP_LOC591426.1.1|m.19353,0,0,0,0,0,0,0,0,1.00E-25,Transcription factor 20 (TCF-20) (Nuclear factor SPBP) (Protein AR1) (Stromelysin-1 PDGF-responsive element-binding protein) (SPRE-binding protein),TCF20 KIAA0292 SPBP,1960,"regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]",GO:0003677; GO:0003713; GO:0003723; GO:0005634; GO:0005654; GO:0006351; GO:0006355; GO:0008270; GO:0016604; GO:0044212,,,,,"nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; transcription coactivator activity [GO:0003713]; transcription regulatory region DNA binding [GO:0044212]; zinc ion binding [GO:0008270]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]"
Q54BT3,CHOYP_MDR1.1.2|m.22971,0,0,0,0,0,0,0,0,0,ABC transporter B family member 2 (ABC transporter ABCB.2),abcB2 DDB_G0293438,1397,,GO:0005215; GO:0005524; GO:0016021; GO:0042626,,,,PF00664;PF00005;,"integral component of membrane [GO:0016021]; ATP binding [GO:0005524]; ATPase activity, coupled to transmembrane movement of substances [GO:0042626]; transporter activity [GO:0005215]"
H2A0L6,CHOYP_NEMVEDRAFT_V1G201552.4.6|m.22239,0,0,0,0,0,0,0,0,4.00E-42,Putative beta-hexosaminidase (EC 3.2.1.52) (Beta-N-acetylhexosaminidase) (Chitobiase) (N-acetyl-beta-glucosaminidase),,1135,carbohydrate metabolic process [GO:0005975]; chitin catabolic process [GO:0006032],GO:0004563; GO:0005576; GO:0005975; GO:0006032; GO:0030247,PATHWAY: Glycan degradation; chitin degradation. {ECO:0000250|UniProtKB:Q04786}.,,,PF03173;PF00728;,extracellular region [GO:0005576]; beta-N-acetylhexosaminidase activity [GO:0004563]; polysaccharide binding [GO:0030247]; carbohydrate metabolic process [GO:0005975]; chitin catabolic process [GO:0006032]
Q8WV28,CHOYP_PHUM_PHUM128460.6.7|m.60989,0,0,0,0,0,0,0,0,4.00E-14,B-cell linker protein (B-cell adapter containing a SH2 domain protein) (B-cell adapter containing a Src homology 2 domain protein) (Cytoplasmic adapter protein) (Src homology 2 domain-containing leukocyte protein of 65 kDa) (SLP-65),BLNK BASH SLP65,456,B cell differentiation [GO:0030183]; humoral immune response [GO:0006959]; inflammatory response [GO:0006954]; intracellular signal transduction [GO:0035556],GO:0005068; GO:0005070; GO:0005622; GO:0005737; GO:0005829; GO:0005886; GO:0006954; GO:0006959; GO:0030183; GO:0035556,,,,PF00017;,cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular [GO:0005622]; plasma membrane [GO:0005886]; SH3/SH2 adaptor activity [GO:0005070]; transmembrane receptor protein tyrosine kinase adaptor activity [GO:0005068]; B cell differentiation [GO:0030183]; humoral immune response [GO:0006959]; inflammatory response [GO:0006954]; intracellular signal transduction [GO:0035556]
P23978,CHOYP_SC6A5.7.7|m.62985,0,0,0,0,0,0,0,0,8.00E-159,Sodium- and chloride-dependent GABA transporter 1 (GAT-1) (Solute carrier family 6 member 1),Slc6a1 Gabt1 Gat-1 Gat1,599,"gamma-aminobutyric acid import [GO:0051939]; learning [GO:0007612]; negative regulation of synaptic transmission, GABAergic [GO:0032229]; positive regulation of gamma-aminobutyric acid secretion [GO:0014054]; protein homooligomerization [GO:0051260]; response to calcium ion [GO:0051592]; response to cocaine [GO:0042220]; response to estradiol [GO:0032355]; response to lead ion [GO:0010288]; response to organic cyclic compound [GO:0014070]; response to organic substance [GO:0010033]; response to organonitrogen compound [GO:0010243]; response to purine-containing compound [GO:0014074]; response to sucrose [GO:0009744]; response to toxic substance [GO:0009636]",GO:0005328; GO:0005332; GO:0005886; GO:0005887; GO:0007612; GO:0009636; GO:0009744; GO:0009986; GO:0010033; GO:0010243; GO:0010288; GO:0014054; GO:0014070; GO:0014074; GO:0030424; GO:0032229; GO:0032355; GO:0042220; GO:0043005; GO:0046872; GO:0051260; GO:0051592; GO:0051939,,,,PF00209;,"axon [GO:0030424]; cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; gamma-aminobutyric acid:sodium symporter activity [GO:0005332]; metal ion binding [GO:0046872]; neurotransmitter:sodium symporter activity [GO:0005328]; gamma-aminobutyric acid import [GO:0051939]; learning [GO:0007612]; negative regulation of synaptic transmission, GABAergic [GO:0032229]; positive regulation of gamma-aminobutyric acid secretion [GO:0014054]; protein homooligomerization [GO:0051260]; response to calcium ion [GO:0051592]; response to cocaine [GO:0042220]; response to estradiol [GO:0032355]; response to lead ion [GO:0010288]; response to organic cyclic compound [GO:0014070]; response to organic substance [GO:0010033]; response to organonitrogen compound [GO:0010243]; response to purine-containing compound [GO:0014074]; response to sucrose [GO:0009744]; response to toxic substance [GO:0009636]"
Q6Q0C0,CHOYP_SMC2.1.4|m.17837,0,0,0,0,0,0,0,0,0,E3 ubiquitin-protein ligase TRAF7 (EC 2.3.2.27) (RING finger and WD repeat-containing protein 1) (RING finger protein 119) (RING-type E3 ubiquitin transferase TRAF7) (TNF receptor-associated factor 7),TRAF7 RFWD1 RNF119,670,"activation of MAPKKK activity [GO:0000185]; apoptotic process [GO:0006915]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of MAPK cascade [GO:0043410]; protein ubiquitination [GO:0016567]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]",GO:0000151; GO:0000185; GO:0004842; GO:0005886; GO:0006351; GO:0006355; GO:0006915; GO:0008270; GO:0016567; GO:0031410; GO:0043231; GO:0043410; GO:2001235,PATHWAY: Protein modification; protein ubiquitination.,,,PF00400;PF13445;,"cytoplasmic vesicle [GO:0031410]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; ubiquitin ligase complex [GO:0000151]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; activation of MAPKKK activity [GO:0000185]; apoptotic process [GO:0006915]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of MAPK cascade [GO:0043410]; protein ubiquitination [GO:0016567]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]"
B5X165,CHOYP_SMG9.1.1|m.2906,0,0,0,0,0,0,0,0,2.00E-126,Protein SMG9 (Protein smg-9 homolog),smg9,505,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]",GO:0000184,,,,PF10220;,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]"
Q5U4U6,CHOYP_T23O.5.6|m.52216,0,0,0,0,0,0,0,0,2.00E-80,"Tryptophan 2,3-dioxygenase (TDO) (EC 1.13.11.11) (Tryptamin 2,3-dioxygenase) (Tryptophan oxygenase) (TO) (TRPO) (Tryptophan pyrrolase) (Tryptophanase)",tdo2,406,protein homotetramerization [GO:0051289]; tryptophan catabolic process to kynurenine [GO:0019441],GO:0004833; GO:0019441; GO:0020037; GO:0046872; GO:0051289,PATHWAY: Amino-acid degradation; L-tryptophan degradation via kynurenine pathway; L-kynurenine from L-tryptophan: step 1/2. {ECO:0000255|HAMAP-Rule:MF_03020}.,,,PF03301;,"heme binding [GO:0020037]; metal ion binding [GO:0046872]; tryptophan 2,3-dioxygenase activity [GO:0004833]; protein homotetramerization [GO:0051289]; tryptophan catabolic process to kynurenine [GO:0019441]"
Q75A43,CHOYP_TBB2.2.2|m.53000,0,0,0,0,0,0,0,0,4.00E-79,Tubulin gamma chain (Gamma-tubulin),TUB4 ADR076C,470,cytoplasmic microtubule organization [GO:0031122]; microtubule nucleation [GO:0007020]; mitotic spindle organization in nucleus [GO:0030472]; positive regulation of cytoplasmic translation [GO:2000767],GO:0000928; GO:0003924; GO:0005200; GO:0005525; GO:0005634; GO:0005822; GO:0005824; GO:0005874; GO:0007020; GO:0030472; GO:0031122; GO:2000767,,,cd02188;,PF00091;PF03953;,"gamma-tubulin small complex, spindle pole body [GO:0000928]; inner plaque of spindle pole body [GO:0005822]; microtubule [GO:0005874]; nucleus [GO:0005634]; outer plaque of spindle pole body [GO:0005824]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; cytoplasmic microtubule organization [GO:0031122]; microtubule nucleation [GO:0007020]; mitotic spindle organization in nucleus [GO:0030472]; positive regulation of cytoplasmic translation [GO:2000767]"
B1AQJ2,CHOYP_USP36.1.2|m.17402,0,0,0,0,0,0,0,0,1.00E-140,Ubiquitin carboxyl-terminal hydrolase 36 (EC 3.4.19.12) (Deubiquitinating enzyme 36) (Ubiquitin thioesterase 36) (Ubiquitin-specific-processing protease 36),Usp36 Kiaa1453,1098,positive regulation of protein targeting to mitochondrion [GO:1903955]; protein deubiquitination [GO:0016579]; regulation of mitophagy [GO:1903146]; ubiquitin-dependent protein catabolic process [GO:0006511],GO:0003723; GO:0004843; GO:0005730; GO:0006511; GO:0016579; GO:0016607; GO:1903146; GO:1903955,,,,PF00443;,nuclear speck [GO:0016607]; nucleolus [GO:0005730]; RNA binding [GO:0003723]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; positive regulation of protein targeting to mitochondrion [GO:1903955]; protein deubiquitination [GO:0016579]; regulation of mitophagy [GO:1903146]; ubiquitin-dependent protein catabolic process [GO:0006511]
Q28298,CHOYP_AGO2.1.1|m.17145,0,0,0,0,0,0,0,0,2.00E-17,Ribosome-binding protein 1 (180 kDa ribosome receptor) (RRp),RRBP1 P180,1534,protein transport [GO:0015031]; signal transduction [GO:0007165]; translation [GO:0006412],GO:0004872; GO:0005840; GO:0006412; GO:0007165; GO:0015031; GO:0030176,,,,PF05104;,integral component of endoplasmic reticulum membrane [GO:0030176]; ribosome [GO:0005840]; receptor activity [GO:0004872]; protein transport [GO:0015031]; signal transduction [GO:0007165]; translation [GO:0006412]
Q96KG7,CHOYP_CELE_Y64G10A.7.3.4|m.53262,0,0,0,0,0,0,0,0,1.00E-27,Multiple epidermal growth factor-like domains protein 10 (Multiple EGF-like domains protein 10),MEGF10 KIAA1780,1140,apoptotic process involved in development [GO:1902742]; engulfment of apoptotic cell [GO:0043652]; homotypic cell-cell adhesion [GO:0034109]; muscle cell development [GO:0055001]; recognition of apoptotic cell [GO:0043654]; regulation of muscle cell differentiation [GO:0051147]; regulation of skeletal muscle tissue development [GO:0048641]; skeletal muscle satellite cell activation [GO:0014719]; skeletal muscle satellite cell differentiation [GO:0014816]; skeletal muscle satellite cell proliferation [GO:0014841],GO:0001849; GO:0001891; GO:0005044; GO:0014719; GO:0014816; GO:0014841; GO:0016021; GO:0016323; GO:0034109; GO:0042995; GO:0043652; GO:0043654; GO:0048641; GO:0051147; GO:0055001; GO:1902742,,,,PF12661;PF00053;,basolateral plasma membrane [GO:0016323]; cell projection [GO:0042995]; integral component of membrane [GO:0016021]; phagocytic cup [GO:0001891]; complement component C1q binding [GO:0001849]; scavenger receptor activity [GO:0005044]; apoptotic process involved in development [GO:1902742]; engulfment of apoptotic cell [GO:0043652]; homotypic cell-cell adhesion [GO:0034109]; muscle cell development [GO:0055001]; recognition of apoptotic cell [GO:0043654]; regulation of muscle cell differentiation [GO:0051147]; regulation of skeletal muscle tissue development [GO:0048641]; skeletal muscle satellite cell activation [GO:0014719]; skeletal muscle satellite cell differentiation [GO:0014816]; skeletal muscle satellite cell proliferation [GO:0014841]
P98158,CHOYP_CO4A1.1.2|m.36472,0,0,0,0,0,0,0,0,1.00E-15,Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin),Lrp2,4660,aging [GO:0007568]; animal organ regeneration [GO:0031100]; endosomal transport [GO:0016197]; hemoglobin import [GO:0020028]; hormone secretion [GO:0046879]; lipoprotein transport [GO:0042953]; negative regulation of endopeptidase activity [GO:0010951]; receptor-mediated endocytosis [GO:0006898]; response to drug [GO:0042493]; response to retinoic acid [GO:0032526]; response to vitamin D [GO:0033280]; response to X-ray [GO:0010165]; transcytosis [GO:0045056]; vitamin metabolic process [GO:0006766],GO:0004872; GO:0005509; GO:0005615; GO:0005737; GO:0005768; GO:0005903; GO:0005905; GO:0006766; GO:0006898; GO:0007568; GO:0010165; GO:0010951; GO:0016020; GO:0016021; GO:0016197; GO:0016324; GO:0020028; GO:0030165; GO:0030492; GO:0031100; GO:0031526; GO:0032403; GO:0032526; GO:0033280; GO:0042493; GO:0042562; GO:0042953; GO:0043234; GO:0045056; GO:0045121; GO:0046879; GO:0050750,,,,PF12662;PF07645;PF00057;PF00058;,apical plasma membrane [GO:0016324]; brush border [GO:0005903]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; endosome [GO:0005768]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; membrane raft [GO:0045121]; protein complex [GO:0043234]; calcium ion binding [GO:0005509]; hemoglobin binding [GO:0030492]; hormone binding [GO:0042562]; low-density lipoprotein particle receptor binding [GO:0050750]; PDZ domain binding [GO:0030165]; protein complex binding [GO:0032403]; receptor activity [GO:0004872]; aging [GO:0007568]; animal organ regeneration [GO:0031100]; endosomal transport [GO:0016197]; hemoglobin import [GO:0020028]; hormone secretion [GO:0046879]; lipoprotein transport [GO:0042953]; negative regulation of endopeptidase activity [GO:0010951]; receptor-mediated endocytosis [GO:0006898]; response to drug [GO:0042493]; response to retinoic acid [GO:0032526]; response to vitamin D [GO:0033280]; response to X-ray [GO:0010165]; transcytosis [GO:0045056]; vitamin metabolic process [GO:0006766]
Q8R242,CHOYP_CTBS.1.1|m.54468,0,0,0,0,0,0,0,0,9.00E-25,Di-N-acetylchitobiase (EC 3.2.1.-),Ctbs,366,chitin catabolic process [GO:0006032]; oligosaccharide catabolic process [GO:0009313],GO:0004568; GO:0005615; GO:0005764; GO:0006032; GO:0009313; GO:0070062,,,,PF00704;,extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; lysosome [GO:0005764]; chitinase activity [GO:0004568]; chitin catabolic process [GO:0006032]; oligosaccharide catabolic process [GO:0009313]
Q17QH8,CHOYP_D39U1.1.1|m.29364,0,0,0,0,0,0,0,0,2.00E-91,Epimerase family protein SDR39U1 (EC 1.1.1.-) (Short-chain dehydrogenase/reductase family 39U member 1),SDR39U1,294,,GO:0016491; GO:0050662,,,,PF08338;PF01370;,coenzyme binding [GO:0050662]; oxidoreductase activity [GO:0016491]
D4ACX8,CHOYP_DS.1.1|m.62106,0,0,0,0,0,0,0,0,0,Protocadherin-16 (Protein dachsous homolog 1),Dchs1,3291,branching involved in ureteric bud morphogenesis [GO:0001658]; cell migration involved in endocardial cushion formation [GO:0003273]; cochlea development [GO:0090102]; condensed mesenchymal cell proliferation [GO:0072137]; digestive tract development [GO:0048565]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; mitral valve formation [GO:0003192]; neural tube development [GO:0021915]; neurogenesis [GO:0022008]; ossification involved in bone maturation [GO:0043931]; pattern specification process [GO:0007389]; post-anal tail morphogenesis [GO:0036342]; protein localization to plasma membrane [GO:0072659],GO:0001658; GO:0003192; GO:0003273; GO:0005509; GO:0005622; GO:0005886; GO:0007156; GO:0007157; GO:0007389; GO:0016021; GO:0021915; GO:0022008; GO:0035329; GO:0036342; GO:0043931; GO:0045177; GO:0048565; GO:0072137; GO:0072659; GO:0090102,,,,PF00028;,apical part of cell [GO:0045177]; integral component of membrane [GO:0016021]; intracellular [GO:0005622]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; branching involved in ureteric bud morphogenesis [GO:0001658]; cell migration involved in endocardial cushion formation [GO:0003273]; cochlea development [GO:0090102]; condensed mesenchymal cell proliferation [GO:0072137]; digestive tract development [GO:0048565]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; mitral valve formation [GO:0003192]; neural tube development [GO:0021915]; neurogenesis [GO:0022008]; ossification involved in bone maturation [GO:0043931]; pattern specification process [GO:0007389]; post-anal tail morphogenesis [GO:0036342]; protein localization to plasma membrane [GO:0072659]
Q90705,CHOYP_EEF2.2.2|m.54908,0,0,0,0,0,0,0,0,8.00E-160,Elongation factor 2 (EF-2),EEF2,858,,GO:0003746; GO:0003924; GO:0005525; GO:0005737,,,,PF00679;PF14492;PF03764;PF03144;,cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]
Q61080,CHOYP_FOXF1.1.1|m.4194,0,0,0,0,0,0,0,0,2.00E-62,Forkhead box protein F1 (Forkhead-related protein FKHL5) (Forkhead-related transcription factor 1) (FREAC-1) (Hepatocyte nuclear factor 3 forkhead homolog 8) (HFH-8),Foxf1 Fkhl5 Foxf1a Freac1 Hfh8,378,"animal organ morphogenesis [GO:0009887]; blood vessel development [GO:0001568]; branching involved in open tracheal system development [GO:0060446]; cardiac left ventricle morphogenesis [GO:0003214]; cellular response to cytokine stimulus [GO:0071345]; cellular response to organic cyclic compound [GO:0071407]; detection of wounding [GO:0014822]; determination of left/right symmetry [GO:0007368]; digestive tract development [GO:0048565]; ductus arteriosus closure [GO:0097070]; embryonic digestive tract development [GO:0048566]; embryonic digestive tract morphogenesis [GO:0048557]; embryonic ectodermal digestive tract morphogenesis [GO:0048613]; embryonic foregut morphogenesis [GO:0048617]; endocardial cushion development [GO:0003197]; epithelial cell differentiation involved in mammary gland alveolus development [GO:0061030]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; establishment of epithelial cell apical/basal polarity [GO:0045198]; extracellular matrix organization [GO:0030198]; heart development [GO:0007507]; in utero embryonic development [GO:0001701]; lateral mesodermal cell differentiation [GO:0048371]; lung alveolus development [GO:0048286]; lung development [GO:0030324]; lung lobe morphogenesis [GO:0060463]; lung morphogenesis [GO:0060425]; lung vasculature development [GO:0060426]; mesenchyme migration [GO:0090131]; mesoderm development [GO:0007498]; midgut development [GO:0007494]; morphogenesis of a branching structure [GO:0001763]; negative regulation of inflammatory response [GO:0050728]; negative regulation of mast cell degranulation [GO:0043305]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; pancreas development [GO:0031016]; positive regulation of cell migration [GO:0030335]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of smooth muscle cell differentiation [GO:0051150]; renal system development [GO:0072001]; respiratory tube development [GO:0030323]; right lung morphogenesis [GO:0060461]; single organismal cell-cell adhesion [GO:0016337]; smoothened signaling pathway [GO:0007224]; smooth muscle cell differentiation [GO:0051145]; somitogenesis [GO:0001756]; trachea development [GO:0060438]; ureter development [GO:0072189]; vasculogenesis [GO:0001570]; venous blood vessel development [GO:0060841]",GO:0000122; GO:0000977; GO:0001228; GO:0001568; GO:0001570; GO:0001701; GO:0001756; GO:0001763; GO:0002053; GO:0003197; GO:0003214; GO:0003677; GO:0003705; GO:0005634; GO:0007224; GO:0007368; GO:0007494; GO:0007498; GO:0007507; GO:0009887; GO:0010811; GO:0014822; GO:0016337; GO:0030198; GO:0030323; GO:0030324; GO:0030335; GO:0031016; GO:0043305; GO:0044212; GO:0045198; GO:0045893; GO:0045944; GO:0048286; GO:0048371; GO:0048557; GO:0048565; GO:0048566; GO:0048613; GO:0048617; GO:0050728; GO:0051145; GO:0051150; GO:0060425; GO:0060426; GO:0060438; GO:0060441; GO:0060446; GO:0060461; GO:0060463; GO:0060841; GO:0061030; GO:0071345; GO:0071407; GO:0072001; GO:0072189; GO:0090131; GO:0097070,,,,PF00250;,"nucleus [GO:0005634]; DNA binding [GO:0003677]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding [GO:0003705]; transcription regulatory region DNA binding [GO:0044212]; transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding [GO:0001228]; animal organ morphogenesis [GO:0009887]; blood vessel development [GO:0001568]; branching involved in open tracheal system development [GO:0060446]; cardiac left ventricle morphogenesis [GO:0003214]; cellular response to cytokine stimulus [GO:0071345]; cellular response to organic cyclic compound [GO:0071407]; detection of wounding [GO:0014822]; determination of left/right symmetry [GO:0007368]; digestive tract development [GO:0048565]; ductus arteriosus closure [GO:0097070]; embryonic digestive tract development [GO:0048566]; embryonic digestive tract morphogenesis [GO:0048557]; embryonic ectodermal digestive tract morphogenesis [GO:0048613]; embryonic foregut morphogenesis [GO:0048617]; endocardial cushion development [GO:0003197]; epithelial cell differentiation involved in mammary gland alveolus development [GO:0061030]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; establishment of epithelial cell apical/basal polarity [GO:0045198]; extracellular matrix organization [GO:0030198]; heart development [GO:0007507]; in utero embryonic development [GO:0001701]; lateral mesodermal cell differentiation [GO:0048371]; lung alveolus development [GO:0048286]; lung development [GO:0030324]; lung lobe morphogenesis [GO:0060463]; lung morphogenesis [GO:0060425]; lung vasculature development [GO:0060426]; mesenchyme migration [GO:0090131]; mesoderm development [GO:0007498]; midgut development [GO:0007494]; morphogenesis of a branching structure [GO:0001763]; negative regulation of inflammatory response [GO:0050728]; negative regulation of mast cell degranulation [GO:0043305]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; pancreas development [GO:0031016]; positive regulation of cell migration [GO:0030335]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of smooth muscle cell differentiation [GO:0051150]; renal system development [GO:0072001]; respiratory tube development [GO:0030323]; right lung morphogenesis [GO:0060461]; single organismal cell-cell adhesion [GO:0016337]; smooth muscle cell differentiation [GO:0051145]; smoothened signaling pathway [GO:0007224]; somitogenesis [GO:0001756]; trachea development [GO:0060438]; ureter development [GO:0072189]; vasculogenesis [GO:0001570]; venous blood vessel development [GO:0060841]"
Q90705,CHOYP_LOC100203564.1.1|m.22544,0,0,0,0,0,0,0,0,0,Elongation factor 2 (EF-2),EEF2,858,,GO:0003746; GO:0003924; GO:0005525; GO:0005737,,,,PF00679;PF14492;PF03764;PF03144;,cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]
A6NJI9,CHOYP_LOC100370463.1.1|m.30276,1,0,0,0,0,0,0,0,3.00E-43,Leucine-rich repeat-containing protein 72,LRRC72,287,,,,,,,
P34714,CHOYP_LOC100374633.1.2|m.21988,0,0,0,0,0,0,0,0,2.00E-61,SPARC (Basement-membrane protein 40) (BM-40) (Osteonectin) (ON) (Secreted protein acidic and rich in cysteine),ost-1 sparc C44B12.2,264,anatomical structure development [GO:0048856]; multicellular organism development [GO:0007275]; signal transduction [GO:0007165],GO:0005509; GO:0005518; GO:0005604; GO:0005615; GO:0007165; GO:0007275; GO:0048856; GO:0050840,,,cd00252;,PF09289;PF07648;PF10591;,basement membrane [GO:0005604]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; collagen binding [GO:0005518]; extracellular matrix binding [GO:0050840]; anatomical structure development [GO:0048856]; multicellular organism development [GO:0007275]; signal transduction [GO:0007165]
O67118,CHOYP_LOC100374651.3.4|m.52010,0,0,0,0,0,0,0,0,1.00E-15,Chaperone protein DnaK (HSP70) (Heat shock 70 kDa protein) (Heat shock protein 70),dnaK aq_996,632,protein folding [GO:0006457],GO:0005524; GO:0006457,,,,PF00012;,ATP binding [GO:0005524]; protein folding [GO:0006457]
Q2A865,CHOYP_LOC100375514.2.6|m.12927,0,0,0,0,0,0,0,0,2.00E-88,Sodium-dependent neutral amino acid transporter B(0)AT1 (Solute carrier family 6 member 19) (System B(0) neutral amino acid transporter AT1),Slc6a19 B0at1,634,response to nutrient [GO:0007584],GO:0005328; GO:0005887; GO:0007584; GO:0015175; GO:0031526; GO:0070062,,,,PF00209;,brush border membrane [GO:0031526]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; neurotransmitter:sodium symporter activity [GO:0005328]; neutral amino acid transmembrane transporter activity [GO:0015175]; response to nutrient [GO:0007584]
Q6FRC1,CHOYP_LOC100377001.2.2|m.52324,0,0,0,0,0,0,0,0,3.00E-22,"Protein FMP52, mitochondrial",FMP52 CAGL0H09768g,233,,GO:0005741,,,,PF08732;,mitochondrial outer membrane [GO:0005741]
O15484,CHOYP_LOC100554578.1.2|m.7421,1,0,0,0,0,0,0,0,0,Calpain-5 (EC 3.4.22.-) (Calpain htra-3) (New calpain 3) (nCL-3),CAPN5 NCL3,640,proteolysis [GO:0006508]; signal transduction [GO:0007165],GO:0004198; GO:0005737; GO:0005925; GO:0006508; GO:0007165; GO:0009986; GO:0070062,,,cd04046;cd00214;cd00044;,PF01067;PF00648;,cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; proteolysis [GO:0006508]; signal transduction [GO:0007165]
O43257,CHOYP_LOC100649205.1.1|m.39938,1,0,0,0,0,0,0,0,1.00E-49,Zinc finger HIT domain-containing protein 1 (Cyclin-G1-binding protein 1) (Zinc finger protein subfamily 4A member 1) (p18 Hamlet),ZNHIT1 CGBP1 ZNFN4A1,154,histone exchange [GO:0043486]; regulation of histone deacetylation [GO:0031063],GO:0000812; GO:0005634; GO:0005654; GO:0031063; GO:0031491; GO:0042826; GO:0043486; GO:0046872,,,,PF04438;,nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Swr1 complex [GO:0000812]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; nucleosome binding [GO:0031491]; histone exchange [GO:0043486]; regulation of histone deacetylation [GO:0031063]
P10447,CHOYP_LOC100841619.1.1|m.40382,0,0,0,0,0,0,0,0,4.00E-14,Tyrosine-protein kinase transforming protein Abl (EC 2.7.10.2) (V-abl),ABL,439,,GO:0004715; GO:0005524,,,,PF07714;PF00017;PF00018;,ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]
Q99N92,CHOYP_LOC101159300.1.1|m.26609,0.5,0,0,0,0,0,0,0,2.00E-18,"39S ribosomal protein L27, mitochondrial (L27mt) (MRP-L27)",Mrpl27,148,translation [GO:0006412],GO:0003723; GO:0003735; GO:0005739; GO:0005762; GO:0006412,,,,PF01016;,mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]
P98163,CHOYP_LOC578599.1.8|m.12749,0,0,0,0,0,0,0,0,3.00E-35,Putative vitellogenin receptor (Protein yolkless) (YL),yl CG1372,1984,oogenesis [GO:0048477],GO:0005509; GO:0005886; GO:0008196; GO:0016021; GO:0030135; GO:0031410; GO:0048477,,,,PF12662;PF07645;PF00057;PF00058;,coated vesicle [GO:0030135]; cytoplasmic vesicle [GO:0031410]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; vitellogenin receptor activity [GO:0008196]; oogenesis [GO:0048477]
Q95KE5,CHOYP_LOC657466.1.1|m.38710,0.5,0,0,0,0,0,0,0,2.00E-28,"39S ribosomal protein L43, mitochondrial (L43mt) (MRP-L43) (Retina-specific 15.7 kDa protein)",MRPL43,159,mitochondrial translational elongation [GO:0070125]; mitochondrial translational initiation [GO:0070124],GO:0003735; GO:0005743; GO:0005762; GO:0070124; GO:0070125,,,,PF05047;,mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; structural constituent of ribosome [GO:0003735]; mitochondrial translational elongation [GO:0070125]; mitochondrial translational initiation [GO:0070124]
Q9BW85,CHOYP_NEMVEDRAFT_V1G237797.1.1|m.40688,0,0,0,0,0,0,0,0,4.00E-88,Coiled-coil domain-containing protein 94,CCDC94,323,,,,,,PF04502;,
Q16649,CHOYP_NFIL3.1.1|m.26076,0.5,0,0,0,0,0,0,0,7.00E-21,Nuclear factor interleukin-3-regulated protein (E4 promoter-binding protein 4) (Interleukin-3 promoter transcriptional activator) (Interleukin-3-binding protein 1) (Transcriptional activator NF-IL3A),NFIL3 E4BP4 IL3BP1,462,cellular response to interleukin-4 [GO:0071353]; circadian rhythm [GO:0007623]; immune response [GO:0006955]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of gene expression [GO:0010628]; transcription from RNA polymerase II promoter [GO:0006366],GO:0000122; GO:0000977; GO:0000979; GO:0001078; GO:0003677; GO:0003700; GO:0003714; GO:0005634; GO:0006366; GO:0006955; GO:0007623; GO:0010628; GO:0071353,,,,PF07716;PF06529;,"nucleus [GO:0005634]; DNA binding [GO:0003677]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; transcription corepressor activity [GO:0003714]; transcription factor activity, sequence-specific DNA binding [GO:0003700]; transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding [GO:0001078]; cellular response to interleukin-4 [GO:0071353]; circadian rhythm [GO:0007623]; immune response [GO:0006955]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of gene expression [GO:0010628]; transcription from RNA polymerase II promoter [GO:0006366]"
Q69ZS0,CHOYP_PDZRN3.1.1|m.18229,0,0,0,0,0,0,0,0,2.00E-89,E3 ubiquitin-protein ligase PDZRN3 (EC 2.3.2.27) (PDZ domain-containing RING finger protein 3) (RING-type E3 ubiquitin transferase PDZRN3) (Semaphorin cytoplasmic domain-associated protein 3) (Protein SEMACAP3),Pdzrn3 Kiaa1095 Semcap3,1063,neuromuscular junction development [GO:0007528]; protein ubiquitination [GO:0016567],GO:0004842; GO:0005634; GO:0005654; GO:0005829; GO:0007528; GO:0008270; GO:0016567; GO:0031594; GO:0061630,PATHWAY: Protein modification; protein ubiquitination.,,,PF00595;,cytosol [GO:0005829]; neuromuscular junction [GO:0031594]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; neuromuscular junction development [GO:0007528]; protein ubiquitination [GO:0016567]
B9EKR1,CHOYP_PTPRT.17.45|m.42361,0,0,0,0,0,0,0,0,8.00E-74,Receptor-type tyrosine-protein phosphatase zeta (R-PTP-zeta) (EC 3.1.3.48),Ptprz1,2312,axonogenesis [GO:0007409]; hematopoietic progenitor cell differentiation [GO:0002244]; learning or memory [GO:0007611]; oligodendrocyte differentiation [GO:0048709]; peptidyl-tyrosine dephosphorylation [GO:0035335]; regulation of oligodendrocyte progenitor proliferation [GO:0070445],GO:0002244; GO:0004725; GO:0005578; GO:0007409; GO:0007611; GO:0016021; GO:0031226; GO:0035335; GO:0048709; GO:0070445; GO:0072534,,,cd00063;,PF00194;PF00041;PF00102;,integral component of membrane [GO:0016021]; intrinsic component of plasma membrane [GO:0031226]; perineuronal net [GO:0072534]; proteinaceous extracellular matrix [GO:0005578]; protein tyrosine phosphatase activity [GO:0004725]; axonogenesis [GO:0007409]; hematopoietic progenitor cell differentiation [GO:0002244]; learning or memory [GO:0007611]; oligodendrocyte differentiation [GO:0048709]; peptidyl-tyrosine dephosphorylation [GO:0035335]; regulation of oligodendrocyte progenitor proliferation [GO:0070445]
O18973,CHOYP_RABX5.1.2|m.26033,0,0,0,0,0,0,0,0,4.00E-152,Rab5 GDP/GTP exchange factor (Rabex-5),RABGEF1 RABEX5,492,endocytosis [GO:0006897]; protein transport [GO:0015031],GO:0003677; GO:0005769; GO:0006897; GO:0008270; GO:0015031; GO:0055037,,,,PF02204;PF01754;,early endosome [GO:0005769]; recycling endosome [GO:0055037]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270]; endocytosis [GO:0006897]; protein transport [GO:0015031]
P58751,CHOYP_RELN.3.4|m.48195,0,0,0,0,0,0,0,0,0,Reelin (EC 3.4.21.-),Reln,3462,axon guidance [GO:0007411]; brain development [GO:0007420]; cell adhesion [GO:0007155]; cell morphogenesis involved in differentiation [GO:0000904]; cellular response to dexamethasone stimulus [GO:0071549]; central nervous system development [GO:0007417]; cerebral cortex development [GO:0021987]; cerebral cortex tangential migration [GO:0021800]; dentate gyrus development [GO:0021542]; glial cell differentiation [GO:0010001]; hypothalamus development [GO:0021854]; locomotory behavior [GO:0007626]; memory [GO:0007613]; midgut development [GO:0007494]; neuron migration [GO:0001764]; orbitofrontal cortex development [GO:0021769]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of small GTPase mediated signal transduction [GO:0051057]; response to amino acid [GO:0043200]; response to axon injury [GO:0048678]; response to corticosterone [GO:0051412]; response to drug [GO:0042493]; response to electrical stimulus [GO:0051602]; response to ethanol [GO:0045471]; response to fatty acid [GO:0070542]; response to hormone [GO:0009725]; response to insecticide [GO:0017085]; response to lithium ion [GO:0010226]; response to mechanical stimulus [GO:0009612]; response to organic cyclic compound [GO:0014070]; response to pain [GO:0048265]; response to progesterone [GO:0032570]; response to toxic substance [GO:0009636]; social behavior [GO:0035176]; spinal cord patterning [GO:0021511],GO:0000904; GO:0001764; GO:0004712; GO:0005578; GO:0005615; GO:0005737; GO:0007155; GO:0007411; GO:0007417; GO:0007420; GO:0007494; GO:0007613; GO:0007626; GO:0008236; GO:0009612; GO:0009636; GO:0009725; GO:0010001; GO:0010226; GO:0014070; GO:0017085; GO:0018108; GO:0021511; GO:0021542; GO:0021769; GO:0021800; GO:0021854; GO:0021987; GO:0030424; GO:0030425; GO:0032570; GO:0035176; GO:0042493; GO:0043005; GO:0043025; GO:0043200; GO:0043204; GO:0045471; GO:0045860; GO:0046872; GO:0048265; GO:0048678; GO:0051057; GO:0051412; GO:0051602; GO:0070542; GO:0071549,,,cd08544;,PF02014;,axon [GO:0030424]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; extracellular space [GO:0005615]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; proteinaceous extracellular matrix [GO:0005578]; metal ion binding [GO:0046872]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; serine-type peptidase activity [GO:0008236]; axon guidance [GO:0007411]; brain development [GO:0007420]; cell adhesion [GO:0007155]; cell morphogenesis involved in differentiation [GO:0000904]; cellular response to dexamethasone stimulus [GO:0071549]; central nervous system development [GO:0007417]; cerebral cortex development [GO:0021987]; cerebral cortex tangential migration [GO:0021800]; dentate gyrus development [GO:0021542]; glial cell differentiation [GO:0010001]; hypothalamus development [GO:0021854]; locomotory behavior [GO:0007626]; memory [GO:0007613]; midgut development [GO:0007494]; neuron migration [GO:0001764]; orbitofrontal cortex development [GO:0021769]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of small GTPase mediated signal transduction [GO:0051057]; response to amino acid [GO:0043200]; response to axon injury [GO:0048678]; response to corticosterone [GO:0051412]; response to drug [GO:0042493]; response to electrical stimulus [GO:0051602]; response to ethanol [GO:0045471]; response to fatty acid [GO:0070542]; response to hormone [GO:0009725]; response to insecticide [GO:0017085]; response to lithium ion [GO:0010226]; response to mechanical stimulus [GO:0009612]; response to organic cyclic compound [GO:0014070]; response to pain [GO:0048265]; response to progesterone [GO:0032570]; response to toxic substance [GO:0009636]; social behavior [GO:0035176]; spinal cord patterning [GO:0021511]
A6H603,CHOYP_TRIADDRAFT_19804.1.1|m.8993,0.5,0,0,0,0,0,0,0,2.00E-35,NACHT domain- and WD repeat-containing protein 1,Nwd1,1563,RNA splicing [GO:0008380],GO:0005524; GO:0005682; GO:0005829; GO:0008380; GO:0071011; GO:0071013,,,,PF12894;PF00400;,catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; precatalytic spliceosome [GO:0071011]; U5 snRNP [GO:0005682]; ATP binding [GO:0005524]; RNA splicing [GO:0008380]
Q32N22,CHOYP_TRIADDRAFT_60787.1.1|m.6621,0,0,0,0,0,0,0,0,1.00E-15,TATA box-binding protein-associated factor RNA polymerase I subunit B (RNA polymerase I-specific TBP-associated factor 63 kDa) (TAFI63) (TATA box-binding protein-associated factor 1B) (TBP-associated factor 1B),taf1b,582,RNA polymerase I transcriptional preinitiation complex assembly at the promoter for the nuclear large rRNA transcript [GO:0001189],GO:0001164; GO:0001187; GO:0001189; GO:0046872; GO:0070860,,,,PF11781;,"RNA polymerase I core factor complex [GO:0070860]; metal ion binding [GO:0046872]; RNA polymerase I CORE element sequence-specific DNA binding [GO:0001164]; transcription factor activity, RNA polymerase I CORE element binding transcription factor recruiting [GO:0001187]; RNA polymerase I transcriptional preinitiation complex assembly at the promoter for the nuclear large rRNA transcript [GO:0001189]"
Q9CRB3,CHOYP_contig_010354|m.12065,1,0,0,0,0,0,0,0,3.00E-30,5-hydroxyisourate hydrolase (HIU hydrolase) (HIUHase) (EC 3.5.2.17) (Transthyretin-related protein),Urah,118,purine nucleobase metabolic process [GO:0006144]; urate catabolic process [GO:0019628],GO:0005739; GO:0005777; GO:0006144; GO:0016787; GO:0019628; GO:0033971,PATHWAY: Purine metabolism; urate degradation; (S)-allantoin from urate: step 2/3.,,,PF00576;,mitochondrion [GO:0005739]; peroxisome [GO:0005777]; hydrolase activity [GO:0016787]; hydroxyisourate hydrolase activity [GO:0033971]; purine nucleobase metabolic process [GO:0006144]; urate catabolic process [GO:0019628]
Q9VT65,CHOYP_contig_022851|m.26077,0,0,0,0,0,0,0,0,5.00E-71,Calpain-B (EC 3.4.22.-) (Calcium-activated neutral proteinase B) (CANP B) [Cleaved into: Calpain-B catalytic subunit 1; Calpain-B catalytic subunit 2],CalpB CG8107,925,border follicle cell migration [GO:0007298]; neuron remodeling [GO:0016322]; protein autoprocessing [GO:0016540]; proteolysis [GO:0006508]; sensory perception of pain [GO:0019233],GO:0004198; GO:0005509; GO:0005737; GO:0006508; GO:0007298; GO:0016020; GO:0016322; GO:0016540; GO:0019233,,,cd00214;cd00044;,PF01067;PF00648;,cytoplasm [GO:0005737]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; border follicle cell migration [GO:0007298]; neuron remodeling [GO:0016322]; protein autoprocessing [GO:0016540]; proteolysis [GO:0006508]; sensory perception of pain [GO:0019233]
Q6CSB9,CHOYP_ACT3A.1.1|m.25941,0,0,0,0,0,0,0,0,8.00E-20,Actin-related protein 4 (Actin-like protein ARP4) (Actin-like protein 4),ARP4 KLLA0D02288g,520,"chromatin remodeling [GO:0006338]; DNA repair [GO:0006281]; kinetochore assembly [GO:0051382]; regulation of transcription from RNA polymerase II promoter [GO:0006357]; transcription, DNA-templated [GO:0006351]",GO:0000812; GO:0003682; GO:0004402; GO:0006281; GO:0006338; GO:0006351; GO:0006357; GO:0031011; GO:0035267; GO:0043140; GO:0051382,,,,PF00022;,"Ino80 complex [GO:0031011]; NuA4 histone acetyltransferase complex [GO:0035267]; Swr1 complex [GO:0000812]; ATP-dependent 3'-5' DNA helicase activity [GO:0043140]; chromatin binding [GO:0003682]; histone acetyltransferase activity [GO:0004402]; chromatin remodeling [GO:0006338]; DNA repair [GO:0006281]; kinetochore assembly [GO:0051382]; regulation of transcription from RNA polymerase II promoter [GO:0006357]; transcription, DNA-templated [GO:0006351]"
A5HK05,CHOYP_APBP2.1.1|m.62244,0,0,0,0,0,0,0,0,0,Amyloid protein-binding protein 2 (Amyloid beta precursor protein-binding protein 2) (APP-BP2),Appbp2,585,intracellular transport [GO:0046907]; protein transport [GO:0015031],GO:0005634; GO:0005874; GO:0015031; GO:0030659; GO:0046907,,,,PF13374;,cytoplasmic vesicle membrane [GO:0030659]; microtubule [GO:0005874]; nucleus [GO:0005634]; intracellular transport [GO:0046907]; protein transport [GO:0015031]
Q5FVB0,CHOYP_ATXN10.1.1|m.33209,0,0,0,0,0,0,0,0,4.00E-45,Ataxin-10 (Spinocerebellar ataxia type 10 protein homolog),atxn10,485,,GO:0048471,,,,PF09759;,perinuclear region of cytoplasm [GO:0048471]
O14975,CHOYP_BRAFLDRAFT_102226.1.1|m.48829,0,0,0,0,0,0,0,0,1.00E-143,"Very long-chain acyl-CoA synthetase (VLACS) (VLCS) (EC 6.2.1.-) (Fatty acid transport protein 2) (FATP-2) (Fatty-acid-coenzyme A ligase, very long-chain 1) (Long-chain-fatty-acid--CoA ligase) (EC 6.2.1.3) (Solute carrier family 27 member 2) (THCA-CoA ligase) (Very long-chain-fatty-acid-CoA ligase)",SLC27A2 ACSVL1 FACVL1 FATP2 VLACS,620,bile acid biosynthetic process [GO:0006699]; fatty acid alpha-oxidation [GO:0001561]; fatty acid beta-oxidation [GO:0006635]; long-chain fatty acid import [GO:0044539]; long-chain fatty acid metabolic process [GO:0001676]; methyl-branched fatty acid metabolic process [GO:0097089]; neutrophil degranulation [GO:0043312]; very long-chain fatty acid catabolic process [GO:0042760],GO:0001561; GO:0001676; GO:0004467; GO:0005102; GO:0005524; GO:0005739; GO:0005778; GO:0005779; GO:0005788; GO:0005789; GO:0005886; GO:0006635; GO:0006699; GO:0015245; GO:0019899; GO:0030176; GO:0031957; GO:0035579; GO:0042760; GO:0043312; GO:0044539; GO:0050197; GO:0070062; GO:0070251; GO:0097089; GO:0102391,,,,PF00501;PF13193;,endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of peroxisomal membrane [GO:0005779]; mitochondrion [GO:0005739]; peroxisomal membrane [GO:0005778]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; ATP binding [GO:0005524]; decanoate--CoA ligase activity [GO:0102391]; enzyme binding [GO:0019899]; fatty acid transporter activity [GO:0015245]; long-chain fatty acid-CoA ligase activity [GO:0004467]; phytanate-CoA ligase activity [GO:0050197]; pristanate-CoA ligase activity [GO:0070251]; receptor binding [GO:0005102]; very long-chain fatty acid-CoA ligase activity [GO:0031957]; bile acid biosynthetic process [GO:0006699]; fatty acid alpha-oxidation [GO:0001561]; fatty acid beta-oxidation [GO:0006635]; long-chain fatty acid import [GO:0044539]; long-chain fatty acid metabolic process [GO:0001676]; methyl-branched fatty acid metabolic process [GO:0097089]; neutrophil degranulation [GO:0043312]; very long-chain fatty acid catabolic process [GO:0042760]
Q90ZE4,CHOYP_BRAFLDRAFT_118108.1.1|m.58962,0.5,0,0,0,0,0,0,0,9.00E-160,Presenilin-2 (PS-2) (Zf-PS2) (EC 3.4.23.-) (Pre2),psen2,441,beta-amyloid formation [GO:0034205]; brain development [GO:0007420]; calcium ion transport [GO:0006816]; intracellular signal transduction [GO:0035556]; melanocyte differentiation [GO:0030318]; membrane protein ectodomain proteolysis [GO:0006509]; negative regulation of apoptotic process [GO:0043066]; neurogenesis [GO:0022008]; Notch receptor processing [GO:0007220]; Notch signaling pathway [GO:0007219]; protein processing [GO:0016485]; somite development [GO:0061053],GO:0000139; GO:0004175; GO:0004190; GO:0005634; GO:0005789; GO:0005887; GO:0006509; GO:0006816; GO:0007219; GO:0007220; GO:0007420; GO:0016485; GO:0022008; GO:0030018; GO:0030318; GO:0034205; GO:0035556; GO:0043025; GO:0043066; GO:0048471; GO:0061053,,,,PF01080;,endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; Z disc [GO:0030018]; aspartic-type endopeptidase activity [GO:0004190]; endopeptidase activity [GO:0004175]; beta-amyloid formation [GO:0034205]; brain development [GO:0007420]; calcium ion transport [GO:0006816]; intracellular signal transduction [GO:0035556]; melanocyte differentiation [GO:0030318]; membrane protein ectodomain proteolysis [GO:0006509]; negative regulation of apoptotic process [GO:0043066]; neurogenesis [GO:0022008]; Notch receptor processing [GO:0007220]; Notch signaling pathway [GO:0007219]; protein processing [GO:0016485]; somite development [GO:0061053]
Q9D4P0,CHOYP_BRAFLDRAFT_284242.1.1|m.13711,0.5,0,0,0,0,0,0,0,9.00E-108,ADP-ribosylation factor-like protein 5B (ADP-ribosylation factor-like protein 8),Arl5b Arl8,179,small GTPase mediated signal transduction [GO:0007264],GO:0005525; GO:0005622; GO:0007264,,,,PF00025;,intracellular [GO:0005622]; GTP binding [GO:0005525]; small GTPase mediated signal transduction [GO:0007264]
Q7Z7G8,CHOYP_BRAFLDRAFT_75094.1.2|m.24898,0,0,0,0,0,0,0,0,3.00E-116,Vacuolar protein sorting-associated protein 13B (Cohen syndrome protein 1),VPS13B CHS1 COH1 KIAA0532,4022,protein transport [GO:0015031],GO:0015031,,,,PF12624;PF06650;PF16909;,protein transport [GO:0015031]
G3XD24,CHOYP_CAHD1.5.6|m.53893,0,0,0,0,0,0,0,0,0.000004,Methyl-accepting chemotaxis protein PctA,pctA PA4309,629,chemotaxis [GO:0006935]; response to amino acid [GO:0043200],GO:0004871; GO:0005886; GO:0006935; GO:0016021; GO:0016597; GO:0043200,,,cd06225;,PF02743;PF00672;PF00015;,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; amino acid binding [GO:0016597]; signal transducer activity [GO:0004871]; chemotaxis [GO:0006935]; response to amino acid [GO:0043200]
Q15438,CHOYP_CYH1.1.1|m.66676,0,0,0,0,0,0,0,0,0,"Cytohesin-1 (PH, SEC7 and coiled-coil domain-containing protein 1) (SEC7 homolog B2-1)",CYTH1 D17S811E PSCD1,398,regulation of ARF protein signal transduction [GO:0032012]; regulation of cell adhesion [GO:0030155]; vesicle-mediated transport [GO:0016192],GO:0000139; GO:0005086; GO:0005737; GO:0005829; GO:0005886; GO:0008289; GO:0016192; GO:0030155; GO:0031234; GO:0032012,,,,PF00169;PF01369;,cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; ARF guanyl-nucleotide exchange factor activity [GO:0005086]; lipid binding [GO:0008289]; regulation of ARF protein signal transduction [GO:0032012]; regulation of cell adhesion [GO:0030155]; vesicle-mediated transport [GO:0016192]
P31396,CHOYP_DGRI_GH14972.1.1|m.64210,0,0,0,0,0,0,0,0,1.00E-27,Probable nuclear hormone receptor HR3 (dHR3) (Nuclear receptor subfamily 1 group F member 4),Hr46 Hr3 NR1F4 CG11823,487,"metamorphosis [GO:0007552]; mushroom body development [GO:0016319]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of development, heterochronic [GO:0040034]; transcription, DNA-templated [GO:0006351]",GO:0000122; GO:0000977; GO:0003707; GO:0004879; GO:0004887; GO:0005634; GO:0006351; GO:0007552; GO:0008270; GO:0016319; GO:0040034; GO:0045944,,,,PF00104;PF00105;,"nucleus [GO:0005634]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding [GO:0004879]; steroid hormone receptor activity [GO:0003707]; thyroid hormone receptor activity [GO:0004887]; zinc ion binding [GO:0008270]; metamorphosis [GO:0007552]; mushroom body development [GO:0016319]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of development, heterochronic [GO:0040034]; transcription, DNA-templated [GO:0006351]"
Q9D773,CHOYP_ISCW_ISCW005878.1.1|m.39374,0,0,0,0,0,0,0,0,8.00E-51,"39S ribosomal protein L2, mitochondrial (L2mt) (MRP-L2)",Mrpl2,306,mitochondrial translation [GO:0032543]; translation [GO:0006412],GO:0003723; GO:0003735; GO:0005739; GO:0005762; GO:0006412; GO:0032543,,,,PF00181;PF03947;,mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]; translation [GO:0006412]
H2MTR9,CHOYP_LOC100367423.1.1|m.23397,0,0,0,0,0,0,0,0,4.00E-60,Afadin- and alpha-actinin-binding protein (ADIP) (Afadin DIL domain-interacting protein) (SSX2-interacting protein),ssx2ip,583,cell adhesion [GO:0007155]; determination of left/right symmetry [GO:0007368],GO:0005737; GO:0005813; GO:0005874; GO:0005912; GO:0007155; GO:0007368; GO:0036064,,,,PF11559;,adherens junction [GO:0005912]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; cell adhesion [GO:0007155]; determination of left/right symmetry [GO:0007368]
Q8WXX7,CHOYP_LOC100376759.2.2|m.59482,1,0,0,0,0,0,0,0,2.00E-18,Autism susceptibility gene 2 protein,AUTS2 KIAA0442,1259,innate vocalization behavior [GO:0098582]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of histone H4-K16 acetylation [GO:2000620]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; righting reflex [GO:0060013],GO:0003682; GO:0005634; GO:0045944; GO:0051571; GO:0060013; GO:0098582; GO:2000620,,,,,nucleus [GO:0005634]; chromatin binding [GO:0003682]; innate vocalization behavior [GO:0098582]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of histone H4-K16 acetylation [GO:2000620]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; righting reflex [GO:0060013]
A2AX52,CHOYP_LOC100486063.6.9|m.44250,0,0,0,0,0,0,0,0,3.00E-90,Collagen alpha-4(VI) chain,Col6a4 Dvwa,2309,cell adhesion [GO:0007155]; protein heterotrimerization [GO:0070208],GO:0005576; GO:0005578; GO:0005581; GO:0007155; GO:0043234; GO:0070208,,,,PF01391;PF00092;,collagen trimer [GO:0005581]; extracellular region [GO:0005576]; protein complex [GO:0043234]; proteinaceous extracellular matrix [GO:0005578]; cell adhesion [GO:0007155]; protein heterotrimerization [GO:0070208]
P70610,CHOYP_LOC100549486.1.1|m.54965,0.5,0,0,0,0,0,0,0,1.00E-137,Double C2-like domain-containing protein beta (Doc2-beta),Doc2b,412,calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; exocytosis [GO:0006887]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; positive regulation of insulin secretion [GO:0032024]; positive regulation of vesicle fusion [GO:0031340]; protein localization [GO:0008104],GO:0005509; GO:0005544; GO:0005737; GO:0005886; GO:0006887; GO:0008104; GO:0019905; GO:0030276; GO:0031340; GO:0032024; GO:0045956; GO:0048791; GO:0070382; GO:0098793,,,,PF00168;,cytoplasm [GO:0005737]; exocytic vesicle [GO:0070382]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; clathrin binding [GO:0030276]; syntaxin binding [GO:0019905]; calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; exocytosis [GO:0006887]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; positive regulation of insulin secretion [GO:0032024]; positive regulation of vesicle fusion [GO:0031340]; protein localization [GO:0008104]
O70244,CHOYP_LOC100705265.3.3|m.40296,0,0,0,0,0,0,0,0,0,Cubilin (460 kDa receptor) (Glycoprotein 280) (gp280) (Intrinsic factor-cobalamin receptor) (Intrinsic factor-vitamin B12 receptor),Cubn Ifcr,3623,cholesterol metabolic process [GO:0008203]; cobalamin transport [GO:0015889]; hemoglobin import [GO:0020028]; in utero embryonic development [GO:0001701]; protein homotrimerization [GO:0070207]; receptor-mediated endocytosis [GO:0006898]; response to nutrient [GO:0007584]; vitamin metabolic process [GO:0006766],GO:0001701; GO:0004872; GO:0005509; GO:0005765; GO:0005905; GO:0006766; GO:0006898; GO:0007584; GO:0008203; GO:0010008; GO:0015235; GO:0015889; GO:0016020; GO:0020028; GO:0030135; GO:0030492; GO:0030666; GO:0031419; GO:0031526; GO:0042802; GO:0043202; GO:0043234; GO:0070207,,,cd00041;,PF00431;PF00008;PF12947;PF07645;,brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; coated vesicle [GO:0030135]; endocytic vesicle membrane [GO:0030666]; endosome membrane [GO:0010008]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; protein complex [GO:0043234]; calcium ion binding [GO:0005509]; cobalamin binding [GO:0031419]; cobalamin transporter activity [GO:0015235]; hemoglobin binding [GO:0030492]; identical protein binding [GO:0042802]; receptor activity [GO:0004872]; cholesterol metabolic process [GO:0008203]; cobalamin transport [GO:0015889]; hemoglobin import [GO:0020028]; in utero embryonic development [GO:0001701]; protein homotrimerization [GO:0070207]; receptor-mediated endocytosis [GO:0006898]; response to nutrient [GO:0007584]; vitamin metabolic process [GO:0006766]
P70684,CHOYP_LOC591898.1.2|m.28918,0,0,0,0,0,0,0,0,1.00E-60,15-hydroxyprostaglandin dehydrogenase [NAD(+)] (15-PGDH) (EC 1.1.1.141) (Prostaglandin dehydrogenase 1),HPGD PGDH1,265,ductus arteriosus closure [GO:0097070]; female pregnancy [GO:0007565]; negative regulation of cell cycle [GO:0045786]; ovulation [GO:0030728]; parturition [GO:0007567]; prostaglandin metabolic process [GO:0006693]; thrombin-activated receptor signaling pathway [GO:0070493]; transforming growth factor beta receptor signaling pathway [GO:0007179],GO:0003824; GO:0004957; GO:0005737; GO:0006693; GO:0007179; GO:0007565; GO:0007567; GO:0016404; GO:0030728; GO:0045786; GO:0051287; GO:0070403; GO:0070493; GO:0097070,,,,PF00106;,cytoplasm [GO:0005737]; 15-hydroxyprostaglandin dehydrogenase (NAD+) activity [GO:0016404]; catalytic activity [GO:0003824]; NAD binding [GO:0051287]; NAD+ binding [GO:0070403]; prostaglandin E receptor activity [GO:0004957]; ductus arteriosus closure [GO:0097070]; female pregnancy [GO:0007565]; negative regulation of cell cycle [GO:0045786]; ovulation [GO:0030728]; parturition [GO:0007567]; prostaglandin metabolic process [GO:0006693]; thrombin-activated receptor signaling pathway [GO:0070493]; transforming growth factor beta receptor signaling pathway [GO:0007179]
Q6DFB7,CHOYP_LOC592888.1.1|m.63240,0,0,0,0,0,0,0,0,2.00E-85,Centrosomal protein POC5 (Protein of centriole 5),poc5,572,cell cycle [GO:0007049],GO:0005814; GO:0007049,,,,,centriole [GO:0005814]; cell cycle [GO:0007049]
O70244,CHOYP_MASP2.1.1|m.3029,0,0,0,0,0,0,0,0,5.00E-11,Cubilin (460 kDa receptor) (Glycoprotein 280) (gp280) (Intrinsic factor-cobalamin receptor) (Intrinsic factor-vitamin B12 receptor),Cubn Ifcr,3623,cholesterol metabolic process [GO:0008203]; cobalamin transport [GO:0015889]; hemoglobin import [GO:0020028]; in utero embryonic development [GO:0001701]; protein homotrimerization [GO:0070207]; receptor-mediated endocytosis [GO:0006898]; response to nutrient [GO:0007584]; vitamin metabolic process [GO:0006766],GO:0001701; GO:0004872; GO:0005509; GO:0005765; GO:0005905; GO:0006766; GO:0006898; GO:0007584; GO:0008203; GO:0010008; GO:0015235; GO:0015889; GO:0016020; GO:0020028; GO:0030135; GO:0030492; GO:0030666; GO:0031419; GO:0031526; GO:0042802; GO:0043202; GO:0043234; GO:0070207,,,cd00041;,PF00431;PF00008;PF12947;PF07645;,brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; coated vesicle [GO:0030135]; endocytic vesicle membrane [GO:0030666]; endosome membrane [GO:0010008]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; protein complex [GO:0043234]; calcium ion binding [GO:0005509]; cobalamin binding [GO:0031419]; cobalamin transporter activity [GO:0015235]; hemoglobin binding [GO:0030492]; identical protein binding [GO:0042802]; receptor activity [GO:0004872]; cholesterol metabolic process [GO:0008203]; cobalamin transport [GO:0015889]; hemoglobin import [GO:0020028]; in utero embryonic development [GO:0001701]; protein homotrimerization [GO:0070207]; receptor-mediated endocytosis [GO:0006898]; response to nutrient [GO:0007584]; vitamin metabolic process [GO:0006766]
P0DJG4,CHOYP_NEMVEDRAFT_V1G160170.1.1|m.66042,3.5,0,0,0,0,0,0,0,4.00E-27,Testicular haploid expressed gene protein-like (Theg spermatid-like protein),THEGL,465,,,,,,PF14912;,
P28699,CHOYP_RORA.1.2|m.59037,0,0,0,0,0,0,0,0,1.00E-40,Retinoic acid receptor gamma (RAR-gamma) (Nuclear receptor subfamily 1 group B member 3),rarg nr1b3,476,"transcription, DNA-templated [GO:0006351]",GO:0003707; GO:0003708; GO:0005634; GO:0006351; GO:0008270; GO:0043565,,,,PF00104;PF00105;,"nucleus [GO:0005634]; retinoic acid receptor activity [GO:0003708]; sequence-specific DNA binding [GO:0043565]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]; transcription, DNA-templated [GO:0006351]"
P33628,CHOYP_TBA1.7.9|m.44107,0,0,0,0,0,0,0,0,4.00E-67,Tubulin alpha chain (Fragment),TUBA,113,microtubule-based process [GO:0007017],GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017,,,,PF00091;,cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]
O00461,CHOYP_TVAG_168130.1.2|m.10205,4,0,0,0,0,0,0,0,7.00E-11,"Golgi integral membrane protein 4 (Golgi integral membrane protein, cis) (GIMPc) (Golgi phosphoprotein 4) (Golgi-localized phosphoprotein of 130 kDa) (Golgi phosphoprotein of 130 kDa)",GOLIM4 GIMPC GOLPH4 GPP130,696,transport [GO:0006810],GO:0000139; GO:0005794; GO:0005796; GO:0005801; GO:0006810; GO:0010008; GO:0016020; GO:0016021; GO:0030133; GO:0030139; GO:0032580,,,,,cis-Golgi network [GO:0005801]; endocytic vesicle [GO:0030139]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi lumen [GO:0005796]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; transport vesicle [GO:0030133]; transport [GO:0006810]
Q03650,CHOYP_contig_041717|m.47768,0,0,0,0,0,0,0,0,0.000000002,"Cysteine-rich, acidic integral membrane protein",CRAM,945,endocytosis [GO:0006897],GO:0005886; GO:0006897; GO:0016021; GO:0020016,,,,PF07016;,ciliary pocket [GO:0020016]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; endocytosis [GO:0006897]
Q8IZS6,CHOYP_BRAFLDRAFT_126379.1.3|m.5102,1,0,0,0,0,0,0,0,4.00E-13,Tctex1 domain-containing protein 3 (T-complex testis-specific protein 3) (T-complex-associated testis-expressed protein 3) (Tcte-3),TCTE3 TCTEX1D3,198,transport [GO:0006810],GO:0003774; GO:0005737; GO:0005874; GO:0006810; GO:0016020; GO:0030286,,,,PF03645;,cytoplasm [GO:0005737]; dynein complex [GO:0030286]; membrane [GO:0016020]; microtubule [GO:0005874]; motor activity [GO:0003774]; transport [GO:0006810]
P70031,CHOYP_CCKAR.4.6|m.43964,0,0,0,0,0,0,0,0,6.00E-87,Cholecystokinin receptor (CCK-XLR),cckar,453,,GO:0004930; GO:0005886; GO:0016021,,,,PF00001;,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G-protein coupled receptor activity [GO:0004930]
H2A0L4,CHOYP_CHI1.1.1|m.40259,0,0,0,0,0,0,0,0,0,Putative chitinase 1 (EC 3.2.1.14) (Chitinase-like protein 1) (Clp1),,468,carbohydrate metabolic process [GO:0005975]; chitin catabolic process [GO:0006032],GO:0004568; GO:0005576; GO:0005975; GO:0006032,,,,PF00704;,extracellular region [GO:0005576]; chitinase activity [GO:0004568]; carbohydrate metabolic process [GO:0005975]; chitin catabolic process [GO:0006032]
Q9V9Z1,CHOYP_DSEC_GM12928.1.1|m.11933,0,0,0,0,0,0,0,0,0.000000003,"39S ribosomal protein L32, mitochondrial (L32mt) (MRP-L32)",mRpL32 CG12220,195,mitochondrial translation [GO:0032543]; translation [GO:0006412],GO:0003735; GO:0005743; GO:0005762; GO:0006412; GO:0032543,,,,,mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]; translation [GO:0006412]
Q7T1K4,CHOYP_ER.1.2|m.14189,1.5,0,0,0,0,0,0,0,1.00E-42,Androgen receptor (bfAR) (Dihydrotestosterone receptor) (Nuclear receptor subfamily 3 group C member 4),ar nr3c4,777,"regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]",GO:0003700; GO:0004882; GO:0005496; GO:0005497; GO:0005634; GO:0005737; GO:0006351; GO:0006355; GO:0008270; GO:0043565; GO:0050681,,,,PF02166;PF00104;PF00105;,"cytoplasm [GO:0005737]; nucleus [GO:0005634]; androgen binding [GO:0005497]; androgen receptor activity [GO:0004882]; androgen receptor binding [GO:0050681]; sequence-specific DNA binding [GO:0043565]; steroid binding [GO:0005496]; transcription factor activity, sequence-specific DNA binding [GO:0003700]; zinc ion binding [GO:0008270]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]"
Q96MM6,CHOYP_HSPA12B.1.1|m.36165,0,0,0,0,0,0,0,0,1.00E-24,Heat shock 70 kDa protein 12B,HSPA12B C20orf60,686,,GO:0005524,,,,,ATP binding [GO:0005524]
Q9ESM0,CHOYP_IP6K1.1.1|m.54347,0,0,0,0,0,0,0,0,1.00E-108,Inositol hexakisphosphate kinase 1 (InsP6 kinase 1) (EC 2.7.4.21) (Inositol hexaphosphate kinase 1),Ip6k1 Ihpk1,433,phosphatidylinositol phosphorylation [GO:0046854],GO:0000832; GO:0001650; GO:0005524; GO:0005829; GO:0008440; GO:0046854; GO:0052723; GO:0052724,,,,PF03770;,"cytosol [GO:0005829]; fibrillar center [GO:0001650]; ATP binding [GO:0005524]; inositol hexakisphosphate 1-kinase activity [GO:0052723]; inositol hexakisphosphate 3-kinase activity [GO:0052724]; inositol hexakisphosphate 5-kinase activity [GO:0000832]; inositol-1,4,5-trisphosphate 3-kinase activity [GO:0008440]; phosphatidylinositol phosphorylation [GO:0046854]"
Q9M1W7,CHOYP_KLH26.1.2|m.8792,3,0,0,0,0,0,0,0,9.00E-11,F-box/kelch-repeat protein SKIP30 (SKP1-interacting partner 30),SKIP30 At3g63220 F16M2.70,352,protein ubiquitination [GO:0016567],GO:0016567,PATHWAY: Protein modification; protein ubiquitination.,,,PF01344;,protein ubiquitination [GO:0016567]
Q5RDY3,CHOYP_KLHL24.1.4|m.8833,0,0,0,0,0,0,0,0,4.00E-41,Kelch repeat and BTB domain-containing protein 2,KBTBD2,623,,,,,,PF07707;PF00651;PF01344;,
Q38SD2,CHOYP_LOC100366408.1.1|m.37601,0,0,0,0,0,0,0,0,0,Leucine-rich repeat serine/threonine-protein kinase 1 (EC 2.7.11.1),LRRK1 KIAA1790,2015,bone resorption [GO:0045453]; intracellular signal transduction [GO:0035556]; negative regulation of peptidyl-tyrosine phosphorylation [GO:0050732]; osteoclast development [GO:0036035]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; protein phosphorylation [GO:0006468]; small GTPase mediated signal transduction [GO:0007264],GO:0004674; GO:0004871; GO:0005524; GO:0005525; GO:0005737; GO:0005739; GO:0005829; GO:0006468; GO:0007264; GO:0035556; GO:0036035; GO:0042802; GO:0045453; GO:0046872; GO:0050731; GO:0050732; GO:0090263; GO:1902533,,,,PF12796;PF16095;PF00069;PF08477;,cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; signal transducer activity [GO:0004871]; bone resorption [GO:0045453]; intracellular signal transduction [GO:0035556]; negative regulation of peptidyl-tyrosine phosphorylation [GO:0050732]; osteoclast development [GO:0036035]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; protein phosphorylation [GO:0006468]; small GTPase mediated signal transduction [GO:0007264]
D2GXS7,CHOYP_LOC100369014.9.9|m.53367,1,0,0,0,0,0,0,0,0.0000004,Tripartite motif-containing protein 2 (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRIM2) (RING-type E3 ubiquitin transferase TRIM2),TRIM2,744,regulation of neuron apoptotic process [GO:0043523],GO:0004842; GO:0005737; GO:0008270; GO:0043523,PATHWAY: Protein modification; protein ubiquitination.,,,PF00630;PF01436;PF00643;PF13445;,cytoplasm [GO:0005737]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; regulation of neuron apoptotic process [GO:0043523]
Q3TLD5,CHOYP_LOC100371571.1.1|m.2417,0.5,0,0,0,0,0,0,0,5.00E-34,Unconventional prefoldin RPB5 interactor (Protein NNX3) (Protein phosphatase 1 regulatory subunit 19) (RNA polymerase II subunit 5-mediating protein) (RPB5-mediating protein),Uri1 Nnx3 Ppp1r19 Rmp Uri,531,"cellular response to growth factor stimulus [GO:0071363]; cellular response to steroid hormone stimulus [GO:0071383]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of phosphatase activity [GO:0010923]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; regulation of cell growth [GO:0001558]; regulation of transcription from RNA polymerase II promoter [GO:0006357]; response to virus [GO:0009615]; transcription, DNA-templated [GO:0006351]",GO:0000122; GO:0001106; GO:0001558; GO:0003682; GO:0004864; GO:0005634; GO:0005654; GO:0005665; GO:0005737; GO:0005739; GO:0005829; GO:0006351; GO:0006357; GO:0009615; GO:0010923; GO:0019212; GO:0030425; GO:0051219; GO:0071363; GO:0071383; GO:2001243,,,,PF02996;,"cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; DNA-directed RNA polymerase II, core complex [GO:0005665]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; phosphatase inhibitor activity [GO:0019212]; phosphoprotein binding [GO:0051219]; protein phosphatase inhibitor activity [GO:0004864]; RNA polymerase II transcription corepressor activity [GO:0001106]; cellular response to growth factor stimulus [GO:0071363]; cellular response to steroid hormone stimulus [GO:0071383]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of phosphatase activity [GO:0010923]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; regulation of cell growth [GO:0001558]; regulation of transcription from RNA polymerase II promoter [GO:0006357]; response to virus [GO:0009615]; transcription, DNA-templated [GO:0006351]"
Q69ZM6,CHOYP_LOC100372921.2.2|m.56247,1,0,0,0,0,0,0,0,2.00E-91,Serine/threonine-protein kinase 36 (EC 2.7.11.1) (Fused homolog),Stk36 Kiaa1278,1316,brain development [GO:0007420]; cilium assembly [GO:0060271]; epithelial cilium movement [GO:0003351]; positive regulation of hh target transcription factor activity [GO:0007228]; positive regulation of smoothened signaling pathway [GO:0045880]; post-embryonic development [GO:0009791]; regulation of sequence-specific DNA binding transcription factor activity [GO:0051090],GO:0003351; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0007228; GO:0007420; GO:0008134; GO:0009791; GO:0045880; GO:0046872; GO:0051090; GO:0060271,,,,PF00069;,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; transcription factor binding [GO:0008134]; brain development [GO:0007420]; cilium assembly [GO:0060271]; epithelial cilium movement [GO:0003351]; positive regulation of hh target transcription factor activity [GO:0007228]; positive regulation of smoothened signaling pathway [GO:0045880]; post-embryonic development [GO:0009791]; regulation of sequence-specific DNA binding transcription factor activity [GO:0051090]
Q0V8M0,CHOYP_LOC100489126.1.1|m.18822,0,0,0,0,0,0,0,0,3.00E-143,Protein KRI1 homolog,KRI1,705,"endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000447]",GO:0000447; GO:0005730; GO:0030686,,,,PF05178;PF12936;,"90S preribosome [GO:0030686]; nucleolus [GO:0005730]; endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000447]"
P0CT43,CHOYP_LOC100493440.1.2|m.17291,0,0,0,0,0,0,0,0,0.00000006,Transposon Tf2-8 polyprotein (Retrotransposable element Tf2 155 kDa protein),Tf2-8 Tf2-9 SPAC13D1.02c SPAC19D5.09c,1333,DNA integration [GO:0015074]; DNA recombination [GO:0006310],GO:0003677; GO:0003723; GO:0003887; GO:0003964; GO:0004190; GO:0004519; GO:0006310; GO:0015074; GO:0046872,,,,PF12382;PF00665;PF00078;,aspartic-type endopeptidase activity [GO:0004190]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]
P70031,CHOYP_LOC100890822.1.2|m.23399,0,0,0,0,0,0,0,0,0.00000001,Cholecystokinin receptor (CCK-XLR),cckar,453,,GO:0004930; GO:0005886; GO:0016021,,,,PF00001;,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G-protein coupled receptor activity [GO:0004930]
A8K0R7,CHOYP_LOC100900174.1.1|m.14983,0,0,0,0,0,0,0,0,7.00E-15,Zinc finger protein 839 (Renal carcinoma antigen NY-REN-50),ZNF839 C14orf131,811,,GO:0046872,,,,PF15961;,metal ion binding [GO:0046872]
P70031,CHOYP_LOC101076498.2.2|m.25096,0,0,0,0,0,0,0,0,6.00E-20,Cholecystokinin receptor (CCK-XLR),cckar,453,,GO:0004930; GO:0005886; GO:0016021,,,,PF00001;,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G-protein coupled receptor activity [GO:0004930]
Q8WXR4,CHOYP_LOC373229.2.3|m.43412,0,0,0,0,0,0,0,0,1.00E-141,Myosin-IIIb (EC 2.7.11.1),MYO3B,1341,response to stimulus [GO:0050896]; visual perception [GO:0007601],GO:0003774; GO:0004674; GO:0005524; GO:0005737; GO:0007601; GO:0016459; GO:0050896,,,,PF00612;PF00063;PF00069;,cytoplasm [GO:0005737]; myosin complex [GO:0016459]; ATP binding [GO:0005524]; motor activity [GO:0003774]; protein serine/threonine kinase activity [GO:0004674]; response to stimulus [GO:0050896]; visual perception [GO:0007601]
P38650,CHOYP_LOC577805.3.4|m.46026,0.5,0,0,0,0,0,0,0,1.00E-39,"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic) (MAP 1C)",Dync1h1 Dhc1 Dnch1 Dnchc1 Dnec1 Dyhc Map1c,4644,microtubule-based movement [GO:0007018]; transport [GO:0006810],GO:0003777; GO:0005524; GO:0005737; GO:0005874; GO:0006810; GO:0007018; GO:0016887; GO:0030286,,,,PF07728;PF12780;PF08385;PF08393;PF03028;PF12777;,cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; microtubule motor activity [GO:0003777]; microtubule-based movement [GO:0007018]; transport [GO:0006810]
Q9GKY8,CHOYP_LOC662408.1.1|m.44393,0.5,0,0,0,0,0,0,0,1.00E-148,Junctophilin-1 (JP-1) (Junctophilin type 1) (Mitsugumin-72) (Mg72),JPH1 JP1 MG72,662,,GO:0005886; GO:0016021; GO:0030314; GO:0033017,,,,PF02493;,integral component of membrane [GO:0016021]; junctional membrane complex [GO:0030314]; plasma membrane [GO:0005886]; sarcoplasmic reticulum membrane [GO:0033017]
Q52KK4,CHOYP_NAF1.1.1|m.13716,0,0,0,0,0,0,0,0,3.00E-44,H/ACA ribonucleoprotein complex non-core subunit NAF1,Naf1,457,pseudouridine synthesis [GO:0001522]; ribosome biogenesis [GO:0042254]; rRNA processing [GO:0006364],GO:0001522; GO:0003723; GO:0005634; GO:0005732; GO:0005737; GO:0006364; GO:0042254,,,,PF04410;,cytoplasm [GO:0005737]; nucleus [GO:0005634]; small nucleolar ribonucleoprotein complex [GO:0005732]; RNA binding [GO:0003723]; pseudouridine synthesis [GO:0001522]; ribosome biogenesis [GO:0042254]; rRNA processing [GO:0006364]
A8TX70,CHOYP_NEMVEDRAFT_V1G52068.2.3|m.36345,0,0,0,0,0,0,0,0,2.00E-24,Collagen alpha-5(VI) chain (Collagen alpha-1(XXIX) chain) (von Willebrand factor A domain-containing protein 4),COL6A5 COL29A1 VWA4,2615,cell adhesion [GO:0007155]; collagen catabolic process [GO:0030574],GO:0005576; GO:0005578; GO:0005581; GO:0007155; GO:0030574,,,,PF01391;PF00092;,collagen trimer [GO:0005581]; extracellular region [GO:0005576]; proteinaceous extracellular matrix [GO:0005578]; cell adhesion [GO:0007155]; collagen catabolic process [GO:0030574]
Q5ZID2,CHOYP_PDCD2L.1.1|m.43699,0,0,0,0,0,0,0,0,3.00E-63,Programmed cell death protein 2-like,PDCD2L RCJMB04_27n18,379,,GO:0005737,,,,PF04194;,cytoplasm [GO:0005737]
Q96GD3,CHOYP_SCMH1.1.1|m.1166,0.5,0,0,0,0,0,0,0,1.00E-160,Polycomb protein SCMH1 (Sex comb on midleg homolog 1),SCMH1,660,"anatomical structure morphogenesis [GO:0009653]; anterior/posterior pattern specification [GO:0009952]; chromatin remodeling [GO:0006338]; gene silencing [GO:0016458]; negative regulation of transcription, DNA-templated [GO:0045892]; spermatogenesis [GO:0007283]; transcription, DNA-templated [GO:0006351]",GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0006338; GO:0006351; GO:0007283; GO:0009653; GO:0009952; GO:0010369; GO:0016458; GO:0045892,,,,PF02820;PF17208;PF00536;PF12140;,"chromocenter [GO:0010369]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; transcription factor activity, sequence-specific DNA binding [GO:0003700]; anatomical structure morphogenesis [GO:0009653]; anterior/posterior pattern specification [GO:0009952]; chromatin remodeling [GO:0006338]; gene silencing [GO:0016458]; negative regulation of transcription, DNA-templated [GO:0045892]; spermatogenesis [GO:0007283]; transcription, DNA-templated [GO:0006351]"
Q6ZPY2,CHOYP_SMG5.1.1|m.21320,0,0,0,0,0,0,0,0,0,Protein SMG5 (EST1-like protein B) (SMG-5 homolog),Smg5 Est1b Kiaa1089,1017,"mRNA export from nucleus [GO:0006406]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; regulation of dephosphorylation [GO:0035303]; regulation of RNA stability [GO:0043487]; regulation of telomere maintenance [GO:0032204]; telomere maintenance via telomerase [GO:0007004]",GO:0000184; GO:0000932; GO:0004540; GO:0005634; GO:0005697; GO:0005737; GO:0006406; GO:0007004; GO:0031625; GO:0032204; GO:0035303; GO:0042162; GO:0042826; GO:0043021; GO:0043487; GO:0051721; GO:0070034; GO:0070182,,,,PF10374;PF10373;PF13638;,"cytoplasm [GO:0005737]; nucleus [GO:0005634]; P-body [GO:0000932]; telomerase holoenzyme complex [GO:0005697]; DNA polymerase binding [GO:0070182]; histone deacetylase binding [GO:0042826]; protein phosphatase 2A binding [GO:0051721]; ribonuclease activity [GO:0004540]; ribonucleoprotein complex binding [GO:0043021]; telomerase RNA binding [GO:0070034]; telomeric DNA binding [GO:0042162]; ubiquitin protein ligase binding [GO:0031625]; mRNA export from nucleus [GO:0006406]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; regulation of dephosphorylation [GO:0035303]; regulation of RNA stability [GO:0043487]; regulation of telomere maintenance [GO:0032204]; telomere maintenance via telomerase [GO:0007004]"
P56719,CHOYP_AAEL_AAEL010626.1.1|m.52019,0,0,0,0,0,0,0,0,1.00E-11,Orexin receptor type 2 (Ox-2-R) (Ox2-R) (Ox2R) (Hypocretin receptor type 2),Hcrtr2,460,"cellular response to hormone stimulus [GO:0032870]; circadian sleep/wake cycle process [GO:0022410]; feeding behavior [GO:0007631]; G-protein coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218]; phospholipase C-activating G-protein coupled receptor signaling pathway [GO:0007200]; regulation of circadian sleep/wake cycle, sleep [GO:0045187]; regulation of circadian sleep/wake cycle, wakefulness [GO:0010840]; regulation of cytosolic calcium ion concentration [GO:0051480]; response to peptide [GO:1901652]",GO:0004930; GO:0005887; GO:0007186; GO:0007200; GO:0007218; GO:0007631; GO:0010840; GO:0016499; GO:0017046; GO:0022410; GO:0032870; GO:0045187; GO:0051480; GO:1901652,,,,PF00001;PF03827;,"integral component of plasma membrane [GO:0005887]; G-protein coupled receptor activity [GO:0004930]; orexin receptor activity [GO:0016499]; peptide hormone binding [GO:0017046]; cellular response to hormone stimulus [GO:0032870]; circadian sleep/wake cycle process [GO:0022410]; feeding behavior [GO:0007631]; G-protein coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218]; phospholipase C-activating G-protein coupled receptor signaling pathway [GO:0007200]; regulation of circadian sleep/wake cycle, sleep [GO:0045187]; regulation of circadian sleep/wake cycle, wakefulness [GO:0010840]; regulation of cytosolic calcium ion concentration [GO:0051480]; response to peptide [GO:1901652]"
Q8NF91,CHOYP_ACTN.2.2|m.63975,0,0,0,0,0,0,0,0,4.00E-37,Nesprin-1 (Enaptin) (KASH domain-containing protein 1) (KASH1) (Myocyte nuclear envelope protein 1) (Myne-1) (Nuclear envelope spectrin repeat protein 1) (Synaptic nuclear envelope protein 1) (Syne-1),SYNE1 C6orf98 KIAA0796 KIAA1262 KIAA1756 MYNE1,8797,cytoskeletal anchoring at nuclear membrane [GO:0090286]; Golgi organization [GO:0007030]; muscle cell differentiation [GO:0042692]; nuclear matrix anchoring at nuclear membrane [GO:0090292]; nucleus organization [GO:0006997]; spermatogenesis [GO:0007283],GO:0000932; GO:0003723; GO:0003779; GO:0005521; GO:0005634; GO:0005635; GO:0005640; GO:0005654; GO:0005730; GO:0005737; GO:0005794; GO:0005856; GO:0006997; GO:0007030; GO:0007283; GO:0016021; GO:0019899; GO:0030017; GO:0031965; GO:0034993; GO:0042692; GO:0042802; GO:0042803; GO:0045211; GO:0051015; GO:0090286; GO:0090292,,,cd00014;,PF00307;PF10541;PF00435;,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; LINC complex [GO:0034993]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear outer membrane [GO:0005640]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; postsynaptic membrane [GO:0045211]; sarcomere [GO:0030017]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; lamin binding [GO:0005521]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; cytoskeletal anchoring at nuclear membrane [GO:0090286]; Golgi organization [GO:0007030]; muscle cell differentiation [GO:0042692]; nuclear matrix anchoring at nuclear membrane [GO:0090292]; nucleus organization [GO:0006997]; spermatogenesis [GO:0007283]
Q04281,CHOYP_BRAFLDRAFT_278777.1.1|m.1970,0,0,0,0,0,0,0,0,1.00E-55,Homeobox protein XHOX-7.1 (Fragment),,295,"multicellular organism development [GO:0007275]; regulation of transcription, DNA-templated [GO:0006355]",GO:0005634; GO:0006355; GO:0007275; GO:0043565,,,,PF00046;,"nucleus [GO:0005634]; sequence-specific DNA binding [GO:0043565]; multicellular organism development [GO:0007275]; regulation of transcription, DNA-templated [GO:0006355]"
Q8WWF6,CHOYP_DNAJB6B.1.2|m.1265,0,0,0,0,0,0,0,0,5.00E-39,DnaJ homolog subfamily B member 3,DNAJB3 HCG3,145,,GO:0070062,,,cd06257;,PF00226;,extracellular exosome [GO:0070062]
O70400,CHOYP_ISCW_ISCW000210.2.4|m.14990,0,0,0,0,0,0,0,0,1.00E-10,PDZ and LIM domain protein 1 (C-terminal LIM domain protein 1) (Elfin) (LIM domain protein CLP-36),Pdlim1 Clim1,327,"regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]",GO:0001666; GO:0003713; GO:0005667; GO:0005737; GO:0005856; GO:0005913; GO:0005925; GO:0006355; GO:0008270; GO:0098641,,,,PF15936;PF00412;PF00595;,"cell-cell adherens junction [GO:0005913]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; focal adhesion [GO:0005925]; transcription factor complex [GO:0005667]; cadherin binding involved in cell-cell adhesion [GO:0098641]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]"
Q9R1C6,CHOYP_ISCW_ISCW016328.1.1|m.10256,0,0,0,0,0,0,0,0,2.00E-149,Diacylglycerol kinase epsilon (DAG kinase epsilon) (EC 2.7.1.107) (Diglyceride kinase epsilon) (DGK-epsilon),Dgke,564,intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; protein kinase C-activating G-protein coupled receptor signaling pathway [GO:0007205],GO:0004143; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0007205; GO:0016020; GO:0016021; GO:0016301; GO:0035556; GO:0046834; GO:0046872,,,cd00029;,PF00130;PF00609;PF00781;,cytoplasm [GO:0005737]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleus [GO:0005634]; ATP binding [GO:0005524]; diacylglycerol kinase activity [GO:0004143]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; protein kinase C-activating G-protein coupled receptor signaling pathway [GO:0007205]
P27398,CHOYP_LOC100165317.1.1|m.8504,0,0,0,0,0,0,0,0,6.00E-76,Calpain-D (EC 3.4.22.-) (Calcium-activated neutral proteinase D) (CANP D) (Small optic lobes protein),sol CalpD CG1391,1594,nervous system development [GO:0007399]; proteolysis [GO:0006508]; temperature compensation of the circadian clock [GO:0010378]; visual perception [GO:0007601],GO:0004198; GO:0005622; GO:0005737; GO:0006508; GO:0007399; GO:0007601; GO:0008270; GO:0010378,,,cd00044;,PF00648;PF00641;,cytoplasm [GO:0005737]; intracellular [GO:0005622]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; zinc ion binding [GO:0008270]; nervous system development [GO:0007399]; proteolysis [GO:0006508]; temperature compensation of the circadian clock [GO:0010378]; visual perception [GO:0007601]
Q3T0W7,CHOYP_LOC100369330.1.1|m.48177,0,0,0,0,0,0,0,0,1.00E-41,Ubiquitin-like protein ATG12 (Autophagy-related protein 12) (APG12-like),ATG12,140,autophagosome assembly [GO:0000045]; C-terminal protein lipidation [GO:0006501]; innate immune response [GO:0045087]; mitophagy [GO:0000422]; nucleophagy [GO:0044804],GO:0000045; GO:0000422; GO:0006501; GO:0019776; GO:0034045; GO:0034274; GO:0044804; GO:0045087,,,cd01612;,PF04110;,Atg12-Atg5-Atg16 complex [GO:0034274]; pre-autophagosomal structure membrane [GO:0034045]; Atg8 ligase activity [GO:0019776]; autophagosome assembly [GO:0000045]; C-terminal protein lipidation [GO:0006501]; innate immune response [GO:0045087]; mitophagy [GO:0000422]; nucleophagy [GO:0044804]
S4R2P9,CHOYP_LOC100371845.3.3|m.62472,0,0,0,0,0,0,0,0,1.00E-156,Sodium/calcium exchanger 3 (Na(+)/Ca(2+)-exchange protein 3) (Solute carrier family 8 member 3),Slc8a3 Ncx3,928,calcium ion export from cell [GO:1990034]; calcium ion import into cell [GO:1990035]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport into cytosol [GO:0060402]; cell communication [GO:0007154]; cellular calcium ion homeostasis [GO:0006874]; cellular response to cAMP [GO:0071320]; cellular response to hypoxia [GO:0071456]; hematopoietic progenitor cell differentiation [GO:0002244]; learning [GO:0007612]; long-term synaptic potentiation [GO:0060291]; memory [GO:0007613]; metal ion transport [GO:0030001]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial calcium ion transport [GO:0006851]; myelination [GO:0042552]; oligodendrocyte differentiation [GO:0048709]; regulation of skeletal muscle contraction [GO:0014819]; sodium ion transmembrane transport [GO:0035725]; telencephalon development [GO:0021537],GO:0002244; GO:0005432; GO:0005741; GO:0005789; GO:0005874; GO:0005887; GO:0006851; GO:0006874; GO:0007154; GO:0007612; GO:0007613; GO:0014819; GO:0015368; GO:0016528; GO:0021537; GO:0030001; GO:0030054; GO:0031226; GO:0031594; GO:0035725; GO:0042383; GO:0042552; GO:0043197; GO:0043204; GO:0046872; GO:0048471; GO:0048709; GO:0051560; GO:0060291; GO:0060402; GO:0070588; GO:0071320; GO:0071456; GO:0099580; GO:1990034; GO:1990035,,,,PF03160;PF01699;PF16494;,cell junction [GO:0030054]; dendritic spine [GO:0043197]; endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; intrinsic component of plasma membrane [GO:0031226]; microtubule [GO:0005874]; mitochondrial outer membrane [GO:0005741]; neuromuscular junction [GO:0031594]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; sarcolemma [GO:0042383]; sarcoplasm [GO:0016528]; calcium:cation antiporter activity [GO:0015368]; calcium:sodium antiporter activity [GO:0005432]; ion antiporter activity involved in regulation of postsynaptic membrane potential [GO:0099580]; metal ion binding [GO:0046872]; calcium ion export from cell [GO:1990034]; calcium ion import into cell [GO:1990035]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport into cytosol [GO:0060402]; cell communication [GO:0007154]; cellular calcium ion homeostasis [GO:0006874]; cellular response to cAMP [GO:0071320]; cellular response to hypoxia [GO:0071456]; hematopoietic progenitor cell differentiation [GO:0002244]; learning [GO:0007612]; long-term synaptic potentiation [GO:0060291]; memory [GO:0007613]; metal ion transport [GO:0030001]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial calcium ion transport [GO:0006851]; myelination [GO:0042552]; oligodendrocyte differentiation [GO:0048709]; regulation of skeletal muscle contraction [GO:0014819]; sodium ion transmembrane transport [GO:0035725]; telencephalon development [GO:0021537]
A4IF63,CHOYP_LOC100373444.72.79|m.60850,0,0,0,0,0,0,0,0,3.00E-13,Tripartite motif-containing protein 2 (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRIM2) (RING-type E3 ubiquitin transferase TRIM2),TRIM2,744,regulation of neuron apoptotic process [GO:0043523],GO:0004842; GO:0005737; GO:0008270; GO:0043523,PATHWAY: Protein modification; protein ubiquitination.,,,PF00630;PF01436;PF00643;PF13445;,cytoplasm [GO:0005737]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; regulation of neuron apoptotic process [GO:0043523]
A4IF63,CHOYP_LOC100375551.2.2|m.63719,0.5,0,0,0,0,0,0,0,0.000000003,Tripartite motif-containing protein 2 (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRIM2) (RING-type E3 ubiquitin transferase TRIM2),TRIM2,744,regulation of neuron apoptotic process [GO:0043523],GO:0004842; GO:0005737; GO:0008270; GO:0043523,PATHWAY: Protein modification; protein ubiquitination.,,,PF00630;PF01436;PF00643;PF13445;,cytoplasm [GO:0005737]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; regulation of neuron apoptotic process [GO:0043523]
Q3V384,CHOYP_LOC100642494.1.1|m.58088,0,0,0,0,0,0,0,0,5.00E-143,Lactation elevated protein 1,Lace1,480,,GO:0005524; GO:0005739,,,,PF03969;,mitochondrion [GO:0005739]; ATP binding [GO:0005524]
Q5E9P6,CHOYP_LOC100699837.1.1|m.54956,0,0,0,0,0,0,0,0,7.00E-76,Seipin (Bernardinelli-Seip congenital lipodystrophy type 2 protein homolog),BSCL2,394,fat cell differentiation [GO:0045444]; lipid catabolic process [GO:0016042]; lipid particle organization [GO:0034389]; lipid storage [GO:0019915]; negative regulation of lipid catabolic process [GO:0050995],GO:0016042; GO:0019915; GO:0030176; GO:0034389; GO:0045444; GO:0050995,,,,PF06775;,integral component of endoplasmic reticulum membrane [GO:0030176]; fat cell differentiation [GO:0045444]; lipid catabolic process [GO:0016042]; lipid particle organization [GO:0034389]; lipid storage [GO:0019915]; negative regulation of lipid catabolic process [GO:0050995]
A2AVA0,CHOYP_LOC100906063.3.3|m.63970,0,0,0,0,0,0,0,0,3.00E-14,"Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 (Polydom)",Svep1,3567,cell adhesion [GO:0007155],GO:0003682; GO:0005509; GO:0005576; GO:0005615; GO:0005737; GO:0007155; GO:0016020,,,cd00033;cd00152;,PF00008;PF07645;PF07699;PF12661;PF02494;PF00354;PF00084;PF00092;,cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; cell adhesion [GO:0007155]
Q9UA35,CHOYP_LOC574602.1.1|m.44079,0.5,0,0,0,0,0,0,0,1.00E-132,Solute carrier family 28 member 3 (Concentrative Na(+)-nucleoside cotransporter 3) (hfCNT),SLC28A3 CNT3,683,,GO:0005337; GO:0005887,,,,PF07670;PF07662;PF01773;,integral component of plasma membrane [GO:0005887]; nucleoside transmembrane transporter activity [GO:0005337]
Q6DJN2,CHOYP_LOC584052.1.1|m.6375,0,0,0,0,0,0,0,0,1.00E-39,TNF receptor-associated factor 6-B (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRAF6) (RING-type E3 ubiquitin transferase TRAF6-B),traf6-b,556,activation of NF-kappaB-inducing kinase activity [GO:0007250]; immune response [GO:0006955]; protein K63-linked ubiquitination [GO:0070534]; regulation of apoptotic process [GO:0042981],GO:0004842; GO:0005737; GO:0006955; GO:0007250; GO:0008270; GO:0042981; GO:0070534,PATHWAY: Protein modification; protein ubiquitination.,,,PF02176;,cytoplasm [GO:0005737]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; activation of NF-kappaB-inducing kinase activity [GO:0007250]; immune response [GO:0006955]; protein K63-linked ubiquitination [GO:0070534]; regulation of apoptotic process [GO:0042981]
Q9ULI1,CHOYP_LOC763845.1.1|m.35345,0,0,0,0,0,0,0,0,3.00E-69,NACHT and WD repeat domain-containing protein 2 (Leucine-rich repeat and WD repeat-containing protein KIAA1239),NWD2 KIAA1239,1742,,,,,,PF13271;,
Q9BKZ9,CHOYP_PHUM_PHUM122670.1.1|m.38346,0,0,0,0,0,0,0,0,3.00E-112,Protein Fe65 homolog,feh-1 Y54F10AM.2,665,"embryo development ending in birth or egg hatching [GO:0009792]; feeding behavior [GO:0007631]; nematode larval development [GO:0002119]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]",GO:0001540; GO:0002119; GO:0005634; GO:0005737; GO:0005856; GO:0006351; GO:0006355; GO:0007631; GO:0008134; GO:0009792,,,,PF00640;,"cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleus [GO:0005634]; beta-amyloid binding [GO:0001540]; transcription factor binding [GO:0008134]; embryo development ending in birth or egg hatching [GO:0009792]; feeding behavior [GO:0007631]; nematode larval development [GO:0002119]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]"
O23095,CHOYP_RLA1.8.12|m.25631,0,0,0,0,0,0,0,0,2.00E-23,60S acidic ribosomal protein P1-2,RPP1B At4g00810 T18A10.9,113,cytoplasmic translation [GO:0002181]; positive regulation of protein kinase activity [GO:0045860]; translational elongation [GO:0006414],GO:0002181; GO:0003735; GO:0005634; GO:0005829; GO:0006414; GO:0022625; GO:0022626; GO:0030295; GO:0045860,,,,,cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; nucleus [GO:0005634]; protein kinase activator activity [GO:0030295]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; positive regulation of protein kinase activity [GO:0045860]; translational elongation [GO:0006414]
Q9Z223,CHOYP_TRIADDRAFT_23075.1.1|m.48886,0,0,0,0,0,0,0,0,2.00E-60,Molybdopterin synthase catalytic subunit (EC 2.8.1.12) (Molybdenum cofactor synthesis protein 2 large subunit) (Molybdenum cofactor synthesis protein 2B) (MOCS2B),Mocs2,189,molybdopterin cofactor biosynthetic process [GO:0032324]; Mo-molybdopterin cofactor biosynthetic process [GO:0006777],GO:0005634; GO:0005829; GO:0006777; GO:0016607; GO:0019008; GO:0030366; GO:0032324; GO:0042802; GO:0070062,PATHWAY: Cofactor biosynthesis; molybdopterin biosynthesis. {ECO:0000255|HAMAP-Rule:MF_03052}.,,cd00756;,PF02391;,cytosol [GO:0005829]; extracellular exosome [GO:0070062]; molybdopterin synthase complex [GO:0019008]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; molybdopterin synthase activity [GO:0030366]; Mo-molybdopterin cofactor biosynthetic process [GO:0006777]; molybdopterin cofactor biosynthetic process [GO:0032324]
E1BJS7,CHOYP_ZF_BBOX_RING_-1.3.10|m.29555,0,0,0,0,0,0,0,0,3.00E-10,E3 ubiquitin-protein ligase TRIM71 (EC 2.3.2.27) (Protein lin-41 homolog) (RING-type E3 ubiquitin transferase TRIM71) (Tripartite motif-containing protein 71),TRIM71 LIN41,868,3'-UTR-mediated mRNA destabilization [GO:0061158]; fibroblast growth factor receptor signaling pathway [GO:0008543]; G1/S transition of mitotic cell cycle [GO:0000082]; miRNA mediated inhibition of translation [GO:0035278]; miRNA metabolic process [GO:0010586]; neural tube closure [GO:0001843]; neural tube development [GO:0021915]; positive regulation of gene silencing by miRNA [GO:2000637]; protein autoubiquitination [GO:0051865]; regulation of gene silencing by miRNA [GO:0060964]; regulation of neural precursor cell proliferation [GO:2000177]; stem cell proliferation [GO:0072089],GO:0000082; GO:0000932; GO:0001843; GO:0004842; GO:0008270; GO:0008543; GO:0010586; GO:0021915; GO:0030371; GO:0035198; GO:0035278; GO:0051865; GO:0060964; GO:0061158; GO:0061630; GO:0072089; GO:2000177; GO:2000637,PATHWAY: Protein modification; protein ubiquitination.,,,PF00630;PF01436;PF00643;,P-body [GO:0000932]; miRNA binding [GO:0035198]; translation repressor activity [GO:0030371]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; 3'-UTR-mediated mRNA destabilization [GO:0061158]; fibroblast growth factor receptor signaling pathway [GO:0008543]; G1/S transition of mitotic cell cycle [GO:0000082]; miRNA mediated inhibition of translation [GO:0035278]; miRNA metabolic process [GO:0010586]; neural tube closure [GO:0001843]; neural tube development [GO:0021915]; positive regulation of gene silencing by miRNA [GO:2000637]; protein autoubiquitination [GO:0051865]; regulation of gene silencing by miRNA [GO:0060964]; regulation of neural precursor cell proliferation [GO:2000177]; stem cell proliferation [GO:0072089]
A4IF63,CHOYP_contig_041876|m.48001,0.5,0,0,0,0,0,0,0,0.000004,Tripartite motif-containing protein 2 (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRIM2) (RING-type E3 ubiquitin transferase TRIM2),TRIM2,744,regulation of neuron apoptotic process [GO:0043523],GO:0004842; GO:0005737; GO:0008270; GO:0043523,PATHWAY: Protein modification; protein ubiquitination.,,,PF00630;PF01436;PF00643;PF13445;,cytoplasm [GO:0005737]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; regulation of neuron apoptotic process [GO:0043523]
Q5JWF8,CHOYP_ACT3.1.3|m.23292,0,0,0,0,0,0,0,0,5.00E-48,Actin-like protein 10,ACTL10 C20orf134,245,,,,,,PF00022;,
P55040,CHOYP_AGAP_AGAP007681.1.1|m.36727,0,0,0,0,0,0,0,0,4.00E-27,GTP-binding protein GEM (GTP-binding mitogen-induced T-cell protein) (RAS-like protein KIR),GEM KIR,296,cell surface receptor signaling pathway [GO:0007166]; chromosome organization [GO:0051276]; immune response [GO:0006955]; metaphase plate congression [GO:0051310]; mitotic nuclear division [GO:0007067]; signal transduction [GO:0007165]; small GTPase mediated signal transduction [GO:0007264],GO:0000287; GO:0003924; GO:0005525; GO:0005634; GO:0006955; GO:0007067; GO:0007165; GO:0007166; GO:0007264; GO:0009898; GO:0019003; GO:0030496; GO:0051233; GO:0051276; GO:0051310; GO:0072686,,,,PF00071;,cytoplasmic side of plasma membrane [GO:0009898]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; spindle midzone [GO:0051233]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; magnesium ion binding [GO:0000287]; cell surface receptor signaling pathway [GO:0007166]; chromosome organization [GO:0051276]; immune response [GO:0006955]; metaphase plate congression [GO:0051310]; mitotic nuclear division [GO:0007067]; signal transduction [GO:0007165]; small GTPase mediated signal transduction [GO:0007264]
Q8N5I2,CHOYP_ARRD3.2.2|m.64983,0,0,0,0,0,0,0,0,5.00E-12,Arrestin domain-containing protein 1,ARRDC1,433,,GO:0005886; GO:0031410; GO:0070062,,,,PF02752;PF00339;,cytoplasmic vesicle [GO:0031410]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886]
P41436,CHOYP_BIR7B.2.2|m.60973,0,0,0,0,0,0,0,0,1.00E-39,Apoptosis inhibitor IAP,IAP,275,,GO:0008270,,,cd00022;,PF00653;,zinc ion binding [GO:0008270]
Q3UWM4,CHOYP_BRAFLDRAFT_119367.1.1|m.59963,0,0,0,0,0,0,0,0,0,Lysine-specific demethylase 7A (EC 1.14.11.-) (JmjC domain-containing histone demethylation protein 1D) (Lysine-specific demethylase 7),Kdm7a Jhdm1d Kdm7 Kiaa1718,940,"histone H3-K27 demethylation [GO:0071557]; histone H3-K36 demethylation [GO:0070544]; histone H3-K9 demethylation [GO:0033169]; histone H4-K20 demethylation [GO:0035574]; midbrain development [GO:0030901]; positive regulation of transcription, DNA-templated [GO:0045893]; transcription, DNA-templated [GO:0006351]",GO:0005506; GO:0005654; GO:0005730; GO:0006351; GO:0008270; GO:0016706; GO:0030901; GO:0032454; GO:0033169; GO:0035064; GO:0035574; GO:0035575; GO:0045893; GO:0051864; GO:0070544; GO:0071557; GO:0071558,,,,PF02373;PF00628;,"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; histone demethylase activity (H3-K27 specific) [GO:0071558]; histone demethylase activity (H3-K36 specific) [GO:0051864]; histone demethylase activity (H3-K9 specific) [GO:0032454]; histone demethylase activity (H4-K20 specific) [GO:0035575]; iron ion binding [GO:0005506]; methylated histone binding [GO:0035064]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors [GO:0016706]; zinc ion binding [GO:0008270]; histone H3-K27 demethylation [GO:0071557]; histone H3-K36 demethylation [GO:0070544]; histone H3-K9 demethylation [GO:0033169]; histone H4-K20 demethylation [GO:0035574]; midbrain development [GO:0030901]; positive regulation of transcription, DNA-templated [GO:0045893]; transcription, DNA-templated [GO:0006351]"
B6CZ61,CHOYP_BRAFLDRAFT_123291.1.1|m.11923,3.5,0,0,0,0,0,0,0,1.00E-56,Leucine-rich repeat-containing protein 51 (Protein LRTOMT1),Lrrc51 Lrtomt1,192,,GO:0005737,,,,,cytoplasm [GO:0005737]
P27657,CHOYP_BRAFLDRAFT_126555.6.6|m.54234,0.5,0,0,0,0,0,0,0,1.00E-81,Pancreatic triacylglycerol lipase (PL) (Pancreatic lipase) (EC 3.1.1.3),Pnlip,465,lipid catabolic process [GO:0016042]; lipid metabolic process [GO:0006629]; post-embryonic development [GO:0009791]; response to lipid [GO:0033993]; response to peptide hormone [GO:0043434],GO:0004806; GO:0005615; GO:0006629; GO:0009791; GO:0016042; GO:0016298; GO:0033993; GO:0043434; GO:0046872,,,cd00707;,PF00151;PF01477;,extracellular space [GO:0005615]; lipase activity [GO:0016298]; metal ion binding [GO:0046872]; triglyceride lipase activity [GO:0004806]; lipid catabolic process [GO:0016042]; lipid metabolic process [GO:0006629]; post-embryonic development [GO:0009791]; response to lipid [GO:0033993]; response to peptide hormone [GO:0043434]
Q6NT55,CHOYP_BRAFLDRAFT_61250.5.14|m.37733,0,0,0,0,0,0,0,0,3.00E-129,Cytochrome P450 4F22 (EC 1.14.14.-),CYP4F22,531,icosanoid metabolic process [GO:0006690],GO:0004497; GO:0005506; GO:0005789; GO:0006690; GO:0016705; GO:0020037; GO:0031090,,,,PF00067;,"endoplasmic reticulum membrane [GO:0005789]; organelle membrane [GO:0031090]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]; icosanoid metabolic process [GO:0006690]"
Q9P0W8,CHOYP_BRAFLDRAFT_65681.1.1|m.445,0.5,0,0,0,0,0,0,0,5.00E-23,Spermatogenesis-associated protein 7 (HSD-3.1) (Spermatogenesis-associated protein HSD3),SPATA7 HSD3,599,photoreceptor cell maintenance [GO:0045494]; protein localization to photoreceptor connecting cilium [GO:1903621]; protein localization to photoreceptor outer segment [GO:1903546]; response to stimulus [GO:0050896]; visual perception [GO:0007601],GO:0005654; GO:0005739; GO:0005829; GO:0005930; GO:0007601; GO:0015630; GO:0032391; GO:0036064; GO:0045494; GO:0050896; GO:1903546; GO:1903621,,,,PF15244;,axoneme [GO:0005930]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; photoreceptor connecting cilium [GO:0032391]; photoreceptor cell maintenance [GO:0045494]; protein localization to photoreceptor connecting cilium [GO:1903621]; protein localization to photoreceptor outer segment [GO:1903546]; response to stimulus [GO:0050896]; visual perception [GO:0007601]
P15989,CHOYP_CO6A3.3.5|m.39796,0,0,0,0,0,0,0,0,2.00E-104,Collagen alpha-3(VI) chain,COL6A3,3137,cell adhesion [GO:0007155],GO:0004867; GO:0005578; GO:0005581; GO:0007155,,,cd00063;,PF01391;PF00014;PF00092;,collagen trimer [GO:0005581]; proteinaceous extracellular matrix [GO:0005578]; serine-type endopeptidase inhibitor activity [GO:0004867]; cell adhesion [GO:0007155]
A8Y5U1,CHOYP_CZH5ORF51.1.1|m.25147,0,0,0,0,0,0,0,0,3.00E-40,UPF0600 protein C5orf51 homolog,si:dkey-46a10.3 wu:fd42g01,276,,,,,,,
Q9Y5E9,CHOYP_FAT1.2.4|m.36735,0,0,0,0,0,0,0,0,4.00E-18,Protocadherin beta-14 (PCDH-beta-14),PCDHB14,798,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell adhesion [GO:0007155]; chemical synaptic transmission [GO:0007268]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; synapse assembly [GO:0007416],GO:0005509; GO:0005887; GO:0007155; GO:0007156; GO:0007268; GO:0007416; GO:0016021; GO:0016339,,,,PF00028;PF08266;PF16492;,integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell adhesion [GO:0007155]; chemical synaptic transmission [GO:0007268]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; synapse assembly [GO:0007416]
Q6IS24,CHOYP_GALT1.1.1|m.33853,0,0,0,0,0,0,0,0,1.00E-86,Putative polypeptide N-acetylgalactosaminyltransferase-like protein 3 (EC 2.4.1.41) (Polypeptide GalNAc transferase-like protein 3) (GalNAc-T-like protein 3) (pp-GaNTase-like protein 3) (Protein-UDP acetylgalactosaminyltransferase-like protein 3) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase-like protein 3) (Williams-Beuren syndrome chromosomal region 17 protein),WBSCR17 GALNTL3,598,protein glycosylation [GO:0006486],GO:0000139; GO:0004653; GO:0006486; GO:0016021; GO:0030246; GO:0046872,PATHWAY: Protein modification; protein glycosylation.,,,PF00535;PF00652;,Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; protein glycosylation [GO:0006486]
Q8QZZ7,CHOYP_LOC100227090.1.1|m.1313,0,0,0,0,0,0,0,0,1.00E-42,EKC/KEOPS complex subunit Tprkb (TP53RK-binding protein),Tprkb,175,tRNA processing [GO:0008033],GO:0005634; GO:0005829; GO:0008033; GO:0019901,,,,PF08617;,cytosol [GO:0005829]; nucleus [GO:0005634]; protein kinase binding [GO:0019901]; tRNA processing [GO:0008033]
Q4LDE5,CHOYP_LOC100367084.3.22|m.29143,0,0,0,0,0,0,0,0,2.00E-41,"Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 (CCP module-containing protein 22) (Polydom) (Selectin-like osteoblast-derived protein) (SEL-OB) (Serologically defined breast cancer antigen NY-BR-38)",SVEP1 C9orf13 CCP22 SELOB,3571,cell adhesion [GO:0007155],GO:0003682; GO:0005509; GO:0005615; GO:0005737; GO:0007155; GO:0016020,,,cd00033;,PF00008;PF07645;PF07699;PF12661;PF02494;PF00354;PF00084;PF00092;,cytoplasm [GO:0005737]; extracellular space [GO:0005615]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; cell adhesion [GO:0007155]
Q8N157,CHOYP_LOC100373327.2.13|m.16978,0,0,0,0,0,0,0,0,0,Jouberin (Abelson helper integration site 1 protein homolog) (AHI-1),AHI1,1196,cellular protein localization [GO:0034613]; central nervous system development [GO:0007417]; ciliary basal body docking [GO:0097711]; cilium assembly [GO:0060271]; cloaca development [GO:0035844]; heart looping [GO:0001947]; hindbrain development [GO:0030902]; Kupffer's vesicle development [GO:0070121]; left/right axis specification [GO:0070986]; morphogenesis of a polarized epithelium [GO:0001738]; negative regulation of apoptotic process [GO:0043066]; otic vesicle development [GO:0071599]; photoreceptor cell outer segment organization [GO:0035845]; positive regulation of polarized epithelial cell differentiation [GO:0030862]; positive regulation of receptor internalization [GO:0002092]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; pronephric duct morphogenesis [GO:0039023]; pronephric nephron tubule morphogenesis [GO:0039008]; regulation of behavior [GO:0050795]; retina layer formation [GO:0010842]; specification of axis polarity [GO:0065001]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vesicle-mediated transport [GO:0016192],GO:0001738; GO:0001947; GO:0002092; GO:0005813; GO:0005814; GO:0005829; GO:0005911; GO:0005912; GO:0005929; GO:0007169; GO:0007417; GO:0010842; GO:0016192; GO:0030862; GO:0030902; GO:0034613; GO:0035844; GO:0035845; GO:0036038; GO:0036064; GO:0039008; GO:0039023; GO:0042802; GO:0043066; GO:0045944; GO:0050795; GO:0060271; GO:0065001; GO:0070121; GO:0070986; GO:0071599; GO:0097711; GO:0097730,,,,PF00018;PF00400;,adherens junction [GO:0005912]; cell-cell junction [GO:0005911]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; MKS complex [GO:0036038]; non-motile cilium [GO:0097730]; identical protein binding [GO:0042802]; cellular protein localization [GO:0034613]; central nervous system development [GO:0007417]; ciliary basal body docking [GO:0097711]; cilium assembly [GO:0060271]; cloaca development [GO:0035844]; heart looping [GO:0001947]; hindbrain development [GO:0030902]; Kupffer's vesicle development [GO:0070121]; left/right axis specification [GO:0070986]; morphogenesis of a polarized epithelium [GO:0001738]; negative regulation of apoptotic process [GO:0043066]; otic vesicle development [GO:0071599]; photoreceptor cell outer segment organization [GO:0035845]; positive regulation of polarized epithelial cell differentiation [GO:0030862]; positive regulation of receptor internalization [GO:0002092]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; pronephric duct morphogenesis [GO:0039023]; pronephric nephron tubule morphogenesis [GO:0039008]; regulation of behavior [GO:0050795]; retina layer formation [GO:0010842]; specification of axis polarity [GO:0065001]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vesicle-mediated transport [GO:0016192]
P22897,CHOYP_LOC100378295.1.4|m.3278,0,0,0,0,0,0,0,0,3.00E-167,Macrophage mannose receptor 1 (MMR) (C-type lectin domain family 13 member D) (C-type lectin domain family 13 member D-like) (Human mannose receptor) (hMR) (Macrophage mannose receptor 1-like protein 1) (CD antigen CD206),MRC1 CLEC13D CLEC13DL MRC1L1,1456,cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; receptor-mediated endocytosis [GO:0006898],GO:0001618; GO:0004872; GO:0004888; GO:0005537; GO:0005886; GO:0005887; GO:0006898; GO:0009986; GO:0010008; GO:0071222; GO:0071346; GO:0071353,,,cd00062;,PF00040;PF00059;PF00652;,cell surface [GO:0009986]; endosome membrane [GO:0010008]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; mannose binding [GO:0005537]; receptor activity [GO:0004872]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; receptor-mediated endocytosis [GO:0006898]
Q3T0Y3,CHOYP_LOC100552374.1.1|m.21979,0,0,0,0,0,0,0,0,2.00E-36,Sulfotransferase family cytosolic 1B member 1 (ST1B1) (Sulfotransferase 1B1) (EC 2.8.2.-),SULT1B1,296,epithelial cell differentiation [GO:0030855]; flavonoid metabolic process [GO:0009812]; steroid metabolic process [GO:0008202]; sulfation [GO:0051923]; thyroid hormone metabolic process [GO:0042403]; xenobiotic metabolic process [GO:0006805],GO:0004062; GO:0005737; GO:0006805; GO:0008202; GO:0009812; GO:0030855; GO:0042403; GO:0051923,,,,PF00685;,cytoplasm [GO:0005737]; aryl sulfotransferase activity [GO:0004062]; epithelial cell differentiation [GO:0030855]; flavonoid metabolic process [GO:0009812]; steroid metabolic process [GO:0008202]; sulfation [GO:0051923]; thyroid hormone metabolic process [GO:0042403]; xenobiotic metabolic process [GO:0006805]
Q5RJ80,CHOYP_LOC100697720.1.2|m.5790,0,0,0,0,0,0,0,0,2.00E-10,Caprin-2 (RNA granule protein 140),caprin2 rng140 si:ch211-11c20.4,914,dorsal/ventral pattern formation [GO:0009953]; negative regulation of translation [GO:0017148]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of Wnt signaling pathway [GO:0030177]; positive regulation of Wnt signaling pathway involved in dorsal/ventral axis specification [GO:2000055]; regulation of growth [GO:0040008],GO:0003723; GO:0005737; GO:0005886; GO:0009953; GO:0017148; GO:0030177; GO:0040008; GO:0046872; GO:0050775; GO:0061003; GO:0090263; GO:2000055,,,,PF00386;PF12287;,cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; dorsal/ventral pattern formation [GO:0009953]; negative regulation of translation [GO:0017148]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of Wnt signaling pathway [GO:0030177]; positive regulation of Wnt signaling pathway involved in dorsal/ventral axis specification [GO:2000055]; regulation of growth [GO:0040008]
Q8IYB9,CHOYP_LOC100721364.1.1|m.15879,0,0,0,0,0,0,0,0,2.00E-66,Zinc finger protein 595,ZNF595,648,"regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]",GO:0003677; GO:0003700; GO:0005634; GO:0006351; GO:0006355; GO:0046872,,,cd07765;,PF01352;PF00096;PF13912;,"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; transcription factor activity, sequence-specific DNA binding [GO:0003700]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]"
Q5SSZ7,CHOYP_LOC100727159.1.1|m.60272,0,0,0,0,0,0,0,0,1.00E-74,E3 ubiquitin-protein ligase ZNRF3 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase ZNRF3) (Zinc/RING finger protein 3),Znrf3,913,"canonical Wnt signaling pathway [GO:0060070]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; negative regulation of Wnt signaling pathway [GO:0030178]; protein ubiquitination [GO:0016567]; stem cell proliferation [GO:0072089]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt receptor catabolic process [GO:0038018]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]",GO:0004842; GO:0005109; GO:0005887; GO:0006511; GO:0008270; GO:0016567; GO:0030178; GO:0038018; GO:0060070; GO:0060071; GO:0072089; GO:0090090; GO:2000051,PATHWAY: Protein modification; protein ubiquitination.,,,PF13639;,"integral component of plasma membrane [GO:0005887]; frizzled binding [GO:0005109]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; canonical Wnt signaling pathway [GO:0060070]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; negative regulation of Wnt signaling pathway [GO:0030178]; protein ubiquitination [GO:0016567]; stem cell proliferation [GO:0072089]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt receptor catabolic process [GO:0038018]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"
D8VNS8,CHOYP_MFAP4.3.3|m.62664,0,0,0,0,0,0,0,0,2.00E-54,Ryncolin-2,,347,,GO:0005576,,,cd00087;,PF01391;PF00147;,extracellular region [GO:0005576]
O08550,CHOYP_MLL.1.1|m.33426,0,0,0,0,0,0,0,0,6.00E-121,Histone-lysine N-methyltransferase 2B (Lysine N-methyltransferase 2B) (EC 2.1.1.43) (Myeloid/lymphoid or mixed-lineage leukemia protein 4 homolog) (Trithorax homolog 2) (WW domain-binding protein 7) (WBP-7),Kmt2b Mll2 Trx2 Wbp7,2713,"gene silencing [GO:0016458]; histone H3-K4 methylation [GO:0051568]; histone H3-K4 trimethylation [GO:0080182]; histone lysine methylation [GO:0034968]; memory [GO:0007613]; oocyte differentiation [GO:0009994]; ovarian follicle development [GO:0001541]; ovulation [GO:0030728]; regulation of histone H3-K4 methylation [GO:0051569]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]",GO:0001541; GO:0003677; GO:0005634; GO:0006351; GO:0006355; GO:0007613; GO:0008270; GO:0009994; GO:0016458; GO:0030728; GO:0034968; GO:0035097; GO:0042800; GO:0051568; GO:0051569; GO:0080182,,,,PF05965;PF05964;PF00628;PF00856;PF02008;,"histone methyltransferase complex [GO:0035097]; nucleus [GO:0005634]; DNA binding [GO:0003677]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; zinc ion binding [GO:0008270]; gene silencing [GO:0016458]; histone H3-K4 methylation [GO:0051568]; histone H3-K4 trimethylation [GO:0080182]; histone lysine methylation [GO:0034968]; memory [GO:0007613]; oocyte differentiation [GO:0009994]; ovarian follicle development [GO:0001541]; ovulation [GO:0030728]; regulation of histone H3-K4 methylation [GO:0051569]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]"
Q8TD19,CHOYP_NEK9.1.1|m.19497,0.5,0,0,0,0,0,0,0,0,Serine/threonine-protein kinase Nek9 (EC 2.7.11.1) (Nercc1 kinase) (Never in mitosis A-related kinase 9) (NimA-related protein kinase 9) (NimA-related kinase 8) (Nek8),NEK9 KIAA1995 NEK8 NERCC,979,cell division [GO:0051301]; mitotic nuclear division [GO:0007067]; mitotic nuclear envelope disassembly [GO:0007077],GO:0004674; GO:0005524; GO:0005634; GO:0005829; GO:0007067; GO:0007077; GO:0019901; GO:0046872; GO:0051301,,,,PF00069;PF00415;,cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; cell division [GO:0051301]; mitotic nuclear division [GO:0007067]; mitotic nuclear envelope disassembly [GO:0007077]
P81718,CHOYP_PTPRT.30.45|m.53464,0,0,0,0,0,0,0,0,1.00E-54,Tyrosine-protein phosphatase non-receptor type 6 (EC 3.1.3.48) (Protein-tyrosine phosphatase SHP-1),Ptpn6 Ptph6,613,cell differentiation [GO:0030154]; cell proliferation [GO:0008283]; protein dephosphorylation [GO:0006470]; regulation of ERK1 and ERK2 cascade [GO:0070372]; response to wounding [GO:0009611],GO:0004725; GO:0005001; GO:0005634; GO:0005737; GO:0006470; GO:0008283; GO:0009611; GO:0030154; GO:0046703; GO:0070372,,,,PF00017;PF00102;,cytoplasm [GO:0005737]; nucleus [GO:0005634]; natural killer cell lectin-like receptor binding [GO:0046703]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; cell differentiation [GO:0030154]; cell proliferation [GO:0008283]; protein dephosphorylation [GO:0006470]; regulation of ERK1 and ERK2 cascade [GO:0070372]; response to wounding [GO:0009611]
Q2PPJ7,CHOYP_RGPA1.1.1|m.50924,0,0,0,0,0,0,0,0,0,Ral GTPase-activating protein subunit alpha-2 (250 kDa substrate of Akt) (AS250) (p220),RALGAPA2 C20orf74 KIAA1272,1873,activation of GTPase activity [GO:0090630]; regulation of small GTPase mediated signal transduction [GO:0051056],GO:0005096; GO:0005615; GO:0005737; GO:0005829; GO:0005886; GO:0046982; GO:0051056; GO:0090630,,,,PF02145;,cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; GTPase activator activity [GO:0005096]; protein heterodimerization activity [GO:0046982]; activation of GTPase activity [GO:0090630]; regulation of small GTPase mediated signal transduction [GO:0051056]
Q80ZA5,CHOYP_S4A8.1.1|m.28334,0,0,0,0,0,0,0,0,0,Sodium-driven chloride bicarbonate exchanger (Solute carrier family 4 member 10),Slc4a10 Ncbe,1117,anion transmembrane transport [GO:0098656]; bicarbonate transport [GO:0015701]; nervous system development [GO:0007399]; regulation of intracellular pH [GO:0051453]; sodium ion transport [GO:0006814],GO:0005452; GO:0005887; GO:0006814; GO:0007399; GO:0008509; GO:0015293; GO:0015297; GO:0015701; GO:0051453; GO:0098656,,,,PF07565;PF00955;,integral component of plasma membrane [GO:0005887]; anion transmembrane transporter activity [GO:0008509]; antiporter activity [GO:0015297]; inorganic anion exchanger activity [GO:0005452]; symporter activity [GO:0015293]; anion transmembrane transport [GO:0098656]; bicarbonate transport [GO:0015701]; nervous system development [GO:0007399]; regulation of intracellular pH [GO:0051453]; sodium ion transport [GO:0006814]
Q8IZU2,CHOYP_WDR17.1.1|m.17546,0,0,0,0,0,0,0,0,0,WD repeat-containing protein 17,WDR17,1322,,GO:0005737,,,,PF12894;PF00400;,cytoplasm [GO:0005737]
Q9ULM3,CHOYP_YETS2.1.1|m.302,0,0,0,0,0,0,0,0,6.00E-89,YEATS domain-containing protein 2,YEATS2 KIAA1197,1422,"histone H3 acetylation [GO:0043966]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]",GO:0000122; GO:0005671; GO:0017025; GO:0043966; GO:0045892; GO:0072686,,,,PF03366;,"Ada2/Gcn5/Ada3 transcription activator complex [GO:0005671]; mitotic spindle [GO:0072686]; TBP-class protein binding [GO:0017025]; histone H3 acetylation [GO:0043966]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]"
Q5RKZ7,CHOYP_BRAFLDRAFT_118735.1.1|m.6990,0,0,0,0,0,0,0,0,2.00E-162,"Molybdenum cofactor biosynthesis protein 1 [Includes: GTP 3',8-cyclase (EC 4.1.99.22) (Molybdenum cofactor biosynthesis protein A); Cyclic pyranopterin monophosphate synthase (EC 4.6.1.17) (Molybdenum cofactor biosynthesis protein C)]",Mocs1,636,molybdopterin cofactor biosynthetic process [GO:0032324]; Mo-molybdopterin cofactor biosynthetic process [GO:0006777],GO:0005525; GO:0006777; GO:0019008; GO:0032324; GO:0046872; GO:0051539; GO:0061798; GO:0061799,PATHWAY: Cofactor biosynthesis; molybdopterin biosynthesis.,,cd01420;,PF01967;PF06463;PF04055;,"molybdopterin synthase complex [GO:0019008]; 4 iron, 4 sulfur cluster binding [GO:0051539]; cyclic pyranopterin monophosphate synthase activity [GO:0061799]; GTP 3',8'-cyclase activity [GO:0061798]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; Mo-molybdopterin cofactor biosynthetic process [GO:0006777]; molybdopterin cofactor biosynthetic process [GO:0032324]"
Q86GV3,CHOYP_GCY.2.4|m.33243,0,0,0,0,0,0,0,0,0,Receptor-type guanylate cyclase gcy-28 (EC 4.6.1.2) (GCY-X1),gcy-28 T01A4.1,1276,cGMP biosynthetic process [GO:0006182]; chemotaxis [GO:0006935]; intracellular signal transduction [GO:0035556]; olfactory behavior [GO:0042048]; sensory perception of chemical stimulus [GO:0007606]; sensory processing [GO:0050893]; signal transduction [GO:0007165],GO:0004383; GO:0004672; GO:0005524; GO:0005525; GO:0005886; GO:0006182; GO:0006935; GO:0007165; GO:0007606; GO:0008074; GO:0016021; GO:0030424; GO:0030425; GO:0035556; GO:0042048; GO:0043005; GO:0043204; GO:0044297; GO:0046872; GO:0050893,,,,PF01094;PF00211;PF07714;,"axon [GO:0030424]; cell body [GO:0044297]; dendrite [GO:0030425]; guanylate cyclase complex, soluble [GO:0008074]; integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; cGMP biosynthetic process [GO:0006182]; chemotaxis [GO:0006935]; intracellular signal transduction [GO:0035556]; olfactory behavior [GO:0042048]; sensory perception of chemical stimulus [GO:0007606]; sensory processing [GO:0050893]; signal transduction [GO:0007165]"
Q91766,CHOYP_LOC100023660.1.1|m.30865,0,0,0,0,0,0,0,0,0,Hepatocyte nuclear factor 4-alpha (HNF-4-alpha) (Nuclear receptor subfamily 2 group A member 1),hnf4a hnf4 nr2a1,464,"transcription, DNA-templated [GO:0006351]",GO:0003700; GO:0003707; GO:0005634; GO:0006351; GO:0008270; GO:0043565,,,,PF00104;PF00105;,"nucleus [GO:0005634]; sequence-specific DNA binding [GO:0043565]; steroid hormone receptor activity [GO:0003707]; transcription factor activity, sequence-specific DNA binding [GO:0003700]; zinc ion binding [GO:0008270]; transcription, DNA-templated [GO:0006351]"
P71359,CHOYP_LOC100370129.1.4|m.6950,0,0,0,0,0,0,0,0,5.00E-41,ATP-dependent DNA helicase RecQ (EC 3.6.4.12),recQ HI_0728,619,DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; SOS response [GO:0009432],GO:0003677; GO:0005524; GO:0005694; GO:0005737; GO:0006260; GO:0006281; GO:0006310; GO:0009378; GO:0009432; GO:0043140,,,,PF00270;PF00271;PF00570;PF16124;PF09382;,chromosome [GO:0005694]; cytoplasm [GO:0005737]; ATP binding [GO:0005524]; ATP-dependent 3'-5' DNA helicase activity [GO:0043140]; DNA binding [GO:0003677]; four-way junction helicase activity [GO:0009378]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; SOS response [GO:0009432]
Q02763,CHOYP_LOC100371242.3.6|m.39821,0,0,0,0,0,0,0,0,5.00E-13,Angiopoietin-1 receptor (EC 2.7.10.1) (Endothelial tyrosine kinase) (Tunica interna endothelial cell kinase) (Tyrosine kinase with Ig and EGF homology domains-2) (Tyrosine-protein kinase receptor TEK) (Tyrosine-protein kinase receptor TIE-2) (hTIE2) (p140 TEK) (CD antigen CD202b),TEK TIE2 VMCM VMCM1,1124,angiogenesis [GO:0001525]; cell-cell signaling [GO:0007267]; definitive hemopoiesis [GO:0060216]; endochondral ossification [GO:0001958]; endothelial cell proliferation [GO:0001935]; glomerulus vasculature development [GO:0072012]; heart development [GO:0007507]; heart trabecula formation [GO:0060347]; leukocyte migration [GO:0050900]; MAPK cascade [GO:0000165]; negative regulation of angiogenesis [GO:0016525]; negative regulation of apoptotic process [GO:0043066]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of inflammatory response [GO:0050728]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of actin cytoskeleton reorganization [GO:2000251]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; protein autophosphorylation [GO:0046777]; protein oligomerization [GO:0051259]; regulation of endothelial cell apoptotic process [GO:2000351]; regulation of establishment or maintenance of cell polarity [GO:0032878]; regulation of vascular permeability [GO:0043114]; response to cAMP [GO:0051591]; response to estrogen [GO:0043627]; response to hypoxia [GO:0001666]; response to peptide hormone [GO:0043434]; signal transduction [GO:0007165]; sprouting angiogenesis [GO:0002040]; substrate adhesion-dependent cell spreading [GO:0034446]; Tie signaling pathway [GO:0048014]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],GO:0000165; GO:0001525; GO:0001666; GO:0001934; GO:0001935; GO:0001938; GO:0001958; GO:0002040; GO:0004672; GO:0004713; GO:0004714; GO:0004872; GO:0005088; GO:0005524; GO:0005576; GO:0005737; GO:0005815; GO:0005886; GO:0005887; GO:0005902; GO:0005911; GO:0005925; GO:0007165; GO:0007169; GO:0007267; GO:0007507; GO:0009925; GO:0009986; GO:0010595; GO:0014068; GO:0016323; GO:0016324; GO:0016525; GO:0018108; GO:0032878; GO:0034446; GO:0043066; GO:0043114; GO:0043434; GO:0043552; GO:0043627; GO:0045121; GO:0045766; GO:0046777; GO:0048014; GO:0050728; GO:0050900; GO:0051259; GO:0051591; GO:0051894; GO:0051897; GO:0060216; GO:0060347; GO:0070374; GO:0072012; GO:1902533; GO:2000251; GO:2000351; GO:2000352,,,cd00063;,PF00041;PF10430;PF07714;,apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; microtubule organizing center [GO:0005815]; microvillus [GO:0005902]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein tyrosine kinase activity [GO:0004713]; Ras guanyl-nucleotide exchange factor activity [GO:0005088]; receptor activity [GO:0004872]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; angiogenesis [GO:0001525]; cell-cell signaling [GO:0007267]; definitive hemopoiesis [GO:0060216]; endochondral ossification [GO:0001958]; endothelial cell proliferation [GO:0001935]; glomerulus vasculature development [GO:0072012]; heart development [GO:0007507]; heart trabecula formation [GO:0060347]; leukocyte migration [GO:0050900]; MAPK cascade [GO:0000165]; negative regulation of angiogenesis [GO:0016525]; negative regulation of apoptotic process [GO:0043066]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of inflammatory response [GO:0050728]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of actin cytoskeleton reorganization [GO:2000251]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; protein autophosphorylation [GO:0046777]; protein oligomerization [GO:0051259]; regulation of endothelial cell apoptotic process [GO:2000351]; regulation of establishment or maintenance of cell polarity [GO:0032878]; regulation of vascular permeability [GO:0043114]; response to cAMP [GO:0051591]; response to estrogen [GO:0043627]; response to hypoxia [GO:0001666]; response to peptide hormone [GO:0043434]; signal transduction [GO:0007165]; sprouting angiogenesis [GO:0002040]; substrate adhesion-dependent cell spreading [GO:0034446]; Tie signaling pathway [GO:0048014]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]
Q5E960,CHOYP_LOC100372290.2.2|m.40459,0,0,0,0,0,0,0,0,7.00E-54,Zinc transporter ZIP3 (Solute carrier family 39 member 3) (Zrt- and Irt-like protein 3) (ZIP-3),SLC39A3 ZIP3,314,cell morphogenesis [GO:0000902]; embryonic cranial skeleton morphogenesis [GO:0048701]; in utero embryonic development [GO:0001701]; limb development [GO:0060173]; T cell homeostasis [GO:0043029],GO:0000902; GO:0001701; GO:0005385; GO:0016021; GO:0043029; GO:0048701; GO:0060173,,,,PF02535;,integral component of membrane [GO:0016021]; zinc ion transmembrane transporter activity [GO:0005385]; cell morphogenesis [GO:0000902]; embryonic cranial skeleton morphogenesis [GO:0048701]; in utero embryonic development [GO:0001701]; limb development [GO:0060173]; T cell homeostasis [GO:0043029]
Q9UKK3,CHOYP_LOC100373327.1.13|m.13252,0,0,0,0,0,0,0,0,0,Poly [ADP-ribose] polymerase 4 (PARP-4) (EC 2.4.2.30) (193 kDa vault protein) (ADP-ribosyltransferase diphtheria toxin-like 4) (ARTD4) (PARP-related/IalphaI-related H5/proline-rich) (PH5P) (Vault poly(ADP-ribose) polymerase) (VPARP),PARP4 ADPRTL1 KIAA0177 PARPL,1724,cell death [GO:0008219]; cellular protein modification process [GO:0006464]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; inflammatory response [GO:0006954]; protein ADP-ribosylation [GO:0006471]; response to drug [GO:0042493]; transport [GO:0006810],GO:0003677; GO:0003950; GO:0005634; GO:0005737; GO:0005829; GO:0005876; GO:0006281; GO:0006464; GO:0006471; GO:0006810; GO:0006954; GO:0006974; GO:0008219; GO:0016020; GO:0019899; GO:0030529; GO:0042493; GO:0070062,,,cd00027;,PF00533;PF00644;PF08487;PF00092;,cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intracellular ribonucleoprotein complex [GO:0030529]; membrane [GO:0016020]; nucleus [GO:0005634]; spindle microtubule [GO:0005876]; DNA binding [GO:0003677]; enzyme binding [GO:0019899]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; cell death [GO:0008219]; cellular protein modification process [GO:0006464]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; inflammatory response [GO:0006954]; protein ADP-ribosylation [GO:0006471]; response to drug [GO:0042493]; transport [GO:0006810]
Q8C761,CHOYP_LOC100373809.1.2|m.35126,1.5,0,0,0,0,0,0,0,1.00E-144,WD repeat-containing protein 60,Wdr60,999,cilium assembly [GO:0060271]; embryonic skeletal system morphogenesis [GO:0048704],GO:0000242; GO:0000922; GO:0005615; GO:0005868; GO:0005929; GO:0031021; GO:0048704; GO:0060271; GO:0070062; GO:0097546,,,,PF00400;,ciliary base [GO:0097546]; cilium [GO:0005929]; cytoplasmic dynein complex [GO:0005868]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; interphase microtubule organizing center [GO:0031021]; pericentriolar material [GO:0000242]; spindle pole [GO:0000922]; cilium assembly [GO:0060271]; embryonic skeletal system morphogenesis [GO:0048704]
P13813,CHOYP_LOC100375776.1.3|m.8907,0,0,0,0,0,0,0,0,9.00E-26,110 kDa antigen (PK110) (Fragment),,296,,,,,,,
O43903,CHOYP_LOC100485604.1.1|m.45268,0,0,0,0,0,0,0,0,1.00E-59,Growth arrest-specific protein 2 (GAS-2),GAS2,313,apoptotic process [GO:0006915]; cell cycle arrest [GO:0007050]; regulation of cell shape [GO:0008360],GO:0005829; GO:0005884; GO:0006915; GO:0007050; GO:0008360; GO:0016020,,,cd00014;,PF00307;PF02187;,actin filament [GO:0005884]; cytosol [GO:0005829]; membrane [GO:0016020]; apoptotic process [GO:0006915]; cell cycle arrest [GO:0007050]; regulation of cell shape [GO:0008360]
Q62627,CHOYP_LOC100649375.1.1|m.21222,0,0,0,0,0,0,0,0,0.000000008,PRKC apoptosis WT1 regulator protein (Prostate apoptosis response 4 protein) (Par-4) (Transcriptional repressor Par-4-like protein PAWR),Pawr Par4,332,"actin filament bundle assembly [GO:0051017]; activation of cysteine-type endopeptidase activity [GO:0097202]; apoptotic process [GO:0006915]; calcium ion import into cell [GO:1990035]; cellular response to estradiol stimulus [GO:0071392]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to interleukin-1 [GO:0071347]; cellular response to vitamin E [GO:0071306]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; negative regulation of calcium ion import [GO:0090281]; positive regulation of action potential [GO:0045760]; positive regulation of apoptotic process [GO:0043065]; positive regulation of hindgut contraction [GO:0060450]; positive regulation of leukocyte tethering or rolling [GO:1903238]; positive regulation of neuronal action potential [GO:1904457]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of neutrophil extravasation [GO:2000391]; positive regulation of phosphoprotein phosphatase activity [GO:0032516]; positive regulation of relaxation of smooth muscle [GO:1901082]; regulation of transcription, DNA-templated [GO:0006355]; response to estradiol [GO:0032355]; response to iron(II) ion [GO:0010040]; response to lipopolysaccharide [GO:0032496]; response to wounding [GO:0009611]; transcription, DNA-templated [GO:0006351]",GO:0003779; GO:0005080; GO:0005634; GO:0005737; GO:0006351; GO:0006355; GO:0006915; GO:0008157; GO:0009611; GO:0010040; GO:0030424; GO:0032355; GO:0032496; GO:0032516; GO:0043005; GO:0043025; GO:0043065; GO:0043525; GO:0045760; GO:0050965; GO:0050966; GO:0051017; GO:0060450; GO:0071306; GO:0071347; GO:0071372; GO:0071392; GO:0090281; GO:0097202; GO:1901082; GO:1903238; GO:1904457; GO:1990035; GO:2000391,,,,,"axon [GO:0030424]; cytoplasm [GO:0005737]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; actin binding [GO:0003779]; protein kinase C binding [GO:0005080]; protein phosphatase 1 binding [GO:0008157]; actin filament bundle assembly [GO:0051017]; activation of cysteine-type endopeptidase activity [GO:0097202]; apoptotic process [GO:0006915]; calcium ion import into cell [GO:1990035]; cellular response to estradiol stimulus [GO:0071392]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to interleukin-1 [GO:0071347]; cellular response to vitamin E [GO:0071306]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; negative regulation of calcium ion import [GO:0090281]; positive regulation of action potential [GO:0045760]; positive regulation of apoptotic process [GO:0043065]; positive regulation of hindgut contraction [GO:0060450]; positive regulation of leukocyte tethering or rolling [GO:1903238]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of neuronal action potential [GO:1904457]; positive regulation of neutrophil extravasation [GO:2000391]; positive regulation of phosphoprotein phosphatase activity [GO:0032516]; positive regulation of relaxation of smooth muscle [GO:1901082]; regulation of transcription, DNA-templated [GO:0006355]; response to estradiol [GO:0032355]; response to iron(II) ion [GO:0010040]; response to lipopolysaccharide [GO:0032496]; response to wounding [GO:0009611]; transcription, DNA-templated [GO:0006351]"
Q8K2L8,CHOYP_LOC100659825.1.1|m.62706,0.5,0,0,0,0,0,0,0,3.00E-139,Trafficking protein particle complex subunit 12 (Tetratricopeptide repeat protein 15) (TPR repeat protein 15),Trappc12 Ttc15,797,metaphase plate congression [GO:0051310]; positive regulation of protein localization to kinetochore [GO:1905342]; regulation of kinetochore assembly [GO:0090234]; vesicle-mediated transport [GO:0016192],GO:0000776; GO:0004175; GO:0005634; GO:0005793; GO:0016192; GO:0051310; GO:0090234; GO:1905342,,,,,endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; kinetochore [GO:0000776]; nucleus [GO:0005634]; endopeptidase activity [GO:0004175]; metaphase plate congression [GO:0051310]; positive regulation of protein localization to kinetochore [GO:1905342]; regulation of kinetochore assembly [GO:0090234]; vesicle-mediated transport [GO:0016192]
P08004,CHOYP_LOC100907845.2.3|m.23111,0,0,0,0,0,0,0,0,3.00E-19,Chitin synthase 1 (EC 2.4.1.16) (Chitin-UDP acetyl-glucosaminyl transferase 1),CHS1 YNL192W N1404,1131,barrier septum site selection [GO:0000918]; cell separation after cytokinesis [GO:0000920]; cell wall chitin biosynthetic process [GO:0006038]; fungal-type cell wall organization [GO:0031505],GO:0000918; GO:0000920; GO:0004100; GO:0005886; GO:0006038; GO:0016021; GO:0030428; GO:0031505; GO:0045009,,,,PF01644;PF08407;,cell septum [GO:0030428]; chitosome [GO:0045009]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; chitin synthase activity [GO:0004100]; barrier septum site selection [GO:0000918]; cell separation after cytokinesis [GO:0000920]; cell wall chitin biosynthetic process [GO:0006038]; fungal-type cell wall organization [GO:0031505]
Q5HZZ6,CHOYP_MED8B.1.1|m.7004,1,0,0,0,0,0,0,0,8.00E-72,Mediator of RNA polymerase II transcription subunit 8-A (Mediator complex subunit 8-A),med8-a,268,"protein ubiquitination [GO:0016567]; transcription, DNA-templated [GO:0006351]",GO:0001104; GO:0006351; GO:0016567; GO:0016592,PATHWAY: Protein modification; protein ubiquitination.,,,PF10232;,"mediator complex [GO:0016592]; RNA polymerase II transcription cofactor activity [GO:0001104]; protein ubiquitination [GO:0016567]; transcription, DNA-templated [GO:0006351]"
Q5XXB5,CHOYP_MSH2.1.1|m.18340,0,0,0,0,0,0,0,0,0,DNA mismatch repair protein Msh2 (MutS protein homolog 2),MSH2,933,cell cycle [GO:0007049]; mismatch repair [GO:0006298],GO:0005524; GO:0006298; GO:0007049; GO:0030983; GO:0032301,,,,PF01624;PF05188;PF05192;PF05190;PF00488;,MutSalpha complex [GO:0032301]; ATP binding [GO:0005524]; mismatched DNA binding [GO:0030983]; cell cycle [GO:0007049]; mismatch repair [GO:0006298]
Q641W3,CHOYP_NUFIP1.1.1|m.8979,0,0,0,0,0,0,0,0,1.00E-42,Nuclear fragile X mental retardation-interacting protein 1 (Nuclear FMRP-interacting protein 1),Nufip1,486,box C/D snoRNP assembly [GO:0000492]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein oligomerization [GO:0051259],GO:0000492; GO:0001650; GO:0005634; GO:0005726; GO:0008023; GO:0016363; GO:0022626; GO:0030515; GO:0045944; GO:0046872; GO:0048786; GO:0051259; GO:0070761,,,,PF10453;,cytosolic ribosome [GO:0022626]; fibrillar center [GO:0001650]; nuclear matrix [GO:0016363]; nucleus [GO:0005634]; perichromatin fibrils [GO:0005726]; pre-snoRNP complex [GO:0070761]; presynaptic active zone [GO:0048786]; transcription elongation factor complex [GO:0008023]; metal ion binding [GO:0046872]; snoRNA binding [GO:0030515]; box C/D snoRNP assembly [GO:0000492]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein oligomerization [GO:0051259]
Q8CIC2,CHOYP_NUPL2.1.2|m.4693,0,0,0,0,0,0,0,0,5.00E-23,Nucleoporin-like protein 2 (NLP-1),Nupl2,420,mRNA transport [GO:0051028]; protein export from nucleus [GO:0006611],GO:0001750; GO:0003723; GO:0005049; GO:0005634; GO:0005643; GO:0005654; GO:0005829; GO:0006611; GO:0031965; GO:0046872; GO:0051028,,,,,cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; photoreceptor outer segment [GO:0001750]; metal ion binding [GO:0046872]; nuclear export signal receptor activity [GO:0005049]; RNA binding [GO:0003723]; mRNA transport [GO:0051028]; protein export from nucleus [GO:0006611]
Q5DRB6,CHOYP_PCDH1.2.3|m.8055,0,0,0,0,0,0,0,0,2.00E-94,Protocadherin gamma-A4 (PCDH-gamma-A4),PCDHGA4,931,cell adhesion [GO:0007155]; cell-cell signaling [GO:0007267]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nervous system development [GO:0007399],GO:0005509; GO:0005887; GO:0007155; GO:0007156; GO:0007267; GO:0007399,,,,PF00028;PF08266;PF16492;PF15974;,integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155]; cell-cell signaling [GO:0007267]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nervous system development [GO:0007399]
Q8VCX6,CHOYP_PNO1.2.3|m.47801,0,0,0,0,0,0,0,0,8.00E-74,Kaptin,Kptn,430,actin filament organization [GO:0007015],GO:0007015; GO:0015629; GO:0030426; GO:0032420; GO:0048471,,,,,actin cytoskeleton [GO:0015629]; growth cone [GO:0030426]; perinuclear region of cytoplasm [GO:0048471]; stereocilium [GO:0032420]; actin filament organization [GO:0007015]
E9Q612,CHOYP_PTPRK.6.20|m.6291,0,0,0,0,0,0,0,0,1.00E-59,Receptor-type tyrosine-protein phosphatase O (R-PTP-O) (EC 3.1.3.48) (Glomerular epithelial protein 1) (Protein tyrosine phosphatase U2) (PTP-U2) (PTPase U2),Ptpro GLEPP1 Ptpn15 PTPU2,1226,axon guidance [GO:0007411]; cell morphogenesis [GO:0000902]; glomerular visceral epithelial cell differentiation [GO:0072112]; glomerulus development [GO:0032835]; lamellipodium assembly [GO:0030032]; monocyte chemotaxis [GO:0002548]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of glomerular filtration [GO:0003105]; peptidyl-tyrosine dephosphorylation [GO:0035335]; regulation of glomerular filtration [GO:0003093]; slit diaphragm assembly [GO:0036060],GO:0000902; GO:0002548; GO:0003093; GO:0003105; GO:0004725; GO:0005886; GO:0007411; GO:0016021; GO:0016324; GO:0016328; GO:0017147; GO:0030032; GO:0032835; GO:0035335; GO:0036060; GO:0042803; GO:0043197; GO:0070062; GO:0072112; GO:0090090,,,cd00063;,PF00041;PF00102;,apical plasma membrane [GO:0016324]; dendritic spine [GO:0043197]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886]; protein homodimerization activity [GO:0042803]; protein tyrosine phosphatase activity [GO:0004725]; Wnt-protein binding [GO:0017147]; axon guidance [GO:0007411]; cell morphogenesis [GO:0000902]; glomerular visceral epithelial cell differentiation [GO:0072112]; glomerulus development [GO:0032835]; lamellipodium assembly [GO:0030032]; monocyte chemotaxis [GO:0002548]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of glomerular filtration [GO:0003105]; peptidyl-tyrosine dephosphorylation [GO:0035335]; regulation of glomerular filtration [GO:0003093]; slit diaphragm assembly [GO:0036060]
P36609,CHOYP_SMP_158990.1.1|m.28205,0.5,0,0,0,0,0,0,0,5.00E-79,Neuronal calcium sensor 2 (NCS-2),ncs-2 F10G8.5,190,,GO:0005509,,,cd00051;,PF00036;PF13499;,calcium ion binding [GO:0005509]
P62257,CHOYP_UBE2H.1.1|m.49863,0.5,0,0,0,0,0,0,0,2.00E-90,Ubiquitin-conjugating enzyme E2 H (EC 2.3.2.23) ((E3-independent) E2 ubiquitin-conjugating enzyme H) (EC 2.3.2.24) (E2 ubiquitin-conjugating enzyme H) (UBCH2) (Ubiquitin carrier protein H) (Ubiquitin-conjugating enzyme E2-20K) (Ubiquitin-protein ligase H),Ube2h,183,proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K11-linked ubiquitination [GO:0070979]; protein K48-linked ubiquitination [GO:0070936],GO:0004842; GO:0005524; GO:0005737; GO:0031625; GO:0043161; GO:0061630; GO:0061631; GO:0070936; GO:0070979,PATHWAY: Protein modification; protein ubiquitination. {ECO:0000255|PROSITE-ProRule:PRU00388}.,,,PF00179;,cytoplasm [GO:0005737]; ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K11-linked ubiquitination [GO:0070979]; protein K48-linked ubiquitination [GO:0070936]
A4IIK1,CHOYP_BRAFLDRAFT_65562.1.1|m.14267,0,0,0,0,0,0,0,0,2.00E-24,Malignant fibrous histiocytoma-amplified sequence 1 homolog,mfhas1,997,signal transduction [GO:0007165]; small GTPase mediated signal transduction [GO:0007264],GO:0005525; GO:0005622; GO:0007165; GO:0007264,,,,PF16095;PF13855;PF08477;,intracellular [GO:0005622]; GTP binding [GO:0005525]; signal transduction [GO:0007165]; small GTPase mediated signal transduction [GO:0007264]
Q7Z5J8,CHOYP_BRAFLDRAFT_75707.1.1|m.8533,0,0,0,0,0,0,0,0,0,Ankyrin and armadillo repeat-containing protein,ANKAR,1434,,GO:0005634; GO:0005737; GO:0016021,,,,PF12796;PF00514;,cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]
O22558,CHOYP_BRAFLDRAFT_81321.5.10|m.45062,2,0,0,0,0,0,0,0,1.00E-23,Serine/threonine-protein kinase STY8 (EC 2.7.11.1) (Serine/threonine/tyrosine-protein kinase 8),STY8 At2g17700,546,chloroplast organization [GO:0009658]; intracellular signal transduction [GO:0035556],GO:0004674; GO:0004712; GO:0004871; GO:0005524; GO:0005829; GO:0009658; GO:0016597; GO:0035556,,,,PF07714;,cytosol [GO:0005829]; amino acid binding [GO:0016597]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; signal transducer activity [GO:0004871]; chloroplast organization [GO:0009658]; intracellular signal transduction [GO:0035556]
P32577,CHOYP_BRAFLDRAFT_81321.6.10|m.48025,0,0,0,0,0,0,0,0,4.00E-22,Tyrosine-protein kinase CSK (EC 2.7.10.2) (C-Src kinase),Csk,450,adaptive immune response [GO:0002250]; adherens junction organization [GO:0034332]; brain development [GO:0007420]; cellular response to peptide hormone stimulus [GO:0071375]; innate immune response [GO:0045087]; negative regulation of bone resorption [GO:0045779]; negative regulation of cell proliferation [GO:0008285]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of Golgi to plasma membrane protein transport [GO:0042997]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of kinase activity [GO:0033673]; negative regulation of low-density lipoprotein particle clearance [GO:0010989]; negative regulation of phagocytosis [GO:0050765]; oligodendrocyte differentiation [GO:0048709]; peptidyl-tyrosine autophosphorylation [GO:0038083]; positive regulation of MAP kinase activity [GO:0043406]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of Fc receptor mediated stimulatory signaling pathway [GO:0060368]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],GO:0002250; GO:0004713; GO:0004715; GO:0005102; GO:0005524; GO:0005737; GO:0005911; GO:0006468; GO:0007169; GO:0007420; GO:0008285; GO:0010989; GO:0019903; GO:0031234; GO:0032715; GO:0033673; GO:0034332; GO:0038083; GO:0042997; GO:0043406; GO:0045087; GO:0045121; GO:0045779; GO:0046777; GO:0046872; GO:0048709; GO:0050765; GO:0060368; GO:0070062; GO:0070064; GO:0070373; GO:0071375,,,,PF07714;PF00017;PF00018;,cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; membrane raft [GO:0045121]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; proline-rich region binding [GO:0070064]; protein phosphatase binding [GO:0019903]; protein tyrosine kinase activity [GO:0004713]; receptor binding [GO:0005102]; adaptive immune response [GO:0002250]; adherens junction organization [GO:0034332]; brain development [GO:0007420]; cellular response to peptide hormone stimulus [GO:0071375]; innate immune response [GO:0045087]; negative regulation of bone resorption [GO:0045779]; negative regulation of cell proliferation [GO:0008285]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of Golgi to plasma membrane protein transport [GO:0042997]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of kinase activity [GO:0033673]; negative regulation of low-density lipoprotein particle clearance [GO:0010989]; negative regulation of phagocytosis [GO:0050765]; oligodendrocyte differentiation [GO:0048709]; peptidyl-tyrosine autophosphorylation [GO:0038083]; positive regulation of MAP kinase activity [GO:0043406]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of Fc receptor mediated stimulatory signaling pathway [GO:0060368]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]
P08053,CHOYP_CALM.32.50|m.48894,2,0,0,0,0,0,0,0,2.00E-34,Myosin regulatory light chain (Calcium-binding light chain),,147,,GO:0005509; GO:0016459,,,cd00051;,PF00036;PF13499;,myosin complex [GO:0016459]; calcium ion binding [GO:0005509]
Q3TT38,CHOYP_CF106.1.1|m.14354,0,0,0,0,0,0,0,0,1.00E-85,Uncharacterized protein C6orf106 homolog,D17Wsu92e,291,macroautophagy [GO:0016236],GO:0000407; GO:0005776; GO:0016236; GO:0043130,,,cd14947;,PF16158;,autophagosome [GO:0005776]; pre-autophagosomal structure [GO:0000407]; ubiquitin binding [GO:0043130]; macroautophagy [GO:0016236]
Q71B07,CHOYP_DPY19L3.1.1|m.7532,0,0,0,0,0,0,0,0,0,Probable C-mannosyltransferase DPY19L3 (EC 2.4.1.-) (Dpy-19-like protein 3) (Protein dpy-19 homolog 3),Dpy19l3,716,protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan [GO:0018406],GO:0000030; GO:0005637; GO:0016021; GO:0018406,,,,PF10034;,integral component of membrane [GO:0016021]; nuclear inner membrane [GO:0005637]; mannosyltransferase activity [GO:0000030]; protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan [GO:0018406]
Q9GV77,CHOYP_FREM2.1.1|m.31430,0,0,0,0,0,0,0,0,0,Extracellular matrix protein 3 (FREM2 homolog),ECM3,3103,cell communication [GO:0007154]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; multicellular organism development [GO:0007275],GO:0005509; GO:0005886; GO:0007154; GO:0007156; GO:0007275; GO:0016021,,,,PF03160;,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; cell communication [GO:0007154]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; multicellular organism development [GO:0007275]
Q502D1,CHOYP_GLOD5.1.1|m.25831,0.5,0,0,0,0,0,0,0,5.00E-60,Glyoxalase domain-containing protein 5,glod5 zgc:112315,163,,,,,,PF00903;,
Q6PCM2,CHOYP_INT6.1.1|m.13005,0,0,0,0,0,0,0,0,0,Integrator complex subunit 6 (Int6) (DBI-1) (Protein DDX26),Ints6 Dbi1 Ddx26,883,snRNA processing [GO:0016180],GO:0005654; GO:0015629; GO:0016180; GO:0032039,,,,PF15300;PF13519;,actin cytoskeleton [GO:0015629]; integrator complex [GO:0032039]; nucleoplasm [GO:0005654]; snRNA processing [GO:0016180]
Q9P0M2,CHOYP_LOC100176099.1.1|m.40368,1,0,0,0,0,0,0,0,1.00E-17,A-kinase anchor protein 7 isoform gamma (AKAP-7 isoform gamma) (A-kinase anchor protein 18 kDa) (AKAP 18) (Protein kinase A-anchoring protein 7 isoform gamma) (PRKA7 isoform gamma),AKAP7 AKAP18,348,protein localization [GO:0008104]; regulation of protein kinase A signaling [GO:0010738],GO:0000166; GO:0005634; GO:0005829; GO:0008104; GO:0010738; GO:0034237; GO:0051018,,,,PF10469;PF10470;,cytosol [GO:0005829]; nucleus [GO:0005634]; nucleotide binding [GO:0000166]; protein kinase A binding [GO:0051018]; protein kinase A regulatory subunit binding [GO:0034237]; protein localization [GO:0008104]; regulation of protein kinase A signaling [GO:0010738]
Q6P3V7,CHOYP_LOC100366770.1.1|m.55784,0.5,0,0,0,0,0,0,0,2.00E-106,Tetratricopeptide repeat protein 41 (TPR repeat protein 41) (Grp94-neighboring nucleotidase),Ttc41 Gnn,1309,,GO:0005737,,,,,cytoplasm [GO:0005737]
Q6PFY8,CHOYP_LOC100369333.14.32|m.32582,0,0,0,0,0,0,0,0,6.00E-15,Tripartite motif-containing protein 45,Trim45,580,bone development [GO:0060348],GO:0005654; GO:0005829; GO:0008270; GO:0045171; GO:0060348,,,,PF00630;PF00643;PF13445;,cytosol [GO:0005829]; intercellular bridge [GO:0045171]; nucleoplasm [GO:0005654]; zinc ion binding [GO:0008270]; bone development [GO:0060348]
Q3SZ21,CHOYP_LOC100370537.1.1|m.10589,0,0,0,0,0,0,0,0,3.00E-43,Ribonuclease P protein subunit p30 (RNaseP protein p30) (EC 3.1.26.5) (RNase P subunit 2),RPP30 RNASEP2,268,"RNA phosphodiester bond hydrolysis, endonucleolytic [GO:0090502]; tRNA processing [GO:0008033]",GO:0003723; GO:0004526; GO:0005655; GO:0008033; GO:0090502,,,,PF01876;,"nucleolar ribonuclease P complex [GO:0005655]; ribonuclease P activity [GO:0004526]; RNA binding [GO:0003723]; RNA phosphodiester bond hydrolysis, endonucleolytic [GO:0090502]; tRNA processing [GO:0008033]"
Q9VY28,CHOYP_LOC100375481.1.1|m.4496,0,0,0,0,0,0,0,0,5.00E-33,"Probable 28S ribosomal protein S25, mitochondrial (MRP-S25) (S25mt)",mRpS25 CG14413,167,mitochondrial translation [GO:0032543]; translation [GO:0006412],GO:0003735; GO:0005763; GO:0006412; GO:0032543,,,,PF05047;,mitochondrial small ribosomal subunit [GO:0005763]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]; translation [GO:0006412]
Q4V8C9,CHOYP_LOC100378322.1.1|m.16268,0,0,0,0,0,0,0,0,4.00E-59,Leucine-rich repeat-containing protein 56,Lrrc56,548,,,,,,PF12799;,
A6BM72,CHOYP_LOC100555755.1.1|m.58711,0,0,0,0,0,0,0,0,3.00E-51,Multiple epidermal growth factor-like domains protein 11 (Multiple EGF-like domains protein 11),MEGF11 KIAA1781 UNQ1949/PRO4432,1044,homotypic cell-cell adhesion [GO:0034109]; retina layer formation [GO:0010842],GO:0010842; GO:0016021; GO:0016323; GO:0034109,,,,PF12661;PF00053;,basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; homotypic cell-cell adhesion [GO:0034109]; retina layer formation [GO:0010842]
Q9UGM3,CHOYP_LOC100636340.4.4|m.50991,0,0,0,0,0,0,0,0,0,Deleted in malignant brain tumors 1 protein (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein),DMBT1 GP340,2413,cellular protein metabolic process [GO:0044267]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; multicellular organism development [GO:0007275]; protein transport [GO:0015031]; viral process [GO:0016032],GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0007275; GO:0008329; GO:0015031; GO:0016032; GO:0019898; GO:0030670; GO:0030855; GO:0035375; GO:0042589; GO:0043152; GO:0044267; GO:0045087; GO:0048306; GO:0051607; GO:0070062,,,cd00041;,PF00431;PF00530;PF00100;,cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extrinsic component of membrane [GO:0019898]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589]; calcium-dependent protein binding [GO:0048306]; scavenger receptor activity [GO:0005044]; signaling pattern recognition receptor activity [GO:0008329]; zymogen binding [GO:0035375]; cellular protein metabolic process [GO:0044267]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; multicellular organism development [GO:0007275]; protein transport [GO:0015031]; viral process [GO:0016032]
Q2M385,CHOYP_LOC100721584.1.1|m.52602,0,0,0,0,0,0,0,0,2.00E-149,Macrophage-expressed gene 1 protein (Macrophage gene 1 protein) (Mpg-1),MPEG1,716,,GO:0016021,,,,PF01823;,integral component of membrane [GO:0016021]
Q148G5,CHOYP_LOC101078914.1.1|m.34199,0.5,0,0,0,0,0,0,0,0,"Proline dehydrogenase 1, mitochondrial (EC 1.5.5.2) (Proline oxidase)",PRODH,593,proline catabolic process to glutamate [GO:0010133],GO:0004657; GO:0005739; GO:0005759; GO:0010133; GO:0071949,PATHWAY: Amino-acid degradation; L-proline degradation into L-glutamate; L-glutamate from L-proline: step 1/2. {ECO:0000250|UniProtKB:O43272}.,,,PF01619;,mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; FAD binding [GO:0071949]; proline dehydrogenase activity [GO:0004657]; proline catabolic process to glutamate [GO:0010133]
Q62805,CHOYP_LOC567820.1.1|m.51203,0,0,0,0,0,0,0,0,0.0000003,Galanin receptor type 1 (GAL1-R) (GALR-1),Galr1 Galnr Galnr1,346,adenylate cyclase-activating G-protein coupled receptor signaling pathway [GO:0007189]; G-protein coupled receptor signaling pathway [GO:0007186]; negative regulation of adenylate cyclase activity [GO:0007194]; positive regulation of cortisol secretion [GO:0051464]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944],GO:0004966; GO:0005886; GO:0005887; GO:0007186; GO:0007189; GO:0007194; GO:0007204; GO:0016021; GO:0017046; GO:0042923; GO:0045944; GO:0051464,,,,PF00001;,integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; galanin receptor activity [GO:0004966]; neuropeptide binding [GO:0042923]; peptide hormone binding [GO:0017046]; adenylate cyclase-activating G-protein coupled receptor signaling pathway [GO:0007189]; G-protein coupled receptor signaling pathway [GO:0007186]; negative regulation of adenylate cyclase activity [GO:0007194]; positive regulation of cortisol secretion [GO:0051464]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]
O43822,CHOYP_LOC576797.1.1|m.8986,0.5,0,0,0,0,0,0,0,3.00E-50,Protein C21orf2 (C21orf-HUMF09G8.5) (Leucine-rich repeat-containing protein 76) (YF5/A2),C21orf2 LRRC76,256,cilium assembly [GO:0060271]; cytoskeleton organization [GO:0007010]; regulation of cell shape [GO:0008360]; smoothened signaling pathway [GO:0007224],GO:0005737; GO:0005739; GO:0005886; GO:0007010; GO:0007224; GO:0008360; GO:0032391; GO:0036064; GO:0060271,,,,,ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; photoreceptor connecting cilium [GO:0032391]; plasma membrane [GO:0005886]; cilium assembly [GO:0060271]; cytoskeleton organization [GO:0007010]; regulation of cell shape [GO:0008360]; smoothened signaling pathway [GO:0007224]
Q8WV99,CHOYP_LOC588827.1.1|m.11601,0,0,0,0,0,0,0,0,3.00E-83,AN1-type zinc finger protein 2B (Arsenite-inducible RNA-associated protein-like protein) (AIRAP-like protein),ZFAND2B AIRAPL,257,"SRP-dependent cotranslational protein targeting to membrane, translocation [GO:0006616]",GO:0005783; GO:0006616; GO:0008270,,,,PF01428;,"endoplasmic reticulum [GO:0005783]; zinc ion binding [GO:0008270]; SRP-dependent cotranslational protein targeting to membrane, translocation [GO:0006616]"
Q6PFY8,CHOYP_LOC591441.1.1|m.19965,0,0,0,0,0,0,0,0,3.00E-13,Tripartite motif-containing protein 45,Trim45,580,bone development [GO:0060348],GO:0005654; GO:0005829; GO:0008270; GO:0045171; GO:0060348,,,,PF00630;PF00643;PF13445;,cytosol [GO:0005829]; intercellular bridge [GO:0045171]; nucleoplasm [GO:0005654]; zinc ion binding [GO:0008270]; bone development [GO:0060348]
Q9P0M2,CHOYP_LOC754150.1.1|m.29730,0.5,0,0,0,0,0,0,0,2.00E-19,A-kinase anchor protein 7 isoform gamma (AKAP-7 isoform gamma) (A-kinase anchor protein 18 kDa) (AKAP 18) (Protein kinase A-anchoring protein 7 isoform gamma) (PRKA7 isoform gamma),AKAP7 AKAP18,348,protein localization [GO:0008104]; regulation of protein kinase A signaling [GO:0010738],GO:0000166; GO:0005634; GO:0005829; GO:0008104; GO:0010738; GO:0034237; GO:0051018,,,,PF10469;PF10470;,cytosol [GO:0005829]; nucleus [GO:0005634]; nucleotide binding [GO:0000166]; protein kinase A binding [GO:0051018]; protein kinase A regulatory subunit binding [GO:0034237]; protein localization [GO:0008104]; regulation of protein kinase A signaling [GO:0010738]
A6BM72,CHOYP_MEG10.11.91|m.21604,0,0,0,0,0,0,0,0,3.00E-27,Multiple epidermal growth factor-like domains protein 11 (Multiple EGF-like domains protein 11),MEGF11 KIAA1781 UNQ1949/PRO4432,1044,homotypic cell-cell adhesion [GO:0034109]; retina layer formation [GO:0010842],GO:0010842; GO:0016021; GO:0016323; GO:0034109,,,,PF12661;PF00053;,basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; homotypic cell-cell adhesion [GO:0034109]; retina layer formation [GO:0010842]
Q6DJF8,CHOYP_MET23.1.1|m.14359,0,0,0,0,0,0,0,0,2.00E-84,Methyltransferase-like protein 23 (EC 2.1.1.-),mettl23,234,,GO:0005737; GO:0008168; GO:0016021,,,,PF10294;,cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; methyltransferase activity [GO:0008168]
Q54F07,CHOYP_METK1.1.2|m.59870,0,0,0,0,0,0,0,0,8.00E-170,S-adenosylmethionine synthase (AdoMet synthase) (EC 2.5.1.6) (Methionine adenosyltransferase) (MAT),metK DDB_G0291179,384,methionine metabolic process [GO:0006555]; one-carbon metabolic process [GO:0006730]; S-adenosylmethionine biosynthetic process [GO:0006556],GO:0004478; GO:0005524; GO:0005829; GO:0006555; GO:0006556; GO:0006730; GO:0045335; GO:0046872; GO:0048269,PATHWAY: Amino-acid biosynthesis; S-adenosyl-L-methionine biosynthesis; S-adenosyl-L-methionine from L-methionine: step 1/1. {ECO:0000250|UniProtKB:Q00266}.,,,PF02773;PF02772;PF00438;,cytosol [GO:0005829]; methionine adenosyltransferase complex [GO:0048269]; phagocytic vesicle [GO:0045335]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; methionine adenosyltransferase activity [GO:0004478]; methionine metabolic process [GO:0006555]; one-carbon metabolic process [GO:0006730]; S-adenosylmethionine biosynthetic process [GO:0006556]
Q99836,CHOYP_MYD88.5.7|m.41603,0,0,0,0,0,0,0,0,7.00E-68,Myeloid differentiation primary response protein MyD88,MYD88,296,3'-UTR-mediated mRNA stabilization [GO:0070935]; apoptotic process [GO:0006915]; cell surface receptor signaling pathway [GO:0007166]; cellular response to mechanical stimulus [GO:0071260]; defense response to Gram-positive bacterium [GO:0050830]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; negative regulation of apoptotic process [GO:0043066]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of interleukin-23 production [GO:0032747]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of type I interferon production [GO:0032481]; regulation of inflammatory response [GO:0050727]; response to interleukin-1 [GO:0070555]; signal transduction [GO:0007165]; toll-like receptor 9 signaling pathway [GO:0034162]; toll-like receptor signaling pathway [GO:0002224],GO:0002224; GO:0002755; GO:0005123; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006915; GO:0006954; GO:0007165; GO:0007166; GO:0010008; GO:0032481; GO:0032740; GO:0032747; GO:0032755; GO:0034162; GO:0042802; GO:0043066; GO:0043123; GO:0043621; GO:0045087; GO:0050727; GO:0050830; GO:0051092; GO:0070555; GO:0070935; GO:0070976; GO:0071260,,,cd08312;,PF00531;PF01582;,cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; death receptor binding [GO:0005123]; identical protein binding [GO:0042802]; protein self-association [GO:0043621]; TIR domain binding [GO:0070976]; 3'-UTR-mediated mRNA stabilization [GO:0070935]; apoptotic process [GO:0006915]; cell surface receptor signaling pathway [GO:0007166]; cellular response to mechanical stimulus [GO:0071260]; defense response to Gram-positive bacterium [GO:0050830]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; negative regulation of apoptotic process [GO:0043066]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of interleukin-23 production [GO:0032747]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of type I interferon production [GO:0032481]; regulation of inflammatory response [GO:0050727]; response to interleukin-1 [GO:0070555]; signal transduction [GO:0007165]; toll-like receptor 9 signaling pathway [GO:0034162]; toll-like receptor signaling pathway [GO:0002224]
Q06725,CHOYP_N2F1A.1.1|m.63063,0,0,0,0,0,0,0,0,0,Nuclear receptor subfamily 2 group F member 1-A (COUP transcription factor 1-A) (COUP-TFalpha-A) (zCOUP-TFI) (Seven-up related 44) (Svp[44]) (zSvp[44]) (Steroid receptor homolog SVP 44),nr2f1a nr2f1 svp44 si:dkeyp-10a3.1,411,"endothelial cell proliferation [GO:0001935]; transcription, DNA-templated [GO:0006351]; vasculature development [GO:0001944]",GO:0001935; GO:0001944; GO:0003707; GO:0004879; GO:0005634; GO:0006351; GO:0008270; GO:0043565,,,,PF00104;PF00105;,"nucleus [GO:0005634]; RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding [GO:0004879]; sequence-specific DNA binding [GO:0043565]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]; endothelial cell proliferation [GO:0001935]; transcription, DNA-templated [GO:0006351]; vasculature development [GO:0001944]"
O34383,CHOYP_SC6A5.5.7|m.49357,0,0,0,0,0,0,0,0,3.00E-13,Uncharacterized sodium-dependent transporter YocR,yocR BSU19340,445,,GO:0005328; GO:0005886; GO:0016021,,,,PF00209;,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; neurotransmitter:sodium symporter activity [GO:0005328]
Q05B65,CHOYP_SRFB1.1.2|m.18320,0,0,0,0,0,0,0,0,1.00E-19,Serum response factor-binding protein 1 (SRF-dependent transcription regulation-associated protein),SRFBP1,428,"maturation of SSU-rRNA [GO:0030490]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]",GO:0005634; GO:0006351; GO:0006355; GO:0030490; GO:0030686; GO:0048471,,,,PF09073;,"90S preribosome [GO:0030686]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; maturation of SSU-rRNA [GO:0030490]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]"
Q5M823,CHOYP_TAD2A.1.1|m.27478,0,0,0,0,0,0,0,0,7.00E-58,NudC domain-containing protein 2,Nudcd2,157,developmental process [GO:0032502]; protein folding [GO:0006457],GO:0000777; GO:0000922; GO:0005737; GO:0005815; GO:0005829; GO:0006457; GO:0032502; GO:0051082; GO:0070062,,,,PF04969;,condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; microtubule organizing center [GO:0005815]; spindle pole [GO:0000922]; unfolded protein binding [GO:0051082]; developmental process [GO:0032502]; protein folding [GO:0006457]
Q6P7B7,CHOYP_ZFY27.1.1|m.31417,0,0,0,0,0,0,0,0,5.00E-25,Protrudin (Zinc finger FYVE domain-containing protein 27),Zfyve27,404,endoplasmic reticulum tubular network formation [GO:0071787]; neuron projection development [GO:0031175]; neurotrophin TRK receptor signaling pathway [GO:0048011]; positive regulation of axon extension [GO:0045773]; protein localization to plasma membrane [GO:0072659]; vesicle-mediated transport [GO:0016192],GO:0005783; GO:0016021; GO:0016192; GO:0030176; GO:0030424; GO:0030425; GO:0031175; GO:0032584; GO:0043621; GO:0045773; GO:0046872; GO:0048011; GO:0055038; GO:0071782; GO:0071787; GO:0072659,,,,PF01363;,axon [GO:0030424]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum tubular network [GO:0071782]; growth cone membrane [GO:0032584]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; recycling endosome membrane [GO:0055038]; metal ion binding [GO:0046872]; protein self-association [GO:0043621]; endoplasmic reticulum tubular network formation [GO:0071787]; neuron projection development [GO:0031175]; neurotrophin TRK receptor signaling pathway [GO:0048011]; positive regulation of axon extension [GO:0045773]; protein localization to plasma membrane [GO:0072659]; vesicle-mediated transport [GO:0016192]
Q6H236,CHOYP_contig_050507|m.60115,0,0,0,0,0,0,0,0,5.00E-16,Paternally-expressed gene 3 protein,PEG3,2387,"apoptotic process [GO:0006915]; transcription, DNA-templated [GO:0006351]",GO:0000981; GO:0003676; GO:0005634; GO:0005737; GO:0006351; GO:0006915; GO:0046872,,,,PF02023;PF00096;PF13912;,"cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; RNA polymerase II transcription factor activity, sequence-specific DNA binding [GO:0000981]; apoptotic process [GO:0006915]; transcription, DNA-templated [GO:0006351]"
None,CHOYP_contig_048148|m.56980,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_050355|m.59899,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_020442|m.23651,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100175021.11.11|m.63958,3.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_047908|m.56622,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100502592.1.1|m.27996,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100497926.1.2|m.30153,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100367405.1.2|m.10570,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_024730|m.28114,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC589390.1.1|m.11589,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_032690|m.37333,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_IWS1.1.1|m.13973,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_007858|m.9121,1.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100123521.1.2|m.20656,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_052729|m.63227,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_TMEM16.2.2|m.41752,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_BRAFLDRAFT_65711.1.1|m.18159,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_PTPRQ.6.8|m.45809,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_005830|m.6680,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_PROF.2.2|m.41295,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100374741.54.83|m.47294,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_047916|m.56635,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_BRAFLDRAFT_74513.1.2|m.2725,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_NEMVEDRAFT_V1G203842.1.1|m.60815,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC587740.1.4|m.22830,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_010861|m.12544,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_MUC5B.1.1|m.15734,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100353582.2.2|m.63483,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_018098|m.21196,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_TVAG_268110.13.13|m.65590,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_RS3A.12.15|m.49134,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_046854|m.55054,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_BRAFLDRAFT_128887.2.2|m.46965,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_043301|m.50018,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_024156|m.27442,1,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_BRAFLDRAFT_76943.1.1|m.58001,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_BRAFLDRAFT_114866.4.5|m.35626,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_ADAR.2.3|m.45677,5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_BRAFLDRAFT_120041.1.1|m.6386,1.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_BRAFLDRAFT_90196.2.2|m.42787,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_003275|m.3667,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_NEMVEDRAFT_V1G164392.3.3|m.59979,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC594151.1.2|m.7270,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_021632|m.24849,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_026389|m.30064,2.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_012962|m.14885,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC764949.1.1|m.44351,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_012849|m.14773,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_003695|m.4176,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,LYSC_HUMAN,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_039097|m.44266,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_GEMIN4.1.1|m.16714,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_ACE.4.4|m.17563,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100697793.5.6|m.62286,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_BRAFLDRAFT_87634.1.1|m.39992,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_024218|m.27505,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_031272|m.35693,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_031279|m.35700,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100186936.1.2|m.12235,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC584416.1.1|m.34286,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100637925.3.4|m.48236,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100375342.3.3|m.40363,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100533388.4.6|m.45039,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_DOCK3.1.2|m.49353,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,K1M1_SHEEP,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_MEG10.61.91|m.50119,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_047333|m.55799,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_GLNA.1.5|m.1591,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100376265.4.4|m.28000,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_TRIADDRAFT_62546.2.2|m.56798,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_SCP.6.12|m.50694,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_BDHB.1.1|m.9128,1,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_FUT2.4.5|m.54048,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_049099|m.58219,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_ZNF510.1.1|m.10853,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100533315.1.3|m.40003,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,KRUC_SHEEP,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_TVAG_087500.4.4|m.60594,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC575793.1.2|m.34691,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_PFB0115W.2.2|m.65461,1,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_PY03350.1.1|m.8097,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_TIF1A.4.8|m.23900,1.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_046530|m.54559,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_TRI45.18.23|m.48495,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_019914|m.23170,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_025014|m.28472,1,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_NEMVEDRAFT_V1G69851.3.4|m.5191,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_DYAK_GE25484.1.1|m.6273,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_025210|m.28720,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_MEG10.22.91|m.28727,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_BRAFLDRAFT_237339.1.1|m.15256,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_BRAFLDRAFT_120990.1.18|m.2376,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_BRAFLDRAFT_89105.1.1|m.2234,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_TVAG_410100.4.6|m.41037,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_052570|m.63028,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_053133|m.63737,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_044225|m.51129,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_NAEGRDRAFT_49892.1.1|m.10608,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_BRAFLDRAFT_99539.1.1|m.55866,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_038058|m.42964,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_018118|m.21239,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_004652|m.5338,1.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_041073|m.46786,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_034686|m.39375,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_036974|m.41637,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100692795.2.2|m.50682,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_031433|m.35919,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_048267|m.57131,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_IMG5_163910.1.1|m.46747,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_024342|m.27673,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_044629|m.51700,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_007032|m.8066,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_BRAFLDRAFT_91321.5.10|m.37054,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_DPSE_GA28568.7.9|m.48623,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_AAEL_AAEL013229.2.2|m.57593,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_053995|m.64585,1,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_022826|m.26063,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100369686.2.2|m.30008,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_029139|m.33073,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_030819|m.35130,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_NEMVEDRAFT_V1G206150.1.1|m.39762,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC373275.7.7|m.63851,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_MEGF6A.1.2|m.17795,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC578656.9.15|m.53454,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100368521.3.3|m.41435,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_046883|m.55107,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_047498|m.56019,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_015931|m.18654,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_000189|m.198,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100368219.4.5|m.58416,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_MEG10.50.91|m.46730,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100617548.1.1|m.64248,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_021736|m.24962,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_045427|m.52825,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_051254|m.61184,5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100378116.3.3|m.60538,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_EF1B.3.7|m.35082,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_042244|m.48592,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_030528|m.34754,1.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_036657|m.41264,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_026140|m.29796,1,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOAG_00625.1.1|m.34418,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_008114|m.9394,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100488715.1.1|m.61241,1,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_004193|m.4802,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_BRAFLDRAFT_235412.1.2|m.52493,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_PHUM_PHUM377430.1.2|m.29459,1,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_000003|m.1,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_INT2.1.1|m.52909,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_050773|m.60479,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_ASPM.1.4|m.6650,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_RS3A.11.15|m.43498,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100708650.1.3|m.10354,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_ODPX.1.1|m.29098,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_KCP.10.13|m.44423,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_015439|m.17989,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_012437|m.14312,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_006293|m.7131,1.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_034390|m.39050,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100374116.1.1|m.37009,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_041336|m.47149,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_042864|m.49442,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_050158|m.59641,1,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100375194.5.7|m.46447,1,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_043041|m.49677,2,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_043212|m.49892,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_034695|m.39383,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_BRAFLDRAFT_117849.2.3|m.4489,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_BRAFLDRAFT_161161.1.1|m.39447,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100370236.1.3|m.7766,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_DMOJ_GI17052.1.1|m.4566,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LCAZH_2403.1.1|m.47655,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,LYSC_CHICK,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_BRAFLDRAFT_282752.2.2|m.17526,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_002305|m.2519,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_010233|m.11921,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC101058182.1.1|m.57909,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC101165968.6.7|m.55758,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_005913|m.6764,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_TSP_10783.1.2|m.5651,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_019189|m.22478,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_EF-1A.2.9|m.10123,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_IMG5_109580.1.1|m.27791,7,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_DFA_00978.1.1|m.17875,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100904558.2.2|m.26621,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_025411|m.28960,1.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_SQPA.2.2|m.61080,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_INF2.3.5|m.13728,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_050842|m.60581,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_024372|m.27722,2,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100374741.65.83|m.53330,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_008016|m.9273,1,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_005908|m.6759,1,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100370844.1.2|m.30341,1,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_042616|m.49103,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_ISCW_ISCW019177.4.4|m.63940,1,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_041025|m.46710,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_023259|m.26467,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_PTPRA.9.22|m.46547,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_DMOJ_GI19977.1.1|m.66449,1.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_BRAFLDRAFT_87336.4.9|m.23926,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100543236.1.2|m.20322,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_012819|m.14744,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100370504.1.2|m.17506,7.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CAS1_BOVIN,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_KARG.8.11|m.45498,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100496973.2.8|m.19997,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_041706|m.47739,1,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_042130|m.48414,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_NRX3A.1.1|m.1705,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_024665|m.28048,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_039068|m.44246,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_054868|m.65463,1,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC753176.2.3|m.33553,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_051311|m.61287,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_AAEL_AAEL002467.1.2|m.47358,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_PMAR_PMAR009545.1.1|m.28734,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_MPPA.2.2|m.18273,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_CALMB.1.1|m.41570,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_009697|m.11280,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_NEMVEDRAFT_V1G224392.2.3|m.36325,1,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_BRAFLDRAFT_87294.6.6|m.64622,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_NEMVEDRAFT_V1G233709.6.13|m.49823,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_028488|m.32431,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_050044|m.59512,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_047294|m.55755,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC576665.1.2|m.10868,1,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_KPYK.4.4|m.48513,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_042295|m.48677,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_025272|m.28780,1,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_028737|m.32661,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_BRAFLDRAFT_91321.1.10|m.20278,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_AGAP_AGAP010186.1.1|m.62505,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_036103|m.40829,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_RS3A.15.15|m.63175,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_BRAFLDRAFT_64071.9.35|m.13313,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100366763.1.1|m.53709,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_DMOJ_GI12939.2.3|m.20888,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100372197.3.3|m.56377,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_GSPATT00009499001.1.1|m.34366,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_TBB2.2.2|m.53003,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_EGFR.2.3|m.61781,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LACBIDRAFT_295117.3.10|m.29879,1,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_RSSA.3.10|m.22114,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_050253|m.59761,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100639574.1.1|m.40201,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_MYSTI_04398.1.1|m.27734,3,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_051433|m.61487,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_TRIM2.13.59|m.25214,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_004756|m.5453,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_BRAFLDRAFT_117849.3.3|m.5503,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_050222|m.59713,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_BRAFLDRAFT_118619.2.2|m.4663,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_BRAFLDRAFT_95739.2.2|m.57592,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_WHITE.1.1|m.38819,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_020370|m.23576,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_BRAFLDRAFT_282065.1.2|m.590,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_021664|m.24884,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_CHCHD1.1.1|m.25210,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_KLLA0E01035G.1.1|m.13451,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_051534|m.61634,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100374839.1.1|m.63735,1,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_003213|m.3589,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100120260.1.1|m.41887,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_EIN_155680.6.6|m.56323,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_048122|m.56947,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LR16A.3.3|m.59539,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_RS27L.3.4|m.33064,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_RL23A.6.6|m.63333,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_DYAK_GE21870.1.1|m.28467,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_RS2.7.10|m.39920,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_TRIB2.1.1|m.226,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_043053|m.49693,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_048781|m.57879,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_046551|m.54588,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_005138|m.5873,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_BRAFLDRAFT_119491.1.1|m.58761,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_005134|m.5869,1,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC662241.1.1|m.66905,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_039465|m.44679,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_PCYB_062570.1.1|m.58917,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100373892.1.2|m.44404,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_001740|m.1863,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_015023|m.17360,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_TRIM3.37.58|m.39048,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100175021.7.11|m.58378,2,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_BRAFLDRAFT_87283.1.1|m.46768,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_NEMVEDRAFT_V1G221688.1.1|m.52819,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100907797.3.4|m.54168,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_PLXA3.1.1|m.51322,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100377311.6.14|m.34688,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_023675|m.26925,2.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_037561|m.42354,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_CASP7.8.23|m.23670,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_025862|m.29523,1.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_025058|m.28495,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_CLCN7.2.3|m.47039,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_F48E3.8.1.1|m.46349,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_TRIADDRAFT_55768.1.2|m.4473,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100377755.1.1|m.1006,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100378999.1.1|m.36850,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_055303|m.65981,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_002597|m.2856,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_RS3A.8.15|m.27209,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_BRAFLDRAFT_67741.2.2|m.37743,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_CASP7.21.23|m.63852,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_NEMVEDRAFT_V1G201445.4.5|m.54666,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_BRAFLDRAFT_85994.7.10|m.36866,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100898095.9.19|m.32685,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC101077787.2.3|m.65668,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100369333.22.32|m.39414,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_BRAFLDRAFT_70742.1.1|m.8525,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_FMRF.2.4|m.37051,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_NEMVEDRAFT_V1G198667.12.15|m.51327,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100367232.4.5|m.45036,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_BRAFLDRAFT_129914.1.3|m.8213,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_CASP10.4.7|m.45631,1,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_BRAFLDRAFT_206799.1.23|m.3242,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_037938|m.42800,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100202812.1.1|m.31203,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_TVAG_286470.1.2|m.41541,1,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_031271|m.35690,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_BRAFLDRAFT_117187.2.4|m.3553,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_042249|m.48611,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_028013|m.31792,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_CDC42.11.11|m.60002,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_039100|m.44268,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_050863|m.60613,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100865129.1.1|m.45329,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_031486|m.35972,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_BRAFLDRAFT_93247.1.1|m.7558,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_BRAFLDRAFT_234854.2.2|m.58013,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_GIMA4.4.7|m.42250,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100371228.1.4|m.6670,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_ZGC_113208.1.1|m.15618,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_TVAG_008910.2.4|m.37672,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100374741.27.83|m.24541,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_SI_CH211-197G15.7.1.3|m.4409,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_026676|m.30376,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100168620.4.4|m.40081,4,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_041380|m.47215,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_TVAG_355490.1.22|m.8202,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_TBA.3.6|m.29937,1,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_021494|m.24691,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_WKK_06610.2.2|m.50131,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_049367|m.58596,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_TIMP2B.1.1|m.29629,4,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC578897.1.1|m.11932,1,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100374819.2.7|m.48237,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_025311|m.28826,3,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_010659|m.12347,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_032666|m.37309,1,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_043576|m.50359,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_035123|m.39896,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_053627|m.64220,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_CASP7.16.23|m.50828,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100376426.1.3|m.28097,6.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_SCP.5.12|m.49390,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_NEMVEDRAFT_V1G214844.9.34|m.28637,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_TB11.01.6740.1.1|m.42560,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_022641|m.25871,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100633059.1.1|m.20098,1,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC756958.1.2|m.17672,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_005454|m.6186,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_039943|m.45170,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_038408|m.43447,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_EEF2.1.2|m.44023,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_055842|m.66464,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_EF1A2.2.3|m.37043,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_051346|m.61337,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_023172|m.26349,3,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_TMEL_0889.1.2|m.168,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_C1QT3.4.8|m.22821,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_ZN521.2.3|m.13584,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_026871|m.30597,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_MEG10.19.91|m.24289,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_008923|m.10388,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100213495.2.2|m.51531,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_038946|m.44119,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_S28A3.2.3|m.7477,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_025861|m.29521,2.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_023043|m.26235,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_051715|m.61878,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_044612|m.51675,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_CASP7.2.23|m.5415,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_TVAG_417100.1.2|m.19129,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_TENA.5.5|m.43448,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100367089.2.4|m.1910,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_026679|m.30379,1,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100555223.1.1|m.47612,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100329955.1.1|m.11340,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100374974.15.16|m.58657,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_050710|m.60376,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_033090|m.37804,1,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_027703|m.31406,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_NEMVEDRAFT_V1G241446.1.2|m.22601,1,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_BRAFLDRAFT_67264.4.6|m.42082,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_041068|m.46778,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_026106|m.29754,8.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100635182.1.1|m.5368,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_047394|m.55871,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_014279|m.16311,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_043845|m.50665,4.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_BRAFLDRAFT_90706.2.2|m.29119,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_035889|m.40603,2.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_040503|m.45959,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_002467|m.2727,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_DERE_GG18317.1.1|m.44730,1.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_039208|m.44410,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_VOLCADRAFT_88866.1.1|m.15255,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_055359|m.66029,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_BRAFLDRAFT_85511.15.23|m.46769,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100491753.1.3|m.45589,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,TRFL_HUMAN,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_024935|m.28365,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_038126|m.43051,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100373444.7.79|m.3209,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100186276.4.5|m.12980,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_033663|m.38288,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100371059.1.1|m.25395,1.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_BRAFLDRAFT_84494.3.5|m.41159,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_NEFH.1.2|m.59956,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_044310|m.51269,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_KARG.9.11|m.50527,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_038062|m.42970,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_013437|m.15402,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_048603|m.57625,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_014867|m.17143,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_014863|m.17135,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_052658|m.63135,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_TDRD3.2.2|m.8522,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_037727|m.42549,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_038765|m.43871,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_004202|m.4814,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_042378|m.48796,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_002707|m.2981,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_021455|m.24647,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100376214.9.11|m.53354,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_026910|m.30632,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_026398|m.30077,3,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_054223|m.64734,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_030744|m.35041,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_TRIM5.1.2|m.60878,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_040978|m.46621,5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_BRAFLDRAFT_276226.1.2|m.21725,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100690874.1.2|m.62880,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100906268.2.2|m.44952,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_MEGF6.1.59|m.1169,1,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_PHUM_PHUM049590.1.4|m.14204,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_028566|m.32498,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_048626|m.57669,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_038766|m.43872,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_003595|m.4058,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_CED1.9.29|m.29470,4,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_DPER_GL24378.1.1|m.64285,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_027327|m.31055,2,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_OSHV1_GP010.1.2|m.28853,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_025865|m.29527,4,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100377244.1.2|m.31458,1.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_005659|m.6448,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_BRAFLDRAFT_126750.1.1|m.40768,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_TSP_09282.1.1|m.18814,1,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_009887|m.11524,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_040238|m.45604,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100373888.8.9|m.60548,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_015918|m.18639,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_PY04960.1.1|m.26352,1,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_011170|m.12887,1,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_PITG_07096.1.1|m.4922,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_BRAFLDRAFT_117282.2.6|m.13259,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_016010|m.18750,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_053989|m.64582,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_BRAFLDRAFT_118054.1.1|m.18488,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_TRIADDRAFT_32712.2.4|m.28430,2,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_043874|m.50696,4.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_BRAFLDRAFT_129063.1.1|m.15419,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_042449|m.48875,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_040481|m.45927,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_CHS2.1.1|m.63783,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_050483|m.60085,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_YL086.1.1|m.33481,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_TVAG_328180.1.1|m.55509,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_MEG11.8.25|m.39826,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_031003|m.35364,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100485356.1.1|m.21339,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_025192|m.28699,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_EIN_155680.4.6|m.52358,1.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_042540|m.49007,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_044678|m.51771,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_039741|m.44927,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_VWDE.5.13|m.28163,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_003840|m.4375,3,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_INVS.2.6|m.8331,2,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_BRAFLDRAFT_122381.3.4|m.23140,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_RHDF1.2.3|m.45435,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_ACT.13.27|m.39351,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_RAC1.2.3|m.23406,1,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC101067075.1.2|m.30552,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_BRAFLDRAFT_125516.1.1|m.13150,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_004461|m.5117,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_RED1.1.2|m.60684,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_000121|m.127,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_023655|m.26913,13,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100891466.2.10|m.9752,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_CGL.1.2|m.31959,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_BRAFLDRAFT_99603.1.1|m.4456,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_2AAA.1.1|m.13307,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_CAD89.1.1|m.14552,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_HBX5.1.1|m.11081,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100892516.1.1|m.38152,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_CBG20816.1.1|m.49333,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_AAEL_AAEL008069.2.2|m.60921,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC101158638.1.2|m.5931,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_ACA1_394750.1.2|m.54181,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_041218|m.46991,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_TACC3.3.3|m.16099,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_040513|m.45971,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100377934.1.1|m.48699,2.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_BRAFLDRAFT_282105.2.2|m.59782,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_031630|m.36105,1,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_RS3A.1.15|m.2270,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_047907|m.56621,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100934353.1.1|m.11772,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_MEGF6.35.59|m.42904,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_RN213.7.13|m.45976,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_LOC100533220.2.2|m.13990,0.5,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_007754|m.8963,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_MYD88.4.7|m.31202,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
None,CHOYP_contig_039638|m.44850,0,0,0,0,0,0,0,0,None,None,None,None,None,None,None,None,None,None,None
